id,source,query
CG100_Alcohol-use disorders: diagnosis and management of physical complications & Overview,CG100,What are the recommended management strategies for physical complications of alcohol-use disorders?
CG100_Recommendations: 1.1 Acute alcohol withdrawal - Part 1,CG100,What are the criteria for hospital admission during acute alcohol withdrawal?
CG100_Recommendations: 1.1 Acute alcohol withdrawal - Part 2,CG100,What are the recommended pharmacological treatments for acute alcohol withdrawal?
CG100_Recommendations: 1.1 Acute alcohol withdrawal - Part 3,CG100,What is the recommended management of delirium tremens and alcohol withdrawal seizures according to NICE guidelines?
CG100_Recommendations: 1.2 Wernicke's encephalopathy,CG100,What is the recommended thiamine treatment for suspected Wernicke's encephalopathy?
CG100_Recommendations: 1.3 Alcohol-related liver disease - Part 1,CG100,What are the indications for liver biopsy in diagnosing alcohol-related liver disease?
CG100_Recommendations: 1.3 Alcohol-related liver disease - Part 2,CG100,When should corticosteroid treatment be considered for severe alcohol-related hepatitis?
CG100_Recommendations: 1.4 Alcohol-related pancreatitis - Part 1,CG100,What are the recommended diagnostic and treatment options for alcohol-related pancreatitis?
CG100_Recommendations: 1.4 Alcohol-related pancreatitis - Part 2,CG100,What are the nutritional support recommendations for acute alcohol-related pancreatitis?
CG100_Recommendations: Terms used in this guideline - Part 1,CG100,What are the assessment tools for monitoring alcohol withdrawal severity?
CG100_Recommendations: Terms used in this guideline - Part 2,CG100,What are the criteria for diagnosing harmful and hazardous drinking according to NICE guidelines?
CG100_Context,CG100,What are the recommended management strategies for alcohol withdrawal syndrome in adults?
CG100_Recommendations for research: 1 Admission to hospital for acute alcohol withdrawal,CG100,What is the effectiveness of hospital admission versus outpatient management for mild or moderate acute alcohol withdrawal in achieving long-term abstinence?
CG100_Recommendations for research: 2 Dosing regimens for acute alcohol withdrawal,CG100,"What are the safety and effectiveness of symptom-triggered, fixed-dosing, and front-loading regimens for managing acute alcohol withdrawal?"
CG100_Recommendations for research: 3 Drugs for the management of alcohol withdrawal & Recommendations for research: 4 Assessment and monitoring,CG100,"What is the effectiveness of clomethiazole compared to chlordiazepoxide, carbamazepine, or benzodiazepines in managing acute alcohol withdrawal?"
CG100_Recommendations for research: 5 Wernicke's encephalopathy,CG100,What is the most effective route of thiamine administration to prevent Wernicke's encephalopathy during alcohol withdrawal?
"CG103_Delirium: prevention, diagnosis and management in hospital and long-term care & Overview & Recommendations: 1.1 Think delirium",CG103,What are the key strategies for preventing delirium in hospitalized and long-term care patients?
CG103_Recommendations: 1.2 Risk factor assessment,CG103,What are the key risk factors for delirium in hospitalized or long-term care patients?
CG103_Recommendations: 1.3 Indicators of delirium: at presentation,CG103,What are the key indicators of delirium at presentation in at-risk patients?
CG103_Recommendations: 1.4 Preventing delirium - Part 1,CG103,What are the best strategies for preventing delirium in hospitalized patients at risk?
CG103_Recommendations: 1.4 Preventing delirium - Part 2,CG103,What are the recommended strategies for preventing infections and promoting recovery in hospitalized patients?
CG103_Recommendations: 1.5 Indicators of delirium: daily observations,CG103,What are the recommended daily observation practices for detecting delirium in hospitalized or long-term care patients?
CG103_Recommendations: 1.6 Assessment and diagnosis,CG103,What are the recommended assessment tools for diagnosing delirium in clinical practice?
CG103_Recommendations: 1.7 Treating delirium,CG103,What are the recommended management strategies for treating delirium according to NICE guidelines?
CG103_Recommendations: 1.8 Information and support & Recommendations: Terms used in this guideline,CG103,What information and support should be provided to patients and families about delirium?
CG103_Recommendations for research: 1 Delirium assessment tools,CG103,What is the diagnostic accuracy and usability of delirium assessment tools for patients with cognitive impairments or language barriers in various healthcare settings?
CG103_Recommendations for research: 2 Pharmacological prevention,CG103,What is the most effective and cost-effective pharmacological prevention for delirium in high-risk hospitalized patients?
CG103_Recommendations for research: 3 Pharmacological treatment,CG103,"What is the most effective medication for treating delirium in hospitalized patients: atypical antipsychotics, typical antipsychotics, or benzodiazepines?"
CG103_Recommendations for research: 4 Multicomponent intervention,CG103,What is the effectiveness of multicomponent non-pharmacological interventions in preventing delirium in long-term care residents?
CG103_Recommendations for research: 5 Delirium in long-term care,CG103,What is the prevalence and impact of delirium in long-term care residents?
CG103_Recommendations for research: 6 Education programme,CG103,What is the effectiveness of staff education programs in reducing delirium incidence and improving recognition in hospitalized patients?
CG103_Rationale and impact: Indicators of delirium: daily observations,CG103,What are the recommended methods for daily observation and recording of delirium indicators in care settings?
CG103_Rationale and impact: Assessment and diagnosis - Part 1,CG103,What is the recommended assessment tool for diagnosing delirium in clinical practice?
CG103_Rationale and impact: Assessment and diagnosis - Part 2,CG103,What are the recommended delirium assessment tools for critical care and post-surgical settings?
CG103_Context,CG103,What are the best strategies for preventing delirium in hospitalized older adults?
CG104_Metastatic malignant disease of unknown primary origin in adults: diagnosis and management & Overview,CG104,What are the recommended diagnostic and management strategies for metastatic malignant disease of unknown primary in adults?
CG104_Recommendations: 1.1 Organisation of services and support - Part 1,CG104,What are the recommended team members and responsibilities for a CUP service in hospitals?
CG104_Recommendations: 1.1 Organisation of services and support - Part 2,CG104,What are the recommended procedures for managing patients with cancer of unknown primary according to NICE guidelines?
CG104_Recommendations: 1.1 Organisation of services and support - Part 3,CG104,What are the recommended organizational structures and data collection practices for managing cancer of unknown primary (CUP) and metastatic unknown origin (MUO) in hospitals and cancer networks?
CG104_Recommendations: 1.2 Diagnosis - Part 1,CG104,What are the recommended initial diagnostic investigations for patients with malignancy of unknown primary?
CG104_Recommendations: 1.2 Diagnosis - Part 2,CG104,"When should tumour markers like AFP, hCG, PSA, or CA125 be measured in patients with suspected germ-cell tumors or other cancers?"
CG104_Recommendations: 1.2 Diagnosis - Part 3,CG104,When should 18F-FDG PET-CT be considered for patients with cancer of unknown primary presenting with extra-cervical disease?
CG104_Recommendations: 1.3 Factors influencing management decisions,CG104,What factors should be considered when deciding to stop investigations for cancer of unknown primary?
CG104_Recommendations: 1.4 Managing specific presentations,CG104,What are the recommended management strategies for patients with squamous carcinoma involving upper- or mid-neck nodes?
CG104_Recommendations: 1.5 Systemic treatment,CG104,What are the considerations for chemotherapy in patients with confirmed cancer of unknown primary (CUP)?
CG104_Recommendations: Terms used in this guideline & Recommendations for research: 1 Clinical studies group for CUP,CG104,What are the definitions of malignancy of undefined primary origin and carcinoma of unknown primary in NICE guidelines?
CG104_Recommendations for research: 2 Use of PET-CT in the MUO diagnostic pathway & Recommendations for research: 3 Decision aids,CG104,What is the role of early PET-CT in the diagnostic pathway for cancer of unknown primary?
CG104_Recommendations for research: 4 Gene-expression-based profiling & Recommendations for research: 5 Defining optimal systemic therapy,CG104,What is the role of gene-expression-based profiling in guiding chemotherapy for cancer of unknown primary?
CG104_Context - Part 1,CG104,What are the current diagnostic and management guidelines for cancer of unknown primary origin (CUP) and malignancy of undefined primary origin (MUO)?
CG104_Context - Part 2,CG104,What are the recommended management strategies for patients with cancer of unknown primary (CUP) according to NICE guidelines?
CG109_Transient loss of consciousness ('blackouts') in over 16s & Overview,CG109,What is the recommended assessment and referral process for transient loss of consciousness in people over 16?
CG109_Introduction - Part 1,CG109,What are the recommended steps for initial assessment and referral of adults with transient loss of consciousness?
CG109_Introduction - Part 2,CG109,How should transient loss of consciousness be assessed and managed to determine its underlying mechanism?
CG109_Recommendations: 1.1 Initial assessment - Part 1,CG109,What is the initial assessment process for suspected transient loss of consciousness?
CG109_Recommendations: 1.1 Initial assessment - Part 2,CG109,What are the recommended steps for obtaining patient history and performing tests after a transient loss of consciousness?
CG109_Recommendations: 1.1 Initial assessment - Part 3,CG109,What are the urgent assessment and referral criteria for transient loss of consciousness?
CG109_Recommendations: 1.1 Initial assessment - Part 4,CG109,What are the criteria for diagnosing uncomplicated vasovagal syncope and situational syncope?
CG109_Recommendations: 1.2 Further assessment and referral - Part 1,CG109,What are the recommended steps for assessing suspected postural hypotension and epilepsy in primary care?
CG109_Recommendations: 1.2 Further assessment and referral - Part 2,CG109,What are the clinical features and assessment criteria for distinguishing syncope from epileptic seizures?
CG109_Recommendations: 1.3 Specialist cardiovascular assessment and diagnosis - Part 1,CG109,What are the recommended diagnostic approaches for different types of syncope based on patient history?
CG109_Recommendations: 1.3 Specialist cardiovascular assessment and diagnosis - Part 2,CG109,What are the recommended investigations for exercise-induced syncope and suspected cardiac arrhythmia?
CG109_Recommendations: 1.3 Specialist cardiovascular assessment and diagnosis - Part 3,CG109,When should a tilt test or carotid sinus massage be used to diagnose vasovagal or carotid sinus syncope?
CG109_Recommendations: 1.4 If the cause of TLoC remains uncertain,CG109,What are the recommended assessments for unexplained transient loss of consciousness when the cause remains uncertain?
CG109_Recommendations: 1.5 Information for people with TLoC - Part 1,CG109,What information should I know about driving and work safety after experiencing a transient loss of consciousness?
CG109_Recommendations: 1.5 Information for people with TLoC - Part 2,CG109,What advice should be given to patients with uncomplicated vasovagal syncope or postural hypotension?
CG109_Terms used in this guideline - Part 1,CG109,What is the definition of arrhythmia and how is it diagnosed using a 12-lead ECG?
CG109_Terms used in this guideline - Part 2,CG109,What are the causes and management of carotid sinus syncope?
CG109_Terms used in this guideline - Part 3,CG109,What are the clinical features and management of inherited long QT and short QT syndromes?
CG109_Terms used in this guideline - Part 4,CG109,What are the clinical features and management of short QT syndrome?
CG109_Recommendations for research: 1 Development of a robust system for promoting good-quality information from a witnessed TLoC,CG109,Does providing information to patients and carers about witnessed TLoC events help improve diagnosis accuracy and reduce inappropriate referrals?
CG109_Recommendations for research: 2 Investigation of the accuracy of automated ECG interpretation & Recommendations for research: 3 Diagnostic yield of repeated ECG and physiological parameter recording,CG109,"Does automated ECG interpretation improve diagnostic accuracy for syncope patients compared to expert reading, especially in detecting long QT syndrome?"
CG109_Recommendations for research: 4 Investigation of the benefit and cost effectiveness of 12-lead ECG & Recommendations for research: 5 Cost effectiveness of implantable event recorders in people with TLoC,CG109,What is the clinical and cost effectiveness of using a 12-lead ECG to diagnose uncomplicated fainting in patients with transient loss of consciousness?
CG110_Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors & Overview,CG110,What strategies can improve access and engagement with antenatal care for pregnant women with complex social factors?
CG110_Introduction,CG110,What are the recommended approaches for providing antenatal care to women with complex social factors?
CG110_Key priorities for implementation: General recommendations - Part 1,CG110,What are the recommended service organization and data recording practices for antenatal care in women with complex social factors?
CG110_Key priorities for implementation: General recommendations - Part 2 & Key priorities for implementation: Pregnant women who misuse substances (alcohol and/or drugs),CG110,What are the recommended approaches for providing antenatal care to women who misuse substances?
"CG110_Key priorities for implementation: Pregnant women who are recent migrants, asylum seekers or refugees, or who have difficulty reading or speaking English & Key priorities for implementation: Young pregnant women aged under 20",CG110,What are effective strategies for providing antenatal information to pregnant women who are recent migrants or have language barriers?
CG110_Key priorities for implementation: Pregnant women who experience domestic abuse,CG110,What are the recommended protocols for managing domestic abuse in pregnant women?
CG110_Recommendations: 1.1 General recommendations - Part 2,CG110,What are the recommended practices for safeguarding and information sharing during antenatal care?
CG110_Recommendations: 1.2 Pregnant women who misuse substances (alcohol and/or drugs) - Part 1,CG110,What are recommended approaches for providing coordinated antenatal care to pregnant women who misuse substances?
CG110_Recommendations: 1.2 Pregnant women who misuse substances (alcohol and/or drugs) - Part 2,CG110,What support and information should be provided to pregnant women who misuse substances?
"CG110_Recommendations: 1.3 Pregnant women who are recent migrants, asylum seekers or refugees, or who have difficulty reading or speaking English - Part 1",CG110,What strategies can healthcare providers use to improve antenatal care access for recent migrants and women with language barriers?
"CG110_Recommendations: 1.3 Pregnant women who are recent migrants, asylum seekers or refugees, or who have difficulty reading or speaking English - Part 2 & Recommendations: 1.4 Young pregnant women aged under 20",CG110,What training should healthcare professionals receive to address the needs of young pregnant women under 20 from migrant or refugee backgrounds?
CG110_Recommendations: 1.4 Young pregnant women aged under 20,CG110,What strategies can healthcare professionals use to improve antenatal care access for pregnant women under 20?
CG110_Recommendations: 1.5 Pregnant women who experience domestic abuse - Part 1,CG110,What are the recommended practices for supporting pregnant women experiencing domestic abuse during antenatal care?
CG110_Recommendations: 1.5 Pregnant women who experience domestic abuse - Part 2 & Recommendations for research: 1 Training for healthcare staff,CG110,What training is recommended for healthcare staff to improve interactions with pregnant women facing complex social issues?
CG110_Recommendations for research: 2 Effect of early booking on obstetric and neonatal outcomes,CG110,Does early antenatal booking by 10 or 12 weeks improve outcomes for pregnant women with complex social problems?
CG110_Recommendations for research: 3 How can different service models be assessed?,CG110,What data should be collected to assess the effectiveness of different models of maternity care?
CG110_Recommendations for research: 4 Models of service provision,CG110,What are the different models of service provision for socially complex pregnant women in the UK and how do their outcomes compare?
CG110_Recommendations for research: 5 Antenatal appointments for women who misuse substances,CG110,What strategies can improve antenatal appointment attendance among women who misuse substances?
CG111_Bedwetting in under 19s & Overview & Introduction - Part 1,CG111,What are the recommended assessment and treatment options for bedwetting in children and young people under 19?
CG111_Introduction - Part 2,CG111,What are the recommended assessment and management strategies for bedwetting in children and young people up to 19 years?
CG111_Key priorities for implementation,CG111,What are the recommended management strategies for bedwetting in children and young people?
CG111_Recommendations: 1.1 Principles of care & Recommendations: 1.2 Information for the child or young person and family,CG111,What information should be provided to children and families about managing bedwetting?
CG111_Recommendations: 1.3 Assessment and investigation - Part 1,CG111,What are the recommended assessment and investigation procedures for children with bedwetting?
CG111_Recommendations: 1.3 Assessment and investigation - Part 2,CG111,What are the recommended assessments and investigations for bedwetting in children and young people?
CG111_Recommendations: 1.3 Assessment and investigation - Part 3,CG111,What are the recommended assessments and management strategies for secondary bedwetting in children and young people?
CG111_Recommendations: 1.4 Planning management,CG111,How should healthcare professionals plan and discuss treatment options for bedwetting with children and their families?
"CG111_Recommendations: 1.5 Advice on fluid intake, diet and toileting patterns",CG111,What are the recommended fluid intake and toileting practices for children with bedwetting?
CG111_Recommendations: 1.6 Lifting and waking & Recommendations: 1.7 Reward systems,CG111,What are effective strategies for waking and reward systems in managing bedwetting in children and young people?
CG111_Recommendations: 1.8 Initial treatment: alarms - Part 1,CG111,What are the recommended initial treatments for bedwetting in children and young people?
CG111_Recommendations: 1.8 Initial treatment: alarms - Part 2,CG111,What are the key considerations for using alarms to treat bedwetting in children and young people?
CG111_Recommendations: 1.9 Lack of response to alarm treatment & Recommendations: 1.10 Initial treatment: desmopressin - Part 1,CG111,What are the recommended treatment options for children with bedwetting who do not respond to alarm therapy?
CG111_Recommendations: 1.10 Initial treatment: desmopressin - Part 2,CG111,What are the guidelines for using desmopressin to treat bedwetting in children with behavioural or developmental difficulties?
CG111_Recommendations: 1.11 Children and young people experiencing recurrence of bedwetting & Recommendations: 1.12 Lack of response to initial treatment options,CG111,What are the recommended management options for children and young people with recurrent bedwetting after initial treatment?
CG111_Recommendations: 1.13 Anticholinergics,CG111,What are the recommended approaches for using anticholinergics in managing bedwetting in children and young people?
CG111_Recommendations: 1.14 Tricyclics & Recommendations: 1.15 Training programmes for the management of bedwetting,CG111,What are the recommended treatments for bedwetting in children and young people according to NICE guidelines?
CG111_Recommendations: 1.16 Children under 5 years with bedwetting,CG111,What are the recommended management strategies for bedwetting in children under 5 years old?
CG111_Recommendations: Terms used in this guideline,CG111,What is the definition of bedwetting according to NICE guidelines?
CG111_Research recommendations: 1 Multicomponent treatments,CG111,What are the most effective and cost-effective components of multicomponent treatments for bedwetting in children and young people under 19?
CG111_Research recommendations: 2 Standard interventions & Research recommendations: 3 Psychological functioning and quality of life,CG111,What is the clinical and cost effectiveness of standard interventions like alarm and desmopressin for treating bedwetting in children and young people?
CG111_Research recommendations: 4 Complementary therapies,CG111,What is the effectiveness of acupuncture and hypnotherapy in reducing bedwetting and improving self-esteem in children and young people?
CG111_Research recommendations: 5 Bedwetting in adolescents,CG111,What is the prevalence and long-term impact of bedwetting and soiling in adolescents?
CG112_Sedation in under 19s: using sedation for diagnostic and therapeutic procedures & Overview,CG112,What are the recommendations for sedation in children and young people under 19 years old?
CG112_Introduction - Part 1,CG112,What are the recommended sedation techniques for paediatric diagnostic and therapeutic procedures?
CG112_Introduction - Part 2,CG112,"What are the differences between moderate, conscious, and deep sedation in clinical practice?"
"CG112_Key priorities for implementation: Pre‑sedation assessment, communication, patient information and consent",CG112,What are the key components of pre‑sedation assessment and patient consent in children and young people?
CG112_Key priorities for implementation: Personnel and training & Key priorities for implementation: Clinical environment and monitoring,CG112,What training and competencies are required for healthcare professionals administering sedation to children and young people?
"CG112_Recommendations: 1.1 Pre‑sedation assessment, communication, patient information and consent",CG112,What are the recommended pre‑sedation assessment procedures and consent processes for children and young people?
CG112_Recommendations: 1.2 Fasting & Recommendations: 1.3 Psychological preparation,CG112,What are the fasting requirements for children undergoing sedation for elective procedures?
CG112_Recommendations: 1.5 Discharge criteria & Recommendations: 1.6 Painless imaging,CG112,What are the discharge criteria for children and young people in emergency care?
CG112_Recommendations: 1.7 Clinical environment and monitoring,CG112,What are the recommended monitoring practices during moderate and deep sedation in children and young people?
CG112_Recommendations: 1.8 Painful procedures & Recommendations: 1.9 Dental procedures,CG112,What are the recommended sedation options for children undergoing painful or dental procedures?
CG112_Recommendations: 1.10 Endoscopy & Recommendations for research: 1 Pre‑sedation assessment & Recommendations for research: 2 Training for personnel involved in sedation,CG112,What factors should be assessed in children to determine the need for sedation during diagnostic and therapeutic procedures?
CG112_Recommendations for research: 3 Drugs combination & Recommendations for research: 4 Development of a national registry of sedation,CG112,What are the safe and effective drug combinations for moderate sedation in children undergoing minor painful procedures?
CG113_Generalised anxiety disorder and panic disorder in adults: management & Overview & Recommendations: 1.1 Principles of care for people with generalised anxiety disorder (GAD),CG113,What are the recommended management strategies for adults with generalized anxiety disorder and comorbid learning disabilities?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 1,CG113,What is the stepped-care approach for managing generalized anxiety disorder (GAD)?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 2,CG113,What are the criteria for diagnosing generalized anxiety disorder in primary care?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 3,CG113,What are the recommended treatments for managing substance misuse in patients with generalized anxiety disorder?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 4,CG113,What are the recommended self-help and psychological interventions for generalized anxiety disorder according to NICE guidelines?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 5,CG113,What are the recommended high-intensity psychological interventions for generalized anxiety disorder according to NICE guidelines?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 6,CG113,What are the recommended medication options and considerations for treating generalized anxiety disorder according to NICE guidelines?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 7,CG113,What are the recommended management strategies for inadequate response to antidepressant treatment in depression?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 8,CG113,What are the recommended treatment options for treatment-resistant generalized anxiety disorder (GAD) according to NICE guidelines?
CG113_Recommendations: 1.2 Stepped care for people with GAD - Part 9,CG113,What are the risks and benefits of combining antidepressants with psychological treatments for treatment-resistant anxiety disorders?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 1,CG113,What are the recommended steps for diagnosing and managing panic disorder in primary care?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 2,CG113,What is the recommended management for patients presenting with panic attacks in emergency settings?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 3,CG113,What are the recommended psychological and pharmacological treatments for moderate to severe panic disorder?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 4,CG113,What factors should be considered when choosing antidepressant medication for depression?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 5,CG113,What are the best practices for safely stopping antidepressants to minimize withdrawal symptoms?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 6,CG113,What are the recommended management strategies for discontinuation symptoms of antidepressants in panic disorder?
CG113_Recommendations: 1.3 Stepped care for people with panic disorder - Part 7,CG113,What are the recommended monitoring and follow-up procedures for pharmacological and psychological treatments in panic disorder?
CG113_Recommendations for research: 1 A comparison of the clinical and cost effectiveness of sertraline and CBT in people with GAD that has not responded to guided self-help and psychoeducation & Recommendations for research: 2 The clinical and cost effectiveness of 2 CBT-based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control for the treatment of GAD,CG113,What is the effectiveness of sertraline compared to cognitive behavioural therapy for treating generalized anxiety disorder that has not responded to initial interventions?
CG113_Recommendations for research: 2 The clinical and cost effectiveness of 2 CBT-based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control for the treatment of GAD,CG113,What is the clinical and cost effectiveness of computerised cognitive behavioural therapy and guided bibliotherapy compared to waiting-list control for generalized anxiety disorder?
CG113_Recommendations for research: 3 The effectiveness of physical activity compared with waiting-list control for the treatment of GAD,CG113,What is the clinical effectiveness of physical activity compared to waiting-list control for treating generalized anxiety disorder?
CG113_Recommendations for research: 4 The effectiveness of chamomile and ginkgo biloba in the treatment of GAD,CG113,Are chamomile and ginkgo biloba effective for treating generalized anxiety disorder compared to placebo?
CG113_Recommendations for research: 5 The clinical and cost effectiveness of a primary care-based collaborative care approach to improving the treatment of GAD compared with usual care & Recommendations for research: 6 The clinical and cost effectiveness of 2 CBT-based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control for the treatment of panic disorder,CG113,What is the effectiveness of collaborative care models in treating generalized anxiety disorder in primary care settings?
CG113_Recommendations for research: 6 The clinical and cost effectiveness of 2 CBT-based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control for the treatment of panic disorder,CG113,What is the clinical and cost effectiveness of low-intensity CBT-based interventions like CCBT and guided bibliotherapy for panic disorder compared to waiting-list control?
CG113_Context - Part 1,CG113,What are the diagnostic criteria for generalised anxiety disorder according to NICE guidelines?
CG113_Context - Part 2,CG113,What are the recommended treatments for generalized anxiety disorder and panic disorder in adults?
"CG115_Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence & Overview",CG115,What are the recommended methods for diagnosing and managing harmful drinking and alcohol dependence in adults and young people?
CG115_Recommendations: 1.1 Principles of care - Part 1,CG115,What are the recommended approaches for building trust and providing information to people who misuse alcohol?
CG115_Recommendations: 1.1 Principles of care - Part 2,CG115,What are the recommended approaches for supporting families and carers of individuals who misuse alcohol?
CG115_Recommendations: 1.2 Identification and assessment - Part 1,CG115,What are the recommended assessment tools for alcohol misuse and dependence according to NICE guidelines?
CG115_Recommendations: 1.2 Identification and assessment - Part 2,CG115,What are the recommended treatment goals for alcohol dependence in specialist services according to NICE guidelines?
CG115_Recommendations: 1.2 Identification and assessment - Part 3,CG115,What are the components of a comprehensive assessment for adults referred to specialist alcohol services?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 1,CG115,What are the recommended interventions for alcohol misuse and how should they be implemented?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 2,CG115,What are the recommended approaches for care coordination and case management in alcohol treatment?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 3,CG115,What are the recommended pharmacological and psychological interventions for harmful drinkers and people with mild alcohol dependence according to NICE guidelines?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 4,CG115,What are the recommended drug regimens for assisted withdrawal in alcohol dependence?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 5,CG115,What are the recommended medication regimens for community-based assisted alcohol withdrawal?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 6,CG115,"What are the recommendations for prescribing benzodiazepines in children, older adults, and people with liver impairment?"
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 7,CG115,What are the recommended interventions and safety considerations for managing alcohol withdrawal and post-withdrawal treatment options?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 8,CG115,What are the recommended dosing and monitoring guidelines for acamprosate and naltrexone in alcohol dependence treatment?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 9,CG115,What are the recommended precautions and monitoring requirements for disulfiram treatment in alcohol misuse?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 10,CG115,What are the recommended approaches for managing alcohol misuse in children and young people according to NICE guidelines?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 11,CG115,What are the recommended psychological interventions for treating alcohol misuse in children and young people aged 10 to 17?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 12,CG115,What are the recommended family therapy approaches for adolescents with behavioral or mental health issues?
CG115_Recommendations: 1.3 Interventions for alcohol misuse - Part 13,CG115,What are the recommended treatments for alcohol misuse with comorbid opioid or stimulant dependence?
CG115_Recommendations for research: 1 Is contingency management effective in reducing alcohol consumption in people who misuse alcohol compared with standard care?,CG115,Is contingency management effective in reducing alcohol consumption compared to standard care?
CG115_Recommendations for research: 2 What methods are most effective for assessing and diagnosing the presence and severity of alcohol misuse in children and young people?,CG115,What are the most effective methods for assessing and diagnosing alcohol misuse in children and young people?
CG115_Recommendations for research: 3 Is acupuncture effective in reducing alcohol consumption compared with standard care?,CG115,Is acupuncture effective in reducing alcohol consumption compared to standard care?
CG115_Recommendations for research: 4 For which service users who are moderately and severely dependent on alcohol is an assertive community treatment model a clinically and cost-effective intervention compared with standard care?,CG115,What is the clinical and cost-effectiveness of assertive community treatment for moderately and severely alcohol-dependent service users compared to standard care?
"CG115_Recommendations for research: 5 For people with moderate and severe alcohol dependence who have significant comorbid problems, is an intensive residential rehabilitation programme clinically and cost effective when compared with intensive community-based care?",CG115,What is the clinical and cost-effectiveness of residential rehabilitation compared to community-based care for people with moderate to severe alcohol dependence and complex comorbidities?
"CG115_Recommendations for research: 6 For people with alcohol dependence, which medication is most likely to improve adherence and thereby promote abstinence and prevent relapse?",CG115,Which medication is most effective for improving adherence and preventing relapse in alcohol dependence?
CG115_Context - Part 1,CG115,What are the recommended approaches for diagnosing and managing alcohol dependence in adults and young people?
CG115_Context - Part 2,CG115,What are the recommended interventions for alcohol misuse and dependence?
CG115_Context - Part 3,CG115,What are the recommended approaches for diagnosing and managing alcohol misuse and withdrawal?
CG116_Food allergy in under 19s: assessment and diagnosis & Overview,CG116,What are the recommended methods for diagnosing food allergy in children and young people under 19?
CG116_Introduction,CG116,What are the recommended approaches for diagnosing and managing food allergy in primary care?
CG116_Recommendations: Assessment and allergy-focused clinical history - Part 1,CG116,What are the signs and symptoms of food allergy in children and young people?
CG116_Recommendations: Assessment and allergy-focused clinical history - Part 2,CG116,What questions should be asked during an allergy-focused clinical history for suspected food allergy in children?
CG116_Recommendations: Diagnosis - Part 1,CG116,What are the recommended diagnostic approaches for IgE-mediated and non-IgE-mediated food allergies in children?
CG116_Recommendations: Diagnosis - Part 2,CG116,What information should be provided to children and parents about food allergies and elimination diets?
CG116_Recommendations for research: 1 Prevalence and natural history of non-IgE-mediated food allergy & Recommendations for research: 2 Clinical predictors of non-IgE-mediated food allergy,CG116,What are the clinical features that predict non-IgE-mediated food allergy in children and young people?
CG116_Recommendations for research: 3 Information needs for children and young people during their care pathway to diagnosis of food allergy & Recommendations for research: 4 Values of skin prick testing and specific IgE antibody testing and their predictive value,CG116,What information do children and young people with food allergies and their families need during the diagnostic process?
CG116_Recommendations for research: 5 Modes of provision of support to healthcare professionals,CG116,What is the effectiveness of dietetic telephone support for healthcare professionals in diagnosing and managing non-IgE-mediated food allergy in infants?
"CG118_Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas & Overview & Introduction - Part 1",CG118,What are the recommended colonoscopic surveillance intervals for adults with ulcerative colitis or Crohn's disease to prevent colorectal cancer?
CG118_Introduction - Part 2,CG118,What are the NICE guidelines for colonoscopic surveillance in patients with IBD or adenomas?
CG118_Recommendations: People with inflammatory bowel disease,CG118,What are the recommended surveillance intervals for colonoscopy in people with inflammatory bowel disease based on their risk level?
CG118_Recommendations: People with adenomas & Recommendations: Providing information and support,CG118,What information should be provided to patients about colonoscopic surveillance for colorectal adenomas?
CG118_Recommendations for research,CG118,What is the effectiveness of colonoscopic surveillance programs in improving survival for people at increased risk of colorectal cancer?
CG120_Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings & Overview,CG120,What are the recommended approaches for assessing and managing coexisting severe mental illness and substance misuse in adults?
CG120_Recommendations: 1.1 Principles of care - Part 1,CG120,What are the recommended approaches for communicating with adults and young people with psychosis and coexisting substance misuse?
CG120_Recommendations: 1.1 Principles of care - Part 2,CG120,What interventions are recommended for supporting families and carers of adults with psychosis and substance misuse?
CG120_Recommendations: 1.1 Principles of care - Part 3,CG120,What are the recommended safeguarding procedures for adults with psychosis and substance misuse?
CG120_Recommendations: 1.2 Recognition of psychosis with coexisting substance misuse,CG120,How should healthcare professionals assess for psychosis in patients with substance misuse?
CG120_Recommendations: 1.3 Primary care,CG120,How should primary care providers manage referrals and physical health monitoring for patients with psychosis and substance misuse?
CG120_Recommendations: 1.4 Secondary care mental health services - Part 1,CG120,What are the recommended approaches for managing psychosis with coexisting substance misuse in secondary mental health care?
CG120_Recommendations: 1.4 Secondary care mental health services - Part 2,CG120,What are the recommended approaches for assessing and managing substance misuse in adults and young people with psychosis?
CG120_Recommendations: 1.4 Secondary care mental health services - Part 3,CG120,What are the recommended approaches for assessing and managing substance misuse in adults and young people with psychosis?
CG120_Recommendations: 1.4 Secondary care mental health services - Part 4,CG120,How should treatment plans be tailored for patients with psychosis and substance misuse?
CG120_Recommendations: 1.5 Substance misuse services,CG120,What are the recommended practices for assessing and managing coexisting psychosis and substance misuse?
CG120_Recommendations: 1.6 Inpatient mental health services,CG120,What are the NICE recommendations for managing substance misuse in inpatient mental health services?
CG120_Recommendations: 1.7 Staffed accommodation,CG120,What are the recommendations for providing staffed accommodation to people with psychosis and coexisting substance misuse?
CG120_Recommendations: 1.8 Specific issues for young people with psychosis and coexisting substance misuse,CG120,What are the recommended management strategies for young people with psychosis and substance misuse?
"CG120_Recommendations: Terms used in this guideline & Recommendations for research: 1 Determining prevalence, risk and protective factors, and course of illness",CG120,"What are the prevalence, risk factors, and clinical outcomes of coexisting psychosis and substance misuse?"
CG120_Recommendations for research: 2 Predicting the onset of substance misuse in young people with psychosis,CG120,What are the risk factors for developing substance misuse in young people with psychosis?
CG120_Recommendations for research: 3 Psychosocial interventions versus standard care,CG120,Are psychosocial interventions effective and cost-effective for treating substance misuse in people with psychosis?
CG120_Recommendations for research: 4 Environmental interventions versus standard care,CG120,What is the clinical and cost effectiveness of environmental interventions compared to standard care for people with psychosis and substance misuse?
CG120_Recommendations for research: 5 Clozapine versus other pharmacological interventions,CG120,Is clozapine cost-effective and clinically effective compared to other antipsychotics for people with psychosis and substance misuse?
CG120_Context,CG120,What are the recommended approaches for managing coexisting substance misuse in adults with psychosis?
CG122_Ovarian cancer: recognition and initial management & Overview & Recommendations: 1.1 Detection in primary care - Part 1,CG122,What are the recommended initial signs and symptoms for ovarian cancer detection in primary care?
CG122_Recommendations: 1.1 Detection in primary care - Part 2,CG122,What are the recommended tests for ovarian cancer in women over 50 with recent symptoms suggestive of IBS?
CG122_Recommendations: 1.2 Establishing the diagnosis in secondary care - Part 1,CG122,What are the recommended tumor markers and imaging procedures for diagnosing suspected ovarian cancer in secondary care?
CG122_Recommendations: 1.2 Establishing the diagnosis in secondary care - Part 2,CG122,What are the recommended imaging and tissue diagnosis procedures for suspected ovarian cancer?
CG122_Recommendations: 1.3 Information and support for women with newly diagnosed ovarian cancer,CG122,"What information should be provided to women with newly diagnosed ovarian cancer regarding treatment options, side effects, and psychosocial support?"
CG122_Recommendations: 1.4 Management of suspected early (stage 1) ovarian cancer,CG122,What is the recommended management of early stage ovarian cancer according to NICE guidelines?
CG122_Recommendations: 1.5 Management of advanced (stage 2 to 4) ovarian cancer - Part 1,CG122,What are the recommended first-line chemotherapy options for advanced ovarian cancer according to NICE guidelines?
CG122_Recommendations: 1.5 Management of advanced (stage 2 to 4) ovarian cancer - Part 2,CG122,What are the NICE recommendations for maintenance therapy with rucaparib and olaparib in advanced epithelial ovarian cancer?
CG122_Recommendations: 1.5 Management of advanced (stage 2 to 4) ovarian cancer - Part 3,CG122,What are the NICE recommendations for maintenance treatment options in advanced high-grade epithelial ovarian cancer?
CG122_Recommendations: 1.6 Systemic anticancer therapy for recurrent or relapsed ovarian cancer - Part 1,CG122,What systemic anticancer therapies are recommended for recurrent ovarian cancer according to NICE guidelines?
CG122_Recommendations: 1.6 Systemic anticancer therapy for recurrent or relapsed ovarian cancer - Part 2,CG122,What are the NICE recommendations for maintenance therapy options in relapsed platinum-sensitive high-grade epithelial ovarian cancer?
CG122_Recommendations: Terms used in this guideline & Recommendations for research,CG122,What is the role of primary surgery versus chemotherapy alone in the treatment of advanced ovarian cancer?
CG124_Hip fracture: management & 3 more sections,CG124,What are the recommended imaging options for occult hip fractures?
CG124_Recommendations: 1.3 Analgesia & Recommendations: 1.4 Anaesthesia,CG124,What are the recommended pain management strategies for patients with hip fractures?
CG124_Recommendations: 1.5 Planning the theatre team & Recommendations: 1.6 Surgical procedures - Part 1,CG124,What are the recommended surgical procedures and team planning for hip fracture management according to NICE guidelines?
CG124_Recommendations: 1.6 Surgical procedures - Part 2 & Recommendations: 1.7 Mobilisation strategies,CG124,What is the recommended surgical approach and implant choice for hemiarthroplasty in displaced intracapsular hip fractures?
CG124_Recommendations: 1.8 Multidisciplinary management - Part 1,CG124,What are the key components of multidisciplinary management for hip fracture patients?
CG124_Recommendations: 1.8 Multidisciplinary management - Part 2 & Recommendations: 1.9 Patient and carer information,CG124,What information should be provided to patients and carers about delirium management and rehabilitation options after hip fracture?
CG124_Recommendations for research: 1 Imaging options in occult hip fracture,CG124,What is the clinical and cost effectiveness of CT compared to MRI in diagnosing occult hip fractures?
CG124_Recommendations for research: 2 Anaesthesia,CG124,What is the clinical and cost effectiveness of regional versus general anaesthesia on postoperative morbidity in people with hip fracture?
CG124_Recommendations for research: 3 Undisplaced intracapsular hip fractures,CG124,What are the clinical features and optimal management strategies for undisplaced intracapsular hip fractures?
CG124_Recommendations for research: 4 Intensive rehabilitation therapies after hip fracture,CG124,What is the effectiveness of intensive physiotherapy and occupational therapy after hip fracture?
CG124_Recommendations for research: 5 Early supported discharge in care home patients,CG124,What is the clinical and cost effectiveness of early supported discharge for care home patients with hip fracture?
CG124_Recommendations for research: 6 Long-term effectiveness of total hip replacement & Recommendations for research: 7 Femoral component design,CG124,What is the long-term clinical and cost effectiveness of total hip replacement compared to hemiarthroplasty for adults with displaced intracapsular hip fracture?
CG124_Rationale and impact: Total hip replacement versus hemiarthroplasty - Part 1,CG124,What are the indications for choosing total hip replacement over hemiarthroplasty in patients with displaced intracapsular hip fractures?
CG124_Rationale and impact: Total hip replacement versus hemiarthroplasty - Part 2,CG124,What factors should be considered when deciding on total hip arthroplasty for patients with cognitive impairment?
CG124_Rationale and impact: Femoral component design used for hemiarthroplasties - Part 1,CG124,What factors should be considered when choosing a femoral component for hemiarthroplasty?
CG124_Rationale and impact: Femoral component design used for hemiarthroplasties - Part 2,CG124,What is the role of registry data in evaluating long-term outcomes of femoral components in hemiarthroplasty patients?
CG124_Context - Part 1,CG124,What are the recommended management and treatment options for different types of hip fractures?
CG124_Context - Part 2,CG124,What are the recommended management strategies for adult patients with hip fracture from admission to discharge?
CG126_Stable angina: management & Introduction - Part 1,CG126,What are the recommended management strategies for stable angina to improve symptoms and quality of life?
CG126_Introduction - Part 2,CG126,What are the current management options for stable angina according to NICE guidelines?
CG126_Key priorities for implementation - Part 1,CG126,"What are the recommended treatment options for stable angina, including drug therapy and revascularisation procedures?"
CG126_Key priorities for implementation - Part 2 & Recommendations: 1.1 Diagnosis,CG126,What are the recommended criteria for multidisciplinary team discussions on revascularisation strategies in stable angina?
CG126_Recommendations: 1.2 Information and support for people with stable angina,CG126,What information and support should be provided to people with stable angina?
CG126_Recommendations: 1.3 General principles for treating people with stable angina,CG126,What are the recommended treatments and management strategies for stable angina according to NICE guidelines?
CG126_Recommendations: 1.4 Anti-anginal drug treatment - Part 1,CG126,What is the recommended initial drug treatment for stable angina according to NICE guidelines?
CG126_Recommendations: 1.4 Anti-anginal drug treatment - Part 2,CG126,What are the recommended treatment options for stable angina when first-line beta blockers or calcium channel blockers are not effective or tolerated?
CG126_Recommendations: 1.4 Anti-anginal drug treatment - Part 3,CG126,What are the recommended anti-anginal medications for stable angina management according to NICE guidelines?
CG126_Recommendations: 1.5 Investigation and revascularisation - Part 1,CG126,What are the indications for revascularisation in stable angina patients not responding to medical treatment?
CG126_Recommendations: 1.5 Investigation and revascularisation - Part 2,CG126,What are the considerations for choosing between CABG and PCI in patients with multivessel coronary artery disease?
CG126_Recommendations: 1.5 Investigation and revascularisation - Part 3 & Recommendations: 1.6 Pain interventions,CG126,What are the recommended management options and considerations for stable angina according to NICE guidelines?
CG126_Recommendations: 1.7 Stable angina that has not responded to treatment & Recommendations: 1.8 Cardiac syndrome X & Recommendations for research: 1 Adding a newer anti-anginal drug to a calcium channel blocker,CG126,What are the treatment options for stable angina unresponsive to medication and revascularisation?
CG126_Recommendations for research: 2 Management of stable angina in people with evidence of ischaemia on non-invasive functional testing,CG126,Should patients with stable angina and reversible ischaemia on non-invasive testing undergo routine coronary angiography and revascularisation?
CG126_Recommendations for research: 3 Early revascularisation strategy for people with angina and multivessel disease & Recommendations for research: 4 Cardiac rehabilitation,CG126,What is the effectiveness of early revascularisation compared to continued drug treatment for stable angina with multivessel disease?
CG126_Recommendations for research: 5 Patient self-management plans,CG126,What is the effectiveness of self-management plans for patients with stable angina?
"CG128_Autism spectrum disorder in under 19s: recognition, referral and diagnosis & Overview",CG128,What are the key signs and symptoms to recognise autism spectrum disorder in children and young people under 19?
"CG128_Recommendations: 1.1 Local pathway for recognition, referral and diagnostic assessment of possible autism - Part 1",CG128,What is the recommended process for recognizing and referring children for autism diagnosis according to NICE guidelines?
"CG128_Recommendations: 1.1 Local pathway for recognition, referral and diagnostic assessment of possible autism - Part 2",CG128,What skills are required for autism diagnostic assessment and communication with autistic children and their families?
CG128_Recommendations: 1.2 Recognising children and young people who may be autistic - Part 1,CG128,What are the key signs and considerations for recognising autism in children and young people?
CG128_Recommendations: 1.2 Recognising children and young people who may be autistic - Part 2,CG128,How can autism be accurately diagnosed in children and young people with learning disabilities or verbal abilities?
CG128_Recommendations: 1.3 Referring children and young people to the autism team - Part 1,CG128,When should children be referred to the autism team for regression or developmental concerns?
CG128_Recommendations: 1.3 Referring children and young people to the autism team - Part 2,CG128,What are the recommended procedures for referring children and young people to autism services?
CG128_Recommendations: 1.3 Referring children and young people to the autism team - Part 3,CG128,How should healthcare professionals communicate the referral process for autism to parents and young people?
CG128_Recommendations: 1.4 After referral to the autism team - Part 1,CG128,What are the criteria for referring a child or young person for autism diagnostic assessment?
CG128_Recommendations: 1.4 After referral to the autism team - Part 2,CG128,How is the need for an autism diagnostic assessment determined and what information should be gathered?
CG128_Recommendations: 1.5 Autism diagnostic assessment for children and young people - Part 1,CG128,What are the key components of the autism diagnostic assessment for children and young people?
CG128_Recommendations: 1.5 Autism diagnostic assessment for children and young people - Part 2,CG128,What are the recommended clinical assessment procedures for diagnosing autism in children and young people?
CG128_Recommendations: 1.5 Autism diagnostic assessment for children and young people - Part 3,CG128,What are the challenges in diagnosing autism in children with complex coexisting conditions or communication difficulties?
CG128_Recommendations: 1.6 After the autism diagnostic assessment & Recommendations: 1.7 Medical investigations,CG128,When should genetic testing or EEG be considered during an autism diagnostic assessment?
CG128_Recommendations: 1.8 Communicating the results from the autism diagnostic assessment,CG128,"How should the results of an autism diagnostic assessment be communicated to parents, carers, and young people?"
CG128_Recommendations: 1.9 Information and support for families and carers & Recommendations for research: 1 Training professionals & Recommendations for research: 2 Gathering information in schools or nurseries,CG128,What strategies are effective for training professionals to recognize autism early in children and young people?
CG128_Recommendations for research: 3 Additional assessments & Recommendations for research: 4 Comparative genomic hybridisation array & Rationale and impact,CG128,"What is the role of additional assessments like IQ, language, and motor ability tests in diagnosing autism in preschool children?"
CG128_Context - Part 1,CG128,How should clinicians assess and refer children and young people with suspected autism spectrum disorder and ADHD?
CG128_Context - Part 2,CG128,What are the recommended practices for diagnosing autism in children and young people?
CG134_Anaphylaxis: assessment and referral after emergency treatment & Overview,CG134,What is the recommended assessment and referral process after emergency treatment for anaphylaxis?
CG134_Introduction - Part 1,CG134,What are the key signs and symptoms of suspected anaphylaxis and how should it be diagnosed?
CG134_Introduction - Part 2,CG134,What are the key considerations for diagnosing and managing anaphylaxis in clinical practice?
CG134_Recommendations: 1.1 List of all recommendations - Part 1,CG134,What are the recommended procedures for diagnosing and managing suspected anaphylactic reactions?
CG134_Recommendations: 1.1 List of all recommendations - Part 2,CG134,What are the recommended procedures for managing suspected anaphylaxis in children and adults?
CG134_Recommendations: Terms used in this guideline & Recommendations for research: 1 Mediators of anaphylactic reactions,CG134,What are the alternative chemical mediators to mast cell tryptase for diagnosing anaphylaxis?
CG134_Recommendations for research: 2 The frequency and effects of biphasic reactions & Recommendations for research: 3 Length of observation period following emergency treatment for anaphylaxis,CG134,What is the recommended observation period after emergency treatment for anaphylaxis to prevent biphasic reactions?
CG134_Recommendations for research: 4 Prevalence of anaphylactic reactions and related outcomes & Recommendations for research: 5 Effect of specialist services on health-related quality of life,CG134,What is the annual incidence and outcomes of anaphylactic reactions in the UK?
CG135_Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation & Overview & Introduction,CG135,How can healthcare professionals improve identification and consent rates for deceased organ donation?
CG135_Person-centred care,CG135,How should healthcare professionals obtain informed consent for organ donation from patients with decision-making capacity?
CG135_Recommendations: Identifying patients who are potential donors & Recommendations: Patients who have capacity,CG135,How should healthcare professionals identify potential organ donors in end-of-life care?
CG135_Recommendations: Assessing best interests,CG135,How should healthcare professionals assess a patient's best interests for organ donation when the patient lacks capacity?
CG135_Recommendations: Seeking consent to organ donation,CG135,How should healthcare professionals seek consent for organ donation when a patient lacks capacity?
CG135_Recommendations: Approach to those close to the patient,CG135,What is the recommended multidisciplinary team composition for discussing organ donation with families?
CG135_Recommendations: Discussions in all cases - Part 1,CG135,What are the recommended practices for approaching families about organ donation in end-of-life care?
CG135_Recommendations: Discussions in all cases - Part 2,CG135,What information should healthcare teams provide to families about organ donation and end-of-life care?
"CG135_Recommendations: Organisation of the identification, referral and consent processes",CG135,What are the recommended processes for identifying and obtaining consent from organ donors in hospitals?
CG135_Recommendations for research,CG135,What factors influence family consent for organ donation and how can the consent process be improved?
CG136_Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services & Overview,CG136,What factors contribute to improving the experience of care for adults using NHS mental health services?
CG136_Introduction - Part 1,CG136,What are the key principles for improving patient experience in NHS care?
CG136_Introduction - Part 2,CG136,What are the key elements to improve service user experience in adult mental health services according to NICE guidelines?
CG136_Recommendations: 1.1 Care and support across all points on the care pathway - Part 1,CG136,What strategies can mental health professionals use to promote social inclusion and reduce stigma for service users?
CG136_Recommendations: 1.1 Care and support across all points on the care pathway - Part 2,CG136,What are best practices for culturally sensitive mental health assessment and treatment?
CG136_Recommendations: 1.1 Care and support across all points on the care pathway - Part 3,CG136,How should mental health professionals involve and support families and carers in patient care?
CG136_Recommendations: 1.1 Care and support across all points on the care pathway - Part 4,CG136,What support should be provided to parents with mental health conditions to access care and childcare services?
CG136_Recommendations: 1.2 Access to care,CG136,What are the recommended procedures for ensuring timely and accessible mental health service referrals and appointments?
CG136_Recommendations: 1.3 Assessment,CG136,What should healthcare professionals do to ensure a respectful and effective mental health assessment process?
CG136_Recommendations: 1.4 Community care - Part 1,CG136,What are best practices for developing and implementing community care plans that promote social inclusion and independence?
CG136_Recommendations: 1.4 Community care - Part 2,CG136,What are the recommended practices for involving families and providing access to care plans for mental health service users?
CG136_Recommendations: 1.5 Assessment and referral in a crisis - Part 1,CG136,What are the recommended procedures for assessing and referring individuals in mental health crisis according to NICE guidelines?
CG136_Recommendations: 1.5 Assessment and referral in a crisis - Part 2,CG136,What are the recommended procedures for managing mental health crises and ensuring timely specialist assessment?
CG136_Recommendations: 1.6 Hospital care - Part 1,CG136,"What are the recommended practices for hospital admission, orientation, and ongoing mental health support for service users?"
CG136_Recommendations: 1.6 Hospital care - Part 2,CG136,What are the recommended practices for multidisciplinary care coordination and patient involvement in mental health hospital settings?
CG136_Recommendations: 1.7 Discharge and transfer of care,CG136,What are best practices for planning and communicating discharge and transfer of care in mental health services?
CG136_Recommendations: 1.8 Assessment and treatment under the Mental Health Act - Part 1,CG136,What are the key considerations for assessing and explaining detention under the Mental Health Act?
CG136_Recommendations: 1.8 Assessment and treatment under the Mental Health Act - Part 2,CG136,What are the procedures for managing complaints and use of restraint under the Mental Health Act?
CG136_Research recommendations: 1 Training in the use of the national quality standard and guidance on service user experience of care & Research recommendations: 2 Late access to services and compulsory and intensive treatment,CG136,What is the impact of training mental health staff in the national quality standard on service user experience of care?
CG136_Research recommendations: 3 Shared decision‑making & Research recommendations: 4 Activities and occupations on inpatient wards,CG136,What are the key aspects of shared decision-making valued by adult mental health service users?
"CG136_Research recommendations: 5 Compulsion, control and restraint",CG136,How is compulsory treatment and restraint used in adult mental health services and what is their impact on service users?
CG138_Patient experience in adult NHS services: improving the experience of care for people using adult NHS services & Overview,CG138,What are the key components of a good patient experience in adult NHS services?
CG138_Introduction - Part 1,CG138,"What strategies can NHS providers use to improve patient experience and ensure dignity, compassion, and respect?"
CG138_Introduction - Part 2,CG138,What are the key components of a good patient experience in adult NHS services?
CG138_Recommendations: 1.1 Knowing the patient as an individual,CG138,How can healthcare professionals ensure they recognize and address individual patient needs and circumstances during consultations?
CG138_Recommendations: 1.2 Essential requirements of care - Part 1,CG138,What are the essential principles for respecting patient dignity and meeting fundamental needs in NHS care?
CG138_Recommendations: 1.2 Essential requirements of care - Part 2,CG138,What are the best practices for supporting patient independence and managing pain relief in hospital settings?
CG138_Recommendations: 1.3 Tailoring healthcare services for each patient - Part 1,CG138,How can healthcare professionals tailor services to meet individual patient needs and preferences?
CG138_Recommendations: 1.3 Tailoring healthcare services for each patient - Part 2,CG138,What are patients' rights regarding refusing treatment and involving family members in decision-making?
CG138_Recommendations: 1.4 Continuity of care and relationships,CG138,What are best practices for ensuring continuity of care and effective communication among healthcare professionals?
CG138_Recommendations: 1.5 Enabling patients to actively participate in their care - Part 1,CG138,How can healthcare professionals improve communication and patient participation in their care?
CG138_Recommendations: 1.5 Enabling patients to actively participate in their care - Part 2,CG138,"What information should healthcare providers give to patients about their condition, treatment options, and self-management support?"
CG139_Healthcare-associated infections: prevention and control in primary and community care & 3 more sections,CG139,What are the recommended hand decontamination procedures in primary and community care settings to prevent healthcare-associated infections?
CG139_Key priorities for implementation: Long-term urinary catheters,CG139,What factors should be considered when selecting a long-term urinary catheter?
CG139_Key priorities for implementation: Vascular access devices,CG139,What are the recommended infection prevention practices for vascular access device management?
CG139_Recommendations: 1.1 Standard principles - Part 1,CG139,What are the standard infection prevention and control principles for healthcare workers?
CG139_Recommendations: 1.1 Standard principles - Part 2,CG139,What are the recommended hand decontamination procedures for healthcare workers?
CG139_Recommendations: 1.1 Standard principles - Part 3,CG139,What are the recommended practices for the use of personal protective equipment and hand hygiene in healthcare settings?
CG139_Recommendations: 1.1 Standard principles - Part 4,CG139,What are the recommended precautions for the safe use and disposal of sharps in healthcare settings?
CG139_Recommendations: 1.1 Standard principles - Part 5,CG139,What are the best practices for the safe disposal and management of sharps and healthcare waste?
CG139_Recommendations: 1.2 Long-term urinary catheters - Part 1,CG139,What are the recommended training and management practices for long-term urinary catheter use?
CG139_Recommendations: 1.2 Long-term urinary catheters - Part 2,CG139,What are the best practices for aseptic catheter insertion and maintenance?
CG139_Recommendations: 1.2 Long-term urinary catheters - Part 3,CG139,What are the best practices for managing long-term indwelling urinary catheters to prevent infections and complications?
CG139_Recommendations: 1.3 Enteral feeding - Part 1,CG139,What are the recommended practices for training and preparing enteral feeds for home use?
CG139_Recommendations: 1.3 Enteral feeding - Part 2,CG139,How should enteral feeding feeds be prepared stored and administered safely?
CG139_Recommendations: 1.4 Vascular access devices - Part 1,CG139,What are the recommended practices for infection prevention and site care in vascular access device management?
CG139_Recommendations: 1.4 Vascular access devices - Part 2,CG139,What are the recommended dressing change intervals and techniques for central venous access devices?
CG139_Recommendations: 1.4 Vascular access devices - Part 3,CG139,What are the recommended infection prevention practices for vascular access device management?
CG139_Recommendations: 1.4 Vascular access devices - Part 4,CG139,What are the recommended practices for preventing catheter-related bloodstream infections and managing needleless device use?
CG139_Recommendations: Terms used in this guidance,CG139,What are the recommended hand hygiene practices for healthcare workers to prevent infection transmission?
CG139_Recommendations for research: 1 Standard principles of infection prevention and control,CG139,What are the barriers faced by patients and carers in adhering to infection prevention and control principles at home?
CG139_Recommendations for research: 2 Hand decontamination,CG139,What is the clinical and cost effectiveness of hand decontamination products without running water for removing visible contamination in community healthcare settings?
CG139_Recommendations for research: 3 Intermittent urinary catheters: catheter selection,CG139,What is the most effective and cost-effective type of intermittent urinary catheter for reducing urinary tract infections and improving patient comfort?
CG139_Recommendations for research: 4 Indwelling urinary catheters: catheter selection,CG139,"What is the clinical and cost effectiveness of impregnated, hydrophilic, and silicone indwelling urinary catheters in reducing urinary tract infections and complications?"
CG139_Recommendations for research: 5 Indwelling urinary catheters: antibiotic prophylaxis,CG139,What is the effectiveness of single-dose antibiotic prophylaxis in preventing urinary tract infections during recatheterisation of long-term indwelling urinary catheter patients?
CG139_Recommendations for research: 6 Vascular access devices: skin decontamination,CG139,What is the most effective chlorhexidine solution for preventing VAD-related infections and bacteraemia?
CG139_Context - Part 1,CG139,What are the key strategies for preventing healthcare-associated infections in primary and community care settings?
CG139_Context - Part 2,CG139,What are the current standards for preventing healthcare-associated infections in primary and community care settings?
CG140_Palliative care for adults: strong opioids for pain relief & Overview & Recommendations: Communication,CG140,What information should healthcare professionals provide to patients and carers about strong opioids for pain management in advanced disease?
CG140_Recommendations: Starting strong opioids – titrating the dose & Recommendations: First-line maintenance treatment,CG140,What is the recommended starting dose and titration process for oral morphine in patients with advanced pain?
CG140_Recommendations: First-line treatment if oral opioids are not suitable – transdermal patches & Recommendations: First-line treatment if oral opioids are not suitable – subcutaneous delivery & Recommendations: First-line treatment for breakthrough pain in patients who can take oral opioids,CG140,What are the recommended first-line options for opioid delivery when oral opioids are not suitable?
CG140_Recommendations: Management of constipation & Recommendations: Management of nausea,CG140,What are the recommended strategies for managing constipation in patients starting strong opioid therapy?
CG140_Recommendations: Management of drowsiness & Recommendation for research,CG140,What are effective strategies for managing drowsiness and CNS side effects in patients starting or adjusting strong opioid therapy?
CG140_Context - Part 1,CG140,What are the best practices for titrating strong opioids in managing pain for patients with advanced or progressive diseases?
CG140_Context - Part 2,CG140,What are the recommended first-line strong opioid treatments for pain management in adults with advanced disease according to NICE guidelines?
CG141_Acute upper gastrointestinal bleeding in over 16s: management & Overview & Recommendations: 1.1 Risk assessment,CG141,What is the recommended risk assessment process for managing acute upper gastrointestinal bleeding in patients aged 16 and over?
CG141_Recommendations: 1.2 Resuscitation and initial management,CG141,What are the recommended blood transfusion protocols for managing massive bleeding?
CG141_Recommendations: 1.3 Timing of endoscopy & Recommendations: 1.4 Management of non-variceal bleeding,CG141,What are the recommended timing and endoscopic treatment options for acute upper gastrointestinal bleeding?
"CG141_Recommendations: 1.5 Management of variceal bleeding & Recommendations: 1.6 Control of bleeding and prevention of re-bleeding in patients on NSAIDs, aspirin or clopidogrel",CG141,What is the recommended management of variceal bleeding and prevention of re-bleeding according to NICE guidelines?
CG141_Recommendations: 1.7 Primary prophylaxis for acutely ill patients in critical care & Recommendations: 1.8 Information and support for patients and carers,CG141,What are the recommendations for acid-suppression therapy to prevent upper gastrointestinal bleeding in critically ill patients?
CG141_Context,CG141,What are the recommended diagnostic and treatment strategies for managing acute upper gastrointestinal bleeding in hospital?
CG142_Autism spectrum disorder in adults: diagnosis and management & Overview & Introduction - Part 1,CG142,What are the recommended approaches for diagnosing autism spectrum disorder in adults?
CG142_Introduction - Part 2 & Key priorities for implementation: General principles of care,CG142,What are the principles for providing effective and respectful care to autistic adults?
CG142_Key priorities for implementation: Identification and assessment & Key priorities for implementation: Interventions for autism,CG142,What are the recommended assessment and intervention strategies for autism in adults without a moderate or severe learning disability?
CG142_Key priorities for implementation: Organisation and delivery of care,CG142,What are the recommended practices for organizing and delivering autism care pathways?
CG142_Recommendations: 1.1 General principles of care - Part 1,CG142,What are the principles for providing respectful and person-centered care to autistic adults?
CG142_Recommendations: 1.1 General principles of care - Part 2,CG142,What strategies can healthcare professionals use to adapt communication and physical environments for autistic adults during assessment and support?
CG142_Recommendations: 1.1 General principles of care - Part 3,CG142,What are the recommended support and care strategies for autistic adults with caring responsibilities?
CG142_Recommendations: 1.1 General principles of care - Part 4,CG142,How should healthcare professionals involve families and carers in the care of autistic adults?
CG142_Recommendations: 1.2 Identification and assessment - Part 1,CG142,What are the recommended procedures for assessing autism in adults?
CG142_Recommendations: 1.2 Identification and assessment - Part 2,CG142,What are the recommended assessment methods for diagnosing autism spectrum disorder in adults?
CG142_Recommendations: 1.2 Identification and assessment - Part 3,CG142,What are the recommended components of a comprehensive assessment and risk management plan for autistic adults?
CG142_Recommendations: 1.2 Identification and assessment - Part 4,CG142,When should a second opinion be considered for an autism diagnosis in adults?
CG142_Recommendations: 1.3 Identifying the correct interventions and monitoring their use,CG142,What are the recommended approaches for selecting and monitoring interventions for autistic adults?
CG142_Recommendations: 1.4 Interventions for autism - Part 1,CG142,What psychosocial interventions are recommended for improving social interaction and life skills in autistic adults?
CG142_Recommendations: 1.4 Interventions for autism - Part 2,CG142,What are the recommended interventions for supporting employment in autistic adults without learning disabilities?
CG142_Recommendations: 1.5 Interventions for behaviour that challenges - Part 1,CG142,What are recommended psychosocial interventions for managing behaviour that challenges in autistic adults?
CG142_Recommendations: 1.5 Interventions for behaviour that challenges - Part 2,CG142,What are the recommended psychosocial and pharmacological interventions for managing behaviour that challenges in autistic adults?
CG142_Recommendations: 1.6 Interventions for coexisting mental disorders,CG142,What are recommended psychosocial and pharmacological interventions for coexisting mental disorders in autistic adults?
"CG142_Recommendations: 1.7 Assessment and interventions for families, partners and carers",CG142,"What support and assessment options are available for families, partners, and carers of autistic adults?"
CG142_Recommendations: 1.8 Organisation and delivery of care - Part 1,CG142,What are the key principles for developing effective local care pathways for autistic adults?
CG142_Recommendations: 1.8 Organisation and delivery of care - Part 2,CG142,What are the recommended features of local care pathways for autistic adults according to NICE guidelines?
CG142_Recommendations: 1.8 Organisation and delivery of care - Part 3,CG142,What are the recommended features and staffing requirements for residential care for autistic adults?
CG142_Recommendations: Terms used in this guideline - Part 1,CG142,What is augmentative communication and how is it used for people with communication difficulties?
CG142_Recommendations: Terms used in this guideline - Part 2,CG142,What are effective strategies for managing sensory sensitivities in autistic individuals?
CG142_Recommendations for research: 1 Facilitated self-help for anxiety and depression in autistic adults,CG142,What is the effectiveness of facilitated self-help for treating mild anxiety and depression in autistic adults?
CG142_Recommendations for research: 2 The structure and organisation of specialist teams,CG142,What team structures and organization models are associated with improved care for autistic people?
CG142_Recommendations for research: 3 Augmentative communication devices for autistic adults,CG142,What is the clinical and cost effectiveness of augmentative communication devices for autistic adults?
CG143_Sickle cell disease: managing acute painful episodes in hospital & Overview,CG143,What are the recommended management strategies for acute painful episodes in hospitalized patients with sickle cell disease?
CG143_Introduction,CG143,What are the recommended management strategies for acute painful sickle cell episodes in hospital?
CG143_Recommendations: Individualised assessment at presentation,CG143,What are the recommended management and assessment protocols for acute painful sickle cell episodes in hospital?
CG143_Recommendations: Primary analgesia,CG143,What are the recommended analgesia options for managing acute painful sickle cell episodes?
CG143_Recommendations: Reassessment and ongoing management,CG143,How should pain relief be reassessed and managed in patients with sickle cell crises?
CG143_Recommendations: Possible acute complications & Recommendations: Management of underlying pathology,CG143,What are the signs and complications to monitor during an acute sickle cell episode?
CG143_Recommendations: Non-pharmacological interventions & 3 more sections,CG143,What are the recommended non-pharmacological strategies for managing acute sickle cell pain?
CG143_Recommendations for research: 1 Pain management for patients with an acute painful sickle cell episode & Recommendations for research: 2 Use of low-molecular-weight heparin to treat patients with an acute painful sickle cell episode & Recommendations for research: 3 Non-pharmacological interventions for patients with an acute painful sickle cell episode,CG143,"What are the most effective pain management strategies, including opioid formulations and routes of administration, for acute sickle cell episodes?"
CG145_Spasticity in under 19s: management & Overview & Introduction,CG145,What are the recommended management strategies for spasticity in children and young people with non-progressive brain disorders?
CG145_Key priorities for implementation - Part 1,CG145,What are the principles of care and management strategies for children and young people with spasticity?
CG145_Key priorities for implementation - Part 2,CG145,What are the indications for intrathecal baclofen therapy in children with spasticity?
CG145_Recommendations: 1.1 Principles of care - Part 1,CG145,What are the recommended care pathways and management programmes for children and young people with spasticity?
CG145_Recommendations: 1.1 Principles of care - Part 2,CG145,What support and monitoring are recommended for children with spasticity at risk of hip displacement?
CG145_Recommendations: 1.2 Physical therapy (physiotherapy and/or occupational therapy) - Part 1,CG145,What are the recommended approaches for designing and implementing physical therapy programs for children with spasticity?
CG145_Recommendations: 1.2 Physical therapy (physiotherapy and/or occupational therapy) - Part 2,CG145,What are the recommended physical therapy strategies for postural management and muscle strengthening in children at risk of contractures or deformities?
CG145_Recommendations: 1.3 Orthoses - Part 1,CG145,What are the recommendations for using orthoses in children with spasticity to improve function and prevent contractures?
CG145_Recommendations: 1.3 Orthoses - Part 2,CG145,What are the indications and considerations for using ankle–foot and trunk orthoses in children with cerebral palsy?
CG145_Recommendations: 1.4 Oral drugs - Part 1,CG145,What are the guidelines for using oral diazepam and baclofen in children with spasticity?
CG145_Recommendations: 1.4 Oral drugs - Part 2 & Recommendations: 1.5 Botulinum toxin type A,CG145,What are the recommendations for managing adverse effects and treatment strategies for oral diazepam and baclofen in children with spasticity?
CG145_Recommendations: 1.5 Botulinum toxin type A - Part 1,CG145,What are the indications and contraindications for botulinum toxin type A treatment in children with focal spasticity?
CG145_Recommendations: 1.5 Botulinum toxin type A - Part 2,CG145,What precautions should be taken before administering botulinum toxin type A to children with spasticity?
CG145_Recommendations: 1.5 Botulinum toxin type A - Part 3,CG145,What are the recommended practices for administering botulinum toxin type A in children and young people?
CG145_Recommendations: 1.6 Intrathecal baclofen - Part 1,CG145,What are the indications and contraindications for intrathecal baclofen therapy in children with spasticity?
CG145_Recommendations: 1.6 Intrathecal baclofen - Part 2,CG145,What information should be provided to children and young people and their families before intrathecal baclofen pump implantation or testing?
CG145_Recommendations: 1.6 Intrathecal baclofen - Part 3,CG145,How is the response to intrathecal baclofen therapy assessed in children with spasticity?
CG145_Recommendations: 1.6 Intrathecal baclofen - Part 4,CG145,How is the response to intrathecal baclofen therapy monitored and managed in children and young people?
CG145_Recommendations: 1.7 Orthopaedic surgery,CG145,What are the indications and considerations for orthopaedic surgery in children and young people with spasticity?
CG145_Recommendations: 1.8 Selective dorsal rhizotomy,CG145,What are the criteria and considerations for selecting children with cerebral palsy for selective dorsal rhizotomy?
CG145_Recommendations: Terms used in this guideline - Part 1,CG145,What are the indications and recommended uses of botulinum toxin type A for managing spasticity?
CG145_Recommendations: Terms used in this guideline - Part 2,CG145,What are the recommended assessments and interventions for managing gross motor function and hip migration in children with neuromuscular conditions?
CG145_Recommendations: Terms used in this guideline - Part 3 & Recommendations for research: 1 Inhibitors of functional ability,CG145,What are the main factors that inhibit functional ability in children and young people with upper motor neurone lesions?
CG145_Recommendations for research: 2 Botulinum toxin type A & Recommendations for research: 2 Botulinum toxin type A,CG145,What is the clinical and cost effectiveness of botulinum toxin type A for managing focal spasticity in children and young people at GMFCS levels I to III?
CG145_Recommendations for research: 3 Intrathecal baclofen,CG145,What is the effectiveness of intrathecal baclofen pump therapy for managing spasticity in children and young people at GMFCS levels IV and V?
CG145_Recommendations for research: 4 Selective dorsal rhizotomy,CG145,What are the long-term outcomes of selective dorsal rhizotomy followed by intensive rehabilitation in children with cerebral palsy at GMFCS levels II and III?
CG146_Osteoporosis: assessing the risk of fragility fracture & Overview & Introduction - Part 1,CG146,What are the recommended risk assessment tools for fragility fractures in adults with osteoporosis?
CG146_Introduction - Part 2,CG146,What are the recommended risk assessment tools for predicting fragility fractures in the UK?
CG146_Recommendations: Targeting risk assessment,CG146,What are the criteria for fracture risk assessment in adults according to NICE guidelines?
CG146_Recommendations: Methods of risk assessment - Part 1,CG146,How should fracture risk be estimated and assessed in adults using tools like FRAX or QFracture?
CG146_Recommendations: Methods of risk assessment - Part 2,CG146,What are the indications for measuring bone mineral density in people under 40 with risk factors for osteoporosis?
CG146_Recommendations for research: 1 Using GP practice lists to identify people at high risk & Recommendations for research: 2 FRAX and QFracture in adults receiving bone protective therapy,CG146,What is the effectiveness of using GP practice lists to identify high-risk patients for fracture risk assessment?
CG146_Recommendations for research: 3 FRAX and QFracture in adults with secondary causes of osteoporosis,CG146,How effective are FRAX and QFracture in predicting fracture risk in adults with secondary causes of osteoporosis?
CG146_Recommendations for research: 4 BMD with FRAX,CG146,What is the added value of including BMD in FRAX assessment for fracture risk prediction?
CG146_Recommendations for research: 5 FRAX and QFracture in adults living in residential care,CG146,What is the effectiveness of FRAX and QFracture in predicting fracture risk in elderly care home residents?
CG147_Peripheral arterial disease: diagnosis and management & Overview & Recommendations: 1.1 Information requirements,CG147,What information should be provided to patients about peripheral arterial disease diagnosis and management?
CG147_Recommendations: 1.2 Secondary prevention of cardiovascular disease in people with peripheral arterial disease,CG147,What are the recommended secondary prevention strategies for peripheral arterial disease?
CG147_Recommendations: 1.3 Diagnosis,CG147,What are the recommended methods for diagnosing peripheral arterial disease in people with diabetes?
CG147_Recommendations: 1.4 Imaging for revascularisation & Recommendations: 1.5 Management of intermittent claudication - Part 1,CG147,What are the recommended imaging options before revascularisation for peripheral arterial disease?
CG147_Recommendations: 1.5 Management of intermittent claudication - Part 2,CG147,What is the recommended use of autologous vein for infra-inguinal bypass surgery in intermittent claudication?
CG147_Recommendations: 1.6 Management of critical limb ischaemia - Part 1,CG147,What are the recommended revascularisation options for managing critical limb ischaemia?
CG147_Recommendations: 1.6 Management of critical limb ischaemia - Part 2,CG147,What are the recommended management strategies for critical limb ischemic pain according to NICE guidelines?
CG147_Recommendations for research: Key recommendations for research - Part 1,CG147,What are the most effective diagnostic tools for detecting peripheral arterial disease in people with diabetes?
CG147_Recommendations for research: Key recommendations for research - Part 2,CG147,What is the clinical and cost effectiveness of angioplasty compared to bypass surgery for treating critical limb ischemia caused by infra-geniculate artery disease?
CG147_Recommendations for research: Other recommendations for research - Part 1,CG147,What are the attitudes and beliefs of patients with peripheral arterial disease regarding their condition and treatment outcomes?
CG147_Recommendations for research: Other recommendations for research - Part 2,CG147,What is the effectiveness of chemical sympathectomy compared to other pain management options for critical limb ischemia?
CG147_Rationale and impact,CG147,What is the recommended method for diagnosing peripheral arterial disease in people with diabetes?
CG147_Context,CG147,What are the recommended diagnostic and management strategies for peripheral arterial disease in patients with diabetes?
CG148_Urinary incontinence in neurological disease: assessment and management & Overview & Recommendations: 1.1 Assessment of lower urinary tract dysfunction in patients with neurological conditions - Part 1,CG148,What is the recommended approach for assessing urinary incontinence in patients with neurological disease?
CG148_Recommendations: 1.1 Assessment of lower urinary tract dysfunction in patients with neurological conditions - Part 2,CG148,What are the recommended assessments and investigations for diagnosing urinary tract infections and bladder dysfunction in patients with neurological conditions?
CG148_Recommendations: 1.1 Assessment of lower urinary tract dysfunction in patients with neurological conditions - Part 3,CG148,When should urodynamic investigations be performed for patients with neurogenic lower urinary tract dysfunction?
CG148_Recommendations: 1.2 Information and support,CG148,What information and training should be provided to patients with neurogenic urinary tract dysfunction regarding bladder management?
CG148_Recommendations: 1.3 Treatment to improve bladder storage - Part 1,CG148,What are the recommended behavioral and pharmacological treatments for bladder storage issues in neurogenic lower urinary tract dysfunction?
CG148_Recommendations: 1.3 Treatment to improve bladder storage - Part 2,CG148,What are the indications and considerations for using botulinum toxin type A in treating overactive bladder in adults and children?
CG148_Recommendations: 1.3 Treatment to improve bladder storage - Part 3,CG148,What are the indications and considerations for bladder wall injections with botulinum toxin type A in adults and children with neurogenic bladder?
CG148_Recommendations: 1.4 Treatment for stress incontinence & Recommendations: 1.5 Treatment to improve bladder emptying,CG148,What are the recommended treatments for stress incontinence in people with neurological conditions?
CG148_Recommendations: 1.6 Management with catheter valves & Recommendations: 1.7 Management with ileal conduit diversion,CG148,What are the considerations for using catheter valves as an alternative to drainage bags in urinary management?
CG148_Recommendations: 1.8 Treatment to prevent urinary tract infection,CG148,What are the recommendations for antibiotic prophylaxis to prevent urinary tract infections in people with neurogenic lower urinary tract dysfunction?
CG148_Recommendations: 1.9 Monitoring and surveillance protocols,CG148,What are the recommended monitoring and surveillance protocols for renal function in people with neurogenic lower urinary tract dysfunction?
CG148_Recommendations: 1.10 Potential complications: providing information and initial management,CG148,What are the signs and management strategies for renal complications and bladder stones in patients with neurogenic urinary tract dysfunction?
CG148_Recommendations: 1.11 Access to and interaction with services - Part 1,CG148,What are the recommended practices for providing information and contact details to patients with neurogenic lower urinary tract dysfunction and their carers?
CG148_Recommendations: 1.11 Access to and interaction with services - Part 2,CG148,What are the best practices for transferring care of neurogenic lower urinary tract dysfunction from paediatric to adult services?
CG148_Recommendations: Terms used in this guideline - Part 1,CG148,What are the indications and procedures for augmentation cystoplasty in bladder reconstruction?
CG148_Recommendations: Terms used in this guideline - Part 2,CG148,What is neurogenic bladder and how is it managed?
CG148_Recommendations: Terms used in this guideline - Part 3,CG148,What are the clinical features and management options for sacral agenesis and spina bifida?
CG148_Recommendations for research: 1 Safety and efficacy of antimuscarinics,CG148,What is the safety and efficacy of newer antimuscarinic drugs for neurogenic lower urinary tract dysfunction compared to placebo or other antimuscarinics?
CG148_Recommendations for research: 2 Safety and efficacy of botulinum toxin,CG148,What is the safety and effectiveness of botulinum toxin injections for neurogenic lower urinary tract dysfunction compared to usual care or other treatments?
CG148_Recommendations for research: 3 Management strategies to reduce the risk of symptomatic urinary tract infections,CG148,What management strategies can reduce the risk of urinary tract infections in people with neurogenic bladder dysfunction?
CG148_Recommendations for research: 4 Bladder management strategies,CG148,What are the long-term risks and quality of life outcomes associated with different bladder management strategies for neurological lower urinary tract dysfunction?
CG148_Context - Part 1,CG148,What are the management strategies for neurogenic lower urinary tract dysfunction in patients with neurological disease?
CG148_Context - Part 2,CG148,What are the recommended management strategies for neurogenic lower urinary tract dysfunction and its impact on quality of life?
CG150_Headaches in over 12s: diagnosis and management & Overview,CG150,What are the recommended approaches for diagnosing and managing migraines and other headaches in people aged 12 and over?
CG150_Recommendations: 1.1 Assessment,CG150,What are the key features that indicate the need for further investigation or referral in patients presenting with headache?
CG150_Recommendations: 1.2 Diagnosis - Part 1,CG150,"What are the key features used to differentiate tension-type headache, migraine, and cluster headache?"
CG150_Recommendations: 1.2 Diagnosis - Part 2 & Recommendations: 1.2 Diagnosis - Part 3,CG150,What are the diagnostic criteria for migraine with aura and how should it be managed?
CG150_Recommendations: 1.3 Management - Part 1,CG150,What are the recommended acute treatments for migraine with or without aura according to NICE guidelines?
CG150_Recommendations: 1.3 Management - Part 2,CG150,What are the recommended combination therapies for acute migraine treatment according to NICE guidelines?
CG150_Recommendations: 1.3 Management - Part 3,CG150,What are the recommended non-oral treatments for acute migraine when oral medications are not tolerated?
CG150_Recommendations: 1.3 Management - Part 4,CG150,What are the recommended prophylactic treatments for migraine and their associated benefits and risks?
CG150_Recommendations: 1.3 Management - Part 5,CG150,Should gabapentin be used for migraine prophylaxis?
CG150_Recommendations: 1.3 Management - Part 6,CG150,What are the recommended prophylactic treatments for preventing episodic and chronic migraine according to NICE guidelines?
CG150_Recommendations: 1.3 Management - Part 7,CG150,What are the recommended treatments for menstrual-related migraine that does not respond to standard acute therapy?
CG150_Recommendations: 1.3 Management - Part 8,CG150,What are the recommended acute and prophylactic treatments for cluster headache according to NICE guidelines?
CG150_Recommendations: 1.3 Management - Part 9,CG150,What is the recommended approach for managing medication overuse headache and withdrawal of overused headache medications?
CG150_Recommendations: Terms used in this guideline,CG150,What are the clinical features and distinguishing signs of acute narrow-angle glaucoma?
CG150_Context,CG150,What are the recommended approaches for diagnosing and managing primary headache disorders in adults and young people?
CG150_Recommendations for research: 1 Amitriptyline to prevent recurrent migraine,CG150,Is amitriptyline effective and cost-effective for preventing recurrent migraine?
CG150_Recommendations for research: 2 Pizotifen to prevent recurrent migraine,CG150,Is pizotifen effective and cost-effective for preventing recurrent migraine in children and adults?
CG150_Recommendations for research: 3 Topiramate to prevent recurrent cluster headache & Recommendations for research: 4 Psychological interventions to manage chronic headache disorders,CG150,Is topiramate effective and cost-effective for preventing recurrent cluster headaches?
CG150_Recommendations for research: 5 Pharmacological treatments for headache prophylaxis to aid withdrawal treatment in medication overuse headache,CG150,Does pharmacological prophylaxis or steroid treatment facilitate medication withdrawal in medication overuse headache?
CG151_Neutropenic sepsis: prevention and management in people with cancer & Overview & Introduction - Part 1,CG151,What are the recommended strategies for preventing and managing neutropenic sepsis in cancer patients receiving chemotherapy?
"CG151_Introduction - Part 2 & Key priorities for implementation: Information, support and training",CG151,What are the recommended practices for preventing and managing neutropenic sepsis in cancer patients?
CG151_Key priorities for implementation: Reducing the risk of septic complications of anticancer treatment,CG151,What is the recommended use of fluoroquinolone prophylaxis to prevent septic complications in neutropenic cancer patients?
CG151_Key priorities for implementation: Managing suspected neutropenic sepsis in secondary and tertiary care,CG151,What is the recommended initial antibiotic treatment for suspected neutropenic sepsis in adults and children?
CG151_Key priorities for implementation: Managing confirmed neutropenic sepsis,CG151,How should neutropenic sepsis be managed in patients at high or low risk of septic complications?
CG151_Recommendations: 1.2 Reducing the risk of septic complications of anticancer treatment & Recommendations: 1.3 When to refer patients in the community for suspected neutropenic sepsis,CG151,What are the recommended practices for prophylaxis and management of neutropenic sepsis in adult cancer patients?
CG151_Recommendations: 1.4 Managing suspected neutropenic sepsis in secondary and tertiary care - Part 1,CG151,What is the recommended initial antibiotic treatment for suspected neutropenic sepsis?
CG151_Recommendations: 1.4 Managing suspected neutropenic sepsis in secondary and tertiary care - Part 2,CG151,When should aminoglycosides or glycopeptide antibiotics be used in the initial treatment of suspected neutropenic sepsis?
CG151_Recommendations: 1.5 Managing confirmed neutropenic sepsis,CG151,What are the recommended management strategies for confirmed neutropenic sepsis?
CG151_Recommendations: Terms used in this guideline & Recommendations for research: 1 Service provision for neutropenic sepsis in patients with cancer,CG151,What is the recommended management of neutropenic sepsis in cancer patients receiving anticancer treatment?
CG151_Recommendations for research: 2 Patient support and information & Recommendations for research: 3 Signs and symptoms that predict neutropenic sepsis in the community,CG151,What are the best ways to support and provide information to patients and carers after neutropenic sepsis?
"CG151_Recommendations for research: 4 Reducing the risk of complications of anticancer treatment in children and young people, and in adults diagnosed with lymphoma",CG151,"What is the effectiveness of fluoroquinolone antibiotics and G-CSF for preventing neutropenic sepsis in children, young people, and adults with lymphoma undergoing anticancer treatment?"
CG151_Recommendations for research: 5 Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis,CG151,What is the evidence for switching from inpatient intravenous to outpatient oral antibiotics within 24 hours for neutropenic sepsis?
CG151_Advice from the Health Protection Agency,CG151,What are the recommendations for preventing septic complications in neutropenic patients undergoing anticancer treatment?
CG153_Psoriasis: assessment and management & Overview & Recommendations: 1.1 Principles of care - Part 1,CG153,What are the recommended strategies for assessing and managing psoriasis in adults and children?
CG153_Recommendations: 1.1 Principles of care - Part 2,CG153,What strategies improve medication adherence and patient support in managing psoriasis?
CG153_Recommendations: 1.2 Assessment and referral - Part 1,CG153,How should clinicians assess the severity and impact of psoriasis to determine the need for specialist referral?
CG153_Recommendations: 1.2 Assessment and referral - Part 2,CG153,What are the recommended tools for assessing psoriasis severity and impact on quality of life?
CG153_Recommendations: 1.2 Assessment and referral - Part 3,CG153,What are the criteria for referring children with psoriasis to a specialist?
CG153_Recommendations: 1.2 Assessment and referral - Part 4,CG153,How should adults with psoriasis be screened for psoriatic arthritis in primary care?
CG153_Recommendations: 1.2 Assessment and referral - Part 5,CG153,What are the recommended management strategies for patients with psoriasis and comorbid depression?
CG153_Recommendations: 1.3 Topical treatment - Part 1,CG153,What is the recommended first-line topical treatment for psoriasis according to NICE guidelines?
CG153_Recommendations: 1.3 Topical treatment - Part 2,CG153,What is the recommended follow-up schedule after starting topical treatment for psoriasis in adults and children?
CG153_Recommendations: 1.3 Topical treatment - Part 3,CG153,What are the recommended safe durations for using potent and very potent topical corticosteroids in psoriasis treatment?
CG153_Recommendations: 1.3 Topical treatment - Part 4,CG153,What is the recommended monitoring schedule for children using topical corticosteroids for psoriasis?
CG153_Recommendations: 1.3 Topical treatment - Part 5,CG153,What are the recommended topical treatments for psoriasis of the scalp in children and young people?
CG153_Recommendations: 1.3 Topical treatment - Part 6,CG153,What are the recommended topical treatments for scalp psoriasis if initial corticosteroid therapy is ineffective?
CG153_Recommendations: 1.3 Topical treatment - Part 7,CG153,What are the recommended topical treatments for scalp psoriasis in adults and children?
CG153_Recommendations: 1.3 Topical treatment - Part 8,CG153,"What are the recommended topical treatments and precautions for psoriasis involving the face, flexures, or genitals?"
CG153_Recommendations: 1.4 Phototherapy (broad- or narrowband UVB light and PUVA) - Part 1,CG153,"What are the indications and safety considerations for using phototherapy, including UVB and PUVA, in the treatment of psoriasis?"
CG153_Recommendations: 1.4 Phototherapy (broad- or narrowband UVB light and PUVA) - Part 2,CG153,Should co-therapy with acitretin be routinely combined with PUVA in psoriasis treatment?
CG153_Recommendations: 1.4 Phototherapy (broad- or narrowband UVB light and PUVA) - Part 3,CG153,What are the safety standards and training requirements for healthcare professionals administering phototherapy?
CG153_Recommendations: 1.5 Systemic treatment - Part 1,CG153,What are the guidelines for prescribing systemic treatments for psoriasis?
CG153_Recommendations: 1.5 Systemic treatment - Part 2,CG153,What are the recommended systemic treatments for moderate to severe psoriasis according to NICE guidelines?
CG153_Recommendations: 1.5 Systemic treatment - Part 3,CG153,What are the recommended medication regimens and dosing strategies for treating pustular psoriasis with methotrexate and ciclosporin?
CG153_Recommendations: 1.5 Systemic treatment - Part 4,CG153,What are the recommended monitoring protocols for hepatotoxicity in patients receiving methotrexate for psoriasis?
CG153_Recommendations: 1.5 Systemic treatment - Part 5,CG153,What are the recommended monitoring and risk assessment procedures for hepatotoxicity in patients with psoriasis on methotrexate therapy?
CG153_Recommendations: 1.5 Systemic treatment - Part 6,CG153,What is the most cost-effective medication option for treating plaque psoriasis in adults with high PASI and DLQI scores who have not responded to conventional treatments?
CG153_Recommendations: 1.5 Systemic treatment - Part 7,CG153,What are the criteria for switching to an alternative targeted immunomodulatory treatment in adults with plaque psoriasis?
CG153_Recommendations: 1.5 Systemic treatment - Part 8,CG153,What are the options for managing plaque psoriasis in children and young people who do not respond to conventional treatments?
CG153_Recommendations: Terms used in this guideline,CG153,What is the difference between conventional systemic treatments and targeted immunomodulatory treatments in managing immune-related conditions?
CG153_Recommendations for research: 1 Assessment of disease severity and impact,CG153,What are the validated tools for assessing disease severity and impact in psoriasis and psoriatic arthritis in clinical practice?
CG153_Recommendations for research: 2 Methotrexate and risk of hepatotoxicity,CG153,"What is the risk of hepatotoxicity associated with methotrexate compared to other systemic or targeted treatments for psoriasis, and how do factors like obesity, alcohol use, or diabetes influence this risk?"
CG153_Recommendations for research: 3 Rapid escalation to systemic treatments & Recommendations for research: 4 Self-management,CG153,Does early systemic treatment improve long-term outcomes and prognosis in psoriasis patients?
CG153_Recommendations for research: 5 Topical treatment,CG153,What are the best practices for using topical treatments to safely and effectively maintain psoriasis control?
CG153_Context - Part 1,CG153,What are the recommended active topical treatments for plaque psoriasis?
CG153_Context - Part 2,CG153,What are the recommended treatment options and care pathways for managing psoriasis across different severity levels?
CG155_Psychosis and schizophrenia in children and young people: recognition and management & Overview & Recommendations: 1.1 General principles of care - Part 1,CG155,What are the recommended approaches for recognizing and managing psychosis and schizophrenia in children and young people?
CG155_Recommendations: 1.1 General principles of care - Part 2,CG155,What are the recommended communication strategies and cultural considerations when supporting children and young people with psychosis or schizophrenia?
CG155_Recommendations: 1.1 General principles of care - Part 3,CG155,How can healthcare professionals ensure culturally appropriate care and smooth transitions for children and young people with psychosis from diverse backgrounds?
CG155_Recommendations: 1.2 Possible psychosis,CG155,What are the recommended assessment and management strategies for children and young people with possible psychosis according to NICE guidelines?
CG155_Recommendations: 1.3 First episode psychosis - Part 1,CG155,What are the recommended assessment procedures for children and young people experiencing first episode psychosis?
CG155_Recommendations: 1.3 First episode psychosis - Part 2,CG155,"How should mental health professionals develop and implement care, crisis, and support plans for children and young people with mental health conditions?"
CG155_Recommendations: 1.3 First episode psychosis - Part 3,CG155,What are the recommended treatment options for first episode psychosis in children and young people?
CG155_Recommendations: 1.3 First episode psychosis - Part 4,CG155,What factors should be considered when choosing an antipsychotic medication for children and young people?
CG155_Recommendations: 1.3 First episode psychosis - Part 5,CG155,What baseline investigations should be performed before starting antipsychotic medication in children and young people?
CG155_Recommendations: 1.3 First episode psychosis - Part 6,CG155,How should clinicians justify and record off-label antipsychotic dosages and monitor treatment effects in children and young people?
CG155_Recommendations: 1.3 First episode psychosis - Part 7,CG155,What are the NICE recommendations for psychological interventions and family involvement in treating children and young people with psychosis or schizophrenia?
CG155_Recommendations: 1.3 First episode psychosis - Part 8,CG155,What are the recommended components and session structure for delivering cognitive-behavioral therapy to children and young people with psychosis?
CG155_Recommendations: 1.4 Subsequent acute episodes of psychosis or schizophrenia - Part 1,CG155,What are the recommended pharmacological and psychological interventions for children and young people experiencing an acute relapse of psychosis or schizophrenia?
CG155_Recommendations: 1.4 Subsequent acute episodes of psychosis or schizophrenia - Part 2,CG155,What psychological interventions are recommended for children and young people with psychosis or schizophrenia?
CG155_Recommendations: 1.5 Referral in crisis and challenging behaviour - Part 1,CG155,What are the NICE guidelines for managing crisis and challenging behaviour in children and young people with mental health issues?
CG155_Recommendations: 1.5 Referral in crisis and challenging behaviour - Part 2,CG155,How should healthcare professionals involve children and young people in shared decision-making during hospital care?
CG155_Recommendations: 1.6 Early post-acute period,CG155,How should relapse be monitored after discontinuing antipsychotic medication in children and young people?
CG155_Recommendations: 1.7 Promoting recovery and providing possible future care in primary care,CG155,What are the NICE guidelines for monitoring and managing physical health in children and young people with psychosis or schizophrenia in primary care?
CG155_Recommendations: 1.8 Promoting recovery and providing possible future care in secondary care - Part 1,CG155,What psychological and pharmacological interventions are recommended for children and young people with psychosis or schizophrenia?
CG155_Recommendations: 1.8 Promoting recovery and providing possible future care in secondary care - Part 2,CG155,What are the recommended management strategies for children and young people with psychosis or schizophrenia who do not respond to initial treatment?
CG155_Recommendations: 1.8 Promoting recovery and providing possible future care in secondary care - Part 3,CG155,When should clozapine be offered to children and young people with schizophrenia?
"CG155_Recommendations for research: 1 What are the long-term outcomes, both psychotic and non‑psychotic, for children and young people with attenuated or transient psychotic symptoms suggestive of a developing psychosis, and can the criteria for 'at risk states' be refined to better predict those who will and those who will not go on to develop psychosis?",CG155,What are the long-term outcomes and risk factors for children and young people with attenuated or transient psychotic symptoms?
CG155_Recommendations for research: 2 What is the clinical and cost effectiveness for family intervention combined with individual CBT in the treatment of children and young people considered to be at high risk of developing psychosis and their parents or carers?,CG155,What is the clinical and cost effectiveness of family intervention combined with individual CBT for preventing psychosis in high-risk children and young people?
"CG155_Recommendations for research: 3 What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic medication and compared with psychological intervention and antipsychotic medication combined, in young people with first episode psychosis?",CG155,What is the effectiveness of psychological interventions compared to antipsychotic medication for first episode psychosis in young people?
CG155_Recommendations for research: 4 What is the clinical effectiveness of clozapine for children and young people with schizophrenia with symptoms unresponsive to antipsychotic medication and psychological treatment combined?,CG155,What is the clinical effectiveness of clozapine for treatment-resistant schizophrenia in children and young people?
CG155_Recommendations for research: 5 What is the most effective management strategy for preventing the development of excessive weight gain and metabolic syndrome associated with the use of antipsychotic medication in children and young people?,CG155,What are the most effective strategies to prevent weight gain and metabolic syndrome in children and young people taking antipsychotic medication?
CG155_Supplementary information on baseline investigations and monitoring,CG155,What are the recommended baseline investigations and monitoring schedule for children prescribed antipsychotic medication?
CG155_Context - Part 1,CG155,What are the early signs and management strategies for psychosis and schizophrenia in children and young people?
CG155_Context - Part 2,CG155,What are the recommended treatments and support options for children and young people with psychosis or schizophrenia?
CG156_Fertility problems: assessment and treatment & Overview,CG156,What are the recommended approaches for assessing and treating fertility problems?
CG156_Recommendations: 1.1 Principles of care,CG156,What information should be provided to couples experiencing fertility problems to support informed decision-making?
CG156_Recommendations: 1.2 Initial advice to people concerned about delays in conception - Part 1,CG156,What is the recommended frequency of sexual intercourse to improve chances of conception?
CG156_Recommendations: 1.2 Initial advice to people concerned about delays in conception - Part 2,CG156,What are the recommendations for timing artificial insemination around ovulation?
CG156_Recommendations: 1.2 Initial advice to people concerned about delays in conception - Part 3,CG156,What are the recommended lifestyle and health advice for improving fertility in men and women?
CG156_Recommendations: 1.2 Initial advice to people concerned about delays in conception - Part 4,CG156,When should women be offered fertility assessment after trying to conceive?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 1,CG156,What are the recommended methods for assessing ovarian reserve in fertility investigations?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 2,CG156,How can age and ovarian response measures predict success in natural conception and IVF outcomes?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 3,CG156,What tests are recommended or not recommended for assessing fertility in women?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 4,CG156,What are the recommended investigations for suspected tubal and uterine abnormalities in women seeking fertility assessment?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 5,CG156,What are the criteria for advising couples on unprotected sex when the man is HIV positive?
CG156_Recommendations: 1.3 Investigation of fertility problems and management strategies - Part 6,CG156,What are the recommended precautions and screening procedures for hepatitis C and rubella in women planning pregnancy?
CG156_Recommendations: 1.4 Medical and surgical management of male factor fertility problems,CG156,What are the recommended medical and surgical treatments for male factor infertility?
CG156_Recommendations: 1.5 Ovulation disorders - Part 1,CG156,What are the recommended first-line treatments for ovarian stimulation in women with WHO Group 2 ovulation disorders?
CG156_Recommendations: 1.5 Ovulation disorders - Part 2,CG156,What are the recommended treatments for women with WHO Group 2 anovulatory infertility and obesity?
CG156_Recommendations: 1.5 Ovulation disorders - Part 3,CG156,What are the recommended treatments and monitoring strategies for women with polycystic ovary syndrome undergoing ovulation induction?
CG156_Recommendations: 1.6 Tubal and uterine surgery & Recommendations: 1.7 Medical and surgical management of endometriosis,CG156,What are the recommended surgical options for tubal and uterine conditions to improve fertility?
CG156_Recommendations: 1.8 Unexplained infertility,CG156,What are the recommended treatments for unexplained infertility according to NICE guidelines?
CG156_Recommendations: 1.9 Intrauterine insemination,CG156,What are the indications for using intrauterine insemination as a fertility treatment?
CG156_Recommendations: 1.10 Prediction of IVF success,CG156,"How do age, BMI, lifestyle factors, and previous pregnancy history affect IVF success rates?"
CG156_Recommendations: 1.11 Access criteria for IVF - Part 1,CG156,What are the NICE guidelines for access to IVF treatment in women aged 40 to 42 years?
CG156_Recommendations: 1.11 Access criteria for IVF - Part 2,CG156,When should women with no previous IVF treatment and normal ovarian reserve be referred directly for IVF?
CG156_Recommendations: 1.12 Procedures used during IVF treatment - Part 1,CG156,What are the recommended procedures and regimens for ovarian stimulation during IVF treatment?
CG156_Recommendations: 1.12 Procedures used during IVF treatment - Part 2,CG156,What is the recommended ultrasound monitoring protocol during ovarian stimulation for IVF?
CG156_Recommendations: 1.12 Procedures used during IVF treatment - Part 3,CG156,What are the recommended embryo transfer strategies and practices in IVF according to NICE guidelines?
CG156_Recommendations: 1.12 Procedures used during IVF treatment - Part 4,CG156,What are the recommended embryo transfer practices and luteal phase support options in IVF treatment according to NICE guidelines?
CG156_Recommendations: 1.13 Intracytoplasmic sperm injection,CG156,What are the indications and genetic considerations for intracytoplasmic sperm injection (ICSI)?
CG156_Recommendations: 1.14 Donor insemination - Part 1,CG156,What are the indications and counselling considerations for donor insemination in fertility treatment?
CG156_Recommendations: 1.14 Donor insemination - Part 2,CG156,What counseling should be offered to potential semen donors regarding genetic and reproductive implications?
CG156_Recommendations: 1.15 Oocyte donation,CG156,What are the indications and screening requirements for oocyte donation?
CG156_Recommendations: 1.16 People with cancer who wish to preserve fertility - Part 1,CG156,What are the guidelines for fertility preservation in cancer patients before treatment?
CG156_Recommendations: 1.16 People with cancer who wish to preserve fertility - Part 2,CG156,What are the recommended methods for fertility preservation in cancer patients?
CG156_Recommendations: 1.17 Long-term safety of assisted reproductive technologies for women with infertility and their children,CG156,What are the long-term health outcomes and safety considerations of assisted reproductive technologies for women and children?
CG156_Terms used in this guideline & Recommendations for research: 1 Expectant management before IVF,CG156,What is the recommended duration of expectant management before IVF for women of different age groups?
CG156_Recommendations for research: 2 Embryo selection for single embryo transfer & Recommendations for research: 3 Adjuvant luteal phase support treatments in IVF & Recommendations for research: 4 Long-term safety of ovarian stimulation and ovulation induction for women,CG156,What are the current recommendations for embryo selection to improve single embryo transfer success rates?
CG156_Recommendations for research: 5 Long-term effects of IVF with or without intracytoplasmic sperm injection in children,CG156,What are the long-term health outcomes for children conceived through IVF with or without ICSI over 20 years?
CG156_Figures and tables to support chances of conception and embryo quality recommendations - Part 1,CG156,What are the chances of conceiving a clinical pregnancy based on age and number of cycles?
CG156_Figures and tables to support chances of conception and embryo quality recommendations - Part 2,CG156,What is the likelihood of conceiving a clinical pregnancy after multiple cycles of insemination based on age and sperm quality?
CG156_Context,CG156,What are the recommended investigations and treatment options for infertility according to NICE guidelines?
CG158_Antisocial behaviour and conduct disorders in children and young people: recognition and management & Overview,CG158,What are the recommended strategies for recognizing and managing conduct disorders in children and young people?
CG158_Recommendations: 1.1 General principles of care - Part 1,CG158,What are the recommended approaches for assessing and working with children and young people with conduct disorder from diverse cultural and social backgrounds?
CG158_Recommendations: 1.1 General principles of care - Part 2,CG158,What are the best practices for supporting transition and discharge in mental health services for children and young people?
CG158_Recommendations: 1.2 Selective prevention,CG158,What are the recommended classroom-based emotional learning programs for preventing conduct disorder in at-risk children aged 3 to 7?
CG158_Recommendations: 1.3 Identification and assessment - Part 1,CG158,What are the recommended initial assessment procedures for children and young people with suspected conduct disorder?
CG158_Recommendations: 1.3 Identification and assessment - Part 2,CG158,What are the key components of a comprehensive assessment for conduct disorders in children and young people?
CG158_Recommendations: 1.3 Identification and assessment - Part 3,CG158,What are the recommended assessments and care planning procedures for children and young people with suspected learning disabilities or reading difficulties?
CG158_Recommendations: 1.4 Identifying effective treatment and care options,CG158,What factors should be considered when selecting treatment options for children and young people with conduct disorder?
CG158_Recommendations: 1.5 Psychosocial interventions – treatment and indicated prevention - Part 1,CG158,What are the recommended parent training programmes for children at high risk of conduct disorder?
CG158_Recommendations: 1.5 Psychosocial interventions – treatment and indicated prevention - Part 2,CG158,What parent and foster carer training programs are recommended for children aged 3 to 11 with oppositional defiant disorder or conduct disorder?
CG158_Recommendations: 1.5 Psychosocial interventions – treatment and indicated prevention - Part 3,CG158,What are the recommended components and structure of foster carer training programmes for supporting children with behavioural difficulties?
CG158_Recommendations: 1.6 Pharmacological interventions - Part 1,CG158,What are the recommended pharmacological treatments for conduct disorder and associated behaviours in children and young people according to NICE guidelines?
CG158_Recommendations: 1.6 Pharmacological interventions - Part 2,CG158,What are the recommended monitoring and evaluation procedures for risperidone treatment in young people?
CG158_Recommendations: 1.7 Organisation and delivery of care - Part 1,CG158,What are the recommended strategies for improving access to services for children and young people with conduct disorder?
CG158_Recommendations: 1.7 Organisation and delivery of care - Part 2,CG158,What are the recommended features of local care pathways for children and young people with conduct disorder according to NICE guidelines?
CG158_Recommendations: 1.7 Organisation and delivery of care - Part 3,CG158,What are the key components for designing effective local care pathways for children and young people with conduct disorder?
CG158_Recommendations for research,CG158,What is the effectiveness of parent training programmes for conduct disorders in children aged 12 years and over?
CG158_Context - Part 1,CG158,What are the diagnostic criteria and management strategies for conduct disorder in children and young people?
CG158_Context - Part 2,CG158,What are the key considerations for managing conduct disorders in children and young people?
CG158_Context - Part 3,CG158,What are the recommended interventions for children with conduct disorder and how should services coordinate care across agencies?
"CG159_Social anxiety disorder: recognition, assessment and treatment & Overview",CG159,What are the recommended approaches for assessing and treating social anxiety disorder in children and adults?
CG159_Recommendations: 1.1 General principles of care in mental health and general medical settings - Part 1,CG159,What strategies can improve access and reduce distress for patients with social anxiety disorder in healthcare settings?
CG159_Recommendations: 1.1 General principles of care in mental health and general medical settings - Part 2,CG159,What are effective strategies for communicating with children and young people with social anxiety disorder during assessment and treatment?
CG159_Recommendations: 1.2 Identification and assessment of adults - Part 1,CG159,What are the recommended assessment methods for adults with suspected social anxiety disorder?
CG159_Recommendations: 1.2 Identification and assessment of adults - Part 2,CG159,What are the recommended approaches for assessing and treating social anxiety disorder in adults?
CG159_Recommendations: 1.3 Interventions for adults with social anxiety disorder - Part 1,CG159,What are the recommended psychological and pharmacological interventions for adults with social anxiety disorder according to NICE guidelines?
CG159_Recommendations: 1.3 Interventions for adults with social anxiety disorder - Part 2,CG159,What are the recommended pharmacological treatments and monitoring guidelines for social anxiety disorder in adults?
CG159_Recommendations: 1.3 Interventions for adults with social anxiety disorder - Part 3,CG159,What are the recommended pharmacological and psychological treatment options for social anxiety disorder?
CG159_Recommendations: 1.3 Interventions for adults with social anxiety disorder - Part 4,CG159,What are the recommended psychological and pharmacological treatments for social anxiety disorder according to NICE guidelines?
CG159_Recommendations: 1.3 Interventions for adults with social anxiety disorder - Part 5,CG159,What precautions should be taken when prescribing SSRIs or SNRIs to people under 30 for anxiety disorders?
CG159_Recommendations: 1.4 Identification and assessment of children and young people - Part 1,CG159,What are the signs and assessment methods for social anxiety disorder in children and young people?
CG159_Recommendations: 1.4 Identification and assessment of children and young people - Part 2,CG159,What are the recommended assessment procedures for children and young people with suspected social anxiety disorder?
CG159_Recommendations: 1.4 Identification and assessment of children and young people - Part 3,CG159,What assessment tools are recommended for diagnosing social anxiety disorder and related mental health problems in children and young people?
CG159_Recommendations: 1.5 Interventions for children and young people with social anxiety disorder - Part 1,CG159,What are the recommended psychological interventions for children and young people with social anxiety disorder?
CG159_Recommendations: 1.5 Interventions for children and young people with social anxiety disorder - Part 2,CG159,What are the recommended psychological interventions for children and young people with social anxiety disorder?
CG159_Recommendations: 1.6 Interventions that are not recommended to treat social anxiety disorder & Recommendations: 1.7 Specific phobias,CG159,What treatments are not recommended for social anxiety disorder according to NICE guidelines?
CG159_Recommendations for research: 1 Adults' uptake of and engagement with interventions for social anxiety disorder,CG159,What strategies are effective in increasing uptake and engagement with interventions for adults with social anxiety disorder?
CG159_Recommendations for research: 2 Specific versus generic CBT for children and young people with social anxiety disorder,CG159,What is the clinical and cost effectiveness of specific cognitive-behavioral therapy compared to generic anxiety-focused CBT for children and young people with social anxiety disorder?
CG159_Recommendations for research: 3 The role of parents in the treatment of children and young people with social anxiety disorder,CG159,How should parents be involved in the treatment of children and young people with social anxiety disorder?
CG159_Recommendations for research: 4 Individual versus group CBT for children and young people with social anxiety disorder,CG159,What is the effectiveness and cost-effectiveness of individual versus group cognitive behavioral therapy for children and young people with social anxiety disorder?
CG159_Recommendations for research: 5 Combined interventions for adults with social anxiety disorder,CG159,What is the effectiveness of combined psychological and pharmacological treatments compared to single interventions for adults with social anxiety disorder?
CG159_Context - Part 1,CG159,What are the recommended treatments for social anxiety disorder in adults and children?
CG159_Context - Part 2,CG159,What are the recommended psychological and pharmacological treatments for social anxiety disorder?
CG163_Idiopathic pulmonary fibrosis in adults: diagnosis and management & Overview & Recommendations: 1.1 Awareness of clinical features of idiopathic pulmonary fibrosis,CG163,What are the clinical features and diagnostic criteria for idiopathic pulmonary fibrosis in adults?
CG163_Recommendations: 1.2 Diagnosis - Part 1,CG163,What are the recommended diagnostic steps for suspected idiopathic pulmonary fibrosis?
CG163_Recommendations: 1.2 Diagnosis - Part 2,CG163,What are the indications for lung biopsy in diagnosing idiopathic pulmonary fibrosis when clinical features are inconclusive?
CG163_Recommendations: 1.3 Information and support & Recommendations: 1.4 Prognosis,CG163,What information and support should be provided to patients with idiopathic pulmonary fibrosis and their families?
CG163_Recommendations: 1.5 Management - Part 1,CG163,What are the recommended assessments and management strategies for pulmonary rehabilitation and supportive care in idiopathic pulmonary fibrosis?
CG163_Recommendations: 1.5 Management - Part 2,CG163,What are the recommended treatments and management options for idiopathic pulmonary fibrosis?
CG163_Recommendations: 1.5 Management - Part 3,CG163,What are the NICE guidelines for managing idiopathic pulmonary fibrosis?
CG163_Recommendations: 1.6 Review and follow-up,CG163,What are the recommended follow-up assessments and schedule for patients with idiopathic pulmonary fibrosis?
CG163_Recommendations for research: 1 Pulmonary rehabilitation to improve outcomes in people with idiopathic pulmonary fibrosis,CG163,Does pulmonary rehabilitation improve quality of life and lung function in people with idiopathic pulmonary fibrosis?
CG163_Recommendations for research: 2 Ambulatory oxygen to improve outcomes in idiopathic pulmonary fibrosis,CG163,Does ambulatory oxygen improve exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis?
CG163_Recommendations for research: 3 Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis,CG163,Is anti-reflux therapy effective in treating idiopathic pulmonary fibrosis?
CG163_Context,CG163,What are the current recommendations for diagnosing and managing idiopathic pulmonary fibrosis?
"CG164_Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer & Overview",CG164,What are the recommended strategies for managing breast cancer risk in people with a family history of breast or related cancers?
CG164_Recommendations: 1.1 Clinical significance of a family history of breast cancer - Part 1,CG164,What is the recommended approach for taking family history of breast cancer in primary care?
CG164_Recommendations: 1.1 Clinical significance of a family history of breast cancer - Part 2,CG164,What information should be collected for family history assessment in breast cancer risk evaluation?
CG164_Recommendations: 1.1 Clinical significance of a family history of breast cancer - Part 3,CG164,How is carrier probability calculated for BRCA mutations in genetic counseling?
CG164_Recommendations: 1.2 Information and support - Part 1,CG164,What information and support should be provided to patients with concerns about familial breast cancer risk?
CG164_Recommendations: 1.2 Information and support - Part 2,CG164,What information is provided to patients and healthcare professionals about genetic testing and risk management for hereditary breast cancer?
CG164_Recommendations: 1.3 Care of people in primary care - Part 1,CG164,What are the criteria for primary care management and referral for familial breast cancer risk?
CG164_Recommendations: 1.3 Care of people in primary care - Part 2,CG164,When should I refer a woman with a family history of breast cancer to secondary or genetic specialist care?
CG164_Recommendations: 1.4 Care of people in secondary care and specialist genetic clinics - Part 1,CG164,What are the criteria for referring patients to secondary care or specialist genetic clinics for breast cancer risk assessment?
CG164_Recommendations: 1.4 Care of people in secondary care and specialist genetic clinics - Part 2,CG164,"What are the criteria for referring individuals with a family history of breast, ovarian, or other related cancers to a genetic specialist?"
CG164_Recommendations: 1.4 Care of people in secondary care and specialist genetic clinics - Part 3,CG164,What are the criteria for assessing familial breast cancer risk according to NICE guidelines?
CG164_Recommendations: 1.4 Care of people in secondary care and specialist genetic clinics - Part 4,CG164,What are the criteria for referring women to genetic counselling for familial breast cancer risk assessment?
CG164_Recommendations: 1.5 Genetic testing - Part 1,CG164,What are the recommended procedures for genetic testing and counseling for mutation finding in at-risk individuals?
CG164_Recommendations: 1.5 Genetic testing - Part 2,CG164,When should genetic testing for BRCA1 and BRCA2 mutations be offered to individuals with no personal history of breast cancer?
CG164_Recommendations: 1.6 Surveillance and strategies for early detection of breast cancer - Part 1,CG164,What are the recommended surveillance strategies for women at different levels of breast cancer risk?
CG164_Recommendations: 1.6 Surveillance and strategies for early detection of breast cancer - Part 2,CG164,What are the recommended breast cancer screening and surveillance options for women with BRCA or TP53 mutations?
CG164_Recommendations: 1.6 Surveillance and strategies for early detection of breast cancer - Part 3,CG164,What are the NICE recommendations for MRI screening in women at different levels of breast cancer risk?
CG164_Recommendations: 1.6 Surveillance and strategies for early detection of breast cancer - Part 4,CG164,What are the recommendations for MRI surveillance in women at high risk of breast cancer?
CG164_Recommendations: 1.6 Surveillance and strategies for early detection of breast cancer - Part 5,CG164,What are the recommendations for breast cancer surveillance in women with a family history or genetic risk?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 1,CG164,What are the recommended risk reduction strategies for women with a family history of breast cancer?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 2,CG164,What are the recommendations for chemoprevention in women with no personal history of breast cancer?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 3,CG164,What are the recommended chemopreventive options for women at high risk of breast cancer?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 4,CG164,What are the NICE recommendations for chemoprevention options in women at moderate risk of breast cancer?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 5,CG164,What should women consider before undergoing bilateral risk-reducing mastectomy or oophorectomy?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 6,CG164,What are the considerations for bilateral risk-reducing oophorectomy in women at high risk of ovarian or breast cancer?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 7,CG164,What are the guidelines for risk-reducing bilateral salpingo-oophorectomy in women with BRCA mutations?
CG164_Recommendations: 1.7 Risk reduction and treatment strategies - Part 8,CG164,What are the risks and benefits of risk-reducing bilateral salpingo-oophorectomy for women with BRCA or TP53 mutations?
CG164_Recommendations: Summary of recommendations on surveillance for women with no personal history of breast cancer - Part 1,CG164,What are the recommended breast cancer surveillance strategies for women at high risk with no personal history?
CG164_Recommendations: Summary of recommendations on surveillance for women with no personal history of breast cancer - Part 2,CG164,What are the breast cancer surveillance recommendations for women with high or moderate lifetime risk?
CG164_Recommendations: Terms used in this guideline,CG164,What are the criteria for assessing breast cancer risk categories?
CG164_Context & Recommendations for research: 1 Carrier probability calculation models,CG164,What are the criteria for genetic testing in familial breast cancer risk assessment?
CG164_Recommendations for research: 2 Rapid genetic testing & Recommendations for research: 3 Benefits of MRI surveillance in women over 50 years,CG164,What are the benefits of MRI surveillance for women over 50 years with breast cancer?
CG164_Recommendations for research: 3 Benefits of MRI surveillance in women over 50 years & Recommendations for research: 4 Chemoprevention to reduce incidence of breast cancer & Recommendations for research: 5 Impact of risk-reducing surgery,CG164,What are the benefits and limitations of MRI surveillance compared to mammography in women over 50 with a history of breast cancer?
CG164_Recommendations for research: 6 Prevalence of BRCA1 mutations in unselected basal phenotype breast cancer compared with unselected triple negative breast cancer,CG164,What is the prevalence of BRCA1 mutations in unselected basal phenotype versus triple negative breast cancer?
CG165_Hepatitis B (chronic): diagnosis and management & Overview & Recommendations: 1.1 Patient information,CG165,What are the recommended diagnostic and management strategies for chronic hepatitis B?
CG165_Recommendations: 1.2 Assessment and referral in primary care - Part 1,CG165,What tests should be performed in primary care for adults who are HBsAg positive?
CG165_Recommendations: 1.2 Assessment and referral in primary care - Part 2,CG165,What are the recommended specialist referral and testing protocols for pregnant women and children with hepatitis B infection?
CG165_Recommendations: 1.3 Assessment of liver disease in secondary specialist care - Part 1,CG165,What are the recommended assessment methods for liver fibrosis in adults with chronic hepatitis B?
CG165_Recommendations: 1.3 Assessment of liver disease in secondary specialist care - Part 2 & Recommendations: 1.4 Genotype testing,CG165,When should liver biopsy be considered for adults and children with chronic hepatitis B?
CG165_Recommendations: 1.5 Antiviral treatment - Part 1,CG165,What are the criteria for initiating antiviral treatment in adults with chronic hepatitis B?
CG165_Recommendations: 1.5 Antiviral treatment - Part 2,CG165,What are the recommended treatment options for adults with HBeAg-positive chronic hepatitis B and compensated liver disease?
CG165_Recommendations: 1.5 Antiviral treatment - Part 3,CG165,When should nucleoside or nucleotide analogue treatment be stopped in patients with chronic hepatitis B?
CG165_Recommendations: 1.5 Antiviral treatment - Part 4,CG165,What are the recommended treatments for children and adults with chronic hepatitis B according to NICE guidelines?
CG165_Recommendations: 1.5 Antiviral treatment - Part 5,CG165,What are the NICE guidelines for managing hepatitis B in pregnant women and infants?
CG165_Recommendations: 1.5 Antiviral treatment - Part 6,CG165,"What are the recommended treatments and monitoring strategies for hepatitis B and C co-infection, including hepatitis D and prophylactic antiviral use during immunosuppressive therapy?"
CG165_Recommendations: 1.5 Antiviral treatment - Part 7,CG165,What are the recommendations for hepatitis B prophylaxis in patients undergoing immunosuppressive therapy?
CG165_Recommendations: 1.6 Monitoring - Part 1,CG165,What are the recommended monitoring intervals for ALT and HBV DNA levels in adults and children with chronic hepatitis B?
CG165_Recommendations: 1.6 Monitoring - Part 2,CG165,What are the recommended monitoring procedures for children and adults after HBeAg or HBsAg seroconversion following antiviral treatment for hepatitis B?
CG165_Recommendations: 1.6 Monitoring - Part 3,CG165,"What are the recommended monitoring protocols for patients on entecavir, lamivudine, or tenofovir disoproxil for chronic hepatitis B?"
CG165_Recommendations: 1.6 Monitoring - Part 4,CG165,"What monitoring is recommended for patients with decompensated liver disease taking entecavir, lamivudine, or tenofovir disoproxil?"
CG165_Recommendations: 1.7 Surveillance testing for hepatocellular carcinoma in adults with chronic hepatitis B,CG165,What are the recommended surveillance strategies for hepatocellular carcinoma in adults with chronic hepatitis B?
CG165_Recommendations: Terms used in this guidance,CG165,"What are the criteria for diagnosing chronic hepatitis B and the significance of HBsAg, HBeAg, and HBV DNA levels?"
CG165_Recommendations for research: 1 Stopping antiviral treatment in HBeAg-negative disease,CG165,What are the current recommendations for stopping antiviral treatment in HBeAg-negative hepatitis B?
CG165_Recommendations for research: 2 ALT values for children and young people,CG165,Should the upper limit of normal ALT values used to assess chronic hepatitis B activity be different for children and young people?
CG165_Recommendations for research: 3 Long-term safety of tenofovir disoproxil in chronic hepatitis B,CG165,What are the long-term safety considerations and monitoring requirements for tenofovir disoproxil in patients with chronic hepatitis B?
CG165_Recommendations for research: 4 Prophylactic treatment in people receiving immunosuppressive therapy,CG165,What are the recommended prophylactic treatments for HBV reactivation in patients receiving immunosuppressive therapy?
CG165_Context - Part 1,CG165,What are the recommended treatments for managing chronic hepatitis B to prevent liver cirrhosis and hepatocellular carcinoma?
CG165_Context - Part 2,CG165,What are the criteria for initiating antiviral treatment in chronic hepatitis B patients?
CG165_Context - Part 3,CG165,When should antiviral treatment be initiated in patients with chronic hepatitis B?
CG168_Varicose veins: diagnosis and management & Overview & Introduction,CG168,What are the recommended management options for varicose veins in adults according to NICE guidelines?
CG168_Key priorities for implementation,CG168,When should patients with varicose veins be referred to a vascular service?
CG168_Recommendations: 1.1 Information for people with varicose veins & Recommendations: 1.2 Referral to a vascular service,CG168,What information should I receive about varicose veins and their treatment options?
CG168_Recommendations: 1.3 Assessment and treatment in a vascular service & Recommendations: 1.4 Management during pregnancy,CG168,What are the recommended assessment and treatment options for varicose veins according to NICE guidelines?
CG168_Recommendations for research: 1 Natural history of varicose veins,CG168,What factors influence the progression of varicose veins from CEAP stage C2 or C3 to C5 or C6?
CG168_Recommendations for research: 2 Compression as a management option,CG168,What is the effectiveness of compression hosiery compared to no compression for managing symptomatic varicose veins?
CG168_Recommendations for research: 3 Compression after interventional treatment,CG168,What is the clinical and cost effectiveness of compression bandaging or hosiery after interventional treatment for varicose veins?
CG168_Recommendations for research: 4 Truncal treatment with or without concurrent tributary treatment,CG168,What is the clinical and cost effectiveness of concurrent versus delayed tributary treatment during truncal endothermal ablation for varicose veins?
CG168_Recommendations for research: 5 Optimal interventional and conservative treatments at different stages of disease,CG168,What is the most effective treatment for varicose veins at different CEAP stages?
CG170_Autism spectrum disorder in under 19s: support and management & Introduction - Part 1,CG170,What are the recommended support and management strategies for autism spectrum disorder in children and young people?
CG170_Introduction - Part 2,CG170,What are effective interventions and support strategies for autistic children and young people across different ages?
CG170_Key priorities for implementation: Access to health and social care services & Key priorities for implementation: Knowledge and competence of health and social care professionals & Key priorities for implementation: Making adjustments to the social and physical environment and processes of care,CG170,What training should health and social care professionals receive to support autistic children and young people effectively?
CG170_Key priorities for implementation: Psychosocial interventions & Key priorities for implementation: Anticipating and preventing behaviour that challenges & Key priorities for implementation: Psychosocial interventions for behaviour that challenges,CG170,What psychosocial interventions are recommended for managing challenging behaviour in autistic children and young people?
CG170_Key priorities for implementation: Pharmacological interventions for behaviour that challenges & Key priorities for implementation: Families and carers,CG170,What are the recommended pharmacological interventions for managing behaviour that challenges in autistic children and young people?
CG170_Key priorities for implementation: Transition to adult services,CG170,What are the recommended steps for transitioning young people with complex needs to adult mental health services?
CG170_Recommendations: 1.1 General principles of care - Part 1,CG170,What are the recommended care and support arrangements for autistic children and young people with coexisting conditions?
CG170_Recommendations: 1.1 General principles of care - Part 2,CG170,What training should health and social care professionals receive to effectively support autistic children and young people?
CG170_Recommendations: 1.1 General principles of care - Part 3,CG170,What are best practices for supporting autistic children and young people during puberty and major life changes?
CG170_Recommendations: 1.2 Families and carers,CG170,What support and assessments are available for families and carers of children with special needs?
CG170_Recommendations: 1.3 Specific interventions for the core features of autism,CG170,What are effective psychosocial interventions for improving social communication in children and young people with autism?
CG170_Recommendations: 1.4 Interventions for behaviour that challenges - Part 1,CG170,What are effective interventions for managing behaviour that challenges in autistic children and young people?
CG170_Recommendations: 1.4 Interventions for behaviour that challenges - Part 2 & Recommendations: 1.5 Interventions for life skills,CG170,What are the recommended psychosocial and pharmacological interventions for managing behaviour that challenges in children and young people with autism?
CG170_Recommendations: 1.6 Interventions for autism that should not be used,CG170,Which interventions should be avoided for managing autism in children and young people?
CG170_Recommendations: 1.7 Interventions for coexisting problems - Part 1,CG170,What are recommended interventions for managing coexisting mental health and sleep problems in autistic children and young people?
CG170_Recommendations: 1.7 Interventions for coexisting problems - Part 2,CG170,What are the recommended interventions for sleep problems in children with autism?
CG170_Recommendations: 1.8 Transition to adult services,CG170,What are the recommended steps for transitioning autistic young people from child to adult mental health services?
CG170_Recommendations for research: 1 A key worker approach for autistic children and young people and their families,CG170,"What is the effectiveness of a key worker approach for improving parental satisfaction, stress, and child outcomes in autistic children and young people?"
CG170_Recommendations for research: 2 Managing behaviour that challenges in autistic children and young people,CG170,Is group-based parent training effective in reducing challenging behaviour in autistic children and young people?
CG170_Recommendations for research: 3 Treating comorbid anxiety in autistic children and young people,CG170,What is the effectiveness of pharmacological versus psychosocial interventions for anxiety in autistic children and young people?
"CG170_Recommendations for research: 4 Teacher-, parent- and peer-mediated psychosocial interventions in pre‑school autistic children",CG170,What evidence supports the effectiveness of parent- and teacher-mediated psychosocial interventions like LEAP for managing core autism features in preschool children?
CG173_Neuropathic pain in adults: pharmacological management in non-specialist settings & Overview,CG173,What are the recommended pharmacological treatments for neuropathic pain in adults in non-specialist settings?
CG173_Introduction - Part 1,CG173,What are the clinical features and causes of neuropathic pain?
CG173_Introduction - Part 2,CG173,What are the recommended pharmacological treatments for managing neuropathic pain in adults outside of specialist pain services?
CG173_Introduction - Part 3,CG173,What are the recommended pharmacological treatments for neuropathic pain in non-specialist settings according to NICE guidelines?
CG173_Recommendations: 1.1 List of all recommendations - Part 1,CG173,What are the key principles for managing pain and prescribing treatments in patients with chronic pain?
CG173_Recommendations: 1.1 List of all recommendations - Part 2,CG173,What are the recommended initial treatments and management strategies for neuropathic pain according to NICE guidelines?
CG173_Recommendations: 1.1 List of all recommendations - Part 3,CG173,What are the recommended initial and alternative treatments for trigeminal neuralgia according to NICE guidelines?
CG173_Additional information,CG173,"What are the licensed indications and prescribing considerations for duloxetine, gabapentin, pregabalin, and capsaicin cream in neuropathic pain management?"
CG173_Recommendations for research: 1 Monotherapy versus combination therapy for treating neuropathic pain - Part 1,CG173,What is the effectiveness and tolerability of monotherapy versus combination therapy for neuropathic pain?
CG173_Recommendations for research: 1 Monotherapy versus combination therapy for treating neuropathic pain - Part 2,CG173,What is the effectiveness of monotherapy versus combination therapy for treating neuropathic pain in adults?
"CG173_Recommendations for research: 2 Relationship between symptoms, cause of neuropathic pain and its treatment - Part 1",CG173,Is the response to pharmacological treatment for neuropathic pain better predicted by underlying cause or by symptom characteristics?
"CG173_Recommendations for research: 2 Relationship between symptoms, cause of neuropathic pain and its treatment - Part 2",CG173,What are the most effective pharmacological treatments for different types of neuropathic pain in adults?
CG173_Recommendations for research: 3 Carbamazepine for treating trigeminal neuralgia - Part 1,CG173,What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared to other medications?
CG173_Recommendations for research: 3 Carbamazepine for treating trigeminal neuralgia - Part 2,CG173,What is the effectiveness of carbamazepine monotherapy for treating trigeminal neuralgia in adults?
CG173_Recommendations for research: 4 Factors affecting participation and quality of life,CG173,"What factors, including additional care and support, influence participation and quality of life in adults with neuropathic pain?"
CG173_Recommendations for research: 5 Impact of drug-related adverse effects on cost effectiveness and quality of life,CG173,What is the impact of drug-related adverse effects on quality of life and cost-effectiveness in patients with neuropathic pain?
CG173_Recommendations for research: 6 Potential for dependence associated with pharmacological drugs for neuropathic pain,CG173,What is the potential for dependence with pharmacological treatments for neuropathic pain?
CG174_Intravenous fluid therapy in adults in hospital & Overview & Introduction - Part 1,CG174,What are the best practices for prescribing intravenous fluid therapy in adult hospital inpatients?
CG174_Introduction - Part 2,CG174,What are the recommended practices for prescribing and monitoring IV fluid therapy in general hospital wards?
CG174_Key priorities for implementation: Principles and protocols for intravenous fluid therapy,CG174,What are the principles and protocols for prescribing intravenous fluid therapy?
CG174_Key priorities for implementation: Assessment and monitoring,CG174,What are the recommended methods for assessing and monitoring fluid and electrolyte balance in patients receiving IV fluids?
CG174_Key priorities for implementation: Resuscitation & Key priorities for implementation: Routine maintenance & Key priorities for implementation: Training and education,CG174,What are the recommended practices for IV fluid resuscitation and maintenance in adult patients?
CG174_Recommendations: 1.1 Principles and protocols for intravenous fluid therapy - Part 1,CG174,What are the principles and protocols for prescribing intravenous fluid therapy?
CG174_Recommendations: 1.1 Principles and protocols for intravenous fluid therapy - Part 2,CG174,What should be included in an IV fluid management plan for hospitalized patients?
CG174_Recommendations: 1.2 Assessment and monitoring - Part 1,CG174,What are the key indicators for assessing hypovolaemia and fluid responsiveness in adult patients?
CG174_Recommendations: 1.2 Assessment and monitoring - Part 2,CG174,What are the recommended monitoring practices for patients receiving intravenous fluid therapy?
CG174_Recommendations: 1.3 Resuscitation & Recommendations: 1.5 Replacement and redistribution & Recommendations: 1.6 Training and education - Part 2,CG174,What are the recommended IV fluid types and dosages for resuscitation and maintenance in adults?
CG174_Recommendations: 1.6 Training and education - Part 3,CG174,What are the recommended daily water and electrolyte intakes for children based on body weight?
CG174_Recommendations: 1.6 Training and education - Part 4 & Recommendations: Terms used in this guideline & Recommendations for research,CG174,What are the risks and complications associated with intravenous fluid therapy in hospitalized patients?
CG178_Psychosis and schizophrenia in adults: prevention and management & Overview & Recommendations: 1.1 Care across all phases - Part 1,CG178,What are the recommended approaches for managing physical health in adults with psychosis or schizophrenia?
CG178_Recommendations: 1.1 Care across all phases - Part 2,CG178,What are the recommended interventions and monitoring strategies for smoking cessation and metabolic health in people with psychosis or schizophrenia?
CG178_Recommendations: 1.1 Care across all phases - Part 3,CG178,What are the recommended approaches for peer support and self-management in the treatment of psychosis and schizophrenia?
CG178_Recommendations: 1.2 Preventing psychosis,CG178,What are the recommended interventions for preventing psychosis in at-risk individuals?
CG178_Recommendations: 1.3 First episode psychosis - Part 1,CG178,What are the recommended assessments and interventions for first episode psychosis according to NICE guidelines?
CG178_Recommendations: 1.3 First episode psychosis - Part 2,CG178,What are the recommended assessments and treatment options for first-episode psychosis?
CG178_Recommendations: 1.3 First episode psychosis - Part 3,CG178,What are the recommended psychological interventions and medication management strategies for treating psychosis according to NICE guidelines?
CG178_Recommendations: 1.3 First episode psychosis - Part 4,CG178,What are the recommended procedures for monitoring patients starting antipsychotic medication for psychosis or schizophrenia?
CG178_Recommendations: 1.3 First episode psychosis - Part 5,CG178,What are the recommended monitoring practices for physical health and medication effects in people prescribed antipsychotics?
CG178_Recommendations: 1.3 First episode psychosis - Part 6,CG178,What are the recommended components and duration for family interventions in psychosis or schizophrenia?
CG178_Recommendations: 1.4 Subsequent acute episodes of psychosis or schizophrenia and referral in crisis - Part 1,CG178,What are the recommended crisis intervention and treatment options for acute episodes of psychosis or schizophrenia?
CG178_Recommendations: 1.4 Subsequent acute episodes of psychosis or schizophrenia and referral in crisis - Part 2,CG178,What psychological and psychosocial interventions are recommended for managing psychosis and schizophrenia?
CG178_Recommendations: 1.4 Subsequent acute episodes of psychosis or schizophrenia and referral in crisis - Part 3,CG178,What are the recommended approaches for managing violence and aggression in people with psychosis or schizophrenia?
CG178_Recommendations: 1.5 Promoting recovery and possible future care - Part 1,CG178,What are the recommended practices for monitoring physical health in people with psychosis or schizophrenia in primary care?
CG178_Recommendations: 1.5 Promoting recovery and possible future care - Part 2,CG178,What are the recommended strategies for managing cardiovascular risk factors in people with psychosis or schizophrenia?
CG178_Recommendations: 1.5 Promoting recovery and possible future care - Part 3,CG178,What are the recommended psychological and pharmacological interventions for managing psychosis and schizophrenia?
CG178_Recommendations: 1.5 Promoting recovery and possible future care - Part 4,CG178,What are the criteria for prescribing long-acting injectable antipsychotics in schizophrenia treatment?
CG178_Recommendations: 1.5 Promoting recovery and possible future care - Part 5,CG178,What are the recommended treatment options for schizophrenia patients who do not respond to clozapine?
CG178_Recommendations for research: 1 Peer support interventions,CG178,What is the clinical and cost effectiveness of peer support interventions for people with psychosis and schizophrenia?
CG178_Recommendations for research: 2 People who choose not to take antipsychotic medication,CG178,What is the effectiveness of psychological interventions alone compared to treatment as usual for people with psychosis or schizophrenia who refuse or discontinue antipsychotic medication?
CG178_Recommendations for research: 3 The physical health benefits of discontinuing antipsychotic medication,CG178,What are the physical health benefits and risks of discontinuing or reducing antipsychotic medication in first episode psychosis?
CG178_Recommendations for research: 4 Maintaining the benefits of early intervention in psychosis services after discharge,CG178,How can the benefits of early intervention in psychosis services be maintained after discharge?
CG178_Recommendations for research: 5 Interventions for PTSD symptoms in people with psychosis and schizophrenia,CG178,What is the effectiveness of CBT-based trauma reprocessing interventions for reducing PTSD symptoms in people with psychosis and schizophrenia?
CG178_Context - Part 1,CG178,What are the recommended treatment and management strategies for adults with psychosis and schizophrenia?
CG178_Context - Part 2,CG178,What are the recommended early detection and intervention strategies for schizophrenia?
CG179_Pressure ulcers: prevention and management & Introduction - Part 1,CG179,What are the best strategies for preventing pressure ulcers in hospitalized patients?
CG179_Introduction - Part 2 & Key priorities for implementation: Adults: risk assessment,CG179,What are the recommended risk assessment and prevention strategies for pressure ulcers in NHS care?
CG179_Key priorities for implementation: Adults: skin assessment & 4 more sections,CG179,What are the recommended skin assessment and prevention strategies for pressure ulcer risk in adults and children?
CG179_Key priorities for implementation: All ages: healthcare professional training and education & Key priorities for implementation: Adults: management of heel pressure ulcers,CG179,What training should healthcare professionals receive to prevent and manage pressure ulcers?
CG179_Recommendations: Terms used in this guideline,CG179,What are the criteria for assessing risk of pressure ulcers in children and young people?
CG179_Recommendations: 1.1 Prevention: adults - Part 1,CG179,What are the recommended risk assessment and skin inspection procedures for preventing pressure ulcers in adults?
CG179_Recommendations: 1.1 Prevention: adults - Part 2,CG179,What are the recommended strategies for preventing pressure ulcers in adults at high risk?
"CG179_Recommendations: 1.2 Prevention: neonates, infants, children and young people - Part 1",CG179,"What are the recommended risk assessment and prevention strategies for pressure ulcers in neonates, infants, children, and young people?"
"CG179_Recommendations: 1.2 Prevention: neonates, infants, children and young people - Part 2",CG179,What are the recommended strategies for preventing pressure ulcers in children and young people?
CG179_Recommendations: 1.4 Management: adults - Part 1,CG179,What are the recommended management strategies for pressure ulcers in adults according to NICE guidelines?
CG179_Recommendations: 1.4 Management: adults - Part 2,CG179,What are the recommended treatments and management strategies for pressure ulcers in adults according to NICE guidelines?
CG179_Recommendations: 1.4 Management: adults - Part 3,CG179,When should systemic antibiotics be prescribed for adult infections according to NICE guidelines?
"CG179_Recommendations: 1.5 Management: neonates, infants, children and young people - Part 1",CG179,What are the recommended management strategies for pressure ulcers in children and young people?
"CG179_Recommendations: 1.5 Management: neonates, infants, children and young people - Part 2",CG179,What are the recommended treatments and support surfaces for managing pressure ulcers in children and young people?
"CG179_Recommendations: 1.5 Management: neonates, infants, children and young people - Part 3",CG179,What is the recommended approach for treating pressure ulcers in children and young people according to NICE guidelines?
CG179_Recommendations for research: 1 Debridement & Recommendations for research: 2 Negative pressure wound therapy,CG179,What is the effectiveness of enzymatic debridement compared to sharp debridement for healing pressure ulcers in adults?
"CG179_Recommendations for research: 3 Risk assessment in neonates, infants, children and young people & Recommendations for research: 4 Pressure redistributing devices & Recommendations for research: 5 Repositioning",CG179,What are the most effective pressure ulcer risk assessment tools for children?
CG183_Drug allergy: diagnosis and management & Overview & Key priorities for implementation: Assessment - Part 1,CG183,What are the key signs and timing patterns for diagnosing drug allergy?
CG183_Key priorities for implementation: Assessment - Part 2,CG183,"What are the signs and timing of systemic reactions to suspected drug allergies such as DRESS, Stevens-Johnson syndrome, and AGEP?"
CG183_Key priorities for implementation: Documenting and sharing information with other healthcare professionals,CG183,What is the recommended process for documenting suspected drug allergic reactions and sharing this information with healthcare professionals?
CG183_Key priorities for implementation: Providing information and support to patients,CG183,What information should be provided to patients after specialist drug allergy testing?
CG183_Key priorities for implementation: Non‑specialist management and referral to specialist services,CG183,When should patients be referred to a specialist drug allergy service for suspected medication reactions?
CG183_Recommendations: 1.2 Documenting and sharing information with other healthcare professionals,CG183,What are the recommended practices for documenting and sharing drug allergy information in healthcare settings?
CG183_Recommendations: 1.3 Providing information and support to patients,CG183,What information should be provided to patients about drug allergies and safe medication use?
CG183_Recommendations: 1.4 Non‑specialist management and referral to specialist services - Part 1,CG183,What are the recommended management and referral procedures for suspected drug allergies according to NICE guidelines?
CG183_Recommendations: 1.4 Non‑specialist management and referral to specialist services - Part 2,CG183,What are the guidelines for managing NSAID allergies and hypersensitivity reactions?
CG183_Recommendations for research: 1 Designing systems for documenting drug allergy,CG183,What are the most effective and cost-efficient documentation strategies to prevent re-exposure to drug allergies in healthcare settings?
CG183_Recommendations for research: 2 Communicating information about drug allergy & Recommendations for research: 3 Using selective cyclooxygenase 2 inhibitors in people with previous severe allergic reactions to non‑selective non‑steroidal anti‑inflammatory drugs,CG183,What are effective strategies for communicating drug allergy information to patients to improve disclosure and safety?
CG183_Recommendations for research: 3 Using selective cyclooxygenase 2 inhibitors in people with previous severe allergic reactions to non‑selective non‑steroidal anti‑inflammatory drugs,CG183,Should patients with a history of severe allergic reactions to NSAIDs be referred to specialist allergy services before using selective COX-2 inhibitors?
CG183_Recommendations for research: 4 Oral antibiotic challenge for diagnosing antibiotic allergy in children,CG183,What is the effectiveness and safety of oral antibiotic challenge without prior allergy testing in children?
CG183_Context - Part 1,CG183,What are the clinical features and management of drug allergy and adverse drug reactions?
CG183_Context - Part 2,CG183,What are best practices for documenting and managing drug allergies in primary care?
CG184_Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management & Overview,CG184,What are the recommended investigations and management options for gastro-oesophageal reflux disease and dyspepsia in adults?
CG184_Introduction,CG184,What are the current recommendations for managing gastro-oesophageal reflux disease (GORD) when pharmacological treatments fail?
CG184_Key priorities for implementation: Referral guidance for endoscopy & Key priorities for implementation: Interventions for uninvestigated dyspepsia & Key priorities for implementation: Interventions for gastro-oesophageal reflux disease,CG184,What are the indications for urgent endoscopy in patients with dyspepsia and gastrointestinal bleeding?
CG184_Key priorities for implementation: Interventions for peptic ulcer disease & Key priorities for implementation: Referral to a specialist service,CG184,What are the recommended interventions for managing peptic ulcer disease?
CG184_Key priorities for implementation: Surveillance for people with Barrett's oesophagus & Recommendations: 1.1 The community pharmacist,CG184,What are the recommended surveillance strategies for detecting cancer progression in patients with Barrett's oesophagus?
CG184_Recommendations: 1.2 Common elements of care,CG184,What lifestyle modifications are recommended for managing dyspepsia according to NICE guidelines?
CG184_Recommendations: 1.3 Referral guidance for endoscopy,CG184,What are the referral criteria for endoscopy in patients with dyspepsia and gastrointestinal bleeding?
CG184_Recommendations: 1.4 Interventions for uninvestigated dyspepsia & Recommendations: 1.5 Reviewing patient care,CG184,What are the recommended interventions for managing uninvestigated dyspepsia in primary care?
CG184_Recommendations: 1.6 Interventions for GORD - Part 1,CG184,What are the recommended interventions for managing gastro-oesophageal reflux disease (GORD) according to NICE guidelines?
CG184_Recommendations: 1.6 Interventions for GORD - Part 2,CG184,What are the recommended management options for severe oesophagitis unresponsive to initial proton pump inhibitor therapy?
CG184_Recommendations: 1.7 Interventions for peptic ulcer disease - Part 1,CG184,What are the recommended interventions for managing peptic ulcer disease with H pylori infection?
CG184_Recommendations: 1.7 Interventions for peptic ulcer disease - Part 2,CG184,What are the recommendations for managing NSAID use in patients with a history of peptic ulcer?
CG184_Recommendations: 1.8 Interventions for functional dyspepsia,CG184,What are the recommended interventions for managing functional dyspepsia associated with H pylori infection?
CG184_Recommendations: 1.9 Helicobacter pylori testing and eradication - Part 1,CG184,What is the recommended testing and treatment protocol for Helicobacter pylori infection according to NICE guidelines?
CG184_Recommendations: 1.9 Helicobacter pylori testing and eradication - Part 2,CG184,What is the recommended second-line treatment for Helicobacter pylori infection if first-line therapy fails?
CG184_Recommendations: 1.9 Helicobacter pylori testing and eradication - Part 3,CG184,What is the recommended antibiotic regimen for penicillin-allergic patients with H pylori infection?
CG184_Recommendations: 1.10 Laparoscopic fundoplication & 3 more sections,CG184,What are the indications for laparoscopic fundoplication in patients with gastro-oesophageal reflux disease?
CG184_Recommendations for research: 4 Other specialist management & Recommendations for research: 5 Specialist investigation,CG184,What are the effective specialist management options for patients with reflux symptoms unresponsive to high-dose PPIs or post-surgery?
CG185_Bipolar disorder: assessment and management & Overview,CG185,What are the recommended assessment and management strategies for bipolar disorder in adults and young people?
"CG185_Recommendations: 1.1 Care for adults, children and young people across all phases of bipolar disorder - Part 1",CG185,What are the recommended treatment approaches for adults with bipolar disorder across different age groups?
"CG185_Recommendations: 1.1 Care for adults, children and young people across all phases of bipolar disorder - Part 2",CG185,What are the recommended approaches for involving carers in the management of adults with bipolar disorder?
CG185_Recommendations: 1.2 Recognising and managing bipolar disorder in adults in primary care - Part 1,CG185,What are the recommended management strategies for bipolar disorder in primary care?
CG185_Recommendations: 1.2 Recognising and managing bipolar disorder in adults in primary care - Part 2,CG185,What are the recommended physical health checks for people with bipolar disorder in primary care?
CG185_Recommendations: 1.2 Recognising and managing bipolar disorder in adults in primary care - Part 3,CG185,What are the recommended assessments and management strategies for bipolar disorder patients with comorbid cardiovascular and metabolic conditions?
CG185_Recommendations: 1.3 Assessing suspected bipolar disorder in adults in secondary care - Part 1,CG185,What are the recommended steps for assessing suspected bipolar disorder in adults in secondary care?
CG185_Recommendations: 1.3 Assessing suspected bipolar disorder in adults in secondary care - Part 2,CG185,What are the recommended approaches for assessing and managing risks in patients with bipolar disorder?
"CG185_Recommendations: 1.4 Managing crisis, risk and behaviour that challenges in adults with bipolar disorder in secondary care",CG185,What are the recommended risk management strategies for adults with bipolar disorder in secondary care?
CG185_Recommendations: 1.5 Managing mania or hypomania in adults in secondary care - Part 1,CG185,What are the recommended pharmacological treatments for managing mania or hypomania in adults?
CG185_Recommendations: 1.5 Managing mania or hypomania in adults in secondary care - Part 2,CG185,When should lithium or valproate be added to antipsychotic treatment for schizophrenia?
CG185_Recommendations: 1.5 Managing mania or hypomania in adults in secondary care - Part 3,CG185,When should antidepressants be discontinued in patients experiencing mania or hypomania?
CG185_Recommendations: 1.5 Managing mania or hypomania in adults in secondary care - Part 4,CG185,What are the recommended treatments for mixed affective states in bipolar disorder?
CG185_Recommendations: 1.6 Managing bipolar depression in adults in secondary care - Part 1,CG185,What are the recommended psychological and pharmacological treatments for bipolar depression in adults?
CG185_Recommendations: 1.6 Managing bipolar depression in adults in secondary care - Part 2,CG185,What are the recommended treatment options for moderate or severe bipolar depression in patients already taking lithium or valproate?
CG185_Recommendations: 1.6 Managing bipolar depression in adults in secondary care - Part 3,CG185,What are the recommended medication adjustments for treatment-resistant bipolar disorder in young people?
CG185_Recommendations: 1.6 Managing bipolar depression in adults in secondary care - Part 4,CG185,What are the safety considerations and recommended monitoring when prescribing valproate and fluoxetine together?
CG185_Recommendations: 1.7 Managing bipolar disorder in adults in the longer term in secondary care - Part 1,CG185,What are the recommended long-term management strategies for bipolar disorder in adults?
CG185_Recommendations: 1.7 Managing bipolar disorder in adults in the longer term in secondary care - Part 2,CG185,What psychological interventions are recommended for preventing relapse in bipolar disorder?
CG185_Recommendations: 1.7 Managing bipolar disorder in adults in the longer term in secondary care - Part 3,CG185,What are the recommended options if lithium is ineffective or not tolerated in bipolar disorder treatment?
CG185_Recommendations: 1.7 Managing bipolar disorder in adults in the longer term in secondary care - Part 4,CG185,What are the guidelines for stopping valproate in women of childbearing potential?
CG185_Recommendations: 1.8 Monitoring physical health in secondary care,CG185,What are the recommended methods for monitoring physical health in people with bipolar disorder in secondary care?
CG185_Recommendations: 1.9 Promoting recovery and return to primary care,CG185,What are the recommended steps for transferring care of a person with bipolar disorder from secondary to primary care?
CG185_Recommendations: 1.10 How to use medication - Part 1,CG185,What are the recommended practices for initiating and monitoring psychotropic and antipsychotic medications in people with bipolar disorder?
CG185_Recommendations: 1.10 How to use medication - Part 2,CG185,What are the recommended procedures for monitoring and stopping antipsychotic medication safely?
CG185_Recommendations: 1.10 How to use medication - Part 3,CG185,What are the recommended procedures for initiating and monitoring lithium therapy in bipolar disorder?
CG185_Recommendations: 1.10 How to use medication - Part 4,CG185,How should plasma lithium levels and renal function be monitored in people taking lithium therapy?
CG185_Recommendations: 1.10 How to use medication - Part 5,CG185,What are the safety precautions and monitoring requirements for valproate use in men and women of reproductive potential?
CG185_Recommendations: 1.10 How to use medication - Part 6,CG185,When should plasma valproate and lamotrigine levels be measured in patients on these medications?
"CG185_Recommendations: 1.11 Recognising, diagnosing and managing bipolar disorder in children and young people - Part 1",CG185,What are the recommended approaches for diagnosing and managing bipolar disorder in children and young people?
"CG185_Recommendations: 1.11 Recognising, diagnosing and managing bipolar disorder in children and young people - Part 2",CG185,What are the recommended treatments for bipolar disorder in young people according to NICE guidelines?
"CG185_Recommendations: 1.11 Recognising, diagnosing and managing bipolar disorder in children and young people - Part 3",CG185,What are the recommended psychological and pharmacological treatment options for bipolar depression in young people?
CG185_Recommendations: Terms used in this guideline,CG185,What is the definition of depression severity in bipolar disorder according to NICE guidelines?
CG185_Recommendations for research,CG185,"What is the impact of lithium, antipsychotics, or their combination on quality of life in bipolar disorder maintenance treatment?"
CG185_Context,CG185,What are the key considerations for diagnosing and managing bipolar disorder in children and young people?
CG187_Acute heart failure: diagnosis and management & Overview,CG187,What are the recommended approaches for diagnosing and managing acute heart failure in adults?
CG187_Introduction,CG187,What are the recommended management strategies for acute heart failure in adults?
CG187_Key priorities for implementation,CG187,What are the recommended management strategies for acute heart failure in hospital settings?
CG187_Recommendations: 1.1 Organisation of care,CG187,What are the recommended arrangements for specialist heart failure care during hospital admission and after discharge?
"CG187_Recommendations: 1.2 Diagnosis, assessment and monitoring",CG187,What are the recommended diagnostic and assessment procedures for suspected acute heart failure?
CG187_Recommendations: 1.3 Initial pharmacological treatment,CG187,What are the recommended pharmacological treatments for acute heart failure according to NICE guidelines?
CG187_Recommendations: 1.4 Initial non-pharmacological treatment,CG187,When should non-invasive ventilation be used in patients with acute heart failure and pulmonary oedema?
CG187_Recommendations: 1.5 Treatment after stabilisation & Recommendations: 1.6 Valvular surgery and percutaneous intervention,CG187,What is the recommended treatment approach for acute heart failure after stabilization?
CG187_Recommendations: 1.7 Mechanical assist devices & Recommendations for research: 1 Dopamine,CG187,What is the effectiveness of low-dose dopamine in improving diuresis and renal function in acute heart failure patients?
CG187_Recommendations for research: 2 Thiazide,CG187,What is the effectiveness of adding a thiazide diuretic to standard therapy for diuresis in patients with acute heart failure and persistent congestion?
CG187_Recommendations for research: 3 Intra-aortic balloon counter‑pulsation,CG187,Is intra-aortic balloon counter-pulsation more effective than intravenous inotropes for acute heart failure with hypoperfusion?
CG187_Recommendations for research: 4 Ultrafiltration,CG187,What is the evidence for ultrafiltration versus diuretic therapy in managing fluid overload in decompensated heart failure?
CG188_Gallstone disease: diagnosis and management & Introduction,CG188,What are the recommended management strategies for symptomatic gallstone disease in adults?
CG188_Key priorities for implementation & Recommendations: 1.1 Diagnosing gallstone disease,CG188,What are the recommended management strategies for gallstone disease and acute cholecystitis according to NICE guidelines?
CG188_Recommendations: 1.2 Managing gallbladder stones & Recommendations: 1.3 Managing common bile duct stones,CG188,What are the recommended management options for gallbladder and common bile duct stones according to NICE guidelines?
"CG188_Recommendations: 1.4 Patient, family member and carer information & Recommendations: Terms used in this guideline & Recommendations for research: 1 Diagnosing gallstone disease",CG188,What are the benefits and risks of endoscopic ultrasound compared to magnetic resonance cholangiopancreatography for diagnosing common bile duct stones?
CG188_Recommendations for research: 2 Managing gallbladder stones & 3 more sections,CG188,What are the benefits and harms of intraoperative cholangiography in patients with low to intermediate risk of common bile duct stones?
CG191_Pneumonia in adults: diagnosis and management & Overview,CG191,What are the recommended diagnostic and management strategies for pneumonia in adults without COVID-19?
CG191_Introduction - Part 1,CG191,What are the diagnostic and management strategies for community‑acquired and hospital‑acquired pneumonia?
CG191_Introduction - Part 2 & Recommendations: 1.1 Presentation with lower respiratory tract infection,CG191,What are the recommended management strategies for community-acquired pneumonia in adults?
CG191_Recommendations: 1.2 Community-acquired pneumonia - Part 1,CG191,What is the recommended use of CRB65 and CURB65 scoring systems for assessing severity of community-acquired pneumonia outside and inside hospital?
CG191_Recommendations: 1.2 Community-acquired pneumonia - Part 2,CG191,How is the CURB65 score used to assess mortality risk and guide management in community-acquired pneumonia?
CG191_Recommendations: 1.2 Community-acquired pneumonia - Part 3,CG191,What are the criteria for safe discharge and follow-up in patients with community-acquired pneumonia?
CG191_Recommendations: 1.3 Hospital-acquired pneumonia & Recommendations: Terms used in this guideline,CG191,What are the recommended antibiotic treatments for hospital-acquired pneumonia according to NICE guidelines?
CG191_Recommendations for research: 1 Urine antigen testing & Recommendations for research: 2 C-reactive protein-guided antibiotic duration & Recommendations for research: 3 Continuous positive pressure ventilation,CG191,What is the effectiveness of urinary antigen testing for guiding antibiotic treatment in moderate to high severity community-acquired pneumonia?
CG191_Recommendations for research: 4 Hospital-acquired pneumonia,CG191,How can rapid microbiological diagnosis reduce extended-spectrum antibiotic use in hospital-acquired pneumonia?
CG191_More information and committee details,CG191,Where can I find detailed evidence and development information for NICE infection guidelines?
CG192_Antenatal and postnatal mental health: clinical management and service guidance & Overview,CG192,What are the recommended strategies for managing mental health problems during pregnancy and after childbirth according to NICE guideline CG192?
CG192_Recommendations: 1.1 Using this guideline in conjunction with other NICE guidelines,CG192,How should mental health assessments and treatments be managed during pregnancy and the postnatal period according to NICE guidelines?
CG192_Recommendations: 1.2 Considerations for women of childbearing potential,CG192,What considerations should be made when prescribing psychotropic medications to women of childbearing potential?
CG192_Recommendations: 1.3 Principles of care in pregnancy and the postnatal period,CG192,What are the key principles for supporting women with mental health problems during pregnancy and the postnatal period?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 1",CG192,What are the recommended approaches for mental health support and treatment planning for women during pregnancy and the postnatal period?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 2",CG192,What are the recommended approaches for monitoring and managing mental health treatment during pregnancy and the postnatal period?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 3",CG192,What are the recommendations for managing psychotropic medication use in pregnant women with mental health conditions?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 4",CG192,"What are the reproductive safety considerations and risks of using antidepressants, antipsychotics, and benzodiazepines during pregnancy and breastfeeding?"
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 5",CG192,What are the recommendations for managing antipsychotic medication in women planning pregnancy?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 6",CG192,What are the recommendations for managing anti-epileptic drugs in women planning pregnancy or who are pregnant?
"CG192_Recommendations: 1.4 Treatment decisions, advice and monitoring for women who are planning a pregnancy, are pregnant or are in the postnatal period - Part 7",CG192,What are the guidelines for prescribing lithium to women who are pregnant or planning pregnancy?
CG192_Recommendations: 1.5 Recognising mental health problems in pregnancy and the postnatal period and referral - Part 1,CG192,What are the recommended approaches for recognising and referring women with mental health problems during pregnancy and the postnatal period?
CG192_Recommendations: 1.5 Recognising mental health problems in pregnancy and the postnatal period and referral - Part 2,CG192,What are the recommended assessments and referral pathways for mental health concerns in pregnant and postnatal women?
CG192_Recommendations: 1.5 Recognising mental health problems in pregnancy and the postnatal period and referral - Part 3,CG192,When should women be referred to specialist mental health services for severe mental illness during pregnancy or postpartum?
CG192_Recommendations: 1.6 Assessment and care planning in pregnancy and the postnatal period - Part 1,CG192,What are the key components of assessment and care planning for mental health in pregnancy and the postnatal period?
CG192_Recommendations: 1.6 Assessment and care planning in pregnancy and the postnatal period - Part 2,CG192,What are the recommended procedures for managing suspected child maltreatment and self-harm risk during pregnancy?
CG192_Recommendations: 1.7 Providing interventions in pregnancy and the postnatal period,CG192,What are the recommended psychological interventions for mental health problems during pregnancy and the postnatal period?
CG192_Recommendations: 1.8 Treating specific mental health problems in pregnancy and the postnatal period - Part 1,CG192,What are the recommended treatments for depression during pregnancy and the postnatal period?
CG192_Recommendations: 1.8 Treating specific mental health problems in pregnancy and the postnatal period - Part 2,CG192,What are the treatment options for managing depression and anxiety with antidepressants during pregnancy?
CG192_Recommendations: 1.8 Treating specific mental health problems in pregnancy and the postnatal period - Part 3,CG192,What are the recommended psychological interventions for eating disorders during pregnancy and the postnatal period?
CG192_Recommendations: 1.8 Treating specific mental health problems in pregnancy and the postnatal period - Part 4,CG192,What are the recommended psychological interventions for pregnant women with bipolar disorder?
CG192_Recommendations: 1.8 Treating specific mental health problems in pregnancy and the postnatal period - Part 5,CG192,What are the recommended interventions for sleep problems in pregnant women according to NICE guidelines?
CG192_Recommendations: 1.9 Considerations for women and their babies in the postnatal period - Part 1,CG192,What are the recommended postnatal assessments for women and their babies after psychotropic medication use during pregnancy?
CG192_Recommendations: 1.9 Considerations for women and their babies in the postnatal period - Part 2,CG192,What psychological treatments are recommended for women experiencing post-traumatic stress disorder after traumatic birth?
CG192_Recommendations: 1.9 Considerations for women and their babies in the postnatal period - Part 3,CG192,What are the considerations for prescribing antidepressants to breastfeeding women?
CG192_Recommendations: 1.10 The organisation of services,CG192,What are the recommended inpatient care arrangements for women with perinatal mental health problems?
CG192_Recommendations: Terms used in this guideline,CG192,What are the recommended psychological interventions for postnatal anxiety and depression?
CG192_Recommendations for research: 1 Preventing postpartum psychosis,CG192,What are effective methods for identifying women at high risk of postpartum psychosis and preventing its onset?
CG192_Recommendations for research: 2 The safety of drugs for bipolar disorder in pregnancy and the postnatal period,CG192,What is the safety profile of medications used to treat bipolar disorder during pregnancy and the postnatal period?
CG192_Recommendations for research: 3 Psychological interventions focused on the mother‑baby relationship,CG192,Are psychological interventions to improve mother–baby relationships effective for women with diagnosed mental health problems?
CG192_Recommendations for research: 4 Structured clinical management for moderate to severe personality disorders in pregnancy and the postnatal period,CG192,Is structured clinical management effective for improving maternal and fetal outcomes in pregnant women with moderate to severe personality disorders?
CG192_Recommendations for research: 5 Psychological interventions for moderate to severe anxiety disorders in pregnancy,CG192,What psychological interventions are effective for treating moderate to severe anxiety disorders during pregnancy?
CG192_Context - Part 1,CG192,What are the recommended management strategies for mental health problems during pregnancy and the postnatal period?
CG192_Context - Part 2,CG192,What are the recommended approaches for recognizing and managing mental health problems during pregnancy and the postnatal period?
CG19_Dental checks: intervals between oral health reviews & Overview,CG19,What are the recommended intervals between dental check-ups for different patient needs?
CG19_Introduction,CG19,What are the recommended recall intervals for routine dental check-ups based on individual patient risk factors?
CG19_Recommendations: 1.1.1 & 3 more sections,CG19,What factors determine the appropriate interval between oral health reviews for individual patients?
CG19_Recommendations: 1.1.5 & Recommendations: 1.1.6,CG19,What are the recommended intervals between oral health reviews for different age groups?
CG19_Recommendations: 1.1.7 & Recommendations: 1.1.8,CG19,How should dentists determine and review the appropriate recall interval for patients' oral health?
CG19_Implementation in the NHS,CG19,How should NHS dental practices implement and audit personalized recall intervals for routine dental care?
CG19_Recommendations for research,CG19,What is the long-term clinical and cost effectiveness of one-to-one oral health advice in different patient populations?
CG30_Long-acting reversible contraception & Overview,CG30,What are the current recommendations for long-acting reversible contraception management?
CG30_Recommendations: 1.1 Contraception and principles of care - Part 1,CG30,What information should healthcare providers give women about long-acting reversible contraception options?
CG30_Recommendations: 1.1 Contraception and principles of care - Part 2,CG30,What factors should healthcare professionals consider when choosing long-acting reversible contraception for women with medical conditions?
CG30_Recommendations: 1.1 Contraception and principles of care - Part 3,CG30,What training is recommended for healthcare professionals to provide contraceptive care for women with learning disabilities?
CG30_Recommendations for research,CG30,What research is available on the typical use and effectiveness of long-acting reversible contraception in the UK?
CG30_Context,CG30,What are the recommended long-acting reversible contraceptive options for women of reproductive age?
CG31_Obsessive-compulsive disorder and body dysmorphic disorder: treatment & Overview,CG31,What are the recommended treatments for obsessive-compulsive disorder and body dysmorphic disorder in adults and children?
CG31_Recommendations: 1.1 Principles of care for all people with OCD or BDD and their families or carers - Part 1,CG31,What are the principles of care for supporting people with OCD or BDD and their families?
CG31_Recommendations: 1.1 Principles of care for all people with OCD or BDD and their families or carers - Part 2,CG31,How should healthcare professionals involve family members and cultural or religious leaders in the treatment of OCD and BDD?
"CG31_Recommendations: 1.2 Stepped care for adults, young people and children with OCD or BDD",CG31,What is the stepped-care approach for treating OCD and BDD in children and young people?
CG31_Recommendations: 1.3 Step 1: awareness and recognition,CG31,What are the recommended specialist services and multidisciplinary team roles for managing OCD and BDD in primary care?
CG31_Recommendations: 1.4 Step 2: recognition and assessment - Part 1,CG31,What are the recommended assessment procedures for detecting OCD and BDD in high-risk patients?
CG31_Recommendations: 1.4 Step 2: recognition and assessment - Part 2,CG31,What questions should be asked to assess for body dysmorphic disorder in high-risk individuals?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 1,CG31,What are the recommended initial treatment options for adults with OCD?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 2,CG31,What are the recommended treatments for adults with mild to severe OCD or BDD according to NICE guidelines?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 3,CG31,What psychological interventions are recommended for adults with OCD or BDD?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 4,CG31,What are the recommended approaches for involving family members and carers in the treatment of children and young people with OCD or BDD?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 5,CG31,What are the safety considerations and monitoring recommendations for prescribing SSRIs to adults with OCD or body dysmorphic disorder?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 6,CG31,What are the recommended initial pharmacological treatments for adults with OCD and BDD according to NICE guidelines?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 7,CG31,What are the recommended procedures for reviewing and discontinuing SSRI treatment in adults with OCD or BDD after remission?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 8,CG31,What are the recommended treatment options for adults with OCD or BDD who do not respond to initial SSRI or CBT therapy?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 9,CG31,What are the recommended treatment options for adults with body dysmorphic disorder who do not respond to initial therapies?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 10,CG31,What are the recommended treatment options for children and young people with OCD who do not respond to initial CBT?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 11,CG31,How should SSRIs be prescribed and monitored in children and young people with OCD or BDD?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 12,CG31,What are the NICE recommendations for prescribing SSRIs to children and young people with OCD or BDD?
CG31_Recommendations: 1.5 Steps 3 to 5: treatment options for people with OCD or BDD - Part 13,CG31,What is the recommended approach for dosing and discontinuing clomipramine in children and young people with OCD or BDD?
CG31_Recommendations: 1.6 Step 6: intensive treatment and inpatient services for people with OCD or BDD - Part 1,CG31,When is inpatient treatment appropriate for severe OCD or BDD?
CG31_Recommendations: 1.6 Step 6: intensive treatment and inpatient services for people with OCD or BDD - Part 2,CG31,What are the criteria and recommended procedures for assessing suitability for neurosurgical treatment in severe OCD or BDD?
CG31_Recommendations: 1.7 Discharge after recovery,CG31,How should patients with OCD or BDD be monitored after remission and discharge?
CG31_Recommendations for research: 1 Treatment of OCD and BDD among young people and young adults & Recommendations for research: 2 CBT treatment intensity formats among adults with OCD,CG31,What are the most effective treatment options for OCD and BDD in young people aged 12 to 25?
CG31_Recommendations for research: 3 CBT for adults with OCD who have not responded to treatment & 4 more sections,CG31,What is the evidence for the effectiveness of intensive versus spaced cognitive-behavioral therapy for adults with OCD who have not responded to medication and previous CBT?
CG31_Context,CG31,What are the diagnostic criteria and treatment options for obsessive-compulsive disorder and body dysmorphic disorder?
"CG32_Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition & Overview & Introduction",CG32,"What are the recommended practices for initiating and managing oral, enteral, and parenteral nutrition support in adults at risk of malnutrition?"
CG32_Key priorities for implementation,CG32,What are the recommended practices for screening and providing nutrition support to hospitalized patients at risk of malnutrition?
CG32_Recommendations: 1.1 Organisation of nutrition support in hospital and the community,CG32,What training do healthcare professionals need for providing nutrition support in hospitals and the community?
CG32_Recommendations: 1.2 Screening for malnutrition and the risk of malnutrition in hospital and the community,CG32,What are the recommended procedures for screening for malnutrition in hospital and community settings?
CG32_Recommendations: 1.3 Indications for nutrition support in hospital and the community,CG32,What are the indications for initiating nutrition support in hospitalized and community patients?
CG32_Recommendations: 1.4 What to give in hospital and the community - Part 1,CG32,What are the recommended nutritional support guidelines for hospitalized patients without severe illness or refeeding risk?
CG32_Recommendations: 1.4 What to give in hospital and the community - Part 2,CG32,What are the best practices for initiating nutrition support in high-risk malnourished patients?
CG32_Recommendations: 1.4 What to give in hospital and the community - Part 3,CG32,What are the recommended nutritional management strategies for patients at high risk of refeeding syndrome?
CG32_Recommendations: 1.5 Monitoring of nutrition support in hospital and the community - Part 1,CG32,How should patients on long-term nutrition support be monitored in hospital and community settings?
CG32_Recommendations: 1.5 Monitoring of nutrition support in hospital and the community - Part 2,CG32,"What are the recommended monitoring protocols for nutritional, anthropometric, and gastrointestinal parameters during nutrition support?"
CG32_Recommendations: 1.5 Monitoring of nutrition support in hospital and the community - Part 3,CG32,What are the recommended laboratory monitoring protocols for patients on parenteral nutrition?
CG32_Recommendations: 1.6 Oral nutrition support in hospital and the community - Part 1,CG32,What are the best practices for managing dysphagia and oral nutrition support in hospital and community settings?
CG32_Recommendations: 1.6 Oral nutrition support in hospital and the community - Part 2,CG32,When should oral nutrition support be provided to patients with dysphagia or malnutrition?
CG32_Recommendations: 1.7 Enteral tube feeding in hospital and the community - Part 1,CG32,What are the indications and criteria for enteral tube feeding in hospital and community settings?
CG32_Recommendations: 1.7 Enteral tube feeding in hospital and the community - Part 2,CG32,When should post-pyloric feeding be considered for patients with upper gastrointestinal dysfunction?
CG32_Recommendations: 1.7 Enteral tube feeding in hospital and the community - Part 3,CG32,What are the recommended procedures for confirming nasogastric tube placement and managing delayed gastric emptying?
CG32_Recommendations: 1.8 Parenteral nutrition in hospital and the community - Part 1,CG32,When should parenteral nutrition be used in hospitalized and surgical patients?
CG32_Recommendations: 1.8 Parenteral nutrition in hospital and the community - Part 2,CG32,What are the recommended routes and modes of administration for parenteral nutrition in hospital patients?
CG32_Recommendations: 1.9 Supporting patients in the community - Part 1,CG32,What are the recommended support and training procedures for patients and carers managing enteral tube feeding in the community?
CG32_Recommendations: 1.9 Supporting patients in the community - Part 2 & Recommendations for research: 1 Educational intervention for all healthcare professionals,CG32,What training and support should healthcare professionals receive for managing home parenteral nutrition?
CG32_Recommendations for research: 2 Nutritional screening programmes & Recommendations for research: 3 Clinical and cost effectiveness of nutritional monitoring & Recommendations for research: 4 Oral nutritional supplements for those at high risk of malnutrition identified by a screening tool,CG32,"What are the clinical benefits of nutritional screening and intervention for malnutrition risk in primary care, care homes, and hospitals?"
CG49_Faecal incontinence in adults: management & Overview & Introduction,CG49,What are the recommended management strategies for faecal incontinence in adults?
CG49_Key priorities for implementation - Part 1,CG49,What are the recommended management strategies for faecal incontinence in high-risk groups?
CG49_Key priorities for implementation - Part 2,CG49,What are the recommended management options for faecal incontinence in adults?
CG49_Recommendations: 1.1 Good practice in managing faecal incontinence - Part 1,CG49,What are the recommended management strategies for faecal incontinence in high-risk patient groups?
CG49_Recommendations: 1.1 Good practice in managing faecal incontinence - Part 2,CG49,What are the recommended approaches for supporting people with faecal incontinence and addressing its emotional and social impacts?
CG49_Recommendations: 1.2 Baseline assessment,CG49,What is included in the baseline assessment for faecal incontinence?
CG49_Recommendations: 1.3 Initial management - Part 1,CG49,What are the recommended initial management strategies for faecal incontinence?
CG49_Recommendations: 1.3 Initial management - Part 2,CG49,"What are the recommended management strategies for faecal incontinence, including medication options and environmental adaptations?"
CG49_Recommendations: 1.3 Initial management - Part 3,CG49,What are the guidelines for using loperamide hydrochloride in managing acute diarrhea and faecal incontinence?
CG49_Recommendations: 1.4 Specialised management & Recommendations: 1.5 Specialist assessment,CG49,What are the indications for referral to specialist continence services in faecal incontinence management?
CG49_Recommendations: 1.6 Long-term management,CG49,What are the long-term management options and support strategies for people with faecal incontinence who do not want active treatment?
CG49_Recommendations: 1.7 Management of specific groups - Part 1,CG49,What are the recommended bowel management strategies for patients with faecal loading and incontinence?
CG49_Recommendations: 1.7 Management of specific groups - Part 2,CG49,What are the recommended management strategies for faecal incontinence in people with limited mobility or neurological conditions?
CG49_Recommendations: 1.7 Management of specific groups - Part 3,CG49,What are the recommended management options for faecal incontinence in patients with neurogenic bowel disorders?
CG49_Recommendations: 1.8 Surgery - Part 1,CG49,What are the surgical options and considerations for treating faecal incontinence?
CG49_Recommendations: 1.8 Surgery - Part 2,CG49,What are the criteria for selecting sacral nerve stimulation or alternative surgical options for faecal incontinence?
CG49_Recommendations for research: 1 Pelvic floor muscle training,CG49,What is the effectiveness of pelvic floor muscle training in preventing and treating obstetric-related fecal incontinence?
CG49_Recommendations for research: 2 Patient-rated outcomes,CG49,What are the validated patient-rated outcome measures for faecal incontinence?
CG49_Recommendations for research: 3 Self-care educational programmes & Recommendations for research: 4 Bowel management programme,CG49,What are the benefits of self-care educational programmes for patients with faecal incontinence?
CG50_Acutely ill adults in hospital: recognising and responding to deterioration & Overview & Introduction - Part 1,CG50,What are the recommended methods for monitoring and responding to clinical deterioration in acutely ill adult hospital patients?
CG50_Introduction - Part 2,CG50,What are the recommendations for managing patient transfers and responses in acute hospital care?
CG50_Key priorities for implementation - Part 1,CG50,What are the recommended physiological monitoring protocols for adult patients in acute hospital settings?
CG50_Key priorities for implementation - Part 2 & Recommendations: Physiological observations in acute hospital settings,CG50,What are the recommended procedures for transferring critically ill patients between critical care and general wards?
CG50_Recommendations: Identifying patients whose clinical condition is deteriorating or is at risk of deterioration & 3 more sections,CG50,What are the recommended physiological parameters and monitoring frequency for early detection of deterioration in adult hospital patients?
CG50_Recommendations: Graded response strategy & Recommendations: Transfer of patients from critical care areas to general wards,CG50,What is the graded response strategy for clinical deterioration in hospital patients?
CG50_Recommendations: Care on the general ward following transfer,CG50,What are the recommended procedures for handover and patient information transfer from critical care to general wards?
CG50_Recommendations for research,CG50,What are the most effective risk assessment tools and response strategies for detecting and managing clinical deterioration in hospital patients?
CG51_Drug misuse in over 16s: psychosocial interventions & Overview,CG51,What are the recommended psychosocial interventions for treating drug misuse in adults over 16?
CG51_Recommendations: 1.1 General considerations,CG51,What are the recommended approaches for involving families and carers in the treatment of people who misuse drugs?
CG51_Recommendations: 1.2 Identification and assessment of drug misuse,CG51,What are the recommended approaches for assessing drug misuse in healthcare settings?
CG51_Recommendations: 1.3 Brief interventions and self-help,CG51,What are the recommended brief intervention strategies for motivating people who misuse drugs in primary care settings?
CG51_Recommendations: 1.4 Formal psychosocial interventions - Part 1,CG51,"What are the recommended psychosocial interventions for drug misuse, including contingency management?"
CG51_Recommendations: 1.4 Formal psychosocial interventions - Part 2,CG51,What are the recommended principles and implementation strategies for contingency management in drug treatment services?
CG51_Recommendations: 1.4 Formal psychosocial interventions - Part 3,CG51,What psychological interventions are recommended for supporting medication adherence and behavioral change in opioid and stimulant misuse?
"CG51_Recommendations: 1.5 Residential, prison and inpatient care",CG51,What are the recommended psychosocial interventions for inpatient and residential treatment of drug misuse?
CG51_Recommendations for research,CG51,What are the most effective methods and settings for implementing contingency management to sustain abstinence from drug misuse?
CG51_Context,CG51,"What are the recommended psychosocial interventions for managing opioid, stimulant, and cannabis misuse?"
CG52_Drug misuse in over 16s: opioid detoxification & Overview,CG52,What are the recommended approaches for opioid detoxification in adults over 16 with opioid dependence?
CG52_Recommendations: 1.1 General considerations - Part 1,CG52,What information should be provided to patients about detoxification from opioid dependence?
CG52_Recommendations: 1.1 General considerations - Part 2,CG52,What are the recommended approaches for involving families and carers in the detoxification process for opioid-dependent individuals?
CG52_Recommendations: 1.2 Assessment - Part 1,CG52,What are the recommended methods for assessing opioid dependence and withdrawal risk during detoxification?
CG52_Recommendations: 1.2 Assessment - Part 2,CG52,What are the considerations and recommended approaches for opioid detoxification in patients with co-occurring mental health or physical health conditions?
CG52_Recommendations: 1.3 Pharmacological interventions in opioid detoxification - Part 1,CG52,What are the recommended pharmacological options for opioid detoxification according to NICE guidelines?
CG52_Recommendations: 1.3 Pharmacological interventions in opioid detoxification - Part 2,CG52,"What are the recommended durations and safety considerations for different methods of opioid detoxification, including ultra-rapid, rapid, and accelerated approaches?"
CG52_Recommendations: 1.3 Pharmacological interventions in opioid detoxification - Part 3,CG52,What are the recommended practices and risks associated with rapid and ultra-rapid opioid detoxification methods?
"CG52_Recommendations: 1.4 Opioid detoxification in community, residential, inpatient and prison settings - Part 1",CG52,When should inpatient versus residential opioid detoxification be considered for patients with comorbid health conditions?
"CG52_Recommendations: 1.4 Opioid detoxification in community, residential, inpatient and prison settings - Part 2",CG52,What is the recommended duration of continued treatment and support after opioid detoxification?
CG52_Recommendations: 1.5 Specific psychosocial interventions - Part 1,CG52,What is the role of contingency management in supporting opioid detoxification and post-detoxification?
CG52_Recommendations: 1.5 Specific psychosocial interventions - Part 2,CG52,What are the principles and best practices for implementing contingency management during drug detoxification?
CG52_Recommendations for research,CG52,What are the safest adjunctive medications to reduce withdrawal symptoms during opioid detoxification?
CG52_Context,CG52,What are the recommended pharmacological treatments for opioid detoxification in community and inpatient settings?
CG57_Atopic eczema in under 12s: diagnosis and management & Overview & Recommendations: 1.1 Diagnosis,CG57,What are the diagnostic criteria for atopic eczema in children under 12 years?
"CG57_Recommendations: 1.2 Assessing severity, psychological and psychosocial wellbeing and quality of life - Part 1",CG57,How should I assess the severity and impact of atopic eczema on a child's quality of life?
"CG57_Recommendations: 1.2 Assessing severity, psychological and psychosocial wellbeing and quality of life - Part 2 & Recommendations: 1.3 Discussing related conditions and how atopic eczema may change over time",CG57,What are the recommended assessment tools for evaluating severity and quality of life in children with atopic eczema?
CG57_Recommendations: 1.4 Identifying and managing trigger factors - Part 1,CG57,How do I identify and manage trigger factors in children with atopic eczema?
CG57_Recommendations: 1.4 Identifying and managing trigger factors - Part 2,CG57,What are the recommended dietary management options for infants with atopic eczema who are not responding to emollients and mild corticosteroids?
CG57_Recommendations: 1.5 Treatment - Part 1,CG57,What is the stepped approach to managing atopic eczema in children?
CG57_Recommendations: 1.5 Treatment - Part 2,CG57,What are the recommended practices for applying and managing emollients in children with atopic eczema?
CG57_Recommendations: 1.5 Treatment - Part 3,CG57,What are the recommended management strategies for atopic eczema in children when topical corticosteroids are ineffective after 7 to 14 days?
CG57_Recommendations: 1.5 Treatment - Part 4,CG57,When should topical corticosteroids be used for atopic eczema in children and what precautions are recommended?
CG57_Recommendations: 1.5 Treatment - Part 5,CG57,When should topical calcineurin inhibitors be used for atopic eczema in children?
CG57_Recommendations: 1.5 Treatment - Part 6,CG57,What are the recommended treatments and management strategies for atopic eczema in children according to NICE guidelines?
CG57_Recommendations: 1.5 Treatment - Part 7,CG57,What are the recommended treatments for herpes simplex infection in children with atopic eczema?
CG57_Recommendations: 1.5 Treatment - Part 8,CG57,What should parents know about the safety and effectiveness of complementary therapies for children with atopic eczema?
CG57_Recommendations: 1.6 Education and adherence to therapy,CG57,How should healthcare professionals educate children with atopic eczema and their families about treatment adherence and skin care practices?
CG57_Recommendations: 1.7 Indications for referral,CG57,What are the indications for referral to a specialist for children with atopic eczema?
CG57_Recommendations for research: 1 Infant feeding & Recommendations for research: 2 Prevention of flares,CG57,What is the recommended infant feeding approach in the first year for children with atopic eczema?
CG57_Recommendations for research: 3 Early intervention,CG57,"What is the impact of early intervention to control atopic eczema in the first year of life on long-term disease severity and development of food allergy, asthma, and allergic rhinitis?"
CG57_Recommendations for research: 4 Adverse effects of topical corticosteroids & Recommendations for research: 5 Education and adherence to therapy,CG57,What are the long-term effects of using topical corticosteroids for 1 to 3 years in children with atopic eczema?
CG57_Rationale and impact,CG57,What are the current NICE recommendations on prescribing emollient bath additives for eczema?
CG57_The algorithm & Context,CG57,What are the recommended management strategies for atopic eczema in children aged 0 to 12 years?
CG61_Irritable bowel syndrome in adults: diagnosis and management & Overview,CG61,What are the recommended approaches for diagnosing and managing irritable bowel syndrome in adults?
CG61_Introduction,CG61,What are the diagnostic criteria and management options for irritable bowel syndrome in primary care?
CG61_Key priorities for implementation: Initial assessment & Key priorities for implementation: Diagnostic tests,CG61,What are the recommended initial assessments and diagnostic tests for irritable bowel syndrome?
CG61_Key priorities for implementation: Dietary and lifestyle advice & Key priorities for implementation: Pharmacological therapy,CG61,What are the recommended lifestyle and pharmacological management strategies for irritable bowel syndrome?
CG61_Recommendations: 1.1 Diagnosis of IBS - Part 1,CG61,What are the criteria for diagnosing irritable bowel syndrome (IBS) according to NICE guidelines?
CG61_Recommendations: 1.1 Diagnosis of IBS - Part 2,CG61,What are the recommended diagnostic tests for irritable bowel syndrome according to NICE guidelines?
CG61_Recommendations: 1.2 Clinical management of IBS - Part 1,CG61,What dietary and lifestyle advice should be given to manage irritable bowel syndrome?
CG61_Recommendations: 1.2 Clinical management of IBS - Part 2,CG61,What dietary and pharmacological options are recommended for managing symptoms of irritable bowel syndrome?
CG61_Recommendations: 1.2 Clinical management of IBS - Part 3,CG61,What is the recommended first-line treatment for diarrhea in people with IBS?
CG61_Recommendations: 1.2 Clinical management of IBS - Part 4,CG61,How should healthcare professionals monitor and follow up patients with IBS prescribed TCAs or SSRIs?
CG61_Recommendations for research: 1 Low-dose antidepressants,CG61,"Are low-dose TCAs, SSRIs, and SNRIs effective and safe as first-line treatments for irritable bowel syndrome?"
CG61_Recommendations for research: 2 Psychological interventions & Recommendations for research: 3 Refractory IBS,CG61,Are psychological interventions like CBT hypnotherapy and psychological therapy equally effective for managing IBS symptoms?
CG61_Recommendations for research: 4 Relaxation and biofeedback,CG61,What is the effectiveness of relaxation and biofeedback therapies for improving symptoms and quality of life in patients with irritable bowel syndrome?
CG61_Recommendations for research: 5 Herbal medicines,CG61,Are herbal medicines safe and effective as first-line treatment for irritable bowel syndrome?
CG64_Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures & 3 more sections,CG64,What are the current recommendations for antibiotic prophylaxis to prevent infective endocarditis in patients undergoing dental or invasive procedures?
CG64_Recommendations: Prophylaxis against infective endocarditis & Recommendations: Infection,CG64,What are the current recommendations for antibiotic prophylaxis to prevent infective endocarditis during dental and other medical procedures?
CG64_Context,CG64,What are the current recommendations for antibiotic prophylaxis to prevent infective endocarditis during dental and non-dental procedures?
CG64_Recommendations for research,CG64,What research is recommended to assess the effectiveness of antibiotic prophylaxis in preventing infective endocarditis?
CG65_Hypothermia: prevention and management in adults having surgery & Overview & Recommendations: 1.1 Perioperative care - Part 1,CG65,What are the best practices for preventing and managing hypothermia in adults undergoing surgery?
CG65_Recommendations: 1.1 Perioperative care - Part 2,CG65,What are the recommended methods for accurately measuring core body temperature in adult patients?
CG65_Recommendations: 1.2 Preoperative phase,CG65,What are the recommended preoperative temperature management strategies to prevent hypothermia?
CG65_Recommendations: 1.3 Intraoperative phase,CG65,What are the recommended intraoperative temperature management practices to prevent hypothermia during surgery?
CG65_Recommendations: 1.4 Postoperative phase & Recommendations: Terms used in this guideline,CG65,What are the recommended procedures for monitoring and managing patient temperature in the postoperative recovery period?
CG65_Context,CG65,What are the best strategies to prevent inadvertent perioperative hypothermia in adult surgical patients?
CG65_Recommendations for research: 1 Combined methods of intraoperative active warming compared with a single method,CG65,What is the effectiveness of combined intraoperative active warming methods versus single methods in preventing perioperative hypothermia?
CG65_Recommendations for research: 2 Forced-air warming compared with conductive fabric warming in laminar flow theatre,CG65,What is the effectiveness of forced-air warming compared to conductive fabric warming in preventing surgical site infections during laminar flow surgery?
CG65_Recommendations for research: 3 Temperature thresholds for preoperative warming,CG65,What is the recommended preoperative temperature target for warming to prevent intraoperative hypothermia?
CG65_Recommendations for research: 4 Effects of nutritional solutions,CG65,Does infusion of amino acids or fructose reduce the risk of perioperative hypothermia in surgical patients?
CG71_Familial hypercholesterolaemia: identification and management & Overview,CG71,What are the recommended strategies for identifying and managing familial hypercholesterolaemia?
CG71_Recommendations: 1.1 Case finding and diagnosis - Part 1,CG71,What are the criteria for diagnosing familial hypercholesterolaemia in primary care?
CG71_Recommendations: 1.1 Case finding and diagnosis - Part 2,CG71,What are the criteria and recommended procedures for diagnosing familial hypercholesterolemia (FH)?
CG71_Recommendations: 1.1 Case finding and diagnosis - Part 3,CG71,Why should coronary heart disease risk estimation tools not be used in people with familial hypercholesterolemia?
CG71_Recommendations: 1.2 Identifying people with FH using cascade testing,CG71,How is cascade testing used to identify relatives with familial hypercholesterolemia (FH)?
CG71_Recommendations: 1.3 Management - Part 1,CG71,What are the recommended drug treatments for adults with familial hypercholesterolaemia according to NICE guidelines?
CG71_Recommendations: 1.3 Management - Part 2,CG71,What is the recommended approach for prescribing ezetimibe with a statin based on cost?
CG71_Recommendations: 1.3 Management - Part 3,CG71,What are the treatment options for adults with familial hypercholesterolaemia who are intolerant to statins or ezetimibe?
CG71_Recommendations: 1.3 Management - Part 4,CG71,What are the recommended statin treatments and dosing guidelines for children and young people with familial hypercholesterolemia?
CG71_Recommendations: 1.3 Management - Part 5,CG71,What are the recommended lifestyle and dietary interventions for managing familial hypercholesterolemia?
CG71_Recommendations: 1.3 Management - Part 6,CG71,What advice should healthcare professionals give to people with familial hypercholesterolaemia about consuming stanols and sterols?
CG71_Recommendations: 1.3 Management - Part 7,CG71,What are the recommendations for smoking cessation support in people with familial hypercholesterolemia?
CG71_Recommendations: 1.3 Management - Part 8,CG71,What are the recommended vascular access options for LDL apheresis in familial hypercholesterolemia?
CG71_Recommendations: 1.4 Information needs and support - Part 1,CG71,What information should be provided to pregnant women with familial hypercholesterolemia?
CG71_Recommendations: 1.4 Information needs and support - Part 2,CG71,What precautions should women with familial hypercholesterolemia take regarding pregnancy and lipid-modifying drug therapy?
CG71_Recommendations: 1.5 Ongoing assessment and monitoring - Part 1,CG71,What is the recommended frequency and components of ongoing review for people with familial hypercholesterolemia?
CG71_Recommendations: 1.5 Ongoing assessment and monitoring - Part 2,CG71,When should patients with familial hypercholesterolemia be referred for coronary heart disease evaluation?
CG71_Recommendations: Terms used in this guideline - Part 1,CG71,What is cascade testing for familial hypercholesterolaemia and how is it performed?
CG71_Recommendations: Terms used in this guideline - Part 2,CG71,What are the recommended statin dosages for managing homozygous familial hypercholesterolemia?
CG71_Recommendations: Terms used in this guideline - Part 3,CG71,What are the criteria for urgent referral for premature coronary heart disease?
CG71_Recommendations for research: 1 Using different thresholds of low-density lipoprotein cholesterol concentration in primary care case finding & Recommendations for research: 2 Long-term monitoring of sub-clinical atherosclerosis in children with FH who are treated with statin therapy,CG71,What are the most effective LDL-C thresholds for primary care case finding of familial hypercholesterolaemia?
CG71_Recommendations for research: 3 Lipid-modifying drug therapy in children,CG71,What is the safety and effectiveness of different doses of lipid-modifying therapy in children with familial hypercholesterolemia?
CG71_Recommendations for research: 4 LDL apheresis for people with heterozygous FH,CG71,"What are the indications, effectiveness, and safety of LDL apheresis for heterozygous familial hypercholesterolemia?"
CG71_Recommendations for research: 5 Pregnancy in women with FH,CG71,What are the risks of fetal malformations and maternal complications in pregnancy for women with familial hypercholesterolemia taking statins?
CG71_Recommendations for research: 6 Cardiovascular evaluation for people with FH,CG71,What is the role of routine cardiovascular screening in asymptomatic individuals with familial hypercholesterolemia?
CG71_Context,CG71,What are the current recommendations for diagnosing and managing familial hypercholesterolaemia?
CG76_Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence & Overview & Introduction - Part 1,CG76,How can healthcare professionals support and involve patients in making informed decisions about prescribed medicines to improve adherence?
CG76_Introduction - Part 2,CG76,How can healthcare professionals support patient adherence to prescribed medicines?
CG76_Key principles,CG76,How can healthcare professionals effectively involve patients in decisions about their medicines?
CG76_Recommendations: 1.1 Patient involvement in decisions about medicines - Part 1,CG76,What strategies can healthcare professionals use to effectively involve patients in decisions about their medicines?
CG76_Recommendations: 1.1 Patient involvement in decisions about medicines - Part 2,CG76,How can healthcare professionals support patient involvement in treatment decisions while respecting their preferences and capacity?
CG76_Recommendations: 1.1 Patient involvement in decisions about medicines - Part 3,CG76,How can I effectively discuss and address patients' concerns and beliefs about medicines during prescribing?
CG76_Recommendations: 1.1 Patient involvement in decisions about medicines - Part 4,CG76,How should healthcare professionals communicate medication information to ensure patient understanding and address individual needs?
CG76_Recommendations: 1.2 Supporting adherence - Part 1,CG76,How can healthcare professionals effectively assess and support medication adherence in patients?
CG76_Recommendations: 1.2 Supporting adherence - Part 2,CG76,How can healthcare professionals support patients to improve medication adherence?
CG76_Recommendations: 1.3 Reviewing medicines,CG76,How should healthcare professionals review and support long-term medication adherence in patients?
CG76_Recommendations: 1.4 Communication between healthcare professionals,CG76,How can healthcare professionals improve communication to ensure coordinated care and medication safety?
"CG76_Recommendations for research: 1 Developing effective, equitable interventions to support adherence to appropriate prescriptions",CG76,What are effective strategies for addressing perceptual and practical barriers to medication adherence?
CG76_Recommendations for research: 2 Informed choice and shared decision-making,CG76,What are the most effective ways to communicate the benefits and risks of medicines to support informed choice and shared decision-making?
CG76_Recommendations for research: 3 Support processes: prescribing˗related consultations and medicines review,CG76,How can healthcare professionals improve medicines reviews to support informed choice and medication adherence?
CG77_Antisocial personality disorder: prevention and management & Overview,CG77,What are the recommended strategies for managing crises in people with antisocial personality disorder?
CG77_Recommendations: 1.1 General principles for working with people with antisocial personality disorder - Part 1,CG77,What are the recommended approaches for engaging people with antisocial personality disorder in treatment and ensuring they are not excluded from health and social care services?
CG77_Recommendations: 1.1 General principles for working with people with antisocial personality disorder - Part 2,CG77,How should staff adapt interventions for people with antisocial personality disorder and learning or physical disabilities?
CG77_Recommendations: 1.2 Prevention of antisocial personality disorder – working with children and young people and their families,CG77,What are effective strategies for preventing antisocial personality disorder in children and young people?
CG77_Recommendations: 1.3 Assessment and risk management of antisocial personality disorder - Part 1,CG77,What are the recommended assessment methods for antisocial personality disorder in secondary and forensic mental health services?
CG77_Recommendations: 1.3 Assessment and risk management of antisocial personality disorder - Part 2,CG77,What are the recommended procedures for assessing and managing violence risk in primary and secondary mental health care?
CG77_Recommendations: 1.3 Assessment and risk management of antisocial personality disorder - Part 3,CG77,What are the criteria for referring patients to forensic services in secondary mental health care?
CG77_Recommendations: 1.4 Treatment and management of antisocial personality disorder and related and comorbid disorders - Part 1,CG77,What are the recommended psychological treatments for antisocial personality disorder and associated comorbidities?
CG77_Recommendations: 1.4 Treatment and management of antisocial personality disorder and related and comorbid disorders - Part 2,CG77,What are recommended psychological interventions for young offenders with antisocial behaviour in institutional care?
CG77_Recommendations: 1.5 Psychopathy and dangerous and severe personality disorder,CG77,What are recommended interventions for managing psychopathy and dangerous and severe personality disorder (DSPD) in community and institutional settings?
CG77_Recommendations: 1.6 Organisation and planning of services - Part 1,CG77,What are the recommended staff training and support strategies for managing antisocial personality disorder in mental health services?
CG77_Recommendations: 1.6 Organisation and planning of services - Part 2,CG77,What training and supervision are recommended for staff working with individuals with antisocial personality disorder?
CG77_Recommendations: Terms used in this guideline,CG77,What are the recommended family-based interventions for managing children's conduct problems according to NICE guidelines?
CG77_Recommendations for research: 1 Severity as a potential moderator of effect in group-based cognitive and behavioural interventions,CG77,How does the severity of offending behavior affect the effectiveness of group-based cognitive and behavioral interventions?
CG77_Recommendations for research: 2 Group-based cognitive and behavioural interventions for populations outside criminal justice settings,CG77,What is the effectiveness of group-based cognitive and behavioural interventions in reducing antisocial behaviours in people with antisocial personality disorder?
CG77_Recommendations for research: 3 Effectiveness of multisystemic therapy versus functional family therapy,CG77,What is the clinical and cost effectiveness of multisystemic therapy compared to functional family therapy for adolescents with conduct disorders?
CG77_Recommendations for research: 4 Interventions for infants at high risk of developing conduct disorders,CG77,What is the effectiveness of parent-training programmes focused on sensitivity enhancement in preventing conduct disorders in high-risk infants?
CG77_Recommendations for research: 5 Treatment of comorbid anxiety disorders in antisocial personality disorder,CG77,What is the impact of treating comorbid anxiety disorders on long-term outcomes in antisocial personality disorder?
CG77_Recommendations for research: 6 Using selective serotonin reuptake inhibitors to increase cooperative behaviour in people with antisocial personality disorder in a prison setting,CG77,How effective are SSRIs in improving cooperative behavior in individuals with antisocial personality disorder?
CG77_Recommendations for research: 7 A therapeutic community approach for antisocial personality disorder in a prison setting,CG77,What is the clinical and cost effectiveness of therapeutic community approaches for treating antisocial personality disorder in prisons compared to routine care?
CG77_Context - Part 1,CG77,What are the recommended treatment and management strategies for antisocial personality disorder in primary and forensic healthcare settings?
CG77_Context - Part 2,CG77,What are the recommended approaches for managing antisocial personality disorder in adults?
CG78_Borderline personality disorder: recognition and management & Overview,CG78,What are the recommended strategies for managing borderline personality disorder?
CG78_Recommendations: 1.1 General principles for working with people with borderline personality disorder - Part 1,CG78,What are the principles for providing access and support to people with borderline personality disorder?
CG78_Recommendations: 1.1 General principles for working with people with borderline personality disorder - Part 2,CG78,What are the recommended approaches for managing transitions and treatment endings in people with borderline personality disorder?
CG78_Recommendations: 1.2 Recognition and management in primary care,CG78,What are the criteria for referring patients with suspected borderline personality disorder to mental health services in primary care?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 1,CG78,What are the recommended assessment and care planning procedures for managing borderline personality disorder in community mental health services?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 2,CG78,What are the recommended risk assessment and management strategies for individuals with borderline personality disorder?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 3,CG78,What are the recommended psychological and drug treatment options for managing borderline personality disorder?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 4,CG78,What are the recommended approaches for managing crises in people with borderline personality disorder?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 5,CG78,What are the NICE guidelines for short-term drug treatment during a crisis in people with borderline personality disorder?
CG78_Recommendations: 1.3 Assessment and management by community mental health services - Part 6,CG78,What are the recommended practices for monitoring drug treatment during a mental health crisis?
CG78_Recommendations: 1.4 Inpatient services,CG78,What are the criteria for inpatient admission for people with borderline personality disorder according to NICE guidelines?
CG78_Recommendations: 1.5 Organisation and planning of services,CG78,What are the recommended roles and responsibilities of specialist personality disorder services within mental health trusts?
CG78_Recommendations for research: 1 Development of an agreed set of outcomes measures,CG78,What are the recommended outcome measures for assessing interventions in people with borderline personality disorder?
CG78_Recommendations for research: 2 Psychological therapy programmes for people with borderline personality disorder,CG78,What is the effectiveness of psychological therapy programs like dialectical behaviour therapy or mentalisation-based therapy for borderline personality disorder in community settings?
CG78_Recommendations for research: 3 Outpatient psychosocial interventions & Recommendations for research: 4 Mood stabilisers,CG78,What is the effectiveness of outpatient psychosocial interventions for borderline personality disorder?
CG78_Recommendations for research: 5 Developing a care pathway,CG78,What is the most effective care pathway for managing borderline personality disorder?
CG78_Context - Part 1,CG78,What are the recommended treatment approaches for severe borderline personality disorder in adults and young people?
CG78_Context - Part 2,CG78,What are the recommended management strategies for borderline personality disorder?
CG81_Advanced breast cancer: diagnosis and treatment & Overview & Recommendations: 1.1 Diagnosis and assessment,CG81,What imaging techniques are recommended for diagnosing and assessing metastases in advanced breast cancer?
CG81_Recommendations: 1.2 Providing information and support for decision making,CG81,How should healthcare professionals assess and support patient preferences for information and decision making?
CG81_Recommendations: 1.3 Systemic disease-modifying therapy - Part 1,CG81,What is the recommended systemic therapy for ER-positive advanced breast cancer according to NICE guidelines?
CG81_Recommendations: 1.3 Systemic disease-modifying therapy - Part 2,CG81,What is the recommended sequence of systemic chemotherapy for patients with advanced breast cancer who are not suitable for anthracyclines?
CG81_Recommendations: 1.4 Supportive care,CG81,What are the recommended supportive care practices for patients with advanced breast cancer?
CG81_Recommendations: 1.5 Managing complications - Part 1,CG81,What are the current recommendations for managing cancer-related fatigue in patients with advanced breast cancer?
CG81_Recommendations: 1.5 Managing complications - Part 2 & Recommendations for research: 1 Assessment of the role of exercise,CG81,What are the recommended palliative care strategies for managing symptoms and psychological support in patients with uncontrolled local disease?
CG81_Recommendations for research: 2 Endocrine therapy & 3 more sections,CG81,What is the most effective endocrine therapy sequence for postmenopausal women with ER-positive breast cancer who progress on aromatase inhibitors?
CG81_Recommendations for research: 6 Uncontrolled local disease & Context,CG81,What are the recommended management strategies for uncontrolled local breast cancer disease?
CG83_Rehabilitation after critical illness in adults & Overview & Introduction - Part 1,CG83,What are the recommended rehabilitation strategies for adults after critical illness in intensive care units?
CG83_Introduction - Part 2,CG83,What are the key considerations for supporting patients and families during critical illness and intensive care?
CG83_Introduction - Part 3,CG83,What are the current recommendations for improving recovery and rehabilitation after critical illness?
CG83_Recommendations: Key principle of care,CG83,How should healthcare professionals coordinate and review rehabilitation care pathways after critical illness?
CG83_Recommendations: During the critical care stay,CG83,What are the recommended assessments and rehabilitation strategies for patients at risk of morbidity during critical care?
CG83_Recommendations: Before discharge from critical care,CG83,What assessments and information should be provided to patients and families before discharge from critical care?
CG83_Recommendations: During ward-based care,CG83,What are the recommended steps for rehabilitating patients after discharge from critical care?
CG83_Recommendations: Before discharge to home or community care,CG83,What are the key components of a functional assessment before discharging a patient from inpatient rehabilitation?
CG83_Recommendations: 2 to 3 months after discharge from critical care - Part 1,CG83,What are the recommended assessments and referral criteria for patients 2 to 3 months after discharge from critical care?
CG83_Recommendations: 2 to 3 months after discharge from critical care - Part 2,CG83,What are the signs of physical and non-physical morbidity in critically ill patients requiring rehabilitation?
CG83_Recommendations for research,CG83,"What are the most effective methods for identifying and managing risk of critical illness-related physical, psychological, and cognitive morbidity?"
CG84_Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management & Overview,CG84,What are the recommended management strategies for gastroenteritis with diarrhea and vomiting in children under 5?
CG84_Introduction & Key priorities for implementation: Diagnosis,CG84,What are the recommended diagnostic criteria for stool microbiological investigations in children with suspected infective gastroenteritis?
CG84_Key priorities for implementation: Assessing dehydration and shock,CG84,How can I assess clinical dehydration and shock using symptoms and signs?
CG84_Key priorities for implementation: Fluid management,CG84,What are the recommended fluid management strategies for children with gastroenteritis and dehydration?
CG84_Key priorities for implementation: Nutritional management & Key priorities for implementation: Information and advice for parents and carers,CG84,What is the recommended nutritional management for children recovering from gastroenteritis?
CG84_Recommendations: 1.1 Diagnosis,CG84,What are the clinical signs and laboratory investigations recommended for diagnosing gastroenteritis in children?
CG84_Recommendations: 1.2 Assessing dehydration and shock - Part 1,CG84,What are the clinical signs of dehydration and shock in children?
CG84_Recommendations: 1.2 Assessing dehydration and shock - Part 2,CG84,What are the clinical signs indicating increasing severity of dehydration in children?
CG84_Recommendations: 1.3 Fluid management - Part 1,CG84,What are the recommended fluid management strategies for children with gastroenteritis and dehydration?
CG84_Recommendations: 1.3 Fluid management - Part 2,CG84,What is the recommended fluid management approach for children with shock or dehydration according to NICE guidelines?
CG84_Recommendations: 1.4 Nutritional management & Recommendations: 1.5 Antibiotic therapy & Recommendations: 1.6 Other therapies,CG84,What are the recommended nutritional and antibiotic management strategies for children with gastroenteritis?
CG84_Recommendations: 1.7 Escalation of care,CG84,What are the criteria for escalating care in children with suspected dehydration or shock during remote or face-to-face assessment?
CG84_Recommendations: 1.8 Information and advice for parents and carers - Part 1,CG84,What is the recommended management of dehydration in children with gastroenteritis?
CG84_Recommendations: 1.8 Information and advice for parents and carers - Part 2,CG84,What are the recommended management and prevention strategies for dehydration and spread of gastroenteritis in children?
CG84_Recommendations for research: 1 Assessing dehydration and shock,CG84,What clinical signs and symptoms best predict dehydration severity in children with gastroenteritis in primary care?
CG84_Recommendations for research: 2 Administration of ORS solution by nasogastric tube,CG84,Is nasogastric administration of ORS solution safe and effective for children who cannot tolerate oral rehydration compared to intravenous fluids?
CG84_Recommendations for research: 3 Fluid management,CG84,Is rapid intravenous rehydration safe and cost-effective for children with dehydration compared to traditional slower methods?
CG84_Recommendations for research: 4 Other therapies: ondansetron & Recommendations for research: 5 Other therapies: probiotics,CG84,What is the safety and effectiveness of oral ondansetron for persistent vomiting in children with gastroenteritis?
CG89_Child maltreatment: when to suspect maltreatment in under 18s & Overview,CG89,What are the signs of child maltreatment in children under 18?
CG89_Introduction - Part 1,CG89,What are the clinical features indicating child maltreatment that healthcare professionals should recognize?
CG89_Introduction - Part 2,CG89,What are the recommended procedures for healthcare professionals when suspecting child maltreatment?
CG89_Recommendations: Definitions of terms used in this guidance,CG89,What are the criteria for suspecting child maltreatment according to NICE guidelines?
CG89_Recommendations: Using this guidance - Part 1,CG89,What are the recommended steps for healthcare professionals to identify and assess possible child maltreatment?
CG89_Recommendations: Using this guidance - Part 2,CG89,How should healthcare professionals assess and manage concerns about child maltreatment?
CG89_Recommendations: 1.1 Physical features - Part 1,CG89,"What are the signs of child maltreatment related to bruising, bites, and injuries?"
CG89_Recommendations: 1.1 Physical features - Part 2,CG89,"What are the signs of child maltreatment related to thermal injuries, fractures, intracranial injuries, and eye trauma?"
CG89_Recommendations: 1.1 Physical features - Part 3,CG89,"What are the signs of child maltreatment related to eye injuries, spinal injuries, and genital trauma?"
CG89_Recommendations: 1.1 Physical features - Part 4,CG89,When should sexual abuse be suspected in children with sexually transmitted infections or ano-genital symptoms?
CG89_Recommendations: 1.1 Physical features - Part 5,CG89,"How should healthcare professionals assess for sexual abuse in 16- and 17-year-olds with hepatitis B, anogenital warts, or other STIs?"
CG89_Recommendations: 1.2 Clinical presentations - Part 1,CG89,"What are the signs of child maltreatment related to sexual abuse, life-threatening events, and poisoning?"
CG89_Recommendations: 1.2 Clinical presentations - Part 2,CG89,What are the signs of child maltreatment associated with unexplained medical conditions and injury patterns?
CG89_Recommendations: 1.3 Neglect – failure of provision and failure of supervision - Part 1,CG89,What are the signs of neglect related to a child's hygiene and basic needs according to NICE guidelines?
CG89_Recommendations: 1.3 Neglect – failure of provision and failure of supervision - Part 2,CG89,"What are the signs of neglect related to a child's supervision, nutrition, and access to healthcare?"
"CG89_Recommendations: 1.4 Emotional, behavioural, interpersonal and social functioning - Part 1",CG89,What are the signs of child maltreatment related to emotional and behavioral changes?
"CG89_Recommendations: 1.4 Emotional, behavioural, interpersonal and social functioning - Part 2",CG89,"What are the signs of child maltreatment associated with self-harm, eating disturbances, wetting, sexualised behaviour, and runaway behaviour?"
CG89_Recommendations: 1.5 Parent–child interactions,CG89,What are the signs of emotional abuse and neglect in parent–child interactions?
CG89_Recommendations for research,CG89,What are the current research priorities for differentiating abusive fractures from accidental or disease-related fractures in children?
CG91_Depression in adults with a chronic physical health problem: recognition and management & Overview,CG91,How should depression be recognized and managed in adults with chronic physical health conditions?
CG91_Recommendations: 1.1 Care of all people with depression - Part 1,CG91,What are the recommended approaches for assessing depression in patients with chronic physical health conditions?
CG91_Recommendations: 1.1 Care of all people with depression - Part 2,CG91,What are the recommended practices for delivering psychological interventions for depression?
CG91_Recommendations: 1.2 Stepped care,CG91,What is the stepped-care approach for managing depression according to NICE guidelines?
"CG91_Recommendations: 1.3 Step 1: recognition, assessment and initial management in primary care and general hospital settings - Part 1",CG91,What are the recommended steps for recognizing and assessing depression in patients with chronic physical health problems in primary care?
"CG91_Recommendations: 1.3 Step 1: recognition, assessment and initial management in primary care and general hospital settings - Part 2",CG91,What are the recommended assessment and risk management strategies for patients with depression and chronic physical health conditions?
CG91_Recommendations: 1.4 Step 2: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression - Part 1,CG91,What are the recommended approaches for managing mild to moderate depression with comorbid physical health problems in primary care?
CG91_Recommendations: 1.4 Step 2: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression - Part 2,CG91,What are the recommended psychosocial interventions for managing depression in patients with chronic physical health conditions?
CG91_Recommendations: 1.4 Step 2: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression - Part 3,CG91,What are the recommended approaches for psychological and pharmacological management of mild to moderate depression in patients with chronic physical health conditions?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 1",CG91,What are the recommended psychological and pharmacological treatment options for moderate to severe depression in patients with chronic physical health conditions?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 2",CG91,What are the considerations for prescribing antidepressants to patients with chronic physical health conditions?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 3",CG91,"Which antidepressants are safe to prescribe for patients taking warfarin, aspirin, or triptan medications?"
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 4",CG91,What are the recommended monitoring and management strategies for patients starting antidepressants with regard to discontinuation symptoms and relapse prevention?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 5",CG91,What are the recommended steps for managing antidepressant treatment failure in depression?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 6",CG91,What are the recommended approaches for switching antidepressants and managing discontinuation symptoms in depression treatment?
"CG91_Recommendations: 1.5 Step 3: recognised depression in primary care and general hospital settings – persistent subthreshold depressive symptoms or mild to moderate depression with inadequate response to initial interventions, and moderate and severe depression - Part 7",CG91,What is the recommended duration and follow-up for individual CBT in patients with moderate or severe depression and chronic physical health problems?
CG91_Recommendations: 1.6 Step 4: complex and severe depression & Recommendations for research: 1 Combined medication and CBT for patients with moderate to severe depression and a chronic physical health problem,CG91,What is the effectiveness of combined medication and CBT for moderate to severe depression in patients with chronic physical health problems?
CG91_Recommendations for research: 2 Peer support interventions compared with group-based exercise and treatment as usual for patients with mild to moderate depression and a chronic physical health problem,CG91,What is the effectiveness and cost-effectiveness of peer support and group-based exercise compared to treatment as usual for patients with mild to moderate depression and chronic physical health conditions?
CG91_Recommendations for research: 3 Antidepressant medication compared with placebo in patients with depression and COPD,CG91,What is the effectiveness of antidepressant medication compared to placebo for treating depression and anxiety in patients with COPD?
CG91_Recommendations for research: 4 Behavioural activation compared with antidepressant medication for patients with moderate to severe depression and a chronic physical health problem,CG91,What is the effectiveness of behavioural activation compared to antidepressant medication for moderate to severe depression in patients with chronic physical health conditions?
CG91_Recommendations for research: 5 The effects of collaborative care on physical health outcomes for patients with moderate to severe depression and a chronic physical health problem,CG91,What is the effectiveness of collaborative care on physical health outcomes in patients with moderate to severe depression and chronic physical health conditions?
CG91_Recommendations for research: 6 The effectiveness of physical rehabilitation programmes for patients with a chronic physical health problem and depression,CG91,What is the impact of physical rehabilitation programmes on depression symptoms in patients with chronic physical health conditions?
CG91_Recommendations for research: 7 The efficacy of counselling compared with low-intensity cognitive and behavioural interventions and treatment as usual in the treatment of depression in patients with a chronic physical health problem,CG91,What is the effectiveness of counselling compared to low-intensity cognitive and behavioural interventions and treatment as usual for depression in patients with chronic physical health problems?
CG91_Context - Part 1,CG91,What are the recommended approaches for diagnosing and managing depression in adults with chronic physical health conditions?
CG91_Context - Part 2,CG91,How should depression be diagnosed and managed in patients with physical illnesses according to NICE guidelines?
CG93_Donor milk banks: service operation & Overview,CG93,What are the recommended procedures for recruiting and screening breast milk donors according to NICE guideline CG93?
CG93_Introduction,CG93,What are the safety standards and recommendations for donor breast milk services?
CG93_Key priorities for implementation,CG93,What are the recommended quality assurance procedures for donor milk banks according to NICE guidelines?
CG93_Recommendations: Quality assurance,CG93,What are the recommended quality assurance practices for NHS donor human milk banks?
CG93_Recommendations: Recruiting donors,CG93,What are effective ways to promote breast milk donation to potential donors?
CG93_Recommendations: Screening and selecting donors - Part 1,CG93,What are the screening criteria and questions for selecting milk donors according to NICE guidelines?
CG93_Recommendations: Screening and selecting donors - Part 2,CG93,What questions should be asked to assess a woman's suitability for breast milk donation according to NICE guidelines?
CG93_Recommendations: Serological testing & Recommendations: Consent and continued eligibility,CG93,What are the serological testing requirements for milk donors according to NICE guidelines?
CG93_Recommendations: Training and supporting donors,CG93,What training and support should be provided to donors expressing milk for donation?
CG93_Recommendations: Stopping or suspending milk donations & Recommendations: Expressing milk at home for donation,CG93,What are the reasons to suspend or stop breast milk donation according to NICE guidelines?
CG93_Recommendations: Handling donor milk at home,CG93,How should donors handle and store expressed breast milk for donation to maintain quality?
CG93_Recommendations: Handling donor milk during transportation,CG93,What are the recommended procedures for transporting and storing donor milk to ensure its quality and safety?
CG93_Recommendations: Handling donor milk at the milk bank - Part 1,CG93,What are the recommended procedures for handling and testing donor milk at the milk bank?
CG93_Recommendations: Handling donor milk at the milk bank - Part 2,CG93,What are the microbial contamination thresholds and storage guidelines for pasteurized donor human milk?
CG93_Recommendations: Tracking and tracing,CG93,How should donor milk be tracked and documented from donation to administration in neonatal units?
CG93_Recommendations for research,CG93,What are the effects of milk handling processes on the nutritional and immunological properties of donor breast milk?
CG95_Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis & Overview,CG95,What is the recommended approach for assessing recent-onset chest pain of suspected cardiac origin?
CG95_Recommendations: 1.1 Providing information for people with chest pain,CG95,What information should healthcare professionals provide to patients with chest pain about investigations and management?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 1,CG95,What are the initial assessment steps for suspected acute coronary syndrome in patients with chest pain?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 2,CG95,What are the criteria for urgent hospital referral in suspected acute coronary syndrome?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 3,CG95,What is the recommended protocol for performing and interpreting resting 12-lead ECGs in suspected acute coronary syndrome?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 4,CG95,What are the recommended initial management steps for suspected acute coronary syndrome?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 5,CG95,What are the recommended assessments and biochemical marker tests for diagnosing acute coronary syndrome in hospital?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 6,CG95,What is the recommended approach for using high-sensitivity troponin tests to diagnose non-ST elevation myocardial infarction?
CG95_Recommendations: 1.2 People presenting with acute chest pain - Part 7,CG95,What is the recommended management for suspected acute coronary syndrome with raised troponin levels?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 1,CG95,What are the clinical features used to diagnose stable angina based on patient history and symptom characteristics?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 2,CG95,What are the clinical features and risk factors used to diagnose stable angina?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 3,CG95,When should I perform a resting 12-lead ECG in suspected stable angina cases?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 4,CG95,What are the recommended diagnostic tests for stable angina when clinical assessment is inconclusive?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 5,CG95,What are the recommended non-invasive and invasive investigations for diagnosing myocardial ischaemia and stable angina?
CG95_Recommendations: 1.3 People presenting with stable chest pain - Part 6 & Recommendations: Terms used in this guideline,CG95,What are the criteria for diagnosing significant coronary artery disease on CT coronary angiography?
CG95_Recommendations for research: 1 Cost-effectiveness of multislice CT coronary angiography for ruling out obstructive coronary artery disease in people with troponin-negative acute coronary syndromes & Recommendations for research: 2 Refining the use of telephone advice in people with chest pain,CG95,Is multislice CT coronary angiography cost-effective for ruling out obstructive coronary artery disease in troponin-negative acute coronary syndromes?
CG95_Recommendations for research: 3 Establishing a national registry for people who are undergoing initial assessment for stable angina,CG95,Should a national registry be established to improve assessment and management of stable angina?
CG95_Recommendations for research: 4 Information about presenting and explaining tests,CG95,How should information about diagnostic pathways for chest pain be communicated to ensure informed consent?
CG95_Context,CG95,How should healthcare professionals assess and diagnose suspected cardiac chest pain in adults?
CG97_Lower urinary tract symptoms in men: management & Overview & Recommendations: 1.1 Initial assessment - Part 1,CG97,What is the recommended initial assessment process for men with lower urinary tract symptoms according to NICE guideline CG97?
CG97_Recommendations: 1.1 Initial assessment - Part 2,CG97,When should serum creatinine testing be performed in men with lower urinary tract symptoms?
CG97_Recommendations: 1.2 Specialist assessment,CG97,What assessments are recommended for men with lower urinary tract symptoms during specialist evaluation?
CG97_Recommendations: 1.3 Conservative management - Part 1,CG97,What are the conservative management options for men with urinary incontinence and LUTS?
CG97_Recommendations: 1.3 Conservative management - Part 2,CG97,What are the recommended management options for urinary incontinence and LUTS in men according to NICE guidelines?
CG97_Recommendations: 1.4 Drug treatment - Part 1,CG97,What are the recommended drug treatments for men with lower urinary tract symptoms?
CG97_Recommendations: 1.4 Drug treatment - Part 2,CG97,What are the recommended treatments for men with moderate to severe LUTS and enlarged prostate?
CG97_Recommendations: 1.4 Drug treatment - Part 3,CG97,"What are the recommended review intervals for men on alpha blockers, 5-alpha reductase inhibitors, and anticholinergic medications for LUTS?"
CG97_Recommendations: 1.5 Surgery for voiding symptoms,CG97,What are the surgical options for treating severe voiding symptoms due to benign prostatic enlargement?
CG97_Recommendations: 1.6 Surgery for storage symptoms - Part 1,CG97,What are the indications and considerations for surgical options in managing storage symptoms of the lower urinary tract?
CG97_Recommendations: 1.6 Surgery for storage symptoms - Part 2,CG97,When should sacral nerve stimulation be considered for managing detrusor overactivity in men?
CG97_Recommendations: 1.7 Treating urinary retention & Recommendations: 1.8 Alternative and complementary therapies,CG97,What are the recommended treatments for urinary retention in men according to NICE guidelines?
CG97_Recommendations: 1.9 Providing information & Recommendations for research: 1 Multichannel cystometry & Recommendations for research: 2 Catheterisation,CG97,"What information and support are recommended for men with lower urinary tract symptoms (LUTS) regarding emotional, psychological, and social issues?"
CG97_Recommendations for research: 3 Products for men with urinary incontinence,CG97,What is the clinical and cost effectiveness of absorbent pads versus sheath collectors for managing urinary incontinence in men?
CG97_Recommendations for research: 4 Male slings,CG97,What is the clinical and cost effectiveness of male slings and adjustable compression devices for post-prostatectomy urinary incontinence in men?
CG97_Recommendations for research: 5 Phosphodiesterase-5 inhibitors,CG97,What is the clinical and cost effectiveness of phosphodiesterase-5 inhibitors for treating lower urinary tract symptoms in men without erectile dysfunction?
CG97_Context,CG97,What are the causes and management options for lower urinary tract symptoms in men?
CG98_Jaundice in newborn babies under 28 days & Overview & Context - Part 1,CG98,What are the recommended approaches for diagnosing and managing jaundice in newborns under 28 days?
CG98_Context - Part 2,CG98,What are the recommended bilirubin levels for initiating phototherapy in neonatal jaundice?
CG98_Recommendations: Threshold table & Recommendations: 1.1 Information for parents or carers,CG98,What are the bilirubin thresholds for managing neonatal jaundice in babies 38 weeks or more gestational age?
CG98_Recommendations: 1.2 Care for all babies - Part 1,CG98,What are the key signs of neonatal jaundice to look for in newborns?
CG98_Recommendations: 1.2 Care for all babies - Part 2,CG98,What are the recommended procedures for assessing and managing neonatal jaundice in newborns?
CG98_Recommendations: 1.2 Care for all babies - Part 3,CG98,How should bilirubin levels be measured and interpreted in newborns with jaundice?
CG98_Recommendations: 1.3 Management and treatment of hyperbilirubinaemia,CG98,What are the recommended management and treatment strategies for hyperbilirubinaemia in newborns?
CG98_Recommendations: 1.4 Measuring and monitoring bilirubin thresholds before and during phototherapy - Part 1,CG98,What are the recommended protocols for measuring and monitoring bilirubin levels before and during phototherapy in newborns?
CG98_Recommendations: 1.4 Measuring and monitoring bilirubin thresholds before and during phototherapy - Part 2,CG98,What are the NICE guidelines for using phototherapy to treat neonatal hyperbilirubinaemia?
CG98_Recommendations: 1.4 Measuring and monitoring bilirubin thresholds before and during phototherapy - Part 3,CG98,What are the recommended practices for monitoring and supporting breastfeeding during neonatal phototherapy?
CG98_Recommendations: 1.5 Factors that influence the risk of kernicterus & Recommendations: 1.6 Formal assessment for underlying disease,CG98,What are the risk factors for developing kernicterus in newborns with hyperbilirubinaemia?
CG98_Recommendations: 1.7 Care of babies with prolonged jaundice & Recommendations: 1.8 Intravenous immunoglobulin,CG98,What are the recommended assessments and management strategies for babies with prolonged jaundice?
CG98_Recommendations: 1.9 Exchange transfusion & Recommendations: 1.10 Other therapies,CG98,What are the indications and procedures for exchange transfusion in neonatal hyperbilirubinaemia?
CG98_Recommendations for research: 2 Transcutaneous bilirubin screening and risk factors,CG98,What is the effectiveness of universal transcutaneous bilirubin screening combined with risk assessment in preventing neonatal jaundice complications?
CG98_Recommendations for research: 3 Transcutaneous bilirubinometers,CG98,What is the accuracy of Minolta JM‑103 and BiliChek transcutaneous bilirubinometers compared to serum bilirubin levels in all newborns?
CG98_Recommendations for research: 4 Interruptions during phototherapy & Recommendations for research: 5 National registries,CG98,What is the recommended frequency and duration of interruptions during phototherapy for neonatal hyperbilirubinemia?
CG99_Constipation in children and young people: diagnosis and management & Overview,CG99,What are the recommended approaches for diagnosing and managing constipation in children and young people?
CG99_Introduction,CG99,What are the best practices for early diagnosis and management of childhood constipation?
CG99_Recommendations: 1.1 History-taking and physical examination - Part 1,CG99,What questions should I ask to diagnose constipation in children and young people?
CG99_Recommendations: 1.1 History-taking and physical examination - Part 2,CG99,What are the red flag symptoms indicating an underlying condition in children with constipation?
CG99_Recommendations: 1.1 History-taking and physical examination - Part 3,CG99,What are the key components of physical examination to diagnose idiopathic constipation in children?
CG99_Recommendations: 1.2 Digital rectal examination,CG99,When should a digital rectal examination be performed in children with constipation?
CG99_Recommendations: 1.3 Clinical investigations,CG99,When should gastrointestinal endoscopy or radiography be used in the investigation of idiopathic constipation?
CG99_Recommendations: 1.4 Clinical management - Part 1,CG99,What is the recommended approach to disimpaction in children with idiopathic constipation?
CG99_Recommendations: 1.4 Clinical management - Part 2,CG99,What is the recommended maintenance therapy for children after disimpaction of constipation?
CG99_Recommendations: 1.5 Diet and lifestyle - Part 1,CG99,What are the recommended dietary and behavioral interventions for managing idiopathic constipation in children?
CG99_Recommendations: 1.5 Diet and lifestyle - Part 2 & Recommendations: 1.6 Psychological interventions,CG99,What are the recommended water intake levels for children and young people with idiopathic constipation?
CG99_Recommendations: 1.7 Antegrade colonic enema procedure & Recommendations: 1.8 Information and support,CG99,What are the recommended management and follow-up strategies for children with idiopathic constipation?
CG99_Recommendations: Terms used in this guideline,CG99,What is the recommended management for chronic constipation in children and young people?
CG99_Recommendations for research: 1 Polyethylene glycol 3350 + electrolytes in children under 1,CG99,What is the recommended dosage and effectiveness of polyethylene glycol 3350 with electrolytes for treating constipation in children under 1 year old?
CG99_Recommendations for research: 2 Age-specific information,CG99,How does age-specific information improve children's understanding and management of constipation?
CG99_Recommendations for research: 3 Specialist services & Recommendations for research: 4 Colonic washouts,CG99,What is the clinical and cost effectiveness of nurse-led specialist services compared to traditional secondary care for children with intractable idiopathic constipation?
"NG100_Rheumatoid arthritis in adults: management & Overview & Recommendations: 1.1 Referral, diagnosis and investigations - Part 1",NG100,What are the recommended investigations for diagnosing rheumatoid arthritis in adults?
"NG100_Recommendations: 1.1 Referral, diagnosis and investigations - Part 2",NG100,What are the recommended investigations and risk assessments immediately after diagnosing rheumatoid arthritis?
NG100_Recommendations: 1.2 Treat-to-target strategy & Recommendations: 1.3 Communication and education,NG100,What are the recommended treat-to-target strategies for managing rheumatoid arthritis in adults?
NG100_Recommendations: 1.4 Initial pharmacological management,NG100,What is the recommended initial pharmacological treatment for adults with newly diagnosed active rheumatoid arthritis?
NG100_Recommendations: 1.5 Further pharmacological management - Part 1,NG100,What are the recommended pharmacological options for moderate rheumatoid arthritis after failure of conventional DMARDs?
NG100_Recommendations: 1.5 Further pharmacological management - Part 2,NG100,What are the recommended biological and targeted synthetic DMARDs for severe rheumatoid arthritis unresponsive to conventional therapy?
NG100_Recommendations: 1.5 Further pharmacological management - Part 3,NG100,What are the recommended biological DMARDs for treating severe rheumatoid arthritis in patients who cannot tolerate methotrexate?
NG100_Recommendations: 1.5 Further pharmacological management - Part 4,NG100,What are the recommended biological DMARD options for treating severe rheumatoid arthritis unresponsive to previous biological treatments?
NG100_Recommendations: 1.5 Further pharmacological management - Part 5,NG100,What are the recommended biological and targeted synthetic DMARDs for rheumatoid arthritis treatment?
NG100_Recommendations: 1.6 Symptom control & Recommendations: 1.7 The multidisciplinary team,NG100,What are the recommended approaches for symptom control in rheumatoid arthritis using NSAIDs?
NG100_Recommendations: 1.8 Non-pharmacological management - Part 1,NG100,What non-pharmacological management options are recommended for adults with rheumatoid arthritis?
NG100_Recommendations: 1.8 Non-pharmacological management - Part 2,NG100,What are the recommended psychological interventions for adults with rheumatoid arthritis?
NG100_Recommendations: 1.9 Monitoring - Part 1,NG100,What are the recommended monitoring and review procedures for adults with rheumatoid arthritis?
NG100_Recommendations: 1.9 Monitoring - Part 2,NG100,What are the recommendations for reducing or stopping DMARDs in adults with rheumatoid arthritis who have maintained low disease activity?
NG100_Recommendations: 1.10 Timing and referral for surgery,NG100,When should adults with rheumatoid arthritis be referred for surgical assessment?
NG100_Recommendations: Terms used in this guideline,NG100,What are the recommended use and differences of bridging treatment and DMARD strategies in rheumatoid arthritis management?
NG100_Recommendations for research: Key recommendations for research - Part 1,NG100,What is the effectiveness of non-NSAID analgesics in managing rheumatoid arthritis pain?
NG100_Recommendations for research: Key recommendations for research - Part 2,NG100,What is the role of ultrasound in monitoring disease activity in rheumatoid arthritis patients?
NG100_Recommendations for research: Key recommendations for research - Part 3 & Recommendations for research: Other recommendations for research,NG100,What is the effectiveness of ultrasound in diagnosing rheumatoid arthritis in adults with uncertain clinical assessment?
NG100_Rationale and impact: Investigations following diagnosis,NG100,What investigations are recommended after diagnosing rheumatoid arthritis?
NG100_Rationale and impact: Investigations (ultrasound in diagnosis),NG100,How is ultrasound used to diagnose rheumatoid arthritis in clinical practice?
NG100_Rationale and impact: Treat-to-target strategy - Part 1,NG100,What is the recommended treat-to-target strategy for managing rheumatoid arthritis?
NG100_Rationale and impact: Treat-to-target strategy - Part 2,NG100,How does implementing a treat-to-target strategy affect rheumatoid arthritis management in NHS clinics?
NG100_Rationale and impact: DMARDs - Part 1,NG100,What is the recommended first-line treatment for rheumatoid arthritis with conventional DMARDs?
NG100_Rationale and impact: DMARDs - Part 2,NG100,What are the recommended first-line treatments for rheumatoid arthritis and their associated side effects?
NG100_Rationale and impact: DMARDs - Part 3,NG100,What is the recommended initial treatment strategy for rheumatoid arthritis regarding monotherapy versus combination therapy?
NG100_Rationale and impact: Short-term bridging treatment with glucocorticoids,NG100,What is the effectiveness of short-term glucocorticoids as a bridging therapy when starting a new DMARD in adults with active arthritis?
NG100_Rationale and impact: Symptom control,NG100,What are the NICE recommendations for using NSAIDs and other analgesics to manage symptoms in rheumatoid arthritis?
NG100_Rationale and impact: Monitoring,NG100,What is the recommended frequency of monitoring for rheumatoid arthritis after achieving treatment targets?
NG100_Context,NG100,What are the recommended management strategies for rheumatoid arthritis to relieve symptoms and modify disease progression?
NG101_Early and locally advanced breast cancer: diagnosis and management & Overview & Recommendations: 1.1 Providing information and psychological support,NG101,What support and information should be provided to people with early and locally advanced breast cancer?
NG101_Recommendations: 1.2 Pretreatment assessment,NG101,When should MRI be used in the preoperative assessment of invasive breast cancer?
NG101_Recommendations: 1.3 Assessment of tumour profile and genetic testing,NG101,"What are the recommended methods for assessing ER, PR, and HER2 status in invasive breast cancer?"
NG101_Recommendations: 1.4 Surgery to the breast and axilla - Part 1,NG101,What are the recommended surgical options for breast cancer and Paget's disease according to NICE guidelines?
NG101_Recommendations: 1.4 Surgery to the breast and axilla - Part 2,NG101,When should sentinel lymph node biopsy be performed in patients with invasive breast cancer?
NG101_Recommendations: 1.4 Surgery to the breast and axilla - Part 3,NG101,What are the current NICE recommendations for axillary treatment in invasive breast cancer with sentinel lymph node metastases?
NG101_Recommendations: 1.5 Breast reconstruction - Part 1,NG101,What are the options and considerations for breast reconstruction after mastectomy for breast cancer?
NG101_Recommendations: 1.5 Breast reconstruction - Part 2,NG101,What are the differences between immediate and delayed breast reconstruction options after mastectomy?
NG101_Recommendations: 1.6 Systemic anti-cancer therapy planning - Part 1,NG101,What factors should be considered when planning systemic anti-cancer therapy for invasive breast cancer?
NG101_Recommendations: 1.6 Systemic anti-cancer therapy planning - Part 2,NG101,How can the PREDICT tool be used to estimate prognosis and benefits of adjuvant therapy in women with invasive breast cancer?
NG101_Recommendations: 1.7 Systemic anti-cancer therapy for all receptor subtypes - Part 1,NG101,What are the recommended adjuvant chemotherapy regimens for breast cancer involving taxanes and anthracyclines?
NG101_Recommendations: 1.7 Systemic anti-cancer therapy for all receptor subtypes - Part 2,NG101,What are the benefits and side effects of adding a taxane to anthracycline-containing chemotherapy regimens for breast cancer?
NG101_Recommendations: 1.8 Triple negative (ER/PR/HER2-negative) breast cancer - Part 1,NG101,What is the recommended neoadjuvant chemotherapy regimen for triple-negative breast cancer?
NG101_Recommendations: 1.8 Triple negative (ER/PR/HER2-negative) breast cancer - Part 2,NG101,What are the benefits and risks of adding a platinum to neoadjuvant chemotherapy for triple-negative breast cancer?
NG101_Recommendations: 1.8 Triple negative (ER/PR/HER2-negative) breast cancer - Part 3,NG101,What are the current NICE recommendations for neoadjuvant and adjuvant treatment options in triple-negative breast cancer?
NG101_Recommendations: 1.9 HER2-positive breast cancer - Part 1,NG101,What is the recommended neoadjuvant treatment for HER2-positive breast cancer?
NG101_Recommendations: 1.9 HER2-positive breast cancer - Part 2,NG101,What are the criteria for using pertuzumab with trastuzumab and chemotherapy in HER2-positive early breast cancer?
"NG101_Recommendations: 1.10 Hormone receptor positive, HER2-negative breast cancer",NG101,What are the current recommendations for neoadjuvant chemotherapy in hormone receptor positive breast cancer?
NG101_Recommendations: Adjuvant treatment,NG101,When is olaparib recommended as adjuvant treatment for BRCA-mutated HER2-negative early breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 1,NG101,What are the benefits and risks of neoadjuvant endocrine therapy compared to chemotherapy for hormone receptor-positive breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 2,NG101,What are the current NICE recommendations for adjuvant endocrine therapy in ER-positive invasive breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 3,NG101,What are the treatment options and side effects for endocrine therapy with ovarian function suppression in premenopausal women with ER-positive breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 4,NG101,What is the recommended adjuvant endocrine therapy for postmenopausal women with ER-positive invasive breast cancer at medium or high risk of recurrence?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 5,NG101,What are the recommended endocrine therapy options for ER-positive invasive breast cancer in people with male reproductive organs?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 6,NG101,What are the benefits and risks of extended endocrine therapy for ER-positive invasive breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 7,NG101,What are the benefits and side effects of extended endocrine therapy with tamoxifen or aromatase inhibitors in breast cancer?
NG101_Recommendations: 1.11 Endocrine therapy for hormone receptor positive breast cancer - Part 8,NG101,What are the benefits and risks of endocrine therapy after breast-conserving surgery for ER-positive ductal carcinoma in situ?
NG101_Recommendations: 1.12 Adjuvant bisphosphonate therapy,NG101,What are the current NICE recommendations for adjuvant bisphosphonate therapy in postmenopausal women with invasive breast cancer?
NG101_Recommendations: 1.13 Radiotherapy - Part 1,NG101,What are the recommended radiotherapy techniques for reducing heart and lung dose in breast cancer treatment?
NG101_Recommendations: 1.13 Radiotherapy - Part 2,NG101,What are the benefits and risks of omitting radiotherapy in low-risk early breast cancer patients aged 65 and over?
NG101_Recommendations: 1.13 Radiotherapy - Part 3,NG101,What are the NICE guidelines for adjuvant radiotherapy in breast cancer treatment?
NG101_Recommendations: 1.13 Radiotherapy - Part 4,NG101,What are the NICE guidelines for breast boost radiotherapy after breast-conserving surgery?
NG101_Recommendations: 1.13 Radiotherapy - Part 5,NG101,What are the recommendations for radiotherapy boost and nodal radiotherapy in invasive breast cancer?
NG101_Recommendations: 1.13 Radiotherapy - Part 6,NG101,What are the NICE recommendations for postmastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 1,NG101,What are the recommended strategies for managing lymphoedema risk and menopausal symptoms in breast cancer treatment?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 2,NG101,What are the recommended management options and specialist referral criteria for lymphoedema in breast cancer patients?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 3,NG101,What are the recommended approaches for lymphoedema management and postoperative physiotherapy in breast cancer patients?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 4,NG101,How should healthcare professionals identify and manage shoulder problems in breast cancer patients pre- and post-surgery?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 5,NG101,What are the recommendations for managing menopausal symptoms in women with a history of breast cancer?
NG101_Recommendations: 1.14 Management of treatment side effects and menopausal symptoms - Part 6,NG101,What are the recommended treatments for menopausal symptoms in women with breast cancer who are not taking tamoxifen?
NG101_Recommendations: 1.15 Follow-up,NG101,What is the recommended follow-up imaging and clinical care for patients after breast cancer treatment?
NG101_Recommendations: 1.16 Lifestyle,NG101,What lifestyle changes are recommended to reduce the risk of breast cancer recurrence?
NG101_Recommendations: 1.17 Locally advanced inoperable disease - Part 1,NG101,What are the recommended treatment options for locally advanced inoperable breast cancer according to NICE guidelines?
NG101_Recommendations: 1.17 Locally advanced inoperable disease - Part 2,NG101,"What are the recommended treatments for HER2-positive, locally advanced breast cancer according to NICE guidelines?"
NG101_Recommendations: 1.17 Locally advanced inoperable disease - Part 3 & Recommendations: Terms used in this guideline,NG101,What are the recommended targeted therapies for hormone receptor-positive advanced breast cancer according to NICE guidelines?
NG101_Recommendations for research: Key recommendations for research,NG101,What is the safety and effectiveness of neoadjuvant endocrine therapy in premenopausal women with early breast cancer?
NG101_Recommendations for research: Other recommendations for research - Part 1,NG101,What are the best strategies to reduce arm and shoulder problems after breast cancer treatment and how effective are they?
NG101_Recommendations for research: Other recommendations for research - Part 2,NG101,What is the evidence for using 26 Gy in 5 fractions over 1 week compared to 40 Gy in 15 fractions over 3 weeks for breast cancer radiotherapy?
NG101_Recommendations for research: Other recommendations for research - Part 3,NG101,What is the effectiveness and acceptability of lymphovenous anastomosis and vascularised lymph node transfer during axillary lymph node dissection for reducing secondary lymphoedema in breast cancer patients?
NG101_Recommendations for research: Other recommendations for research - Part 4,NG101,What is the effectiveness and acceptability of lymphovenous anastomosis and vascularised lymph node transfer for breast-cancer-related lymphoedema in different patient groups?
NG101_Recommendations for research: Other recommendations for research - Part 5,NG101,What is the evidence on the long-term effects of ovarian function suppression combined with tamoxifen or aromatase inhibitors in premenopausal women with ER-positive invasive breast cancer?
NG101_Rationale and impact: Providing information and psychological support & Rationale and impact: Predictive factors,NG101,What are the recommended practices for providing psychological support and fertility information to breast cancer patients?
NG101_Rationale and impact: Surgery to the breast,NG101,What is the recommended margin width for re-excision after breast-conserving surgery for DCIS or invasive breast cancer?
NG101_Rationale and impact: Further surgery after breast-conserving surgery - Part 1,NG101,What are the recommended radial margin sizes after breast-conserving surgery to reduce local recurrence in invasive breast cancer?
NG101_Rationale and impact: Further surgery after breast-conserving surgery - Part 2,NG101,What is the recommended surgical margin size for breast-conserving surgery in invasive breast cancer and DCIS to minimize local recurrence?
NG101_Rationale and impact: Further surgery after breast-conserving surgery - Part 3,NG101,How should shared decision making be incorporated into discussions about further surgery for breast cancer patients?
NG101_Rationale and impact: Evaluation and management of a positive axillary lymph node,NG101,What is the recommended management of a positive axillary lymph node in breast cancer patients?
NG101_Rationale and impact: Breast reconstruction & Rationale and impact: Adjuvant therapy planning,NG101,What are the benefits and considerations of immediate versus delayed breast reconstruction after mastectomy?
NG101_Rationale and impact: Adjuvant chemotherapy for invasive breast cancer,NG101,What are the benefits and risks of adding taxanes to anthracycline-based chemotherapy in invasive breast cancer?
NG101_Rationale and impact: Neoadjuvant treatment of triple-negative breast cancer - Part 1,NG101,What is the recommended neoadjuvant chemotherapy regimen for triple-negative breast cancer?
NG101_Rationale and impact: Neoadjuvant treatment of triple-negative breast cancer - Part 2,NG101,What is the evidence for using platinum-based neoadjuvant chemotherapy in older adults and males with breast cancer?
NG101_Rationale and impact: Neoadjuvant treatment of HER2-positive breast cancer,NG101,What are the recommended neoadjuvant chemotherapy regimens for HER2-positive breast cancer?
NG101_Rationale and impact: Biological therapy & Rationale and impact: Neoadjuvant chemotherapy,NG101,What are the current NICE recommendations for adjuvant trastuzumab in small HER2-positive breast tumors?
NG101_Rationale and impact: Neoadjuvant endocrine therapy,NG101,What are the benefits and risks of neoadjuvant endocrine therapy for breast cancer in postmenopausal women?
NG101_Rationale and impact: Adjuvant endocrine therapy for ER-positive invasive breast cancer - Part 1,NG101,What are the recommended endocrine therapy options for premenopausal women with ER-positive invasive breast cancer?
NG101_Rationale and impact: Adjuvant endocrine therapy for ER-positive invasive breast cancer - Part 2,NG101,How should clinicians discuss endocrine therapy options with premenopausal and perimenopausal women with ER-positive invasive breast cancer?
NG101_Rationale and impact: Adjuvant endocrine therapy for ER-positive invasive breast cancer - Part 3,NG101,What are the recommended endocrine therapies for ER-positive invasive breast cancer in people with male reproductive organs?
NG101_Rationale and impact: Adjuvant endocrine therapy for ER-positive invasive breast cancer - Part 4,NG101,What are the guidelines for assessing bone mineral density in men with ER-positive invasive breast cancer starting adjuvant endocrine therapy?
NG101_Rationale and impact: Extended endocrine therapy,NG101,What are the benefits and risks of extending endocrine therapy beyond 5 years for ER-positive invasive breast cancer?
NG101_Rationale and impact: Endocrine therapy for ductal carcinoma in situ,NG101,What are the benefits and risks of endocrine therapy for ER-positive ductal carcinoma in situ?
NG101_Rationale and impact: Adjuvant bisphosphonate therapy,NG101,What are the benefits and risks of adjuvant bisphosphonate therapy in postmenopausal women with invasive breast cancer?
NG101_Rationale and impact: Radiotherapy techniques,NG101,What are the benefits and considerations of using deep inspiratory breath-hold radiotherapy techniques for left-sided breast cancer?
NG101_Rationale and impact: Radiotherapy after breast-conserving surgery,NG101,What are the benefits and risks of radiotherapy after breast-conserving surgery for early breast cancer?
NG101_Rationale and impact: Radiotherapy after mastectomy,NG101,When should postmastectomy radiotherapy be offered to breast cancer patients?
NG101_Rationale and impact: Dose fractionation of external beam radiotherapy - Part 1,NG101,What is the recommended dose fractionation schedule for external beam radiotherapy in breast cancer?
NG101_Rationale and impact: Dose fractionation of external beam radiotherapy - Part 2,NG101,What are the considerations for choosing between 26 Gy in 5 fractions and 40 Gy in 15 fractions for breast radiotherapy?
NG101_Rationale and impact: Dose fractionation of external beam radiotherapy - Part 3,NG101,What are the current recommendations for hypofractionated radiotherapy regimens in breast cancer treatment?
NG101_Rationale and impact: Radiotherapy to nodal areas & Rationale and impact: Radiotherapy after neoadjuvant chemotherapy,NG101,What are the current NICE guidelines on radiotherapy to nodal areas in breast cancer treatment?
NG101_Rationale and impact: Lymphoedema: early identification and risk reduction - Part 1,NG101,What are the recommended strategies for early identification and risk reduction of breast-cancer-related lymphoedema?
NG101_Rationale and impact: Lymphoedema: early identification and risk reduction - Part 2,NG101,What are the recommended strategies for preventing lymphoedema after breast cancer treatment?
NG101_Rationale and impact: Lymphoedema: early identification and risk reduction - Part 3,NG101,What are the current recommendations for surgical prevention of lymphoedema in breast cancer patients?
NG101_Rationale and impact: Lymphoedema management - Part 1,NG101,What are the recommended management options for lymphoedema in breast cancer patients?
NG101_Rationale and impact: Lymphoedema management - Part 2,NG101,"What are the recommended management options for lymphoedema, including conservative, physical activity, and surgical interventions?"
NG101_Rationale and impact: Lymphoedema management - Part 3,NG101,What are the current surgical options for managing breast cancer-related lymphoedema?
NG101_Rationale and impact: Arm and shoulder mobility - Part 1,NG101,What are the recommended practices for arm and shoulder mobility exercises after breast cancer surgery?
NG101_Rationale and impact: Arm and shoulder mobility - Part 2,NG101,What are the criteria for identifying high-risk patients for shoulder problems after breast cancer treatment?
NG101_Rationale and impact: Arm and shoulder mobility - Part 3,NG101,What are the recommended approaches for supervised physiotherapy support to improve shoulder function after radiotherapy or surgery?
NG101_Rationale and impact: Arm and shoulder mobility - Part 4,NG101,What are the most effective ways to deliver physiotherapy or exercise interventions to improve arm and shoulder mobility after breast cancer treatment?
NG101_Rationale and impact: Lifestyle,NG101,What lifestyle changes are recommended to reduce the risk of breast cancer recurrence?
NG101_Context - Part 1,NG101,What are the current NICE guidelines for diagnosing and managing early and locally advanced breast cancer?
NG101_Context - Part 2,NG101,What are the diagnostic and management guidelines for newly diagnosed invasive breast cancer and ductal carcinoma in situ in adults?
NG102_Community pharmacies: promoting health and wellbeing & Overview,NG102,How can community pharmacies promote health and wellbeing within local health and care pathways?
NG102_Recommendations: 1.1 Health and wellbeing hubs,NG102,How can community pharmacies be integrated into local health and wellbeing hubs for improved care and referral pathways?
NG102_Recommendations: 1.2 Overarching principles of good practice for community pharmacy teams - Part 1,NG102,What are the best practices for community pharmacy teams to deliver tailored health and wellbeing interventions?
NG102_Recommendations: 1.2 Overarching principles of good practice for community pharmacy teams - Part 2,NG102,How can community pharmacies effectively promote physical and mental health and wellbeing?
NG102_Recommendations: 1.2 Overarching principles of good practice for community pharmacy teams - Part 3,NG102,What advice should community pharmacy teams provide to patients planning pregnancy or using over-the-counter medications?
NG102_Recommendations: 1.3 Awareness raising and providing information,NG102,What are best practices for providing and explaining health information in pharmacy awareness campaigns?
NG102_Recommendations: 1.4 Advice and education - Part 1,NG102,What advice and education should be provided to patients managing long-term conditions through pharmacy services?
NG102_Recommendations: 1.4 Advice and education - Part 2,NG102,What are the recommended strategies for providing advice and education on smoking cessation and reducing alcohol consumption?
NG102_Recommendations: 1.5 Behavioural support,NG102,What are the recommended behavioural support strategies for smoking cessation and weight management?
NG102_Recommendations: 1.6 Referrals and signposting - Part 1,NG102,What are best practices for making effective referrals and signposting in community pharmacy settings?
NG102_Recommendations: 1.6 Referrals and signposting - Part 2,NG102,What are best practices for community pharmacy referrals and signposting to other services?
NG102_Recommendations: Terms used in this guideline,NG102,What is photo-ageing and how is it used in smoking cessation interventions?
NG102_Recommendations for research: Key recommendations for research - Part 1,NG102,What are effective strategies for increasing access to community pharmacy services among underserved populations?
NG102_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG102,What is the effectiveness and cost effectiveness of community pharmacy-led social prescribing interventions compared to referral or signposting?
NG102_Rationale and impact: Health and wellbeing hubs,NG102,How can community pharmacies be integrated as health and wellbeing hubs within NHS care pathways?
NG102_Rationale and impact: Overarching principles of good practice for community pharmacy teams - Part 1,NG102,"What are the principles for providing high-quality, integrated community pharmacy services to address health inequalities?"
NG102_Rationale and impact: Overarching principles of good practice for community pharmacy teams - Part 2,NG102,How can community pharmacies proactively identify opportunities to promote health and wellbeing services?
NG102_Rationale and impact: Awareness raising and providing information,NG102,How can community pharmacies effectively raise awareness and provide information to improve health outcomes?
NG102_Rationale and impact: Advice and education,NG102,What are the recommended roles of community pharmacies in providing health and wellbeing advice?
NG102_Rationale and impact: Behavioural support,NG102,What are the recommended behavioural support interventions for community pharmacy teams to help with smoking cessation and weight management?
NG102_Rationale and impact: Referrals and signposting - Part 1,NG102,What are the best practices for making effective referrals from community pharmacies?
NG102_Rationale and impact: Referrals and signposting - Part 2,NG102,What are the benefits and challenges of implementing formal referral processes in community pharmacy services?
NG102_Context - Part 1,NG102,What are the community pharmacy contractors' responsibilities beyond dispensing NHS prescriptions?
NG102_Context - Part 2,NG102,What are the roles of community pharmacies in promoting healthy lifestyles and reducing health inequalities?
NG102_Context - Part 3,NG102,What are the public health roles and commissioning arrangements for community pharmacies in promoting wellbeing?
NG103_Flu vaccination: increasing uptake & 6 more sections,NG103,What strategies can be used to increase awareness and uptake of the flu vaccination among eligible populations?
NG103_Recommendations: 1.2 Raising awareness - Part 1,NG103,What are the recommended strategies for raising awareness of flu vaccination among health and social care staff and eligible groups?
NG103_Recommendations: 1.2 Raising awareness - Part 2,NG103,What are the recommended strategies for raising awareness and providing information about free flu vaccination to eligible groups?
NG103_Recommendations: 1.2 Raising awareness - Part 3 & Recommendations: 1.3 Offering vaccination,NG103,What are the recommended strategies for promoting flu vaccination and dispelling myths about its safety?
NG103_Recommendations: 1.3 Offering vaccination & Recommendations: 1.4 Increasing uptake among eligible groups in primary and secondary care,NG103,What strategies are recommended to increase flu vaccination uptake among eligible groups in primary and secondary care?
NG103_Recommendations: 1.4 Increasing uptake among eligible groups in primary and secondary care - Part 1,NG103,What are the recommended strategies for increasing flu vaccination uptake among eligible groups in primary care?
"NG103_Recommendations: 1.4 Increasing uptake among eligible groups in primary and secondary care - Part 2 & Recommendations: 1.5 Audit, monitoring and feedback",NG103,What are the recommended strategies for increasing flu vaccination uptake among high-risk and underserved groups in primary and secondary care?
"NG103_Recommendations: 1.5 Audit, monitoring and feedback & Recommendations: 1.6 Flu vaccination in carers",NG103,What are the recommended audit and monitoring procedures for flu vaccination programs in healthcare settings?
NG103_Recommendations: 1.6 Flu vaccination in carers & Recommendations: 1.7 Employers of health and social care staff,NG103,What are the recommendations for increasing flu vaccination uptake among carers not otherwise eligible?
NG103_Recommendations: 1.7 Employers of health and social care staff - Part 1,NG103,What are the recommended strategies for increasing flu vaccination uptake among health and social care staff?
NG103_Recommendations: 1.7 Employers of health and social care staff - Part 2 & Recommendations: Terms used in this guideline,NG103,What are effective strategies for promoting and increasing flu vaccination uptake among healthcare and social care staff?
NG103_Recommendations: Terms used in this guideline - Part 1,NG103,Which groups are eligible for free flu vaccination according to NICE guidelines?
NG103_Recommendations: Terms used in this guideline - Part 2,NG103,What are the recommended strategies to improve flu vaccination uptake among underserved groups?
NG103_Context - Part 1,NG103,What are the recommended groups for free flu vaccination in the UK?
NG103_Context - Part 2,NG103,What are the flu vaccination uptake rates among different age and risk groups in England?
NG103_Recommendations for research: 1 People in eligible groups & Recommendations for research: 1 People in eligible groups & Recommendations for research: 2 Underserved groups,NG103,What are effective strategies for tailoring and delivering messages to increase flu vaccination uptake among underserved and minority ethnic groups?
NG103_Recommendations for research: 2 Underserved groups & Recommendations for research: 3 Carers,NG103,What are the most effective strategies for increasing flu vaccination uptake among underserved groups and carers?
NG103_Recommendations for research: 3 Carers & Recommendations for research: 4 Opt-out strategies for front-line health and social care staff,NG103,What are the most effective and cost-effective strategies to increase flu vaccination uptake among carers?
NG103_Recommendations for research: 4 Opt-out strategies for front-line health and social care staff & Recommendations for research: 5 Community-based models of flu vaccination,NG103,What is the effectiveness and cost-effectiveness of opt-out strategies to increase flu vaccination uptake among front-line health and social care staff?
NG103_Recommendations for research: 5 Community-based models of flu vaccination & Glossary,NG103,Which community-based models of flu vaccination are effective and cost-effective in increasing uptake among eligible populations?
NG104_Pancreatitis & Overview,NG104,What are the recommended management strategies for acute and chronic pancreatitis in children and adults?
NG104_Recommendations: 1.1 Information and support - Part 1,NG104,What information and support should be provided to patients and families after a diagnosis of pancreatitis?
NG104_Recommendations: 1.1 Information and support - Part 2,NG104,What are the recommended management and lifestyle interventions for acute and chronic pancreatitis according to NICE guidelines?
NG104_Recommendations: 1.2 Acute pancreatitis - Part 1,NG104,What are the recommended diagnostic and management strategies for acute pancreatitis according to NICE guidelines?
NG104_Recommendations: 1.2 Acute pancreatitis - Part 2,NG104,What are the recommended approaches for managing infected pancreatic necrosis in acute pancreatitis?
NG104_Recommendations: 1.3 Chronic pancreatitis - Part 1,NG104,What are the recommended approaches for diagnosing and managing pancreatic duct obstruction in chronic pancreatitis?
NG104_Recommendations: 1.3 Chronic pancreatitis - Part 2,NG104,What are the recommended treatment options for managing pancreatic pseudocysts and associated complications?
NG104_Recommendations: 1.3 Chronic pancreatitis - Part 3,NG104,What is the recommended follow-up for pancreatic exocrine function and diabetes in chronic pancreatitis?
NG104_Recommendations: Terms used in this guideline,NG104,What are the clinical features and management of moderately severe and severe acute pancreatitis?
NG104_Context,NG104,What are the management strategies for acute and chronic pancreatitis?
NG104_Recommendations for research: 1 Diagnosis of chronic pancreatitis,NG104,What is the diagnostic accuracy of MRCP with or without secretin and endoscopic ultrasound for confirming chronic pancreatitis after initial tests?
NG104_Recommendations for research: 2 Speed of intravenous fluid resuscitation for people with acute pancreatitis,NG104,What is the recommended rate of intravenous fluid administration for resuscitation in patients with acute pancreatitis?
NG104_Recommendations for research: 3 Pain management: chronic pancreatitis & Recommendations for research: 4 Pain management: small duct disease,NG104,What is the most effective and cost-effective pain management strategy for chronic pancreatitis with small duct disease?
NG104_Recommendations for research: 5 Management of type 3c diabetes & Recommendations for research: 5 Management of type 3c diabetes,NG104,What is the most effective insulin regimen to prevent hypo- and hyperglycaemia in type 3c diabetes secondary to pancreatitis?
NG105_Preventing suicide in community and custodial settings & Overview,NG105,What strategies are recommended for preventing suicide in community and custodial settings?
NG105_Recommendations: 1.1 Suicide prevention partnerships - Part 1,NG105,What are the recommended strategies for establishing multi-agency partnerships for suicide prevention?
NG105_Recommendations: 1.1 Suicide prevention partnerships - Part 2,NG105,What are the recommended components for effective multi-agency suicide prevention partnerships in custodial settings?
NG105_Recommendations: 1.2 Suicide prevention strategies,NG105,What are effective multi-agency strategies for suicide prevention?
NG105_Recommendations: 1.3 Suicide prevention action plans - Part 1,NG105,What are the recommended actions for developing and implementing a local suicide prevention plan?
NG105_Recommendations: 1.3 Suicide prevention action plans - Part 2,NG105,How should prison and probation services implement recommendations to prevent suicide and self-harm?
NG105_Recommendations: 1.4 Gathering and analysing suicide-related information - Part 1,NG105,What are the recommended methods for collecting and analyzing suicide-related data in healthcare and community settings?
NG105_Recommendations: 1.4 Gathering and analysing suicide-related information - Part 2,NG105,What data should be collected and how should it be analyzed to prevent suicides in residential custodial and detention settings?
NG105_Recommendations: 1.5 Awareness raising by suicide prevention partnerships - Part 1,NG105,What are effective community awareness strategies for suicide prevention and reducing stigma?
NG105_Recommendations: 1.5 Awareness raising by suicide prevention partnerships - Part 2,NG105,How can healthcare organizations develop sensitive and effective suicide awareness materials that align with national initiatives and media guidelines?
NG105_Recommendations: 1.6 Reducing access to methods of suicide - Part 1,NG105,What strategies are recommended to reduce access to methods of suicide in the community and custodial settings?
NG105_Recommendations: 1.6 Reducing access to methods of suicide - Part 2,NG105,What strategies can be used to reduce access to means of suicide in public places?
NG105_Recommendations: 1.7 Training by suicide prevention partnerships,NG105,What training is recommended for suicide prevention partnerships and staff working with high-risk groups?
NG105_Recommendations: 1.8 Supporting people bereaved or affected by a suspected suicide,NG105,What are recommended practices for supporting people affected by a suspected suicide?
NG105_Recommendations: 1.9 Preventing and responding to suicide clusters,NG105,How can healthcare providers identify and respond to suicide clusters effectively?
NG105_Recommendations: 1.10 Reducing the potential harmful effects of media reporting of a suspected suicide,NG105,What are the recommended practices for media reporting of suspected suicides to reduce harm?
NG105_Recommendations: Terms used in this guideline - Part 1,NG105,What is the role of gatekeepers in suicide prevention according to NICE guidelines?
NG105_Recommendations: Terms used in this guideline - Part 2,NG105,What are the high-risk locations and factors associated with suicide prevention?
NG105_Recommendations for research: 1 Non-clinical interventions,NG105,How effective are non-clinical interventions in reducing suicidal behaviors?
NG105_Recommendations for research: 2 Supporting people bereaved or affected by a suicide,NG105,What interventions are effective for supporting people bereaved or affected by suicide in the community?
NG105_Recommendations for research: 3 Suicide prevention in custodial and detention settings,NG105,What interventions are effective in reducing suicide rates in custodial and detention settings?
NG105_Recommendations for research: 4 Training,NG105,How effective and cost-effective is gatekeeper training in preventing suicides?
NG105_Rationale and impact: Suicide prevention partnerships,NG105,What are the key components of effective multi-agency partnerships for suicide prevention in community and custodial settings?
NG105_Rationale and impact: Suicide prevention strategies,NG105,What are effective suicide prevention strategies through multi-agency partnerships?
NG105_Rationale and impact: Suicide prevention action plans,NG105,What are the key components of effective local suicide prevention action plans?
NG105_Rationale and impact: Gathering and analysing suicide-related information,NG105,What are the recommended methods for gathering and analysing suicide-related information to improve prevention strategies?
NG105_Rationale and impact: Awareness raising by suicide prevention partnerships,NG105,What are effective strategies for raising awareness about suicide prevention and available support services?
NG105_Rationale and impact: How suicide prevention partnerships can reduce access to methods of suicide,NG105,How can physical barriers and location restrictions reduce access to suicide methods?
NG105_Rationale and impact: Training by suicide prevention partnerships,NG105,What training is recommended for suicide prevention partnerships to improve identification and support of at-risk individuals?
NG105_Rationale and impact: How suicide prevention partnerships can support people bereaved or affected by a suspected suicide,NG105,What are effective strategies for supporting people bereaved or affected by a suspected suicide?
NG105_Rationale and impact: Preventing and responding to suicide clusters,NG105,What are the recommended strategies for preventing and responding to suicide clusters?
NG105_Rationale and impact: Reducing the potential harmful effects of media reporting of a suspected suicide,NG105,What are the recommended practices for responsible media reporting of suspected suicide to prevent copycat incidents?
NG105_Context - Part 1,NG105,What are the recommended strategies for suicide prevention in high-risk populations?
NG105_Context - Part 2,NG105,What are the recommended interventions for preventing suicide in community and primary care settings?
NG105_Finding more information and resources,NG105,Where can I find additional resources and evidence reviews for NICE guidelines on depression and related mental health conditions?
NG106_Chronic heart failure in adults: diagnosis and management & Overview & Recommendations: 1.1 Team working in the management of heart failure - Part 1,NG106,What are the recommended team roles and responsibilities in the management of chronic heart failure?
NG106_Recommendations: 1.1 Team working in the management of heart failure - Part 2,NG106,What are the key components of a care plan for patients discharged after acute heart failure?
NG106_Recommendations: 1.2 Diagnosing heart failure - Part 1,NG106,What are the recommended diagnostic steps for suspected heart failure?
NG106_Recommendations: 1.2 Diagnosing heart failure - Part 2,NG106,What are the indications and best practices for performing transthoracic echocardiography in patients with suspected heart failure?
NG106_Recommendations: 1.2 Diagnosing heart failure - Part 3,NG106,What are the recommended imaging and diagnostic tests for confirming and evaluating heart failure?
NG106_Recommendations: 1.3 Giving information to people with heart failure,NG106,What information should healthcare professionals provide to patients newly diagnosed with heart failure?
NG106_Recommendations: 1.4 Treating heart failure with reduced ejection fraction - Part 1,NG106,What is the recommended first-line pharmacological treatment for heart failure with reduced ejection fraction?
NG106_Recommendations: 1.4 Treating heart failure with reduced ejection fraction - Part 2,NG106,What are the alternative treatments for heart failure patients intolerant to ACE inhibitors?
NG106_Recommendations: 1.4 Treating heart failure with reduced ejection fraction - Part 3,NG106,How should serum sodium potassium and renal function be monitored when starting or adjusting an MRA in heart failure treatment?
NG106_Recommendations: 1.4 Treating heart failure with reduced ejection fraction - Part 4,NG106,What are the indications for prescribing sacubitril valsartan in chronic heart failure with reduced ejection fraction?
NG106_Recommendations: 1.5 Treating heart failure with reduced ejection fraction in people with chronic kidney disease,NG106,What are the recommended medication adjustments for treating heart failure with reduced ejection fraction in patients with chronic kidney disease?
NG106_Recommendations: 1.6 Managing all types of heart failure - Part 1,NG106,What are the recommended pharmacological treatments for managing different types of heart failure?
NG106_Recommendations: 1.6 Managing all types of heart failure - Part 2,NG106,When should anticoagulation be considered for patients with heart failure in sinus rhythm?
NG106_Recommendations: 1.7 Monitoring treatment for all types of heart failure,NG106,What are the recommended monitoring strategies for patients with chronic heart failure?
NG106_Recommendations: 1.8 Interventional procedures & Recommendations: 1.9 Cardiac rehabilitation,NG106,What are the indications and considerations for implanting a cardioverter defibrillator in patients with heart failure?
NG106_Recommendations: 1.10 Palliative care & Recommendations: Terms used in this guideline,NG106,What are the recommended palliative care approaches for patients with advanced heart failure?
NG106_Recommendations for research: 1 Diuretic therapy for managing fluid overload in people with advanced heart failure in the community,NG106,"What is the clinical and cost effectiveness of oral, subcutaneous, and intravenous diuretic therapy for managing fluid overload in people with advanced heart failure in the community?"
NG106_Recommendations for research: 2 Cardiac MRI versus other imaging techniques for diagnosing heart failure,NG106,What is the most effective imaging technique for diagnosing heart failure?
NG106_Recommendations for research: 3 The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure,NG106,What is the recommended NT-proBNP threshold for diagnosing heart failure in patients with atrial fibrillation?
NG106_Recommendations for research: 4 The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart failure & Recommendations for research: 5 Risk tools for predicting non-sudden death in heart failure,NG106,What are the recommended NT-proBNP thresholds for diagnosing heart failure in patients with advanced chronic kidney disease?
NG106_Context,NG106,What are the recommended treatments and management strategies for heart failure according to NICE guidelines?
NG107_Renal replacement therapy and conservative management & Overview & Recommendations: 1.1 Indications for starting dialysis,NG107,When should dialysis be initiated in patients with chronic kidney disease?
NG107_Recommendations: 1.2 Preparing for renal replacement therapy or conservative management,NG107,When should I start assessing a patient for renal replacement therapy or conservative management?
NG107_Recommendations: 1.3 Choosing modalities of renal replacement therapy or conservative management - Part 1,NG107,What factors should be considered when choosing renal replacement therapy options for patients with kidney failure?
NG107_Recommendations: 1.3 Choosing modalities of renal replacement therapy or conservative management - Part 2,NG107,What are the recommended dialysis options and considerations for patient choice and clinical suitability?
NG107_Recommendations: 1.4 Planning dialysis access formation,NG107,What are the recommended timing and procedures for planning dialysis access formation in patients with end-stage renal disease?
NG107_Recommendations: 1.5 Indications for switching or stopping renal replacement therapy,NG107,What are the indications for switching or stopping renal replacement therapy?
NG107_Recommendations: 1.6 Recognising symptoms,NG107,What are the common symptoms experienced by people on renal replacement therapy or conservative management?
NG107_Recommendations: 1.7 Diet and fluids,NG107,What are the recommended dietary assessments and advice for people starting dialysis or conservative kidney management?
"NG107_Recommendations: 1.8 Information, education and support - Part 1",NG107,What information should be provided to patients and families about renal replacement therapy options and their impact on lifestyle?
"NG107_Recommendations: 1.8 Information, education and support - Part 2",NG107,What information and support should be provided to patients with chronic kidney disease to facilitate informed decision-making about their treatment options?
NG107_Recommendations: 1.9 Coordinating care,NG107,What are best practices for coordinating renal care and ensuring continuity when switching dialysis modalities?
NG107_Recommendations for research: Key recommendations for research - Part 1,NG107,What is the clinical effectiveness of different renal replacement therapy modalities in acute dialysis initiation?
NG107_Recommendations for research: Key recommendations for research - Part 2,NG107,What is the recommended frequency of review for patients on renal replacement therapy?
NG107_Recommendations for research: Other recommendations for research,NG107,What is the clinical and cost effectiveness of strategies for switching renal replacement therapy modality?
NG107_Rationale and impact: Indications for starting renal replacement therapy,NG107,What are the indications for starting dialysis in patients with chronic kidney disease?
NG107_Rationale and impact: Preparing for renal replacement therapy or conservative management – when to assess,NG107,When should patients be referred for assessment of renal replacement therapy?
NG107_Rationale and impact: Preparing for renal replacement therapy or conservative management – how to assess,NG107,What are the recommended assessments before starting renal replacement therapy?
NG107_Rationale and impact: Choosing modalities of renal replacement therapy or conservative management - Part 1,NG107,What factors should be considered when choosing between renal replacement therapy options for chronic kidney disease?
NG107_Rationale and impact: Choosing modalities of renal replacement therapy or conservative management - Part 2,NG107,What are the differences in outcomes and patient experiences between home and in-centre haemodialysis or HDF?
NG107_Rationale and impact: Choosing modalities of renal replacement therapy or conservative management - Part 3,NG107,What are the considerations for sequencing renal replacement therapy modalities in chronic kidney disease?
NG107_Rationale and impact: Planning dialysis access formation - Part 1,NG107,What is the recommended timing for creating dialysis access before starting haemodialysis?
NG107_Rationale and impact: Planning dialysis access formation - Part 2,NG107,What is the recommended timing for creating vascular access before starting dialysis?
NG107_Rationale and impact: Indications for switching or stopping renal replacement therapy,NG107,What are the indications for switching or stopping renal replacement therapy in patients with kidney failure?
NG107_Rationale and impact: Recognising symptoms,NG107,What symptoms should healthcare professionals ask about in patients receiving renal replacement therapy?
NG107_Rationale and impact: Diet and fluids,NG107,What are the recommended dietary and fluid management strategies for people receiving renal replacement therapy or conservative management?
"NG107_Rationale and impact: Frequency of review & Rationale and impact: Information, education and support & Rationale and impact: Decision support interventions",NG107,What is the recommended frequency for reviewing patients on renal replacement therapy or conservative management?
NG107_Rationale and impact: Coordinating care,NG107,What are the recommended strategies for coordinating care in patients starting or changing renal replacement therapy?
NG107_Context - Part 1,NG107,What are the indications and options for renal replacement therapy in chronic kidney disease?
NG107_Context - Part 2,NG107,What are the current treatment options and considerations for renal replacement therapy in adults with chronic kidney disease?
NG108_Decision-making and mental capacity & Overview,NG108,What are the principles for decision-making and assessing mental capacity according to NICE guideline NG108?
NG108_Recommendations: Overarching principles - Part 1,NG108,What training is recommended for healthcare practitioners on the Mental Capacity Act 2005 and advance care planning?
NG108_Recommendations: Overarching principles - Part 2,NG108,What are the recommended practices for supporting decision-making and assessing mental capacity under the Mental Capacity Act 2005?
NG108_Recommendations: Overarching principles - Part 3,NG108,What are the requirements for independent advocacy under the Mental Capacity Act 2005 and Care Act 2014?
NG108_Recommendations: Supporting decision-making - Part 1,NG108,What are best practices for supporting decision-making capacity under the Mental Capacity Act 2005?
NG108_Recommendations: Supporting decision-making - Part 2,NG108,How can practitioners support a person's decision-making by providing accessible information and considering individual factors?
NG108_Recommendations: Supporting decision-making - Part 3,NG108,How can healthcare professionals support informed decision-making and communication for people with impaired capacity?
NG108_Recommendations: Supporting decision-making - Part 4,NG108,What are the recommended practices for documenting and sharing decision-making records in mental capacity assessments?
NG108_Recommendations: Advance care planning - Part 1,NG108,What is advance care planning and how can it help patients at risk of losing capacity?
NG108_Recommendations: Advance care planning - Part 2,NG108,What are the recommended practices for healthcare professionals in supporting advance care planning with patients diagnosed with long-term or life-limiting conditions?
NG108_Recommendations: Advance care planning - Part 3,NG108,What are the key principles for advance care planning and documentation according to NICE guidelines?
NG108_Recommendations: Assessment of mental capacity - Part 1,NG108,How is mental capacity assessed according to the Mental Capacity Act 2005?
NG108_Recommendations: Assessment of mental capacity - Part 2,NG108,How should mental capacity assessments be conducted and documented according to NICE guidelines?
NG108_Recommendations: Assessment of mental capacity - Part 3,NG108,How should health and social care practitioners assess decision-making capacity in a person with communication needs?
NG108_Recommendations: Assessment of mental capacity - Part 4,NG108,How should health and social care practitioners assess capacity in individuals with communication difficulties or executive dysfunction?
NG108_Recommendations: Assessment of mental capacity - Part 5,NG108,How should practitioners document and assess decision-making capacity according to NICE guidelines?
NG108_Recommendations: Best interests decision-making - Part 1,NG108,What are the key steps for making best interests decisions under the Mental Capacity Act 2005?
NG108_Recommendations: Best interests decision-making - Part 2,NG108,How should health and social care professionals involve family and advocates in best interests decision-making under the Mental Capacity Act 2005?
NG108_Recommendations: Best interests decision-making - Part 3,NG108,What are the recommended procedures for making best interests decisions for individuals who lack capacity?
NG108_Recommendations: Best interests decision-making - Part 4,NG108,What are the key steps for making and reviewing best interests decisions for individuals lacking capacity?
NG108_Recommendations: Terms used in this guideline - Part 1,NG108,What is advance care planning and how does it relate to advance decisions to refuse treatment?
NG108_Recommendations: Terms used in this guideline - Part 2,NG108,What is the role of independent advocacy in supporting consent and decision-making for people who lack capacity?
NG108_Recommendations: Terms used in this guideline - Part 3,NG108,What is a lasting power of attorney and how does it relate to mental capacity laws?
NG108_Recommendations: Terms used in this guideline - Part 4,NG108,What are the key steps to support decision-making for patients with impaired mental capacity?
NG108_Recommendations for research: 1 Training and support for practitioners,NG108,What is the effectiveness of training programs on the Mental Capacity Act 2005 for improving practitioners' decision-making and assessment practices?
NG108_Recommendations for research: 2 Targeted interventions to support and improve decision-making capacity for treatment,NG108,"What is the effectiveness of speech and language therapy and psychosocial interventions in improving decision-making capacity in people with dementia, learning disabilities, brain injuries, or mental illness?"
NG108_Recommendations for research: 3 Advocacy and support for decision-making,NG108,What is the effectiveness and acceptability of advocacy in supporting decision-making for people with decision-making needs?
NG108_Recommendations for research: 4 Using mental capacity assessment tools to assess capacity & Recommendations for research: 5 Components of a mental capacity assessment,NG108,What is the effectiveness and acceptability of mental capacity assessment tools compliant with the Mental Capacity Act 2005?
NG108_Context - Part 1,NG108,What are the best practices for assessing mental capacity in adults under the Mental Capacity Act 2005?
NG108_Context - Part 2,NG108,What are best practices for assessing and supporting decision-making capacity in adult care and treatment?
NG108_Context - Part 3,NG108,What are the best practices for assessing mental capacity and making decisions for young people over 16 who lack capacity?
NG109_Urinary tract infection (lower): antimicrobial prescribing & Overview,NG109,What are the recommended antibiotic treatments for lower urinary tract infections in non-catheterized patients?
NG109_Recommendations: 1.1 Managing lower urinary tract infection - Part 1,NG109,What is the recommended management for lower urinary tract infection in pregnant women and men?
NG109_Recommendations: 1.1 Managing lower urinary tract infection - Part 2,NG109,"What is the recommended approach for antibiotic review and susceptibility testing in pregnant women, men, and children with lower urinary tract infections?"
NG109_Recommendations: 1.1 Managing lower urinary tract infection - Part 3,NG109,What are the recommended signs to watch for that indicate when to seek medical help after starting antibiotics for a urinary tract infection?
NG109_Recommendations: 1.2 Managing asymptomatic bacteriuria & Recommendations: 1.3 Self-care,NG109,What is the recommended management of asymptomatic bacteriuria in pregnant women?
NG109_Recommendations: 1.4 Choice of antibiotic - Part 1,NG109,What are the recommended antibiotics for treating lower urinary tract infections in non-pregnant women according to NICE guidelines?
NG109_Recommendations: 1.4 Choice of antibiotic - Part 2,NG109,What are the recommended antibiotics for treating urinary tract infections in pregnant women based on culture results and renal function?
NG109_Recommendations: 1.4 Choice of antibiotic - Part 3,NG109,What are the recommended antibiotics and dosing for urinary tract infections in men aged 16 and over?
NG109_Recommendations: 1.4 Choice of antibiotic - Part 5,NG109,What are the recommended antibiotics and dosages for treating urinary tract infections in children aged 3 months to 16 years?
NG109_Recommendations: 1.4 Choice of antibiotic - Part 6,NG109,What are the recommended antibiotic choices and dosing guidelines for children with urinary tract infections?
NG109_Summary of the evidence: Self-care - Part 1,NG109,What is the effectiveness and safety of using ibuprofen for self-care in women with urinary tract infections?
NG109_Summary of the evidence: Self-care - Part 2,NG109,Are cranberry products effective and safe for preventing urinary tract infections during pregnancy?
NG109_Summary of the evidence: Antibiotics - Part 1,NG109,When should antibiotics be prescribed for uncomplicated lower urinary tract infections in women?
NG109_Summary of the evidence: Antibiotics - Part 2,NG109,What is the effectiveness of antibiotics in treating uncomplicated cystitis in women?
NG109_Summary of the evidence: Antibiotics - Part 3,NG109,"What are the safety considerations and potential risks associated with prescribing antibiotics like penicillin, nitrofurantoin, and trimethoprim?"
NG109_Summary of the evidence: Antibiotics - Part 4,NG109,What are the risks and benefits of antibiotic treatment for uncomplicated urinary tract infections in women?
NG109_Summary of the evidence: Antibiotics - Part 5,NG109,What are the recommended prescribing strategies for uncomplicated lower urinary tract infections in non-pregnant women?
NG109_Summary of the evidence: Antibiotics - Part 6,NG109,"What are the recommended antibiotic management strategies for lower urinary tract infections in non-pregnant women, pregnant women, and men?"
NG109_Summary of the evidence: Antibiotics - Part 7,NG109,What is the recommended management of urinary tract infections in men and children based on NICE guidelines?
NG109_Summary of the evidence: Choice of antibiotic - Part 1,NG109,What is the most appropriate antibiotic choice for treating uncomplicated urinary tract infections in non-pregnant women?
NG109_Summary of the evidence: Choice of antibiotic - Part 2,NG109,What are the recommended antibiotics for uncomplicated lower urinary tract infections in children and non-pregnant women?
NG109_Summary of the evidence: Choice of antibiotic - Part 3,NG109,What are the recommended first-line antibiotics for non-pregnant women with uncomplicated lower urinary tract infections?
NG109_Summary of the evidence: Choice of antibiotic - Part 4,NG109,What are the recommended antibiotics for treating lower urinary tract infections in pregnant women?
NG109_Summary of the evidence: Choice of antibiotic - Part 5,NG109,What are the recommended antibiotics for men with lower urinary tract infections?
NG109_Summary of the evidence: Antibiotic course length - Part 1,NG109,What is the recommended duration of antibiotic treatment for uncomplicated lower urinary tract infections?
NG109_Summary of the evidence: Antibiotic course length - Part 2,NG109,What is the most effective antibiotic treatment duration for asymptomatic bacteriuria in pregnant women?
NG109_Summary of the evidence: Antibiotic course length - Part 3,NG109,What is the recommended duration of antibiotic treatment for uncomplicated lower urinary tract infections in non-pregnant women?
NG109_Summary of the evidence: Antibiotic course length - Part 4,NG109,What is the recommended duration of antibiotic treatment for lower urinary tract infections in pregnant women?
NG109_Other considerations,NG109,What strategies can improve medicines adherence for antibiotics requiring frequent dosing?
"NG10_Violence and aggression: short-term management in mental health, health and community settings & Overview",NG10,What are the recommended short-term management strategies for violence and aggression in mental health and community settings?
NG10_Introduction - Part 1,NG10,What are the recommended strategies for preventing and managing violence and aggression in mental health and healthcare settings?
NG10_Introduction - Part 2,NG10,What are the recommended strategies for managing violence and aggression in mental health and community settings?
NG10_Person-centred care,NG10,What are the principles of person-centred care for managing violence and aggression in mental health service users?
NG10_Key priorities for implementation: Anticipating and reducing the risk of violence and aggression - Part 1,NG10,What training should staff receive to reduce restrictive interventions and manage violence and aggression?
NG10_Key priorities for implementation: Anticipating and reducing the risk of violence and aggression - Part 2,NG10,How can inpatient psychiatric wards effectively reduce violence and aggression among service users?
NG10_Key priorities for implementation: Preventing violence and aggression,NG10,What are the recommended practices for prescribing and using p.r.n. medication to prevent violence and aggression in mental health settings?
NG10_Key priorities for implementation: Using restrictive interventions in inpatient psychiatric settings & Key priorities for implementation: Managing violence and aggression in emergency departments,NG10,What are the recommended approaches for managing violence and aggression in inpatient psychiatric and emergency department settings?
NG10_Key priorities for implementation: Managing violence and aggression in community and primary care settings & Key priorities for implementation: Managing violence and aggression in children and young people,NG10,What are the recommended strategies for managing violence and aggression in children and young people in community and primary care settings?
NG10_Recommendations: Terms used in this guideline - Part 1,NG10,What are the differences between advance decision and advance statement in healthcare planning?
NG10_Recommendations: Terms used in this guideline - Part 2,NG10,What are the recommended levels of observation for managing violence and aggression in mental health settings?
NG10_Recommendations: 1.1 Principles for managing violence and aggression - Part 1,NG10,What are the recommended practices for managing violence and aggression in adult mental health services?
NG10_Recommendations: 1.1 Principles for managing violence and aggression - Part 2,NG10,What are the best practices for involving service users and carers in decision-making about restrictive interventions and respecting their human rights?
NG10_Recommendations: 1.2 Anticipating and reducing the risk of violence and aggression - Part 1,NG10,What training is recommended for staff to reduce restrictive interventions and manage violence and aggression in mental health services?
NG10_Recommendations: 1.2 Anticipating and reducing the risk of violence and aggression - Part 2,NG10,What strategies and procedures does NICE recommend for reducing restrictive interventions and managing violence in inpatient psychiatric settings?
NG10_Recommendations: 1.2 Anticipating and reducing the risk of violence and aggression - Part 3,NG10,How can risk assessments for violence and aggression be effectively conducted in mental health settings?
NG10_Recommendations: 1.2 Anticipating and reducing the risk of violence and aggression - Part 4,NG10,What are effective risk assessment tools and management strategies for violence and aggression in inpatient psychiatric settings?
NG10_Recommendations: 1.3 Preventing violence and aggression - Part 1,NG10,What are the recommended procedures for conducting searches of service users in health and social care settings?
NG10_Recommendations: 1.3 Preventing violence and aggression - Part 2,NG10,What are the recommended practices for managing weapons and de-escalation in mental health settings?
NG10_Recommendations: 1.3 Preventing violence and aggression - Part 3,NG10,What are effective de-escalation techniques for managing aggression in mental health services?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 1,NG10,What are the NICE guidelines for using restrictive interventions in inpatient psychiatric settings?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 2,NG10,What are the recommended levels of observation and assessment protocols for service users in inpatient psychiatric settings?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 3,NG10,What are the recommended practices for observing service users to manage risk of violence and aggression?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 4,NG10,What are the best practices for manual restraint in healthcare settings to ensure safety and dignity?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 5,NG10,When should mechanical restraint be used in mental health settings?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 6,NG10,What are the NICE guidelines for prescribing and monitoring medication during rapid tranquillisation and seclusion?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 7,NG10,What are the recommended procedures for post-incident debrief and review after restrictive interventions in mental health settings?
NG10_Recommendations: 1.4 Using restrictive interventions in inpatient psychiatric settings - Part 8,NG10,What are the recommended procedures for conducting a post-incident review in inpatient psychiatric services?
NG10_Recommendations: 1.5 Managing violence and aggression in emergency departments - Part 1,NG10,What training is recommended for emergency department staff to manage violence and aggression?
NG10_Recommendations: 1.5 Managing violence and aggression in emergency departments - Part 2,NG10,How should emergency department staff be trained to manage excited delirium and psychiatric emergencies?
NG10_Recommendations: 1.6 Managing violence and aggression in community and primary care settings - Part 1,NG10,What training is recommended for staff to prevent and manage violence and aggression in community and primary care settings?
NG10_Recommendations: 1.6 Managing violence and aggression in community and primary care settings - Part 2,NG10,What are the recommended procedures for risk assessment and management of violence and aggression in community mental health settings?
NG10_Recommendations: 1.7 Managing violence and aggression in children and young people - Part 1,NG10,What training should CAMHS staff have for managing violence and aggression in children and young people?
NG10_Recommendations: 1.7 Managing violence and aggression in children and young people - Part 2,NG10,What are the recommended strategies for managing violence and aggression in children and young people according to NICE guidelines?
NG10_Recommendations: 1.7 Managing violence and aggression in children and young people - Part 3,NG10,What are the recommended practices for managing challenging behavior in children and young people in mental health settings?
NG10_Recommendations for research: 1 Medication for promoting de‑escalation & Recommendations for research: 2 Violence related to drug or alcohol misuse,NG10,What medication is effective for promoting de-escalation in people at risk of violence?
NG10_Recommendations for research: 3 Advance statements and decisions & Recommendations for research: 4 Content and nature of effective de‑escalation,NG10,What is the role of advance statements in managing and preventing violence and aggression in mental health services?
NG10_Recommendations for research: 5 Long duration or very frequent manual restraint,NG10,What are the recommended approaches and alternatives to long‑duration or frequent manual restraint in managing agitation and violence?
NG10_Implementation: getting started: Manual restraint - Part 1,NG10,What are the recommended practices for manual restraint to ensure safety and prevent harm?
NG10_Implementation: getting started: Manual restraint - Part 2,NG10,What are the recommended practices for manual restraint to ensure patient safety and prevent death?
NG10_Implementation: getting started: Rapid tranquillisation - Part 1,NG10,What are the recommended medications and protocols for rapid tranquillisation in mental health emergencies?
NG10_Implementation: getting started: Rapid tranquillisation - Part 2,NG10,What are the recommended medications and considerations for rapid tranquillisation in mental health emergencies?
NG10_Implementation: getting started: Formal external post-incident reviews,NG10,What are the recommended procedures for conducting formal external post-incident reviews in mental health services?
NG110_Prostatitis (acute): antimicrobial prescribing & Overview,NG110,What is the recommended antimicrobial treatment for acute prostatitis?
NG110_Recommendations: 1.1 Managing acute prostatitis,NG110,What is the recommended antibiotic treatment for acute prostatitis and when should I refer for hospital care?
NG110_Recommendations: 1.2 Self-care,NG110,What are the recommended self-care strategies for managing pain in acute prostatitis?
NG110_Recommendations: 1.3 Choice of antibiotic - Part 1,NG110,What are the recommended antibiotics and treatment durations for acute prostatitis in adults?
NG110_Recommendations: 1.3 Choice of antibiotic - Part 2 & Summary of the evidence: Self-care,NG110,What are the recommended antibiotic choices and review periods for treating acute prostatitis?
NG110_Summary of the evidence: Antibiotics - Part 1,NG110,What are the recommended antibiotic treatments and safety considerations for acute prostatitis?
NG110_Summary of the evidence: Antibiotics - Part 2,NG110,What are the recommended antibiotic treatments for acute prostatitis and how should resistance be managed?
NG110_Summary of the evidence: Choice of antibiotic - Part 1,NG110,What are the recommended antibiotics for treating acute prostatitis based on current guidelines?
NG110_Summary of the evidence: Choice of antibiotic - Part 2,NG110,What are the recommended oral antibiotics for treating acute prostatitis according to NICE guidelines?
NG110_Summary of the evidence: Choice of antibiotic - Part 3,NG110,What are the recommended intravenous antibiotics for severe acute prostatitis according to NICE guidelines?
NG110_Summary of the evidence: Antibiotic course length - Part 1,NG110,What is the recommended duration of antibiotic treatment for acute prostatitis according to NICE guidelines?
NG110_Summary of the evidence: Antibiotic course length - Part 2,NG110,What is the recommended duration of antibiotic treatment for acute prostatitis according to NICE guidelines?
"NG110_Summary of the evidence: Antibiotic prophylaxis for preventing infective complications, including acute prostatitis, after biopsy & Other considerations",NG110,What is the recommended antibiotic prophylaxis to prevent infective complications after prostate biopsy?
NG111_Pyelonephritis (acute): antimicrobial prescribing & Overview,NG111,What is the recommended antimicrobial treatment for acute pyelonephritis in adults without a catheter?
NG111_Recommendations: 1.1 Managing acute pyelonephritis - Part 1,NG111,What is the recommended management and antibiotic treatment for acute pyelonephritis in adults and children?
NG111_Recommendations: 1.1 Managing acute pyelonephritis - Part 2 & Recommendations: 1.2 Self-care,NG111,What are the indications for hospital referral in adults with acute pyelonephritis?
NG111_Recommendations: 1.3 Choice of antibiotic - Part 1,NG111,What are the recommended antibiotics for acute pyelonephritis based on local antimicrobial resistance data?
NG111_Recommendations: 1.3 Choice of antibiotic - Part 2,NG111,What are the recommended antibiotic options and dosages for treating urinary tract infections in adults?
NG111_Recommendations: 1.3 Choice of antibiotic - Part 3,NG111,What are the recommended antibiotic treatments for urinary tract infections in pregnant women?
NG111_Recommendations: 1.3 Choice of antibiotic - Part 4,NG111,What are the recommended antibiotic treatments for children under 16 years according to NICE guidelines?
NG111_Recommendations: 1.3 Choice of antibiotic - Part 5,NG111,How should antibiotics be prescribed and managed for children with infections according to NICE guidelines?
NG111_Summary of the evidence: Self-care & Summary of the evidence: Antibiotics,NG111,What are the recommended self-care strategies and antibiotic treatments for managing acute pyelonephritis?
NG111_Summary of the evidence: Choice of antibiotic - Part 1,NG111,What is the most effective antibiotic choice for treating complicated urinary tract infections and acute pyelonephritis?
NG111_Summary of the evidence: Choice of antibiotic - Part 2,NG111,What is the most effective antibiotic treatment for acute pyelonephritis in pregnant women?
NG111_Summary of the evidence: Choice of antibiotic - Part 3,NG111,What are the recommended antibiotic treatments for children with acute pyelonephritis and what are their safety considerations?
NG111_Summary of the evidence: Choice of antibiotic - Part 4,NG111,What are the recommended antibiotic options and dosing considerations for treating acute pyelonephritis?
NG111_Summary of the evidence: Choice of antibiotic - Part 5,NG111,What are the recommended first-line oral antibiotics for treating acute pyelonephritis in non-pregnant women and men?
NG111_Summary of the evidence: Choice of antibiotic - Part 6,NG111,What are the recommended first-line intravenous antibiotics for acute pyelonephritis in patients unable to take oral medication?
NG111_Summary of the evidence: Choice of antibiotic - Part 7,NG111,What are the recommended antibiotic treatments for pregnant women and children with acute pyelonephritis?
NG111_Summary of the evidence: Antibiotic course length - Part 1,NG111,What is the recommended duration of antibiotic treatment for acute pyelonephritis in adults?
NG111_Summary of the evidence: Antibiotic course length - Part 2,NG111,What is the recommended duration of antibiotic treatment for acute pyelonephritis in different patient groups?
NG111_Summary of the evidence: Antibiotic dose frequency & Summary of the evidence: Antibiotic route of administration - Part 1,NG111,What is the most effective route and dosing frequency of antibiotics for treating acute pyelonephritis in adults and children?
NG111_Summary of the evidence: Antibiotic route of administration - Part 2,NG111,What is the most effective route of antibiotic administration for treating acute pyelonephritis in children?
NG111_Other considerations,NG111,What are the best strategies to improve medicines adherence in patients with acute pyelonephritis?
NG112_Urinary tract infection (recurrent): antimicrobial prescribing & Overview,NG112,What are the recommended antimicrobial prescribing strategies for preventing recurrent urinary tract infections in people without a catheter?
NG112_Recommendations: 1.1 Preventing recurrent urinary tract infections,NG112,What are the recommended management and prevention strategies for recurrent urinary tract infections?
NG112_Recommendations: 1.2 Treatments for preventing recurrent UTI - Part 1,NG112,What are the recommendations for using vaginal oestrogen to prevent recurrent urinary tract infections?
NG112_Recommendations: 1.2 Treatments for preventing recurrent UTI - Part 2,NG112,What are the recommendations for single-dose antibiotic prophylaxis for recurrent urinary tract infections in women?
NG112_Recommendations: 1.2 Treatments for preventing recurrent UTI - Part 3,NG112,What are the guidelines for using methenamine hippurate as prophylaxis for recurrent urinary tract infections?
NG112_Recommendations: 1.2 Treatments for preventing recurrent UTI - Part 4,NG112,What are the considerations and advice when prescribing daily antibiotic prophylaxis for recurrent urinary tract infections?
NG112_Recommendations: 1.2 Treatments for preventing recurrent UTI - Part 5,NG112,What are the recommendations for antibiotic prophylaxis in children with recurrent urinary tract infections?
NG112_Recommendations: 1.3 Self-care,NG112,What are the self-care options for women with recurrent urinary tract infections?
NG112_Recommendations: 1.4 Choice of antibiotic or antiseptic prophylaxis - Part 1,NG112,What are the recommended antibiotic and antiseptic options for preventing recurrent urinary tract infections?
NG112_Recommendations: 1.4 Choice of antibiotic or antiseptic prophylaxis - Part 2,NG112,How should antibiotics be selected and dosed for urinary tract infections in patients with hepatic or renal impairment?
NG112_Recommendations: 1.4 Choice of antibiotic or antiseptic prophylaxis - Part 3,NG112,What are the recommended prophylactic treatments and dosages for urinary tract infections in children under 16 years?
NG112_Recommendations: 1.4 Choice of antibiotic or antiseptic prophylaxis - Part 4,NG112,What are the recommended antibiotic choices and dosing guidelines for treating urinary tract infections in children?
NG112_Recommendations: Terms used in the guideline,NG112,What factors contribute to complicated lower urinary tract infections?
NG112_Recommendations for research,NG112,What is the clinical and cost effectiveness of methenamine hippurate compared to antibiotics for preventing recurrent urinary tract infections in various populations?
NG112_Summary of the evidence: Oestrogens (2018) - Part 1,NG112,What is the effectiveness of vaginal oestrogen for preventing recurrent urinary tract infections in postmenopausal women?
NG112_Summary of the evidence: Oestrogens (2018) - Part 2,NG112,What are the risks and benefits of using vaginal oestrogen for menopausal genitourinary symptoms?
NG112_Summary of the evidence: Oestrogens (2018) - Part 3,NG112,What is the effectiveness of vaginal oestrogen in preventing recurrent urinary tract infections in women during menopause?
NG112_Summary of the evidence: Oestrogens (2018) - Part 4,NG112,What are the current NICE recommendations for using vaginal oestrogen to treat recurrent urinary tract infections in menopausal women?
NG112_Summary of the evidence: Methenamine hippurate (2024) - Part 1,NG112,What is the effectiveness and safety of methenamine hippurate compared to daily antibiotic prophylaxis for recurrent urinary tract infections in women?
NG112_Summary of the evidence: Methenamine hippurate (2024) - Part 2,NG112,What is the effectiveness of methenamine hippurate compared to daily antibiotics for preventing recurrent urinary tract infections in women?
NG112_Summary of the evidence: Methenamine hippurate (2024) - Part 3,NG112,When should specialist advice be sought for prescribing methenamine hippurate for recurrent urinary tract infections?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 1,NG112,What is the effectiveness of antibiotic prophylaxis in preventing recurrent urinary tract infections in women?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 2,NG112,What is the effectiveness of nitrofurantoin prophylaxis in preventing recurrent urinary tract infections in adults and children?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 3,NG112,What is the effectiveness and safety of antibiotic prophylaxis in preventing renal scars and urinary tract infections in children?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 4,NG112,What are the risks and adverse effects of antibiotic prophylaxis for recurrent urinary tract infections in women and pregnant women?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 5,NG112,What are the recommendations for antibiotic prophylaxis in recurrent urinary tract infections?
NG112_Summary of the evidence: Antibiotic prophylaxis (2018) - Part 6,NG112,What are the recommended management strategies for recurrent urinary tract infections in children and young people?
NG112_Summary of the evidence: Choice of antibiotic or antiseptic prophylaxis (2018) - Part 1,NG112,What is the most effective antibiotic prophylaxis for preventing recurrent urinary tract infections in adults and children?
NG112_Summary of the evidence: Choice of antibiotic or antiseptic prophylaxis (2018) - Part 2,NG112,What are the risks and benefits of using nitrofurantoin for antibiotic prophylaxis in urinary tract infections?
NG112_Summary of the evidence: Choice of antibiotic or antiseptic prophylaxis (2018) - Part 3,NG112,What are the recommended first-line antibiotics for non-life-threatening infection prophylaxis to prevent antibiotic resistance?
NG112_Summary of the evidence: Antibiotic dosing and course length (2018) - Part 1,NG112,What is the effectiveness of single-dose versus daily antibiotic prophylaxis for recurrent urinary tract infections in women?
NG112_Summary of the evidence: Antibiotic dosing and course length (2018) - Part 2,NG112,What are the recommended antibiotic dosing and duration for prophylaxis in women at risk of urinary tract infections?
NG112_Summary of the evidence: Self-care (2018) - Part 1,NG112,What is the effectiveness of probiotics and cranberry products in preventing recurrent urinary tract infections?
NG112_Summary of the evidence: Self-care (2018) - Part 2,NG112,What is the effectiveness of cranberry products in preventing recurrent urinary tract infections in women and pregnant women?
NG112_Summary of the evidence: Self-care (2018) - Part 3,NG112,What is the effectiveness of cranberry products in preventing recurrent urinary tract infections in children?
NG112_Summary of the evidence: Self-care (2018) - Part 4,NG112,What are the safety and effectiveness of cranberry products and D-mannose for preventing recurrent urinary tract infections?
NG112_Summary of the evidence: Self-care (2018) - Part 5,NG112,"What is the evidence for using probiotics, cranberry products, or D‑mannose to prevent recurrent urinary tract infections?"
NG113_Urinary tract infection (catheter-associated): antimicrobial prescribing & Overview,NG113,What is the recommended antimicrobial prescribing approach for catheter-associated urinary tract infections?
NG113_Recommendations: 1.1 Managing catheter-associated urinary tract infection - Part 1,NG113,What are the recommended management and treatment strategies for catheter-associated urinary tract infections?
NG113_Recommendations: 1.1 Managing catheter-associated urinary tract infection - Part 2,NG113,When should I change antibiotics based on urine culture results in urinary tract infections?
NG113_Recommendations: 1.2 Self-care & Recommendations: 1.3 Choice of antibiotic - Part 1,NG113,What are the recommended self-care practices for managing catheter-associated urinary tract infections?
NG113_Recommendations: 1.3 Choice of antibiotic - Part 2,NG113,What are the recommended antibiotics and dosages for treating urinary tract infections in adults?
NG113_Recommendations: 1.3 Choice of antibiotic - Part 3,NG113,What are the recommended antibiotics and dosing for urinary tract infections in pregnant women?
NG113_Recommendations: 1.3 Choice of antibiotic - Part 4,NG113,What are the recommended antibiotic options and dosing guidelines for children with urinary tract infections under 16 years?
NG113_Recommendations: 1.3 Choice of antibiotic - Part 5 & Recommendations: 1.3 Choice of antibiotic - Part 6 & Recommendations: 1.4 Preventing catheter-associated urinary tract infections,NG113,Should antibiotic prophylaxis be used to prevent catheter-associated urinary tract infections?
NG113_Terms used in this guideline & Summary of the evidence: Self-care,NG113,What are the recommended management strategies for catheter-associated urinary tract infections?
NG113_Summary of the evidence: Antibiotics for managing catheter-associated UTI - Part 1,NG113,What are the recommended antibiotic treatments for catheter-associated urinary tract infections?
NG113_Summary of the evidence: Antibiotics for managing catheter-associated UTI - Part 2,NG113,What is the evidence for changing the catheter before antibiotics in catheter-associated urinary tract infections?
NG113_Summary of the evidence: Antibiotics for managing catheter-associated UTI - Part 3,NG113,"What are the precautions and contraindications for prescribing antibiotics such as penicillins, cephalosporins, nitrofurantoin, trimethoprim, and fluoroquinolones in pregnancy, children, and patients with renal impairment?"
NG113_Summary of the evidence: Antibiotics for managing catheter-associated UTI - Part 4,NG113,What are the recommended antibiotic treatment protocols for catheter-associated urinary tract infections?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 1,NG113,What is the evidence for antibiotic prophylaxis to prevent catheter-associated urinary tract infections in long-term catheter users?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 2,NG113,What is the effectiveness of antibiotic prophylaxis in preventing urinary tract infections in children and adults using intermittent catheterisation?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 3,NG113,What is the effectiveness of antibiotic prophylaxis in preventing urinary tract infections in patients with short-term catheterisation in hospital?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 4,NG113,What is the evidence for antibiotic prophylaxis to prevent urinary tract infections after urinary catheter removal?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 5,NG113,What is the effectiveness of antibiotic prophylaxis in preventing urinary tract infections after urodynamic procedures?
NG113_Summary of the evidence: Antibiotic prophylaxis for preventing catheter-associated UTI - Part 6,NG113,What are the recommendations for antibiotic prophylaxis to prevent catheter-associated urinary tract infections?
NG113_Other considerations,NG113,What are the recommendations for antibiotic prophylaxis to prevent urinary tract infections during short-term hospital catheterisation?
NG114_Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing & Overview,NG114,What are the recommended antibiotic prescribing strategies for acute exacerbations of COPD?
NG114_Recommendations: 1.1 Managing an acute exacerbation of COPD with antibiotics - Part 1,NG114,What are the criteria for prescribing antibiotics during an acute exacerbation of COPD?
NG114_Recommendations: 1.1 Managing an acute exacerbation of COPD with antibiotics - Part 2,NG114,When should I seek medical help or specialist advice for worsening symptoms of an acute COPD exacerbation?
NG114_Recommendations: 1.2 Choice of antibiotic - Part 1,NG114,What is the recommended antibiotic treatment for acute exacerbation of COPD in adults?
NG114_Recommendations: 1.2 Choice of antibiotic - Part 2,NG114,When should intravenous antibiotics be reviewed and stepped down to oral therapy in infection management?
NG114_Terms used in the guideline,NG114,What are the classifications and symptoms used to determine the severity of COPD exacerbations?
NG114_Summary of the evidence: Antibiotics - Part 1,NG114,What is the evidence for the effectiveness of antibiotics in treating acute exacerbations of COPD?
NG114_Summary of the evidence: Antibiotics - Part 2,NG114,What is the effectiveness of antibiotics in treating acute exacerbations of COPD across different care settings?
NG114_Summary of the evidence: Antibiotics - Part 3,NG114,What are the safety considerations and potential side effects of using antibiotics for infections?
NG114_Summary of the evidence: Antibiotics - Part 4,NG114,When should antibiotics be prescribed for acute exacerbations of COPD in the UK?
NG114_Summary of the evidence: Antibiotics - Part 5,NG114,What is the evidence for the effectiveness of antibiotics in treating acute exacerbations of COPD?
NG114_Summary of the evidence: Antibiotics - Part 6,NG114,When should antibiotics be prescribed for acute exacerbations of COPD?
NG114_Summary of the evidence: Choice of antibiotics - Part 1,NG114,What is the effectiveness of first-line versus second-line antibiotics for treating acute exacerbations of chronic bronchitis?
NG114_Summary of the evidence: Choice of antibiotics - Part 2,NG114,What is the most effective antibiotic choice for treating acute exacerbations of COPD?
NG114_Summary of the evidence: Choice of antibiotics - Part 3,NG114,What is the most appropriate antibiotic choice for treating acute exacerbations of COPD to minimize resistance and adverse effects?
NG114_Summary of the evidence: Choice of antibiotics - Part 4,NG114,What are the recommended antibiotic choices and management strategies for acute exacerbations of COPD?
NG114_Summary of the evidence: Choice of antibiotics - Part 5,NG114,What are the recommended antibiotic options for treating acute exacerbations of respiratory infections in patients at higher risk of treatment failure?
NG114_Summary of the evidence: Antibiotic course length - Part 1,NG114,What is the optimal duration of antibiotic treatment for acute exacerbations of COPD?
NG114_Summary of the evidence: Antibiotic course length - Part 2 & Other considerations,NG114,What is the recommended duration of antibiotic treatment for acute exacerbations to minimize adverse effects and antimicrobial resistance?
NG115_Chronic obstructive pulmonary disease in over 16s: diagnosis and management & Overview,NG115,What are the recommended diagnostic and management strategies for COPD in people aged 16 and older?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 1,NG115,What are the recommended diagnostic criteria and assessment methods for COPD?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 2,NG115,What are the recommended procedures for diagnosing COPD using spirometry?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 3,NG115,What are the recommended investigations for diagnosing COPD in non-smoking patients with normal spirometry?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 4,NG115,What are the recommended management and referral procedures for people with alpha-1 antitrypsin deficiency?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 5,NG115,How can longitudinal observation and bronchodilator response testing differentiate COPD from asthma?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 6,NG115,How is the severity of airflow obstruction assessed and classified in COPD?
NG115_Recommendations: 1.1 Diagnosing COPD - Part 7,NG115,When should I refer a patient with COPD for specialist advice or further assessment?
NG115_Recommendations: 1.2 Managing stable COPD - Part 1,NG115,What are the recommended non-pharmacological and inhaled therapy options for managing stable COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 2,NG115,When should inhaler therapy be adjusted for COPD patients based on symptom improvement and lung function?
NG115_Recommendations: 1.2 Managing stable COPD - Part 3,NG115,When should I consider adding ICS to COPD treatment with LAMA+LABA?
NG115_Recommendations: 1.2 Managing stable COPD - Part 4,NG115,What are the recommended delivery systems and training protocols for inhaler use in stable COPD management?
NG115_Recommendations: 1.2 Managing stable COPD - Part 5,NG115,What are the recommended practices for nebuliser use and oral therapy in COPD management?
NG115_Recommendations: 1.2 Managing stable COPD - Part 6,NG115,What are the guidelines for using mucolytic and prophylactic antibiotic therapy in COPD management?
NG115_Recommendations: 1.2 Managing stable COPD - Part 7,NG115,What are the guidelines for prescribing and monitoring prophylactic azithromycin in COPD patients?
NG115_Recommendations: 1.2 Managing stable COPD - Part 8,NG115,What are the criteria for prescribing long-term oxygen therapy in COPD patients?
NG115_Recommendations: 1.2 Managing stable COPD - Part 9,NG115,What are the guidelines for long-term oxygen therapy in COPD patients?
NG115_Recommendations: 1.2 Managing stable COPD - Part 10,NG115,What are the criteria for prescribing ambulatory oxygen therapy in COPD patients?
NG115_Recommendations: 1.2 Managing stable COPD - Part 11,NG115,What treatments are recommended for pulmonary hypertension caused by COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 12,NG115,What are the criteria for lung volume reduction surgery in patients with severe COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 13,NG115,What are the criteria for lung volume reduction surgery and lung transplantation in COPD patients?
NG115_Recommendations: 1.2 Managing stable COPD - Part 14,NG115,"What are the recommended multidisciplinary management strategies for COPD, including the role of respiratory nurse specialists and physiotherapy?"
NG115_Recommendations: 1.2 Managing stable COPD - Part 15,NG115,What are the recommended nutritional management strategies for patients with COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 16,NG115,"What are the recommended assessments and educational support for people with COPD regarding daily activities, travel, diving, and self-management?"
NG115_Recommendations: 1.2 Managing stable COPD - Part 17,NG115,What are the recommended self-management and exacerbation action plans for people with COPD according to NICE guidelines?
NG115_Recommendations: 1.2 Managing stable COPD - Part 18,NG115,What information is available on patient education and self-management strategies for COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 19,NG115,What are the criteria for assessing fitness for general surgery in patients with COPD?
NG115_Recommendations: 1.2 Managing stable COPD - Part 20,NG115,What are the recommended follow-up assessments and frequency for patients with different stages of COPD in primary care?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 1,NG115,What are the criteria for hospital admission in patients with COPD exacerbations?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 2,NG115,What are the recommended assessments and management strategies for acute COPD exacerbations in hospital and home settings?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 3,NG115,What are the recommended delivery systems and corticosteroid treatment protocols for COPD exacerbations?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 4,NG115,What are the recommended practices for oxygen therapy management during COPD exacerbations?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 5,NG115,What are the recommended strategies for monitoring recovery in patients after a COPD exacerbation?
NG115_Recommendations: 1.3 Managing exacerbations of COPD - Part 6,NG115,What are the recommended monitoring and discharge planning procedures for patients recovering from respiratory failure?
NG115_Recommendations: Terms used in this guideline,NG115,What are the criteria for diagnosing asthmatic features and managing exacerbations in asthma patients?
NG115_Recommendations for research: Key recommendations for research - Part 1,NG115,What is the effectiveness of early pulmonary rehabilitation during hospital admission for COPD exacerbations in improving quality of life and reducing hospital readmissions?
NG115_Recommendations for research: Key recommendations for research - Part 2,NG115,What is the effectiveness of inhaled therapies for people with both COPD and asthma?
NG115_Recommendations for research: Other recommendations for research,NG115,What is the effectiveness of mucolytic therapy in preventing exacerbations in people with COPD?
NG115_Rationale and impact: Incidental findings on chest X-ray or CT scans,NG115,What should healthcare professionals do if incidental findings of emphysema or chronic airways disease are detected on chest X-ray or CT scan performed for other reasons?
NG115_Rationale and impact: Assessing severity and using prognostic factors,NG115,Why is the BODE index not recommended for assessing prognosis in COPD patients?
NG115_Rationale and impact: Inhaled combination therapy - Part 1,NG115,What are the benefits and considerations of inhaled combination therapy with LAMA+LABA for COPD management?
NG115_Rationale and impact: Inhaled combination therapy - Part 2,NG115,"What are the indications and considerations for starting triple therapy with LAMA, LABA, and ICS in COPD management?"
NG115_Rationale and impact: Inhaled combination therapy - Part 3,NG115,What are the clinical and cost considerations for using single versus multiple inhaler devices in COPD treatment?
NG115_Rationale and impact: Oral prophylactic antibiotic therapy,NG115,What are the guidelines for using prophylactic antibiotics in COPD patients to prevent exacerbations?
NG115_Rationale and impact: Long-term oxygen therapy,NG115,What are the safety considerations and eligibility criteria for long-term oxygen therapy in COPD patients?
NG115_Rationale and impact: Ambulatory and short-burst oxygen therapy & Rationale and impact: Managing pulmonary hypertension and cor pulmonale,NG115,What is the evidence for using ambulatory or short-burst oxygen therapy in patients with mild or no hypoxaemia?
"NG115_Rationale and impact: Lung volume reduction procedures, bullectomy and lung transplantation",NG115,What are the criteria for referring patients with severe COPD for lung volume reduction surgery or endobronchial valve treatment?
NG115_Rationale and impact: Risk factors for COPD exacerbations,NG115,What are the modifiable risk factors for COPD exacerbations?
"NG115_Rationale and impact: Self-management, education and telehealth monitoring",NG115,What are the recommended components of self-management plans for COPD patients?
NG115_Rationale and impact: Duration of oral corticosteroids for managing exacerbations,NG115,What is the recommended duration of oral corticosteroids for managing exacerbations?
NG115_Context,NG115,What are the current recommendations for managing COPD patients who continue to experience symptoms despite inhaled triple therapy?
NG116_Post-traumatic stress disorder & Overview & Recommendations: 1.1 Recognition of post-traumatic stress disorder - Part 1,NG116,What are the key symptoms and assessment questions for diagnosing post-traumatic stress disorder (PTSD)?
NG116_Recommendations: 1.1 Recognition of post-traumatic stress disorder - Part 2,NG116,What are the recommended approaches for screening and managing trauma-related symptoms in children and refugees?
NG116_Recommendations: 1.2 Assessment and coordination of care,NG116,What are the recommended assessment and care coordination procedures for patients with PTSD in primary care?
NG116_Recommendations: 1.3 Access to care,NG116,How can access to PTSD services be improved for vulnerable populations?
NG116_Recommendations: 1.4 Principles of care - Part 1,NG116,What are best practices for involving and supporting families of people with PTSD?
NG116_Recommendations: 1.4 Principles of care - Part 2 & Recommendations: 1.5 Language and culture,NG116,What are effective treatment strategies for family members with PTSD who experienced the same traumatic event?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 1",NG116,What are the recommended approaches for engaging and supporting treatment adherence in patients with PTSD?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 2",NG116,Should psychologically-focused debriefing be used to prevent or treat PTSD in children and adults?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 3",NG116,What are the recommended psychological interventions for treating PTSD in children and young people?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 4",NG116,What are the recommended psychological interventions for children and young people with PTSD according to NICE guidelines?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 5",NG116,What are the recommended psychological interventions for treating PTSD in adults?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 6",NG116,What are the recommended trauma-focused CBT and EMDR interventions for adults with PTSD?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 7",NG116,What are the recommended psychological interventions for adults with PTSD according to NICE guidelines?
"NG116_Recommendations: 1.6 Management of PTSD in children, young people and adults - Part 8",NG116,What are the current NICE recommendations for using antipsychotics like risperidone in the treatment of PTSD in adults?
NG116_Recommendations: 1.7 Care for people with PTSD and complex needs,NG116,What are the recommended approaches for treating PTSD with comorbid depression and complex needs?
NG116_Recommendations: 1.8 Disaster planning,NG116,What should be included in disaster plans for providing psychosocial support and mental health services?
NG116_Recommendations: Terms used in this guideline,NG116,What are the key differences between acute stress disorder and complex PTSD?
NG116_Recommendations for research: Key recommendations for research - Part 1,NG116,What is the clinical and cost effectiveness of trauma-informed approaches for treating PTSD?
NG116_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG116,What are the prognostic and prescriptive factors influencing the choice of PTSD treatment?
NG116_Rationale and impact: Supporting transitions between services,NG116,What are best practices for supporting transitions between mental health services to ensure continuity of care?
NG116_Rationale and impact: Access to care,NG116,How can access to PTSD treatment be improved through flexible and remote care options?
NG116_Rationale and impact: Principles of care - Part 1,NG116,What are effective strategies for peer support and maintaining safe environments in PTSD care?
NG116_Rationale and impact: Principles of care - Part 2,NG116,How does involving family members and carers in PTSD treatment impact patient outcomes and carer support?
NG116_Rationale and impact: Planning treatment and supporting engagement & Rationale and impact: Active monitoring,NG116,What are the recommended approaches for planning treatment and supporting engagement in people with PTSD?
NG116_Rationale and impact: Psychologically-focused debriefing & Rationale and impact: Psychological interventions for the prevention of PTSD in children and young people - Part 1,NG116,What are the recommended psychological interventions for preventing PTSD in children and young people after trauma?
NG116_Rationale and impact: Psychological interventions for the prevention of PTSD in children and young people - Part 2,NG116,What are the recommended trauma-focused cognitive-behavioral therapy approaches for children and young people with acute stress disorder or PTSD symptoms?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in children and young people - Part 1,NG116,What is the effectiveness of trauma-focused CBT for treating PTSD in children and young people?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in children and young people - Part 2 & Rationale and impact: Drug treatments for children and young people,NG116,What are the current recommendations for treating PTSD in children and young people?
NG116_Rationale and impact: Psychological interventions for the prevention of PTSD in adults,NG116,What is the effectiveness of trauma-focused CBT in preventing PTSD in adults after recent trauma?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in adults - Part 1,NG116,What are the recommended psychological interventions for treating PTSD in adults?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in adults - Part 2,NG116,What is the evidence for the effectiveness of trauma-focused CBT and EMDR in treating non-combat-related trauma?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in adults - Part 3,NG116,What are the recommended computerised trauma-focused CBT interventions for adults with PTSD?
NG116_Rationale and impact: Psychological interventions for the treatment of PTSD in adults - Part 4,NG116,What are the current NICE recommendations for non-trauma-focused and computerised trauma-focused CBT interventions for adults with PTSD?
NG116_Rationale and impact: Drug treatments in adults - Part 1,NG116,What are the recommended drug treatments for adults with post-traumatic stress disorder (PTSD)?
NG116_Rationale and impact: Drug treatments in adults - Part 2,NG116,Should antipsychotics be used as a first-line treatment for PTSD or only as an adjunct after psychological therapies?
NG116_Rationale and impact: Care for people with post-traumatic stress disorder and complex needs,NG116,What are the recommended approaches for managing post-traumatic stress disorder with complex needs and coexisting conditions?
NG116_Context,NG116,What are the recommended approaches for diagnosing and managing post-traumatic stress disorder in children and adults?
"NG117_Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing & Overview",NG117,What are the recommended antibiotics for treating acute exacerbations of non-cystic fibrosis bronchiectasis?
NG117_Recommendations: 1.1 Managing an acute exacerbation of bronchiectasis (non-cystic fibrosis) - Part 1,NG117,What are the recommended antibiotic treatments for acute exacerbations of bronchiectasis?
NG117_Recommendations: 1.1 Managing an acute exacerbation of bronchiectasis (non-cystic fibrosis) - Part 2 & Recommendations: 1.2 Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 1,NG117,What are the criteria for reassessment and referral in acute exacerbations of bronchiectasis?
NG117_Recommendations: 1.2 Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 2,NG117,What are the recommended antibiotics and dosages for treating pneumonia in adults?
NG117_Recommendations: 1.2 Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 3,NG117,What are the recommended antibiotic choices and dosing considerations for treating bronchiectasis exacerbations?
NG117_Recommendations: 1.2 Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 4,NG117,What are the recommended antibiotics and dosages for treating children and young people under 18 with bacterial infections?
NG117_Recommendations: 1.2 Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 5,NG117,"How should antibiotics be managed and dosed in children with bronchiectasis, considering factors like age, severity, and resistance?"
NG117_Recommendations: 1.3 Preventing acute exacerbations of bronchiectasis (non-cystic fibrosis) & Terms used in this guideline,NG117,What are the recommendations for preventing acute exacerbations of bronchiectasis without using routine antibiotics?
NG117_Rationales: Treatment,NG117,What are the recommended antibiotic treatment strategies for acute exacerbations of bronchiectasis?
NG117_Rationales: Reassessment & Rationales: Referral and seeking specialist advice,NG117,When should patients with bronchiectasis be referred to hospital for worsening symptoms?
NG117_Rationales: Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 1,NG117,What is the recommended antibiotic treatment for an acute exacerbation of bronchiectasis?
NG117_Rationales: Choice of antibiotic for treating an acute exacerbation of bronchiectasis - Part 2,NG117,What are the recommended first-line intravenous antibiotics for severe bronchiectasis exacerbations?
NG117_Rationales: Preventing acute exacerbations of bronchiectasis (non-cystic fibrosis) and choice of antibiotic - Part 1,NG117,When should prophylactic antibiotics be considered for preventing exacerbations in bronchiectasis patients?
NG117_Rationales: Preventing acute exacerbations of bronchiectasis (non-cystic fibrosis) and choice of antibiotic - Part 2,NG117,What is the evidence for using prophylactic antibiotics to prevent exacerbations in bronchiectasis?
NG118_Renal and ureteric stones: assessment and management & Overview & Recommendations: 1.1 Diagnostic imaging,NG118,What is the recommended imaging approach for diagnosing renal colic in adults and children?
NG118_Recommendations: 1.2 Pain management,NG118,What are the recommended pain management options for suspected renal colic according to NICE guidelines?
NG118_Recommendations: 1.3 Medical expulsive therapy & Recommendations: 1.4 Stenting before shockwave lithotripsy,NG118,What are the recommendations for medical expulsive therapy using alpha blockers for distal ureteric stones?
NG118_Recommendations: 1.5 Surgical treatments (including shockwave lithotripsy) - Part 1,NG118,What are the recommended surgical options for treating renal stones in children and young people?
NG118_Recommendations: 1.5 Surgical treatments (including shockwave lithotripsy) - Part 2,NG118,What are the recommended surgical options for ureteric stones of different sizes in adults and children?
NG118_Recommendations: 1.5 Surgical treatments (including shockwave lithotripsy) - Part 3 & Recommendations: 1.6 Stenting after ureteroscopy for adults with ureteric stones less than 20 mm,NG118,What is the recommended timing for surgical treatment of ureteric stones in adults with renal colic?
NG118_Recommendations: 1.6 Stenting after ureteroscopy for adults with ureteric stones less than 20 mm & Recommendations: 1.7 Metabolic testing,NG118,What are the recommendations for stenting after ureteroscopy for ureteric stones less than 20 mm?
NG118_Recommendations: 1.8 Preventing recurrence - Part 1,NG118,What dietary and lifestyle advice is recommended to prevent kidney stone recurrence?
NG118_Recommendations: 1.8 Preventing recurrence - Part 2 & Recommendations: Terms used in this guideline,NG118,What are the recommended medical treatments for preventing recurrent calcium oxalate kidney stones in children and young people?
NG118_Recommendations for research: 1 Metabolic assessment & Recommendations for research: 2 Alpha blockers and ureteroscopy & Recommendations for research: 3 Preventive treatment following shockwave lithotripsy,NG118,What is the effectiveness of full metabolic assessment compared to standard advice for recurrent calcium oxalate kidney stones?
NG118_Recommendations for research: 4 Frequency of follow‑up imaging & Recommendations for research: 5 Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration,NG118,What is the effectiveness of 6-monthly follow-up imaging for recurrent calcium renal or ureteric stones?
NG118_Rationale and impact: Diagnostic imaging,NG118,What is the recommended imaging modality for diagnosing renal stones in adults and children?
NG118_Rationale and impact: Pain management - Part 1,NG118,What are the recommended first-line treatments for pain relief in suspected renal colic?
NG118_Rationale and impact: Pain management - Part 2,NG118,What are the recommended pain management options for renal colic in adults and children?
NG118_Rationale and impact: Medical expulsive therapy,NG118,What is the effectiveness of alpha blockers for medical expulsive therapy in adults with small distal ureteric stones?
NG118_Rationale and impact: Stenting before shockwave lithotripsy,NG118,Should pre-treatment stenting be used before shockwave lithotripsy for renal or ureteric stones?
NG118_Rationale and impact: Surgical treatments (including shockwave lithotripsy) - Part 1,NG118,What are the recommended surgical options for treating ureteric stones of different sizes?
NG118_Rationale and impact: Surgical treatments (including shockwave lithotripsy) - Part 2,NG118,What are the recommended treatment options for ureteric stones of different sizes according to NICE guidelines?
NG118_Rationale and impact: Surgical treatments (including shockwave lithotripsy) - Part 3,NG118,What are the recommended treatment options for renal stones measuring 10 to 20 mm in adults?
NG118_Rationale and impact: Surgical treatments (including shockwave lithotripsy) - Part 4,NG118,What are the recommended treatment options for ureteric and renal stones in children and young people based on stone size?
NG118_Rationale and impact: Surgical treatments (including shockwave lithotripsy) - Part 5,NG118,What are the recommended treatment options for children with renal stones larger than 20 mm?
NG118_Rationale and impact: Timing of surgical treatment for ureteric stones,NG118,What is the recommended timing for surgical treatment of ureteric stones in adults with renal colic?
NG118_Rationale and impact: Medical expulsive therapy as adjunctive to shockwave lithotripsy,NG118,What is the evidence for using alpha blockers as adjunctive therapy with shockwave lithotripsy for small ureteric stones?
NG118_Rationale and impact: Stenting after ureteroscopy,NG118,Should stents be routinely used after ureteroscopy for ureteric stones less than 20 mm?
NG118_Rationale and impact: Metabolic testing,NG118,What metabolic tests are recommended for patients with renal or ureteric stones?
NG118_Rationale and impact: Frequency of follow‑up imaging,NG118,What is the optimal frequency of follow-up imaging for patients with renal or ureteric stones?
NG118_Rationale and impact: Preventing recurrence - Part 1,NG118,What are the recommended dietary and medical interventions to prevent kidney stone recurrence?
NG118_Rationale and impact: Preventing recurrence - Part 2,NG118,What is the evidence for using thiazides to prevent recurrent calcium oxalate kidney stones in adults with hypercalciuria?
NG118_Context,NG118,What are the current treatment options and management strategies for renal and ureteric stones?
NG119_Cerebral palsy in adults & Overview,NG119,What are the recommended care and support strategies for adults with cerebral palsy?
NG119_Recommendations: 1.1 Service organisation - Part 1,NG119,What are the recommended pathways and support services for adults with cerebral palsy to access multidisciplinary care?
NG119_Recommendations: 1.1 Service organisation - Part 2,NG119,What are the recommended strategies for providing mental health support and ensuring accessible care for adults with cerebral palsy?
NG119_Recommendations: 1.1 Service organisation - Part 3,NG119,What is the recommended frequency for reviewing adults with cerebral palsy?
NG119_Recommendations: 1.2 Function and participation - Part 1,NG119,What are the recommended interventions for improving communication and participation in adults with cerebral palsy?
NG119_Recommendations: 1.2 Function and participation - Part 2,NG119,What are the recommended assessments and support options for adults with cerebral palsy to improve vocational and independent living skills?
NG119_Recommendations: 1.2 Function and participation - Part 3,NG119,What are the recommendations for managing assistive technology and physical activity in adults with cerebral palsy?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 1,NG119,What are the recommended approaches for managing abnormal muscle tone in adults with cerebral palsy?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 2,NG119,What are the recommended treatments for spasticity and dystonia in adults according to NICE guidelines?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 3,NG119,What are the criteria for referring adults with cerebral palsy for botulinum toxin type A or intrathecal baclofen treatment?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 4,NG119,What are the recommended assessments and treatment options for intrathecal baclofen and selective dorsal rhizotomy in adults with cerebral palsy?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 5,NG119,What are the recommended treatments and considerations for managing dystonia in adults with cerebral palsy?
NG119_Recommendations: 1.3 Managing abnormal muscle tone - Part 6,NG119,What are the indications and considerations for using intrathecal baclofen or deep brain stimulation to treat dystonia in cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 1,NG119,How should clinicians assess and manage fracture risk in adults with cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 2,NG119,What are the recommended approaches for assessing and managing mental health problems in adults with cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 3,NG119,What are the best practices for assessing and managing mental health and nutritional issues in adults with cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 4,NG119,What are the recommended strategies for screening and managing respiratory and nutritional problems in adults with cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 5,NG119,What are the recommended prophylactic treatments and management strategies for respiratory infections and respiratory failure in adults with cerebral palsy?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 6,NG119,What are the recommended options for assisted ventilation in adults with cerebral palsy and respiratory failure?
NG119_Recommendations: 1.4 Assessment and monitoring of clinical complications and comorbidities - Part 7,NG119,What are the recommended pain assessment tools for adults with cerebral palsy who have communication difficulties?
NG119_Recommendations: Terms used in this guideline - Part 1,NG119,What is an advance care plan and how is it used in healthcare?
NG119_Recommendations: Terms used in this guideline - Part 2,NG119,What are the recommended assessments and interventions for managing mobility and communication in adults with cerebral palsy?
NG119_Recommendations for research: Key recommendations for research - Part 1,NG119,What is the most effective method for guiding botulinum toxin type A injections in treating focal spasticity in adults with cerebral palsy?
NG119_Recommendations for research: Key recommendations for research - Part 2,NG119,Are prophylactic antibiotics effective and cost-effective for respiratory symptoms in adults with cerebral palsy?
NG119_Rationale and impact: Access to services and moving into adults' services - Part 1,NG119,What are the recommended pathways for accessing specialist services for adults with cerebral palsy?
NG119_Rationale and impact: Access to services and moving into adults' services - Part 2,NG119,What strategies can improve access and continuity of care for adults with cerebral palsy?
NG119_Rationale and impact: Ongoing care - Part 1,NG119,What is the recommended approach for ongoing care and annual reviews for adults with cerebral palsy?
NG119_Rationale and impact: Ongoing care - Part 2,NG119,How often should adults with cerebral palsy have reviews to monitor their needs and prevent deterioration?
NG119_Rationale and impact: Communication - Part 1,NG119,What strategies can improve communication for adults with cerebral palsy?
NG119_Rationale and impact: Communication - Part 2,NG119,What is the evidence for using augmentative and alternative communication systems in adults with cerebral palsy and communication difficulties?
NG119_Rationale and impact: Vocational skills and independent living,NG119,What interventions support independent living and vocational skills development for adults with cerebral palsy?
NG119_Rationale and impact: Electronic assistive technology,NG119,What are the NICE recommendations for electronic assistive technology for adults with cerebral palsy?
"NG119_Rationale and impact: Physical activity, orthopaedic surgery and orthotics - Part 1",NG119,What are the benefits of physical activity for adults with cerebral palsy?
"NG119_Rationale and impact: Physical activity, orthopaedic surgery and orthotics - Part 2",NG119,What are the indications for orthopaedic surgery in adults with cerebral palsy?
NG119_Rationale and impact: Agreeing goals for treatment and initial management of spasticity and dystonia,NG119,How should treatment goals be established for managing spasticity and dystonia in cerebral palsy?
NG119_Rationale and impact: Drug treatments for spasticity - Part 1,NG119,What are the recommended drug treatments for spasticity in adults?
NG119_Rationale and impact: Drug treatments for spasticity - Part 2,NG119,When should botulinum toxin type A injections be considered for adults with focal spasticity?
NG119_Rationale and impact: Neurosurgical treatments to reduce spasticity - Part 1,NG119,What are the indications and risks of intrathecal baclofen and dorsal rhizotomy for reducing spasticity in adults?
NG119_Rationale and impact: Neurosurgical treatments to reduce spasticity - Part 2,NG119,What are the risks and benefits of selective dorsal rhizotomy for spasticity in cerebral palsy?
NG119_Rationale and impact: Drug treatments for dystonia - Part 1,NG119,What are the recommended drug treatments for dystonia in adults with cerebral palsy?
NG119_Rationale and impact: Drug treatments for dystonia - Part 2,NG119,What are the guidelines for using botulinum toxin type A injections in adults with focal dystonia?
NG119_Rationale and impact: Neurosurgical treatments to reduce dystonia - Part 1,NG119,What are the neurosurgical options for treating dystonia in adults with cerebral palsy?
NG119_Rationale and impact: Neurosurgical treatments to reduce dystonia - Part 2,NG119,When should deep brain stimulation be considered for treating dystonia according to NICE guidelines?
NG119_Rationale and impact: Bone and joint disorders - Part 1,NG119,What are the recommended strategies for assessing fracture risk in adults with cerebral palsy?
NG119_Rationale and impact: Bone and joint disorders - Part 2,NG119,When should adults with cerebral palsy be referred to a specialist for osteoporosis assessment and management?
NG119_Rationale and impact: Mental health problems,NG119,What are the best practices for assessing and monitoring mental health in adults with cerebral palsy?
NG119_Rationale and impact: Difficulties with eating and nutritional problems,NG119,What are the best practices for assessing and managing nutritional problems in adults with cerebral palsy?
NG119_Rationale and impact: Identifying and monitoring respiratory disorders,NG119,What are the recommended methods for monitoring respiratory health in adults with cerebral palsy?
NG119_Rationale and impact: Prophylactic treatments for respiratory infections - Part 1,NG119,What are the recommended prophylactic measures to prevent respiratory infections in adults with cerebral palsy?
NG119_Rationale and impact: Prophylactic treatments for respiratory infections - Part 2,NG119,What are the recommended chest physiotherapy and swallowing assessments for adults with cerebral palsy to prevent respiratory infections?
"NG119_Rationale and impact: Discussing the management of respiratory failure, and assisted ventilation for respiratory failure and sleep apnoea - Part 1",NG119,What are the recommended approaches for discussing and planning assisted ventilation for respiratory failure and sleep apnoea?
"NG119_Rationale and impact: Discussing the management of respiratory failure, and assisted ventilation for respiratory failure and sleep apnoea - Part 2",NG119,What are the recommended management options for sleep apnoea in adults with cerebral palsy?
NG119_Rationale and impact: Pain,NG119,What are the recommended methods for assessing pain in adults with cerebral palsy and communication difficulties?
NG119_Context - Part 1,NG119,What are the recommended management strategies for adults with cerebral palsy to improve independence and quality of life?
NG119_Context - Part 2,NG119,What are the recommended care arrangements and support needs for adults with cerebral palsy as they age?
NG11_Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges & Overview,NG11,What are effective interventions for managing challenging behaviour in people with learning disabilities?
NG11_Context - Part 1,NG11,What are effective strategies for managing behaviour that challenges in people with learning disabilities?
NG11_Context - Part 2,NG11,How can care environments be modified to reduce behaviour that challenges in individuals with learning disabilities?
NG11_Recommendations: 1.1 General principles of care - Part 1,NG11,What are the principles for supporting people with learning disabilities and challenging behaviour?
NG11_Recommendations: 1.1 General principles of care - Part 2,NG11,What training and supervision are recommended for staff working with people with learning disabilities and behaviour that challenges?
NG11_Recommendations: 1.1 General principles of care - Part 3,NG11,How should care pathways be developed and managed for people with learning disabilities and challenging behaviour?
NG11_Recommendations: 1.2 Physical healthcare,NG11,What are the recommended components of an annual physical health check for people with a learning disability?
NG11_Recommendations: 1.3 Support and interventions for family members or carers,NG11,What support and interventions are recommended for family members or carers of individuals with learning disabilities and challenging behavior?
NG11_Recommendations: 1.4 Early identification of the emergence of behaviour that challenges,NG11,How can I identify early signs of challenging behavior in children and adults with learning disabilities?
NG11_Recommendations: 1.5 Assessment of behaviour that challenges - Part 1,NG11,What are the key steps in conducting an initial assessment of behaviour that challenges in individuals with a learning disability?
NG11_Recommendations: 1.5 Assessment of behaviour that challenges - Part 2,NG11,What are the key components of initial assessment for behaviour that challenges in people with learning disabilities?
NG11_Recommendations: 1.5 Assessment of behaviour that challenges - Part 3,NG11,What are the recommended steps for assessing and managing behaviour that challenges according to NICE guidelines?
NG11_Recommendations: 1.5 Assessment of behaviour that challenges - Part 4,NG11,What are the recommended methods for conducting a functional assessment of challenging behaviour?
NG11_Recommendations: 1.6 Behaviour support plan,NG11,How should a behaviour support plan be developed and implemented for individuals with learning disabilities exhibiting challenging behaviour?
NG11_Recommendations: 1.7 Psychological and environmental interventions - Part 1,NG11,What are effective early interventions for managing challenging behavior in children with learning disabilities?
NG11_Recommendations: 1.7 Psychological and environmental interventions - Part 2,NG11,What are the recommended behavioural and psychological interventions for managing challenging behaviour in children and adults?
NG11_Recommendations: 1.8 Medication - Part 1,NG11,When should antipsychotic medication be considered for managing behaviour that challenges in people with learning disabilities?
NG11_Recommendations: 1.8 Medication - Part 2,NG11,How should medication be reviewed and monitored for effectiveness and side effects in people with learning disabilities?
NG11_Recommendations: 1.9 Reactive strategies - Part 1,NG11,When should reactive strategies be used for managing behaviour that challenges in people with learning disabilities?
NG11_Recommendations: 1.9 Reactive strategies - Part 2 & Recommendations: 1.10 Interventions for coexisting health problems,NG11,What are the best practices for reducing restrictive interventions in people with learning disabilities?
NG11_Recommendations: 1.11 Interventions for sleep problems,NG11,What are the recommended behavioral interventions for sleep problems in people with learning disabilities?
NG11_Recommendations: Terms used in this guideline - Part 1,NG11,What are the recommended strategies for managing challenging behaviour in children and adults?
NG11_Recommendations: Terms used in this guideline - Part 2,NG11,What are the recommended approaches for managing self-harm and self-injury in young people aged 13 to 17?
NG11_Recommendations for research: 1 Preventing behaviour that challenges from developing in children aged under 5 years with a learning disability,NG11,Can positive behaviour support in children under 5 with learning disabilities prevent the development of challenging behaviour?
NG11_Recommendations for research: 2 Interventions to reduce the frequency and extent of moderate to severe behaviour that challenges in community settings,NG11,Are behavioral interventions based on applied behavior analysis or antipsychotic medication effective in reducing challenging behaviors in adults with learning disabilities?
NG11_Recommendations for research: 3 Locally accessible care,NG11,What are the benefits of providing locally accessible care for people with learning disabilities and challenging behaviour compared to out-of-area placements?
"NG11_Recommendations for research: 4 Factors associated with sustained, high-quality residential care",NG11,What factors are associated with maintaining high-quality residential care for people with learning disabilities and challenging behavior?
NG120_Cough (acute): antimicrobial prescribing & Overview,NG120,When should antibiotics be prescribed for acute cough in adults and children?
NG120_Recommendations: 1.1 Managing acute cough - Part 1,NG120,What are the recommended management strategies for acute cough in adults with suspected COVID-19?
NG120_Recommendations: 1.1 Managing acute cough - Part 2,NG120,What are the recommended treatments and management strategies for acute cough associated with upper respiratory tract infections or bronchitis according to NICE guidelines?
NG120_Recommendations: 1.1 Managing acute cough - Part 3,NG120,What are the risk factors for complications in patients with acute cough?
NG120_Recommendations: 1.2 Self-care,NG120,What self-care treatments are recommended for cough relief in adults and children?
NG120_Recommendations: 1.3 Choice of antibiotic - Part 1,NG120,What is the recommended antibiotic for treating acute cough in adults according to NICE guidelines?
NG120_Recommendations: 1.3 Choice of antibiotic - Part 2,NG120,What are the recommended antibiotic dosages and course lengths for children under 18 years?
NG120_Terms used in the guideline,NG120,What are the recommended self-care treatments for acute cough?
NG120_Summary of the evidence: Self-care - Part 1,NG120,What is the effectiveness of honey in reducing cough severity and duration in children with upper respiratory tract infections?
NG120_Summary of the evidence: Self-care - Part 2,NG120,What are the recommended herbal treatments for acute cough in upper respiratory tract infections?
NG120_Summary of the evidence: Self-care - Part 3,NG120,What is the effectiveness of Pelargonium sidoides in treating acute bronchitis symptoms in adults and children?
NG120_Summary of the evidence: Self-care - Part 4,NG120,What are the effects and risks of using NSAIDs for treating symptoms of the common cold in adults?
NG120_Summary of the evidence: Self-care - Part 5,NG120,Are over-the-counter cough suppressants like codeine and dextromethorphan effective for treating acute cough in adults and children?
NG120_Summary of the evidence: Self-care - Part 6,NG120,Are over-the-counter antihistamines and decongestants effective for treating coughs in children and adults with the common cold?
NG120_Summary of the evidence: Self-care - Part 7,NG120,What are the recommended self-care treatments for acute cough in children and adults?
NG120_Summary of the evidence: Self-care - Part 8,NG120,What are the recommended treatments for acute cough in adults and children according to NICE guidelines?
NG120_Summary of the evidence: Self-care - Part 9,NG120,What are the recommended uses and safety considerations for over-the-counter cough suppressants containing dextromethorphan or pholcodine?
NG120_Summary of the evidence: Bronchodilators - Part 1,NG120,What is the effectiveness of beta-2 agonists in treating cough in children and adults with acute bronchitis?
NG120_Summary of the evidence: Bronchodilators - Part 2,NG120,Should bronchodilators be used for acute cough in patients without underlying airways disease?
NG120_Summary of the evidence: Corticosteroids - Part 1,NG120,What is the effectiveness of inhaled corticosteroids in reducing cough in adults with acute or subacute respiratory tract infections?
NG120_Summary of the evidence: Corticosteroids - Part 2,NG120,When should inhaled or oral corticosteroids be prescribed for acute cough in patients with underlying airways disease?
NG120_Summary of the evidence: Mucolytics,NG120,Should mucolytics be used to treat cough in children with acute respiratory infections?
NG120_Summary of the evidence: No antibiotic - Part 1,NG120,Should antibiotics be prescribed for acute bronchitis in adults?
NG120_Summary of the evidence: No antibiotic - Part 2,NG120,What is the effectiveness of antibiotics in reducing symptoms and duration of acute bronchitis in adults?
NG120_Summary of the evidence: No antibiotic - Part 3,NG120,What is the effectiveness of antibiotics in reducing cough duration in acute bronchitis?
NG120_Summary of the evidence: No antibiotic - Part 4,NG120,Which subgroups with acute lower respiratory tract infection are most likely to benefit from antibiotics?
NG120_Summary of the evidence: No antibiotic - Part 5,NG120,What are the risks and adverse effects of using tetracyclines and other antibiotics in treating acute bronchitis and respiratory infections?
NG120_Summary of the evidence: Back-up antibiotics - Part 1,NG120,What are the recommendations for using back-up antibiotics in adults and children with acute cough?
NG120_Summary of the evidence: Back-up antibiotics - Part 2,NG120,What are the recommended management strategies for acute cough in people who are systemically very unwell or at higher risk of complications?
NG120_Summary of the evidence: Back-up antibiotics - Part 3,NG120,When should antibiotics be prescribed for acute cough with suspected respiratory infection or bronchitis?
NG120_Summary of the evidence: Choice of antibiotic - Part 1,NG120,What is the recommended antibiotic for treating acute cough or bronchitis in adults according to NICE guidelines?
NG120_Summary of the evidence: Choice of antibiotic - Part 2,NG120,What are the recommended first-line antibiotics for adults and children unable to take doxycycline?
NG120_Summary of the evidence: Antibiotic course length & Other considerations,NG120,What is the recommended duration of antibiotic treatment for acute cough according to NICE guidelines?
NG121_Intrapartum care for women with existing medical conditions or obstetric complications and their babies & Overview,NG121,What are the recommended intrapartum care practices for women with pre-existing medical conditions or obstetric complications?
NG121_Recommendations: 1.1 Information for women with existing medical conditions,NG121,What information should be provided to women with medical conditions about intrapartum care and how it may affect their labour and birth?
NG121_Recommendations: 1.2 Planning for intrapartum care with women with existing medical conditions – involving a multidisciplinary team,NG121,How should a multidisciplinary team plan and review intrapartum care for women with pre-existing medical conditions?
NG121_Recommendations: 1.3 Heart disease - Part 1,NG121,What are the recommended risk assessment procedures for women with heart disease during pregnancy?
NG121_Recommendations: 1.3 Heart disease - Part 2,NG121,What are the recommended anticoagulation management strategies for women with mechanical heart valves during pregnancy and labour?
NG121_Recommendations: 1.3 Heart disease - Part 3,NG121,When should anticoagulation be stopped during labour for women with mechanical heart valves?
NG121_Recommendations: 1.3 Heart disease - Part 4,NG121,What are the recommended strategies for managing mode of birth and fluid balance in pregnant women with heart disease?
NG121_Recommendations: 1.3 Heart disease - Part 5,NG121,What are the recommended fluid management strategies for pregnant women with severe heart disease?
NG121_Recommendations: 1.3 Heart disease - Part 6,NG121,What are the recommended signs and investigations for diagnosing heart failure in women during the intrapartum period?
NG121_Recommendations: 1.3 Heart disease - Part 7,NG121,What are the recommended management strategies for women with heart failure due to cardiomyopathy during pregnancy and postpartum?
NG121_Recommendations: 1.3 Heart disease - Part 8,NG121,What are the recommendations for regional anaesthesia and intrapartum monitoring in women with heart disease during labour?
NG121_Recommendations: 1.3 Heart disease - Part 9,NG121,What is the recommended management of the third stage of labour for women with different types of modified WHO heart disease?
NG121_Recommendations: 1.4 Asthma,NG121,What are the recommended pain relief options for women with asthma during labour?
NG121_Recommendations: 1.5 Long-term systemic steroids,NG121,What are the recommended steroid management protocols for pregnant women with adrenal insufficiency during labor and delivery?
NG121_Recommendations: 1.6 Bleeding disorders - Part 1,NG121,What are the considerations for using regional anaesthesia in women with bleeding disorders during childbirth?
NG121_Recommendations: 1.6 Bleeding disorders - Part 2,NG121,What precautions should be taken during delivery for women with immune thrombocytopenic purpura?
NG121_Recommendations: 1.6 Bleeding disorders - Part 3,NG121,What are the recommended management strategies for the third stage of labour in women with bleeding disorders?
NG121_Recommendations: 1.7 Subarachnoid haemorrhage or arteriovenous malformation of the brain - Part 1,NG121,What are the recommended management strategies for women with cerebrovascular malformations during labor and delivery?
NG121_Recommendations: 1.7 Subarachnoid haemorrhage or arteriovenous malformation of the brain - Part 2,NG121,What are the recommended management options for women at high risk of cerebral haemorrhage during childbirth?
NG121_Recommendations: 1.8 Acute kidney injury or chronic kidney disease - Part 1,NG121,What are the recommended fluid management practices for pregnant women with chronic kidney disease during labor?
NG121_Recommendations: 1.8 Acute kidney injury or chronic kidney disease - Part 2,NG121,What are the recommended fluid management strategies for women with kidney disease during pregnancy and postpartum?
NG121_Recommendations: 1.8 Acute kidney injury or chronic kidney disease - Part 3,NG121,What are the recommended timing and mode of birth for women with different stages of chronic kidney disease?
NG121_Recommendations: 1.9 Obesity - Part 1,NG121,What are the recommendations for fetal assessment and positioning in labour for women with a BMI over 30?
NG121_Recommendations: 1.9 Obesity - Part 2,NG121,What are the recommended intrapartum care practices for women with a BMI over 30 kg/m2 during the second stage of labour?
NG121_Recommendations: 1.10 Information for women with obstetric complications or no antenatal care,NG121,What information should be provided to women with obstetric complications or no antenatal care during labour?
NG121_Recommendations: 1.11 Risk assessment for women with obstetric complications or no antenatal care - Part 1,NG121,What are the recommended risk assessment and maternal observation protocols for women in labour with obstetric complications or no antenatal care?
NG121_Recommendations: 1.11 Risk assessment for women with obstetric complications or no antenatal care - Part 2,NG121,What are the recommended maternal observation frequencies for women in labour with sepsis or intrapartum haemorrhage?
NG121_Recommendations: 1.12 Pyrexia,NG121,What are the recommendations for managing fever in women in labour?
NG121_Recommendations: 1.13 Sepsis - Part 1,NG121,What are the recommended management and multidisciplinary review procedures for women with sepsis during labour according to NICE guidelines?
NG121_Recommendations: 1.13 Sepsis - Part 2,NG121,What are the recommended analgesia options for women in labour with sepsis or suspected sepsis?
NG121_Recommendations: 1.13 Sepsis - Part 3,NG121,What are the recommended analgesia and fetal monitoring practices for women in labour with sepsis or suspected sepsis?
NG121_Recommendations: 1.13 Sepsis - Part 4,NG121,What are the recommended antimicrobial treatments for women in labour with sepsis or suspected sepsis?
NG121_Recommendations: 1.13 Sepsis - Part 5,NG121,What are the recommended antimicrobial management and monitoring for women with sepsis or suspected sepsis immediately after childbirth?
NG121_Recommendations: 1.14 Intrapartum haemorrhage - Part 1,NG121,What are the recommended management steps for intrapartum haemorrhage with signs of shock?
NG121_Recommendations: 1.14 Intrapartum haemorrhage - Part 2,NG121,What are the recommended management strategies for intrapartum bleeding during labor?
NG121_Recommendations: 1.15 Breech presenting in labour,NG121,What are the risks and benefits of vaginal birth versus caesarean section for women with breech presentation in labour?
NG121_Recommendations: 1.16 Small-for-gestational-age baby,NG121,What are the recommended fetal monitoring methods for small-for-gestational-age babies during labour?
NG121_Recommendations: 1.17 Large-for-gestational-age baby,NG121,What are the recommended management options for suspected large-for-gestational-age babies during labor?
NG121_Recommendations: 1.18 No antenatal care - Part 1,NG121,What are the recommended management and assessment procedures for women with no antenatal care during labour?
NG121_Recommendations: 1.18 No antenatal care - Part 2,NG121,What tests should be offered to women with no antenatal care?
NG121_Recommendations: 1.19 Previous caesarean section - Part 1,NG121,What are the management options and risks for women with a previous caesarean section during labour?
NG121_Recommendations: 1.19 Previous caesarean section - Part 2 & Recommendations: 1.20 Labour after 42 weeks of pregnancy,NG121,What are the recommended management strategies for labour after 42 weeks of pregnancy?
NG121_Recommendations: 1.20 Labour after 42 weeks of pregnancy,NG121,What are the recommendations for fetal and maternal monitoring during labour after 42 weeks of pregnancy?
NG121_Recommendations: Terms used in this guideline,NG121,What are the considerations for managing pregnant women with chronic kidney disease and mechanical heart valves?
NG121_Recommendations for research: 1 Subarachnoid haemorrhage or arteriovenous malformation of the brain & Recommendations for research: 2 Needle siting in pregnant women who are obese,NG121,Does caesarean section reduce the risk of cerebral haemorrhage in women with a history of subarachnoid haemorrhage or arteriovenous malformation?
NG121_Recommendations for research: 3 Obesity as a risk factor for perinatal morbidity and mortality & Recommendations for research: 4 Risk assessment for women in labour with signs of sepsis & Recommendations for research: 5 Previous caesarean section,NG121,What is the impact of obesity on perinatal morbidity and mortality?
NG121_Rationale and impact: Information for women with existing medical conditions,NG121,What information should healthcare professionals provide to pregnant women with pre-existing medical conditions about intrapartum care?
NG121_Rationale and impact: Planning for intrapartum care with women with existing medical conditions – involving a multidisciplinary team,NG121,How should multidisciplinary teams be involved in intrapartum care for women with pre-existing medical conditions?
NG121_Rationale and impact: Risk assessment for women with heart disease - Part 1,NG121,What are the recommended approaches for risk assessment in pregnant women with heart disease?
NG121_Rationale and impact: Risk assessment for women with heart disease - Part 2,NG121,How should women with heart disease be monitored during pregnancy and childbirth?
NG121_Rationale and impact: Management of anticoagulation for women with mechanical heart valves - Part 1,NG121,What is the recommended management of anticoagulation for women with mechanical heart valves during pregnancy and labour?
NG121_Rationale and impact: Management of anticoagulation for women with mechanical heart valves - Part 2,NG121,What are the recommended management strategies for women on warfarin during labour and postpartum?
NG121_Rationale and impact: Mode of birth for women with heart disease,NG121,What are the NICE guidelines for mode of birth in women with heart disease?
NG121_Rationale and impact: Fluid management for women with heart disease,NG121,What are the recommended fluid management strategies for women with heart disease during labor and delivery?
NG121_Rationale and impact: Diagnosis and management of heart failure for all women in the intrapartum period,NG121,What are the recommended methods for diagnosing heart failure in women during the intrapartum period?
NG121_Rationale and impact: Anaesthesia and analgesia for women with heart disease,NG121,What are the recommended anaesthesia and analgesia options for women with heart disease during labour?
NG121_Rationale and impact: Management of the third stage of labour for women with heart disease,NG121,What are the recommended management strategies for the third stage of labour in women with heart disease?
NG121_Rationale and impact: Analgesia for women with asthma & Rationale and impact: Prostaglandins for women with asthma,NG121,What are the recommended options for pain relief and labour induction in women with asthma?
NG121_Rationale and impact: Long-term systemic steroids,NG121,What are the recommended steroid management protocols for women on long-term systemic steroids during labour and birth?
NG121_Rationale and impact: Regional anaesthesia and analgesia for women with bleeding disorders,NG121,What are the considerations for using regional anaesthesia in women with bleeding disorders and low platelet counts?
NG121_Rationale and impact: Modifying the birth plan according to platelet count or function,NG121,What are the recommended birth plan modifications for women with thrombocytopenia or ITP?
NG121_Rationale and impact: Management of the third stage of labour for women with bleeding disorders,NG121,What are the recommended management strategies for the third stage of labour in women with bleeding disorders?
NG121_Rationale and impact: Mode of birth and management of the second stage of labour for women with subarachnoid haemorrhage or arteriovenous malformation of the brain - Part 1,NG121,What are the recommended management strategies for the second stage of labour in women with subarachnoid haemorrhage or brain arteriovenous malformations?
NG121_Rationale and impact: Mode of birth and management of the second stage of labour for women with subarachnoid haemorrhage or arteriovenous malformation of the brain - Part 2,NG121,What are the risks and considerations for regional analgesia in women with a history of subarachnoid haemorrhage or cerebrovascular malformations?
NG121_Rationale and impact: Fluid management for women with kidney disease,NG121,What are the recommended fluid management strategies for pregnant women with kidney disease?
NG121_Rationale and impact: Timing and mode of birth for women with kidney disease & Rationale and impact: Assessing fetal presentation early in labour for women with a BMI over 30,NG121,What are the recommended practices for assessing fetal presentation early in labor for women with a BMI over 30?
NG121_Rationale and impact: Assessing fetal presentation early in labour for women with a BMI over 30 & Rationale and impact: Anaesthesia and analgesia for women with a BMI over 30,NG121,What is the recommended approach for assessing fetal presentation in women with a BMI over 30 during early labour?
NG121_Rationale and impact: Anaesthesia and analgesia for women with a BMI over 30 & Rationale and impact: Fetal monitoring for women with a BMI over 30,NG121,What are the recommended fetal monitoring practices for women with a BMI over 30 during labour?
NG121_Rationale and impact: Fetal monitoring for women with a BMI over 30 & Rationale and impact: Position in labour for women with a BMI over 30,NG121,What are the recommended fetal monitoring methods for women with a BMI over 30 during labour?
NG121_Rationale and impact: Position in labour for women with a BMI over 30 & Rationale and impact: Equipment needs for women in labour with a BMI over 30,NG121,What equipment is recommended for women with a BMI over 30 during labour?
NG121_Rationale and impact: Equipment needs for women in labour with a BMI over 30,NG121,What equipment is recommended for women with a BMI over 30 during labour?
NG121_Rationale and impact: Information for women with obstetric complications or no antenatal care,NG121,What information should healthcare professionals provide to women with obstetric complications to support informed decision making?
NG121_Rationale and impact: Risk assessment for women with obstetric complications or no antenatal care - Part 1,NG121,What are the recommended risk assessment and maternal observation protocols for women with obstetric complications or no antenatal care during labor?
NG121_Rationale and impact: Risk assessment for women with obstetric complications or no antenatal care - Part 2,NG121,How should maternal vital signs and blood loss be monitored during intrapartum haemorrhage to ensure timely intervention?
NG121_Rationale and impact: Use of antipyretics for women in labour with a fever & Rationale and impact: Fetal blood sampling for women in labour with a fever,NG121,What are the guidelines for using antipyretics in women in labour with a fever?
NG121_Rationale and impact: Mode of birth for women with sepsis or suspected sepsis,NG121,What is the recommended mode of birth for women with sepsis or suspected sepsis during labour?
NG121_Rationale and impact: Anaesthesia for women in labour with sepsis and signs of organ dysfunction,NG121,What are the recommended anaesthesia options for women in labour with sepsis and signs of organ dysfunction?
NG121_Rationale and impact: Analgesia for women in labour with sepsis or suspected sepsis,NG121,What are the recommended pain relief options for women in labour with sepsis or suspected sepsis?
NG121_Rationale and impact: Fetal monitoring for women in labour with sepsis or suspected sepsis,NG121,What are the recommended practices for fetal monitoring in women in labour with sepsis or suspected sepsis?
NG121_Rationale and impact: Antimicrobial treatment for women in labour with sepsis or suspected sepsis,NG121,What is the recommended timing and choice of antimicrobial treatment for women in labour with suspected sepsis?
NG121_Rationale and impact: Care for women with sepsis or suspected sepsis immediately after the birth,NG121,What is the recommended care for women with sepsis immediately after childbirth?
NG121_Rationale and impact: Intrapartum haemorrhage,NG121,What are the recommended management strategies for intrapartum haemorrhage during labor?
NG121_Rationale and impact: Breech presenting in labour,NG121,What are the current NICE recommendations for managing breech presentation in labour?
NG121_Rationale and impact: Small-for-gestational-age baby,NG121,What is the recommended fetal monitoring for suspected small-for-gestational-age babies during labour?
NG121_Rationale and impact: Large-for-gestational-age baby,NG121,What are the recommended management options for laboring women with suspected large-for-gestational-age babies?
NG121_Rationale and impact: No antenatal care,NG121,What are the recommended intrapartum care procedures for women with no antenatal care?
NG121_Rationale and impact: Previous caesarean section - Part 1,NG121,What are the recommendations for managing women with a previous caesarean section during labour?
NG121_Rationale and impact: Previous caesarean section - Part 2,NG121,What pain relief options are recommended for women with a previous caesarean section during labour?
NG121_Rationale and impact: Labour after 42 weeks of pregnancy,NG121,What is the recommended monitoring approach for women in labour after 42 weeks of pregnancy?
NG121_Context,NG121,What are the recommended risk assessment and care planning procedures for women at high risk of complications during pregnancy and labour?
NG122_Lung cancer: diagnosis and management & Overview & Access to services and referral,NG122,What are the recommended referral criteria for suspected lung cancer according to NICE guidelines?
NG122_Communication,NG122,What are best practices for communicating diagnosis and treatment options to patients with lung cancer?
NG122_Diagnosis and staging: 1.3 Effectiveness of diagnostic and staging investigations - Part 1,NG122,What are the recommended imaging and biopsy techniques for staging and diagnosing lung cancer?
NG122_Diagnosis and staging: 1.3 Effectiveness of diagnostic and staging investigations - Part 2,NG122,What are the recommended procedures for sampling and staging in suspected lung cancer?
NG122_Diagnosis and staging: 1.3 Effectiveness of diagnostic and staging investigations - Part 3,NG122,What is the recommended approach for intrathoracic nodal staging in patients with suspected lung cancer?
NG122_Diagnosis and staging: 1.3 Effectiveness of diagnostic and staging investigations - Part 4,NG122,What are the recommended imaging investigations for staging and detecting metastases in non-small cell lung cancer?
NG122_Diagnosis and staging: 1.3 Effectiveness of diagnostic and staging investigations - Part 5,NG122,What is the role of multidisciplinary teams and clinical nurse specialists in the diagnosis and management of lung cancer?
NG122_Treatment: 1.4 Stop smoking interventions and services,NG122,What are the recommended smoking cessation interventions for patients diagnosed with lung cancer?
NG122_Treatment: 1.5 Assessing people with non-small-cell lung cancer for treatment with curative intent - Part 1,NG122,What are the recommended assessments for evaluating suitability for curative surgery in non-small-cell lung cancer patients?
NG122_Treatment: 1.5 Assessing people with non-small-cell lung cancer for treatment with curative intent - Part 2,NG122,What are the criteria for offering surgery or radiotherapy to patients with lung conditions based on lung function tests?
NG122_Treatment: 1.6 Surgery and radiotherapy with curative intent for non-small-cell lung cancer - Part 1,NG122,What are the surgical and radiotherapy options for curative treatment of non-small-cell lung cancer?
NG122_Treatment: 1.6 Surgery and radiotherapy with curative intent for non-small-cell lung cancer - Part 2,NG122,What are the recommended radiotherapy options for patients with stage IIIA or IIIB non-small-cell lung cancer who cannot tolerate chemoradiotherapy?
NG122_Treatment: 1.7 Combination treatment for non-small-cell lung cancer - Part 1,NG122,What are the recommended combination treatments for non-small-cell lung cancer?
NG122_Treatment: 1.7 Combination treatment for non-small-cell lung cancer - Part 2,NG122,What are the recommended treatment options for operable stage IIIA–N2 non-small-cell lung cancer?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 1,NG122,What are the recommended systemic anti-cancer therapy options for squamous non-small-cell lung cancer with no targetable mutations and PD-L1 less than 50%?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 2,NG122,What are the treatment options for RET fusion positive squamous non-small-cell lung cancer with PD-L1 less than 50%?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 3,NG122,What are the treatment options for NTRK fusion positive squamous non-small-cell lung cancer with PD-L1 less than 50%?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 4,NG122,What are the systemic anti-cancer therapy options for squamous non-small-cell lung cancer with METex14 skipping alteration and PD-L1 expression?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 5,NG122,What are the systemic anti-cancer therapy options for BRAF V600 positive squamous non-small-cell lung cancer with PD-L1 less than 50%?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 6,NG122,What are the recommended systemic anti-cancer therapies for non-squamous non-small-cell lung cancer with no targetable mutations and PD-L1 50% or higher?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 7,NG122,What are the recommended systemic anti-cancer therapies for NTRK fusion positive non-squamous non-small-cell lung cancer with high PD-L1 expression?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 8,NG122,What are the treatment options for KRAS G12C positive non-small-cell lung cancer with PD-L1 less than 50%?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 9,NG122,What are the recommended systemic anti-cancer therapies for non-small-cell lung cancer with METex14 skipping and PD-L1 50% or higher?
NG122_Treatment: 1.8 Systemic anti-cancer therapy (SACT) for advanced non-small-cell lung cancer - Part 10,NG122,What are the systemic anti-cancer therapy options for people with BRAF V600 positive non-small-cell lung cancer and high PD-L1 expression?
NG122_Treatment: 1.9 Assessing people with small-cell lung cancer,NG122,What is the recommended timeframe for thoracic oncologist assessment in small-cell lung cancer patients?
NG122_Treatment: 1.10 First-line treatment for limited-stage disease small-cell lung cancer & Treatment: 1.11 Surgery for small-cell lung cancer,NG122,What is the recommended first-line treatment for limited-stage small-cell lung cancer?
NG122_Treatment: 1.12 First-line treatment for extensive-stage disease small-cell lung cancer & Treatment: 1.13 Maintenance treatment for small-cell lung cancer,NG122,What is the recommended first-line treatment for extensive-stage small-cell lung cancer?
NG122_Treatment: 1.14 Second-line treatment for small-cell lung cancer that has relapsed after first-line treatment & Palliative interventions and supportive and palliative care: 1.15 Providing palliative care,NG122,What are the second-line treatment options for relapsed small-cell lung cancer?
NG122_Palliative interventions and supportive and palliative care: 1.16 Palliative radiotherapy & Palliative interventions and supportive and palliative care: 1.17 Managing endobronchial obstruction & Palliative interventions and supportive and palliative care: 1.18 Other palliative treatments,NG122,What are the recommended palliative radiotherapy options for managing endobronchial obstruction in lung cancer patients?
"NG122_Palliative interventions and supportive and palliative care: 1.19 Managing brain metastases & Palliative interventions and supportive and palliative care: 1.20 Bone metastases & Palliative interventions and supportive and palliative care: 1.21 Managing other symptoms: weight loss, loss of appetite, difficulty swallowing, fatigue and depression",NG122,What are the recommended treatments for managing brain metastases and associated symptoms according to NICE guidelines?
NG122_Follow-up and patient perspectives & Recommendations for research: 1 Immunotherapy after multimodality treatment,NG122,What are the recommended follow-up procedures and patient experience considerations for lung cancer management?
NG122_Recommendations for research: 2 Stereotactic ablative radiotherapy compared with surgery & Recommendations for research: 3 Routine contrast-enhanced brain CT,NG122,What is the clinical effectiveness of stereotactic ablative radiotherapy compared to surgery for stage I and IIA non-small-cell lung cancer?
NG122_Recommendations for research: 4 Prophylactic cranial irradiation compared with routine MRI follow-up in extensive-stage small-cell lung cancer,NG122,What is the clinical and cost effectiveness of prophylactic cranial irradiation versus routine MRI follow-up in extensive-stage small-cell lung cancer?
NG122_Rationale and impact: Diagnosis and staging - Part 1,NG122,What are the benefits of using EBUS-TBNA and EUS-FNA for mediastinal lymph node assessment in lung cancer diagnosis?
NG122_Rationale and impact: Diagnosis and staging - Part 2,NG122,When is surgical mediastinal staging indicated for lung cancer patients with negative EBUS-TBNA or EUS-FNA results?
NG122_Rationale and impact: Brain imaging for people having treatment with curative intent,NG122,When should brain imaging be performed in patients with non-small cell lung cancer undergoing curative treatment?
NG122_Rationale and impact: Surgery and radiotherapy with curative intent for non-small-cell lung cancer - Part 1,NG122,What are the recommended surgical and radiotherapy options for non-small-cell lung cancer?
NG122_Rationale and impact: Surgery and radiotherapy with curative intent for non-small-cell lung cancer - Part 2,NG122,What is the effectiveness of stereotactic ablative radiotherapy compared to surgery for non-small cell lung cancer?
NG122_Rationale and impact: Management of operable stage IIIA–N2 non-small-cell lung cancer,NG122,What is the evidence for using chemoradiotherapy combined with surgery in operable stage IIIA-N2 non-small-cell lung cancer?
NG122_Rationale and impact: First-line treatment for limited-stage disease small-cell lung cancer,NG122,What is the recommended radiotherapy schedule for limited-stage small-cell lung cancer?
NG122_Rationale and impact: Thoracic radiotherapy and prophylactic cranial irradiation in small-cell lung cancer,NG122,What are the current NICE recommendations for thoracic radiotherapy and prophylactic cranial irradiation in small-cell lung cancer?
NG122_Context - Part 1,NG122,What are the main risk factors for lung cancer and how can it be prevented?
NG122_Context - Part 2,NG122,What are the current diagnostic and treatment options for lung cancer according to NICE guidelines?
NG123_Urinary incontinence and pelvic organ prolapse in women: management & Overview,NG123,What are the recommended management options for urinary incontinence and pelvic organ prolapse in women?
NG123_Recommendations: 1.1 Organisation of specialist services - Part 1,NG123,What are the recommended compositions and roles of multidisciplinary teams for managing urinary incontinence and pelvic organ prolapse?
NG123_Recommendations: 1.1 Organisation of specialist services - Part 2,NG123,What are the recommended team members and specialist services for managing complex pelvic floor dysfunction and mesh-related problems?
NG123_Recommendations: 1.2 Collecting data on surgery and surgical complications,NG123,What data should be recorded in the national registry for surgery of urinary incontinence and pelvic organ prolapse in women?
NG123_Recommendations: 1.3 Assessing urinary incontinence - Part 1,NG123,What is the recommended approach for assessing and managing urinary incontinence in women?
NG123_Recommendations: 1.3 Assessing urinary incontinence - Part 2,NG123,What are the recommended procedures for diagnosing and assessing urinary incontinence in women according to NICE guidelines?
NG123_Recommendations: 1.3 Assessing urinary incontinence - Part 3,NG123,What are the recommended assessments and indications for referral in women with urinary incontinence?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 1,NG123,What are the non-surgical management options for urinary incontinence in women?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 2,NG123,What are the recommended treatments for overactive bladder when bladder training alone is ineffective?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 3,NG123,What are the guidelines for using bladder catheters in women with urinary incontinence?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 4,NG123,What are the recommended treatments and considerations for managing urinary incontinence and overactive bladder in women?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 5,NG123,What are the recommended pharmacological treatments for overactive bladder and urinary incontinence in women according to NICE guidelines?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 6,NG123,What are the recommended invasive procedures for treating overactive bladder according to NICE guidelines?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 7,NG123,What are the treatment options for women with overactive bladder unresponsive to medication and non-surgical management?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 8,NG123,What are the recommended treatments for overactive bladder in women according to NICE guidelines?
NG123_Recommendations: 1.4 Non-surgical management of urinary incontinence - Part 9,NG123,What are the long-term considerations and risks of percutaneous sacral nerve stimulation in women?
NG123_Recommendations: 1.5 Surgical management of stress urinary incontinence - Part 1,NG123,What are the long-term risks and benefits of mesh procedures for stress urinary incontinence?
NG123_Recommendations: 1.5 Surgical management of stress urinary incontinence - Part 2,NG123,What information should be provided to women about intramural bulking agents used for stress urinary incontinence?
NG123_Recommendations: 1.5 Surgical management of stress urinary incontinence - Part 3,NG123,What procedures should not be offered for stress urinary incontinence in women?
NG123_Recommendations: 1.6 Assessing pelvic organ prolapse - Part 1,NG123,What is the recommended approach for assessing pelvic organ prolapse in women?
NG123_Recommendations: 1.6 Assessing pelvic organ prolapse - Part 2,NG123,What are the recommended assessment methods for pelvic organ prolapse in women?
NG123_Recommendations: 1.7 Non-surgical management of pelvic organ prolapse - Part 1,NG123,What are the non-surgical management options for pelvic organ prolapse?
NG123_Recommendations: 1.7 Non-surgical management of pelvic organ prolapse - Part 2,NG123,What are the recommendations for using pessaries in managing pelvic organ prolapse?
NG123_Recommendations: 1.8 Surgical management of pelvic organ prolapse - Part 1,NG123,What are the recommended surgical options for pelvic organ prolapse and their associated risks?
NG123_Recommendations: 1.8 Surgical management of pelvic organ prolapse - Part 2,NG123,What are the recommended surgical options and data recording procedures for uterine prolapse treatment according to NICE guidelines?
NG123_Recommendations: 1.8 Surgical management of pelvic organ prolapse - Part 3,NG123,What are the surgical options for women with uterine prolapse who wish to preserve their uterus?
NG123_Recommendations: 1.8 Surgical management of pelvic organ prolapse - Part 4,NG123,What are the recommended surgical options for anterior vaginal wall prolapse according to NICE guidelines?
NG123_Recommendations: 1.8 Surgical management of pelvic organ prolapse - Part 5,NG123,What are the recommended follow-up procedures after pelvic organ prolapse surgery?
NG123_Recommendations: 1.9 Surgery for women with both stress urinary incontinence and pelvic organ prolapse,NG123,What are the considerations for concurrent surgery for stress urinary incontinence and pelvic organ prolapse in women?
NG123_Recommendations: 1.10 Assessing complications associated with mesh surgery - Part 1,NG123,What are the symptoms of mesh-related complications after urinary incontinence or pelvic organ prolapse surgery?
NG123_Recommendations: 1.10 Assessing complications associated with mesh surgery - Part 2,NG123,What are the recommended investigations for suspected mesh-related complications after pelvic mesh surgery?
NG123_Recommendations: 1.10 Assessing complications associated with mesh surgery - Part 3,NG123,What are the recommended investigations for assessing mesh complications after pelvic floor mesh surgery?
NG123_Recommendations: 1.11 Managing complications associated with mesh surgery - Part 1,NG123,What are the recommended management options for vaginal mesh complications after pelvic surgery?
NG123_Recommendations: 1.11 Managing complications associated with mesh surgery - Part 2,NG123,What are the risks and management options for vaginal complications after mesh surgery for pelvic organ prolapse?
NG123_Recommendations: 1.11 Managing complications associated with mesh surgery - Part 3,NG123,What are the risks and management options for women considering mesh excision for persistent voiding dysfunction?
NG123_Recommendations: Terms used in this guideline - Part 1,NG123,What are the treatment options for overactive bladder and stress urinary incontinence?
NG123_Recommendations: Terms used in this guideline - Part 2,NG123,What are the treatment options for uterine prolapse and stress urinary incontinence in women?
NG123_Recommendations: Additional information,NG123,What is the most cost-effective medication for overactive bladder based on NICE guidelines?
NG123_Recommendations for research: Key recommendations for research - Part 1,NG123,What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women?
NG123_Recommendations for research: Key recommendations for research - Part 2,NG123,What are the long-term outcomes and patient satisfaction associated with pessary use versus surgical treatment for pelvic organ prolapse in women?
NG123_Recommendations for research: Other recommendations for research,NG123,What is the long-term effectiveness of botulinum toxin type A injections for overactive bladder in women?
NG123_Rationale and impact: Organisation of specialist services,NG123,What is the recommended organization of specialist multidisciplinary teams for managing pelvic floor disorders?
NG123_Rationale and impact: Collecting data on surgery and surgical complications,NG123,What are the recommendations for collecting data on surgical complications in procedures for urinary incontinence and pelvic organ prolapse?
NG123_Rationale and impact: Urodynamic testing,NG123,When is urodynamic testing indicated for women with stress urinary incontinence?
NG123_Rationale and impact: Pelvic floor muscle training,NG123,What is the effectiveness of pelvic floor muscle training compared to surgery for stress urinary incontinence?
NG123_Rationale and impact: Absorbent containment products,NG123,What are the recommended review procedures for absorbent containment products used in urinary incontinence management?
NG123_Rationale and impact: Medicines for overactive bladder & Rationale and impact: Botulinum toxin type A injection,NG123,What are the NICE recommendations for using botulinum toxin type A injections in overactive bladder management?
NG123_Rationale and impact: Botulinum toxin type A injection,NG123,What is the recommended starting dose of botulinum toxin type A for overactive bladder treatment?
NG123_Rationale and impact: Surgical management of stress urinary incontinence - Part 1,NG123,What are the surgical options for managing stress urinary incontinence in women?
NG123_Rationale and impact: Surgical management of stress urinary incontinence - Part 2,NG123,What are the differences between retropubic and transobturator mid-urethral mesh slings for stress urinary incontinence?
NG123_Rationale and impact: Assessing pelvic organ prolapse,NG123,What is the recommended method for assessing pelvic organ prolapse in clinical practice?
NG123_Rationale and impact: Non-surgical management of pelvic organ prolapse - Part 1,NG123,What are the non-surgical management options for pelvic organ prolapse?
NG123_Rationale and impact: Non-surgical management of pelvic organ prolapse - Part 2,NG123,What are the best practices for managing pessary use and preventing complications in women with pelvic organ prolapse?
NG123_Rationale and impact: Surgical management of pelvic organ prolapse - Part 1,NG123,What are the risks and benefits of surgical options for pelvic organ prolapse?
NG123_Rationale and impact: Surgical management of pelvic organ prolapse - Part 2,NG123,What are the surgical options for uterine and vault prolapse and their associated risks and benefits?
NG123_Rationale and impact: Surgical management of pelvic organ prolapse - Part 3,NG123,What are the recommended surgical options for anterior and posterior pelvic organ prolapse?
NG123_Rationale and impact: Surgery for women with both stress urinary incontinence and pelvic organ prolapse,NG123,What are the benefits and risks of concurrent surgery for stress urinary incontinence and pelvic organ prolapse?
NG123_Rationale and impact: Assessing complications associated with mesh surgery,NG123,What are the recommended investigations for assessing mesh-related complications in women?
NG123_Rationale and impact: Managing complications associated with mesh surgery,NG123,What are the recommended management strategies for complications associated with mesh surgery in women?
NG123_Context - Part 1,NG123,What are the different types of urinary incontinence and their clinical features?
NG123_Context - Part 2,NG123,What are the recommended management options for pelvic organ prolapse and associated surgical complications?
NG123_Finding more information and resources,NG123,Where can I find additional resources and evidence reviews for NICE gynaecological and urological guidelines?
NG124_Specialist neonatal respiratory care for babies born preterm & Overview,NG124,What are the recommended respiratory support strategies for preterm babies in neonatal care?
NG124_Recommendations: 1.1 Risk factors for bronchopulmonary dysplasia,NG124,What are the risk factors for developing bronchopulmonary dysplasia in preterm infants?
NG124_Recommendations: 1.2 Respiratory support for preterm babies - Part 1,NG124,What are the recommended respiratory support options for preterm babies before admission to the neonatal unit?
NG124_Recommendations: 1.2 Respiratory support for preterm babies - Part 2,NG124,What are the recommended respiratory support options for preterm babies requiring oxygen therapy?
NG124_Recommendations: 1.2 Respiratory support for preterm babies - Part 3,NG124,What are the recommended ventilation techniques for preterm infants with respiratory distress syndrome?
NG124_Recommendations: 1.3 Managing respiratory disorders - Part 1,NG124,What are the recommendations for using dexamethasone to prevent bronchopulmonary dysplasia in preterm infants?
NG124_Recommendations: 1.3 Managing respiratory disorders - Part 2,NG124,What are the benefits and risks of using dexamethasone in preterm babies aged 8 days or older?
NG124_Recommendations: 1.3 Managing respiratory disorders - Part 3,NG124,What are the recommended uses and dosing guidelines for caffeine citrate in preterm infants with apnoea?
NG124_Recommendations: 1.4 Monitoring - Part 1,NG124,What are the recommended methods for monitoring oxygen saturation and carbon dioxide levels in preterm babies?
NG124_Recommendations: 1.4 Monitoring - Part 2,NG124,How should blood pressure be managed in preterm babies to ensure adequate tissue perfusion?
NG124_Recommendations: 1.5 Sedation and analgesia - Part 1,NG124,What are the recommendations for using morphine for sedation and analgesia in preterm infants?
NG124_Recommendations: 1.5 Sedation and analgesia - Part 2,NG124,What are the recommended premedications for elective non-urgent intubation in preterm infants?
"NG124_Recommendations: 1.6 Involving, supporting and informing parents and carers - Part 1",NG124,What are the recommended ways to involve and support parents and carers of preterm babies on respiratory support?
"NG124_Recommendations: 1.6 Involving, supporting and informing parents and carers - Part 2",NG124,What information and support should be provided to parents and carers of preterm babies on respiratory support?
"NG124_Recommendations: 1.6 Involving, supporting and informing parents and carers - Part 3",NG124,What are the recommended practices for neonatal units to support parents of preterm babies on respiratory support?
NG124_Recommendations: 1.7 Discharge planning - Part 1,NG124,What are the key considerations for discharge planning and parent support for preterm babies on respiratory support?
NG124_Recommendations: 1.7 Discharge planning - Part 2,NG124,What information should parents and carers receive about caring for their baby after discharge from hospital?
NG124_Recommendations: Terms used in this guideline - Part 1,NG124,What is automated oxygen titration and how does it work in neonatal care?
NG124_Recommendations: Terms used in this guideline - Part 2,NG124,What are the neurodevelopmental outcomes assessed at 18 months or older in infants?
NG124_Recommendations for research: Key recommendations for research - Part 1,NG124,What is the most effective method for delivering surfactant in preterm infants?
NG124_Recommendations for research: Key recommendations for research - Part 2,NG124,What is the optimal oxygen saturation target for preterm babies to improve survival without complications?
NG124_Recommendations for research: Other recommendations for research,NG124,What are the best practices for respiratory support and management of preterm babies in neonatal care?
NG124_Rationale and impact: Risk factors for bronchopulmonary dysplasia,NG124,What are the risk factors for developing bronchopulmonary dysplasia in preterm infants?
NG124_Rationale and impact: Respiratory support before admission to the neonatal unit,NG124,What is the recommended respiratory support for preterm babies in the delivery room to reduce mortality and bronchopulmonary dysplasia?
NG124_Rationale and impact: Surfactant,NG124,What are the recommended methods for administering surfactant to preterm infants?
NG124_Rationale and impact: Oxygen,NG124,What are the best practices for delivering oxygen to preterm infants?
NG124_Rationale and impact: Ventilation techniques - Part 1,NG124,What are the recommended non-invasive ventilation techniques for preterm infants in neonatal care?
NG124_Rationale and impact: Ventilation techniques - Part 2 & Rationale and impact: Nitric oxide,NG124,What is the recommended primary mode of invasive ventilation for preterm babies with respiratory distress?
NG124_Rationale and impact: Corticosteroids - Part 1,NG124,When should dexamethasone be used in preterm infants to prevent bronchopulmonary dysplasia?
NG124_Rationale and impact: Corticosteroids - Part 2,NG124,Why should dexamethasone and NSAIDs not be used together in neonatal care?
NG124_Rationale and impact: Diuretics,NG124,What is the evidence for using diuretics in preterm babies on respiratory support?
NG124_Rationale and impact: Caffeine citrate - Part 1,NG124,What is the recommended timing and duration for caffeine citrate therapy in preterm infants to prevent bronchopulmonary dysplasia?
NG124_Rationale and impact: Caffeine citrate - Part 2,NG124,What are the recommended dosing and monitoring guidelines for caffeine citrate in neonatal apnoea?
NG124_Rationale and impact: Patent ductus arteriosus,NG124,When should treatment for patent ductus arteriosus be considered in newborns?
NG124_Rationale and impact: Oxygen monitoring,NG124,What is the recommended method for monitoring oxygen saturation in preterm babies?
NG124_Rationale and impact: Carbon dioxide monitoring,NG124,What are the recommended target ranges for carbon dioxide levels in preterm babies on invasive ventilation?
NG124_Rationale and impact: Blood pressure,NG124,What are the recommended methods for measuring blood pressure in preterm babies?
NG124_Rationale and impact: Morphine,NG124,When should morphine be used for pain management in preterm infants?
NG124_Rationale and impact: Premedication before intubation,NG124,What are the recommended premedication options before elective intubation in preterm babies?
NG124_Rationale and impact: Involving parents and carers while their preterm baby is on respiratory support,NG124,What are the recommended ways to involve parents and carers in the care of preterm babies on respiratory support?
NG124_Rationale and impact: Supporting and informing parents and carers while their preterm baby is on respiratory support,NG124,What support and information should be provided to parents of preterm babies on respiratory support?
NG124_Rationale and impact: Neonatal unit services & Rationale and impact: Discharge planning – planning safe discharge,NG124,What are the recommended practices for neonatal discharge planning and parental communication for preterm babies?
NG124_Rationale and impact: Discharge planning – preparing for discharge,NG124,What information should be provided to parents and carers of preterm babies on respiratory support before discharge?
NG124_Context - Part 1,NG124,What are the recommended respiratory management strategies for preterm babies at risk of bronchopulmonary dysplasia?
NG124_Context - Part 2,NG124,What are the best practices for providing respiratory support to preterm babies to prevent bronchopulmonary dysplasia?
NG125_Surgical site infections: prevention and treatment & Overview & Recommendations: 1.1 Information for patients and carers,NG125,What information should be provided to patients and carers about preventing and recognizing surgical site infections?
NG125_Recommendations: 1.2 Preoperative phase - Part 1,NG125,What are the recommended preoperative skin preparation and decolonisation procedures to prevent surgical site infections?
NG125_Recommendations: 1.2 Preoperative phase - Part 2,NG125,What are the recommended practices for hair removal and theatre wear to prevent surgical site infections?
NG125_Recommendations: 1.2 Preoperative phase - Part 3,NG125,When should antibiotic prophylaxis be used in surgical procedures?
NG125_Recommendations: 1.3 Intraoperative phase - Part 1,NG125,What are the recommended hand decontamination procedures for surgical teams during intraoperative care?
NG125_Recommendations: 1.3 Intraoperative phase - Part 2,NG125,What are the recommended practices for wound irrigation and intracavity lavage to prevent surgical site infections?
NG125_Recommendations: 1.3 Intraoperative phase - Part 3,NG125,What are the recommended practices for preventing surgical site infections during wound management?
NG125_Recommendations: 1.4 Postoperative phase - Part 1,NG125,What are the recommended wound dressing practices after surgery for primary and secondary intention healing?
NG125_Recommendations: 1.4 Postoperative phase - Part 2,NG125,What are the recommended dressings and management strategies for surgical wounds healing by secondary intention?
NG125_Recommendations: Terms used in this guideline,NG125,What is the definition and significance of surgical wound classification in infection prevention?
NG125_Recommendations for research: Key recommendations for research - Part 1,NG125,What is the effectiveness of nasal decolonisation with mupirocin and chlorhexidine body wash in preventing surgical site infections?
NG125_Recommendations for research: Key recommendations for research - Part 2,NG125,What is the effectiveness of applying antiseptics and antibiotics before wound closure in preventing surgical site infections?
NG125_Recommendations for research: Other recommendations for research,NG125,What is the effectiveness of nasal decolonisation timing and body wash in preventing surgical site infections?
NG125_Rationale and impact: Nasal decolonisation - Part 1,NG125,What are the recommendations for nasal decolonisation to prevent surgical site infections caused by Staphylococcus aureus?
NG125_Rationale and impact: Nasal decolonisation - Part 2,NG125,What are the current NICE recommendations on the use of mupirocin and chlorhexidine for surgical site infection prevention and antimicrobial resistance monitoring?
NG125_Rationale and impact: Antiseptic skin preparation - Part 1,NG125,What is the recommended antiseptic skin preparation to prevent surgical site infections?
NG125_Rationale and impact: Antiseptic skin preparation - Part 2,NG125,What are the safety considerations for using skin antiseptics in babies and during surgical procedures?
NG125_Rationale and impact: Antiseptics and antibiotics before wound closure - Part 1,NG125,What is the current evidence on the use of topical antiseptics and antibiotics before wound closure to prevent surgical site infections?
NG125_Rationale and impact: Antiseptics and antibiotics before wound closure - Part 2,NG125,What is the effectiveness of gentamicin-collagen implants in reducing surgical site infections after cardiac surgery?
NG125_Rationale and impact: Closure methods,NG125,What are the recommended closure methods for wound management in caesarean births?
NG125_Context,NG125,What are the best strategies for preventing surgical site infections?
NG126_Ectopic pregnancy and miscarriage: diagnosis and initial management & Overview & Recommendations: 1.1 Support and information giving - Part 1,NG126,What are the recommended initial management and diagnostic approaches for ectopic pregnancy and miscarriage in women up to 13 weeks of pregnancy?
NG126_Recommendations: 1.1 Support and information giving - Part 2,NG126,What information should be provided to women and their partners during early pregnancy loss care?
NG126_Recommendations: 1.2 Early pregnancy assessment services,NG126,What are the recommended services and staffing requirements for early pregnancy assessment clinics?
NG126_Recommendations: 1.3 Symptoms and signs of ectopic pregnancy and initial assessment - Part 1,NG126,What are the symptoms and signs of ectopic pregnancy and how should it be initially assessed?
NG126_Recommendations: 1.3 Symptoms and signs of ectopic pregnancy and initial assessment - Part 2,NG126,What are the recommended management and referral criteria for women with early pregnancy bleeding and pain?
NG126_Recommendations: 1.4 Diagnosis of viable intrauterine pregnancy and of tubal ectopic pregnancy - Part 1,NG126,What are the recommended ultrasound procedures for diagnosing viable intrauterine pregnancy and ectopic pregnancy?
NG126_Recommendations: 1.4 Diagnosis of viable intrauterine pregnancy and of tubal ectopic pregnancy - Part 2,NG126,What is the recommended timing for repeat ultrasound scans in early pregnancy assessment?
NG126_Recommendations: 1.4 Diagnosis of viable intrauterine pregnancy and of tubal ectopic pregnancy - Part 3,NG126,What ultrasound signs indicate a tubal ectopic pregnancy in early pregnancy?
NG126_Recommendations: 1.4 Diagnosis of viable intrauterine pregnancy and of tubal ectopic pregnancy - Part 4,NG126,What is the recommended approach for diagnosing ectopic pregnancy using ultrasound and hCG measurements?
NG126_Recommendations: 1.4 Diagnosis of viable intrauterine pregnancy and of tubal ectopic pregnancy - Part 5,NG126,What are the recommended management strategies for abnormal serum hCG changes in early pregnancy?
NG126_Recommendations: 1.5 Management of miscarriage - Part 1,NG126,What are the recommended management options for threatened and confirmed miscarriage according to NICE guidelines?
NG126_Recommendations: 1.5 Management of miscarriage - Part 2,NG126,What are the management options for women with confirmed miscarriage who do not want expectant management?
NG126_Recommendations: 1.5 Management of miscarriage - Part 3,NG126,What is the recommended medical management protocol for missed and incomplete miscarriage?
NG126_Recommendations: 1.5 Management of miscarriage - Part 4,NG126,What should women with a positive pregnancy test after 3 weeks do to rule out ectopic or molar pregnancy?
NG126_Recommendations: 1.6 Management of tubal ectopic pregnancy - Part 1,NG126,What are the management options and follow-up procedures for tubal ectopic pregnancy?
NG126_Recommendations: 1.6 Management of tubal ectopic pregnancy - Part 2,NG126,What are the criteria for offering systemic methotrexate to women with ectopic pregnancy?
NG126_Recommendations: 1.6 Management of tubal ectopic pregnancy - Part 3,NG126,What are the treatment options for ectopic pregnancy based on serum hCG levels and ultrasound findings?
NG126_Recommendations: 1.6 Management of tubal ectopic pregnancy - Part 4 & Recommendations: 1.7 Anti-D immunoglobulin prophylaxis,NG126,What is the recommended surgical approach for treating ectopic pregnancy according to NICE guidelines?
NG126_Recommendations: Terms used in this guideline & Recommendations for research: 1 Early pregnancy assessment units,NG126,What are the benefits and outcomes of early pregnancy assessment units compared to other models of care?
NG126_Recommendations for research: 2 Ultrasound for determining a viable intrauterine pregnancy,NG126,What is the optimal timing and frequency of ultrasound scans for diagnosing early pregnancy viability and complications?
NG126_Recommendations for research: 3 Effectiveness of progestogens in women with recurrent miscarriage & Recommendations for research: 4 Effectiveness of different progestogens in women at risk of miscarriage,NG126,What is the effectiveness of progesterone in preventing recurrent miscarriage?
"NG126_Recommendations for research: 5 Management of miscarriage & Recommendations for research: 6 Comparison between expectant, medical or surgical management of ectopic pregnancy",NG126,What is the impact of different management strategies on women's psychological and emotional outcomes after miscarriage?
NG126_Rationale and impact: Using ultrasound for diagnosis of a tubal ectopic pregnancy,NG126,What ultrasound features are most reliable for diagnosing a tubal ectopic pregnancy?
NG126_Rationale and impact: Progestogens for preventing miscarriage,NG126,What is the evidence for using micronised vaginal progesterone to prevent miscarriage in women with early pregnancy bleeding and previous miscarriage?
NG126_Rationale and impact: Medical management of miscarriage - Part 1,NG126,What are the recommended medical treatments for miscarriage management?
NG126_Rationale and impact: Medical management of miscarriage - Part 2,NG126,How do recent NICE guideline updates on miscarriage management affect clinical practice and resource use?
NG126_Rationale and impact: Expectant management of tubal ectopic pregnancy & Context,NG126,What are the criteria for expectant management of ectopic pregnancy?
NG127_Suspected neurological conditions: recognition and referral & 3 more sections,NG127,What are the criteria for referring adults with suspected neurological blackouts to specialist assessment?
NG127_Recommendations for adults aged over 16: 1.2 Dizziness and vertigo in adults - Part 1,NG127,What are the recommended assessments and referral criteria for sudden-onset dizziness and vertigo in adults?
NG127_Recommendations for adults aged over 16: 1.2 Dizziness and vertigo in adults - Part 2,NG127,What are the recommended management strategies for benign paroxysmal positional vertigo (BPPV) in adults?
"NG127_Recommendations for adults aged over 16: 1.3 Facial pain, atraumatic",NG127,What are the recommended assessments and referral pathways for atraumatic facial pain with neurological signs or suspected temporal arteritis?
NG127_Recommendations for adults aged over 16: 1.4 Gait unsteadiness,NG127,What are the recommended assessments and referral pathways for adults with gait unsteadiness?
NG127_Recommendations for adults aged over 16: 1.5 Handwriting difficulties & Recommendations for adults aged over 16: 1.6 Headaches in adults,NG127,What are the recommended assessments and referral criteria for adults with unexplained handwriting difficulties?
NG127_Recommendations for adults aged over 16: 1.7 Limb or facial weakness in adults - Part 1,NG127,What are the causes and management strategies for recurrent limb or facial weakness in functional neurological disorder?
NG127_Recommendations for adults aged over 16: 1.7 Limb or facial weakness in adults - Part 2,NG127,What are the recommended management and referral criteria for adults with functional neurological disorder presenting with limb weakness?
NG127_Recommendations for adults aged over 16: 1.8 Memory failure and cognitive deterioration - Part 1,NG127,What are the recommended assessments for progressive memory problems in adults?
NG127_Recommendations for adults aged over 16: 1.8 Memory failure and cognitive deterioration - Part 2,NG127,What are the referral criteria for adults with dense amnesia according to NICE guidelines?
NG127_Recommendations for adults aged over 16: 1.9 Posture distortion in adults,NG127,What are the signs and management options for cervical dystonia in adults?
NG127_Recommendations for adults aged over 16: 1.10 Sensory symptoms including tingling or numbness in adults - Part 1,NG127,"What are the recommended assessments for sensory symptoms such as numbness, tingling, or altered sensation in adults?"
NG127_Recommendations for adults aged over 16: 1.10 Sensory symptoms including tingling or numbness in adults - Part 2,NG127,What are the recommended assessments and management strategies for cervical or lumbar radiculopathy?
NG127_Recommendations for adults aged over 16: 1.10 Sensory symptoms including tingling or numbness in adults - Part 3,NG127,When should adults with stable cervical or lumbar radiculopathy be referred for specialist assessment?
NG127_Recommendations for adults aged over 16: 1.11 Sleep disorders in adults,NG127,What are the recommended approaches for managing sleep disorders in adults according to NICE guidelines?
NG127_Recommendations for adults aged over 16: 1.12 Smell or taste problems,NG127,What are the recommended assessments for adults with sudden or persistent smell or taste disturbances?
"NG127_Recommendations for adults aged over 16: 1.13 Speech, swallowing and language problems in adults - Part 1",NG127,What are the recommended referral procedures for adults with sudden-onset speech or language disturbances?
"NG127_Recommendations for adults aged over 16: 1.13 Speech, swallowing and language problems in adults - Part 2",NG127,What are the causes of persistent dysphonia and how should it be evaluated?
NG127_Recommendations for adults aged over 16: 1.14 Tics and involuntary movements in adults,NG127,What are the recommended management and referral criteria for tics and involuntary movements in adults?
NG127_Recommendations for adults aged over 16: 1.15 Tremor in adults,NG127,What are the recommended assessments and management strategies for adult tremor suspected to be essential tremor or Parkinson's disease?
NG127_Recommendations for adults aged over 16: 1.16 Information and support & Recommendations for children aged under 16,NG127,What information and support should be provided to adults with suspected neurological conditions according to NICE guidelines?
"NG127_Recommendations for children aged under 16: 1.17 Attention, concentration and memory problems",NG127,"What are the recommended approaches for managing attention, concentration, and memory problems in children with epilepsy?"
NG127_Recommendations for children aged under 16: 1.18 Blackouts and other paroxysmal events,NG127,What are the recommended assessment and referral procedures for children under 12 experiencing blackouts?
"NG127_Recommendations for children aged under 16: 1.19 Confusion, acute",NG127,What should be done when a child presents with unexplained acute confusion?
NG127_Recommendations for children aged under 16: 1.20 Dizziness and vertigo in children,NG127,What are the causes and management of dizziness and vertigo in children?
NG127_Recommendations for children aged under 16: 1.21 Headaches in children - Part 1,NG127,What are the urgent referral criteria for headaches in children under 12 years?
NG127_Recommendations for children aged under 16: 1.21 Headaches in children - Part 2,NG127,How should recurrent headache in children be evaluated for underlying hypertension?
NG127_Recommendations for children aged under 16: 1.22 Head shape or size abnormalities - Part 1,NG127,What are the recommended steps for assessing abnormal head size in children under 4 years old?
NG127_Recommendations for children aged under 16: 1.22 Head shape or size abnormalities - Part 2,NG127,What are the recommended assessments and management strategies for positional plagiocephaly in infants under 1 year?
NG127_Recommendations for children aged under 16: 1.23 Hypotonia ('floppiness'),NG127,What are the recommended clinical assessments for infants under 1 year presenting with hypotonia or floppiness?
NG127_Recommendations for children aged under 16: 1.24 Limb or facial weakness in children,NG127,What are the recommended assessments and referral criteria for children presenting with sudden or progressive limb or facial weakness?
"NG127_Recommendations for children aged under 16: 1.25 Motor development delay or regression, and unsteadiness",NG127,What are the recommended assessments and referral pathways for children with motor development delay or regression?
NG127_Recommendations for children aged under 16: 1.26 Posture distortion in children,NG127,What are the recommended assessments and referral criteria for children with abnormal neck posture following head or neck trauma?
NG127_Recommendations for children aged under 16: 1.27 Sensory symptoms such as tingling or numbness in children,NG127,What are the indications for neurological assessment in children with tingling or numbness?
NG127_Recommendations for children aged under 16: 1.28 Sleep disorders in children - Part 1,NG127,What are the signs of sleep disorders that require urgent referral in children?
NG127_Recommendations for children aged under 16: 1.28 Sleep disorders in children - Part 2,NG127,What advice should I give to parents about sleep hygiene for children with insomnia?
NG127_Recommendations for children aged under 16: 1.29 Speech problems in children,NG127,What are the recommended actions for children with new-onset slurred or disrupted speech?
NG127_Recommendations for children aged under 16: 1.30 Squint,NG127,What are the recommended referral criteria for children with new-onset squint?
NG127_Recommendations for children aged under 16: 1.31 Tics and involuntary movements in children,NG127,What are the recommended management and referral criteria for tics and involuntary movements in children?
NG127_Recommendations for children aged under 16: 1.32 Tremor in children,NG127,What are the recommended assessments and management strategies for tremor in children?
NG127_Terms used in this guideline & Rationale: recommendations for adults aged over 16: Blackouts in adults,NG127,What are the recommended referral pathways for patients presenting with dizziness or suspected neurological disorders?
NG127_Rationale: recommendations for adults aged over 16: Dizziness and vertigo in adults - Part 1,NG127,What are the recommended clinical assessments for differentiating benign vestibular vertigo from stroke in adults with sudden-onset dizziness?
NG127_Rationale: recommendations for adults aged over 16: Dizziness and vertigo in adults - Part 2,NG127,What are the causes and management strategies for sudden-onset dizziness with no neurological deficits?
"NG127_Rationale: recommendations for adults aged over 16: Facial pain, atraumatic",NG127,What are the signs and symptoms indicating the need for urgent referral in atraumatic facial pain?
NG127_Rationale: recommendations for adults aged over 16: Gait unsteadiness & Rationale: recommendations for adults aged over 16: Handwriting difficulties,NG127,What are the causes and management of gait unsteadiness in adults?
NG127_Rationale: recommendations for adults aged over 16: Limb or facial weakness in adults - Part 1,NG127,What are the signs and urgent management steps for sudden-onset limb or facial weakness suggesting stroke?
NG127_Rationale: recommendations for adults aged over 16: Limb or facial weakness in adults - Part 2,NG127,What are the causes and management options for lower limb claudication without vascular disease?
NG127_Rationale: recommendations for adults aged over 16: Memory failure and cognitive deterioration,NG127,What are the recommended approaches for assessing memory failure and cognitive deterioration in adults?
NG127_Rationale: recommendations for adults aged over 16: Posture distortion in adults,NG127,What are the clinical features and management of cervical dystonia in adults?
NG127_Rationale: recommendations for adults aged over 16: Sensory symptoms including tingling or numbness in adults - Part 1,NG127,What are the recommended assessments and management strategies for sensory symptoms like tingling or numbness in adults?
NG127_Rationale: recommendations for adults aged over 16: Sensory symptoms including tingling or numbness in adults - Part 2,NG127,What are the causes of numbness and tingling in the limbs and when should I seek specialist assessment?
NG127_Rationale: recommendations for adults aged over 16: Sleep disorders in adults,NG127,What are the recommended assessments for sleep disorders in adults?
NG127_Rationale: recommendations for adults aged over 16: Smell or taste problems,NG127,What are the recommended assessments and management for smell or taste problems in adults?
"NG127_Rationale: recommendations for adults aged over 16: Speech, swallowing and language problems in adults",NG127,What are the signs and symptoms of speech and language problems that require urgent assessment in adults?
NG127_Rationale: recommendations for adults aged over 16: Tics and involuntary movements in adults,NG127,What are the recommended management strategies for tics and involuntary movements in adults?
NG127_Rationale: recommendations for adults aged over 16: Tremor in adults,NG127,How can I differentiate between Parkinson's disease tremor and essential tremor in adults?
NG127_Rationale: recommendations for adults aged over 16: Information and support,NG127,What information and support should healthcare professionals provide to adults presenting with neurological symptoms?
"NG127_Rationale: recommendations for children aged under 16: Attention, concentration and memory problems",NG127,"What are the recommended approaches for assessing attention, concentration, and memory problems in children with suspected epilepsy?"
NG127_Rationale: recommendations for children aged under 16: Blackouts and other paroxysmal events,NG127,What are the recommended assessments for children under 12 experiencing blackouts or transient loss of consciousness?
"NG127_Rationale: recommendations for children aged under 16: Confusion, acute",NG127,What are the emergency management steps for acute confusion in children?
NG127_Rationale: recommendations for children aged under 16: Dizziness and vertigo in children,NG127,What are the causes and recommended assessments for dizziness in children?
NG127_Rationale: recommendations for children aged under 16: Headaches in children,NG127,What are the red flag symptoms indicating serious intracranial pathology in children with headaches?
NG127_Rationale: recommendations for children aged under 16: Head shape or size abnormalities,NG127,What are the recommended approaches for assessing head shape abnormalities in children under 4 years old?
NG127_Rationale: recommendations for children aged under 16: Hypotonia ('floppiness') & Rationale: recommendations for children aged under 16: Limb or facial weakness in children,NG127,What are the signs and urgent referral criteria for hypotonia and limb weakness in infants and children?
NG127_Rationale: recommendations for children aged under 16: Motor development delay and unsteadiness,NG127,What are the recommended assessments for motor development delay and unsteadiness in children?
NG127_Rationale: recommendations for children aged under 16: Posture distortion in children,NG127,What are the recommended assessments for abnormal posture in children with no recent trauma?
NG127_Rationale: recommendations for children aged under 16: Sensory symptoms such as tingling or numbness in children,NG127,What are the indications for urgent referral in children with tingling or numbness symptoms?
NG127_Rationale: recommendations for children aged under 16: Sleep disorders in children - Part 1,NG127,What are the signs and symptoms of sleep disorders in children with neuromuscular conditions?
NG127_Rationale: recommendations for children aged under 16: Sleep disorders in children - Part 2,NG127,What are the recommended approaches for diagnosing and managing sleep disorders in children?
NG127_Rationale: recommendations for children aged under 16: Speech problems in children,NG127,What are the signs that require urgent neurological assessment in children with new-onset slurred or disrupted speech?
NG127_Rationale: recommendations for children aged under 16: Squint,NG127,When should children with squint be urgently referred to ophthalmology?
NG127_Rationale: recommendations for children aged under 16: Tics and involuntary movements in children,NG127,What are the recommended management strategies for tics and involuntary movements in children?
NG127_Rationale: recommendations for children aged under 16: Tremor in children,NG127,When should children with tremor be referred for neurological assessment?
NG127_Context,NG127,What are the criteria for referring patients with neurological symptoms in primary care?
NG128_Stroke and transient ischaemic attack in over 16s: diagnosis and initial management & Overview & Recommendations: 1.1 Rapid recognition of symptoms and diagnosis - Part 1,NG128,What is the recommended initial management for suspected transient ischaemic attack (TIA)?
NG128_Recommendations: 1.1 Rapid recognition of symptoms and diagnosis - Part 2,NG128,What is the recommended urgent referral process for suspected transient ischemic attack (TIA)?
NG128_Recommendations: 1.2 Imaging for people who have had a suspected TIA or acute non-disabling stroke - Part 1,NG128,What imaging is recommended for suspected TIA and non-disabling stroke?
NG128_Recommendations: 1.2 Imaging for people who have had a suspected TIA or acute non-disabling stroke - Part 2,NG128,What are the criteria for carotid endarterectomy in patients with symptomatic carotid stenosis?
NG128_Recommendations: 1.3 Specialist care for people with acute stroke,NG128,What is the recommended process for imaging in acute stroke assessment?
NG128_Recommendations: 1.4 Pharmacological treatments and thrombectomy for people with acute stroke - Part 1,NG128,What are the criteria and timing for thrombolysis and thrombectomy in acute ischemic stroke management?
NG128_Recommendations: 1.4 Pharmacological treatments and thrombectomy for people with acute stroke - Part 2,NG128,What are the criteria for offering thrombectomy and thrombolysis in acute ischemic stroke patients within 24 hours of symptom onset?
NG128_Recommendations: 1.4 Pharmacological treatments and thrombectomy for people with acute stroke - Part 3,NG128,"What are the recommended treatments for acute stroke, including use of aspirin, anticoagulation, and management of haemorrhagic versus ischaemic stroke?"
NG128_Recommendations: 1.4 Pharmacological treatments and thrombectomy for people with acute stroke - Part 4,NG128,What is the recommended method for reversing warfarin in patients with intracerebral haemorrhage?
NG128_Recommendations: 1.5 Maintenance or restoration of homeostasis - Part 1,NG128,What are the recommendations for oxygen therapy and blood pressure management in acute stroke patients?
NG128_Recommendations: 1.5 Maintenance or restoration of homeostasis - Part 2,NG128,When should blood pressure be lowered in patients with acute intracerebral hemorrhage or ischemic stroke?
NG128_Recommendations: 1.6 Nutrition and hydration - Part 1,NG128,What are the recommended procedures for assessing and managing swallowing and nutrition in patients with acute stroke?
NG128_Recommendations: 1.6 Nutrition and hydration - Part 2,NG128,What are the recommended methods for screening and managing malnutrition in stroke patients?
NG128_Recommendations: 1.7 Optimal positioning and early mobilisation for people with acute stroke & Recommendations: 1.8 Avoiding aspiration pneumonia,NG128,What are the recommendations for positioning and early mobilisation in acute stroke care?
NG128_Recommendations: 1.9 Surgery for people with acute stroke - Part 1,NG128,When should surgical intervention be considered for acute intracerebral haemorrhage?
NG128_Recommendations: 1.9 Surgery for people with acute stroke - Part 2,NG128,What are the criteria for considering decompressive hemicraniectomy in patients with large middle cerebral artery infarcts?
NG128_Recommendations: Terms used in this guideline,NG128,What is high-intensity mobilisation and its role in early stroke rehabilitation?
NG128_Additional information,NG128,What is the recommended time frame for initiating statin therapy after an acute ischemic stroke?
NG128_Recommendations for research: Key recommendations for research - Part 1,NG128,What is the evidence for early MRI brain scanning improving outcomes after suspected transient ischaemic attack?
NG128_Recommendations for research: Key recommendations for research - Part 2,NG128,Does withdrawal or modification of oral fluids prevent aspiration pneumonia after stroke?
NG128_Recommendations for research: Key recommendations for research - Part 3,NG128,What is the recommended aspirin dose for secondary prevention after acute ischemic stroke or TIA in patients already taking aspirin?
NG128_Rationale and impact: Initial management of suspected and confirmed transient ischaemic attack (aspirin),NG128,What is the recommended initial management of suspected transient ischaemic attack with aspirin?
NG128_Rationale and impact: Initial management of suspected and confirmed transient ischaemic attack - Part 1,NG128,What is the recommended timing for specialist assessment in suspected transient ischaemic attack?
NG128_Rationale and impact: Initial management of suspected and confirmed transient ischaemic attack - Part 2,NG128,What are the recommended urgent assessment and management procedures for suspected TIA?
NG128_Rationale and impact: Imaging for people who have had a suspected TIA or acute non-disabling stroke - Part 1,NG128,What is the recommended use of CT imaging for suspected transient ischemic attack or non-disabling stroke?
NG128_Rationale and impact: Imaging for people who have had a suspected TIA or acute non-disabling stroke - Part 2,NG128,What are the criteria for using MRI in the assessment of transient ischemic attack patients?
NG128_Rationale and impact: Thrombectomy for people with acute ischaemic stroke - Part 1,NG128,What are the indications and timing for thrombectomy in acute ischemic stroke patients?
NG128_Rationale and impact: Thrombectomy for people with acute ischaemic stroke - Part 2,NG128,What are the criteria and considerations for performing thrombectomy in acute ischemic stroke patients?
NG128_Rationale and impact: Thrombectomy for people with acute ischaemic stroke - Part 3,NG128,What are the current NICE guidelines for thrombectomy in posterior circulation stroke within 24 hours?
NG128_Rationale and impact: Blood pressure control for people with acute intracerebral haemorrhage - Part 1,NG128,What are the recommended blood pressure targets and management strategies for acute intracerebral haemorrhage?
NG128_Rationale and impact: Blood pressure control for people with acute intracerebral haemorrhage - Part 2,NG128,What are the current recommendations for rapid blood pressure lowering in acute intracerebral haemorrhage?
NG128_Rationale and impact: Blood pressure control for people with acute intracerebral haemorrhage - Part 3,NG128,What is the evidence on the impact of intensive blood pressure lowering on quality of life and cognitive function in patients with hypertension?
NG128_Rationale and impact: Optimal positioning for people with acute stroke,NG128,What is the recommended positioning for patients with acute stroke?
NG128_Rationale and impact: Early mobilisation for people with acute stroke,NG128,What are the NICE guidelines on early mobilisation timing and intensity for acute stroke patients?
NG128_Rationale and impact: Decompressive hemicraniectomy for people with acute stroke - Part 1,NG128,What are the indications and considerations for decompressive hemicraniectomy in acute stroke patients?
NG128_Rationale and impact: Decompressive hemicraniectomy for people with acute stroke - Part 2,NG128,What are the current NICE recommendations for timing and eligibility criteria for decompressive hemicraniectomy after stroke?
NG128_Context - Part 1,NG128,What are the current NICE recommendations for acute stroke management and secondary prevention?
NG128_Context - Part 2,NG128,What are the recommended acute management and care pathways for adults with suspected or confirmed stroke or TIA?
NG128_Finding more information and resources,NG128,Where can I find additional resources and detailed evidence on NICE guidance for cardiovascular conditions?
NG129_Crohn’s disease: management & Overview,NG129,What are the recommended management strategies for Crohn's disease in children and adults?
NG129_Recommendations: 1.1 Providing information and support,NG129,"What information and support should be provided to patients with Crohn's disease regarding treatment options, side effects, and lifestyle considerations?"
NG129_Recommendations: 1.2 Inducing remission in Crohn's disease - Part 1,NG129,What are the recommended treatments for inducing remission in Crohn's disease?
NG129_Recommendations: 1.2 Inducing remission in Crohn's disease - Part 2,NG129,What are the recommended treatments for severe Crohn's disease exacerbations according to NICE guidelines?
NG129_Recommendations: 1.2 Inducing remission in Crohn's disease - Part 3,NG129,When should methotrexate be added to corticosteroid therapy for Crohn's disease?
NG129_Recommendations: 1.2 Inducing remission in Crohn's disease - Part 4,NG129,What are the recommended treatment options and considerations for using infliximab or adalimumab in Crohn's disease management?
NG129_Recommendations: 1.2 Inducing remission in Crohn's disease - Part 5,NG129,What are the criteria for prescribing infliximab for children with severe active Crohn's disease?
NG129_Recommendations: 1.3 Maintaining remission in Crohn's disease - Part 1,NG129,What are the recommended follow-up and monitoring strategies for patients with Crohn's disease who opt for no maintenance treatment?
NG129_Recommendations: 1.3 Maintaining remission in Crohn's disease - Part 2,NG129,When should azathioprine or mercaptopurine be used to maintain remission in inflammatory bowel disease?
NG129_Recommendations: 1.4 Maintaining remission in Crohn's disease after surgery - Part 1,NG129,What are the recommended strategies for maintaining remission in Crohn's disease after surgery according to NICE guidelines?
NG129_Recommendations: 1.4 Maintaining remission in Crohn's disease after surgery - Part 2,NG129,Should biologics or budesonide be used to maintain remission after complete ileocolonic Crohn's disease resection?
NG129_Recommendations: 1.5 Surgery,NG129,When should surgery be considered for Crohn's disease limited to the distal ileum?
NG129_Recommendations: 1.6 Monitoring for osteopenia and assessing fracture risk & Recommendations: 1.7 Conception and pregnancy & Recommendations: Terms used in this guideline,NG129,What are the recommendations for monitoring bone mineral density in children and young people with risk factors for osteoporosis?
NG129_Recommendations for research,NG129,What are the benefits and risks of enteral nutrition for maintaining remission after Crohn's disease surgery?
NG129_Rationale and impact: Maintaining remission in Crohn's disease after surgery - Part 1,NG129,What are the recommended medications for maintaining remission after surgery in Crohn's disease?
NG129_Rationale and impact: Maintaining remission in Crohn's disease after surgery - Part 2,NG129,What are the recommended treatments for maintaining remission after Crohn's disease surgery?
NG129_Context,NG129,What are the recommended treatment options for inducing and maintaining remission in Crohn's disease?
NG129_Finding more information and resources,NG129,Where can I find additional resources and evidence for NICE guidelines on inflammatory bowel disease?
NG12_Suspected cancer: recognition and referral & Overview,NG12,What are the recommended criteria for referring patients with suspected cancer in primary care?
NG12_Introduction,NG12,What are the key signs of child maltreatment that healthcare professionals should recognize?
NG12_Recommendations organised by site of cancer: 1.1 Lung and pleural cancers,NG12,What are the indications for urgent chest X-ray referral in suspected lung cancer and mesothelioma?
NG12_Recommendations organised by site of cancer: 1.2 Upper gastrointestinal tract cancers - Part 1,NG12,"What are the referral criteria for suspected oesophageal, pancreatic, and stomach cancers according to NICE guidelines?"
NG12_Recommendations organised by site of cancer: 1.2 Upper gastrointestinal tract cancers - Part 2,NG12,"What are the indications for suspected stomach, gall bladder, and liver cancer referrals and investigations?"
NG12_Recommendations organised by site of cancer: 1.3 Lower gastrointestinal tract cancers - Part 1,NG12,What are the criteria for using faecal immunochemical testing (FIT) to refer adults for suspected colorectal cancer?
NG12_Recommendations organised by site of cancer: 1.3 Lower gastrointestinal tract cancers - Part 2,NG12,What are the criteria for suspected colorectal and anal cancer referrals based on FIT results and clinical symptoms?
NG12_Recommendations organised by site of cancer: 1.4 Breast cancer,NG12,When should I refer a patient for suspected breast cancer based on age and symptoms?
NG12_Recommendations organised by site of cancer: 1.5 Gynaecological cancers - Part 1,NG12,What are the criteria for referring women with suspected ovarian cancer to specialist services?
NG12_Recommendations organised by site of cancer: 1.5 Gynaecological cancers - Part 2,NG12,What tests are recommended for ovarian cancer in women aged 50 or over with symptoms suggestive of IBS?
NG12_Recommendations organised by site of cancer: 1.5 Gynaecological cancers - Part 3,NG12,"What are the referral criteria for suspected endometrial, cervical, vulval, or vaginal cancer in women?"
NG12_Recommendations organised by site of cancer: 1.6 Urological cancers - Part 1,NG12,What are the indications for referring patients with suspected prostate or bladder cancer according to NICE guidelines?
NG12_Recommendations organised by site of cancer: 1.6 Urological cancers - Part 2,NG12,What are the indications for suspected urological cancers based on haematuria and other symptoms?
NG12_Recommendations organised by site of cancer: 1.7 Skin cancers - Part 1,NG12,What are the criteria for referring suspected melanoma using the 7-point checklist?
NG12_Recommendations organised by site of cancer: 1.7 Skin cancers - Part 2,NG12,When should suspected basal cell carcinomas be referred for specialist assessment?
NG12_Recommendations organised by site of cancer: 1.8 Head and neck cancers,NG12,What are the criteria for suspected head and neck cancer referrals in primary care?
NG12_Recommendations organised by site of cancer: 1.9 Brain and central nervous system cancers,NG12,What are the indications for urgent brain MRI or CT scan in adults with neurological decline?
NG12_Recommendations organised by site of cancer: 1.10 Haematological cancers - Part 1,NG12,What are the indications for urgent blood tests to diagnose leukaemia in adults and children?
NG12_Recommendations organised by site of cancer: 1.10 Haematological cancers - Part 2,NG12,What are the referral criteria for suspected non-Hodgkin's lymphoma in adults and children?
NG12_Recommendations organised by site of cancer: 1.11 Sarcomas,NG12,"What are the recommended referral pathways for suspected bone or soft tissue sarcoma in children, young people, and adults?"
NG12_Recommendations organised by site of cancer: 1.12 Childhood cancers,NG12,"What are the indications for urgent referral for childhood neuroblastoma, retinoblastoma, and Wilms' tumour?"
NG12_Recommendations organised by site of cancer: 1.13 Non-site-specific symptoms,NG12,What symptoms should prompt urgent investigation for suspected cancer in adults with unexplained weight loss or appetite loss?
"NG12_Recommendations on patient support, safety netting and the diagnostic process: 1.14 Patient information and support - Part 1",NG12,What information should be provided to patients and carers about suspected cancer referrals and diagnostic procedures?
"NG12_Recommendations on patient support, safety netting and the diagnostic process: 1.14 Patient information and support - Part 2 & Recommendations on patient support, safety netting and the diagnostic process: 1.15 Safety netting",NG12,How should healthcare professionals communicate cancer diagnosis and support information to patients from diverse cultural backgrounds?
"NG12_Recommendations on patient support, safety netting and the diagnostic process: 1.16 The diagnostic process",NG12,What are the recommended steps for the diagnostic process and referral management in suspected cancer cases?
NG12_Recommendations organised by symptom and findings of primary care investigations: Abdominal symptoms - Part 1,NG12,What are the recommended investigations for ovarian cancer in women with persistent abdominal distension?
NG12_Recommendations organised by symptom and findings of primary care investigations: Abdominal symptoms - Part 2,NG12,"What are the recommended investigations for abdominal, pelvic, or rectal masses suspected of being cancer?"
NG12_Recommendations organised by symptom and findings of primary care investigations: Abdominal symptoms - Part 3,NG12,What are the recommended investigations for abdominal or pelvic pain suggestive of cancer in adults?
NG12_Recommendations organised by symptom and findings of primary care investigations: Abdominal symptoms - Part 4,NG12,What are the recommended investigations for suspected gastrointestinal or ovarian cancer in patients with change in bowel habit or dyspepsia?
NG12_Recommendations organised by symptom and findings of primary care investigations: Abdominal symptoms - Part 5,NG12,What are the recommended investigations for suspected oesophageal or stomach cancer in patients with dysphagia or reflux?
NG12_Recommendations organised by symptom and findings of primary care investigations: Bleeding - Part 1,NG12,"What are the recommended investigations for unexplained bleeding, bruising, or petechiae in primary care?"
NG12_Recommendations organised by symptom and findings of primary care investigations: Bleeding - Part 2,NG12,What are the recommended investigations for post-menopausal bleeding in women over 55?
NG12_Recommendations organised by symptom and findings of primary care investigations: Gynaecological symptoms,NG12,What are the recommended investigations for unexplained vaginal discharge in women aged 55 and over?
NG12_Recommendations organised by symptom and findings of primary care investigations: Lumps or masses - Part 1,NG12,What are the recommended assessments and referral pathways for unexplained lumps or masses suspected of being cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Lumps or masses - Part 2 & Recommendations organised by symptom and findings of primary care investigations: Lumps or masses - Part 3,NG12,What are the recommended referral pathways for unexplained lymphadenopathy in adults?
NG12_Recommendations organised by symptom and findings of primary care investigations: Neurological symptoms in adults,NG12,What are the recommended investigations for progressive neurological symptoms in adults suspected of brain cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Pain,NG12,What are the recommended investigations for persistent back pain in adults over 60?
NG12_Recommendations organised by symptom and findings of primary care investigations: Respiratory symptoms - Part 1,NG12,What are the recommended investigations for suspected lung or mesothelioma cancer in patients with unexplained chest symptoms aged 40 and over?
NG12_Recommendations organised by symptom and findings of primary care investigations: Respiratory symptoms - Part 2,NG12,What are the recommended investigations for suspected lung or mesothelioma cancer in patients with unexplained shortness of breath and chest signs?
NG12_Recommendations organised by symptom and findings of primary care investigations: Skeletal symptoms,NG12,"What are the signs of cancer in older adults with back pain, bone pain, or unexplained fractures?"
NG12_Recommendations organised by symptom and findings of primary care investigations: Skin or surface symptoms,NG12,What are the recommended actions for unexplained skin lesions or surface symptoms suggestive of cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Urological symptoms - Part 1,NG12,What are the recommended investigations for urological symptoms suggestive of cancer in primary care?
NG12_Recommendations organised by symptom and findings of primary care investigations: Urological symptoms - Part 2,NG12,What are the recommended investigations for testicular changes suspected of cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Non‑specific features of cancer - Part 1,NG12,What are the recommended investigations for unexplained appetite loss in women aged 50 and over?
NG12_Recommendations organised by symptom and findings of primary care investigations: Non‑specific features of cancer - Part 2,NG12,"What are the recommended investigations for suspected cancer in patients presenting with deep vein thrombosis, new-onset diabetes with weight loss, or unexplained fatigue?"
NG12_Recommendations organised by symptom and findings of primary care investigations: Non‑specific features of cancer - Part 3,NG12,What are the recommended investigations for unexplained fever and persistent infection in adults?
NG12_Recommendations organised by symptom and findings of primary care investigations: Non‑specific features of cancer - Part 4,NG12,What are the indications for suspected lymphoma referral in adults presenting with night sweats and lymphadenopathy?
NG12_Recommendations organised by symptom and findings of primary care investigations: Non‑specific features of cancer - Part 5,NG12,What are the recommended investigations for unexplained weight loss in adults to screen for cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Primary care investigations - Part 1,NG12,What are the recommended investigations for suspected cancer based on blood test findings in primary care?
NG12_Recommendations organised by symptom and findings of primary care investigations: Primary care investigations - Part 2,NG12,What are the dermoscopy features suggestive of melanoma in skin examinations?
NG12_Recommendations organised by symptom and findings of primary care investigations: Primary care investigations - Part 3,NG12,"What are the indications for referring patients with suspected cancer based on digital rectal exam, faecal tests, and imaging findings?"
NG12_Recommendations organised by symptom and findings of primary care investigations: Primary care investigations - Part 4,NG12,What are the indications for referring a patient with jaundice over 40 for suspected pancreatic cancer?
NG12_Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 1,NG12,What are the symptoms in children that suggest urgent referral for possible leukemia or other cancers?
NG12_Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 2,NG12,What are the urgent referral criteria for suspected lymphoma or sarcoma in children and young people with lymphadenopathy or enlarging lumps?
NG12_Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 3,NG12,What are the recommended investigations for unexplained bone pain and swelling in children and young people?
NG12_Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 4,NG12,What are the symptoms that require urgent referral for suspected lymphoma or leukemia in children and young people?
NG12_Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 5 & Recommendations organised by symptom and findings of primary care investigations: Symptoms in children and young people - Part 6,NG12,What are the signs and referral recommendations for suspected childhood retinoblastoma?
NG12_Terms used in this guideline,NG12,What are the definitions of urgent and very urgent referrals in cancer diagnosis according to NICE guidelines?
NG12_Recommendations for research,NG12,What is the diagnostic accuracy of age-adjusted and fixed PSA thresholds for detecting prostate cancer in symptomatic men?
NG12_Rationale and impact: Prostate-specific antigen testing for prostate cancer - Part 1,NG12,What are the current recommendations for prostate-specific antigen testing and referral thresholds for prostate cancer?
NG12_Rationale and impact: Prostate-specific antigen testing for prostate cancer - Part 2 & Context - Part 1,NG12,What are the recommended age-specific PSA thresholds for prostate cancer referral in primary care?
NG12_Context - Part 2,NG12,What is the recommended risk threshold for suspected cancer referrals in primary care?
NG130_Ulcerative colitis: management & Overview & Recommendations: 1.1 Patient information and support,NG130,What information should be provided to patients and families about ulcerative colitis management and surveillance?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 1,NG130,What is the recommended initial treatment for mild-to-moderate proctosigmoiditis and left-sided ulcerative colitis?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 2,NG130,What is the recommended initial treatment for inducing remission in mild-to-moderate ulcerative colitis?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 3,NG130,What are the recommended treatment options for moderately to severely active ulcerative colitis after conventional therapy failure?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 4,NG130,What are the alternative biological treatments for moderately to severely active ulcerative colitis if previous biological therapy has failed or is not tolerated?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 5,NG130,What are the NICE recommendations for using etrasimod and infliximab in treating ulcerative colitis in children and young people?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 6,NG130,What is the recommended management and treatment review process for ulcerative colitis according to NICE guidelines?
NG130_Recommendations: 1.2 Inducing remission in people with ulcerative colitis - Part 7,NG130,What are the indications for adding intravenous ciclosporin or considering surgery in severe ulcerative colitis?
NG130_Recommendations: 1.3 Information about treatment options for people who are considering surgery,NG130,"What information should be provided to patients with ulcerative colitis considering surgery about treatment options, risks, and postoperative management?"
NG130_Recommendations: 1.4 Maintaining remission in people with ulcerative colitis - Part 1,NG130,What are the recommended options for maintaining remission in ulcerative colitis after a mild-to-moderate flare?
NG130_Recommendations: 1.4 Maintaining remission in people with ulcerative colitis - Part 2,NG130,What are the recommended medications and dosing strategies for maintaining remission in ulcerative colitis?
NG130_Recommendations: 1.5 Pregnant women & Recommendations: 1.6 Monitoring - Part 1,NG130,What are the recommended monitoring procedures for bone health and growth in children and young people with ulcerative colitis?
NG130_Recommendations: 1.6 Monitoring - Part 2,NG130,What are the recommended methods for monitoring pubertal development in young people with ulcerative colitis?
NG130_Recommendations: Terms used in this guideline - Part 1,NG130,What are the biological treatments and JAK inhibitors used for ulcerative colitis management?
NG130_Recommendations: Terms used in this guideline - Part 2,NG130,What is the recommended duration of oral corticosteroid therapy for active paediatric ulcerative colitis?
NG130_Recommendations for research: Key recommendations for research,NG130,What is the effectiveness of topical immunomodulators like tacrolimus in inducing remission in proctitis resistant to standard treatment?
NG130_Recommendations for research: Other recommendations for research from the 2019 update,NG130,What are the most effective treatment options for inducing remission in moderate and refractory ulcerative colitis?
NG130_Recommendations for research: Other recommendations for research from the 2013 guideline - Part 1,NG130,"What are the benefits and risks of methotrexate, ciclosporin, tacrolimus, adalimumab, and infliximab for inducing remission in refractory subacute ulcerative colitis?"
NG130_Recommendations for research: Other recommendations for research from the 2013 guideline - Part 2,NG130,What are the most accurate risk assessment tools for predicting the need for surgery in adults with acute severe ulcerative colitis?
NG130_Rationale and impact: Inducing remission in people with mild-to-moderate ulcerative colitis - Part 1,NG130,What are the recommended treatments for inducing remission in mild-to-moderate ulcerative colitis?
NG130_Rationale and impact: Inducing remission in people with mild-to-moderate ulcerative colitis - Part 2,NG130,What are the recommended treatment options for mild-to-moderate proctosigmoiditis or left-sided ulcerative colitis?
NG130_Rationale and impact: Inducing remission in people with mild-to-moderate ulcerative colitis - Part 3,NG130,What is the most effective first-line treatment for mild-to-moderate extensive ulcerative colitis?
NG130_Rationale and impact: Inducing remission in people with mild-to-moderate ulcerative colitis - Part 4,NG130,What are the current NICE recommendations for using corticosteroids in mild-to-moderate ulcerative colitis?
NG130_Context - Part 1,NG130,What are the clinical features and management strategies for ulcerative colitis?
NG130_Context - Part 2,NG130,What are the recommended treatment options and management strategies for ulcerative colitis in adults and children?
"NG131_Prostate cancer: diagnosis and management & Overview & Recommendations: 1.1 Information and decision support for people with prostate cancer, their partners and carers - Part 1",NG131,What are the recommended approaches for providing information and decision support to patients with prostate cancer?
"NG131_Recommendations: 1.1 Information and decision support for people with prostate cancer, their partners and carers - Part 2",NG131,What are the recommended approaches for discussing treatment options and their impact on quality of life with people with prostate cancer?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 1,NG131,What are the recommendations for using multiparametric MRI and biopsy in diagnosing prostate cancer?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 2,NG131,What are the risks and disadvantages of prostate biopsy?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 3,NG131,What are the current recommendations for prostate biopsy and MRI in diagnosing prostate cancer?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 4,NG131,What are the recommended follow-up procedures after a negative prostate biopsy with elevated PSA and MRI findings?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 5,NG131,What are the recommended imaging and risk stratification methods for staging prostate cancer according to NICE guidelines?
NG131_Recommendations: 1.2 Assessment and diagnosis - Part 6,NG131,When should isotope bone scans be offered to men with localized prostate cancer?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 1,NG131,What are the treatment options and potential side effects for localized prostate cancer?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 2,NG131,"What are the long-term effects of active surveillance, prostatectomy, and radiotherapy on disease progression and metastasis in prostate cancer?"
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 3,NG131,"What are the long-term effects of active surveillance, radical prostatectomy, and radical radiotherapy on urinary incontinence, erectile dysfunction, and bowel function in localized prostate cancer?"
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 4,NG131,What are the recommended treatment options for localized prostate cancer according to NICE guidelines?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 5,NG131,What is the recommended protocol for active surveillance in prostate cancer management?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 6,NG131,What are the recommended radiotherapy options for localized prostate cancer according to NICE guidelines?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 7,NG131,What are the recommended treatment options for high-risk non-metastatic prostate cancer according to NICE guidelines?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 8,NG131,"What are the benefits and risks of using docetaxel chemotherapy for high-risk, non-metastatic prostate cancer?"
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 9,NG131,What are the side effects and management options for patients receiving docetaxel chemotherapy for prostate cancer?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 10,NG131,Should high-intensity focused ultrasound and cryotherapy be offered to patients with locally advanced prostate cancer outside of clinical trials?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 11,NG131,What are the recommended follow-up protocols for prostate cancer patients after radical treatment or on watchful waiting?
NG131_Recommendations: 1.3 Localised and locally advanced prostate cancer - Part 12,NG131,What are the recommended management strategies for biochemical relapse after radical prostate cancer treatment?
NG131_Recommendations: 1.4 People having hormone therapy - Part 1,NG131,What are the recommended management strategies for hot flushes and sexual dysfunction in men undergoing long-term androgen deprivation therapy?
NG131_Recommendations: 1.4 People having hormone therapy - Part 2,NG131,What are the treatment options for erectile dysfunction when PDE5 inhibitors are contraindicated or ineffective?
NG131_Recommendations: 1.5 Metastatic prostate cancer - Part 1,NG131,What are the recommended palliative care approaches for metastatic prostate cancer?
NG131_Recommendations: 1.5 Metastatic prostate cancer - Part 2,NG131,What are the recommended treatment options for metastatic prostate cancer according to NICE guidelines?
NG131_Recommendations: 1.5 Metastatic prostate cancer - Part 3,NG131,What are the criteria for prescribing docetaxel in hormone-refractory prostate cancer?
NG131_Recommendations: 1.5 Metastatic prostate cancer - Part 4,NG131,What are the recommended bone-targeted therapies for hormone-relapsed metastatic prostate cancer?
NG131_Recommendations: Terms used in this guideline - Part 1,NG131,What are the criteria for active surveillance in localized prostate cancer?
NG131_Recommendations: Terms used in this guideline - Part 2,NG131,What are the different surgical options for prostatectomy and their indications?
NG131_Recommendations for research: Key recommendations for research,NG131,What is the most effective follow-up protocol for patients under active surveillance for prostate cancer?
NG131_Recommendations for research: Other recommendations for research,NG131,What is the diagnostic accuracy of staging investigations for clinical stage 3 prostate cancer?
NG131_Rationale and impact: MRI and biopsy,NG131,What is the role of multiparametric MRI in guiding prostate biopsy and detecting clinically significant prostate cancer?
NG131_Rationale and impact: If the MRI or biopsy is negative - Part 1,NG131,What follow-up procedures are recommended after a negative MRI or prostate biopsy?
NG131_Rationale and impact: If the MRI or biopsy is negative - Part 2,NG131,What are the recommended follow-up strategies for patients with negative prostate biopsy and low-risk multiparametric MRI findings?
NG131_Rationale and impact: Risk stratification for localised or locally advanced prostate cancer,NG131,What is the recommended 5-tier risk stratification model for localized prostate cancer?
NG131_Rationale and impact: Bone scans for newly diagnosed prostate cancer,NG131,When should bone scans be used for staging in newly diagnosed prostate cancer patients?
NG131_Rationale and impact: Treatment options for localised and locally advanced prostate cancer - Part 1,NG131,What are the recommended treatment options for low-risk prostate cancer according to NICE guidelines?
NG131_Rationale and impact: Treatment options for localised and locally advanced prostate cancer - Part 2,NG131,What are the recommended treatment options for different risk groups in prostate cancer according to NICE guidelines?
NG131_Rationale and impact: Multiparametric MRI for active surveillance,NG131,How is multiparametric MRI used in active surveillance protocols for prostate cancer?
NG131_Rationale and impact: Radiotherapy - Part 1,NG131,What are the recommended radiotherapy options and dosing schedules for intermediate and high-risk prostate cancer?
NG131_Rationale and impact: Radiotherapy - Part 2,NG131,What are the current recommendations for using brachytherapy in high-risk localized prostate cancer?
NG131_Rationale and impact: Docetaxel chemotherapy,NG131,What are the indications and benefits of using docetaxel chemotherapy in prostate cancer treatment?
NG131_Rationale and impact: Follow up,NG131,What are the recommended follow-up strategies after radical treatment for localized or locally advanced prostate cancer?
NG131_Rationale and impact: Bone-targeted therapies (bisphosphonates),NG131,What are the current recommendations for using bisphosphonates like zoledronic acid in hormone-refractory metastatic prostate cancer?
NG131_Context - Part 1,NG131,What are the early detection and diagnosis strategies for prostate cancer?
NG131_Context - Part 2,NG131,What are the current NICE guidelines for the diagnosis and management of prostate cancer?
"NG132_Hyperparathyroidism (primary): diagnosis, assessment and initial management & Overview & Recommendations: 1.1 Diagnostic testing in primary care - Part 1",NG132,What are the recommended diagnostic tests for primary hyperparathyroidism?
NG132_Recommendations: 1.1 Diagnostic testing in primary care - Part 2,NG132,What are the recommended procedures for measuring parathyroid hormone and calcium levels in primary care?
NG132_Recommendations: 1.2 Testing and assessment in secondary care,NG132,What are the recommended tests for diagnosing and assessing primary hyperparathyroidism?
NG132_Recommendations: 1.3 Referral for surgery,NG132,When should patients with primary hyperparathyroidism be referred for parathyroid surgery?
NG132_Recommendations: 1.4 Surgical management - Part 1,NG132,What are the recommended preoperative imaging options for primary hyperparathyroidism surgery?
NG132_Recommendations: 1.4 Surgical management - Part 2,NG132,What are the criteria for determining successful surgery in primary hyperparathyroidism and recommended follow-up?
NG132_Recommendations: 1.5 Non-surgical management,NG132,What are the non-surgical treatment options for primary hyperparathyroidism?
NG132_Recommendations: 1.6 Monitoring - Part 1,NG132,What is the recommended monitoring schedule for patients with primary hyperparathyroidism?
NG132_Recommendations: 1.6 Monitoring - Part 2,NG132,When should specialist endocrine review be sought after parathyroid surgery for multigland disease or recurrence?
NG132_Recommendations: 1.7 Pregnancy,NG132,What is the recommended management of primary hyperparathyroidism during pregnancy?
NG132_Recommendations: 1.8 Information and support,NG132,What information should be provided to patients about primary hyperparathyroidism and its management?
NG132_Recommendations: Terms used in this guideline,NG132,What are the symptoms and management of hypercalcaemia in primary hyperparathyroidism?
NG132_Recommendations for research,NG132,What are the recommended management options for primary hyperparathyroidism during pregnancy?
NG132_Rationale and impact: Diagnostic testing in primary care - Part 1,NG132,What are the recommended diagnostic tests for primary hyperparathyroidism in primary care?
NG132_Rationale and impact: Diagnostic testing in primary care - Part 2,NG132,When should PTH measurement be considered in patients with suspected primary hyperparathyroidism?
NG132_Rationale and impact: Testing and assessment in secondary care,NG132,What are the recommended tests for diagnosing primary hyperparathyroidism in secondary care?
NG132_Rationale and impact: Referral for surgery,NG132,When should surgery be considered for patients with primary hyperparathyroidism?
NG132_Rationale and impact: Surgical management - Part 1,NG132,What are the recommended surgical options for managing primary hyperparathyroidism based on preoperative imaging results?
NG132_Rationale and impact: Surgical management - Part 2,NG132,What is the role of intraoperative PTH monitoring in parathyroid surgery?
NG132_Rationale and impact: Non-surgical management,NG132,What are the non-surgical treatment options for primary hyperparathyroidism?
NG132_Rationale and impact: Monitoring,NG132,What is the recommended monitoring schedule for serum calcium levels after parathyroid surgery?
NG132_Rationale and impact: Pregnancy & Rationale and impact: Information and support,NG132,What are the recommended management strategies for primary hyperparathyroidism during pregnancy?
NG132_Context,NG132,What are the diagnostic and management guidelines for primary hyperparathyroidism?
NG133_Hypertension in pregnancy: diagnosis and management & Overview,NG133,What are the recommended management strategies for hypertension in pregnancy according to NICE guidelines?
NG133_Recommendations: 1.1 Reducing the risk of hypertensive disorders in pregnancy - Part 1,NG133,What are the symptoms of pre-eclampsia and when should pregnant women seek medical advice?
NG133_Recommendations: 1.1 Reducing the risk of hypertensive disorders in pregnancy - Part 2,NG133,What are the recommendations for aspirin use to prevent pre-eclampsia in pregnant women with moderate risk factors?
NG133_Recommendations: 1.2 Assessment of proteinuria in hypertensive disorders of pregnancy,NG133,What are the recommended methods for assessing proteinuria in pregnant women with hypertensive disorders?
NG133_Recommendations: 1.3 Management of chronic hypertension in pregnancy - Part 1,NG133,What are the recommended management strategies for chronic hypertension in pregnancy?
NG133_Recommendations: 1.3 Management of chronic hypertension in pregnancy - Part 2,NG133,What are the recommended management strategies for hypertension in pregnant women according to NICE guidelines?
NG133_Recommendations: 1.3 Management of chronic hypertension in pregnancy - Part 3,NG133,Should aspirin be prescribed for pre-eclampsia prevention in pregnancy in the UK?
NG133_Recommendations: 1.3 Management of chronic hypertension in pregnancy - Part 4,NG133,What are the recommended postnatal blood pressure monitoring and management for women with chronic hypertension?
NG133_Recommendations: 1.4 Management of gestational hypertension - Part 1,NG133,What are the recommended management and treatment options for gestational hypertension?
NG133_Recommendations: 1.4 Management of gestational hypertension - Part 2,NG133,What are the recommended management options for gestational hypertension according to NICE guidelines?
NG133_Recommendations: 1.4 Management of gestational hypertension - Part 3,NG133,What are the NICE guidelines for timing of birth and postnatal management in women with gestational hypertension?
NG133_Recommendations: 1.4 Management of gestational hypertension - Part 4,NG133,When should antihypertensive treatment be started or adjusted after delivery in women with gestational hypertension?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 1,NG133,What are the recommended methods for assessing pre-eclampsia in pregnant women?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 2,NG133,What are the recommended management strategies for pre-eclampsia in pregnancy?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 3,NG133,What are the recommended antihypertensive treatments for pregnant women with pre-eclampsia?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 4,NG133,What are the recommended timings and considerations for planned birth in women with pre-eclampsia?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 5,NG133,What are the recommended postnatal blood pressure monitoring protocols for women with pre-eclampsia?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 6,NG133,What are the postnatal management and blood pressure targets for women with pre-eclampsia after childbirth?
NG133_Recommendations: 1.5 Management of pre-eclampsia - Part 7,NG133,What follow-up care is recommended for women after pre-eclampsia?
NG133_Recommendations: 1.6 Fetal monitoring - Part 1,NG133,What are the recommended fetal monitoring procedures for women with chronic hypertension during pregnancy?
NG133_Recommendations: 1.6 Fetal monitoring - Part 2,NG133,What are the recommended fetal monitoring procedures for women with pre-eclampsia or severe gestational hypertension?
NG133_Recommendations: 1.7 Intrapartum care,NG133,What is the recommended intrapartum care for women with hypertensive disorders during labour according to NICE guidelines?
"NG133_Recommendations: 1.8 Medical management of severe hypertension, severe pre-eclampsia or eclampsia in a critical care setting - Part 1",NG133,What is the recommended management of severe hypertension and pre-eclampsia with magnesium sulfate in critical care?
"NG133_Recommendations: 1.8 Medical management of severe hypertension, severe pre-eclampsia or eclampsia in a critical care setting - Part 2",NG133,What are the recommended treatments for severe hypertension in pregnant women with eclampsia?
"NG133_Recommendations: 1.8 Medical management of severe hypertension, severe pre-eclampsia or eclampsia in a critical care setting - Part 3",NG133,What are the recommended management strategies for HELLP syndrome in pregnancy?
"NG133_Recommendations: 1.9 Antihypertensive treatment during the postnatal period, including during breastfeeding - Part 1",NG133,What are the recommendations for prescribing antihypertensive medications during breastfeeding?
"NG133_Recommendations: 1.9 Antihypertensive treatment during the postnatal period, including during breastfeeding - Part 2",NG133,How can antihypertensive treatment be safely managed in women who wish to breastfeed?
"NG133_Recommendations: 1.9 Antihypertensive treatment during the postnatal period, including during breastfeeding - Part 3",NG133,What are the recommended antihypertensive treatments for women in the postnatal period?
NG133_Recommendations: 1.10 Advice and follow-up at transfer to community care - Part 1,NG133,What is the risk of recurrence and long-term cardiovascular health after hypertensive disorders of pregnancy?
NG133_Recommendations: 1.10 Advice and follow-up at transfer to community care - Part 2,NG133,What are the recommended strategies to reduce cardiovascular risk in women with a history of hypertensive disorders of pregnancy?
NG133_Recommendations: 1.10 Advice and follow-up at transfer to community care - Part 3,NG133,What are the recommendations for pre-pregnancy counseling and risk reduction in women with a history of pre-eclampsia?
NG133_Recommendations: Terms used in this guideline - Part 1,NG133,"What are the definitions and distinctions between chronic hypertension, gestational hypertension, and pre-eclampsia in pregnancy?"
NG133_Recommendations: Terms used in this guideline - Part 2,NG133,What are the criteria for diagnosing severe pre-eclampsia and maternal organ dysfunction in pregnancy?
NG133_Recommendations for research: Key recommendations for research - Part 1,NG133,What is the effectiveness and safety of antihypertensive medications for managing chronic hypertension in pregnancy?
NG133_Recommendations for research: Key recommendations for research - Part 2,NG133,"What are the recommended antihypertensive treatments for women in the postnatal period, including safety during breastfeeding?"
NG133_Recommendations for research: Other recommendations for research (from 2010 guideline),NG133,What is the role of haematological and biochemical monitoring in women with gestational hypertension?
NG133_Rationale and impact: Assessment of proteinuria - Part 1,NG133,What is the recommended method for assessing proteinuria in suspected pre-eclampsia?
NG133_Rationale and impact: Assessment of proteinuria - Part 2,NG133,What is the recommended threshold for ACR to diagnose severe pre-eclampsia in pregnant women?
NG133_Rationale and impact: Treatment of chronic hypertension - Part 1,NG133,What are the recommended antihypertensive treatments for managing chronic hypertension in pregnant women?
NG133_Rationale and impact: Treatment of chronic hypertension - Part 2,NG133,What is the recommended dose of aspirin for preventing preterm birth in pregnant women with chronic hypertension?
NG133_Rationale and impact: Monitoring and treatment of gestational hypertension,NG133,What are the recommended blood pressure targets for managing gestational hypertension?
NG133_Rationale and impact: Assessment of women with pre-eclampsia,NG133,What are the recommended assessments and risk prediction tools for women with pre-eclampsia during antenatal care?
NG133_Rationale and impact: Monitoring and treatment of pre-eclampsia and timing of birth - Part 1,NG133,What are the recommended monitoring and treatment strategies for pre-eclampsia and timing of birth?
NG133_Rationale and impact: Monitoring and treatment of pre-eclampsia and timing of birth - Part 2,NG133,What are the recommended pharmacological treatments for pre-eclampsia in pregnancy?
"NG133_Rationale and impact: Antihypertensive treatment during the postnatal period, including during breastfeeding",NG133,What are the recommended antihypertensive treatments for women in the postnatal period who are breastfeeding?
NG133_Rationale and impact: Risk of recurrence of hypertensive disorders of pregnancy and long-term cardiovascular disease,NG133,What is the risk of recurrent hypertensive disorders and cardiovascular disease in women with a history of pregnancy-related hypertension?
NG133_Context - Part 1,NG133,What are the current NICE guidelines for managing hypertension during pregnancy?
NG133_Context - Part 2,NG133,"What are the current NICE guidelines for managing pregnancy with chronic hypertension, gestational hypertension, and pre-eclampsia?"
NG134_Depression in children and young people: identification and management & Overview,NG134,What are the recommended approaches for diagnosing and managing depression in children and young people aged 5 to 18?
NG134_Recommendations: 1.1 Care of all children and young people with depression - Part 1,NG134,What are the recommended approaches for engaging children and young people with depression and their families in treatment decisions?
NG134_Recommendations: 1.1 Care of all children and young people with depression - Part 2,NG134,What are the recommended management and assessment strategies for depression in children and young people?
NG134_Recommendations: 1.1 Care of all children and young people with depression - Part 3,NG134,What are the recommended approaches for managing depression in children and young people within community and school settings?
NG134_Recommendations: 1.1 Care of all children and young people with depression - Part 4,NG134,What are effective strategies for preventing bullying in children and young people with depression?
NG134_Recommendations: 1.2 Stepped care - Part 1,NG134,What are the steps involved in the stepped-care model for managing depression in children and young people?
NG134_Recommendations: 1.2 Stepped care - Part 2,NG134,What are the recommended management strategies for depression in children and young people across different tiers of mental health services?
"NG134_Recommendations: 1.3 Step 1: Detection, risk profiling and referral - Part 1",NG134,What are the recommended training and assessment practices for detecting depression in children and young people in primary care and community settings?
"NG134_Recommendations: 1.3 Step 1: Detection, risk profiling and referral - Part 2",NG134,What are the recommended approaches for supporting children and young people after recent adverse life events according to NICE guidelines?
"NG134_Recommendations: 1.3 Step 1: Detection, risk profiling and referral - Part 3",NG134,"What are the criteria for referring children and young people with depression to CAMHS tiers 2, 3, or 4?"
NG134_Recommendations: 1.4 Step 2: Recognition of depression in children and young people,NG134,What are the recommended screening tools for detecting depression in children and young people aged 11 and older?
NG134_Recommendations: 1.5 Step 3: Managing mild depression - Part 1,NG134,What are the recommended management options for children and young people with mild depression?
NG134_Recommendations: 1.5 Step 3: Managing mild depression - Part 2,NG134,What psychological therapies are recommended for adolescents with mild depression after 2 to 3 months of watchful waiting?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 1,NG134,What psychological therapies are recommended for children and young people with moderate to severe depression?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 2,NG134,What are the recommended treatment options for moderate to severe depression in young people aged 12 to 18 years?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 3,NG134,What are the recommended approaches for managing depression in children unresponsive to initial treatments?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 4,NG134,What are the NICE recommendations for prescribing fluoxetine to children and young people with depression?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 5,NG134,What are the recommended second-line antidepressants for children and young people with depression who do not tolerate fluoxetine?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 6,NG134,What are the recommended practices for prescribing antidepressants to children and young people with depression?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 7,NG134,What are the guidelines for prescribing St John's wort to children and young people with depression?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 8,NG134,What are the NICE recommendations for inpatient treatment and discharge planning for children and young people with mental health conditions?
NG134_Recommendations: 1.6 Steps 4 and 5: Managing moderate to severe depression - Part 9,NG134,How should primary care professionals be informed about the management and relapse prevention of children and young people with recurrent depression?
NG134_Recommendations: 1.7 Transfer to adult services,NG134,What are the criteria for transferring young people from CAMHS to adult mental health services for depression?
NG134_Recommendations: Terms used in this guideline,NG134,What are the recommended psychosocial interventions for young people with depression according to NICE guidelines?
NG134_Recommendations for research: Key recommendations for research - Part 1,NG134,What is the effectiveness of psychological therapies for children aged 5 to 11 with depression?
NG134_Recommendations for research: Key recommendations for research - Part 2,NG134,What is the effectiveness of brief psychosocial interventions delivered by non-psychiatrists for depression in adolescents?
NG134_Recommendations for research: Other recommendations for research,NG134,What is the effectiveness of group mindfulness therapy for adolescents with mild depression?
NG134_Rationale and impact: Treatments for mild depression - Part 1,NG134,What are the recommended psychological therapies for children aged 5 to 11 with mild depression?
NG134_Rationale and impact: Treatments for mild depression - Part 2,NG134,What are the most effective psychological therapies for adolescents with mild depression?
NG134_Rationale and impact: Treatments for mild depression - Part 3,NG134,What is the evidence for the effectiveness of behavioural activation compared to other psychological therapies for depression in children and young people?
NG134_Rationale and impact: Treatments for moderate to severe depression - Part 1,NG134,What psychological therapies are recommended for children aged 5 to 11 with moderate to severe depression?
NG134_Rationale and impact: Treatments for moderate to severe depression - Part 2,NG134,What is the most effective psychological therapy for adolescents with moderate to severe depression?
NG134_Rationale and impact: Treatments for moderate to severe depression - Part 3,NG134,What is the effectiveness of psychodynamic psychotherapy compared to other treatments for depression in young people?
NG134_Context,NG134,What are the recommended approaches for diagnosing and managing depression in children and young people?
NG135_Alcohol interventions in secondary and further education & Overview,NG135,What are effective alcohol prevention interventions in secondary and further education settings?
NG135_Recommendations: 1.1 Planning alcohol education - Part 1,NG135,How should schools plan and deliver effective alcohol education as part of relationships and health education programs?
NG135_Recommendations: 1.1 Planning alcohol education - Part 2,NG135,"What are best practices for planning and delivering age-appropriate, tailored alcohol education in schools?"
NG135_Recommendations: 1.1 Planning alcohol education - Part 3,NG135,What are the recommended safeguarding and referral procedures for pupils with concerns about alcohol-related harm or other issues?
NG135_Recommendations: 1.2 Delivering universal alcohol education,NG135,What are the recommended approaches for delivering effective and safe alcohol education in schools?
NG135_Recommendations: 1.3 Targeted interventions - Part 1,NG135,How should pupils be selected and involved in targeted interventions for alcohol misuse to avoid stigma and negative self-perceptions?
NG135_Recommendations: 1.3 Targeted interventions - Part 2,NG135,How can healthcare professionals tailor interventions to address individual risk factors and prevent the normalization of unhealthy drinking behaviors in group settings?
NG135_Recommendations: Terms used in this guideline,NG135,What is a whole-school approach to promoting health and wellbeing in schools?
NG135_Recommendations for research: Key recommendations for research - Part 1,NG135,"What are the most effective components of alcohol education delivery for children and young people aged 11 to 25, including those with special educational needs and disabilities?"
NG135_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG135,How effective are education-based alcohol prevention interventions for children and young people aged 11 to 25 with SEND?
NG135_Rationale and impact: Organising alcohol education - Part 1,NG135,What are the recommended approaches for organizing alcohol education in schools?
NG135_Rationale and impact: Organising alcohol education - Part 2,NG135,How can schools effectively involve parents and carers in alcohol education programs?
NG135_Rationale and impact: Planning alcohol education content,NG135,How should alcohol education be tailored for different age groups and pupils with special educational needs?
NG135_Rationale and impact: Confidentiality and safeguarding,NG135,How should schools handle confidentiality and safeguarding when discussing alcohol-related issues with pupils?
NG135_Rationale and impact: Referral for further support,NG135,What are the recommended referral pathways for safeguarding and mental health support in school-based alcohol education programs?
NG135_Rationale and impact: Structuring alcohol education,NG135,How should alcohol education be structured for young people to promote understanding and healthy choices?
NG135_Rationale and impact: Using additional support for alcohol education,NG135,What are the best practices for using external providers to deliver alcohol education in schools?
NG135_Rationale and impact: Selecting pupils for targeted interventions - Part 1,NG135,What are the recommended approaches for selecting pupils for targeted interventions to prevent alcohol misuse in schools?
NG135_Rationale and impact: Selecting pupils for targeted interventions - Part 2,NG135,What are the best practices for implementing targeted alcohol education interventions in schools?
NG135_Rationale and impact: Tailoring targeted interventions,NG135,How should schools assess individual risk factors to tailor interventions for pupils at risk of alcohol misuse?
NG135_Rationale and impact: Avoiding unintended consequences of group interventions,NG135,What are the risks of unintended consequences in group interventions for alcohol misuse prevention?
NG135_Context,NG135,What are the current NICE recommendations for preventing alcohol use among children and young people aged 11 to 25 with special educational needs?
NG136_Hypertension in adults: diagnosis and management & Overview & Recommendations: 1.1 Measuring blood pressure - Part 1,NG136,What are the recommended procedures for measuring blood pressure in adults to ensure accuracy?
NG136_Recommendations: 1.1 Measuring blood pressure - Part 2,NG136,What are the recommended procedures for measuring blood pressure to diagnose postural hypotension?
NG136_Recommendations: 1.2 Diagnosing hypertension - Part 1,NG136,How is hypertension diagnosed using blood pressure measurements and ambulatory monitoring?
NG136_Recommendations: 1.2 Diagnosing hypertension - Part 2,NG136,What is the recommended method for confirming a diagnosis of hypertension using home blood pressure monitoring?
NG136_Recommendations: 1.3 Assessing cardiovascular risk and target organ damage,NG136,How should cardiovascular risk be assessed and managed in people with hypertension?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 1,NG136,What lifestyle interventions are recommended for managing hypertension?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 2,NG136,What are the criteria for starting antihypertensive medication in adults with stage 1 or stage 2 hypertension?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 3,NG136,When should antihypertensive treatment be considered for people over 80 with stage 1 hypertension?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 4,NG136,What are the blood pressure targets for people aged 80 and over with hypertension or diabetes according to NICE guidelines?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 5,NG136,What are the recommendations for self-monitoring blood pressure in people with hypertension?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 6,NG136,What are the blood pressure targets for adults with hypertension using ABPM or HBPM?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 7,NG136,What are the recommended antihypertensive drugs for women of childbearing potential?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 8,NG136,What is the recommended antihypertensive treatment for adults with cardiovascular disease according to NICE guidelines?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 9,NG136,What are the recommended first-line antihypertensive treatments for adults with or without type 2 diabetes according to NICE guidelines?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 10,NG136,What are the recommended diuretics for treating hypertension when a calcium channel blocker is not tolerated?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 11,NG136,What are the recommended next steps for managing resistant hypertension according to NICE guidelines?
NG136_Recommendations: 1.4 Treating and monitoring hypertension - Part 12,NG136,When should I consider adding low-dose spironolactone for resistant hypertension and what precautions are needed?
NG136_Recommendations: 1.5 Identifying who to refer for same-day specialist review,NG136,When should patients with severe hypertension be referred for same-day specialist assessment?
NG136_Recommendations: Terms used in this guideline - Part 1,NG136,What is accelerated hypertension and how is it diagnosed?
NG136_Recommendations: Terms used in this guideline - Part 2,NG136,What are the blood pressure thresholds for diagnosing different stages of hypertension?
NG136_Recommendations for research: Key recommendations for research - Part 1,NG136,What is the recommended blood pressure target for people over 80 with hypertension?
NG136_Recommendations for research: Key recommendations for research - Part 2,NG136,What is the clinical and cost effectiveness of relaxation therapies for managing primary hypertension in adults?
NG136_Recommendations for research: Other recommendations for research,NG136,What are the recommended blood pressure targets for adults with aortic aneurysm or previous stroke?
NG136_Rationale and impact: Diagnosing hypertension - Part 1,NG136,What is the most accurate method for diagnosing hypertension in clinical practice?
NG136_Rationale and impact: Diagnosing hypertension - Part 2,NG136,What is the most accurate and cost-effective method for diagnosing hypertension in primary care?
NG136_Rationale and impact: Relaxation therapies,NG136,What is the current evidence on relaxation therapies for managing hypertension?
NG136_Rationale and impact: Starting antihypertensive drug treatment - Part 1,NG136,What are the NICE recommendations for starting antihypertensive treatment in people with stage 1 hypertension and different cardiovascular risk levels?
NG136_Rationale and impact: Starting antihypertensive drug treatment - Part 2,NG136,What are the current NICE recommendations for initiating antihypertensive treatment in adults with low to moderate cardiovascular risk?
NG136_Rationale and impact: Starting antihypertensive drug treatment - Part 3,NG136,What are the blood pressure treatment thresholds for people over 80 years old with hypertension?
NG136_Rationale and impact: Monitoring treatment and blood pressure targets - Part 1,NG136,What are the recommended methods for monitoring blood pressure in adults with hypertension?
NG136_Rationale and impact: Monitoring treatment and blood pressure targets - Part 2,NG136,What are the recommended blood pressure targets for people without cardiovascular disease?
NG136_Rationale and impact: Monitoring treatment and blood pressure targets - Part 3,NG136,What are the recommended blood pressure targets for adults with type 2 diabetes according to NICE guidelines?
NG136_Rationale and impact: Monitoring treatment and blood pressure targets - Part 4,NG136,What are the current blood pressure targets for managing cardiovascular disease and stroke patients according to NICE guidelines?
NG136_Rationale and impact: Choosing antihypertensive drug treatment for people with cardiovascular disease,NG136,What is the recommended antihypertensive drug treatment for people with cardiovascular disease?
NG136_Rationale and impact: Step 1 treatment - Part 1,NG136,What are the current recommendations for initiating antihypertensive treatment in primary hypertension?
NG136_Rationale and impact: Step 1 treatment - Part 2,NG136,What are the current NICE recommendations for initial antihypertensive treatment in adults with type 2 diabetes?
NG136_Rationale and impact: Step 2 and 3 treatment,NG136,What are the recommended options for step 2 and 3 antihypertensive treatment in hypertension management?
NG136_Rationale and impact: Step 4 treatment,NG136,What are the current recommendations for step 4 treatment of resistant hypertension?
NG136_Rationale and impact: Identifying who to refer for same-day specialist review,NG136,What are the criteria for same-day referral for severe hypertension with emergency symptoms?
NG136_Context,NG136,"What are the current recommendations for diagnosing and managing hypertension in adults, including those with type 2 diabetes?"
NG137_Twin and triplet pregnancy & Overview,NG137,What are the recommended antenatal care practices for women with twin or triplet pregnancies?
NG137_Recommendations: 1.1 Determining gestational age and chorionicity - Part 1,NG137,What is the recommended timing and method for determining chorionicity and amnionicity in twin and triplet pregnancies?
NG137_Recommendations: 1.1 Determining gestational age and chorionicity - Part 2,NG137,How is chorionicity and amnionicity determined in twin and triplet pregnancies?
NG137_Recommendations: 1.2 General care,NG137,How should care be tailored for women with twin or triplet pregnancies regarding emotional support and nutritional management?
NG137_Recommendations: 1.3 Delivery of antenatal and intrapartum care - Part 1,NG137,What are the recommended practices for delivering antenatal and intrapartum care in twin and triplet pregnancies?
NG137_Recommendations: 1.3 Delivery of antenatal and intrapartum care - Part 2,NG137,What is the recommended schedule of antenatal appointments for women with twin pregnancies according to NICE guidelines?
NG137_Recommendations: 1.3 Delivery of antenatal and intrapartum care - Part 3,NG137,What are the recommended antenatal appointment schedules for women with triplet pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 1,NG137,What are the recommended screening options for chromosomal anomalies in twin and triplet pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 2,NG137,What are the recommended screening and monitoring procedures for chromosomal abnormalities and preterm birth risk in twin and triplet pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 3,NG137,What are the current NICE recommendations for screening and monitoring fetal growth in twin and triplet pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 4,NG137,What are the recommended monitoring intervals and criteria for fetal growth assessment in twin and triplet pregnancies according to NICE guidelines?
NG137_Recommendations: 1.4 Fetal complications - Part 5,NG137,What are the recommended ultrasound monitoring protocols for feto-fetal transfusion syndrome in monochorionic twin pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 6,NG137,What are the recommended monitoring protocols for fetal growth restriction in monochorionic twin pregnancies?
NG137_Recommendations: 1.4 Fetal complications - Part 7,NG137,What is the recommended ultrasound monitoring schedule for twin anemia polycythaemia sequence (TAPS) in monochorionic pregnancies?
NG137_Recommendations: 1.5 Preventing preterm birth - Part 1,NG137,What are the recommended strategies for preventing preterm birth in women with twin or triplet pregnancies?
NG137_Recommendations: 1.5 Preventing preterm birth - Part 2,NG137,What are the recommended interventions to prevent preterm birth in twin and triplet pregnancies?
NG137_Recommendations: 1.6 Maternal complications,NG137,What is the recommended screening for hypertensive disorders in twin and triplet pregnancies?
NG137_Recommendations: 1.7 Indications for referral to a tertiary level fetal medicine centre,NG137,What are the indications for referral to a tertiary fetal medicine centre during pregnancy?
NG137_Recommendations: 1.8 Planning birth: information and support,NG137,What information should be provided to women with twin or triplet pregnancies about birth planning and support?
NG137_Recommendations: 1.9 Timing of birth - Part 1,NG137,What is the recommended timing of birth for twin and triplet pregnancies according to NICE guidelines?
NG137_Recommendations: 1.9 Timing of birth - Part 2,NG137,When should planned birth be offered for twin and triplet pregnancies according to NICE guidelines?
NG137_Recommendations: 1.10 Mode of birth - Part 1,NG137,What are the recommended modes of birth for women with uncomplicated twin pregnancies after 32 weeks?
NG137_Recommendations: 1.10 Mode of birth - Part 2,NG137,"What are the NICE guidelines for mode of birth in preterm, twin, and triplet pregnancies?"
NG137_Recommendations: 1.11 Fetal monitoring during labour in twin pregnancy - Part 1,NG137,What are the recommendations for fetal monitoring during labour in twin pregnancies?
NG137_Recommendations: 1.11 Fetal monitoring during labour in twin pregnancy - Part 2,NG137,What are the best practices for monitoring and interpreting cardiotocography in twin pregnancies?
NG137_Recommendations: 1.11 Fetal monitoring during labour in twin pregnancy - Part 3,NG137,What are the recommended management strategies for abnormal fetal monitoring in twin pregnancies during labour?
NG137_Recommendations: 1.11 Fetal monitoring during labour in twin pregnancy - Part 4,NG137,What are the indications for performing an emergency caesarean section during twin labor based on fetal monitoring?
NG137_Recommendations: 1.12 Analgesia,NG137,What are the recommended analgesia options for women during vaginal or caesarean birth in twin or triplet pregnancies?
NG137_Recommendations: 1.13 Managing the third stage of labour - Part 1,NG137,What are the recommended management options for the third stage of labour in women with twin or triplet pregnancies?
NG137_Recommendations: 1.13 Managing the third stage of labour - Part 2,NG137,What are the recommendations for blood transfusion management in women with twin or triplet pregnancies during labor?
NG137_Recommendations: Terms used in this guideline - Part 1,NG137,What is active management of the third stage of labor and how is it performed in vaginal and caesarean births?
NG137_Recommendations: Terms used in this guideline - Part 2,NG137,What are the management options for twin-to-twin transfusion syndrome in monochorionic pregnancies?
NG137_Recommendations for research: Key recommendations for research,NG137,What is the effectiveness of progesterone in preventing preterm birth in women with twin or triplet pregnancies and previous preterm birth?
NG137_Recommendations for research: Other recommendations for research & Rationale and impact: Intrapartum care,NG137,What are the recommended methods for estimating gestational age in twin and triplet pregnancies?
NG137_Rationale and impact: Screening for chromosomal conditions & Rationale and impact: Screening for preterm birth,NG137,What are the current NICE recommendations for screening for chromosomal conditions in twin and triplet pregnancies?
NG137_Rationale and impact: Screening for fetal growth restriction and feto-fetal transfusion syndrome in the first trimester,NG137,What are the recommended first trimester screening methods for fetal growth restriction and feto-fetal transfusion syndrome?
NG137_Rationale and impact: Diagnostic monitoring for fetal growth restriction in dichorionic twin and trichorionic triplet pregnancies - Part 1,NG137,What is the recommended ultrasound monitoring schedule for fetal growth restriction in dichorionic twin and triplet pregnancies?
NG137_Rationale and impact: Diagnostic monitoring for fetal growth restriction in dichorionic twin and trichorionic triplet pregnancies - Part 2,NG137,What are the criteria for referring twin or triplet pregnancies with fetal growth restriction to a fetal medicine specialist?
NG137_Rationale and impact: Diagnostic monitoring for feto-fetal transfusion syndrome - Part 1,NG137,How is feto-fetal transfusion syndrome diagnosed and monitored in monochorionic pregnancies?
NG137_Rationale and impact: Diagnostic monitoring for feto-fetal transfusion syndrome - Part 2,NG137,How should fetal monitoring be conducted to detect and manage feto-fetal transfusion syndrome in monochorionic twin pregnancies?
NG137_Rationale and impact: Diagnostic monitoring for fetal growth restriction in monochorionic twin and triplet pregnancy - Part 1,NG137,What is the recommended frequency of ultrasound scans for fetal growth monitoring in monochorionic twin pregnancies?
NG137_Rationale and impact: Diagnostic monitoring for fetal growth restriction in monochorionic twin and triplet pregnancy - Part 2,NG137,What are the recommended monitoring protocols for monochorionic twin pregnancies with fetal weight discordance?
NG137_Rationale and impact: Diagnostic monitoring for twin anaemia polycythaemia sequence - Part 1,NG137,What are the recommended methods for diagnostic monitoring of twin anaemia polycythaemia sequence in complicated monochorionic pregnancies?
NG137_Rationale and impact: Diagnostic monitoring for twin anaemia polycythaemia sequence - Part 2,NG137,What are the recommended management strategies for pregnancies complicated by TAPS in monochorionic twins?
NG137_Rationale and impact: Preventing preterm birth - Part 1,NG137,What is the effectiveness of vaginal progesterone in preventing preterm birth in women with twin pregnancies and a short cervix?
NG137_Rationale and impact: Preventing preterm birth - Part 2,NG137,What are the current recommendations for cervical length screening and progesterone use to prevent preterm birth in women with twin or triplet pregnancies?
NG137_Rationale and impact: Planning birth: information and support,NG137,What information and support should be provided to women during birth planning to ensure shared decision-making?
NG137_Rationale and impact: Timing of birth - Part 1,NG137,What is the recommended timing of planned birth for twin pregnancies according to NICE guidelines?
NG137_Rationale and impact: Timing of birth - Part 2,NG137,What is the recommended timing of planned birth for monochorionic monoamniotic twin pregnancies?
NG137_Rationale and impact: Mode of birth,NG137,What are the recommended modes of birth for twin pregnancies after 32 weeks?
NG137_Rationale and impact: Fetal monitoring during labour in twin pregnancy - Part 1,NG137,What are the recommendations for fetal monitoring during labour in twin pregnancies?
NG137_Rationale and impact: Fetal monitoring during labour in twin pregnancy - Part 2,NG137,What are the recommended practices for cardiotocography monitoring in twin pregnancies during labour?
NG137_Rationale and impact: Analgesia,NG137,What are the recommended analgesia options for women with twin or triplet pregnancies during labour?
NG137_Rationale and impact: Managing the third stage of labour,NG137,What are the recommended management strategies for the third stage of labour in women with multiple pregnancies?
NG137_Context,NG137,What are the recommended antenatal monitoring protocols for twin and triplet pregnancies?
NG138_Pneumonia (community-acquired): antimicrobial prescribing & Overview,NG138,What are the recommended antibiotics for treating community-acquired pneumonia?
NG138_Recommendations: 1.1 Managing community-acquired pneumonia - Part 1,NG138,What are the recommended antibiotic treatments and considerations for managing community-acquired pneumonia in different age groups?
NG138_Recommendations: 1.1 Managing community-acquired pneumonia - Part 2,NG138,When should I seek medical help or hospital referral for community-acquired pneumonia?
NG138_Recommendations: 1.2 Choice of antibiotic - Part 1,NG138,What is the recommended antibiotic treatment for community-acquired pneumonia in adults?
NG138_Recommendations: 1.2 Choice of antibiotic - Part 2 & Recommendations: 1.2 Choice of antibiotic - Part 3,NG138,What are the recommendations for antibiotic use and switching from intravenous to oral therapy in respiratory infections?
NG138_Recommendations: 1.2 Choice of antibiotic - Part 4,NG138,What are the recommended antibiotics and dosages for children with community-acquired pneumonia?
NG138_Recommendations: 1.2 Choice of antibiotic - Part 5,NG138,What are the recommended dosing and duration for antibiotic treatment in children according to NICE guidelines?
NG138_Recommendations: Terms used in the guideline,NG138,What are the clinical features and assessment tools for severe community-acquired pneumonia in children and adults?
NG138_Summary of the evidence: Antibiotic prescribing strategies - Part 1,NG138,What are the recommended antibiotic prescribing strategies for community-acquired pneumonia in adults and children?
NG138_Summary of the evidence: Antibiotic prescribing strategies - Part 2,NG138,What are the recommended antibiotic treatment and switching strategies for pneumonia in children and young people?
NG138_Summary of the evidence: Choice of antibiotics - Part 1,NG138,What are the most effective antibiotics for treating low-severity community-acquired pneumonia in adults?
NG138_Summary of the evidence: Choice of antibiotics - Part 2,NG138,What is the evidence for the effectiveness of antibiotics in treating low-severity community-acquired pneumonia in adults?
NG138_Summary of the evidence: Choice of antibiotics - Part 3,NG138,What are the comparative effectiveness and safety of ertapenem versus ceftriaxone for community-acquired pneumonia?
NG138_Summary of the evidence: Choice of antibiotics - Part 4,NG138,What are the recommended antibiotic treatments for community-acquired pneumonia in adults and children?
NG138_Summary of the evidence: Choice of antibiotics - Part 5,NG138,What are the recommended antibiotic treatments for severe community-acquired pneumonia in children and young people?
NG138_Summary of the evidence: Choice of antibiotics - Part 6,NG138,What are the safety considerations and potential side effects of antibiotics used to treat severe community-acquired pneumonia in children and young people?
NG138_Summary of the evidence: Choice of antibiotics - Part 7,NG138,What are the risks of tendon damage and adverse effects associated with fluoroquinolones and other antibiotics in treating community-acquired pneumonia?
NG138_Summary of the evidence: Choice of antibiotics - Part 8,NG138,What are the recommended antibiotic treatments for community-acquired pneumonia in children and adults according to NICE guidelines?
NG138_Summary of the evidence: Choice of antibiotics - Part 9,NG138,What is the recommended first-line antibiotic for adults with low-severity community-acquired pneumonia?
NG138_Summary of the evidence: Choice of antibiotics - Part 10,NG138,What is the recommended antibiotic treatment for moderate-severity community-acquired pneumonia in adults?
NG138_Summary of the evidence: Choice of antibiotics - Part 11,NG138,What are the recommended antibiotic treatments for adults with high-severity community-acquired pneumonia?
NG138_Summary of the evidence: Choice of antibiotics - Part 12,NG138,What is the recommended antibiotic treatment for children and young people with community-acquired pneumonia?
NG138_Summary of the evidence: Choice of antibiotics - Part 13,NG138,What are the safety netting recommendations for community-acquired pneumonia in children and adults?
NG138_Summary of the evidence: Antibiotic dosage - Part 1,NG138,What is the recommended antibiotic dosage for treating community-acquired pneumonia in children and adults?
NG138_Summary of the evidence: Antibiotic dosage - Part 2,NG138,What is the recommended antibiotic dosing for community-acquired pneumonia in children and adults?
NG138_Summary of the evidence: Antibiotic course length - Part 1,NG138,What is the recommended duration of antibiotic treatment for community-acquired pneumonia in adults and children?
NG138_Summary of the evidence: Antibiotic course length - Part 2,NG138,What is the recommended duration of antibiotic treatment for community-acquired pneumonia in children and adults?
NG138_Summary of the evidence: Antibiotic route of administration - Part 1,NG138,What is the evidence for switching from intravenous to oral antibiotics in community-acquired pneumonia?
NG138_Summary of the evidence: Antibiotic route of administration - Part 2 & Other considerations,NG138,What is the recommended route of antibiotic administration for children and adults with community-acquired pneumonia according to NICE guidelines?
NG139_Pneumonia (hospital-acquired): antimicrobial prescribing & Overview & Recommendations: 1.1 Managing hospital-acquired pneumonia - Part 1,NG139,What are the recommended antimicrobial prescribing strategies for hospital-acquired pneumonia?
NG139_Recommendations: 1.1 Managing hospital-acquired pneumonia - Part 2 & Recommendations: 1.2 Choice of antibiotic - Part 1,NG139,What is the recommended first-line oral antibiotic treatment for hospital-acquired pneumonia in patients who can take oral medicines?
NG139_Recommendations: 1.2 Choice of antibiotic - Part 2,NG139,What are the recommended antibiotics and dosages for treating adult non-severe bacterial infections according to NICE guidelines?
NG139_Recommendations: 1.2 Choice of antibiotic - Part 3,NG139,What are the recommended antibiotic dosing and duration for patients with hepatic or renal impairment according to NICE guidelines?
NG139_Recommendations: 1.2 Choice of antibiotic - Part 4,NG139,What are the recommended antibiotics and dosages for treating bacterial infections in children under 18 years?
NG139_Recommendations: 1.2 Choice of antibiotic - Part 5 & Recommendations: 1.2 Choice of antibiotic - Part 6 & Recommendations: Terms used in the guideline,NG139,What are the recommended antibiotic dosing and duration for treating hospital-acquired pneumonia in children?
NG139_Summary of the evidence: Antibiotic prescribing strategies - Part 1,NG139,What are the recommended antibiotic prescribing strategies for hospital-acquired pneumonia in adults?
NG139_Summary of the evidence: Antibiotic prescribing strategies - Part 2,NG139,What are the recommended antibiotic prescribing strategies for respiratory infections based on recent evidence?
NG139_Summary of the evidence: Choice of antibiotics - Part 1,NG139,What are the recommended antibiotics for hospital-acquired pneumonia in adults?
NG139_Summary of the evidence: Choice of antibiotics - Part 2,NG139,What are the safety considerations and potential side effects of using antibiotics according to NICE guidelines?
NG139_Summary of the evidence: Choice of antibiotics - Part 3,NG139,What are the safety considerations and monitoring requirements for fluoroquinolones and glycopeptides in the treatment of hospital-acquired pneumonia?
NG139_Summary of the evidence: Choice of antibiotics - Part 4,NG139,What are the recommended antibiotic treatment timings and choices for hospital-acquired pneumonia in adults and children?
NG139_Summary of the evidence: Choice of antibiotics - Part 5,NG139,What are the recommended antibiotic choices for non-severe pneumonia in patients with penicillin allergy?
NG139_Summary of the evidence: Choice of antibiotics - Part 6,NG139,What are the recommended antibiotic options for hospital-acquired pneumonia with suspected or confirmed MRSA infection?
"NG139_Summary of the evidence: Antibiotic course length, dosage and route of administration & Other considerations",NG139,What is the recommended duration and route of antibiotic administration for hospital-acquired pneumonia?
NG13_Workplace health: management practices & Overview,NG13,What are the recommended workplace health management practices for supporting employees aged over 50?
NG13_Recommendations: 1.1 Organisational commitment,NG13,What strategies can employers use to promote employee health and wellbeing in the workplace?
NG13_Recommendations: 1.2 Physical work environment & Recommendations: 1.3 Mental wellbeing at work,NG13,What workplace policies support mental wellbeing and stress management according to NICE guidelines?
NG13_Recommendations: 1.4 Fairness and justice,NG13,What are the key principles for promoting fairness and justice in the workplace according to NICE guidelines?
NG13_Recommendations: 1.5 Participation and trust,NG13,How can employers promote employee participation and trust in the workplace?
NG13_Recommendations: 1.6 Senior leadership & Recommendations: 1.7 Role of line managers,NG13,What are the key responsibilities of senior leadership and line managers in promoting workplace health and wellbeing?
NG13_Recommendations: 1.8 Leadership style of line managers,NG13,What are effective leadership styles for line managers to promote team engagement and development?
NG13_Recommendations: 1.9 Training - Part 1,NG13,What training should line managers receive to support employee health and wellbeing in the workplace?
NG13_Recommendations: 1.9 Training - Part 2,NG13,How can line managers be trained to support employees' mental health and wellbeing?
NG13_Recommendations: 1.10 Job design,NG13,What are best practices for designing jobs to promote employee health and wellbeing?
NG13_Recommendations: 1.11 Monitoring and evaluation & Recommendations: Terms used in this guideline,NG13,What are effective methods for monitoring and evaluating workplace health and wellbeing initiatives?
NG13_Recommendations for research: Recommendations for research: effectiveness - Part 1,NG13,What are effective methods for evaluating the implementation and outcomes of workplace health and wellbeing interventions?
NG13_Recommendations for research: Recommendations for research: effectiveness - Part 2,NG13,What are effective methods for measuring the impact of workplace health and wellbeing interventions?
NG13_Recommendations for research: Recommendations for research: older employees,NG13,"What are effective interventions to support older employees' health, wellbeing, and retention in the workplace?"
NG13_Context - Part 1,NG13,What are the health risks associated with physically demanding and sedentary work?
NG13_Context - Part 2,NG13,What workplace factors contribute to employee health and wellbeing according to NICE guidelines?
NG13_Context - Part 3,NG13,What strategies can employers implement to reduce presenteeism and support employees with health conditions at work?
NG13_Context - Part 4,NG13,What strategies can support healthy ageing and employment retention for older workers?
NG140_Abortion care & Overview,NG140,What are the recommended practices for abortion care and service organization according to NICE guideline NG140?
NG140_Recommendations: 1.1 Service organisation - Part 1,NG140,What are the NICE recommendations for improving access and reducing delays in abortion services?
NG140_Recommendations: 1.1 Service organisation - Part 2,NG140,What training should healthcare professionals receive to provide abortion services?
NG140_Recommendations: 1.2 Providing information - Part 1,NG140,"What information should healthcare providers give women about abortion options, risks, and what to expect?"
NG140_Recommendations: 1.2 Providing information - Part 2,NG140,What information should be provided to women having a medical abortion at home to confirm pregnancy has ended and recognize signs that require medical help?
NG140_Recommendations: 1.3 Anti-D prophylaxis,NG140,What are the current NICE recommendations for anti-D prophylaxis in women having a medical or surgical abortion?
NG140_Recommendations: 1.4 Preventing infection,NG140,What are the NICE recommendations for antibiotic prophylaxis in medical and surgical abortion?
NG140_Recommendations: 1.5 Venous thromboembolism prophylaxis,NG140,What are the recommendations for venous thromboembolism prophylaxis in women undergoing abortion?
NG140_Recommendations: 1.6 Choice of procedure for abortion,NG140,What factors should be considered when choosing between medical and surgical abortion up to 23+6 weeks' gestation?
NG140_Recommendations: 1.7 Abortion before definitive ultrasound evidence of an intrauterine pregnancy,NG140,What are the guidelines for performing abortion before definitive ultrasound evidence of intrauterine pregnancy?
NG140_Recommendations: 1.8 Expulsion at home for medical abortion up to and including 10+0 weeks,NG140,What are the guidelines for home expulsion during early medical abortion up to 10 weeks gestation?
NG140_Recommendations: 1.9 Medical abortion up to and including 10+0 weeks - Part 1,NG140,What are the recommended dosages and timing for mifepristone and misoprostol in medical abortion up to 10 weeks gestation?
NG140_Recommendations: 1.9 Medical abortion up to and including 10+0 weeks - Part 2,NG140,What is the recommended dosage and timing for medical abortion using mifepristone and misoprostol up to 10 weeks' gestation?
NG140_Recommendations: 1.10 Medical abortion between 10+1 and 23+6 weeks - Part 1,NG140,What are the recommended doses and timing for mifepristone and misoprostol in medical abortion between 10 and 24 weeks gestation?
NG140_Recommendations: 1.11 Medical abortion after 23+6 weeks - Part 2,NG140,What are the recommended protocols for medical abortion using misoprostol at different gestational ages?
NG140_Recommendations: 1.12 Cervical priming before surgical abortion - Part 1,NG140,What are the recommended protocols for cervical priming before first-trimester surgical abortion according to NICE guidelines?
NG140_Recommendations: 1.12 Cervical priming before surgical abortion - Part 2,NG140,What are the recommended cervical priming methods for surgical abortion up to 23 weeks gestation?
NG140_Recommendations: 1.12 Cervical priming before surgical abortion - Part 3,NG140,What are the recommended methods for cervical priming before surgical abortion between 14 and 24 weeks' gestation?
NG140_Recommendations: 1.13 Anaesthesia and sedation for surgical abortion,NG140,What are the recommended anaesthesia and sedation options for surgical abortion?
NG140_Recommendations: 1.14 Follow-up and support after an abortion,NG140,What follow-up and support options are recommended after a medical abortion up to 10 weeks' gestation?
NG140_Recommendations: 1.15 Improving access to contraception & Recommendations: Terms used in this guideline,NG140,What are the recommended contraceptive options to offer women on the same day as surgical or medical abortion?
NG140_Recommendations for research: Key recommendations for research - Part 1,NG140,What are the recommended antibiotic prophylaxis options for women undergoing surgical abortion?
NG140_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG140,What are the most effective anaesthesia and sedation techniques for surgical abortion?
NG140_Rationale and impact: Service organisation - Part 1,NG140,What strategies can improve access and reduce waiting times for abortion services?
NG140_Rationale and impact: Service organisation - Part 2,NG140,What are the recommended strategies to reduce waiting times and delays for abortion services?
NG140_Rationale and impact: Service organisation - Part 3,NG140,What are the recommended strategies for expanding the role of nurses and midwives in abortion care?
NG140_Rationale and impact: Service organisation - Part 4,NG140,How can reducing waiting times and expanding community-based abortion services improve cost efficiency in NHS healthcare?
NG140_Rationale and impact: Providing information - Part 1,NG140,What information should healthcare providers give to women about abortion options and risks?
NG140_Rationale and impact: Providing information - Part 2,NG140,What information should be provided to women having an abortion due to fetal anomaly and how should it be communicated?
NG140_Rationale and impact: Anti-D prophylaxis,NG140,What are the current NICE recommendations for anti-D prophylaxis in abortion care?
NG140_Rationale and impact: Preventing infection - Part 1,NG140,What are the recommendations for antibiotic prophylaxis in women undergoing medical or surgical abortion?
NG140_Rationale and impact: Preventing infection - Part 2,NG140,What are the current NICE recommendations for antibiotic prophylaxis in medical and surgical abortion?
NG140_Rationale and impact: Venous thromboembolism prophylaxis,NG140,What are the NICE guidelines for venous thromboembolism prophylaxis in women having an abortion?
NG140_Rationale and impact: Choice of procedure for abortion - Part 1,NG140,What are the factors to consider when choosing between medical and surgical abortion?
NG140_Rationale and impact: Choice of procedure for abortion - Part 2,NG140,What are the recommended options for second trimester abortion up to 23+6 weeks?
NG140_Rationale and impact: Abortion before definitive ultrasound evidence of an intrauterine pregnancy,NG140,What are the guidelines for performing abortion before definitive ultrasound evidence of intrauterine pregnancy?
NG140_Rationale and impact: Expulsion at home for medical abortion up to and including 10+0 weeks - Part 1,NG140,What are the safety considerations for home expulsion of medical abortion up to 10 weeks gestation?
NG140_Rationale and impact: Expulsion at home for medical abortion up to and including 10+0 weeks - Part 2,NG140,What are the current NICE recommendations on home expulsion for early medical abortion up to 12 weeks?
NG140_Rationale and impact: Medical abortion up to and including 10+0 weeks - Part 1,NG140,What are the recommended protocols for medical abortion up to 10 weeks gestation?
NG140_Rationale and impact: Medical abortion up to and including 10+0 weeks - Part 2,NG140,What are the benefits of simultaneous versus interval administration of mifepristone and misoprostol for medical abortion up to 10 weeks' gestation?
NG140_Rationale and impact: Medical abortion between 10+1 and 23+6 weeks - Part 1,NG140,What are the recommended misoprostol regimens for medical abortion between 10 and 24 weeks gestation?
NG140_Rationale and impact: Medical abortion between 10+1 and 23+6 weeks - Part 2,NG140,What is the recommended interval between mifepristone and misoprostol for medical abortion between 10 and 24 weeks gestation?
NG140_Rationale and impact: Medical abortion after 23+6 weeks - Part 1,NG140,What are the recommended medical abortion regimens after 23 weeks' gestation?
NG140_Rationale and impact: Medical abortion after 23+6 weeks - Part 2,NG140,What are the recommended drug regimens for medical abortion after 23 weeks' gestation in women with previous uterine surgery?
NG140_Rationale and impact: Cervical priming before surgical abortion - Part 1,NG140,What are the recommended methods and timings for cervical priming before surgical abortion up to 14 weeks?
NG140_Rationale and impact: Cervical priming before surgical abortion - Part 2,NG140,What are the recommended cervical priming methods for surgical abortion between 14 and 24 weeks gestation?
NG140_Rationale and impact: Cervical priming before surgical abortion - Part 3,NG140,What are the recommended timing and methods for cervical priming with osmotic dilators before surgical abortion?
NG140_Rationale and impact: Anaesthesia and sedation for surgical abortion - Part 1,NG140,What are the recommended anaesthesia options for surgical abortion according to NICE guidelines?
NG140_Rationale and impact: Anaesthesia and sedation for surgical abortion - Part 2,NG140,How do NICE guidelines recommend managing sedation options for surgical abortion?
NG140_Rationale and impact: Follow-up and support after an abortion - Part 1,NG140,What are the recommended follow-up options after medical abortion up to 10 weeks gestation?
NG140_Rationale and impact: Follow-up and support after an abortion - Part 2,NG140,What support options are recommended for women after an abortion?
NG140_Rationale and impact: Improving access to contraception - Part 1,NG140,What are the benefits and safety considerations of providing contraception immediately after abortion?
NG140_Rationale and impact: Improving access to contraception - Part 2,NG140,What are the benefits and considerations of immediate versus delayed depot medroxyprogesterone acetate injection after abortion?
NG140_Context,NG140,What are the current best practices for medical and surgical abortion procedures in England and Wales?
NG141_Cellulitis and erysipelas: antimicrobial prescribing & Overview,NG141,What are the recommended antimicrobial prescribing practices for cellulitis and erysipelas in adults and children?
NG141_Recommendations: 1.1 Managing cellulitis and erysipelas - Part 1,NG141,What are the recommended treatments and management strategies for cellulitis and erysipelas?
NG141_Recommendations: 1.1 Managing cellulitis and erysipelas - Part 2,NG141,What are the recommended management and reassessment strategies for cellulitis and erysipelas?
NG141_Recommendations: 1.1 Managing cellulitis and erysipelas - Part 3,NG141,What are the indications for microbiological testing and hospital referral in cellulitis and erysipelas management?
NG141_Recommendations: 1.2 Choice of antibiotic - Part 1,NG141,What is the recommended antibiotic treatment for cellulitis in adults?
NG141_Recommendations: 1.2 Choice of antibiotic - Part 2 & Recommendations: 1.2 Choice of antibiotic - Part 3,NG141,What are the recommended antibiotic choices and dosing considerations for infections around the eyes or nose in pregnant patients?
NG141_Recommendations: 1.2 Choice of antibiotic - Part 4,NG141,What are the recommended antibiotic treatments for children and young people under 18 years?
NG141_Recommendations: 1.2 Choice of antibiotic - Part 5 & Recommendations: 1.2 Choice of antibiotic - Part 6 & Recommendations: 1.2 Choice of antibiotic - Part 7,NG141,What are the guidelines for prescribing intravenous antibiotics and switching to oral antibiotics in children?
NG141_Recommendations: 1.2 Choice of antibiotic - Part 8,NG141,What is the recommended course length for antibiotic treatment of skin infections around the eyes or nose?
NG141_Recommendations: 1.3 Preventing recurrent cellulitis or erysipelas,NG141,What are the recommendations for antibiotic prophylaxis to prevent recurrent cellulitis or erysipelas?
NG141_Recommendations: 1.4 Choice of antibiotic prophylaxis & Recommendations: Terms used in the guideline,NG141,What is the recommended antibiotic prophylaxis for recurrent cellulitis in adults?
NG141_Summary of the evidence: Managing cellulitis and erysipelas - Part 1,NG141,What is the recommended approach to diagnosing and managing cellulitis and erysipelas in adults?
NG141_Summary of the evidence: Managing cellulitis and erysipelas - Part 2,NG141,What are the recommended management and follow-up procedures for cellulitis and erysipelas according to NICE guidelines?
NG141_Summary of the evidence: Choice of antibiotics - Part 1,NG141,What are the recommended antibiotic options for treating cellulitis and erysipelas in adults?
NG141_Summary of the evidence: Choice of antibiotics - Part 2,NG141,What is the evidence for the effectiveness of different antibiotic regimens in treating cellulitis and erysipelas in children and adults?
NG141_Summary of the evidence: Choice of antibiotics - Part 3,NG141,What are the safety considerations and side effects of using cephalosporins and penicillins for skin infections?
NG141_Summary of the evidence: Choice of antibiotics - Part 4,NG141,"What are the safety considerations and monitoring requirements for using tetracyclines, clindamycin, glycopeptides, and linezolid in different patient populations?"
NG141_Summary of the evidence: Choice of antibiotics - Part 5,NG141,What are the recommended antibiotic options and adverse event considerations for treating cellulitis and erysipelas in children and adults?
NG141_Summary of the evidence: Choice of antibiotics - Part 6,NG141,What is the recommended oral antibiotic treatment for cellulitis and erysipelas according to NICE guidelines?
NG141_Summary of the evidence: Choice of antibiotics - Part 7,NG141,What are the recommended antibiotic options for penicillin-allergic patients with cellulitis or erysipelas?
NG141_Summary of the evidence: Choice of antibiotics - Part 8,NG141,What is the recommended antibiotic treatment for infections near the eyes or nose according to NICE guidelines?
NG141_Summary of the evidence: Antibiotic dose frequency & Summary of the evidence: Antibiotic course length,NG141,What is the recommended antibiotic dose frequency and course length for treating cellulitis in adults?
NG141_Summary of the evidence: Antibiotic route of administration - Part 1,NG141,What is the most effective route of antibiotic administration for treating cellulitis in adults?
NG141_Summary of the evidence: Antibiotic route of administration - Part 2,NG141,What is the recommended duration of antibiotic treatment for cellulitis and erysipelas?
NG141_Summary of the evidence: Antibiotic prophylaxis for the prevention of recurrent cellulitis and erysipelas - Part 1,NG141,What is the effectiveness of antibiotic prophylaxis in preventing recurrent cellulitis and erysipelas in adults?
NG141_Summary of the evidence: Antibiotic prophylaxis for the prevention of recurrent cellulitis and erysipelas - Part 2,NG141,What are the criteria and considerations for antibiotic prophylaxis in adults with recurrent cellulitis or erysipelas?
NG142_End of life care for adults: service delivery & Overview,NG142,What are best practices for organising and delivering end of life care services for adults?
"NG142_Recommendations: 1.1 Identifying adults who may be approaching the end of their life, their carers and other people important to them",NG142,What are the recommended tools for identifying adults approaching the end of their life?
NG142_Recommendations: 1.2 Assessing holistic needs,NG142,What is involved in conducting a holistic needs assessment for adults approaching the end of life?
NG142_Recommendations: 1.3 Supporting carers,NG142,How can healthcare providers effectively support adult carers and address their practical and emotional needs at the end of life?
NG142_Recommendations: 1.4 Providing information,NG142,What are best practices for providing information and supporting shared decision making for adults at the end of life?
NG142_Recommendations: 1.5 Reviewing current treatment,NG142,How should healthcare professionals review and optimise treatment plans for adults nearing the end of life?
NG142_Recommendations: 1.6 Advance care planning - Part 1,NG142,What are the recommended practices for advance care planning in adults approaching the end of life?
NG142_Recommendations: 1.6 Advance care planning - Part 2,NG142,What are the NICE recommendations for advance care planning and end-of-life care services?
NG142_Recommendations: 1.7 Reviewing needs,NG142,What are recommended practices for reviewing the needs and care plans of adults approaching the end of life?
NG142_Recommendations: 1.8 Communicating and sharing information between services,NG142,How should health and social care services communicate and share information for adults approaching the end of life?
NG142_Recommendations: 1.9 Providing multipractitioner care,NG142,What are best practices for providing multipractitioner care to adults approaching the end of life?
NG142_Recommendations: 1.10 Providing end of life care coordination,NG142,What are the key recommendations for end of life care coordination in adults?
NG142_Recommendations: 1.11 Transferring people between care settings,NG142,How can care transitions be optimized for adults approaching the end of life to ensure timely and compassionate transfers?
NG142_Recommendations: 1.12 Providing out-of-hours care,NG142,What are the recommendations for out-of-hours end of life care services for adults?
NG142_Recommendations: Terms used in this guideline - Part 1,NG142,What is advance care planning and how is it implemented in end-of-life care?
NG142_Recommendations: Terms used in this guideline - Part 2,NG142,What is the role of a lead healthcare professional in end-of-life care?
NG142_Recommendations for research: 1 Early review of service provision and referral to additional specialist palliative care services,NG142,Does early referral to specialist palliative care improve outcomes for adults with progressive non-cancer diseases?
NG142_Recommendations for research: 2 Electronic registers and information-sharing databases,NG142,Which electronic information-sharing systems are most effective for end-of-life care in the NHS?
NG142_Recommendations for research: 3 Frequency of community-based reviews,NG142,What are the benefits of regular community-based reviews compared to as-needed reviews for non-cancer patients nearing end of life?
NG142_Recommendations for research: 4 Discharge and transfer from hospital,NG142,What are the best practices for discharging patients approaching the end of life from hospital to their residence?
"NG142_Rationale and impact: Identifying adults who may be approaching the end of their life, their carers and people important to them",NG142,What are the recommended methods for identifying adults approaching the end of life to improve care planning?
NG142_Rationale and impact: Assessing holistic needs,NG142,What are the best practices for assessing holistic needs of patients and carers at the end of life?
NG142_Rationale and impact: Supporting carers,NG142,What are the recommended ways to support carers' mental health and well-being?
NG142_Rationale and impact: Providing information,NG142,How can healthcare providers improve communication and information sharing with patients approaching the end of life?
NG142_Rationale and impact: Reviewing current treatment,NG142,What are the recommended practices for reviewing and adapting end of life care in adult patients?
NG142_Rationale and impact: Advance care planning,NG142,What are the best practices for implementing advance care planning for adults approaching the end of life?
NG142_Rationale and impact: Reviewing needs,NG142,How often should care needs be reviewed for people approaching the end of life?
NG142_Rationale and impact: Communicating and sharing information between services,NG142,What are the best practices for sharing electronic health and social care information between services?
NG142_Rationale and impact: Providing multipractitioner care,NG142,What are the benefits of a multipractitioner approach to end-of-life care?
NG142_Rationale and impact: Providing end of life care coordination,NG142,What are the key principles for coordinating end-of-life care to improve communication and reduce hospital admissions?
NG142_Rationale and impact: Transferring people between care settings,NG142,What are the best practices for transferring adults between care settings at the end of life?
NG142_Rationale and impact: Providing out-of-hours care,NG142,What are the recommended out-of-hours services for end-of-life care?
NG142_Context,NG142,What are the recommended models of end of life care for adults with chronic conditions?
NG143_Fever in under 5s: assessment and initial management & Overview,NG143,What are the initial assessment steps for fever in children under 5 with no obvious cause?
NG143_Recommendations: 1.1 Thermometers and the detection of fever,NG143,What are the recommended methods for measuring body temperature in children aged 0 to 5 years?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 1,NG143,What are the clinical signs to assess for serious illness in children with fever?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 2,NG143,What are the recommended clinical assessments for children presenting with fever?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 3,NG143,What are the signs of dehydration and specific illnesses to look for in children with fever?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 4,NG143,What are the clinical signs and symptoms to assess in children with suspected Kawasaki disease?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 5,NG143,What are the recommended assessments for imported infections and risk stratification in children with fever according to NICE guidelines?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 6,NG143,What is the traffic light system for assessing the risk of serious illness in children?
NG143_Recommendations: 1.2 Clinical assessment of children with fever - Part 7,NG143,What are the key symptoms and signs suggestive of meningococcal disease in children with fever?
NG143_Recommendations: 1.3 Management by remote assessment,NG143,How should healthcare professionals conduct remote assessments for children with fever to identify serious illness?
NG143_Recommendations: 1.4 Management by the non-paediatric practitioner - Part 1,NG143,What are the recommended management steps for children with fever when assessed by a non-paediatric healthcare professional?
NG143_Recommendations: 1.4 Management by the non-paediatric practitioner - Part 2,NG143,What are the criteria for managing children with 'green' features at home and when to seek further medical advice?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 1,NG143,What is the recommended management and investigation protocol for febrile children under 3 months?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 2,NG143,What are the recommended investigations for children with fever without apparent source and 'amber' features according to NICE guidelines?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 3,NG143,What are the recommended diagnostic tests for febrile children with suspected urinary tract infection or respiratory illness?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 4,NG143,What are the recommended observation and treatment protocols for children with fever in hospital?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 5,NG143,When should oxygen be administered to children with fever and signs of shock or low oxygen saturation?
NG143_Recommendations: 1.5 Management by the paediatric specialist - Part 6,NG143,What safety net advice should be provided to parents of children with suspected serious infections who are not admitted to hospital?
NG143_Recommendations: 1.6 Antipyretic interventions,NG143,Should antipyretic agents be used solely to reduce fever in children?
NG143_Recommendations: 1.7 Advice for home care & Recommendations: Terms used in this guideline,NG143,What are the recommended home care steps for managing a child's fever?
NG143_Recommendations for research,NG143,What are the signs and symptoms that predict Kawasaki disease in children with prolonged fever?
NG143_Rationale and impact,NG143,What are the clinical features and diagnostic criteria for Kawasaki disease in children?
NG143_Context,NG143,What are the recommended initial assessment and management steps for fever in young children?
NG144_Cannabis-based medicinal products & Overview,NG144,What are the indications and prescribing guidelines for cannabis-based medicinal products according to NICE NG144?
NG144_Recommendations: 1.1 Intractable nausea and vomiting,NG144,What are the guidelines for using nabilone as an add-on treatment for chemotherapy-induced nausea and vomiting?
NG144_Recommendations: 1.2 Chronic pain,NG144,What are the recommended treatments for managing chronic pain in adults according to NICE guidelines?
NG144_Recommendations: 1.3 Spasticity,NG144,What are the criteria for prescribing THC:CBD spray for spasticity in multiple sclerosis patients?
NG144_Recommendations: 1.4 Severe treatment-resistant epilepsy - Part 1,NG144,What are the criteria for using cannabidiol in treatment-resistant epilepsy for tuberous sclerosis complex and Lennox–Gastaut syndrome?
NG144_Recommendations: 1.4 Severe treatment-resistant epilepsy - Part 2,NG144,What are the NICE recommendations for using cannabidiol with clobazam in treating Dravet syndrome?
NG144_Recommendations: 1.5 Prescribing - Part 1,NG144,Who is authorized to prescribe cannabis-based medicinal products and how is shared care managed?
NG144_Recommendations: 1.5 Prescribing - Part 2,NG144,What are the guidelines for prescribing and monitoring cannabis-based medicinal products?
NG144_Recommendations: 1.5 Prescribing - Part 3,NG144,What should healthcare professionals discuss with patients before prescribing cannabis-based medicinal products?
NG144_Recommendations: Terms used in this guideline & Recommendations for research: Key recommendations for research - Part 1,NG144,"What is the clinical and cost effectiveness of cannabidiol (CBD) for managing chronic pain, fibromyalgia, or treatment-resistant epilepsy?"
NG144_Recommendations for research: Key recommendations for research - Part 2,NG144,What is the effectiveness of THC combined with CBD in reducing seizures in treatment-resistant epilepsy?
NG144_Recommendations for research: Other recommendations for research,NG144,What is the effectiveness of cannabis-based medicinal products for treating intractable nausea and vomiting in adults and young people?
NG144_Rationale and impact: Intractable nausea and vomiting - Part 1,NG144,What are the recommended uses of nabilone for intractable chemotherapy-induced nausea and vomiting?
NG144_Rationale and impact: Intractable nausea and vomiting - Part 2,NG144,What are the considerations and potential drug interactions when prescribing nabilone for chemotherapy-induced nausea and vomiting?
NG144_Rationale and impact: Chronic pain,NG144,What is the evidence for using cannabis-based medicinal products to manage chronic pain in adults?
NG144_Rationale and impact: Spasticity - Part 1,NG144,What are the recommendations for using THC:CBD spray to treat spasticity in multiple sclerosis?
NG144_Rationale and impact: Spasticity - Part 2,NG144,What is the current guidance on using THC:CBD spray for spasticity in multiple sclerosis?
NG144_Rationale and impact: Severe treatment-resistant epilepsy - Part 1,NG144,"What is the current evidence on the effectiveness and safety of cannabis-based medicinal products, including CBD and THC, for treatment-resistant epilepsy?"
NG144_Rationale and impact: Severe treatment-resistant epilepsy - Part 2,NG144,What is the current evidence on the safety and effectiveness of cannabis-based medicinal products for severe treatment-resistant epilepsy?
NG144_Rationale and impact: Prescribing: who should prescribe and shared care - Part 1,NG144,Who should prescribe cannabis-based medicinal products for patients with multiple sclerosis or epilepsy?
NG144_Rationale and impact: Prescribing: who should prescribe and shared care - Part 2,NG144,How should shared care be implemented for prescribing and monitoring cannabis-based medicinal products?
NG144_Rationale and impact: Prescribing: factors to think about when prescribing,NG144,What factors should I consider before prescribing cannabis-based medicinal products?
NG144_Rationale and impact: Prescribing: supporting shared decision making,NG144,What are the best practices for supporting shared decision making when prescribing cannabis-based medicinal products?
NG144_Context - Part 1,NG144,Which cannabis-based medicines are licensed for medical use in the UK and what conditions do they treat?
NG144_Context - Part 2,NG144,What are the legal requirements for prescribing cannabis-based medicinal products in the UK?
NG145_Thyroid disease: assessment and management & Overview,NG145,What are the recommended approaches for diagnosing and managing primary thyroid disease?
"NG145_Recommendations: 1.1 Information for people with thyroid disease, their families and carers - Part 1",NG145,What information should be provided to patients and families about managing thyroid disease and treatment options?
"NG145_Recommendations: 1.1 Information for people with thyroid disease, their families and carers - Part 2",NG145,"What information should be provided to patients and families about the causes, treatment options, and risks of thyrotoxicosis and thyroid enlargement?"
NG145_Recommendations: 1.2 Investigating suspected thyroid dysfunction - Part 1,NG145,When should I test for thyroid dysfunction in adults and children?
NG145_Recommendations: 1.2 Investigating suspected thyroid dysfunction - Part 2,NG145,What are the recommended blood tests for diagnosing thyroid dysfunction in adults and children?
NG145_Recommendations: 1.3 Managing primary hypothyroidism,NG145,What is the recommended first-line treatment for primary hypothyroidism in adults and children?
NG145_Recommendations: 1.4 Follow-up and monitoring of primary hypothyroidism,NG145,What are the recommended follow-up and monitoring strategies for primary hypothyroidism in adults and children?
NG145_Recommendations: 1.5 Managing and monitoring subclinical hypothyroidism - Part 1,NG145,What are the criteria for starting levothyroxine treatment in adults with subclinical hypothyroidism?
NG145_Recommendations: 1.5 Managing and monitoring subclinical hypothyroidism - Part 2,NG145,What are the NICE guidelines for monitoring subclinical hypothyroidism in children aged 28 days to 2 years?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 1,NG145,What are the recommended tests for diagnosing thyrotoxicosis in adults and children?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 2,NG145,What are the recommended initial management options for adults with Graves' disease and hyperthyroidism?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 3,NG145,What are the first-line treatment options for adults with Graves' disease?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 4,NG145,What are the recommended treatment options for adults with toxic nodular goitre according to NICE guidelines?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 5,NG145,What are the recommended treatment options for children and young people with Graves' disease or toxic nodular goitre?
NG145_Recommendations: 1.6 Managing thyrotoxicosis - Part 6,NG145,What are the guidelines for prescribing carbimazole to children and young people with Graves' disease?
NG145_Recommendations: 1.7 Follow-up and monitoring of hyperthyroidism - Part 1,NG145,How should follow-up and monitoring be managed after radioactive iodine treatment for hyperthyroidism?
NG145_Recommendations: 1.7 Follow-up and monitoring of hyperthyroidism - Part 2,NG145,What are the recommended follow-up and monitoring protocols for patients after thyroid surgery or antithyroid drug treatment?
NG145_Recommendations: 1.8 Managing and monitoring subclinical hyperthyroidism,NG145,What are the recommended management and monitoring strategies for subclinical hyperthyroidism in adults and young people?
"NG145_Recommendations: 1.9 Diagnosing, managing and monitoring thyroid enlargement with normal thyroid function - Part 1",NG145,What are the recommended diagnostic and management strategies for thyroid enlargement with normal thyroid function?
"NG145_Recommendations: 1.9 Diagnosing, managing and monitoring thyroid enlargement with normal thyroid function - Part 2",NG145,What are the recommended follow-up procedures for adults with non-malignant thyroid enlargement who are not receiving treatment?
NG145_Recommendations: Terms used in this guideline,NG145,What is the difference between hyperthyroidism and thyrotoxicosis?
NG145_Recommendations for research: Key recommendations for research,NG145,What is the effectiveness of levothyroxine and liothyronine combination therapy compared to T4 alone for hypothyroidism?
NG145_Recommendations for research: Other recommendations for research,NG145,What is the effectiveness of percutaneous thermal ablation for benign thyroid nodules?
"NG145_Rationale and impact: Information for people with thyroid disease, their families and carers",NG145,What information should be provided to patients with thyroid disease about treatment options and managing symptoms?
NG145_Rationale and impact: Indications for tests for thyroid dysfunction,NG145,What are the indications for testing thyroid function in patients with autoimmune diseases or atrial fibrillation?
NG145_Rationale and impact: Tests when thyroid dysfunction is suspected,NG145,What is the recommended initial test for suspected thyroid dysfunction according to NICE guidelines?
NG145_Rationale and impact: Tests for people with confirmed primary hypothyroidism,NG145,Should thyroid peroxidase antibody testing be repeated in adults with primary hypothyroidism?
NG145_Rationale and impact: Managing primary hypothyroidism - Part 1,NG145,What are the recommended treatment options for primary hypothyroidism?
NG145_Rationale and impact: Managing primary hypothyroidism - Part 2,NG145,What is the recommended starting dose of levothyroxine for treating hypothyroidism in adults?
NG145_Rationale and impact: Follow-up and monitoring of primary hypothyroidism,NG145,What is the recommended follow-up schedule for monitoring TSH levels in primary hypothyroidism patients?
NG145_Rationale and impact: Managing and monitoring subclinical hypothyroidism - Part 1,NG145,What are the criteria for treating subclinical hypothyroidism in adults?
NG145_Rationale and impact: Managing and monitoring subclinical hypothyroidism - Part 2,NG145,What are the NICE guidelines for testing and managing subclinical hypothyroidism in children and young people?
NG145_Rationale and impact: Tests for people with confirmed thyrotoxicosis - Part 1,NG145,What tests are recommended to determine the cause of thyrotoxicosis in adults and children?
NG145_Rationale and impact: Tests for people with confirmed thyrotoxicosis - Part 2,NG145,When should ultrasound or technetium scanning be used to diagnose Graves' disease?
NG145_Rationale and impact: Initial management in primary/non-specialist care for people with thyrotoxicosis,NG145,What is the recommended initial management of thyrotoxicosis in primary care?
NG145_Rationale and impact: Treatment for adults with Graves' disease - Part 1,NG145,What is the recommended first-line treatment for adults with Graves' disease?
NG145_Rationale and impact: Treatment for adults with Graves' disease - Part 2,NG145,What are the recommended surgical options for treating Graves' disease?
NG145_Rationale and impact: Treatment for adults with toxic nodular goitre,NG145,What is the recommended first-line treatment for hyperthyroidism caused by toxic nodular goitre?
NG145_Rationale and impact: Treatment for children and young people with Graves' disease or toxic nodular goitre,NG145,What is the recommended first-line treatment for children and young people with Graves' disease or toxic nodular goitre?
NG145_Rationale and impact: Antithyroid drugs for people with hyperthyroidism - Part 1,NG145,What is the recommended duration of carbimazole treatment for hyperthyroidism?
NG145_Rationale and impact: Antithyroid drugs for people with hyperthyroidism - Part 2,NG145,What are the differences between block and replace and titration regimens for treating hyperthyroidism in adults?
NG145_Rationale and impact: Follow-up and monitoring of hyperthyroidism,NG145,What is the recommended follow-up and monitoring schedule for hyperthyroidism after radioactive iodine treatment?
NG145_Rationale and impact: Managing and monitoring subclinical hyperthyroidism,NG145,What are the current recommendations for managing and monitoring subclinical hyperthyroidism?
NG145_Rationale and impact: Investigating non-malignant thyroid enlargement with normal thyroid function - Part 1,NG145,What are the recommended ultrasound features for assessing thyroid nodules in non-malignant thyroid enlargement?
NG145_Rationale and impact: Investigating non-malignant thyroid enlargement with normal thyroid function - Part 2,NG145,What are the benefits of using ultrasound guidance for fine needle aspiration of thyroid nodules?
NG145_Rationale and impact: Managing non-malignant thyroid enlargement - Part 1,NG145,What are the recommended management options for non-malignant thyroid enlargement in adults and children?
NG145_Rationale and impact: Managing non-malignant thyroid enlargement - Part 2,NG145,What are the recommended approaches for monitoring non-malignant thyroid enlargement in children and adults?
NG145_Context - Part 1,NG145,What are the diagnostic criteria and management options for hypothyroidism and hyperthyroidism?
NG145_Context - Part 2,NG145,What are the recommended management and follow-up strategies for subclinical thyroid dysfunction in primary care?
NG146_Workplace health: long-term sickness absence and capability to work & Overview & Recommendations: 1.1 Workplace culture and policies - Part 1,NG146,What strategies can organizations implement to support employees returning to work after long-term sickness absence?
NG146_Recommendations: 1.1 Workplace culture and policies - Part 2,NG146,How can organizations effectively monitor and review sickness absence policies and trends to support employee health?
NG146_Recommendations: 1.2 Assessing and certifying fitness for work,NG146,What are the best practices for assessing and certifying fitness for work according to NICE guidelines?
NG146_Recommendations: 1.3 Statement of fitness for work - Part 1,NG146,What are the recommended procedures for managing a statement of fitness for work and supporting employee return to work?
NG146_Recommendations: 1.3 Statement of fitness for work - Part 2,NG146,What are the recommended procedures for explaining the inability to make work adjustments to employees?
NG146_Recommendations: 1.4 Making workplace adjustments,NG146,What are best practices for making and monitoring workplace adjustments for employees returning from sickness absence?
NG146_Recommendations: 1.5 Keeping in touch with people on sickness absence,NG146,What are best practices for keeping in touch with employees on sickness absence to support their return to work?
NG146_Recommendations: 1.6 Early intervention,NG146,What are the recommended early intervention strategies for employees on long-term sickness absence?
NG146_Recommendations: 1.7 Sustainable return to work and reducing recurrence of absence,NG146,What interventions are recommended to support return to work and prevent recurrence for people with musculoskeletal or mental health conditions after long-term absence?
NG146_Recommendations: 1.8 People with a health condition or disability who are not currently employed & Recommendations: Terms used in this guideline - Part 1,NG146,What interventions are recommended to help people with disabilities or health conditions who are not currently employed to return to work?
NG146_Recommendations: Terms used in this guideline - Part 2,NG146,What is graded activity and how is it used in managing musculoskeletal conditions?
NG146_Recommendations for research: Key recommendations for research - Part 1,NG146,What interventions are effective and cost effective for supporting return to work after long-term sickness absence due to mental health conditions in the UK?
NG146_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG146,What interventions are effective and cost-effective for supporting employees in non-centralized organizations to return to work after long-term sickness absence in the UK?
NG146_Rationale and impact: Workplace culture and policies - Part 1,NG146,What are best practices for workplace policies to support sickness absence management and return to work?
NG146_Rationale and impact: Workplace culture and policies - Part 2,NG146,What are the benefits of early access to occupational health interventions for employees returning to work after long-term sickness absence?
NG146_Rationale and impact: Workplace culture and policies - Part 3,NG146,What are effective strategies for supporting employees to return to work after long-term sickness absence in the UK?
NG146_Rationale and impact: Assessing and certifying fitness for work - Part 1,NG146,What are the recommended practices for assessing and certifying fitness for work?
NG146_Rationale and impact: Assessing and certifying fitness for work - Part 2,NG146,How should GPs document and communicate the impact of a patient's health condition on their ability to work in fit notes?
NG146_Rationale and impact: Statement of fitness for work - Part 1,NG146,What are the best practices for managing fit notes and supporting employees returning to work?
NG146_Rationale and impact: Statement of fitness for work - Part 2,NG146,What should employers do if workplace adjustments cannot be agreed for employees returning to work with a disability?
NG146_Rationale and impact: Making workplace adjustments,NG146,What are best practices for making workplace adjustments to support employees returning from sick leave?
NG146_Rationale and impact: Keeping in touch with people on sickness absence - Part 1,NG146,What are the NICE recommendations for keeping in touch with employees on sickness absence?
NG146_Rationale and impact: Keeping in touch with people on sickness absence - Part 2,NG146,What are best practices for maintaining communication with employees on sickness absence to support their return to work?
NG146_Rationale and impact: Early intervention - Part 1,NG146,What are the benefits of early intervention and occupational health services for employee wellbeing and sickness absence?
NG146_Rationale and impact: Early intervention - Part 2,NG146,What are effective strategies for supporting return to work after sickness absence in small and medium-sized UK organizations?
NG146_Rationale and impact: Sustainable return to work and reducing recurrence of absence - Part 1,NG146,What strategies are recommended to support sustainable return to work and prevent recurrence of absence due to musculoskeletal and mental health conditions?
NG146_Rationale and impact: Sustainable return to work and reducing recurrence of absence - Part 2,NG146,What are effective interventions to support return to work for people with mental health conditions?
NG146_Context - Part 1,NG146,What strategies can help employees return to work after long-term sickness absence?
NG146_Context - Part 2,NG146,What support is available for employees with mental health issues and long-term sickness absence?
NG147_Diverticular disease: diagnosis and management & Overview & Recommendations: 1.1 Diverticulosis,NG147,What dietary and lifestyle advice should be given to patients with asymptomatic diverticulosis?
NG147_Recommendations: 1.2 Diverticular disease - Part 1,NG147,What are the recommended investigations and referral criteria for suspected diverticular disease?
NG147_Recommendations: 1.2 Diverticular disease - Part 2,NG147,What are the recommended management strategies for diverticular disease and prevention of complications?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 1,NG147,What are the symptoms and signs of acute diverticulitis and when should I suspect it?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 2,NG147,What are the recommended investigations and management strategies for suspected acute diverticulitis?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 3,NG147,What is the recommended antibiotic prescribing strategy for acute diverticulitis based on severity and patient comorbidities?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 4,NG147,What are the recommended antibiotics for treating acute diverticulitis in adults?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 5,NG147,What is the recommended antibiotic management for complicated acute diverticulitis with suspected abscess?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 6,NG147,What are the recommended management options for diverticular abscesses and perforations according to NICE guidelines?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 7,NG147,What are the factors to consider when choosing between laparoscopic lavage and resectional surgery for diverticular perforation with generalized peritonitis?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 8,NG147,What are the surgical options for managing complicated acute diverticulitis?
NG147_Recommendations: 1.3 Acute diverticulitis - Part 9,NG147,What are the recommended management strategies for recurrent acute diverticulitis according to NICE guidelines?
NG147_Recommendations: 1.4 Information & Recommendations: Terms used in this guideline,NG147,What information should be provided to patients about managing diverticulosis and diverticular disease?
NG147_Recommendations for research: Key recommendations for research - Part 1,NG147,What is the most effective management strategy for diverticular disease in primary care?
NG147_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG147,What are the risk factors for progression from diverticulosis to diverticular disease?
NG147_Rationale and impact: Diverticulosis management and advice,NG147,What lifestyle and dietary advice are recommended for preventing diverticular disease in patients with diverticulosis?
NG147_Rationale and impact: Symptoms and signs of diverticular disease & Rationale and impact: Investigations and referral for diverticular disease,NG147,What are the common symptoms and signs of diverticular disease?
NG147_Rationale and impact: Management and advice for people with diverticular disease & Rationale and impact: Recurrent diverticular disease,NG147,What are the recommended management strategies for symptoms of diverticular disease?
NG147_Rationale and impact: Symptoms and signs of acute diverticulitis & Rationale and impact: Symptoms and signs of complicated acute diverticulitis,NG147,What are the symptoms and signs of acute diverticulitis and how can they be distinguished from other diverticular conditions?
NG147_Rationale and impact: Investigation of suspected acute diverticulitis - Part 1,NG147,What are the recommended diagnostic tests for suspected acute diverticulitis?
NG147_Rationale and impact: Investigation of suspected acute diverticulitis - Part 2,NG147,What are the recommended imaging options for diagnosing acute diverticulitis when contrast CT is contraindicated?
NG147_Rationale and impact: Non-surgical management of acute diverticulitis,NG147,What is the recommended non-surgical management for acute diverticulitis in primary care?
NG147_Rationale and impact: Management of abscesses in complicated acute diverticulitis,NG147,What is the recommended management for abscesses in complicated acute diverticulitis?
NG147_Rationale and impact: Management of bowel perforations in complicated acute diverticulitis,NG147,What are the treatment options for bowel perforation in complicated acute diverticulitis?
NG147_Rationale and impact: Anastomosis for people with complicated acute diverticulitis,NG147,What are the surgical options for managing complicated acute diverticulitis?
NG147_Rationale and impact: Bowel resection for people with complicated acute diverticulitis & Rationale and impact: Elective surgical management after resolution of complicated acute diverticulitis,NG147,What is the recommended extent of bowel resection for complicated acute diverticulitis?
NG147_Rationale and impact: Timing of surgery for complicated acute diverticulitis & Rationale and impact: Management of recurrent acute diverticulitis,NG147,What is the recommended timing for surgery in complicated acute diverticulitis?
NG147_Rationale and impact: Information,NG147,"What information should be provided to patients and their families about diverticulosis, diverticular disease, and diverticulitis?"
NG147_Context,NG147,What are the recommended management strategies for acute diverticulitis and its complications?
"NG148_Acute kidney injury: prevention, detection and management & Overview",NG148,What are the best practices for preventing and managing acute kidney injury in adults and children?
NG148_Recommendations: 1.1 Assessing risk of acute kidney injury - Part 1,NG148,What are the risk factors and indicators for assessing acute kidney injury in adults and children with acute illness?
NG148_Recommendations: 1.1 Assessing risk of acute kidney injury - Part 2,NG148,What are the guidelines for assessing and managing the risk of acute kidney injury before using iodine-based contrast media?
NG148_Recommendations: 1.1 Assessing risk of acute kidney injury - Part 3,NG148,What are the guidelines for assessing kidney injury risk before surgery and during contrast media procedures?
NG148_Recommendations: 1.2 Preventing acute kidney injury - Part 1,NG148,What are the recommended strategies for preventing acute kidney injury in hospitalized adults and children?
NG148_Recommendations: 1.2 Preventing acute kidney injury - Part 2,NG148,What are the recommended precautions to prevent acute kidney injury in patients undergoing iodine-based contrast media procedures?
NG148_Recommendations: 1.2 Preventing acute kidney injury - Part 3,NG148,What precautions should be taken before administering iodine-based contrast media to adults on renal replacement therapy?
NG148_Recommendations: 1.3 Detecting acute kidney injury,NG148,How is acute kidney injury detected and monitored in clinical practice?
NG148_Recommendations: 1.4 Identifying the cause(s) of acute kidney injury,NG148,What are the recommended diagnostic steps for identifying the cause of acute kidney injury?
NG148_Recommendations: 1.5 Managing acute kidney injury - Part 1,NG148,What are the recommended management strategies for acute kidney injury related to urological obstruction?
NG148_Recommendations: 1.5 Managing acute kidney injury - Part 2,NG148,When should I refer a patient for renal replacement therapy in acute kidney injury?
NG148_Recommendations: 1.5 Managing acute kidney injury - Part 3,NG148,When should adults and children with acute kidney injury be referred to a nephrology specialist?
NG148_Recommendations: 1.6 Information and support for patients and carers,NG148,What information should be provided to patients and carers about managing and preventing acute kidney injury?
NG148_Recommendations: Terms used in this guideline,NG148,What is first-pass renal exposure in contrast media administration?
NG148_Recommendations for research: Key recommendations for research - Part 1,NG148,What risk assessment tools are validated for predicting contrast-associated acute kidney injury after iodine-based contrast media?
NG148_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG148,"What are the most effective oral fluid regimens, with or without N-acetylcysteine, for preventing contrast-induced acute kidney injury?"
NG148_Rationale and impact: Assessing risk factors in adults having iodine-based contrast media - Part 1,NG148,What are the recommended methods for assessing kidney function before iodine-based contrast media administration?
NG148_Rationale and impact: Assessing risk factors in adults having iodine-based contrast media - Part 2,NG148,How does using a 30 ml/min/1.73 m2 eGFR threshold impact kidney risk assessment before contrast media?
NG148_Rationale and impact: Preventing acute kidney injury in adults having iodine-based contrast media - Part 1,NG148,What are the recommended hydration strategies to prevent contrast-induced acute kidney injury in adults undergoing iodine-based contrast media procedures?
NG148_Rationale and impact: Preventing acute kidney injury in adults having iodine-based contrast media - Part 2,NG148,What is the effectiveness of oral hydration compared to intravenous hydration in preventing contrast-induced acute kidney injury?
NG148_Context - Part 1,NG148,What are the best practices for early detection and management of acute kidney injury in primary care?
NG148_Context - Part 2,NG148,What are the current NICE recommendations for assessing risk of acute kidney injury before iodine-based contrast media in adults?
NG148_Finding more information and resources,NG148,Where can I find additional resources and evidence for the NICE guideline on acute kidney injury?
NG149_Indoor air quality at home & Overview,NG149,What are effective strategies to improve indoor air quality in residential homes?
NG149_Recommendations: 1.1 Prioritising indoor air quality in local strategy or plans - Part 1,NG149,What strategies can local authorities implement to improve indoor air quality in homes?
NG149_Recommendations: 1.1 Prioritising indoor air quality in local strategy or plans - Part 2,NG149,What are effective strategies for assessing and improving indoor air quality during home visits?
NG149_Recommendations: 1.2 Referrals for a housing assessment,NG149,What are the recommended procedures for health and social care professionals to refer individuals for a housing assessment due to poor indoor air quality?
NG149_Recommendations: 1.3 Raising awareness of poor indoor air quality in the home,NG149,What strategies can local authorities use to raise awareness of poor indoor air quality in homes?
NG149_Recommendations: 1.4 Advice and information for the general population - Part 1,NG149,"What are effective ways to reduce indoor damp, condensation, and mould in homes?"
NG149_Recommendations: 1.4 Advice and information for the general population - Part 2,NG149,What are the recommended measures to reduce indoor air pollution from household materials and appliances?
NG149_Recommendations: 1.5 Healthcare professionals - Part 1,NG149,What are the recommended strategies for reducing indoor air pollution to help manage asthma and respiratory conditions?
NG149_Recommendations: 1.5 Healthcare professionals - Part 2,NG149,What are the recommendations for reducing indoor air pollution risks for pregnant women and infants?
NG149_Recommendations: 1.6 Regulators and building control teams,NG149,What are the current building regulations and enforcement practices for indoor air quality standards?
NG149_Recommendations: 1.7 Architects and designers - Part 1,NG149,What are the best design strategies to reduce indoor air pollution in buildings?
NG149_Recommendations: 1.7 Architects and designers - Part 2,NG149,What are the recommendations for ensuring effective ventilation when building or refurbishing dwellings to improve thermal performance?
"NG149_Recommendations: 1.8 Builders, contractors and developers",NG149,What are the recommended building regulations and material standards for ventilation and heating systems in new and renovated homes?
NG149_Recommendations: 1.9 Rental properties - Part 1,NG149,What are the recommended regulations for ensuring good indoor air quality in rented housing?
NG149_Recommendations: 1.9 Rental properties - Part 2,NG149,"What are the recommended practices for landlords to reduce indoor air pollution and ensure safe ventilation when replacing furniture, flooring, or installing gas appliances?"
NG149_Recommendations: Terms used in this guideline,NG149,What is particulate matter and how does it affect indoor air quality?
NG149_Recommendations for research: Key recommendations for research - Part 1,NG149,What are the most effective interventions to improve indoor air quality at home for people without pre-existing health conditions?
NG149_Recommendations for research: Key recommendations for research - Part 2,NG149,What is the recommended air exchange rate to improve indoor air quality and reduce health risks in homes?
NG149_Recommendations for research: Key recommendations for research - Part 3,NG149,What are the health impacts of indoor air pollutants emitted from building materials in homes?
NG149_Recommendations for research: Other recommendations for research,NG149,What are the best strategies for preventing and fixing damp and mould in residential homes?
NG149_Rationale and impact: Prioritising indoor air quality in local strategy or plans - Part 1,NG149,How can local authorities improve indoor air quality to protect vulnerable groups?
NG149_Rationale and impact: Prioritising indoor air quality in local strategy or plans - Part 2,NG149,What factors should be considered to improve indoor air quality in homes near busy roads or industrial sources?
NG149_Rationale and impact: Prioritising indoor air quality in local strategy or plans - Part 3,NG149,What are the recommended strategies for monitoring indoor air quality in homes to improve public health?
NG149_Rationale and impact: Referrals for a housing assessment,NG149,How can healthcare professionals facilitate housing assessments for patients with poor indoor air quality?
NG149_Rationale and impact: Raising awareness of poor indoor air quality in the home - Part 1,NG149,What are the best ways to improve indoor air quality in homes to reduce health risks?
NG149_Rationale and impact: Raising awareness of poor indoor air quality in the home - Part 2,NG149,What are effective strategies for raising awareness of indoor air quality issues in residential settings?
NG149_Rationale and impact: Advice and information for the general population - Part 1,NG149,What advice can help reduce indoor air pollution from cooking and heating sources?
NG149_Rationale and impact: Advice and information for the general population - Part 2,NG149,What are effective ways to improve indoor air quality and reduce health risks from poor ventilation and indoor pollutants?
NG149_Rationale and impact: Healthcare professionals - Part 1,NG149,What advice should healthcare professionals give to patients about indoor air quality and respiratory health?
NG149_Rationale and impact: Healthcare professionals - Part 2,NG149,What are effective ways to improve indoor air quality for pregnant women and young children?
NG149_Rationale and impact: Regulators and building control teams,NG149,How do building regulations and standards ensure indoor air quality in homes?
NG149_Rationale and impact: Architects and designers - Part 1,NG149,What are the recommended building materials and ventilation strategies to improve indoor air quality and reduce pollutant exposure in homes?
NG149_Rationale and impact: Architects and designers - Part 2,NG149,"What are effective strategies for balancing ventilation, heating, and energy efficiency to improve indoor air quality in homes?"
"NG149_Rationale and impact: Builders, contractors and developers",NG149,What are the building regulation requirements for indoor air quality in residential construction and refurbishment?
NG149_Rationale and impact: Rental properties - Part 1,NG149,What are the legal requirements for heating and ventilation systems in rental properties to ensure occupant health and safety?
NG149_Rationale and impact: Rental properties - Part 2,NG149,What are the best practices for property maintenance to prevent indoor air pollution and health hazards?
NG149_Context,NG149,What are effective strategies to reduce indoor air pollution and protect vulnerable populations from respiratory health risks?
NG149_Finding more information and resources,NG149,Where can I find additional resources and evidence related to NICE environmental health guidance?
NG14_Melanoma: assessment and management & Overview & Stages of melanoma,NG14,What are the recommended assessment and management strategies for melanoma according to NICE guideline NG14?
NG14_Recommendations: 1.1 Communication and support,NG14,What information and support should be provided to people with melanoma throughout their care?
NG14_Recommendations: 1.2 Managing vitamin D levels and concurrent drug treatment,NG14,How should vitamin D levels be managed in patients with melanoma receiving immunosuppressive or immunomodulatory treatments?
NG14_Recommendations: 1.3 Assessing melanoma - Part 1,NG14,How should pigmented skin lesions be assessed for melanoma using dermoscopy and photography?
NG14_Recommendations: 1.3 Assessing melanoma - Part 2,NG14,When should BRAF analysis be performed on melanoma tissue samples in different stages of primary melanoma?
NG14_Recommendations: 1.4 Staging with sentinel lymph node biopsy - Part 1,NG14,When should sentinel lymph node biopsy be performed in melanoma patients?
NG14_Recommendations: 1.4 Staging with sentinel lymph node biopsy - Part 2 & Recommendations: 1.5 Managing stages 0 to II melanoma,NG14,"What are the recommended staging procedures for melanoma in children, young adults, and pregnant women?"
NG14_Recommendations: 1.5 Managing stages 0 to II melanoma & Recommendations: 1.6 Managing stage III melanoma,NG14,What are the recommended excision margins for stages 0 to II melanoma?
NG14_Recommendations: 1.6 Managing stage III melanoma - Part 1,NG14,What are the current recommendations for lymph node dissection and adjuvant treatments in stage III melanoma?
NG14_Recommendations: 1.6 Managing stage III melanoma - Part 2 & Recommendations: 1.7 Treating in-transit metastases in stages III and IV melanoma,NG14,What are the recommended adjuvant treatments and radiotherapy options for stage III melanoma according to NICE guidelines?
NG14_Recommendations: 1.7 Treating in-transit metastases in stages III and IV melanoma,NG14,What are the recommended treatment options for in-transit metastases in stage III and IV melanoma?
NG14_Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma & Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma - Part 1,NG14,What are the recommended management options for stage IV and unresectable stage III melanoma?
NG14_Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma - Part 2,NG14,What are the recommended immunotherapy options for untreated stage IV melanoma?
NG14_Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma - Part 3,NG14,What are the recommended targeted therapies for BRAF V600 mutation-positive melanoma when immunotherapy is contraindicated or unsuitable?
NG14_Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma - Part 4,NG14,What are the recommended treatment options for untreated BRAF-wild type stage IV or unresectable stage III melanoma when immunotherapy is contraindicated?
NG14_Recommendations: 1.8 Managing stage IV and unresectable stage III melanoma - Part 5,NG14,What are the recommended treatment options for people with previously treated melanoma who cannot receive immunotherapy or targeted therapy?
NG14_Recommendations: 1.9 Follow-up after treatment for melanoma - Part 1,NG14,What follow-up care and support are recommended after treatment for melanoma?
NG14_Recommendations: 1.9 Follow-up after treatment for melanoma - Part 2,NG14,What are the recommended follow-up imaging options for women with melanoma during pregnancy?
NG14_Recommendations: 1.9 Follow-up after treatment for melanoma - Part 3,NG14,What is the recommended follow-up schedule for stage I to IV melanoma patients after treatment?
NG14_Recommendations: 1.9 Follow-up after treatment for melanoma - Part 4,NG14,What are the recommended follow-up procedures for patients with melanoma according to NICE guidelines?
NG14_Recommendations for research: Key recommendations for research - Part 1,NG14,What is the role of biomarkers in predicting recurrence and guiding treatment in melanoma?
NG14_Recommendations for research: Key recommendations for research - Part 2,NG14,What are the recommended surveillance imaging intervals and modalities for stage IIB to IIIC melanoma?
NG14_Recommendations for research: Other recommendations for research - Part 1,NG14,What are the most effective diagnostic techniques for atypical Spitzoid melanocytic lesions in predicting melanoma-specific survival?
NG14_Recommendations for research: Other recommendations for research - Part 2,NG14,What is the effectiveness of vitamin D supplementation on survival outcomes in patients with stage I to III melanoma?
NG14_Rationale and impact: BRAF analysis of melanoma tissue samples - Part 1,NG14,What are the current recommendations for BRAF testing in stage IIC to IV melanoma?
NG14_Rationale and impact: BRAF analysis of melanoma tissue samples - Part 2,NG14,How is BRAF V600E immunohistochemistry used in genetic testing for melanoma?
NG14_Rationale and impact: Staging with sentinel lymph node biopsy and imaging - Part 1,NG14,What is the recommended sequence of sentinel lymph node biopsy and imaging in cancer staging?
NG14_Rationale and impact: Staging with sentinel lymph node biopsy and imaging - Part 2 & Rationale and impact: Excision for stages 0 to II melanoma,NG14,What are the recommended imaging practices for staging and follow-up in melanoma patients?
NG14_Rationale and impact: Excision for stages 0 to II melanoma & Rationale and impact: Managing stage III melanoma,NG14,What are the recommended excision margins for stage 0 to II melanoma?
NG14_Rationale and impact: Managing stage III melanoma,NG14,What are the current recommendations for managing stage III melanoma regarding lymph node dissection and sentinel lymph node biopsy?
NG14_Rationale and impact: Treating in-transit metastases in stages III and IV melanoma,NG14,What are the current treatment options for in-transit metastases in stage III and IV melanoma?
NG14_Rationale and impact: Managing stage IV and unresectable stage III melanoma - Part 1,NG14,What are the recommended treatments for stage IV and unresectable stage III melanoma?
NG14_Rationale and impact: Managing stage IV and unresectable stage III melanoma - Part 2,NG14,What are the recommended systemic treatment options for BRAF-mutated melanoma with brain metastases?
NG14_Rationale and impact: Follow-up after treatment for melanoma - Part 1,NG14,What are the recommended follow-up procedures and frequency after treatment for melanoma?
NG14_Rationale and impact: Follow-up after treatment for melanoma - Part 2,NG14,What are the recommended imaging modalities for follow-up in melanoma patients to detect brain metastases?
NG14_Rationale and impact: Follow-up after treatment for melanoma - Part 3,NG14,What is the role of ultrasound in follow-up for melanoma patients with positive sentinel lymph nodes?
NG14_Context,NG14,What are the risk factors and prevention strategies for melanoma skin cancer?
NG150_Supporting adult carers & Overview,NG150,What support and assessments are recommended for adult carers providing unpaid care under NICE guidelines?
NG150_Recommendations: 1.1 Information and support for carers: overarching principles - Part 1,NG150,What information and support should local authorities provide to carers according to NICE guidelines?
NG150_Recommendations: 1.1 Information and support for carers: overarching principles - Part 2,NG150,How can healthcare professionals effectively provide and update information to carers to meet their changing needs?
NG150_Recommendations: 1.1 Information and support for carers: overarching principles - Part 3,NG150,How should health and social care practitioners involve and communicate with carers in care planning and decision making?
NG150_Recommendations: 1.2 Identifying carers - Part 1,NG150,What are the best practices for healthcare professionals to identify and support informal carers?
NG150_Recommendations: 1.2 Identifying carers - Part 2,NG150,How can healthcare professionals identify and support carers of people with care and support needs?
NG150_Recommendations: 1.2 Identifying carers - Part 3,NG150,What strategies can health and social care organizations use to effectively identify and support carers?
NG150_Recommendations: 1.3 Assessing carers' needs - Part 1,NG150,What are the best practices for conducting carers' assessments according to NICE guidelines?
NG150_Recommendations: 1.3 Assessing carers' needs - Part 2,NG150,"What are best practices for arranging and conducting flexible, accessible carers' assessments?"
NG150_Recommendations: 1.3 Assessing carers' needs - Part 3,NG150,"What should be included in a carer's assessment regarding employment, education, and support options?"
NG150_Recommendations: 1.3 Assessing carers' needs - Part 4,NG150,What are the recommended practices for ensuring effective follow-up after a carer's assessment?
"NG150_Recommendations: 1.4 Helping carers stay in, enter or return to work, education and training - Part 1",NG150,What support and advice are available to help carers stay in or return to work and education?
"NG150_Recommendations: 1.4 Helping carers stay in, enter or return to work, education and training - Part 2",NG150,What workplace accommodations are recommended to support employees with caring responsibilities?
"NG150_Recommendations: 1.4 Helping carers stay in, enter or return to work, education and training - Part 3",NG150,What are the benefits and availability of replacement care services for supporting carers to maintain employment or education?
NG150_Recommendations: 1.5 Social and community support for carers - Part 1,NG150,What community support options and carer breaks are recommended for adult carers according to NICE guidelines?
NG150_Recommendations: 1.5 Social and community support for carers - Part 2,NG150,What support options are available for carers after their caring role ends?
NG150_Recommendations: 1.6 Training to provide care and support - Part 1,NG150,What are the recommended components of training programs for carers to ensure safe and effective care?
NG150_Recommendations: 1.6 Training to provide care and support - Part 2,NG150,What training and support should be provided to carers for equipment use and safe moving and handling techniques?
NG150_Recommendations: 1.7 Psychological and emotional support for carers - Part 1,NG150,What are the recommended psychosocial and psychoeducational support options for carers?
NG150_Recommendations: 1.7 Psychological and emotional support for carers - Part 2,NG150,What are the recommended psychotherapy and counselling options for adult carers with mental health problems according to NICE guidelines?
NG150_Recommendations: 1.8 Support during changes to the caring role,NG150,How can healthcare professionals support carers during transitions when the person they care for moves into adult services or a care home?
NG150_Recommendations: 1.9 Support for carers during end of life care and after the person dies - Part 1,NG150,What are best practices for supporting carers during end of life care and after a person's death?
NG150_Recommendations: 1.9 Support for carers during end of life care and after the person dies - Part 2,NG150,What are the recommended approaches for supporting carers during end-of-life care and after a person's death?
NG150_Recommendations: Terms used in this guideline - Part 1,NG150,What is a carer's assessment and how does it support unpaid carers?
NG150_Recommendations: Terms used in this guideline - Part 2 & Recommendations for research: 1 Whole family approach to carer's assessment,NG150,What is the effectiveness and acceptability of a whole family approach to carers' assessments?
"NG150_Recommendations for research: 2 Support for carers to return to work, employment or training & Recommendations for research: 3 Training for carers to reduce caring-related incidents & Recommendations for research: 4 Practical support through carer passport schemes",NG150,What is the effectiveness of personal health and social care budgets in supporting carers to return to work or education?
NG150_Recommendations for research: 5 Practical support for carers through social prescribing & Rationale and impact: The right to information and support,NG150,What is the effectiveness of social prescribing in providing practical support for adult carers?
NG150_Rationale and impact: Sharing information with carers,NG150,What are the best practices for sharing information with carers to improve their understanding and wellbeing?
NG150_Rationale and impact: Working with and involving carers,NG150,What are the best practices for involving and communicating with carers in care planning?
NG150_Rationale and impact: Identifying carers: recommendations for health and social care practitioners - Part 1,NG150,How can health and social care practitioners effectively identify and support carers according to NICE guidelines?
NG150_Rationale and impact: Identifying carers: recommendations for health and social care practitioners - Part 2,NG150,How should health and social care professionals identify and support carers according to NICE guidelines?
NG150_Rationale and impact: Identifying carers: recommendations for health and social care organisations,NG150,How can health and social care organizations improve the identification of carers under the Care Act 2014?
NG150_Rationale and impact: Carers' assessments,NG150,What are the best practices for conducting carers' assessments under the Care Act 2014?
NG150_Rationale and impact: Preparing for and carrying out a carer's assessment - Part 1,NG150,How should practitioners prepare for and conduct a person-centred carer's assessment?
NG150_Rationale and impact: Preparing for and carrying out a carer's assessment - Part 2,NG150,How should hospital assessments for carers be coordinated with community assessments to ensure effective support?
"NG150_Rationale and impact: Work, education and training",NG150,"What are the NICE recommendations for supporting carers' access to work, education, and training opportunities during assessments?"
NG150_Rationale and impact: After a carer's assessment,NG150,What are the recommended practices for following up after a carer's assessment?
"NG150_Rationale and impact: Helping carers stay in, enter or return to work, education and training: advice and support - Part 1",NG150,"What support and advice are available for carers to stay in or return to work, education, or training?"
"NG150_Rationale and impact: Helping carers stay in, enter or return to work, education and training: advice and support - Part 2",NG150,"What is the effectiveness of personal health and social care budgets in supporting carers to return to work, education, or training?"
NG150_Rationale and impact: Flexibilities to support employment,NG150,What workplace adjustments support employment for carers with caring responsibilities?
NG150_Rationale and impact: Replacement care,NG150,What are the NICE recommendations for providing replacement care to support carers' employment and education?
"NG150_Rationale and impact: Community information, advice and support",NG150,What information should be provided to carers about community services and support options?
NG150_Rationale and impact: Carers' breaks,NG150,What are the best practices for providing effective and flexible carers' breaks?
NG150_Rationale and impact: Peer support and support for former carers,NG150,What are the benefits of peer support for carers and former carers?
NG150_Rationale and impact: Advocacy,NG150,What are the legal responsibilities of local authorities to provide advocacy support for adult carers?
NG150_Rationale and impact: Training to provide care and support - Part 1,NG150,What are effective training programs to improve carers' confidence and skills in managing medication and providing emotional support?
NG150_Rationale and impact: Training to provide care and support - Part 2,NG150,What training programs are effective in supporting diverse groups of carers and reducing caring-related incidents?
"NG150_Rationale and impact: Use of equipment and adaptations, and moving and handling",NG150,What training and guidance should be provided to carers for equipment use and safe moving and handling?
NG150_Rationale and impact: Psychosocial and psychoeducational support for carers - Part 1,NG150,What psychosocial and psychoeducational support is recommended for carers to improve their wellbeing and caregiving skills?
NG150_Rationale and impact: Psychosocial and psychoeducational support for carers - Part 2,NG150,What factors should be considered when providing psychological and emotional support to adult carers?
NG150_Rationale and impact: Psychotherapy and counselling,NG150,What is the evidence for psychotherapy and counselling for adult carers of people with mental health problems?
NG150_Rationale and impact: Support during changes to the caring role,NG150,What support and information should be provided to carers during major changes in the cared-for person's health or living situation?
NG150_Rationale and impact: Support for carers during end of life care and after the person dies - Part 1,NG150,What support and information should healthcare professionals provide to carers during end of life care and after death?
NG150_Rationale and impact: Support for carers during end of life care and after the person dies - Part 2,NG150,What are the best practices for supporting carers of people at the end of life at home and in healthcare settings?
NG150_Context - Part 1,NG150,What are the best practices for supporting unpaid carers in the UK?
NG150_Context - Part 2,NG150,What support and assessment options are available for unpaid adult carers under the Care Act 2014?
NG150_Context - Part 3,NG150,What are the recommended practices for supporting adult unpaid carers to improve their wellbeing and resilience?
NG150_Context - Part 4,NG150,How do NICE guidelines support the integration of health and social care for carers under the Care Act 2014?
NG151_Colorectal cancer & Overview & Recommendations: 1.1 Reduction in risk of colorectal cancer in people with Lynch syndrome,NG151,Should people with Lynch syndrome take aspirin to reduce their risk of colorectal cancer?
NG151_Recommendations: 1.2 Information for people with colorectal cancer - Part 1,NG151,"What information should be provided to patients with colorectal cancer about treatment options, side effects, and potential changes during their care?"
NG151_Recommendations: 1.2 Information for people with colorectal cancer - Part 2,NG151,What are the recommended strategies for monitoring and managing side effects during non-surgical treatment for colorectal cancer?
NG151_Recommendations: 1.3 Management of local disease - Part 1,NG151,"What are the treatment options for early rectal cancer (cT1-T2, cN0, M0) and their implications?"
NG151_Recommendations: 1.3 Management of local disease - Part 2,NG151,What are the recommendations for preoperative radiotherapy in early rectal cancer?
NG151_Recommendations: 1.3 Management of local disease - Part 3,NG151,What are the recommended surgical options for treating rectal cancer according to NICE guidelines?
NG151_Recommendations: 1.3 Management of local disease - Part 4,NG151,What are the recommended preoperative treatments for people with colon cancer?
NG151_Recommendations: 1.3 Management of local disease - Part 5,NG151,What are the recommended preoperative systemic anti-cancer therapies for stage T4 colon cancer?
NG151_Recommendations: 1.3 Management of local disease - Part 6,NG151,What are the recommended durations of adjuvant chemotherapy with capecitabine for colon and rectal cancer?
NG151_Recommendations: 1.4 Molecular biomarkers to guide systemic anti-cancer therapy,NG151,What are the recommended molecular biomarkers for guiding systemic anti-cancer therapy in metastatic colorectal cancer?
NG151_Recommendations: 1.5 Management of metastatic disease - Part 1,NG151,What are the considerations for resecting an asymptomatic primary tumour in metastatic colorectal cancer patients?
NG151_Recommendations: 1.5 Management of metastatic disease - Part 2,NG151,What are the recommended treatment options for patients with metastatic colorectal cancer in the liver according to NICE guidelines?
NG151_Recommendations: 1.5 Management of metastatic disease - Part 3,NG151,What are the treatment options for lung metastases in colorectal cancer?
NG151_Recommendations: 1.6 Ongoing care and support - Part 1,NG151,What is the recommended follow-up protocol for detecting recurrence after non-metastatic colorectal cancer surgery?
NG151_Recommendations: 1.6 Ongoing care and support - Part 2,NG151,What are the recommended assessments and treatments for low anterior resection syndrome?
NG151_Recommendations: Terms used in this guideline,NG151,What is beyond-TME surgery for rectal cancer?
NG151_Recommendations for research,NG151,What are the most effective and safe treatment options for low anterior resection syndrome?
NG151_Rationale and impact: Prevention of colorectal cancer in people with Lynch syndrome,NG151,What is the recommended use of aspirin for preventing colorectal cancer in people with Lynch syndrome?
NG151_Rationale and impact: Information for people with colorectal cancer,NG151,What information should be provided to patients with colorectal cancer at different stages of treatment?
NG151_Rationale and impact: Treatment for people with early rectal cancer,NG151,What are the treatment options for early rectal cancer and their associated risks and benefits?
NG151_Rationale and impact: Preoperative treatment for people with rectal cancer,NG151,What is the recommended preoperative treatment for early rectal cancer?
NG151_Rationale and impact: Surgery for people with rectal cancer,NG151,What are the criteria for considering a watch-and-wait strategy after neoadjuvant therapy in rectal cancer patients?
NG151_Rationale and impact: Surgical technique for people with rectal cancer,NG151,What are the recommended surgical techniques for rectal cancer and their cost-effectiveness?
NG151_Rationale and impact: People with locally advanced or recurrent rectal cancer,NG151,What are the benefits and risks of pelvic exenteration for locally advanced or recurrent rectal cancer?
NG151_Rationale and impact: Surgical volumes for rectal cancer operations,NG151,What is the recommended minimum number of rectal cancer surgeries a hospital or surgeon should perform annually?
NG151_Rationale and impact: Preoperative treatment for people with colon cancer,NG151,What is the evidence for preoperative chemotherapy in cT4 colon cancer?
NG151_Rationale and impact: Duration of adjuvant chemotherapy for people with colorectal cancer - Part 1,NG151,What is the recommended duration of adjuvant chemotherapy for colorectal cancer?
NG151_Rationale and impact: Duration of adjuvant chemotherapy for people with colorectal cancer - Part 2,NG151,What is the recommended duration of adjuvant chemotherapy with CAPOX for colon cancer?
NG151_Rationale and impact: Colonic stents in acute large bowel obstruction,NG151,What are the indications and risks of using colonic stents in acute large bowel obstruction?
NG151_Rationale and impact: Molecular biomarkers to guide systemic anti-cancer therapy,NG151,What is the role of BRAF V600E testing in guiding systemic anti-cancer therapy for metastatic colorectal cancer?
NG151_Rationale and impact: People with asymptomatic primary tumour & Rationale and impact: Systemic anti-cancer therapy for people with metastatic colorectal cancer,NG151,What are the benefits and risks of resecting an asymptomatic primary tumour in metastatic colorectal cancer?
NG151_Rationale and impact: People with metastatic colorectal cancer in the liver - Part 1,NG151,What are the benefits and risks of simultaneous versus sequential resection for metastatic colorectal cancer in the liver?
NG151_Rationale and impact: People with metastatic colorectal cancer in the liver - Part 2,NG151,What is the effectiveness of radiofrequency ablation and microwave ablation in treating unresectable liver metastases?
NG151_Rationale and impact: People with metastatic colorectal cancer in the lung,NG151,What is the recommended management approach for lung metastases in patients with metastatic colorectal cancer?
NG151_Rationale and impact: People with metastatic colorectal cancer in the peritoneum,NG151,What are the recommended treatment options for metastatic colorectal cancer involving the peritoneum?
NG151_Rationale and impact: Follow-up for detection of local recurrence and distant metastases,NG151,What is the recommended follow-up protocol for detecting local recurrence and distant metastases in colorectal cancer patients?
NG151_Rationale and impact: Management of low anterior resection syndrome,NG151,What are the symptoms and management options for low anterior resection syndrome in primary care?
NG151_Context - Part 1,NG151,What are the recommended screening and prevention strategies for colorectal cancer in people with Lynch syndrome?
NG151_Context - Part 2,NG151,What are the current treatment options and considerations for managing local and metastatic colorectal cancer?
NG152_Leg ulcer infection: antimicrobial prescribing & Overview,NG152,What are the recommended antimicrobial prescribing practices for leg ulcer infection in adults?
NG152_Recommendations: 1.1 Managing leg ulcer infection in adults - Part 1,NG152,What are the indications for prescribing antibiotics for infected leg ulcers in adults?
NG152_Recommendations: 1.1 Managing leg ulcer infection in adults - Part 2,NG152,What are the recommended practices for reassessing and managing infected leg ulcers in adults?
NG152_Recommendations: 1.2 Choice of antibiotic - Part 1,NG152,What is the recommended antibiotic treatment for infected leg ulcers in adults?
NG152_Recommendations: 1.2 Choice of antibiotic - Part 2 & Recommendations: 1.2 Choice of antibiotic - Part 3 & Recommendations: Terms used in the guideline,NG152,When should intravenous antibiotics be reviewed and switched to oral therapy in adult patients?
NG152_Recommendation for research & Rationales: Treatment - Part 1,NG152,What are the clinical outcomes of topical antibiotics versus oral antibiotics for infected leg ulcers?
NG152_Rationales: Treatment - Part 2,NG152,What are the recommended antibiotic choices and management strategies for infected leg ulcers?
NG152_Rationales: Treatment - Part 3,NG152,What is the effectiveness and safety of silver dressings and topical antiseptics for treating infected leg ulcers?
NG152_Rationales: Reassessment & Rationales: Referral or seeking specialist advice,NG152,When should adults with infected leg ulcers be referred to hospital or specialist care?
NG152_Rationales: Choice of antibiotic - Part 1,NG152,What is the recommended antibiotic for treating infected leg ulcers in adults?
NG152_Rationales: Choice of antibiotic - Part 2,NG152,What are the recommended second-line oral antibiotics for infected leg ulcers when first-choice antibiotics are ineffective?
NG152_Rationales: Choice of antibiotic - Part 3,NG152,What are the recommended antibiotic treatments and course durations for infected leg ulcers according to NICE guidelines?
NG152_Context,NG152,What are the best practices for managing chronic leg ulcers and their bacterial colonization?
NG152_Summary of the evidence: Topical antiseptics - Part 1,NG152,"What are the effectiveness and safety of topical antiseptics like iodine, peroxide, and honey for treating leg ulcers?"
NG152_Summary of the evidence: Topical antiseptics - Part 2,NG152,What are the effectiveness and safety of silver dressings for infected and uninfected leg ulcers?
NG152_Summary of the evidence: Antibiotics & Summary of the evidence: Choice of antibiotic,NG152,What are the effects of antibiotics compared to standard care or placebo for leg ulcer healing?
"NG152_Summary of the evidence: Antibiotic course length, dosage and route of administration & Other considerations: Medicines safety - Part 1",NG152,What are the recommended antibiotic courses and safety considerations for prescribing antibiotics?
NG152_Other considerations: Medicines safety - Part 2 & Other considerations: Medicines adherence,NG152,"What are the safety considerations and monitoring requirements for using tetracyclines, co-trimoxazole, aminoglycosides, glycopeptides, and linezolid?"
NG153_Impetigo: antimicrobial prescribing & Overview,NG153,What is the recommended antimicrobial treatment for impetigo in children and adults?
NG153_Recommendations: 1.1 Managing impetigo - Part 1,NG153,What are the recommended treatments for impetigo in children and adults?
NG153_Recommendations: 1.1 Managing impetigo - Part 2,NG153,What are the recommended antibiotic treatments for impetigo according to NICE guidelines?
NG153_Recommendations: 1.1 Managing impetigo - Part 3,NG153,What are the indications for microbiological testing and specialist referral in impetigo management?
NG153_Recommendations: 1.2 Choice of antimicrobial - Part 1,NG153,What are the recommended antimicrobial treatments for impetigo in adults and children?
NG153_Recommendations: 1.2 Choice of antimicrobial - Part 2,NG153,What are the recommended topical and oral antibiotics for treating impetigo in children?
NG153_Recommendations: 1.2 Choice of antimicrobial - Part 3 & Recommendations: Terms used in the guideline,NG153,What are the recommended antimicrobial treatments and dosing guidelines for impetigo in children?
NG153_Recommendation for research & Rationales: Advice to reduce the spread of impetigo,NG153,What evidence is there comparing antiseptics and antibiotics for treating impetigo?
NG153_Rationales: Initial treatment - Part 1,NG153,What is the recommended initial treatment for localized impetigo?
NG153_Rationales: Initial treatment - Part 2,NG153,What is the recommended treatment for widespread non-bullous impetigo in adults and children?
NG153_Rationales: Reassessment and further treatment & Rationales: Referral and seeking specialist advice,NG153,What are the recommended reassessment and treatment options for impetigo that does not respond to initial therapy?
NG153_Rationales: Choice of antimicrobial - Part 1,NG153,What is the recommended topical antibiotic for non-bullous impetigo when hydrogen peroxide 1% cream is unsuitable?
NG153_Rationales: Choice of antimicrobial - Part 2,NG153,What are the recommended antibiotics for treating impetigo in children and pregnant women?
NG153_Rationales: Choice of antimicrobial - Part 3 & Context,NG153,What is the recommended antibiotic treatment duration for impetigo in adults and children?
NG153_Summary of the evidence: Antimicrobials,NG153,What is the effectiveness and safety of topical and oral antibiotics for skin infections in children and adults?
NG153_Summary of the evidence: Choice of antibiotics - Part 1,NG153,"What are the differences in effectiveness and safety between topical antibiotics like mupirocin, fusidic acid, and neomycin for skin infections?"
NG153_Summary of the evidence: Choice of antibiotics - Part 2 & Summary of the evidence: Course length,NG153,What is the most effective oral antibiotic for treating bacterial infections in children?
NG153_Summary of the evidence: Route of administration - Part 1,NG153,What is the effectiveness and safety of topical versus oral antibiotics for impetigo treatment in children and adults?
NG153_Summary of the evidence: Route of administration - Part 2,NG153,What is the safety and efficacy of topical mupirocin compared to oral erythromycin for skin infections in children and adults?
NG153_Other considerations,NG153,What are the safety considerations and potential risks associated with prescribing antibiotics for skin infections?
NG154_Neonatal parenteral nutrition & Overview,NG154,What are the guidelines for neonatal parenteral nutrition in preterm and critically ill babies?
"NG154_Recommendations: 1.1 Indications for, and timing of, neonatal parenteral nutrition",NG154,What are the indications and timing for initiating neonatal parenteral nutrition in preterm and term infants?
NG154_Recommendations: 1.2 Administration of neonatal parenteral nutrition,NG154,What are the recommended practices for administering neonatal parenteral nutrition and venous access?
NG154_Recommendations: 1.3 Energy needs of babies on neonatal parenteral nutrition & Recommendations: 1.4 Neonatal parenteral nutrition volume,NG154,What are the recommended energy intakes for preterm and term babies on neonatal parenteral nutrition?
NG154_Recommendations: 1.5 Constituents of neonatal parenteral nutrition - Part 1,NG154,What are the recommended glucose and amino acid doses for neonatal parenteral nutrition in preterm and term infants?
NG154_Recommendations: 1.5 Constituents of neonatal parenteral nutrition - Part 2,NG154,What are the recommended lipid infusion rates for preterm and term babies receiving neonatal parenteral nutrition?
NG154_Recommendations: 1.5 Constituents of neonatal parenteral nutrition - Part 3,NG154,What are the recommended non-nitrogen energy to nitrogen ratios in neonatal parenteral nutrition?
NG154_Recommendations: 1.5 Constituents of neonatal parenteral nutrition - Part 4,NG154,What are the recommended calcium and phosphate dosing guidelines for neonatal parenteral nutrition?
NG154_Recommendations: 1.5 Constituents of neonatal parenteral nutrition - Part 5,NG154,"What are the recommended timing and dosing for administering vitamins, electrolytes, magnesium, and trace elements in neonatal parenteral nutrition?"
NG154_Recommendations: 1.6 Standardised neonatal parenteral nutrition formulations ('standardised bags'),NG154,What are the recommendations for using standardised neonatal parenteral nutrition formulations?
NG154_Recommendations: 1.7 Monitoring neonatal parenteral nutrition - Part 1,NG154,How should blood glucose and electrolyte levels be monitored in neonates receiving parenteral nutrition?
NG154_Recommendations: 1.7 Monitoring neonatal parenteral nutrition - Part 2,NG154,When should serum triglyceride levels be monitored in preterm or term infants transitioning from parenteral to enteral nutrition?
NG154_Recommendations: 1.8 Stopping neonatal parenteral nutrition,NG154,When should neonatal parenteral nutrition be stopped in preterm and term infants?
NG154_Recommendations: 1.9 Service design,NG154,What are the recommended team members and responsibilities for neonatal parenteral nutrition services?
NG154_Recommendations: 1.10 Information and support for parents and carers,NG154,What information and support should be provided to parents and carers of babies on parenteral nutrition?
NG154_Recommendations: Terms used in this guideline,NG154,What is a composite lipid emulsion and how is it used in neonatal parenteral nutrition?
NG154_Recommendations for research: 1 Information and support & Recommendations for research: 2 Ratios of non-nitrogen energy to nitrogen & Recommendations for research: 3 Timing of starting neonatal parenteral nutrition,NG154,What are the recommended timings for initiating neonatal parenteral nutrition in critically ill or surgical term infants?
"NG154_Recommendations for research: 4 Venous access & Rationale and impact: Indications for, and timing of, neonatal parenteral nutrition - Part 1",NG154,What are the criteria for initiating neonatal parenteral nutrition in preterm infants based on gestational age?
"NG154_Rationale and impact: Indications for, and timing of, neonatal parenteral nutrition - Part 2",NG154,What are the recommended timings for initiating neonatal parenteral nutrition in critically ill term and preterm babies?
"NG154_Rationale and impact: Indications for, and timing of, neonatal parenteral nutrition - Part 3",NG154,What is the recommended timing for starting parenteral nutrition in critically ill term and preterm babies?
NG154_Rationale and impact: Administration of neonatal parenteral nutrition - Part 1,NG154,What are the recommended practices for administering neonatal parenteral nutrition via peripheral versus central venous access?
NG154_Rationale and impact: Administration of neonatal parenteral nutrition - Part 2,NG154,When should surgically inserted central catheters be used for parenteral nutrition in neonatal patients?
NG154_Rationale and impact: Administration of neonatal parenteral nutrition - Part 3,NG154,What are the recommended practices for protecting parenteral nutrition solutions from light in neonatal care?
NG154_Rationale and impact: Energy needs of babies on neonatal parenteral nutrition,NG154,What are the recommended energy intake ranges for babies on neonatal parenteral nutrition?
NG154_Rationale and impact: Neonatal parenteral nutrition volume,NG154,What is the recommended volume of neonatal parenteral nutrition for preterm and term infants?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – glucose,NG154,What is the recommended glucose intake for neonatal parenteral nutrition?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – amino acids - Part 1,NG154,What is the recommended amino acid dosage for neonatal parenteral nutrition in preterm infants?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – amino acids - Part 2,NG154,What is the recommended upper limit for amino acid intake in neonatal parenteral nutrition?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – lipids and lipid emulsions - Part 1,NG154,What are the recommended lipid doses and administration strategies for neonatal parenteral nutrition?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – lipids and lipid emulsions - Part 2,NG154,What are the recommended lipid emulsions for managing parenteral nutrition-associated liver disease in infants?
"NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – ratios of non-nitrogen energy to nitrogen, and carbohydrates to lipids - Part 1",NG154,What are the recommended ratios of non-nitrogen energy to nitrogen and carbohydrates to lipids in neonatal parenteral nutrition?
"NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – ratios of non-nitrogen energy to nitrogen, and carbohydrates to lipids - Part 2",NG154,What are the recommended lipid and carbohydrate dosages in parenteral nutrition to minimize hyperglycaemia?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – iron,NG154,What are the guidelines for iron supplementation in neonatal parenteral nutrition for preterm infants?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – acetate,NG154,Why is acetate used in neonatal parenteral nutrition and what are the current recommendations?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – calcium and phosphate - Part 1,NG154,What are the recommended calcium and phosphate levels for neonatal parenteral nutrition?
NG154_Rationale and impact: Constituents of neonatal parenteral nutrition – calcium and phosphate - Part 2,NG154,What are the recommended initial and maintenance dosages of calcium and phosphate for neonatal parenteral nutrition?
NG154_Rationale and impact: Other constituents of neonatal parenteral nutrition – general principles - Part 1,NG154,What are the recommendations for vitamin supplementation in neonatal parenteral nutrition?
NG154_Rationale and impact: Other constituents of neonatal parenteral nutrition – general principles - Part 2,NG154,"How often should serum sodium, potassium, magnesium, and trace elements be monitored in neonates on parenteral nutrition?"
NG154_Rationale and impact: Standardised neonatal parenteral nutrition formulation ('standardised bags'),NG154,What are the benefits of using standardised neonatal parenteral nutrition bags compared to individualised formulations?
NG154_Rationale and impact: Monitoring neonatal parenteral nutrition - Part 1,NG154,What are the recommended monitoring procedures for neonatal parenteral nutrition?
NG154_Rationale and impact: Monitoring neonatal parenteral nutrition - Part 2,NG154,"What are the recommended monitoring protocols for serum triglycerides, phosphate, iron status, and liver function in neonatal parenteral nutrition?"
NG154_Rationale and impact: Stopping neonatal parenteral nutrition,NG154,What are the recommended thresholds for stopping neonatal parenteral nutrition based on enteral feed volume?
NG154_Rationale and impact: Service design - Part 1,NG154,What are the recommended multidisciplinary team members for neonatal parenteral nutrition services?
NG154_Rationale and impact: Service design - Part 2,NG154,What are the recommended multidisciplinary team approaches for managing preterm and term babies with complex needs?
NG154_Rationale and impact: Information and support for parents and carers of babies who need neonatal parenteral nutrition,NG154,What information and support should healthcare professionals provide to parents and carers of babies requiring neonatal parenteral nutrition?
NG154_Context,NG154,What are the best practices for initiating and managing parenteral nutrition in preterm and critically ill neonates?
NG155_Tinnitus: assessment and management & Overview & Recommendations: 1.1 Support and information for people with tinnitus - Part 1,NG155,What information and support should healthcare professionals provide to people with tinnitus?
NG155_Recommendations: 1.1 Support and information for people with tinnitus - Part 2,NG155,What information should be provided to patients about tinnitus management and support options?
NG155_Recommendations: 1.2 Referring people with tinnitus - Part 1,NG155,What are the NICE guidelines for referring patients with tinnitus for urgent assessment or specialist care?
NG155_Recommendations: 1.2 Referring people with tinnitus - Part 2,NG155,What are the criteria for referring patients with sudden or rapidly worsening hearing loss and tinnitus?
NG155_Recommendations: 1.3 Assessing the impact of tinnitus using questionnaires - Part 1,NG155,What are the recommended questionnaires for assessing the impact of tinnitus on quality of life and sleep?
NG155_Recommendations: 1.3 Assessing the impact of tinnitus using questionnaires - Part 2,NG155,How should clinicians assess the psychological impact of tinnitus in adults and children?
NG155_Recommendations: 1.4 Investigations - Part 1,NG155,What are the recommended investigations for diagnosing tinnitus according to NICE guidelines?
NG155_Recommendations: 1.4 Investigations - Part 2,NG155,When should imaging be considered for patients with pulsatile tinnitus?
NG155_Recommendations: 1.5 Management of tinnitus - Part 1,NG155,"What are the recommended management options for tinnitus, including amplification devices and psychological therapies?"
NG155_Recommendations: 1.5 Management of tinnitus - Part 2,NG155,What are the recommended psychological therapies for tinnitus-related distress?
NG155_Recommendations: Terms used in this guideline,NG155,What is digital tinnitus-related cognitive behavioural therapy and how does it differ from face-to-face CBT?
NG155_Recommendations for research: Key recommendations for research - Part 1,NG155,What are the recommended methods for assessing tinnitus in general practice?
NG155_Recommendations for research: Key recommendations for research - Part 2,NG155,What is the effectiveness of neuromodulation and psychological therapies for managing tinnitus in children and adults?
NG155_Recommendations for research: Other recommendations for research - Part 1,NG155,"What are the most effective tinnitus questionnaires for children, young people, and people with hearing impairments?"
NG155_Recommendations for research: Other recommendations for research - Part 2,NG155,What is the effectiveness of amplification devices for people with severe-to-profound hearing loss?
NG155_Rationale and impact: Support for people with tinnitus - Part 1,NG155,What support and information should be provided to people with tinnitus and their families?
NG155_Rationale and impact: Support for people with tinnitus - Part 2,NG155,What are the recommended management strategies and support options for people with longstanding tinnitus?
NG155_Rationale and impact: Information for people with tinnitus,NG155,What information should healthcare professionals provide to patients with tinnitus at first contact?
NG155_Rationale and impact: Referring people with tinnitus - Part 1,NG155,What are the criteria for urgent referral of patients with tinnitus?
NG155_Rationale and impact: Referring people with tinnitus - Part 2,NG155,What are the recommended referral pathways and timing for managing persistent tinnitus in adults and children?
NG155_Rationale and impact: Assessing the impact of tinnitus using questionnaires - Part 1,NG155,What are the recommended questionnaires for assessing the impact of tinnitus?
NG155_Rationale and impact: Assessing the impact of tinnitus using questionnaires - Part 2,NG155,What are the recommended methods for assessing the impact of tinnitus in clinical practice?
NG155_Rationale and impact: Assessing how tinnitus affects quality of life,NG155,How should clinicians assess the impact of tinnitus on a patient's quality of life during clinical consultations?
NG155_Rationale and impact: Assessing sleep and the psychological impact of tinnitus - Part 1,NG155,What are recommended methods for assessing the impact of tinnitus on sleep and psychological well-being?
NG155_Rationale and impact: Assessing sleep and the psychological impact of tinnitus - Part 2,NG155,What are the recommended tools for assessing depression and anxiety in patients with tinnitus?
NG155_Rationale and impact: Audiological assessment,NG155,What are the recommended audiological assessments for patients with tinnitus according to NICE guidelines?
NG155_Rationale and impact: Psychoacoustic tests,NG155,Should psychoacoustic tests be used in the assessment of tinnitus?
NG155_Rationale and impact: Imaging to investigate the cause of non-pulsatile tinnitus,NG155,When should imaging be used to investigate non-pulsatile tinnitus?
NG155_Rationale and impact: Imaging to investigate the cause of pulsatile tinnitus,NG155,What is the recommended imaging approach for diagnosing the cause of pulsatile tinnitus?
NG155_Rationale and impact: Amplification devices & Rationale and impact: Sound therapy,NG155,What are the indications for using amplification devices in adults and children with tinnitus and hearing loss?
NG155_Rationale and impact: Psychological therapies for people with tinnitus-related distress - Part 1,NG155,What are the recommended psychological therapies for managing tinnitus-related distress?
NG155_Rationale and impact: Psychological therapies for people with tinnitus-related distress - Part 2,NG155,What are the recommended psychological therapies for tinnitus management according to NICE guidelines?
NG155_Rationale and impact: Betahistine & Rationale and impact: Combining therapies,NG155,What are the recommended treatments for tinnitus according to NICE guidelines?
NG155_Rationale and impact: Neuromodulation & Context,NG155,What is the current evidence on the safety and effectiveness of neuromodulation therapies for tinnitus management?
NG156_Abdominal aortic aneurysm: diagnosis and management & Overview,NG156,What are the recommended methods for diagnosing and monitoring abdominal aortic aneurysms?
NG156_Recommendations: 1.1 Diagnosis - Part 1,NG156,What are the risk factors and screening recommendations for abdominal aortic aneurysm detection in men and women?
NG156_Recommendations: 1.1 Diagnosis - Part 2,NG156,What are the clinical signs and risk factors indicating a possible ruptured abdominal aortic aneurysm?
NG156_Recommendations: 1.1 Diagnosis - Part 3,NG156,What information should be provided to patients diagnosed with an abdominal aortic aneurysm?
NG156_Recommendations: 1.1 Diagnosis - Part 4,NG156,Why are some patients with small or unfit AAAs not suitable for repair according to NICE guidelines?
NG156_Recommendations: 1.2 Monitoring and reducing the risk of rupture,NG156,What are the recommended monitoring and risk reduction strategies for abdominal aortic aneurysm?
NG156_Recommendations: 1.3 Emergency transfer to regional vascular services - Part 1,NG156,What are the criteria for transferring patients with suspected or confirmed ruptured abdominal aortic aneurysm to regional vascular services?
NG156_Recommendations: 1.3 Emergency transfer to regional vascular services - Part 2,NG156,What is the recommended approach to volume resuscitation during transfer of patients with suspected ruptured abdominal aortic aneurysm?
NG156_Recommendations: 1.4 Predicting and improving surgical outcomes - Part 1,NG156,What are the recommended preoperative assessments for elective repair of unruptured abdominal aortic aneurysm?
NG156_Recommendations: 1.4 Predicting and improving surgical outcomes - Part 2,NG156,Should risk assessment tools be used to determine suitability for aneurysm repair in ruptured AAA cases?
NG156_Recommendations: 1.4 Predicting and improving surgical outcomes - Part 3,NG156,Should preoperative beta blockers be used for abdominal aortic aneurysm repair?
NG156_Recommendations: 1.5 Repairing unruptured aneurysms - Part 1,NG156,When should unruptured abdominal aortic aneurysms be repaired?
NG156_Recommendations: 1.5 Repairing unruptured aneurysms - Part 2,NG156,When should endovascular aneurysm repair be considered for unruptured abdominal aortic aneurysm patients with comorbidities?
NG156_Recommendations: 1.5 Repairing unruptured aneurysms - Part 3,NG156,Should epidural analgesia be used during open surgical repair of unruptured abdominal aortic aneurysm?
NG156_Recommendations: 1.6 Repairing ruptured aneurysms - Part 1,NG156,What are the recommended surgical options for repairing ruptured abdominal aortic aneurysms?
NG156_Recommendations: 1.6 Repairing ruptured aneurysms - Part 2,NG156,What is the recommended anesthesia approach for EVAR in ruptured abdominal aortic aneurysm?
NG156_Recommendations: 1.7 Monitoring for complications after endovascular aneurysm repair,NG156,What is the recommended surveillance protocol for monitoring complications after endovascular aneurysm repair?
NG156_Recommendations: 1.8 Managing endoleaks after endovascular aneurysm repair,NG156,What are the recommended management options for endoleaks after endovascular aneurysm repair?
NG156_Recommendations: Terms used in this guideline,NG156,What is the difference between standard and complex EVAR procedures?
NG156_Recommendations for research: Key recommendations for research - Part 1,NG156,What is the optimal monitoring frequency and repair threshold for unruptured abdominal aortic aneurysms?
NG156_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG156,What are the benefits and harms of macrolides for reducing abdominal aortic aneurysm growth and rupture risk?
NG156_Rationale and impact: Identifying asymptomatic abdominal aortic aneurysms,NG156,What are the risk factors and screening recommendations for asymptomatic abdominal aortic aneurysms?
NG156_Rationale and impact: Identifying symptomatic or ruptured abdominal aortic aneurysms,NG156,What are the key signs and symptoms of a ruptured abdominal aortic aneurysm?
NG156_Rationale and impact: Imaging technique,NG156,What is the recommended imaging technique for assessing abdominal aortic aneurysm before repair?
NG156_Rationale and impact: Providing information to people with a diagnosed AAA,NG156,What information should be provided to patients with a diagnosed abdominal aortic aneurysm who are not undergoing repair?
NG156_Rationale and impact: Reducing the risk of rupture,NG156,What are the recommended management strategies to reduce the risk of rupture in patients with abdominal aortic aneurysm?
NG156_Rationale and impact: Monitoring the risk of rupture,NG156,What are the recommended ultrasound surveillance intervals for abdominal aortic aneurysm monitoring according to NICE guidelines?
NG156_Rationale and impact: Emergency transfer to regional vascular services,NG156,What are the criteria for emergency transfer of patients with ruptured abdominal aortic aneurysm to regional vascular services?
NG156_Rationale and impact: Supporting people during transfer,NG156,What are the recommended practices for fluid management during transfer of patients with ruptured abdominal aortic aneurysm?
NG156_Rationale and impact: Predicting surgical outcomes in unruptured aneurysms,NG156,What are the recommended preoperative assessments for predicting surgical outcomes in unruptured aneurysm repair?
NG156_Rationale and impact: Predicting surgical outcomes for ruptured aneurysms,NG156,What are the recommended methods for assessing surgical risk in patients with ruptured abdominal aortic aneurysm?
NG156_Rationale and impact: Improving surgical outcomes,NG156,Should beta blockers be used routinely before abdominal aortic aneurysm repair?
NG156_Rationale and impact: Repairing unruptured aneurysms - Part 1,NG156,What are the criteria for repairing unruptured abdominal aortic aneurysms according to NICE guidelines?
NG156_Rationale and impact: Repairing unruptured aneurysms - Part 2,NG156,What are the considerations for choosing EVAR versus open surgical repair in patients with complex abdominal co-pathologies?
NG156_Rationale and impact: Repairing unruptured aneurysms - Part 3,NG156,What are the indications and considerations for using complex EVAR versus open surgical repair in unruptured abdominal aortic aneurysm?
NG156_Rationale and impact: Repairing unruptured aneurysms - Part 4,NG156,What are the current outcomes and cost considerations for open surgical repair versus EVAR for abdominal aortic aneurysm?
NG156_Rationale and impact: Repairing unruptured aneurysms - Part 5,NG156,What are the current NICE guidelines for the management and surgical repair of unruptured abdominal aortic aneurysms?
NG156_Rationale and impact: Anaesthesia and analgesia during unruptured aneurysm repair,NG156,What are the benefits of using epidural anesthesia in open surgical repair of unruptured abdominal aortic aneurysm?
NG156_Rationale and impact: Repairing ruptured aneurysms - Part 1,NG156,What are the recommended techniques for repairing ruptured abdominal aortic aneurysms according to NICE guidelines?
NG156_Rationale and impact: Repairing ruptured aneurysms - Part 2,NG156,What is the evidence for using tranexamic acid to reduce blood loss in ruptured abdominal aortic aneurysm repair?
NG156_Rationale and impact: Anaesthesia and analgesia during ruptured aneurysm repair & Rationale and impact: Abdominal compartment syndrome,NG156,What are the anesthesia options for ruptured abdominal aortic aneurysm repair?
NG156_Rationale and impact: Monitoring for complications after endovascular aneurysm repair - Part 1,NG156,What is the recommended imaging surveillance protocol after endovascular aneurysm repair?
NG156_Rationale and impact: Monitoring for complications after endovascular aneurysm repair - Part 2,NG156,What is the most accurate imaging technique for detecting endoleaks after endovascular aneurysm repair?
NG156_Rationale and impact: Managing endoleaks after endovascular aneurysm repair,NG156,What are the recommended management strategies for endoleaks after endovascular aneurysm repair?
NG156_Context,NG156,What are the risk factors and screening recommendations for abdominal aortic aneurysm in men and women?
"NG157_Joint replacement (primary): hip, knee and shoulder & Overview & Recommendations: 1.1 Shared decision making and information for people offered hip, knee or shoulder replacement - Part 1",NG157,"What information should I receive about hip, knee, or shoulder replacement surgery and its risks?"
"NG157_Recommendations: 1.1 Shared decision making and information for people offered hip, knee or shoulder replacement - Part 2",NG157,What are the recommended steps for preoperative preparation and postoperative recovery in elective joint replacement surgery?
NG157_Recommendations: 1.2 Preoperative rehabilitation,NG157,What preoperative exercises and lifestyle changes are recommended for patients undergoing hip or knee replacement?
NG157_Recommendations: 1.3 Anaesthesia and analgesia - Part 1,NG157,What are the recommended anaesthesia options for elective hip and knee replacement surgeries?
NG157_Recommendations: 1.3 Anaesthesia and analgesia - Part 2,NG157,What are the recommended anaesthesia options for primary elective shoulder replacement?
NG157_Recommendations: 1.4 Tranexamic acid to minimise blood loss,NG157,What are the NICE recommendations for using tranexamic acid to reduce blood loss in joint replacement surgery?
NG157_Recommendations: 1.5 Preventing infections,NG157,"What are the recommended practices for infection prevention during primary elective hip, knee, or shoulder replacement surgery?"
NG157_Recommendations: 1.6 Avoiding implant selection errors,NG157,What are the recommended intraoperative checks to prevent implant selection errors during joint replacement surgery?
NG157_Recommendations: 1.7 Procedures for primary elective knee replacement,NG157,What are the recommendations for choosing between partial and total knee replacement in osteoarthritis?
NG157_Recommendations: 1.8 Surgical approaches and implants for primary elective hip replacement,NG157,What are the recommended surgical approaches and implant options for primary elective hip replacement?
NG157_Recommendations: 1.9 Procedures for primary elective shoulder replacement,NG157,What are the indications for total shoulder replacement in osteoarthritis without rotator cuff tear?
NG157_Recommendations: 1.10 Postoperative care - Part 1,NG157,"What is the recommended postoperative rehabilitation approach for patients after hip, knee, or shoulder replacement surgery?"
NG157_Recommendations: 1.10 Postoperative care - Part 2,NG157,What are the recommendations for outpatient rehabilitation after orthopedic surgery?
NG157_Recommendations: 1.11 Long-term care,NG157,When should primary care practitioners refer patients with joint replacement to orthopaedic services for worsening symptoms?
NG157_Recommendations for research: Key recommendations for research - Part 1,NG157,"What is the effectiveness of preoperative rehabilitation for hip, knee, or shoulder replacement performed at least 2 months before surgery?"
NG157_Recommendations for research: Key recommendations for research - Part 2,NG157,What is the clinical and cost effectiveness of conventional versus reverse total shoulder arthroplasty for primary shoulder replacement in adults with osteoarthritis and no rotator cuff tear?
NG157_Recommendations for research: Other recommendations for research - Part 1,NG157,What are the best decision aids to support shared decision-making in elective joint replacement?
NG157_Recommendations for research: Other recommendations for research - Part 2,NG157,What are the benefits and risks of different surgical approaches in primary elective hip replacement?
NG157_Recommendations for research: Other recommendations for research - Part 3,NG157,"What are the recommended strategies for supporting rehabilitation after hip, knee, or shoulder replacement in patients with additional needs such as dementia or multiple medical conditions?"
"NG157_Rationale and impact: Shared decision making and information for people offered hip, knee or shoulder replacement",NG157,"What information should be provided to patients about treatment options for hip, knee, or shoulder replacement?"
NG157_Rationale and impact: Decision aids for elective joint replacement,NG157,What are the key components of effective decision aids for elective joint replacement?
NG157_Rationale and impact: Preoperative rehabilitation,NG157,What are the benefits of preoperative rehabilitation for hip and knee replacement surgery?
NG157_Rationale and impact: Anaesthesia and analgesia for hip replacement,NG157,What are the recommended anaesthesia and analgesia options for hip replacement surgery?
NG157_Rationale and impact: Anaesthesia and analgesia for knee replacement,NG157,What is the most effective anaesthesia and analgesia approach for knee replacement surgery?
NG157_Rationale and impact: Anaesthesia and analgesia for shoulder replacement,NG157,What are the recommended anaesthesia options for shoulder replacement surgery?
NG157_Rationale and impact: Tranexamic acid to minimise blood loss,NG157,What is the recommended use of tranexamic acid to reduce blood loss in joint replacement surgery?
NG157_Rationale and impact: Preventing infections,NG157,What are the recommended practices for preventing surgical site infections in joint replacement surgery?
NG157_Rationale and impact: Avoiding implant selection errors,NG157,What are effective strategies to prevent implant selection errors during surgery?
NG157_Rationale and impact: Partial and total knee replacement,NG157,What are the benefits and risks of partial versus total knee replacement for osteoarthritis?
NG157_Rationale and impact: Patella resurfacing,NG157,What are the benefits and cost-effectiveness of patella resurfacing in knee replacement surgery?
NG157_Rationale and impact: Surgical approaches for primary elective hip replacement,NG157,Which surgical approach is recommended for primary elective hip replacement?
NG157_Rationale and impact: Shoulder replacement for osteoarthritis with no rotator cuff tear & Rationale and impact: Shoulder replacement for pain and functional loss for people with a previous proximal humeral fracture,NG157,What are the recommended surgical options for shoulder replacement in osteoarthritis without rotator cuff tear?
NG157_Rationale and impact: Inpatient rehabilitation,NG157,What is the recommended timing for inpatient rehabilitation after hip or knee replacement surgery?
NG157_Rationale and impact: Outpatient rehabilitation,NG157,"What are the recommended outpatient rehabilitation options after hip, knee, or shoulder replacement?"
NG157_Rationale and impact: Long-term care & Context,NG157,What are the recommended follow-up procedures after joint replacement surgery?
"NG158_Venous thromboembolic diseases: diagnosis, management and thrombophilia testing & Overview",NG158,What are the recommended diagnostic and management strategies for venous thromboembolic diseases in adults?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 1,NG158,What are the recommended initial diagnostic steps for suspected deep vein thrombosis (DVT)?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 2,NG158,What is the recommended management for suspected deep vein thrombosis when ultrasound results are delayed?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 3,NG158,What is the recommended management for suspected deep vein thrombosis with negative ultrasound and D-dimer test results?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 4,NG158,What are the recommended actions for managing suspected deep vein thrombosis based on ultrasound scan results in COVID-19 patients?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 5,NG158,What are the indications for using the PERC rule in diagnosing pulmonary embolism?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 6,NG158,What is the recommended imaging approach for suspected pulmonary embolism based on Wells score?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 7,NG158,What are the recommended diagnostic and management strategies for suspected pulmonary embolism according to NICE guidelines?
NG158_Recommendations: 1.1 Diagnosis and initial management - Part 8,NG158,What are the recommended management steps for suspected DVT or PE when D-dimer results are delayed?
NG158_Recommendations: 1.2 Outpatient treatment for low-risk PE,NG158,What are the criteria for outpatient treatment of low-risk pulmonary embolism?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 1,NG158,What are the NICE guidelines for initiating interim anticoagulation in suspected DVT or PE?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 2,NG158,What are the recommended anticoagulation treatments for confirmed DVT or PE according to NICE guidelines?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 3,NG158,What is the recommended anticoagulation management for DVT or PE with renal impairment?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 4,NG158,What are the recommended anticoagulation options for patients with proximal DVT or PE and renal impairment?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 5,NG158,What are the recommended anticoagulation options for treating DVT or PE in patients with active cancer?
NG158_Recommendations: 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE - Part 6,NG158,What are the NICE guidelines for pharmacological treatment of deep vein thrombosis and pulmonary embolism?
NG158_Recommendations: 1.4 Long-term anticoagulation for secondary prevention - Part 1,NG158,What are the recommendations for long-term anticoagulation after proximal DVT or PE?
NG158_Recommendations: 1.4 Long-term anticoagulation for secondary prevention - Part 2,NG158,How should long-term anticoagulation be managed in patients with unprovoked DVT or PE and low bleeding risk?
NG158_Recommendations: 1.4 Long-term anticoagulation for secondary prevention - Part 3,NG158,What are the recommendations for using aspirin as an alternative to anticoagulation in patients who decline continued treatment for DVT or PE?
NG158_Recommendations: 1.5 Information and support for people having anticoagulation treatment,NG158,"What information should be provided to patients on anticoagulation therapy regarding medication use, side effects, and lifestyle considerations?"
NG158_Recommendations: 1.6 Thrombolytic therapy,NG158,What are the indications for thrombolytic therapy in deep vein thrombosis and pulmonary embolism?
NG158_Recommendations: 1.7 Mechanical interventions,NG158,When should an inferior vena cava filter be considered for patients with deep vein thrombosis or pulmonary embolism?
NG158_Recommendations: 1.8 Investigations for cancer,NG158,Should patients with unprovoked DVT or PE be routinely screened for cancer?
NG158_Recommendations: 1.9 Thrombophilia testing,NG158,When should thrombophilia testing be considered for patients with unprovoked DVT or PE?
NG158_Recommendations: Terms used in this guideline,NG158,What is the definition of active cancer in NICE guidelines for thrombosis management?
NG158_Recommendations for research: Key recommendations for research - Part 1,NG158,What is the clinical and cost effectiveness of inferior vena caval filters in treating venous thromboembolism?
NG158_Recommendations for research: Key recommendations for research - Part 2,NG158,What is the accuracy of prediction tools versus clinical judgment for VTE recurrence and bleeding risk in unprovoked DVT or PE?
NG158_Recommendations for research: Other recommendations for research,NG158,What is the most effective pharmacological treatment for DVT or PE in people who use intravenous drugs?
NG158_Rationale and impact: Diagnosis and initial management in people with COVID‑19 - Part 1,NG158,What are the current recommendations for diagnosing pulmonary embolism in people with COVID-19?
NG158_Rationale and impact: Diagnosis and initial management in people with COVID‑19 - Part 2,NG158,When should anticoagulation be stopped in COVID-19 patients receiving respiratory support despite negative imaging results?
NG158_Rationale and impact: D‑dimer testing,NG158,What are the recommendations for D-dimer testing in diagnosing venous thromboembolism?
NG158_Rationale and impact: Pulmonary embolism rule-out criteria (the PERC rule) - Part 1,NG158,What are the criteria for using the PERC rule to rule out pulmonary embolism?
NG158_Rationale and impact: Pulmonary embolism rule-out criteria (the PERC rule) - Part 2,NG158,"How should the PERC rule be applied in patients with suspected pulmonary embolism, especially in those with COVID-19?"
NG158_Rationale and impact: Outpatient treatment for low-risk pulmonary embolism,NG158,What are the benefits and safety considerations of outpatient treatment for low-risk pulmonary embolism?
NG158_Rationale and impact: Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism - Part 1,NG158,What are the recommended anticoagulation treatments for suspected or confirmed deep vein thrombosis and pulmonary embolism?
NG158_Rationale and impact: Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism - Part 2,NG158,What are the recommended anticoagulant options for treating deep vein thrombosis or pulmonary embolism in patients at extremes of body weight?
NG158_Rationale and impact: Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism - Part 3,NG158,What is the recommended anticoagulation treatment for pulmonary embolism with haemodynamic instability?
NG158_Rationale and impact: Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism - Part 4,NG158,What are the current recommendations for choosing anticoagulant therapy for venous thromboembolism in people with active cancer?
NG158_Rationale and impact: Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism - Part 5,NG158,What is the recommended anticoagulation treatment for people with DVT or PE and triple positive antiphospholipid syndrome?
NG158_Rationale and impact: Long-term anticoagulation for secondary prevention - Part 1,NG158,When should long-term anticoagulation be stopped after treatment for DVT or PE?
NG158_Rationale and impact: Long-term anticoagulation for secondary prevention - Part 2,NG158,What are the recommendations for continuing or switching anticoagulant therapy beyond 3 months in patients with VTE?
NG158_Rationale and impact: Long-term anticoagulation for secondary prevention - Part 3,NG158,What are the recommendations for stopping or continuing anticoagulation therapy after a VTE?
NG158_Rationale and impact: Inferior vena caval filters - Part 1,NG158,When should inferior vena caval filters be used in patients with venous thromboembolism?
NG158_Rationale and impact: Inferior vena caval filters - Part 2,NG158,When should IVC filters be considered for patients with pulmonary embolism on anticoagulation therapy?
NG158_Rationale and impact: Investigations for cancer,NG158,Should patients with unprovoked deep vein thrombosis or pulmonary embolism undergo cancer screening if they have no signs or symptoms?
NG158_Context,NG158,What are the recommended diagnostic methods for suspected venous thromboembolism?
NG15_Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use & Overview,NG15,What are the recommended systems and processes for antimicrobial stewardship to promote effective antimicrobial use?
NG15_What is this guideline about and who is it for?,NG15,What are the best practices for antimicrobial stewardship in health and social care settings?
NG15_Person-centred care,NG15,What are the principles of person-centred care and informed decision-making in antimicrobial treatment?
NG15_Recommendations: Terms used in this guideline,NG15,What is antimicrobial stewardship and how does it help prevent antimicrobial resistance?
NG15_Recommendations: 1.1 All antimicrobials - Part 1,NG15,What are the key components of an effective antimicrobial stewardship programme according to NICE guidelines?
NG15_Recommendations: 1.1 All antimicrobials - Part 2,NG15,What are the recommended strategies for establishing and supporting antimicrobial stewardship teams in healthcare settings?
NG15_Recommendations: 1.1 All antimicrobials - Part 3,NG15,What are best practices for antimicrobial stewardship and prescribing guidelines?
NG15_Recommendations: 1.1 All antimicrobials - Part 4,NG15,What are the NICE guidelines for antimicrobial prescribing and stewardship in primary and hospital care?
NG15_Recommendations: 1.1 All antimicrobials - Part 5,NG15,What are the recommended approaches for prescribing antimicrobials and managing antimicrobial use in clinical practice?
NG15_Recommendations: 1.2 New antimicrobials - Part 1,NG15,What are the recommended processes for introducing and monitoring new antimicrobials in healthcare settings?
NG15_Recommendations: 1.2 New antimicrobials - Part 2,NG15,What factors should be considered when evaluating a new antimicrobial for local formulary inclusion?
NG15_Implementation: getting started: The challenge: changing prescribing practice for antimicrobials - Part 1,NG15,What strategies can healthcare organizations use to improve antimicrobial prescribing practices and reduce antimicrobial resistance?
NG15_Implementation: getting started: The challenge: changing prescribing practice for antimicrobials - Part 2,NG15,What strategies can commissioners and healthcare providers use to improve antimicrobial stewardship through data collection and information systems?
NG15_Implementation: getting started: Further resources,NG15,What resources are available to support antimicrobial stewardship and resistance management in primary care?
NG15_Recommendations for research,NG15,What are effective strategies to reduce antimicrobial resistance through antimicrobial stewardship and prescribing practices?
NG164_COVID-19 rapid guideline: haematopoietic stem cell transplantation & Overview,NG164,What are the current NICE recommendations for haemopoietic stem cell transplantation during COVID-19?
NG164_1 Minimising the risks of COVID-19,NG164,What are the recommended strategies to reduce COVID-19 transmission risk in transplant centres?
NG164_2 Pre-transplant care: Transplant recipients,NG164,What precautions should transplant patients take to reduce respiratory infection risk before haematopoietic stem cell transplantation?
NG164_2 Pre-transplant care: Transplant donors & 3 Post-transplant care,NG164,What are the recommended precautions for transplant donors to minimise COVID-19 exposure and transmission risk?
NG164_4 Service provision and organisation,NG164,What are the recommended policies for healthcare staff returning to work after COVID-19 in transplant units?
"NG16_Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset & Overview - Part 1",NG16,"What are effective mid-life strategies to prevent dementia, disability, and frailty in later life?"
NG16_Overview - Part 2,NG16,What interventions can help promote healthy lifestyle changes to reduce dementia and frailty risk in older adults?
NG16_Recommendations: Promoting healthy lifestyles - Part 1,NG16,What are effective strategies to promote healthy lifestyles and reduce dementia risk in the population?
NG16_Recommendations: Promoting healthy lifestyles - Part 2,NG16,"What are effective strategies for promoting healthy behaviors to reduce the risk of dementia, disability, and frailty in mid-life?"
NG16_Recommendations: Promoting healthy lifestyles - Part 3,NG16,What strategies are recommended to prevent illegal tobacco sales and promote smoke-free environments?
NG16_Recommendations: Promoting healthy lifestyles - Part 4,NG16,What strategies can local authorities use to reduce alcohol availability and promote healthy eating?
NG16_Recommendations: Service organisation and delivery - Part 1,NG16,What strategies are recommended for delivering accessible and culturally appropriate behaviour change services to reduce non-communicable diseases?
NG16_Recommendations: Service organisation and delivery - Part 2,NG16,"What strategies can healthcare providers use to promote physical activity and reduce dementia, disability, and frailty risk?"
NG16_Recommendations: Service organisation and delivery - Part 3,NG16,What training and support are recommended for health and social care professionals to promote behaviour change and reduce health risks in older adults?
NG16_Recommendations: Service organisation and delivery - Part 4,NG16,What strategies does NICE recommend for supporting healthy lifestyle changes in the workplace?
NG16_Recommendations: Terms used in this guideline - Part 1,NG16,What is the difference between brief advice and brief interventions in healthcare?
NG16_Recommendations: Terms used in this guideline - Part 2,NG16,What are the recommended individual-level interventions for managing dementia and frailty in older adults?
NG16_Recommendations: Terms used in this guideline - Part 3 & Who should take action?: Introduction - Part 1,NG16,What are the key public health strategies for promoting healthy aging in mid-life?
NG16_Who should take action?: Introduction - Part 2,NG16,Who is responsible for implementing public health actions according to NICE guidelines?
NG16_Context - Part 1,NG16,"What are mid-life strategies to reduce the risk of dementia, disability, and frailty?"
NG16_Context - Part 2,NG16,What are the main types of dementia and how can their risk be reduced?
NG16_Context - Part 3,NG16,What lifestyle factors are associated with successful ageing and increased life expectancy?
NG16_Context - Part 4,NG16,What are the expected health outcomes and disability considerations for older adults in the UK?
NG16_Context - Part 5,NG16,What are the implications of sensory disabilities and frailty for managing older adults with multimorbidity?
NG16_Considerations: General considerations - Part 1,NG16,What are the primary prevention strategies for reducing the risk of dementia and frailty?
NG16_Considerations: General considerations - Part 2,NG16,What are effective strategies for promoting behavioral changes in mid-life to reduce the risk of dementia and frailty?
NG16_Considerations: General considerations - Part 3,NG16,What are effective population and individual strategies for reducing non-communicable diseases through behavior change and addressing social determinants?
NG16_Considerations: General considerations - Part 4,NG16,"What are the current recommendations for alcohol consumption and risk assessment in children, young people, and adults?"
NG16_Considerations: The evidence - Part 1,NG16,"What evidence is available on interventions for mid-life populations to prevent dementia, disability, and frailty?"
NG16_Considerations: The evidence - Part 2,NG16,"What are effective interventions for preventing dementia and frailty related to mid-life vision, hearing, and sleep disorders?"
NG16_Considerations: The evidence - Part 3,NG16,What are the benefits of physical activity and education in reducing dementia risk?
NG16_Considerations: The evidence - Part 4,NG16,What are the recommended interventions to reduce dementia risk through physical activity and behavioral risk management in mid-life?
NG16_Recommendations for research,NG16,What are the most effective interventions to promote healthy behaviors and reduce risk factors for dementia and frailty in mid-life?
NG16_References - Part 1,NG16,What are the latest recommendations for managing multimorbidity in primary care?
NG16_References - Part 2,NG16,What are the key factors influencing healthy aging and dementia prevention in older adults?
NG16_Summary of the methods used to develop this guideline: Introduction & Summary of the methods used to develop this guideline: Guideline development & Summary of the methods used to develop this guideline: Key questions,NG16,"What are the most effective interventions in mid-life to promote healthy behaviors and prevent dementia, frailty, and chronic diseases?"
NG16_Summary of the methods used to develop this guideline: Reviewing the evidence - Part 1,NG16,"What is the evidence on the effectiveness of mid-life interventions for promoting healthy behaviors to prevent dementia, disability, and frailty?"
NG16_Summary of the methods used to develop this guideline: Reviewing the evidence - Part 2,NG16,What are the service delivery factors that influence the uptake and maintenance of healthy lifestyle programmes for adults aged 40 to 64 in the UK?
NG16_Summary of the methods used to develop this guideline: Reviewing the evidence - Part 3 & Summary of the methods used to develop this guideline: Cost effectiveness,NG16,How is the quality of evidence assessed and graded in NICE public health guidelines?
NG16_Summary of the methods used to develop this guideline: How the PHAC formulated the recommendations & The evidence: Introduction,NG16,How does NICE develop recommendations based on evidence and expert consensus?
NG16_The evidence: How the evidence and expert papers link to the recommendations - Part 1,NG16,How are evidence and expert papers used to develop NICE guideline recommendations?
NG16_The evidence: How the evidence and expert papers link to the recommendations - Part 2,NG16,What are the recommended evidence-based practices for clinical management according to NICE guidelines?
NG16_The evidence: Expert papers & The evidence: Economic modelling,NG16,What are the cost-effectiveness considerations for physical activity interventions in mid-life to prevent dementia?
NG16_Gaps in the evidence - Part 1,NG16,What is the evidence on psychosocial risk factors and their impact on dementia and frailty in mid-life?
NG16_Gaps in the evidence - Part 2,NG16,"What is the evidence on the effectiveness of interventions to improve sleep and prevent dementia, disability, and frailty?"
NG17_Type 1 diabetes in adults: diagnosis and management & Overview,NG17,What are the recommended approaches for diagnosing and managing type 1 diabetes in adults?
NG17_Recommendations: 1.1 Diagnosis and early care plan - Part 1,NG17,What are the recommended methods for diagnosing type 1 diabetes in adults?
NG17_Recommendations: 1.1 Diagnosis and early care plan - Part 2,NG17,What are the recommended assessments and care planning steps for adults with new-onset diabetes aged 60 and over to evaluate for pancreatic cancer?
NG17_Recommendations: 1.1 Diagnosis and early care plan - Part 3,NG17,What should be included in an individualized management plan for adults with type 1 diabetes?
NG17_Recommendations: 1.2 Support and individualised care - Part 1,NG17,How should care and support be tailored for adults with type 1 diabetes?
NG17_Recommendations: 1.2 Support and individualised care - Part 2,NG17,What are the recommended follow-up intervals and key components of diabetes review appointments?
NG17_Recommendations: 1.3 Education and information - Part 1,NG17,What are the recommended structured education programmes for adults with type 1 diabetes?
NG17_Recommendations: 1.3 Education and information - Part 2,NG17,What are the recommended strategies for educating adults with type 1 diabetes about self-care and hypoglycemia management?
NG17_Recommendations: 1.4 Dietary management - Part 1,NG17,What are the recommended dietary management strategies for adults with type 1 diabetes?
NG17_Recommendations: 1.4 Dietary management - Part 2,NG17,What are the recommended dietary strategies for managing blood glucose and cardiovascular risk in adults with type 1 diabetes?
NG17_Recommendations: 1.5 Physical activity,NG17,What advice should be given to adults with type 1 diabetes about managing blood glucose during physical activity?
NG17_Recommendations: 1.6 Blood glucose management - Part 1,NG17,What are the recommended blood glucose monitoring and HbA1c target levels for adults with type 1 diabetes?
NG17_Recommendations: 1.6 Blood glucose management - Part 2,NG17,How should adults with type 1 diabetes choose between real-time and flash continuous glucose monitoring?
NG17_Recommendations: 1.6 Blood glucose management - Part 3,NG17,What are the recommended practices for using and monitoring continuous glucose monitoring in adults with type 1 diabetes?
NG17_Recommendations: 1.6 Blood glucose management - Part 4,NG17,What is the recommended frequency for self-monitoring blood glucose in adults with type 1 diabetes?
NG17_Recommendations: 1.6 Blood glucose management - Part 5,NG17,What are the recommended blood glucose targets for adults with type 1 diabetes?
NG17_Recommendations: 1.7 Insulin therapy - Part 1,NG17,What are the recommended insulin regimens for adults with type 1 diabetes?
NG17_Recommendations: 1.7 Insulin therapy - Part 2,NG17,How should I approach switching to a biosimilar insulin in type 1 diabetes management?
NG17_Recommendations: 1.7 Insulin therapy - Part 3,NG17,What are the recommendations for insulin injection devices and site management in adults with type 1 diabetes?
NG17_Recommendations: 1.7 Insulin therapy - Part 4,NG17,What are the guidelines for managing insulin doses during illness in adults with type 1 diabetes?
NG17_Recommendations: 1.8 Referral for islet or pancreas transplantation,NG17,When should adults with type 1 diabetes be referred for islet or pancreas transplantation?
NG17_Recommendations: 1.9 Hypoglycaemia awareness and management - Part 1,NG17,How should hypoglycaemia awareness be assessed and managed in adults with type 1 diabetes?
NG17_Recommendations: 1.9 Hypoglycaemia awareness and management - Part 2,NG17,What are the recommended treatments for severe hypoglycaemia in adults with type 1 diabetes?
NG17_Recommendations: 1.10 Ketone monitoring and managing diabetic ketoacidosis - Part 1,NG17,What are the recommended practices for ketone monitoring and management of diabetic ketoacidosis in adults with type 1 diabetes?
NG17_Recommendations: 1.10 Ketone monitoring and managing diabetic ketoacidosis - Part 2 & Recommendations: 1.11 Associated illness,NG17,What are the recommended management strategies for diabetic ketoacidosis in adults?
NG17_Recommendations: 1.12 Control of cardiovascular risk - Part 1,NG17,What are the recommended strategies for managing cardiovascular risk in adults with type 1 diabetes?
NG17_Recommendations: 1.12 Control of cardiovascular risk - Part 2,NG17,What are the blood pressure targets for adults with type 1 diabetes based on urine albumin:creatinine ratio?
NG17_Recommendations: 1.12 Control of cardiovascular risk - Part 3 & Recommendations: 1.13 Caring for adults with type 1 diabetes in hospital,NG17,What are the recommended strategies for managing hypertension in adults with type 1 diabetes?
NG17_Recommendations: 1.13 Caring for adults with type 1 diabetes in hospital - Part 1,NG17,What is the recommended blood glucose target for adults with type 1 diabetes during surgery or acute illness?
NG17_Recommendations: 1.13 Caring for adults with type 1 diabetes in hospital - Part 2,NG17,How should adults with type 1 diabetes be supported to self-administer insulin while hospitalized?
NG17_Recommendations: 1.14 Managing complications - Part 1,NG17,What are the recommended management strategies for periodontitis in adults with type 1 diabetes?
NG17_Recommendations: 1.14 Managing complications - Part 2,NG17,When should an ophthalmologist be consulted for sudden vision loss or retinal detachment in diabetic patients?
NG17_Recommendations: 1.14 Managing complications - Part 3,NG17,What are the management strategies for autonomic neuropathy in adults with type 1 diabetes?
NG17_Recommendations: 1.14 Managing complications - Part 4,NG17,What are the recommended management strategies for gastroparesis-related vomiting in adults with type 1 diabetes?
NG17_Recommendations: 1.14 Managing complications - Part 5,NG17,When should domperidone be prescribed for gastroparesis in adults with diabetes?
NG17_Recommendations: 1.14 Managing complications - Part 6,NG17,What are the recommended treatments for acute painful neuropathy in adults with type 1 diabetes after rapid blood glucose improvement?
NG17_Recommendations: 1.14 Managing complications - Part 7,NG17,What are the recommended approaches for managing mental health and eating disorders in adults with type 1 diabetes?
NG17_Recommendations: Terms used in this guideline,NG17,What is continuous glucose monitoring and how is it used in diabetes management?
NG17_Recommendations for research,NG17,What clinical features help distinguish type 1 diabetes from other types of diabetes?
NG17_Rationale and impact: Diagnosis - Part 1,NG17,What are the recommended methods for diagnosing and distinguishing between type 1 and type 2 diabetes?
NG17_Rationale and impact: Diagnosis - Part 2,NG17,How does autoantibody testing improve the accuracy of diabetes diagnosis at presentation?
NG17_Rationale and impact: Continuous glucose monitoring - Part 1,NG17,What are the benefits of real-time versus intermittently scanned continuous glucose monitoring for adults with type 1 diabetes?
NG17_Rationale and impact: Continuous glucose monitoring - Part 2,NG17,How can healthcare teams improve access to continuous glucose monitoring for people with diabetes?
NG17_Rationale and impact: Long-acting insulin - Part 1,NG17,What are the recommended long-acting insulins for adults with type 1 diabetes to reduce hypoglycaemia risk?
NG17_Rationale and impact: Long-acting insulin - Part 2,NG17,What are the guidelines for switching to biosimilar insulins in type 1 and type 2 diabetes management?
NG17_Rationale and impact: Periodontitis - Part 1,NG17,What is the impact of periodontal treatment on glycemic control in people with diabetes?
NG17_Rationale and impact: Periodontitis - Part 2,NG17,How can oral healthcare professionals improve care pathways for people with diabetes to enhance oral health outcomes?
NG17_Context,NG17,What are the best practices for insulin management in adults with type 1 diabetes?
NG180_Perioperative care in adults & Overview,NG180,What are the key considerations for perioperative care in adults undergoing elective or emergency surgery?
NG180_Recommendations: 1.1 Information and support for people having surgery,NG180,What are the recommended practices for providing information and support to patients undergoing surgery?
NG180_Recommendations: 1.2 Enhanced recovery programmes,NG180,What are the benefits of enhanced recovery programmes for patients undergoing elective major or complex surgery?
NG180_Recommendations: 1.3 Preoperative care - Part 1,NG180,What are the recommended preoperative assessments and risk management strategies for surgery?
NG180_Recommendations: 1.3 Preoperative care - Part 2,NG180,What are the recommended preoperative nutritional screening and support practices for patients undergoing intermediate or major surgery?
NG180_Recommendations: 1.4 Intraoperative care - Part 1,NG180,What are the recommended intraoperative fluid management strategies for surgical patients?
NG180_Recommendations: 1.4 Intraoperative care - Part 2,NG180,How should the WHO surgical safety checklist be used and customized to improve patient safety during surgical procedures?
NG180_Recommendations: 1.5 Postoperative care,NG180,What is the recommended postoperative care setting for high-risk patients?
NG180_Recommendations: 1.6 Managing pain - Part 1,NG180,What are the recommended strategies for managing postoperative pain with multimodal analgesia?
NG180_Recommendations: 1.6 Managing pain - Part 2,NG180,What are the recommended pain management options for patients unable to take oral opioids after surgery?
NG180_Recommendations: Terms used in this guideline & Recommendations for research: Key recommendations for research - Part 1,NG180,What are the best strategies for perioperative management of anticoagulation in patients on vitamin K antagonists requiring bridging therapy?
NG180_Recommendations for research: Key recommendations for research - Part 2,NG180,Which patients benefit from postoperative care in specialist recovery areas after major surgery?
NG180_Recommendations for research: Other recommendations for research,NG180,What is the optimal timing for administering preoperative carbohydrate drinks?
NG180_Rationale and impact: Information and support for people having surgery,NG180,"What information and support should be provided to patients before, during, and after surgery?"
NG180_Rationale and impact: Enhanced recovery programmes,NG180,What are the benefits and components of enhanced recovery programmes for elective major surgery?
NG180_Rationale and impact: Preoperative care - Part 1,NG180,What are the recommended preoperative assessments and risk stratification tools for surgery?
NG180_Rationale and impact: Preoperative care - Part 2,NG180,What are the current best practices for managing anticoagulation with vitamin K antagonists during surgery?
NG180_Rationale and impact: Intraoperative care - Part 1,NG180,What are the current recommendations for intraoperative fluid management and monitoring during surgery?
NG180_Rationale and impact: Intraoperative care - Part 2,NG180,What are the current recommendations for surgical safety checklists to prevent 'never events' in hospitals?
NG180_Rationale and impact: Postoperative care,NG180,What are the benefits of postoperative care in specialist recovery areas for high-risk surgical patients?
NG180_Rationale and impact: Managing pain - Part 1,NG180,What are the recommended strategies for managing postoperative pain in surgical patients?
NG180_Rationale and impact: Managing pain - Part 2,NG180,What are the current NICE guidelines for using intravenous ketamine and gabapentin in postoperative pain management?
NG181_Rehabilitation for adults with complex psychosis & Overview,NG181,What are the key principles for rehabilitation in adults with complex psychosis according to NICE NG181?
NG181_Recommendations: 1.1 Who should be offered rehabilitation?,NG181,Who should be offered rehabilitation for complex psychosis and treatment-resistant symptoms?
NG181_Recommendations: 1.2 Overarching principles of rehabilitation,NG181,What are the principles of rehabilitation for people with complex psychosis?
NG181_Recommendations: 1.3 Organising the rehabilitation pathway - Part 1,NG181,What are the key components of an effective mental health rehabilitation pathway?
NG181_Recommendations: 1.3 Organising the rehabilitation pathway - Part 2,NG181,How should specialised rehabilitation services for complex psychosis be commissioned and organized?
NG181_Recommendations: 1.3 Organising the rehabilitation pathway - Part 3,NG181,What are best practices for coordinating transitions between rehabilitation services and primary care in mental health?
NG181_Recommendations: 1.3 Organising the rehabilitation pathway - Part 4,NG181,What are the recommended practices for informing patients about supported accommodation options before moving in?
NG181_Recommendations: 1.3 Organising the rehabilitation pathway - Part 5,NG181,"What are the recommended protocols for collaboration between primary care, secondary care, and rehabilitation services in managing physical health conditions?"
NG181_Recommendations: 1.4 Improving access to rehabilitation,NG181,What strategies can improve access to rehabilitation services for people with complex psychosis?
NG181_Recommendations: 1.5 Delivering services within the rehabilitation pathway - Part 1,NG181,What are the recommended multidisciplinary team members and community care practices for inpatient and supported accommodation services for people with complex psychosis?
NG181_Recommendations: 1.5 Delivering services within the rehabilitation pathway - Part 2,NG181,What are the best practices for supporting discharge and community reintegration in mental health rehabilitation?
NG181_Recommendations: 1.5 Delivering services within the rehabilitation pathway - Part 3,NG181,What are the recommended review procedures for out-of-area mental health rehabilitation placements?
NG181_Recommendations: 1.6 Recovery-orientated rehabilitation services - Part 1,NG181,What are the key principles of recovery-oriented rehabilitation services for mental health?
NG181_Recommendations: 1.6 Recovery-orientated rehabilitation services - Part 2,NG181,What training and support are recommended for staff to effectively promote recovery and manage risks in mental health rehabilitation services?
NG181_Recommendations: 1.6 Recovery-orientated rehabilitation services - Part 3,NG181,"What are the recommended approaches for rehabilitation, care planning, and supporting activities of daily living in mental health services?"
NG181_Recommendations: 1.7 Person-centred care planning through assessment and formulation - Part 1,NG181,What are the key components of a comprehensive biopsychosocial assessment for people entering rehabilitation services?
NG181_Recommendations: 1.7 Person-centred care planning through assessment and formulation - Part 2,NG181,What are the recommended approaches for developing a collaborative care plan for people with complex psychosis and co-occurring mental or physical health conditions?
NG181_Recommendations: 1.7 Person-centred care planning through assessment and formulation - Part 3,NG181,How should care plans be reviewed and shared with patients during rehabilitation?
NG181_Recommendations: 1.8 Rehabilitation programmes and interventions - Part 1,NG181,What are effective rehabilitation interventions for improving daily living and social skills in people with complex psychosis?
NG181_Recommendations: 1.8 Rehabilitation programmes and interventions - Part 2,NG181,What are effective strategies for supporting employment and education for people with mental health conditions?
NG181_Recommendations: 1.8 Rehabilitation programmes and interventions - Part 3,NG181,What strategies are recommended to support harm reduction and improve engagement in substance misuse services?
NG181_Recommendations: 1.9 Adjustments to mental health treatments in rehabilitation - Part 1,NG181,How should mental health treatments be adjusted for individuals with psychosis or schizophrenia in rehabilitation settings?
NG181_Recommendations: 1.9 Adjustments to mental health treatments in rehabilitation - Part 2,NG181,What are the recommended pharmacological treatments for complex psychosis unresponsive to clozapine?
NG181_Recommendations: 1.9 Adjustments to mental health treatments in rehabilitation - Part 3,NG181,How should medicines be optimised and monitored in the management of complex psychosis?
NG181_Recommendations: 1.9 Adjustments to mental health treatments in rehabilitation - Part 4,NG181,What are the recommended monitoring protocols for ECGs in patients with complex psychosis on psychotropic medications?
NG181_Recommendations: 1.10 Physical healthcare - Part 1,NG181,What are the recommended strategies for supporting smoking cessation in patients with mental health conditions?
NG181_Recommendations: 1.10 Physical healthcare - Part 2,NG181,What are the recommended physical health assessments and interventions for people with mental health conditions according to NICE guidelines?
NG181_Recommendations: 1.10 Physical healthcare - Part 3,NG181,What are the recommended components of an annual physical health check for people in rehabilitation services?
NG181_Recommendations: 1.10 Physical healthcare - Part 4,NG181,What are the NICE recommendations for managing physical inactivity and comorbidities like COPD and blood-borne infections?
NG181_Recommendations: Terms used in this guideline - Part 1,NG181,What is behavioural activation and how is it used in managing depression?
NG181_Recommendations: Terms used in this guideline - Part 2,NG181,What are the recommended rehabilitation approaches for individuals with complex mental health and physical comorbidities?
NG181_Recommendations: Terms used in this guideline - Part 3,NG181,What are the key components of the Individual Placement and Support (IPS) approach for mental health employment support?
NG181_Recommendations: Terms used in this guideline - Part 4,NG181,What is the role of education and recovery-oriented approaches in mental health rehabilitation?
NG181_Recommendations for research: Key recommendations for research - Part 1,NG181,What are the characteristics of effective high-dependency rehabilitation units for people with complex psychosis?
NG181_Recommendations for research: Key recommendations for research - Part 2,NG181,What are effective structured group activities for improving social skills in people with complex psychosis?
NG181_Recommendations for research: Other recommendations for research - Part 1,NG181,What is the effectiveness of integrated care systems in supporting people with complex psychosis to transition to more independent settings?
NG181_Recommendations for research: Other recommendations for research - Part 2,NG181,What interventions are effective to improve medicines adherence in people with complex psychosis living in supported accommodation?
NG181_Rationale and impact: Who should be offered rehabilitation?,NG181,Who should be offered mental health rehabilitation for severe mental illness?
NG181_Rationale and impact: Overarching principles of rehabilitation,NG181,What are the overarching principles for delivering effective rehabilitation services for people with complex psychosis?
"NG181_Rationale and impact: Organising the rehabilitation pathway, and the lead commissioner - Part 1",NG181,What are the key considerations for organising local rehabilitation pathways and commissioning services for mental health recovery?
"NG181_Rationale and impact: Organising the rehabilitation pathway, and the lead commissioner - Part 2",NG181,What are the recommended approaches for organizing flexible rehabilitation pathways for people with complex psychosis?
NG181_Rationale and impact: Joint working,NG181,What are best practices for integrating rehabilitation care pathways and supporting seamless transitions between services?
NG181_Rationale and impact: Working with other healthcare providers,NG181,How can community-based monitoring of clozapine reduce hospital admissions for people with severe mental illness?
NG181_Rationale and impact: Improving access to rehabilitation,NG181,What strategies can improve access to rehabilitation services for diverse and underserved populations?
NG181_Rationale and impact: Delivering services within the rehabilitation pathway - Part 1,NG181,What are the recommended multidisciplinary team roles for community and inpatient rehabilitation services?
NG181_Rationale and impact: Delivering services within the rehabilitation pathway - Part 2,NG181,What are best practices for community mental health rehabilitation and supported accommodation to promote independence?
NG181_Rationale and impact: Delivering services within the rehabilitation pathway - Part 3,NG181,What are the benefits of providing local inpatient rehabilitation instead of out-of-area placements?
NG181_Rationale and impact: Delivering services within the rehabilitation pathway - Part 4,NG181,How might implementing multidisciplinary team access and supported accommodation quality measures impact healthcare resource allocation?
NG181_Rationale and impact: Recovery-orientated rehabilitation services - Part 1,NG181,What are the key principles of recovery-oriented rehabilitation services for people with complex psychosis?
NG181_Rationale and impact: Recovery-orientated rehabilitation services - Part 2,NG181,What training is recommended for staff to support structured activities and manage risks in mental health rehabilitation services?
NG181_Rationale and impact: Person-centred care planning through assessment and formulation - Part 1,NG181,What should be included in the initial assessment for people entering mental health rehabilitation services?
NG181_Rationale and impact: Person-centred care planning through assessment and formulation - Part 2,NG181,How should care plans be developed and reviewed for people with comorbid health conditions to improve outcomes?
NG181_Rationale and impact: Rehabilitation programmes and interventions - Part 1,NG181,"What are effective rehabilitation interventions to improve daily living, social skills, and community engagement in mental health recovery?"
NG181_Rationale and impact: Rehabilitation programmes and interventions - Part 2,NG181,What are the recommended approaches for addressing substance misuse in rehabilitation services for complex psychosis?
NG181_Rationale and impact: Adjustments to mental health treatments in rehabilitation - Part 1,NG181,What are the recommended adjustments to mental health treatments for people with treatment-resistant psychosis in rehabilitation settings?
NG181_Rationale and impact: Adjustments to mental health treatments in rehabilitation - Part 2,NG181,When should prolactin levels and ECGs be monitored in patients receiving antipsychotic augmentation?
NG181_Rationale and impact: Adjustments to mental health treatments in rehabilitation - Part 3,NG181,What strategies can improve medication adherence in people undergoing mental health rehabilitation?
NG181_Rationale and impact: Physical healthcare - Part 1,NG181,What are the recommended practices for coordinating physical healthcare in mental health rehabilitation services?
NG181_Rationale and impact: Physical healthcare - Part 2,NG181,What are the recommended physical health assessments for people with complex psychosis?
NG181_Rationale and impact: Physical healthcare - Part 3,NG181,What are the recommended management strategies for physical health conditions in people with severe mental illness according to NICE guidelines?
NG181_Context,NG181,What are the recommended approaches for mental health rehabilitation in patients with complex psychosis and treatment-resistant symptoms?
NG182_Insect bites and stings: antimicrobial prescribing & Overview,NG182,What are the recommended antimicrobial prescribing practices for insect bites and stings in children and adults?
NG182_Recommendations: 1.1 Managing insect bites and stings - Part 1,NG182,What is the recommended management for insect bites and stings according to NICE guidelines?
NG182_Recommendations: 1.1 Managing insect bites and stings - Part 2,NG182,When should I refer a patient with an insect bite or sting to specialist care?
NG182_Recommendations: Terms used in the guideline,NG182,"What are the clinical features and management of cellulitis, erysipelas, and erythema migrans?"
NG182_Rationales: Assessment and advice,NG182,What is the recommended first aid for insect bites and stings according to NICE guidelines?
NG182_Rationales: Treatment,NG182,What is the recommended treatment for infected insect bites according to NICE guidelines?
NG182_Rationales: Referral and seeking specialist advice & Summary of the evidence: Antibiotics for infected arthropod bites in adults,NG182,When should I refer a patient with an insect bite or sting for urgent specialist care?
NG182_Summary of the evidence: Oral antihistamines for uninfected mosquito bites in adults,NG182,What is the effectiveness of oral antihistamines in reducing mosquito bite symptoms in adults?
NG182_Summary of the evidence: Antihistamines for uninfected mosquito bites in children & Summary of the evidence: Treatments for uninfected brown recluse spider bites & Context,NG182,What is the recommended treatment for uninfected mosquito bites and brown recluse spider bites in children?
NG183_Behaviour change: digital and mobile health interventions & Overview,NG183,What are the recommended digital and mobile health interventions for promoting healthy behaviors?
NG183_Recommendations: 1.1 Developing digital and mobile health interventions - Part 1,NG183,What are best practices for developing and evaluating digital health interventions for behaviour change?
NG183_Recommendations: 1.1 Developing digital and mobile health interventions - Part 2,NG183,"What should be included in digital health interventions to ensure user privacy, data usage transparency, and stakeholder involvement?"
NG183_Recommendations: 1.2 Commissioning digital and mobile health interventions - Part 1,NG183,What are the NICE recommendations for commissioning digital and mobile health interventions to support behaviour change?
NG183_Recommendations: 1.2 Commissioning digital and mobile health interventions - Part 2,NG183,What factors should be considered when implementing digital health interventions to ensure accessibility and cost-effectiveness?
NG183_Recommendations: 1.3 Using digital and mobile health interventions - Part 1,NG183,What are the recommendations for using digital and mobile health interventions to support behaviour change?
NG183_Recommendations: 1.3 Using digital and mobile health interventions - Part 2,NG183,What are the potential risks and limitations of using digital interventions for health behaviour change?
NG183_Recommendations: 1.4 Diet and physical activity,NG183,What are the recommended digital interventions to promote healthy diet and physical activity?
NG183_Recommendations: 1.5 Smoking,NG183,What digital and mobile health interventions are effective for helping people stop smoking?
NG183_Recommendations: 1.6 Alcohol use,NG183,What are the effective digital and mobile health interventions for reducing alcohol consumption?
NG183_Recommendations: 1.7 Unsafe sexual behaviour,NG183,What are effective online interventions for reducing unsafe sexual behaviour?
NG183_Recommendations: Terms used in this guideline - Part 1,NG183,What are digital and mobile health interventions recommended by NICE for behavior change?
NG183_Recommendations: Terms used in this guideline - Part 2,NG183,What are the considerations for implementing digital health interventions for disordered eating?
NG183_Recommendations for research,NG183,What are the most effective components of digital and mobile health interventions for behavior change?
NG183_Rationale and impact: Developing digital and mobile health interventions - Part 1,NG183,What are best practices for developing effective digital and mobile health interventions for behaviour change?
NG183_Rationale and impact: Developing digital and mobile health interventions - Part 2,NG183,How should digital health interventions be designed to prevent harmful goal setting and ensure user safety?
NG183_Rationale and impact: Commissioning digital and mobile health interventions - Part 1,NG183,What are the NICE recommendations for commissioning digital and mobile health interventions to ensure effectiveness and reduce health inequalities?
NG183_Rationale and impact: Commissioning digital and mobile health interventions - Part 2,NG183,What factors should be considered when commissioning digital and mobile health interventions to ensure accessibility and safety?
NG183_Rationale and impact: Using digital and mobile health interventions - Part 1,NG183,How should healthcare professionals incorporate digital and mobile health interventions into patient care?
NG183_Rationale and impact: Using digital and mobile health interventions - Part 2,NG183,What are the safety considerations and risks associated with digital and mobile health interventions?
NG183_Rationale and impact: Diet and physical activity,NG183,What are the recommended digital and mobile health interventions for promoting healthy diet and physical activity?
NG183_Rationale and impact: Smoking,NG183,What digital and mobile health interventions are effective for smoking cessation?
NG183_Rationale and impact: Alcohol use,NG183,What are the recommended digital interventions for reducing hazardous alcohol consumption?
NG183_Rationale and impact: Unsafe sexual behaviour,NG183,What are the recommended digital interventions for promoting safe sexual behaviour?
NG183_Rationale and impact: Recommendations for research,NG183,What research is available on the effectiveness and potential harms of digital and mobile health interventions for different populations?
NG183_Context,NG183,"How can digital and mobile health interventions support behaviour change for improving physical activity, smoking cessation, and alcohol reduction?"
NG184_Human and animal bites: antimicrobial prescribing & Overview,NG184,What is the recommended approach to antimicrobial prescribing for human and animal bites in adults and children?
NG184_Recommendations: 1.1 Managing human and animal bites - Part 1,NG184,What are the recommended management and assessment procedures for human and animal bites according to NICE guidelines?
NG184_Recommendations: 1.1 Managing human and animal bites - Part 2,NG184,"When should antibiotic prophylaxis be given for human, cat, or dog bites?"
NG184_Recommendations: 1.1 Managing human and animal bites - Part 3,NG184,What are the recommended management and antibiotic treatment guidelines for infected human or animal bites in at-risk patients?
NG184_Recommendations: 1.1 Managing human and animal bites - Part 4,NG184,What are the indications for referring a patient with a human or animal bite to specialist care?
NG184_Recommendations: 1.2 Choice of antibiotic - Part 1,NG184,What are the recommended antibiotics for treating human and pet bite wounds in adults and children?
NG184_Recommendations: 1.2 Choice of antibiotic - Part 2,NG184,What is the recommended duration of antibiotic treatment for bite wounds in different clinical scenarios?
NG184_Recommendations: 1.2 Choice of antibiotic - Part 3,NG184,What are the recommended antibiotics for prophylaxis and treatment of infections in children and young people under 18?
NG184_Rationale and impact: Assessment,NG184,What is the recommended assessment and management for human and animal bites according to NICE guidelines?
NG184_Rationale and impact: Antibiotic prophylaxis for uninfected human and animal bites - Part 1,NG184,"When is antibiotic prophylaxis recommended for human, dog, or cat bites to prevent infection?"
NG184_Rationale and impact: Antibiotic prophylaxis for uninfected human and animal bites - Part 2,NG184,When should antibiotic prophylaxis be given for human and cat bites?
NG184_Rationale and impact: Antibiotic prophylaxis for uninfected human and animal bites - Part 3,NG184,When should antibiotic prophylaxis be given for dog bites?
NG184_Rationale and impact: Treating infected human and animal bites & Rationale and impact: Reassessment & Rationale and impact: Referral and seeking specialist advice,NG184,What is the recommended treatment for infected human or animal bites?
NG184_Rationale and impact: Choice of antibiotic - Part 1,NG184,What is the recommended antibiotic for treating human or animal bites according to NICE guidelines?
NG184_Rationale and impact: Choice of antibiotic - Part 2,NG184,When should intravenous antibiotics be used for bite wounds and what are the recommended antibiotic options?
NG184_Summary of the evidence: Antibiotic efficacy & Summary of the evidence: Choice of antibiotic,NG184,What is the effectiveness of prophylactic antibiotics in preventing infection after human bites?
NG184_Summary of the evidence: Course length & Summary of the evidence: Route of administration & Other considerations: Medicines safety,NG184,What are the safety considerations and common side effects of antibiotics?
NG184_Other considerations: Medicines adherence & Other considerations: Resource implications & Context,NG184,What strategies can improve medicines adherence for patients prescribed antibiotics with frequent dosing or long treatment durations?
NG185_Acute coronary syndromes & Overview,NG185,What are the recommended management strategies for acute coronary syndromes according to NICE guidelines?
NG185_Recommendations: 1.1 STEMI – early management - Part 1,NG185,What is the recommended early management for STEMI according to NICE guidelines?
NG185_Recommendations: 1.1 STEMI – early management - Part 2,NG185,What is the recommended timing and approach for coronary angiography in patients with acute STEMI presenting more than 12 hours after symptom onset?
NG185_Recommendations: 1.1 STEMI – early management - Part 3,NG185,What is the recommended antithrombin therapy during primary PCI for acute STEMI?
NG185_Recommendations: 1.1 STEMI – early management - Part 4,NG185,What is the recommended revascularisation strategy for patients with acute STEMI and multivessel disease with cardiogenic shock?
NG185_Recommendations: 1.1 STEMI – early management - Part 5,NG185,What is the recommended timing for performing an ECG after fibrinolysis in patients with acute STEMI?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 1,NG185,What is the recommended early management and drug therapy for NSTEMI and unstable angina?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 2,NG185,What is the recommended approach to risk assessment and management in patients with unstable angina or NSTEMI?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 3,NG185,When should coronary angiography be performed in patients with unstable angina or NSTEMI?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 4,NG185,What are the benefits and risks of early invasive treatment compared to conservative management for unstable angina or NSTEMI?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 5,NG185,What is the recommended use of unfractionated heparin during PCI for unstable angina or NSTEMI?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 6,NG185,What are the recommended management options for unstable angina and NSTEMI when PCI is not suitable?
NG185_Recommendations: 1.2 NSTEMI and unstable angina – early management - Part 7,NG185,What are the recommended management strategies and treatment options for unstable angina and NSTEMI patients at high bleeding risk?
NG185_Recommendations: 1.3 Hyperglycaemia in acute coronary syndromes,NG185,What are the recommended blood glucose management strategies for hyperglycaemia in patients with acute coronary syndrome?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 1,NG185,What are the recommended drug therapies for secondary prevention after myocardial infarction according to NICE guidelines?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 2,NG185,What is the recommended use and monitoring of ACE inhibitors after myocardial infarction?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 3,NG185,What are the recommended antiplatelet therapies for preventing recurrent cardiovascular events after myocardial infarction?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 4,NG185,What are the recommended anticoagulation and antiplatelet strategies for patients after PCI or MI according to NICE guidelines?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 5,NG185,What is the recommended duration for continuing beta-blockers after a myocardial infarction in patients without reduced left ventricular ejection fraction?
NG185_Recommendations: 1.4 Drug therapy for secondary prevention - Part 6 & Recommendations: 1.5 Coronary revascularisation after an MI,NG185,What are the guidelines for using aldosterone antagonists and statins after a myocardial infarction?
NG185_Recommendations: 1.6 Selected patient subgroups & Recommendations: 1.7 Communication of diagnosis and advice,NG185,What are the recommended treatments for heart failure patients with reduced left ventricular ejection fraction?
NG185_Recommendations: 1.8 Cardiac rehabilitation after an MI - Part 1,NG185,What are the recommended components and considerations for cardiac rehabilitation after a myocardial infarction?
NG185_Recommendations: 1.8 Cardiac rehabilitation after an MI - Part 2,NG185,What are the recommended components and accessibility considerations for cardiac rehabilitation programs after myocardial infarction?
NG185_Recommendations: 1.8 Cardiac rehabilitation after an MI - Part 3,NG185,What should be included in comprehensive cardiac rehabilitation programmes for patients recovering from myocardial infarction?
NG185_Recommendations: 1.8 Cardiac rehabilitation after an MI - Part 4,NG185,How can I use a perceived exertion scale to monitor exercise intensity after a myocardial infarction?
NG185_Recommendations: 1.9 Lifestyle changes after an MI - Part 1,NG185,What dietary changes are recommended after a myocardial infarction to reduce the risk of recurrence?
NG185_Recommendations: 1.9 Lifestyle changes after an MI - Part 2 & Recommendations: Terms used in this guideline,NG185,What are the recommended physical activity levels for improving exercise capacity in adults?
NG185_Recommendations for research: Key recommendations for research - Part 1,NG185,What is the most effective dual antiplatelet therapy for patients aged 75 and over with acute coronary syndrome undergoing PCI?
NG185_Recommendations for research: Key recommendations for research - Part 2,NG185,What is the impact of primary PCI-related time delays on treatment outcomes in acute STEMI patients?
NG185_Recommendations for research: Key recommendations for research - Part 3,NG185,What is the clinical and cost effectiveness of using risk scoring systems in managing unstable angina and NSTEMI compared to clinical assessment alone?
NG185_Recommendations for research: Other recommendations for research - Part 1,NG185,What is the best way to assess and manage hyperglycaemia in patients with acute coronary syndrome and diabetes?
NG185_Recommendations for research: Other recommendations for research - Part 2,NG185,Does continuing beta-blocker therapy beyond one year after myocardial infarction improve outcomes in patients with normal left ventricular function?
NG185_Rationale and impact: Dual antiplatelet therapy for acute STEMI intended for primary PCI - Part 1,NG185,What is the recommended dual antiplatelet therapy for patients with acute STEMI undergoing primary PCI?
NG185_Rationale and impact: Dual antiplatelet therapy for acute STEMI intended for primary PCI - Part 2,NG185,When should prasugrel be used instead of ticagrelor or clopidogrel in patients with acute STEMI?
NG185_Rationale and impact: Antithrombin therapy during primary PCI for acute STEMI,NG185,What is the recommended antithrombin therapy during primary PCI for acute STEMI?
NG185_Rationale and impact: Complete revascularisation with PCI or culprit vessel only PCI for acute STEMI - Part 1,NG185,What is the recommended timing for complete revascularisation with PCI in patients with acute STEMI without cardiogenic shock?
NG185_Rationale and impact: Complete revascularisation with PCI or culprit vessel only PCI for acute STEMI - Part 2,NG185,How does implementing multivessel PCI during primary treatment for STEMI affect clinical practice and resource utilization?
NG185_Rationale and impact: Drug-eluting stents,NG185,What are the benefits of using drug-eluting stents over bare metal stents in primary PCI?
NG185_Rationale and impact: Antiplatelet therapy for STEMI not treated with PCI,NG185,What is the recommended antiplatelet therapy for STEMI patients managed without PCI according to NICE guidelines?
NG185_Rationale and impact: Initial antithrombin therapy for unstable angina and NSTEMI,NG185,What is the recommended initial antithrombin therapy for patients with unstable angina or NSTEMI undergoing early angiography?
NG185_Rationale and impact: Early invasive versus conservative management for unstable angina and NSTEMI - Part 1,NG185,What are the current NICE recommendations for early invasive versus conservative management in patients with unstable angina and NSTEMI?
NG185_Rationale and impact: Early invasive versus conservative management for unstable angina and NSTEMI - Part 2,NG185,What is the recommended timing for coronary angiography in acute coronary syndrome?
NG185_Rationale and impact: Antiplatelet therapy for unstable angina and NSTEMI - Part 1,NG185,When should dual antiplatelet therapy be initiated in patients with unstable angina or NSTEMI?
NG185_Rationale and impact: Antiplatelet therapy for unstable angina and NSTEMI - Part 2,NG185,What is the recommended antiplatelet therapy for unstable angina or NSTEMI when PCI is not performed?
NG185_Rationale and impact: Antiplatelet therapy for people with an indication for anticoagulation,NG185,What is the recommended management of antiplatelet therapy in patients on anticoagulation after PCI?
NG185_Rationale and impact: Duration of beta-blocker treatment after an MI & Context,NG185,What is the recommended duration of beta-blocker therapy after a myocardial infarction in patients with normal left ventricular function?
NG188_COVID-19 rapid guideline: managing the long-term effects of COVID-19 & Overview,NG188,What are the recommended approaches for managing long COVID symptoms in adults and children?
NG188_1 Identification: Case definition,NG188,What are the clinical definitions and diagnostic criteria for long COVID and post-COVID-19 syndrome?
NG188_1 Identification: Advice and written information - Part 1,NG188,What advice and information should be provided to patients recovering from COVID-19 regarding symptoms and self-management?
NG188_1 Identification: Advice and written information - Part 2,NG188,What information is available about COVID-19 vaccines and their effects on long COVID symptoms?
NG188_1 Identification: New and ongoing symptoms after acute COVID-19,NG188,What are the recommended approaches for managing ongoing symptoms after COVID-19 infection?
NG188_1 Identification: Need for further assessment,NG188,What factors should be considered when deciding between remote or in-person assessment for ongoing symptoms after COVID-19?
NG188_1 Identification: Proactive follow-up after acute COVID-19 & 2 Assessment: 2.1,NG188,What are the recommended follow-up procedures for patients after acute COVID-19 infection?
NG188_2 Assessment: 2.2 & 3 more sections,NG188,What should healthcare professionals consider when assessing and supporting patients with post-COVID-19 symptoms?
NG188_2 Assessment: 2.6 & 3 Investigations and referral: 3.1,NG188,What screening tools are recommended for assessing new cognitive symptoms in post-COVID-19 patients?
NG188_3 Investigations and referral: 3.2 & 4 more sections,NG188,What are the indications for urgent referral in post-COVID-19 syndrome?
NG188_3 Investigations and referral: 3.7 & 4 more sections,NG188,When should I consider a chest X-ray for ongoing respiratory symptoms after COVID-19?
NG188_3 Investigations and referral: 3.12,NG188,Should patients be excluded from referral or further assessment for COVID-19 based solely on a negative SARS-CoV-2 test?
NG188_4 Planning care,NG188,What are the recommended care planning and support options for managing post-COVID-19 syndrome in primary care?
NG188_5 Management: 5.1 Self-management and supported self-management,NG188,What self-management strategies are recommended for people recovering from COVID-19?
NG188_5 Management: 5.2 Multidisciplinary rehabilitation,NG188,What are the recommended approaches for multidisciplinary rehabilitation in patients with ongoing COVID-19 symptoms?
NG188_5 Management: 5.3 Additional support,NG188,What support options are recommended for people with post-COVID-19 syndrome who are vulnerable?
"NG188_6 Follow‑up, monitoring and discharge",NG188,What are the recommended follow-up and monitoring strategies for patients with post-COVID-19 syndrome?
NG188_7 Sharing information and continuity of care,NG188,What are the recommended practices for sharing clinical records and ensuring continuity of care in multidisciplinary teams?
NG188_8 Service organisation,NG188,What are the recommended models for multidisciplinary service organization in post-COVID-19 rehabilitation?
NG188_9 Common symptoms,NG188,What are the common symptoms of post-acute COVID-19 in adults and children?
NG188_Recommendations for research: Key recommendations for research,NG188,What are the most effective interventions for managing post-COVID-19 syndrome and how do they vary across different population groups?
NG188_Recommendations for research: Other recommendations for research,NG188,What are the most effective screening tools for diagnosing post-COVID-19 syndrome in adults?
NG188_Rationales: Identification - Part 1,NG188,What are the clinical definitions and terminology used for diagnosing and managing long COVID?
NG188_Rationales: Identification - Part 2,NG188,"What are the clinical definitions and timeframes for acute, ongoing symptomatic, and post-COVID-19 syndrome?"
NG188_Rationales: Identification - Part 3,NG188,What should I do if I experience ongoing symptoms after COVID-19 infection?
NG188_Rationales: Identification - Part 4,NG188,What are the recommended approaches for assessing and managing ongoing symptoms of post-COVID-19 syndrome in children and adults?
NG188_Rationales: Identification - Part 5,NG188,What are the recommended follow-up procedures for patients after acute COVID-19 infection?
NG188_Rationales: Assessment,NG188,What are the recommended approaches for holistic assessment of post-COVID-19 symptoms?
NG188_Rationales: Investigations and referral - Part 1,NG188,What investigations are recommended for assessing persistent symptoms after COVID-19?
NG188_Rationales: Investigations and referral - Part 2,NG188,What are the recommended protocols for safely performing a sit-to-stand test in patients with respiratory conditions?
NG188_Rationales: Investigations and referral - Part 3,NG188,When should I refer a patient for mental health support or multidisciplinary assessment after COVID-19?
NG188_Rationales: Planning care,NG188,What is the recommended approach for planning care and support in self-management for different age groups?
NG188_Rationales: Self-management and supported self-management,NG188,What self-management strategies are recommended for ongoing symptoms of COVID-19?
NG188_Rationales: Multidisciplinary rehabilitation,NG188,What are the key components of multidisciplinary rehabilitation for post-COVID-19 syndrome?
NG188_Rationales: Additional support,NG188,What additional support is recommended for older adults and children with ongoing symptomatic COVID-19 or post-COVID-19 syndrome?
"NG188_Rationales: Follow‑up, monitoring and discharge",NG188,What are the recommended follow-up and monitoring strategies for post-COVID-19 patients?
NG188_Rationales: Sharing information and continuity of care,NG188,How can healthcare providers improve sharing of clinical information to ensure continuity of care across services?
NG188_Rationales: Service organisation,NG188,What are the recommended models for multidisciplinary assessment and service organization for post-COVID-19 syndrome?
NG188_Rationales: Common symptoms,NG188,What are the common symptoms of COVID-19 in children and young people?
NG189_Safeguarding adults in care homes & 3 more sections,NG189,What are the key safeguarding procedures for preventing abuse in care homes?
NG189_Context - Part 1,NG189,What are the best practices for safeguarding adults in residential and nursing care homes?
NG189_Context - Part 2,NG189,What are the procedures for making safeguarding referrals to the local authority in care homes?
NG189_Context - Part 3,NG189,What are the key principles of adult safeguarding according to NICE guidelines and the Care Act 2014?
NG189_Context - Part 4,NG189,What are the six principles of safeguarding in care settings according to the Care Act?
NG189_Context - Part 5 & Recommendations,NG189,How does the NICE guideline recommend ensuring decision-making support for care home residents who lack mental capacity?
NG189_Recommendations: 1.1 Policy and procedure - Part 1,NG189,What are the recommended safeguarding policies and procedures for care homes according to NICE guidelines?
NG189_Recommendations: 1.1 Policy and procedure - Part 2,NG189,What are the recommended procedures for whistleblowing and safeguarding concern reporting in care homes?
NG189_Recommendations: 1.1 Policy and procedure - Part 3,NG189,What are the roles and responsibilities of care home staff and safeguarding leads in safeguarding adults?
NG189_Recommendations: 1.1 Policy and procedure - Part 4 & Recommendations: 1.2 Induction and training in care homes,NG189,What are the recommended induction and training requirements for staff in care homes to ensure safeguarding adults?
NG189_Recommendations: 1.2 Induction and training in care homes - Part 1,NG189,What are the recommended induction and safeguarding training requirements for care home staff?
NG189_Recommendations: 1.2 Induction and training in care homes - Part 2,NG189,What should be included in mandatory safeguarding training for care home staff?
NG189_Recommendations: 1.2 Induction and training in care homes - Part 3,NG189,What are the recommended components of mandatory safeguarding training for healthcare staff?
NG189_Recommendations: 1.2 Induction and training in care homes - Part 4,NG189,What are the recommended methods for delivering effective safeguarding training to care home staff?
"NG189_Recommendations: 1.2 Induction and training in care homes - Part 5 & Recommendations: 1.3 Care home culture, learning and management",NG189,How should care home managers evaluate and promote staff learning and confidence in safeguarding training?
"NG189_Recommendations: 1.3 Care home culture, learning and management - Part 1",NG189,What are the recommended management practices for safeguarding and staff supervision in care homes?
"NG189_Recommendations: 1.3 Care home culture, learning and management - Part 2",NG189,What are the best practices for promoting a safeguarding culture in care homes?
"NG189_Recommendations: 1.3 Care home culture, learning and management - Part 3",NG189,What are best practices for care home managers to gather and respond to safeguarding feedback from residents and their families?
"NG189_Recommendations: 1.3 Care home culture, learning and management - Part 4 & Recommendations: 1.4 Indicators of individual abuse and neglect",NG189,What are the indicators of individual abuse and neglect in care home residents?
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 1,NG189,What are the indicators of abuse and neglect in care home residents?
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 2,NG189,What are the recommended steps for health and social care practitioners when responding to suspected abuse or neglect?
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 3,NG189,What are the signs and indicators of neglect in care home residents according to NICE guidelines?
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 4,NG189,How can I identify and respond to signs of physical or sexual abuse in adult residents?
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 5,NG189,"What are the signs and indicators of sexual, psychological, and financial abuse in care home residents?"
NG189_Recommendations: 1.4 Indicators of individual abuse and neglect - Part 6 & Recommendations: 1.5 Immediate actions to take if you consider abuse or neglect,NG189,What are the immediate actions to take if abuse or neglect is suspected in a care setting?
NG189_Recommendations: 1.5 Immediate actions to take if you consider abuse or neglect & Recommendations: 1.6 Immediate actions to take if you suspect abuse or neglect,NG189,What are the immediate actions to take if abuse or neglect is suspected in a care setting?
NG189_Recommendations: 1.6 Immediate actions to take if you suspect abuse or neglect - Part 1,NG189,What are the immediate actions to take if abuse or neglect is suspected in a care setting?
NG189_Recommendations: 1.6 Immediate actions to take if you suspect abuse or neglect - Part 2,NG189,What are the recommended procedures for gathering information and providing support in suspected abuse or neglect cases in care settings?
NG189_Recommendations: 1.6 Immediate actions to take if you suspect abuse or neglect - Part 3 & Recommendations: 1.7 Responding to reports of abuse or neglect,NG189,What are the recommended procedures for healthcare professionals when responding to reports of suspected abuse or neglect?
NG189_Recommendations: 1.7 Responding to reports of abuse or neglect - Part 1,NG189,What are the recommended procedures for care home safeguarding leads when responding to reports of abuse or neglect?
NG189_Recommendations: 1.7 Responding to reports of abuse or neglect - Part 2,NG189,What are the procedures for safeguarding referrals in care homes according to NICE guidelines?
NG189_Recommendations: 1.7 Responding to reports of abuse or neglect - Part 3 & Recommendations: 1.8 Working with and supporting the resident at risk during a safeguarding enquiry,NG189,What are best practices for supporting residents at risk during a safeguarding enquiry?
NG189_Recommendations: 1.8 Working with and supporting the resident at risk during a safeguarding enquiry - Part 1,NG189,How can I support a resident at risk during a safeguarding enquiry to ensure their involvement and rights are respected?
NG189_Recommendations: 1.8 Working with and supporting the resident at risk during a safeguarding enquiry - Part 2,NG189,What are the requirements for involving advocates in safeguarding adults in care homes according to NICE guidelines?
NG189_Recommendations: 1.8 Working with and supporting the resident at risk during a safeguarding enquiry - Part 3 & Recommendations: 1.9 How care home providers and managers should support care home staff during an enquiry,NG189,What are best practices for supporting residents at risk during a safeguarding enquiry in care homes?
NG189_Recommendations: 1.9 How care home providers and managers should support care home staff during an enquiry - Part 1,NG189,How should care home staff be supported during a safeguarding enquiry?
NG189_Recommendations: 1.9 How care home providers and managers should support care home staff during an enquiry - Part 2 & Recommendations: 1.10 How local authorities should support care homes during an enquiry,NG189,How should local authorities support care homes during safeguarding enquiries?
NG189_Recommendations: 1.10 How local authorities should support care homes during an enquiry & Recommendations: 1.11 Meetings during a safeguarding enquiry,NG189,What are the recommended practices for local authorities to support care homes during safeguarding enquiries?
NG189_Recommendations: 1.11 Meetings during a safeguarding enquiry & Recommendations: 1.12 Indicators of organisational abuse and neglect,NG189,What are the indicators of organisational abuse and neglect in safeguarding practice?
NG189_Recommendations: 1.12 Indicators of organisational abuse and neglect - Part 1,NG189,What are the indicators of organisational abuse and neglect in care homes?
NG189_Recommendations: 1.12 Indicators of organisational abuse and neglect - Part 2,NG189,What are the signs and indicators of organisational abuse and neglect in care settings?
NG189_Recommendations: 1.12 Indicators of organisational abuse and neglect - Part 3,NG189,"What are the signs of organisational abuse related to safeguarding, staffing, and care quality in care homes?"
NG189_Recommendations: 1.12 Indicators of organisational abuse and neglect - Part 4,NG189,What are the signs of organisational abuse and how should they be addressed in care homes?
"NG189_Recommendations: 1.12 Indicators of organisational abuse and neglect - Part 5 & Recommendations: 1.13 How care homes should learn from safeguarding concerns, referrals and enquiries",NG189,"How should care homes learn from safeguarding concerns, referrals, and enquiries according to NICE guidelines?"
"NG189_Recommendations: 1.13 How care homes should learn from safeguarding concerns, referrals and enquiries & Recommendations: Terms used in this guideline",NG189,How should care homes implement learning from safeguarding concerns and referrals to improve practice?
NG189_Recommendations: Terms used in this guideline - Part 1,NG189,What is the role of the enquiry lead in safeguarding adults in care homes?
NG189_Recommendations: Terms used in this guideline - Part 2,NG189,What is the role of safeguarding champions in care homes and how do they support staff and residents?
NG189_Recommendations: Terms used in this guideline - Part 3,NG189,What are the procedures for making a safeguarding referral in care homes?
NG189_Recommendations for research & 7 more sections,NG189,What are the recommended components of e-learning safeguarding training for healthcare professionals and care staff?
NG189_Recommendations for research: 4 E-learning safeguarding training & 4 more sections,NG189,What are effective strategies for embedding learning from Safeguarding Adults Reviews in care home safeguarding policies?
NG189_Rationale and impact: Care home safeguarding policy and procedure - Part 1,NG189,What are the recommended safeguarding policies and procedures for care homes?
NG189_Rationale and impact: Care home safeguarding policy and procedure - Part 2 & Rationale and impact: Care home whistleblowing policy and procedure,NG189,What are the key components of an effective care home whistleblowing policy and procedure?
NG189_Rationale and impact: Care home whistleblowing policy and procedure & Rationale and impact: Care home and care home provider roles and responsibilities,NG189,What are the recommended policies and procedures for whistleblowing in care homes?
"NG189_Rationale and impact: Care home and care home provider roles and responsibilities & Rationale and impact: Local authorities, clinical commissioning groups, and other commissioners",NG189,What are the roles and responsibilities of care home providers regarding safeguarding and governance?
"NG189_Rationale and impact: Local authorities, clinical commissioning groups, and other commissioners & Rationale and impact: Safeguarding Adults Boards",NG189,What are the responsibilities of local authorities and clinical commissioning groups in safeguarding care home residents?
NG189_Rationale and impact: Safeguarding Adults Boards,NG189,What are the recommended practices for Safeguarding Adults Boards to improve communication and partnership working with care homes?
NG189_Rationale and impact: Induction and training in care homes - Part 1,NG189,What are the recommended induction and training requirements for safeguarding in care homes?
NG189_Rationale and impact: Induction and training in care homes - Part 2 & Rationale and impact: What mandatory training should cover,NG189,What topics should be included in mandatory safeguarding training for care home staff?
NG189_Rationale and impact: What mandatory training should cover & Rationale and impact: Further training,NG189,What should mandatory safeguarding training for care home staff include according to NICE guidelines?
NG189_Rationale and impact: Further training & Rationale and impact: How to conduct training,NG189,What are the recommended approaches for providing ongoing safeguarding training for care home staff?
NG189_Rationale and impact: How to conduct training & Rationale and impact: Evaluating training,NG189,What are the recommended methods for conducting safeguarding training in care homes?
NG189_Rationale and impact: Evaluating training & Rationale and impact: Management skills and competence,NG189,How can care home managers effectively evaluate the impact of safeguarding training on staff practice?
NG189_Rationale and impact: Management skills and competence & Rationale and impact: Line management and supervision,NG189,What are the recommended management skills and supervision practices for safeguarding in care homes?
NG189_Rationale and impact: Line management and supervision & Rationale and impact: Care home culture,NG189,What strategies can care home managers use to improve staff confidence in reporting safeguarding concerns?
NG189_Rationale and impact: Care home culture & Rationale and impact: Multi-agency working and shared learning with other organisations,NG189,What strategies can care home managers use to promote a positive safeguarding culture and improve staff reporting of abuse?
NG189_Rationale and impact: Multi-agency working and shared learning with other organisations & Rationale and impact: Record-keeping,NG189,What are the best practices for multi-agency working and shared learning to improve safeguarding in care settings?
NG189_Rationale and impact: Record-keeping & Rationale and impact: Indicators of individual abuse and neglect and immediate actions to take if you consider abuse or neglect,NG189,What are the recommended record-keeping practices for safeguarding residents against abuse and neglect in care homes?
NG189_Rationale and impact: Indicators of individual abuse and neglect and immediate actions to take if you consider abuse or neglect - Part 1,NG189,What are the indicators of abuse and neglect in care homes and how should they be acted upon?
NG189_Rationale and impact: Indicators of individual abuse and neglect and immediate actions to take if you consider abuse or neglect - Part 2 & Rationale and impact: Making sure people are safe,NG189,What are the key indicators of abuse and neglect in care homes?
NG189_Rationale and impact: Making sure people are safe & Rationale and impact: Gathering information,NG189,What are the recommended procedures for safeguarding individuals at risk of abuse or neglect in care settings?
"NG189_Rationale and impact: Gathering information & Rationale and impact: Confidentiality, and discussing and reporting suspected abuse and neglect",NG189,What are the recommended practices for gathering and recording information when abuse or neglect is suspected in care settings?
"NG189_Rationale and impact: Confidentiality, and discussing and reporting suspected abuse and neglect & Rationale and impact: Care home safeguarding leads",NG189,What are the NICE recommendations for discussing and reporting suspected abuse and neglect in care homes?
NG189_Rationale and impact: Care home safeguarding leads & Rationale and impact: Local authorities,NG189,What qualifications and training are recommended for safeguarding leads in care homes?
NG189_Rationale and impact: Local authorities,NG189,What are the NICE recommendations for local authorities on safeguarding and reporting abuse in care homes?
NG189_Rationale and impact: Working with and supporting the resident at risk during a safeguarding enquiry - Part 1,NG189,What are the best practices for supporting care home residents during safeguarding enquiries?
NG189_Rationale and impact: Working with and supporting the resident at risk during a safeguarding enquiry - Part 2 & Rationale and impact: Supporting care home staff who are subject to a safeguarding enquiry,NG189,What are the recommended ways to support care home staff during a safeguarding enquiry?
NG189_Rationale and impact: Supporting care home staff who are subject to a safeguarding enquiry & Rationale and impact: Supporting care home staff,NG189,What are the recommended ways to support care home staff during safeguarding enquiries?
NG189_Rationale and impact: Supporting care home staff,NG189,How can care home managers effectively support staff during safeguarding enquiries?
NG189_Rationale and impact: How local authorities should support care homes during an enquiry,NG189,How should local authorities support care homes during safeguarding enquiries?
NG189_Rationale and impact: Meetings during a safeguarding enquiry,NG189,What are best practices for conducting safeguarding meetings in care homes?
NG189_Rationale and impact: Indicators of organisational abuse and neglect - Part 1,NG189,What are the indicators of organisational abuse and neglect in care homes?
NG189_Rationale and impact: Indicators of organisational abuse and neglect - Part 2,NG189,What are the recommended practices for preventing organisational abuse and neglect in care homes?
NG18_Diabetes (type 1 and type 2) in children and young people: diagnosis and management & Overview & Recommendations: Blood glucose and plasma glucose,NG18,What are the recommended approaches for diagnosing and managing type 1 and type 2 diabetes in children and young people?
NG18_Recommendations: 1.1 Diagnosis - Part 1,NG18,What are the signs and diagnostic criteria for type 1 diabetes in children and young people?
NG18_Recommendations: 1.1 Diagnosis - Part 2,NG18,When should C-peptide testing be used to differentiate types of diabetes in children and young people?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 1,NG18,What education and support should be provided to children and young people with type 1 diabetes and their families?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 2,NG18,What are the NICE guidelines for managing type 1 diabetes in children and young people?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 3,NG18,What is the recommended immunisation schedule for children with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 4,NG18,What are the recommended insulin delivery options and management strategies for children and young people with newly diagnosed type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 5,NG18,What are the recommended dietary management strategies for children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 6,NG18,What advice is available for children and young people with type 1 diabetes regarding low glycaemic index diets and exercise management?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 7,NG18,What are the recommended carbohydrate intake and blood glucose targets for children and young people with type 1 diabetes during exercise?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 8,NG18,What are the recommendations for using continuous glucose monitoring in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 9,NG18,What are the considerations for choosing and using continuous glucose monitoring (CGM) devices in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 10,NG18,What are the recommended blood glucose monitoring practices for children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 11,NG18,What are the recommended strategies for managing hypoglycaemia in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 12,NG18,What are the recommended management strategies for hypoglycaemia in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 13,NG18,What is the recommended management of severe hypoglycaemia in children with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 14,NG18,What psychological support is recommended for children and young people with type 1 diabetes and their families?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 15,NG18,What mental health support is recommended for children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 16,NG18,What are the recommended monitoring and screening protocols for complications in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 17,NG18,What are the recommended screening and monitoring protocols for diabetic retinopathy and diabetic kidney disease in children and young people with type 1 diabetes?
NG18_Recommendations: 1.2 Type 1 diabetes - Part 18,NG18,What are the recommended intervals for oral health reviews in children and young people with type 1 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 1,NG18,What information and education should be provided to children and young people with type 2 diabetes and their families?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 2,NG18,What education and support should be provided to children and young people with type 2 diabetes and their families?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 3,NG18,What are the NICE recommendations for smoking cessation and immunisation in children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 4,NG18,What are the dietary management recommendations for children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 5,NG18,When should insulin be initiated in children and young people with type 2 diabetes according to NICE guidelines?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 6,NG18,How should blood glucose monitoring and HbA1c targets be managed in children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 7,NG18,What are the criteria for offering continuous glucose monitoring to children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 8,NG18,What are the recommendations for using continuous glucose monitoring in children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 9,NG18,"What are the criteria for adding liraglutide, dulaglutide, or empagliflozin to metformin in children and young people with type 2 diabetes?"
NG18_Recommendations: 1.3 Type 2 diabetes - Part 10,NG18,When should insulin be increased in children and young people with type 2 diabetes on metformin and GLP-1 receptor agonists or SGLT2 inhibitors?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 11,NG18,When should insulin be increased in children aged 10 or over with type 2 diabetes on metformin and insulin?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 12,NG18,What factors should be considered when choosing an insulin regimen for children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 13,NG18,How should healthcare teams update school healthcare plans when treating children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 14,NG18,What are the recommended mental health assessments and psychosocial support strategies for children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 15,NG18,What is the recommended frequency for monitoring hypertension and dyslipidaemia in children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 16,NG18,What are the recommended screening and management strategies for diabetic retinopathy and diabetic kidney disease in children and young people with type 2 diabetes?
NG18_Recommendations: 1.3 Type 2 diabetes - Part 17,NG18,What is the importance of oral health reviews for children and young people with type 2 diabetes?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 1,NG18,What are the signs and diagnostic criteria for diabetic ketoacidosis in children and young people?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 2,NG18,What are the diagnostic criteria and initial management steps for diabetic ketoacidosis in children and young people?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 3,NG18,What are the recommended management strategies for children under 2 years with diabetic ketoacidosis?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 4,NG18,What is the recommended initial fluid bolus for children with signs of shock in DKA?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 5,NG18,What are the recommended potassium replacement protocols for children with diabetic ketoacidosis?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 6,NG18,What is the recommended insulin infusion rate for treating DKA in children and young people?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 7,NG18,How should insulin pumps be managed during treatment of diabetic ketoacidosis in children and young people?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 8,NG18,What are the recommended monitoring and management strategies for children with diabetic ketoacidosis?
NG18_Recommendations: 1.4 Diabetic ketoacidosis - Part 9,NG18,What is the recommended management for cerebral oedema in children with DKA after mannitol or hypertonic saline treatment?
NG18_Recommendations: 1.5 Service provision - Part 1,NG18,What is the recommended model of care for children and young people with diabetes?
NG18_Recommendations: 1.5 Service provision - Part 2,NG18,How should healthcare teams support the transition of young people with type 1 diabetes from paediatric to adult services?
NG18_Recommendations: Terms used in this guideline & Recommendations for research: 1 Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous glucose monitoring,NG18,What is the effectiveness and cost effectiveness of continuous glucose monitoring in children and young people with type 1 diabetes?
NG18_Recommendations for research: 2 Effectiveness of glucose-lowering agents used to manage blood glucose levels in children and young people with type 2 diabetes,NG18,What is the effectiveness of glucose-lowering medications in children and young people with type 2 diabetes?
NG18_Recommendations for research: 3 Weekly treatment with glucose-lowering agents for managing blood glucose levels & Recommendations for research: 4 Continuous glucose monitor sensor adhesive to prevent sensitivities,NG18,What is the effectiveness of weekly versus daily glucose-lowering treatment in children and young people with type 2 diabetes?
NG18_Rationale and impact: Continuous glucose monitoring in children with type 1 diabetes - Part 1,NG18,What are the benefits and recommendations for continuous glucose monitoring in children with type 1 diabetes?
NG18_Rationale and impact: Continuous glucose monitoring in children with type 1 diabetes - Part 2,NG18,What factors should be considered when choosing continuous glucose monitoring devices for children and young people with type 1 diabetes?
NG18_Rationale and impact: Continuous glucose monitoring in children with type 1 diabetes - Part 3,NG18,What strategies are recommended to reduce skin sensitivities to continuous glucose monitor sensors in children and young people with type 1 diabetes?
NG18_Rationale and impact: Periodontitis,NG18,What are the recommended oral health review practices for children and young people with diabetes to prevent periodontitis?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 1,NG18,What are the recommended glucose-lowering agents and education strategies for managing type 2 diabetes in children and young people?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 2,NG18,What are the recommended blood glucose monitoring and treatment review practices for children and young people with type 2 diabetes?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 3,NG18,What are the recommended monitoring and review intervals for blood glucose in children and young people with type 2 diabetes?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 4,NG18,Should children and young people with type 2 diabetes be offered continuous glucose monitoring?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 5,NG18,When should insulin be reduced in people with type 2 diabetes who have been on insulin therapy since diagnosis?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 6,NG18,What are the criteria for reducing insulin use in people with type 2 diabetes who have achieved HbA1c targets?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 7,NG18,What are the recommended treatment options for managing type 2 diabetes in children and young people aged 10 years and over?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 8,NG18,What are the current recommendations for selecting glucose-lowering treatments for children and young people with type 2 diabetes?
NG18_Rationale and impact: Glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes - Part 9,NG18,"How do NICE guidelines recommend managing the use of liraglutide, dulaglutide, and empagliflozin in children and young people with type 2 diabetes?"
NG18_Rationale and impact: Fluid therapy for diabetic ketoacidosis - Part 1,NG18,What is the recommended rate of fluid administration for treating diabetic ketoacidosis in children and young people?
NG18_Rationale and impact: Fluid therapy for diabetic ketoacidosis - Part 2,NG18,What are the current NICE recommendations for fluid and electrolyte management in children with diabetic ketoacidosis?
NG18_Context,NG18,What are the recommended management strategies for children and young people with type 1 and type 2 diabetes?
NG190_Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing & Overview,NG190,What are the recommended antimicrobial prescribing strategies for secondary bacterial infections in eczema?
NG190_Recommendations: 1.1 Managing secondary bacterial infections of eczema - Part 1,NG190,What are the recommended management strategies for secondary bacterial infections in eczema patients?
NG190_Recommendations: 1.1 Managing secondary bacterial infections of eczema - Part 2,NG190,What are the considerations for choosing between topical and oral antibiotics for secondary bacterial eczema infections?
NG190_Recommendations: 1.1 Managing secondary bacterial infections of eczema - Part 3,NG190,When should I refer a patient with secondary bacterial eczema infection to specialist care?
NG190_Recommendations: 1.2 Choice of antibiotic - Part 1,NG190,What is the recommended antibiotic treatment for secondary bacterial infection of eczema in adults and children?
NG190_Recommendations: 1.2 Choice of antibiotic - Part 2,NG190,What are the recommended antibiotic treatments for children with secondary bacterial eczema infections?
"NG190_Recommendations: 1.2 Choice of antibiotic - Part 3 & Recommendations: 1.3 Managing secondary bacterial infections of psoriasis, chicken pox, shingles and scabies",NG190,What is the recommended use and dosing of antibiotics for children with hepatic or renal impairment?
NG190_Recommendations for research,NG190,"What is the effectiveness and safety of oral antibiotics versus topical treatments or placebo for infected psoriasis, chicken pox, shingles, or scabies?"
NG190_Rationale and impact: Treatment - Part 1,NG190,What are the recommended treatments for secondary bacterial infection in eczema?
NG190_Rationale and impact: Treatment - Part 2,NG190,When should antibiotics be prescribed for secondary bacterial infection of eczema?
NG190_Rationale and impact: Treatment - Part 3,NG190,"What are the recommended treatments for infected eczema, including the use of topical or oral antibiotics and antiseptics?"
NG190_Rationale and impact: Advice & Rationale and impact: Reassessment,NG190,When should I seek medical help for worsening bacterial eczema infection?
NG190_Rationale and impact: Referral and seeking specialist advice & Rationale and impact: Choice of antibiotic - Part 1,NG190,What is the recommended topical antibiotic for secondary bacterial infection of eczema?
NG190_Rationale and impact: Choice of antibiotic - Part 2,NG190,What is the recommended oral antibiotic for secondary bacterial infection of eczema in children and adults?
NG190_Rationale and impact: Choice of antibiotic - Part 3,NG190,What is the recommended duration and dosage of antibiotics for secondary bacterial infection of eczema?
NG190_Rationale and impact: Treatment & Context,NG190,"What is the recommended management for secondary bacterial infections in psoriasis, chicken pox, shingles, or scabies?"
NG190_Summary of the evidence: Antimicrobials - Part 1,NG190,What is the effectiveness of oral and topical antibiotics for treating infected eczema in children?
NG190_Summary of the evidence: Antimicrobials - Part 2,NG190,What is the effectiveness and safety of topical fusidic acid combined with corticosteroids for infected eczema in children?
NG190_Summary of the evidence: Antimicrobials - Part 3,NG190,What is the impact of topical versus oral antibiotics on antibiotic resistance in skin infections?
NG190_Summary of the evidence: Choice of antibiotics & Summary of the evidence: Course length & Summary of the evidence: Route of administration,NG190,What is the most effective route of antibiotic administration for infected eczema?
NG190_Other considerations,NG190,"What are the safety considerations and potential adverse effects of using antibiotics like fusidic acid, flucloxacillin, and macrolides?"
NG191_COVID-19 rapid guideline: managing COVID-19 & Overview,NG191,What are the recommended management strategies for COVID-19 in hospital and community settings?
NG191_1 Communication and shared decision making,NG191,How should healthcare professionals communicate with COVID-19 patients and their families to support shared decision making and mental wellbeing?
NG191_2 Assessment: 2.1 In the community - Part 1,NG191,What are the signs and symptoms of severe COVID-19 in community settings?
NG191_2 Assessment: 2.1 In the community - Part 2,NG191,What are the recommended methods for assessing dyspnoea and risk of deterioration in community-managed COVID-19 patients?
NG191_2 Assessment: 2.2 In hospital,NG191,What are the recommended assessments and decision-making processes for hospitalized patients with COVID-19?
NG191_3 Management: 3.1 In the community - Part 1,NG191,What are the recommended community care strategies for managing COVID-19 and associated symptoms?
NG191_3 Management: 3.1 In the community - Part 2,NG191,What are the recommended strategies for managing breathlessness in patients with COVID-19?
NG191_3 Management: 3.1 In the community - Part 3,NG191,How can I improve air circulation for someone self-isolating alone with COVID-19?
NG191_3 Management: 3.2 In hospital - Part 1,NG191,How should healthcare professionals decide when to escalate treatment in hospital for patients with uncertain recovery prospects?
NG191_3 Management: 3.2 In hospital - Part 2,NG191,How should respiratory support be escalated or de-escalated in critically ill patients to meet treatment goals?
NG191_3 Management: 3.2 In hospital - Part 3,NG191,What are the criteria for escalating non-invasive respiratory support in COVID-19 patients?
NG191_3 Management: 3.2 In hospital - Part 4,NG191,What are the best practices for implementing prone positioning in COVID-19 patients with respiratory failure?
NG191_3 Management: 3.2 In hospital - Part 5,NG191,What are the indications and safety considerations for using CPAP in COVID-19 patients with hypoxaemia?
NG191_3 Management: 3.2 In hospital - Part 6,NG191,What are the recommended skills and monitoring requirements for staff providing CPAP to patients with COVID-19?
NG191_4 Therapeutics for COVID-19: 4.1 Antivirals - Part 1,NG191,What are the recommended antiviral treatments for COVID-19 in adults and children?
NG191_4 Therapeutics for COVID-19: 4.1 Antivirals - Part 2,NG191,What are the NICE recommendations for using remdesivir and molnupiravir in treating COVID-19 in high-risk adults?
NG191_4 Therapeutics for COVID-19: 4.2 Sotrovimab,NG191,When is sotrovimab recommended for treating COVID-19 in adults and adolescents?
NG191_4 Therapeutics for COVID-19: 4.3 Corticosteroids - Part 1,NG191,What are the recommended corticosteroid treatments for COVID-19 patients requiring supplemental oxygen?
NG191_4 Therapeutics for COVID-19: 4.3 Corticosteroids - Part 2 & 4 Therapeutics for COVID-19: 4.4 Casirivimab and imdevimab – for people hospitalised because of COVID-19,NG191,What is the recommended corticosteroid dosage for children over 44 weeks corrected gestational age with viral respiratory infections?
NG191_4 Therapeutics for COVID-19: 4.5 Tocilizumab,NG191,What are the criteria for using tocilizumab in treating COVID-19 patients?
NG191_4 Therapeutics for COVID-19: 4.6 Baricitinib & 4 Therapeutics for COVID-19: 4.7 Antibiotics,NG191,What are the recommended uses of baricitinib and antibiotics in the treatment of COVID-19?
NG191_4 Therapeutics for COVID-19: 4.8 Azithromycin & 4 Therapeutics for COVID-19: 4.9 Budesonide (inhaled) & 4 Therapeutics for COVID-19: 4.10 Colchicine,NG191,What are the recommended treatments for COVID-19 according to NICE guidelines?
NG191_4 Therapeutics for COVID-19: 4.11 Doxycycline & 4 Therapeutics for COVID-19: 4.12 Ivermectin & 4 Therapeutics for COVID-19: 4.13 Tixagevimab plus cilgavimab,NG191,Should doxycycline or ivermectin be used to treat COVID-19 in the community?
NG191_4 Therapeutics for COVID-19: 4.14 Vitamin D & 5 Preventing and managing acute complications: 5.1 Acute kidney injury (AKI) - Part 1,NG191,What are the recommended approaches for assessing and managing acute kidney injury in patients with COVID-19?
NG191_5 Preventing and managing acute complications: 5.1 Acute kidney injury (AKI) - Part 2,NG191,What are the recommended management strategies for acute hyperkalaemia and post-AKI follow-up in chronic kidney disease?
NG191_5 Preventing and managing acute complications: 5.2 Acute myocardial injury,NG191,What are the recommended diagnostic tests and monitoring strategies for acute myocardial injury in COVID-19 patients?
NG191_5 Preventing and managing acute complications: 5.3 Venous thromboembolism (VTE) prophylaxis - Part 1,NG191,What are the recommendations for venous thromboembolism prophylaxis in hospitalized COVID-19 patients?
NG191_5 Preventing and managing acute complications: 5.3 Venous thromboembolism (VTE) prophylaxis - Part 2,NG191,What is the recommended duration and dosing for LMWH in COVID-19 patients?
NG191_5 Preventing and managing acute complications: 5.3 Venous thromboembolism (VTE) prophylaxis - Part 3,NG191,How should VTE risk be assessed and managed in patients with COVID-19 who experience changes in clinical condition?
NG191_5 Preventing and managing acute complications: 5.3 Venous thromboembolism (VTE) prophylaxis - Part 4,NG191,What are the current recommendations for managing COVID-19 in hospitalized children according to NICE guidelines?
NG191_6 Identifying and managing co-infections: 6.1 Managing viral or fungal pneumonia,NG191,When should antibiotics be used for viral or fungal pneumonia in COVID-19 patients?
NG191_6 Identifying and managing co-infections: 6.2 Other causes of pneumonia - Part 1,NG191,What tests are recommended to identify other causes of pneumonia and guide antibiotic use?
NG191_6 Identifying and managing co-infections: 6.2 Other causes of pneumonia - Part 2,NG191,What are the recommended antibiotics for secondary bacterial pneumonia in COVID-19 patients?
NG191_6 Identifying and managing co-infections: 6.2 Other causes of pneumonia - Part 3,NG191,What factors should be considered when choosing and reviewing antibiotics for respiratory infections?
NG191_6 Identifying and managing co-infections: 6.3 COVID-19-associated pulmonary aspergillosis (CAPA) - Part 1,NG191,What are the recommended diagnostic approaches for COVID-19-associated pulmonary aspergillosis (CAPA) in critically ill patients?
NG191_6 Identifying and managing co-infections: 6.3 COVID-19-associated pulmonary aspergillosis (CAPA) - Part 2,NG191,When should antifungal treatment be initiated for suspected COVID-19-associated pulmonary aspergillosis (CAPA)?
NG191_7 Follow‑up and rehabilitation & 3 more sections,NG191,What are the NICE guidelines for follow-up care and rehabilitation after COVID-19?
NG191_Terms used in the guideline: Hospital-led acute care in the community & 7 more sections,NG191,What are the indications for using non-invasive ventilation in acute respiratory failure?
NG191_Recommendations for research: Key recommendations for research - Part 1,NG191,What is the effectiveness and safety of vitamin D in treating COVID-19?
NG191_Recommendations for research: Key recommendations for research - Part 2,NG191,What are the most accurate tests for diagnosing COVID-19-associated pulmonary aspergillosis (CAPA) and when should they be performed?
NG191_Recommendations for research: Other recommendations for research - Part 1,NG191,What are the outcomes and risk factors associated with COVID-19-associated pulmonary aspergillosis (CAPA)?
NG191_Recommendations for research: Other recommendations for research - Part 2,NG191,Does a multidisciplinary team approach to weaning from CPAP improve weaning times and reduce duration of CPAP therapy in patients with COVID-19 and acute respiratory failure?
NG191_Recommendations for research: Other recommendations for research - Part 3,NG191,What is the evidence on the safety and effectiveness of extended pharmacological VTE prophylaxis after COVID-19 discharge?
NG191_Rationales: Assessment in the community,NG191,What are the recommended oxygen saturation thresholds for assessing severe COVID-19 in children and adults in the community?
NG191_Rationales: Management in hospital - Part 1,NG191,What are the recommended management strategies for non-invasive respiratory support in hospitalized COVID-19 patients?
NG191_Rationales: Management in hospital - Part 2,NG191,What are the indications and monitoring requirements for using CPAP in COVID-19 patients with hypoxaemia?
NG191_Rationales: Antivirals - Part 1,NG191,What are the recommended antiviral treatments for mild and severe COVID-19 according to NICE guidelines?
NG191_Rationales: Antivirals - Part 2,NG191,Is molnupiravir effective and safe for treating COVID-19 in pregnant women and children?
NG191_Rationales: Sotrovimab & Rationales: Corticosteroids,NG191,What are the recommended treatments for COVID-19 patients who are unable to tolerate or do not require supplemental oxygen?
NG191_Rationales: Tocilizumab & Rationales: Baricitinib,NG191,What are the NICE recommendations for using tocilizumab and baricitinib in the treatment of severe COVID-19?
NG191_Rationales: Azithromycin & Rationales: Budesonide (inhaled) & Rationales: Colchicine,NG191,"What are the current NICE recommendations on the use of azithromycin, inhaled budesonide, and colchicine for treating COVID-19?"
NG191_Rationales: Doxycycline,NG191,Should doxycycline be used for treating COVID-19 in community settings?
NG191_Rationales: Ivermectin & Rationales: Tixagevimab plus cilgavimab,NG191,What is the current guidance on using ivermectin for COVID-19 treatment?
NG191_Rationales: Vitamin D,NG191,What is the evidence for using vitamin D to treat COVID-19?
NG191_Rationales: Prevention and management of venous thromboembolism (VTE) prophylaxis - Part 1,NG191,What are the recommended practices for VTE prophylaxis in hospitalized COVID-19 patients?
NG191_Rationales: Prevention and management of venous thromboembolism (VTE) prophylaxis - Part 2,NG191,What are the recommended anticoagulation strategies for young people with severe COVID-19 in hospital?
NG191_Rationales: Prevention and management of venous thromboembolism (VTE) prophylaxis - Part 3,NG191,What are the recommendations for VTE prophylaxis in people with COVID-19 managed in community settings?
NG191_Rationales: Diagnosing and treating COVID-19-associated pulmonary aspergillosis (CAPA) - Part 1,NG191,What are the recommended diagnostic approaches for COVID-19-associated pulmonary aspergillosis (CAPA)?
NG191_Rationales: Diagnosing and treating COVID-19-associated pulmonary aspergillosis (CAPA) - Part 2,NG191,How is COVID-19-associated pulmonary aspergillosis (CAPA) diagnosed and managed in critically ill patients?
NG191_Rationales: Diagnosing and treating COVID-19-associated pulmonary aspergillosis (CAPA) - Part 3,NG191,What are the recommended approaches for diagnosing and managing COVID-19-associated pulmonary aspergillosis (CAPA) with antifungal treatments?
NG191_Context,NG191,What are the current NICE recommendations for managing COVID-19 during the pandemic?
NG191_Finding more information and expert advisory panel details,NG191,Where can I find detailed evidence and expert discussions related to NICE guideline NG191?
NG192_Caesarean birth & Overview & Recommendations: 1.1 Planning mode of birth - Part 1,NG192,What are the benefits and risks of caesarean birth compared to vaginal birth?
NG192_Recommendations: 1.1 Planning mode of birth - Part 2,NG192,What are the benefits and risks of vaginal versus caesarean birth?
NG192_Recommendations: 1.2 Planned caesarean birth - Part 1,NG192,What are the guidelines for planned caesarean birth in breech presentation?
NG192_Recommendations: 1.2 Planned caesarean birth - Part 2,NG192,What are the recommended management and birth planning procedures for placenta accreta spectrum?
NG192_Recommendations: 1.2 Planned caesarean birth - Part 3,NG192,What are the recommended protocols for diagnosing and managing placenta accreta spectrum in maternity units?
NG192_Recommendations: 1.2 Planned caesarean birth - Part 4,NG192,"What are the NICE guidelines on planned caesarean birth for women with hepatitis C, herpes simplex virus, or high BMI?"
NG192_Recommendations: 1.2 Planned caesarean birth - Part 5,NG192,What are the recommendations for supporting women who request a caesarean birth due to childbirth anxiety or tokophobia?
NG192_Recommendations: 1.3 Factors affecting the likelihood of emergency caesarean birth during intrapartum care,NG192,What factors can reduce the likelihood of emergency caesarean birth during labour?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 1,NG192,What are the recommended timing and classification of urgency for caesarean birth according to NICE guidelines?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 2,NG192,What are the recommended anaesthesia and blood management procedures for caesarean birth in women with antepartum haemorrhage or placenta praevia?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 3,NG192,What are the recommended practices for preventing hypothermia and shivering during caesarean birth?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 4,NG192,What are the recommended surgical techniques and infection prevention measures for caesarean birth?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 5,NG192,What are the recommended surgical techniques to minimize complications during caesarean birth?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 6,NG192,What are the recommended techniques for uterine and abdominal wall closure during caesarean birth?
NG192_Recommendations: 1.4 Procedural aspects of caesarean birth - Part 7,NG192,What are the recommended practices for umbilical artery blood gas measurement after caesarean birth?
NG192_Recommendations: 1.5 Care of the baby born by caesarean birth,NG192,What are the recommended practices for caring for babies born by caesarean section?
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 1,NG192,"What are the recommended monitoring procedures after caesarean birth under general, spinal, or epidural anaesthesia?"
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 2,NG192,How should respiratory depression be monitored in women after intrathecal or epidural morphine or diamorphine for caesarean section?
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 3,NG192,What are the recommended pain management options after caesarean birth according to NICE guidelines?
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 4,NG192,What are the recommended pain relief options after caesarean birth?
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 5,NG192,What are the safe pain relief options for women who are breastfeeding after a caesarean section?
NG192_Recommendations: 1.6 Care of the woman after caesarean birth - Part 6,NG192,What are the recommended practices for postoperative care and discharge after caesarean birth?
NG192_Recommendations: 1.7 Recovery after caesarean birth - Part 1,NG192,What are the recommended wound care practices after caesarean birth?
NG192_Recommendations: 1.7 Recovery after caesarean birth - Part 2,NG192,What are the post-caesarean care recommendations for managing urinary and thromboembolic risks?
NG192_Recommendations: 1.8 Pregnancy and childbirth after caesarean birth & Recommendations: Terms used in this guideline,NG192,What are the recommended options for mode of birth after a previous caesarean section?
NG192_Recommendations for research: 1 Short-term and long-term benefits and risks of planned caesarean birth compared to planned vaginal birth & Recommendations for research: 2 Decision-to-birth interval (category 1 urgency),NG192,What are the short-term and long-term benefits and risks of planned caesarean birth compared to planned vaginal birth for women and infants?
NG192_Recommendations for research: 2 Decision-to-birth interval (category 1 urgency) & Recommendations for research: 3 Decision-to-birth interval (category 2 urgency),NG192,What factors influence the decision-to-birth interval in category 1 urgent caesarean sections?
NG192_Recommendations for research: 3 Decision-to-birth interval (category 2 urgency),NG192,What is the impact of decision-to-birth interval on maternal and neonatal outcomes in category 2 caesarean sections?
NG192_Recommendations for research: 4 Maternal request for caesarean birth,NG192,What psychological interventions are effective for women with fear of vaginal childbirth requesting a caesarean section?
NG192_Rationale and impact: Benefits and risks of caesarean and vaginal birth,NG192,What are the benefits and risks of caesarean section compared to vaginal birth?
NG192_Rationale and impact: Placenta accreta spectrum - Part 1,NG192,What is the recommended timing and approach for ultrasound screening for placenta accreta in women with previous uterine surgery?
NG192_Rationale and impact: Placenta accreta spectrum - Part 2,NG192,What are the recommended imaging and management strategies for placenta accreta spectrum?
NG192_Rationale and impact: Placenta accreta spectrum - Part 3,NG192,How does the updated recommendation for ultrasound and MRI use affect the diagnosis and management of placenta accreta?
NG192_Rationale and impact: Maternal choice for caesarean birth - Part 1,NG192,What are the recommendations for supporting maternal choice for caesarean birth?
NG192_Rationale and impact: Maternal choice for caesarean birth - Part 2,NG192,How do NICE guidelines recommend supporting women's choice of caesarean birth within their obstetric unit?
NG192_Rationale and impact: Prevention and management of hypothermia and shivering,NG192,What are the recommended methods for preventing and managing hypothermia and shivering in women undergoing caesarean section?
NG192_Rationale and impact: Methods to reduce infectious morbidity and wound care after caesarean birth,NG192,What are the recommended methods to reduce infectious morbidity and improve wound care after caesarean birth?
NG192_Rationale and impact: Surgical opening technique,NG192,What is the recommended surgical incision technique for caesarean birth in women with obesity or previous cesarean?
NG192_Rationale and impact: Closure of the uterus,NG192,Should surgeons use single or double layer closure for the uterus during caesarean section?
NG192_Rationale and impact: Monitoring after caesarean birth - Part 1,NG192,What are the recommended monitoring protocols after caesarean birth to detect respiratory depression?
NG192_Rationale and impact: Monitoring after caesarean birth - Part 2,NG192,How should women be monitored for respiratory depression after caesarean with intrathecal or epidural opioids?
NG192_Rationale and impact: Pain management after caesarean birth - Part 1,NG192,What are the recommended postoperative analgesia options for women after caesarean birth with regional anesthesia?
NG192_Rationale and impact: Pain management after caesarean birth - Part 2,NG192,What are the recommended pain management options for women after childbirth involving neuraxial or general anesthesia?
NG192_Rationale and impact: Pain management after caesarean birth - Part 3,NG192,What are the current NICE recommendations for opioid use and safety during breastfeeding and postoperative pain management after caesarean section?
NG192_Context,NG192,What are the current recommendations for managing risks and benefits of caesarean birth in women with previous caesarean or planning their birth?
NG193_Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain & Overview,NG193,What are the recommended approaches for assessing and managing chronic primary pain in adults?
"NG193_Recommendations: 1.1 Assessing all types of chronic pain (chronic primary pain, chronic secondary pain, or both) - Part 1",NG193,What are the recommended approaches for assessing and diagnosing different types of chronic pain?
"NG193_Recommendations: 1.1 Assessing all types of chronic pain (chronic primary pain, chronic secondary pain, or both) - Part 2",NG193,What are best practices for assessing the impact of chronic pain on a patient's life and providing tailored management advice?
"NG193_Recommendations: 1.1 Assessing all types of chronic pain (chronic primary pain, chronic secondary pain, or both) - Part 3",NG193,How should healthcare professionals develop and discuss a care and support plan for patients with chronic pain?
"NG193_Recommendations: 1.1 Assessing all types of chronic pain (chronic primary pain, chronic secondary pain, or both) - Part 4",NG193,What should be done when a patient experiences a flare-up of chronic pain?
NG193_Recommendations: 1.2 Managing chronic primary pain - Part 1,NG193,What are the recommended non-pharmacological treatments for managing chronic primary pain?
NG193_Recommendations: 1.2 Managing chronic primary pain - Part 2,NG193,What are the recommended non-pharmacological and pharmacological treatments for managing chronic primary pain according to NICE guidelines?
NG193_Recommendations: 1.2 Managing chronic primary pain - Part 3,NG193,What are the recommendations for prescribing antidepressants and other medications for chronic primary pain in young people aged 16 to 17 years?
NG193_Recommendations: 1.2 Managing chronic primary pain - Part 4,NG193,What are the NICE recommendations for reviewing and reducing antidepressants and dependence-forming medicines?
NG193_Recommendations: Terms used in this guideline,NG193,What are the recommended approaches for managing chronic primary pain according to NICE guidelines?
NG193_Recommendations for research: Key recommendations for research - Part 1,NG193,What is the clinical and cost effectiveness of psychological therapies such as mindfulness and CBT for managing chronic primary pain in adults?
NG193_Recommendations for research: Key recommendations for research - Part 2,NG193,What is the effectiveness of repeat acupuncture or dry needling for chronic primary pain management?
NG193_Recommendations for research: Other recommendations for research - Part 1,NG193,What are the factors that may act as barriers to successfully managing chronic primary pain?
NG193_Recommendations for research: Other recommendations for research - Part 2,NG193,What is the effectiveness of relaxation therapies for managing chronic primary pain?
NG193_Rationale and impact: Assessing chronic pain (chronic primary pain and chronic secondary pain) - Part 1,NG193,What are best practices for assessing and communicating with patients with chronic pain?
NG193_Rationale and impact: Assessing chronic pain (chronic primary pain and chronic secondary pain) - Part 2,NG193,How should healthcare professionals communicate test results and discuss self-management options with patients with chronic pain?
NG193_Rationale and impact: Exercise programmes and physical activity for chronic primary pain - Part 1,NG193,What are the recommended exercise programs for managing chronic primary pain?
NG193_Rationale and impact: Exercise programmes and physical activity for chronic primary pain - Part 2,NG193,What are the cost-effective exercise interventions for managing chronic primary pain?
NG193_Rationale and impact: Psychological therapy for chronic primary pain - Part 1,NG193,What psychological therapies are recommended for managing chronic primary pain?
NG193_Rationale and impact: Psychological therapy for chronic primary pain - Part 2,NG193,What are the recommended psychological and educational interventions for managing chronic primary pain according to NICE guidelines?
NG193_Rationale and impact: Acupuncture for chronic primary pain - Part 1,NG193,What is the evidence for the effectiveness and cost-effectiveness of acupuncture in managing chronic primary pain?
NG193_Rationale and impact: Acupuncture for chronic primary pain - Part 2,NG193,What are the NICE recommendations for using acupuncture or dry needling in managing chronic primary pain?
NG193_Rationale and impact: Electrical physical modalities for chronic primary pain - Part 1,NG193,What is the effectiveness of laser therapy and transcranial magnetic stimulation for managing chronic primary pain?
NG193_Rationale and impact: Electrical physical modalities for chronic primary pain - Part 2,NG193,"Should TENS, ultrasound, and interferential therapy be used for managing chronic primary pain?"
NG193_Rationale and impact: Pain management programmes,NG193,What is the evidence for the effectiveness of pain management programmes in improving quality of life for people with chronic primary or mixed chronic pain?
NG193_Rationale and impact: Manual therapy for chronic primary pain,NG193,What is the evidence for the effectiveness of manual therapy in managing chronic primary pain?
NG193_Rationale and impact: Pharmacological management for chronic primary pain - Part 1,NG193,What is the recommended pharmacological management of chronic primary pain with antidepressants?
NG193_Rationale and impact: Pharmacological management for chronic primary pain - Part 2,NG193,What are the recommended approaches for managing chronic primary pain according to NICE guidelines?
NG193_Rationale and impact: Pharmacological management for chronic primary pain - Part 3,NG193,Should antiepileptics or local anaesthetics be used for managing chronic primary pain?
NG193_Rationale and impact: Pharmacological management for chronic primary pain - Part 4,NG193,What are the recommended approaches for discontinuing medications like opioids and gabapentinoids in patients with chronic primary pain?
NG193_Rationale and impact: Social interventions for chronic pain (chronic primary pain and chronic secondary pain),NG193,What is the evidence for social interventions in managing chronic primary and secondary pain?
NG193_Context,NG193,What are the recommended approaches for assessing and managing chronic primary pain?
NG194_Postnatal care & Overview,NG194,What are the key components of routine postnatal care for women and their babies within the first 8 weeks after birth?
NG194_Recommendations: 1.1 Organisation and delivery of postnatal care - Part 1,NG194,What are the key principles for organizing and delivering postnatal care?
NG194_Recommendations: 1.1 Organisation and delivery of postnatal care - Part 2,NG194,What are the best practices for providing postnatal care information tailored to women's needs and preferences?
NG194_Recommendations: 1.1 Organisation and delivery of postnatal care - Part 3,NG194,What are the recommended procedures for communication and information transfer when women move between maternity and community care services?
NG194_Recommendations: 1.1 Organisation and delivery of postnatal care - Part 4,NG194,What should be covered during the first midwife visit after transfer of care from birth or home birth?
NG194_Recommendations: 1.1 Organisation and delivery of postnatal care - Part 5,NG194,What is the recommended timing for the first postnatal visit by a midwife and health visitor after birth?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 1,NG194,What are the key topics to discuss during postnatal visits to support women's physical and mental health?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 2,NG194,What are the key postnatal assessments and warning signs to monitor after childbirth?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 3,NG194,What are the recommended postnatal follow-up procedures for women with a history of hypertension or pre-eclampsia?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 4,NG194,What are the recommended postnatal care practices for women with pre-existing or gestational diabetes?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 5,NG194,What are the recommended assessments and advice for postpartum vaginal bleeding and perineal wound healing?
NG194_Recommendations: 1.2 Postnatal care of the woman - Part 6,NG194,What are the signs and management strategies for persistent perineal pain after childbirth?
NG194_Recommendations: 1.3 Postnatal care of the baby - Part 1,NG194,What are the recommended postnatal assessment procedures for newborns within the first 72 hours and at 6 to 8 weeks?
NG194_Recommendations: 1.3 Postnatal care of the baby - Part 2,NG194,What are the recommended methods for monitoring and assessing a baby's growth and development in the first few months?
NG194_Recommendations: 1.3 Postnatal care of the baby - Part 3,NG194,What are the recommended safety practices for bed sharing with infants?
NG194_Recommendations: 1.3 Postnatal care of the baby - Part 4,NG194,What are effective strategies to promote emotional attachment between parents and their newborn?
NG194_Recommendations: 1.4 Symptoms and signs of illness in babies - Part 1,NG194,How can I assess symptoms of serious illness in babies during remote consultations?
NG194_Recommendations: 1.4 Symptoms and signs of illness in babies - Part 2,NG194,What are the red flags indicating serious illness in young babies?
NG194_Recommendations: 1.4 Symptoms and signs of illness in babies - Part 3,NG194,What are the signs of serious illness in babies that require immediate emergency assessment?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 1,NG194,What information should healthcare professionals provide to support breastfeeding and inform parents about feeding options?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 2,NG194,What are the recommended practices for healthcare professionals to support breastfeeding in the postnatal period?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 3,NG194,What are the recommended strategies for providing tailored breastfeeding support to new mothers?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 4,NG194,What are the recommended methods for assessing breastfeeding and addressing feeding concerns?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 5,NG194,What information should be provided to parents about safe and responsive formula feeding?
NG194_Recommendations: 1.5 Planning and supporting babies' feeding - Part 6,NG194,What are the recommended methods for lactation suppression and their advantages and disadvantages?
NG194_Recommendations: Terms used in this guideline - Part 1,NG194,What is the definition of bonding and emotional attachment in maternity care?
NG194_Recommendations: Terms used in this guideline - Part 2,NG194,What is first infant formula and when is it recommended for babies?
NG194_Recommendations for research: 1 Length of postpartum stay and first midwife visit after transfer of care & Recommendations for research: 2 Timing of first health visitor visit,NG194,What is the optimal timing for postpartum discharge and the first midwife visit to reduce unplanned health contacts for women and babies?
NG194_Recommendations for research: 3 Clinical tools to assess women's health & Recommendations for research: 4 Perineal pain & Recommendations for research: 5 Breastfeeding support for parents with twins or triplets,NG194,What clinical tools are effective for assessing women's health and pain during the first 8 weeks postpartum?
NG194_Rationale and impact: Principles of care - Part 1,NG194,What are the principles of postnatal care according to NICE guidelines?
NG194_Rationale and impact: Principles of care - Part 2,NG194,What are best practices for providing consistent and evidence-based postnatal information to new parents?
NG194_Rationale and impact: Communication between healthcare professionals at transfer of care,NG194,What information should healthcare professionals communicate during transfer of care for pregnant women and new mothers?
NG194_Rationale and impact: Transfer to community care - Part 1,NG194,What factors determine the appropriate timing for transferring women and babies to community care after birth?
NG194_Rationale and impact: Transfer to community care - Part 2,NG194,"What information should be provided to women after birth regarding next steps, support, and contact points?"
NG194_Rationale and impact: First midwife visit after transfer of care from the place of birth or after a home birth,NG194,What is the recommended timing for the first midwife visit after transfer of care from the place of birth or home birth?
NG194_Rationale and impact: First health visitor visit,NG194,When should the first postnatal health visitor visit be scheduled after birth?
NG194_Rationale and impact: Assessment and care of the woman - Part 1,NG194,What should healthcare professionals assess during postnatal contacts to ensure women's physical and emotional health?
NG194_Rationale and impact: Assessment and care of the woman - Part 2,NG194,What is the recommended timing for the routine postnatal check and assessment tools for women's physical and mental health?
NG194_Rationale and impact: Postpartum bleeding,NG194,What are the signs and symptoms of postpartum haemorrhage that women should be advised to watch for after birth?
NG194_Rationale and impact: Perineal health,NG194,What are the best practices for managing perineal pain and complications after childbirth?
NG194_Rationale and impact: Assessment and care of the baby - Part 1,NG194,What are the recommended postnatal assessment and care procedures for newborns?
NG194_Rationale and impact: Assessment and care of the baby - Part 2,NG194,How can the Baby Check scoring system be used by parents to assess the health of babies up to 6 months old?
NG194_Rationale and impact: Bed sharing,NG194,What are the safe bed sharing practices recommended for parents to reduce the risk of sudden unexpected death in infancy?
NG194_Rationale and impact: Promoting emotional attachment,NG194,What strategies can support emotional attachment between parents and their baby during the antenatal and postnatal periods?
NG194_Rationale and impact: Symptoms and signs of illness in babies - Part 1,NG194,What are the signs and symptoms of serious illness in babies under 6 months?
NG194_Rationale and impact: Symptoms and signs of illness in babies - Part 2 & Rationale and impact: General principles about babies' feeding,NG194,How can the Baby Check scoring system be used effectively during remote assessments of infants?
NG194_Rationale and impact: Giving information about breastfeeding,NG194,What information should healthcare professionals provide to women about breastfeeding benefits and support during the antenatal and postnatal periods?
NG194_Rationale and impact: Role of the healthcare professional supporting breastfeeding,NG194,What training do healthcare professionals need to effectively support breastfeeding in the postnatal period?
NG194_Rationale and impact: Supporting women to breastfeed,NG194,What are the recommended approaches for providing breastfeeding support to new mothers?
NG194_Rationale and impact: Assessing breastfeeding,NG194,What are the recommended methods for assessing breastfeeding in postnatal care?
NG194_Rationale and impact: Formula feeding,NG194,What information and support should healthcare professionals provide to parents who are formula feeding their babies?
NG194_Rationale and impact: Lactation suppression,NG194,What information and support should be provided to women about lactation suppression?
NG194_Context - Part 1,NG194,What are the recommended practices for postnatal care organization and delivery?
NG194_Context - Part 2,NG194,What are the recommended postnatal care practices for families with twins or triplets?
NG195_Neonatal infection: antibiotics for prevention and treatment & Overview,NG195,What are the recommended antibiotics for preventing and treating neonatal bacterial infections?
NG195_Recommendations: 1.1 Information and support - Part 1,NG195,What are the recommended communication strategies for discussing neonatal infection risks and treatment options with parents and carers?
NG195_Recommendations: 1.1 Information and support - Part 2,NG195,What information should be provided to parents about caring for a baby at increased risk of neonatal infection?
NG195_Recommendations: 1.1 Information and support - Part 3,NG195,What are the recommended follow-up and support strategies for parents of babies treated for bacterial meningitis?
NG195_Recommendations: 1.1 Information and support - Part 4,NG195,What are the signs that parents and carers should seek urgent medical help for a newborn?
NG195_Recommendations: 1.2 Preventing early-onset neonatal infection before birth - Part 1,NG195,What are the indications for intrapartum antibiotics to prevent neonatal group B streptococcal infection?
NG195_Recommendations: 1.2 Preventing early-onset neonatal infection before birth - Part 2,NG195,What are the recommended intrapartum antibiotic options for women with penicillin allergies?
NG195_Recommendations: 1.2 Preventing early-onset neonatal infection before birth - Part 3,NG195,What is the recommended management of intrapartum antibiotics for women with prolonged prelabour rupture of membranes and GBS colonization?
NG195_Recommendations: 1.3 Risk factors for and clinical indicators of possible early-onset neonatal infection - Part 1,NG195,What are the risk factors and clinical indicators for early-onset neonatal infection during labor and after birth?
NG195_Recommendations: 1.3 Risk factors for and clinical indicators of possible early-onset neonatal infection - Part 2,NG195,What are the clinical indicators and management recommendations for suspected early-onset neonatal infection?
NG195_Recommendations: Kaiser Permanente neonatal sepsis calculator,NG195,How is the Kaiser Permanente neonatal sepsis calculator used to assess and manage early-onset neonatal infection?
NG195_Recommendations: Management for babies at increased risk of infection,NG195,What are the recommended management and antibiotic timing for babies at risk of early-onset neonatal infection?
NG195_Recommendations: 1.4 Investigations before starting antibiotics in babies who may have early-onset infection - Part 1,NG195,What investigations are recommended before starting antibiotics in babies with suspected early-onset neonatal infection?
NG195_Recommendations: 1.4 Investigations before starting antibiotics in babies who may have early-onset infection - Part 2,NG195,What are the recommended cerebrospinal fluid investigations for suspected bacterial meningitis in babies?
NG195_Recommendations: 1.4 Investigations before starting antibiotics in babies who may have early-onset infection - Part 3,NG195,What are the recommended investigations and treatments for suspected bacterial meningitis and site-specific infections in babies?
NG195_Recommendations: 1.5 Antibiotics for suspected early-onset infection - Part 1,NG195,What is the recommended antibiotic regimen for suspected early-onset neonatal infection?
NG195_Recommendations: 1.5 Antibiotics for suspected early-onset infection - Part 2,NG195,When should a second dose of gentamicin be administered in neonatal sepsis?
NG195_Recommendations: 1.6 Duration of antibiotic treatment for early-onset neonatal infection - Part 1,NG195,When should antibiotics be discontinued in neonates with suspected early-onset infection?
NG195_Recommendations: 1.6 Duration of antibiotic treatment for early-onset neonatal infection - Part 2,NG195,What are the recommended durations and review procedures for antibiotic treatment in neonatal sepsis without meningitis?
NG195_Recommendations: 1.7 Antibiotic-impregnated intravascular catheters for reducing the risk of late-onset neonatal infection,NG195,Should rifampicin-miconazole-impregnated catheters be used in neonatal care to prevent late-onset infections?
NG195_Recommendations: 1.8 Risk factors for and clinical indicators of possible late-onset neonatal infection - Part 1,NG195,What are the clinical indicators of late-onset neonatal infection and how should they be assessed?
NG195_Recommendations: 1.8 Risk factors for and clinical indicators of possible late-onset neonatal infection - Part 2,NG195,What is the recommended timing for administering antibiotics in suspected late-onset neonatal infection?
NG195_Recommendations: 1.9 Investigations before starting antibiotics in babies who may have late-onset infection - Part 1,NG195,What investigations are recommended before starting antibiotics in babies with suspected late-onset neonatal infection?
NG195_Recommendations: 1.9 Investigations before starting antibiotics in babies who may have late-onset infection - Part 2,NG195,What are the current NICE recommendations for performing lumbar puncture and cerebrospinal fluid investigations in babies with suspected bacterial meningitis?
NG195_Recommendations: 1.9 Investigations before starting antibiotics in babies who may have late-onset infection - Part 3,NG195,How should cerebrospinal fluid analysis be interpreted in diagnosing bacterial meningitis in babies?
NG195_Recommendations: 1.10 Antibiotics for late-onset neonatal infection,NG195,What are the recommended antibiotics for late-onset neonatal infection in neonatal intensive care units?
NG195_Recommendations: 1.11 Duration of antibiotic treatment for late-onset neonatal infection - Part 1,NG195,What is the recommended duration of antibiotic treatment for late-onset neonatal infection without meningitis?
NG195_Recommendations: 1.11 Duration of antibiotic treatment for late-onset neonatal infection - Part 2,NG195,What are the recommended treatment durations for neonatal infections based on pathogen type and infection site?
NG195_Recommendations: 1.12 Antifungals to prevent fungal infection during antibiotic treatment for late-onset neonatal infection & Recommendations: 1.13 Avoiding routine use of antibiotics in babies,NG195,What are the recommendations for antifungal prophylaxis in neonates receiving antibiotics for late-onset infection?
NG195_Recommendations: 1.14 Early- and late-onset meningitis (babies in neonatal units) - Part 1,NG195,What is the recommended antibiotic treatment for neonatal meningitis caused by Gram-negative bacteria?
NG195_Recommendations: 1.14 Early- and late-onset meningitis (babies in neonatal units) - Part 2,NG195,What are the current NICE recommendations for fluid management in babies with bacterial meningitis?
NG195_Recommendations: 1.14 Early- and late-onset meningitis (babies in neonatal units) - Part 3,NG195,What are the recommended follow-up and support procedures after antibiotic treatment for bacterial meningitis in infants?
NG195_Recommendations: 1.14 Early- and late-onset meningitis (babies in neonatal units) - Part 4,NG195,What are the recommended follow-up procedures after hospital discharge for babies who had bacterial meningitis?
NG195_Recommendations: 1.14 Early- and late-onset meningitis (babies in neonatal units) - Part 5,NG195,What are the risk factors and management strategies for recurrent bacterial meningitis in infants?
NG195_Recommendations: 1.15 Therapeutic drug monitoring for babies receiving gentamicin,NG195,What are the recommended therapeutic drug monitoring procedures for gentamicin in neonatal patients?
NG195_Recommendations: 1.16 Care setting & Recommendations: 1.17 Planning for care after discharge,NG195,What are the recommended care settings and follow-up procedures for babies discharged after bacterial meningitis?
NG195_Recommendations: Terms used in this guideline,NG195,What is the definition of early-onset neonatal infection according to NICE guidelines?
NG195_Recommendations for research: Key recommendations for research - Part 1,NG195,What are the recommended investigations and treatment durations for early-onset neonatal infection?
NG195_Recommendations for research: Key recommendations for research - Part 2,NG195,What are the accuracy and clinical utility of prediction models for late-onset neonatal infection in the UK?
NG195_Recommendations for research: Other recommendations for research - Part 1,NG195,What is the impact of neonatal infection on the family's quality of life?
NG195_Recommendations for research: Other recommendations for research - Part 2,NG195,What is the effectiveness of antimicrobial-impregnated intravascular catheters in preventing late-onset neonatal bloodstream infections?
NG195_Recommendations for research: Other recommendations for research - Part 3,NG195,What is the recommended antifungal regimen for preventing fungal infections during antibiotic treatment in late-onset neonatal infection?
NG195_Rationale and impact: Information and support,NG195,What information should parents and carers receive about signs of neonatal infection before their baby's discharge?
NG195_Rationale and impact: Information and support after diagnosis,NG195,What support and information should be provided to parents and carers of babies diagnosed with bacterial meningitis?
NG195_Rationale and impact: Intrapartum antibiotics - Part 1,NG195,What are the current recommendations for intrapartum antibiotic use to prevent neonatal group B streptococcal infection?
"NG195_Rationale and impact: Intrapartum antibiotics - Part 2 & Rationale and impact: Women with prolonged prelabour rupture of membranes who have group B streptococcal colonisation, bacteriuria or infection",NG195,What are the recommended intrapartum antibiotics for women with prolonged prelabour rupture of membranes and group B streptococcal colonisation?
"NG195_Rationale and impact: Women with prolonged prelabour rupture of membranes who have group B streptococcal colonisation, bacteriuria or infection",NG195,What is the recommended management for women with prolonged prelabour rupture of membranes and positive group B streptococcus test?
NG195_Rationale and impact: Risk factors for and clinical indicators of possible early-onset neonatal infection - Part 1,NG195,What are the risk factors and clinical indicators for early-onset neonatal infection?
NG195_Rationale and impact: Risk factors for and clinical indicators of possible early-onset neonatal infection - Part 2,NG195,What are the recommended settings for using the neonatal infection risk calculator according to NICE guidelines?
NG195_Rationale and impact: Risk factors for and clinical indicators of possible early-onset neonatal infection - Part 3,NG195,What are the updated risk factors and management strategies for neonatal early-onset group B streptococcal infection?
NG195_Rationale and impact: Lumbar puncture,NG195,What is the recommended timing for performing a lumbar puncture in suspected bacterial meningitis cases?
NG195_Rationale and impact: Cerebrospinal fluid investigations in babies with suspected bacterial meningitis,NG195,What cerebrospinal fluid tests are recommended for diagnosing bacterial meningitis in babies?
NG195_Rationale and impact: Antibiotic-impregnated intravascular catheters for reducing the risk of late-onset neonatal infection,NG195,Should antimicrobial-impregnated intravascular catheters be used to prevent late-onset neonatal infection?
NG195_Rationale and impact: Risk factors for and clinical indicators of possible late-onset neonatal infection - Part 1,NG195,What are the clinical indicators and risk factors for late-onset neonatal infection?
NG195_Rationale and impact: Risk factors for and clinical indicators of possible late-onset neonatal infection - Part 2,NG195,What are the key clinical indicators of late-onset neonatal infection according to NICE guidelines?
NG195_Rationale and impact: Investigations for late-onset neonatal infection - Part 1,NG195,What is the role of C-reactive protein testing alongside blood cultures in diagnosing late-onset neonatal infection?
NG195_Rationale and impact: Investigations for late-onset neonatal infection - Part 2,NG195,What are the recommended investigations for diagnosing late-onset neonatal infection?
NG195_Rationale and impact: Antibiotics for late-onset neonatal infection - Part 1,NG195,What are the recommended antibiotics for late-onset neonatal infection in babies admitted from home?
NG195_Rationale and impact: Antibiotics for late-onset neonatal infection - Part 2,NG195,What is the recommended duration of antibiotic treatment for neonatal infections based on clinical presentation and pathogen identification?
NG195_Rationale and impact: Antifungals to prevent fungal infection during antibiotic treatment for late-onset neonatal infection,NG195,What is the recommended antifungal prophylaxis for preventing fungal infections in neonates receiving antibiotics for late-onset infection?
NG195_Rationale and impact: Early- and late-onset meningitis (babies in neonatal units),NG195,What are the current recommendations for managing early- and late-onset meningitis in neonates in neonatal units?
NG195_Rationale and impact: Fluid restriction for confirmed bacterial meningitis,NG195,What are the current NICE guidelines on fluid management for patients with bacterial meningitis?
NG195_Rationale and impact: Assessing for immunodeficiency and recurrence risk in babies with bacterial meningitis,NG195,What are the recommended assessments for immunodeficiency and recurrence risk in babies with bacterial meningitis?
NG195_Rationale and impact: Identifying and managing complications,NG195,What are the recommended follow-up assessments for long-term complications in patients after bacterial meningitis?
NG195_Rationale and impact: Planning for care after discharge,NG195,What are the recommended steps for planning post-discharge care and psychosocial support for patients recovering from meningitis?
NG195_Rationale and impact: Care after hospital discharge,NG195,What are the recommended follow-up procedures after hospital discharge for patients who had meningitis?
NG195_Rationale and impact: Recurrent bacterial meningitis,NG195,What are the risk factors and management strategies for recurrent bacterial meningitis?
NG195_Context,NG195,What are the recommended practices for managing neonatal bacterial infection and antibiotic use in newborns?
NG196_Atrial fibrillation: diagnosis and management & Overview,NG196,What are the recommended strategies for diagnosing and managing atrial fibrillation in adults?
NG196_Recommendations: 1.1 Detection and diagnosis,NG196,What are the recommended methods for detecting atrial fibrillation in patients with suspected irregular pulse?
NG196_Recommendations: 1.2 Assessment of stroke and bleeding risks - Part 1,NG196,What are the recommended tools for assessing stroke and bleeding risk in patients with atrial fibrillation?
NG196_Recommendations: 1.2 Assessment of stroke and bleeding risks - Part 2,NG196,How should healthcare professionals monitor and support patients to modify bleeding risk factors in atrial fibrillation?
NG196_Recommendations: 1.3 Assessment of cardiac function,NG196,What are the indications for performing transthoracic and transoesophageal echocardiography in patients with atrial fibrillation?
NG196_Recommendations: 1.4 Personalised package of care and information & Recommendations: 1.5 Referral for specialised management,NG196,What are the key components of a personalised care package for atrial fibrillation management?
NG196_Recommendations: 1.6 Stroke prevention - Part 1,NG196,What are the considerations for anticoagulation therapy in stroke prevention for patients with atrial fibrillation?
NG196_Recommendations: 1.6 Stroke prevention - Part 2,NG196,When should vitamin K antagonists be offered for stroke prevention in atrial fibrillation patients?
NG196_Recommendations: 1.6 Stroke prevention - Part 3,NG196,How is time in therapeutic range (TTR) calculated and used to assess anticoagulation control in patients on vitamin K antagonists?
NG196_Recommendations: 1.6 Stroke prevention - Part 4,NG196,When should anticoagulation be reviewed in patients with atrial fibrillation?
NG196_Recommendations: 1.7 Rate and rhythm control - Part 1,NG196,What are the recommended rate control strategies for atrial fibrillation in non-acute settings?
NG196_Recommendations: 1.7 Rate and rhythm control - Part 2,NG196,What are the recommended options for long-term rate and rhythm control in atrial fibrillation management?
NG196_Recommendations: 1.7 Rate and rhythm control - Part 3,NG196,What are the recommended drug options for rhythm control in atrial fibrillation when beta-blockers are contraindicated?
NG196_Recommendations: 1.7 Rate and rhythm control - Part 4,NG196,What are the recommended options and considerations for atrial fibrillation cardioversion and left atrial ablation?
NG196_Recommendations: 1.7 Rate and rhythm control - Part 5,NG196,What is the recommended duration of antiarrhythmic drug treatment after left atrial ablation for atrial fibrillation?
NG196_Recommendations: 1.8 Management for people presenting acutely with atrial fibrillation - Part 1,NG196,What are the recommended management strategies for acute atrial fibrillation?
NG196_Recommendations: 1.8 Management for people presenting acutely with atrial fibrillation - Part 2 & Recommendations: 1.9 Initial management of stroke and atrial fibrillation,NG196,When should anticoagulation therapy be initiated in patients with new-onset atrial fibrillation?
NG196_Recommendations: 1.10 Preventing and managing postoperative atrial fibrillation - Part 1,NG196,What are the recommended strategies for preventing postoperative atrial fibrillation after cardiothoracic surgery?
NG196_Recommendations: 1.10 Preventing and managing postoperative atrial fibrillation - Part 2,NG196,What are the recommended management strategies for postoperative atrial fibrillation after cardiothoracic surgery?
NG196_Recommendations: 1.11 Stopping anticoagulation & Recommendations: Terms used in this guideline,NG196,What are the recommendations for stopping anticoagulation in patients with atrial fibrillation?
NG196_Recommendations for research: Key recommendations for research - Part 1,NG196,What is the accuracy of handheld and wearable devices compared to 12-lead ECG for diagnosing atrial fibrillation?
NG196_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG196,What is the effectiveness of stopping anticoagulation after atrial fibrillation has resolved post-ablation or post-surgery?
NG196_Rationale and impact: Detection and diagnosis,NG196,What is the recommended method for diagnosing persistent atrial fibrillation?
NG196_Rationale and impact: Stroke risk,NG196,What is the recommended stroke risk threshold for initiating anticoagulation in patients with atrial fibrillation according to NICE guidelines?
NG196_Rationale and impact: Bleeding risk - Part 1,NG196,How should bleeding risk be assessed in patients on anticoagulation therapy?
NG196_Rationale and impact: Bleeding risk - Part 2,NG196,How does the use of the ORBIT bleeding risk score impact clinical practice and patient management?
NG196_Rationale and impact: Stroke prevention - Part 1,NG196,What are the considerations for choosing between direct-acting oral anticoagulants and warfarin for stroke prevention?
NG196_Rationale and impact: Stroke prevention - Part 2,NG196,What are the considerations for switching from vitamin K antagonists to direct-acting anticoagulants in stroke prevention?
NG196_Rationale and impact: Rate control,NG196,What are the recommended options for rate control in atrial fibrillation according to NICE guidelines?
NG196_Rationale and impact: Left atrial ablation - Part 1,NG196,What are the recommended ablation options for treating paroxysmal atrial fibrillation when medication fails?
NG196_Rationale and impact: Left atrial ablation - Part 2,NG196,What are the indications and considerations for choosing cryoballoon or laser ablation over radiofrequency ablation in atrial fibrillation treatment?
NG196_Rationale and impact: Preventing recurrence after ablation,NG196,What are the recommendations for preventing recurrence of atrial fibrillation after ablation?
NG196_Rationale and impact: Rate and rhythm control for people presenting acutely,NG196,What are the recommended rate and rhythm control options for acute atrial fibrillation in patients with heart failure?
NG196_Rationale and impact: Preventing postoperative atrial fibrillation,NG196,Should statins be used to prevent atrial fibrillation after cardiothoracic surgery?
NG196_Rationale and impact: Managing atrial fibrillation after cardiothoracic surgery,NG196,What is the recommended management of atrial fibrillation after cardiothoracic surgery in patients without pre-existing atrial fibrillation?
NG196_Rationale and impact: Stopping anticoagulation,NG196,What are the current recommendations for stopping anticoagulation therapy after atrial fibrillation ablation?
NG196_Context,NG196,What are the current NICE guidelines for diagnosing and managing atrial fibrillation in adults?
NG197_Shared decision making & 4 more sections,NG197,How can healthcare organizations effectively embed shared decision making into routine practice?
NG197_Recommendations: 1.1 Embedding shared decision making at an organisational level - Part 1,NG197,How can healthcare organizations develop and implement an effective shared decision making improvement plan?
NG197_Recommendations: 1.1 Embedding shared decision making at an organisational level - Part 2,NG197,What strategies can healthcare organizations use to effectively involve patients in shared decision-making and ensure consistent information sharing?
NG197_Recommendations: 1.1 Embedding shared decision making at an organisational level - Part 3 & Recommendations: 1.2 Putting shared decision making into practice,NG197,What strategies are recommended to promote and implement shared decision making in healthcare settings?
NG197_Recommendations: 1.2 Putting shared decision making into practice - Part 1,NG197,How can healthcare professionals support shared decision making throughout the care process?
NG197_Recommendations: 1.2 Putting shared decision making into practice - Part 2,NG197,What are best practices for shared decision making during healthcare consultations?
NG197_Recommendations: 1.2 Putting shared decision making into practice - Part 3 & Recommendations: 1.3 Patient decision aids,NG197,What are the recommended practices for documenting and supporting shared decision making in clinical care?
"NG197_Recommendations: 1.3 Patient decision aids & Recommendations: 1.4 Communicating risks, benefits and consequences",NG197,What are the recommendations for using patient decision aids to support shared decision making in healthcare?
"NG197_Recommendations: 1.4 Communicating risks, benefits and consequences - Part 1",NG197,How should healthcare professionals communicate risks and benefits to patients during shared decision making?
"NG197_Recommendations: 1.4 Communicating risks, benefits and consequences - Part 2 & Recommendations: Terms used in this guideline",NG197,How should risks be communicated to patients using absolute risk and natural frequencies?
NG197_Recommendations: Terms used in this guideline & Recommendations for research,NG197,What is the three-talk model and how is it used in shared decision making?
NG197_Recommendations for research: 1 Differing intervention effects in different groups & 4 more sections,NG197,What are effective methods for measuring and sustaining shared decision making across different healthcare settings and patient groups?
NG197_Recommendations for research: 3 Sustaining shared decision making & Recommendations for research: 4 Acceptability of shared decision making,NG197,What strategies are effective for implementing and sustaining shared decision making in healthcare organizations and clinical teams?
NG197_Recommendations for research: 4 Acceptability of shared decision making & 3 more sections,NG197,How can shared decision making be adapted for remote consultations?
NG197_Rationale and impact: Embedding shared decision making at an organisational level - Part 1,NG197,How can healthcare organizations effectively embed shared decision making into routine practice?
NG197_Rationale and impact: Embedding shared decision making at an organisational level - Part 2,NG197,What strategies are recommended for implementing and sustaining shared decision making in healthcare organizations?
NG197_Rationale and impact: Putting shared decision making into practice - Part 1,NG197,What are effective strategies for implementing shared decision making in clinical practice?
NG197_Rationale and impact: Putting shared decision making into practice - Part 2,NG197,What are effective strategies for supporting shared decision making in healthcare consultations?
NG197_Rationale and impact: Putting shared decision making into practice - Part 3 & Rationale and impact: Patient decision aids,NG197,What are effective methods to support shared decision making in healthcare consultations?
NG197_Rationale and impact: Patient decision aids,NG197,What are the best practices for using patient decision aids to support shared decision making in healthcare?
"NG197_Rationale and impact: Communicating risks, benefits and consequences & Context",NG197,How should healthcare professionals communicate risks and benefits to support informed decision-making?
NG197_Context - Part 1,NG197,What is shared decision making in healthcare and how is it implemented in clinical practice?
NG198_Acne vulgaris: management & Overview & Recommendations: 1.1 Information and support for people with acne vulgaris,NG198,What information and support should be provided to people with acne vulgaris?
NG198_Recommendations: 1.2 Skin care advice & Recommendations: 1.3 Diet,NG198,What skin care advice is recommended for people with acne?
NG198_Recommendations: 1.4 Referral to specialist care - Part 1,NG198,When should I refer a patient with acne to specialist care?
NG198_Recommendations: 1.4 Referral to specialist care - Part 2,NG198,When should patients with acne be referred to mental health services for psychological distress or mental health disorders?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 1,NG198,What are the first-line treatments for managing mild to severe acne vulgaris?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 2,NG198,What are the recommended treatment options for mild to moderate and moderate to severe acne vulgaris?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 3,NG198,When should topical benzoyl peroxide be considered as an alternative treatment for acne?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 4,NG198,What factors should be considered when discussing acne treatment options with patients?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 5,NG198,When should oral isotretinoin be considered for acne treatment according to NICE guidelines?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 6,NG198,What are the recommended review intervals and criteria for continuing or stopping acne treatments involving antibiotics?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 7,NG198,When should oral isotretinoin be considered for severe acne resistant to standard treatments?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 8,NG198,What are the requirements for prescribing isotretinoin to patients under 18?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 9,NG198,What are the recommended dosing and monitoring guidelines for oral isotretinoin in the treatment of acne?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 10,NG198,What are the recommended physical and intralesional corticosteroid treatments for severe inflammatory acne?
NG198_Recommendations: 1.5 Managing acne vulgaris - Part 11,NG198,What are the recommended treatment options for acne in people with polycystic ovary syndrome?
NG198_Recommendations: 1.6 Relapse,NG198,What are the recommended treatment options for acne relapse after initial therapy?
NG198_Recommendations: 1.7 Maintenance,NG198,What are the recommended maintenance treatments for acne after initial therapy?
NG198_Recommendations: 1.8 Management of acne-related scarring,NG198,What are the treatment options for managing severe acne scars that persist after a year?
NG198_Recommendations: Terms used in this guideline - Part 1,NG198,"What are the differences between mild, moderate, and severe acne according to NICE guidelines?"
NG198_Recommendations: Terms used in this guideline - Part 2,NG198,What are the prescribing requirements for isotretinoin by accredited GPs in dermatology pathways?
NG198_Recommendations for research: Key recommendations for research - Part 1,NG198,What is the most effective treatment for acne in people with polycystic ovary syndrome?
NG198_Recommendations for research: Key recommendations for research - Part 2,NG198,What skin care advice is recommended for people with acne vulgaris?
NG198_Recommendations for research: Other recommendations for research - Part 1,NG198,What are the risk factors for acne vulgaris-related scarring?
NG198_Recommendations for research: Other recommendations for research - Part 2,NG198,What are the benefits of hormone-modifying treatments for acne vulgaris?
NG198_Rationale and impact: Information and support for people with acne vulgaris,NG198,What information and support should be provided to people with acne vulgaris?
NG198_Rationale and impact: Skin care advice - Part 1,NG198,What are the recommended skin care practices for managing acne vulgaris?
NG198_Rationale and impact: Skin care advice - Part 2,NG198,What skin care advice is recommended for people with acne vulgaris?
NG198_Rationale and impact: Diet,NG198,Should a low-glycaemic load diet be recommended for treating acne vulgaris?
NG198_Rationale and impact: Referral to specialist care - Part 1,NG198,What are the criteria for referring patients with acne to specialist care?
NG198_Rationale and impact: Referral to specialist care - Part 2,NG198,What are the recommended criteria for referring patients with acne vulgaris to specialist or mental health services?
NG198_Rationale and impact: First-line treatment options - Part 1,NG198,What are the first-line pharmacological treatments for mild to moderate and moderate to severe acne?
NG198_Rationale and impact: First-line treatment options - Part 2,NG198,What are the recommended antibiotic options for treating acne during pregnancy?
NG198_Rationale and impact: First-line treatment options - Part 3,NG198,How should treatment options for mild to moderate acne be discussed with patients to improve understanding and adherence?
NG198_Rationale and impact: Factors to take into account during consultations,NG198,What factors should be considered during consultations for acne vulgaris management?
NG198_Rationale and impact: Factors to take into account when choosing a treatment option - Part 1,NG198,What factors should be considered when choosing acne treatment options?
NG198_Rationale and impact: Factors to take into account when choosing a treatment option - Part 2,NG198,What are the current NICE recommendations on the use of oral antibiotics as monotherapy for acne treatment?
NG198_Rationale and impact: Factors to take into account at review - Part 1,NG198,What factors should be considered during review of antibiotic treatment duration for acne?
NG198_Rationale and impact: Factors to take into account at review - Part 2,NG198,What are the recommended treatment options for acne vulgaris after failure of initial therapy?
NG198_Rationale and impact: Factors to take into account at review - Part 3,NG198,How does the 12-week review and maximum 6-month antibiotic treatment recommendation impact acne management practice?
NG198_Rationale and impact: Oral isotretinoin treatment - Part 1,NG198,What are the safety considerations and monitoring requirements for oral isotretinoin treatment for acne?
NG198_Rationale and impact: Oral isotretinoin treatment - Part 2,NG198,What are the recommended dosing and monitoring guidelines for oral isotretinoin in acne treatment?
NG198_Rationale and impact: Use of oral corticosteroids in addition to oral isotretinoin,NG198,What is the recommended use of oral corticosteroids alongside oral isotretinoin for acne treatment?
NG198_Rationale and impact: Physical treatments,NG198,What is the effectiveness of photodynamic therapy for moderate to severe acne vulgaris?
NG198_Rationale and impact: Use of intralesional corticosteroids,NG198,What is the recommended dosage of intralesional corticosteroids for inflammatory acne cysts?
NG198_Rationale and impact: Treatment options for people with polycystic ovary syndrome,NG198,What are the recommended first-line treatments for acne in people with polycystic ovary syndrome?
NG198_Rationale and impact: Relapse,NG198,What are the recommended management options for acne relapse after initial treatment?
NG198_Rationale and impact: Maintenance,NG198,What are the recommended maintenance treatments for acne vulgaris after initial clearance?
NG198_Rationale and impact: Managing acne-related scarring - Part 1,NG198,What are the recommended treatments for managing acne-related scarring?
NG198_Rationale and impact: Managing acne-related scarring - Part 2,NG198,What is the evidence for the effectiveness of physical treatments like light devices and chemical peels for acne vulgaris and scarring?
NG198_Context,NG198,What are the recommended treatment options for managing acne vulgaris in young adults?
NG199_Clostridioides difficile infection: antimicrobial prescribing & Overview & Recommendations: 1.1 Managing suspected or confirmed Clostridioides difficile infection,NG199,What are the recommended antimicrobial prescribing strategies for managing suspected or confirmed Clostridioides difficile infection?
NG199_Recommendations: 1.1 Managing suspected or confirmed *Clostridioides difficile* infection - Part 1,NG199,What is the recommended management for suspected or confirmed Clostridioides difficile infection?
NG199_Recommendations: 1.1 Managing suspected or confirmed *Clostridioides difficile* infection - Part 2,NG199,What are the recommended antibiotic treatments for Clostridioides difficile infection in children and adults?
NG199_Recommendations: 1.1 Managing suspected or confirmed *Clostridioides difficile* infection - Part 3,NG199,When should patients with suspected or confirmed Clostridioides difficile infection be referred to hospital?
NG199_Recommendations: 1.2 Choice of antibiotic - Part 1,NG199,What is the recommended antibiotic choice for treating Clostridioides difficile infection in adults and children?
NG199_Recommendations: 1.2 Choice of antibiotic - Part 2,NG199,What are the recommended antibiotics and dosages for treating *Clostridioides difficile* infection in adults?
NG199_Recommendations: 1.3 Preventing C. difficile infection & Recommendations: 1.3 Preventing *C. difficile* infection,NG199,What are the recommended strategies for preventing Clostridioides difficile infection in healthcare settings?
NG199_Recommendations: Terms used in the guideline - Part 1,NG199,What are the criteria for diagnosing and classifying the severity of *Clostridioides difficile* infection?
NG199_Recommendations: Terms used in the guideline - Part 2 & Recommendations for research,NG199,What are the differences in effectiveness and safety between oral teicoplanin and oral vancomycin or fidaxomicin for treating Clostridioides difficile infection?
NG199_Rationale and impact: Assessment - Part 1,NG199,What are the current guidelines for assessing the severity and recurrence of Clostridioides difficile infection?
NG199_Rationale and impact: Assessment - Part 2 & Rationale and impact: Treating suspected or confirmed C. difficile infection,NG199,What are the recommended medication review practices for managing suspected or confirmed Clostridioides difficile infection?
NG199_Rationale and impact: Treating suspected or confirmed *C. difficile* infection - Part 1,NG199,What is the recommended treatment for suspected or confirmed *C. difficile* infection in adults and children?
NG199_Rationale and impact: Treating suspected or confirmed *C. difficile* infection - Part 2,NG199,What are the recommended treatments and management options for recurrent Clostridium difficile infection?
NG199_Rationale and impact: Advice,NG199,What self-care advice should be given to people with Clostridioides difficile infection?
NG199_Rationale and impact: Reassessment,NG199,How should suspected or confirmed Clostridioides difficile infection be monitored and reassessed during treatment?
NG199_Rationale and impact: Referral or seeking specialist advice,NG199,When should patients with suspected or confirmed Clostridioides difficile infection be referred to hospital or specialist care?
NG199_Rationale and impact: Choice of antibiotic - Part 1,NG199,What is the recommended first-line antibiotic for treating a first episode of Clostridioides difficile infection?
NG199_Rationale and impact: Choice of antibiotic - Part 2,NG199,When should oral vancomycin be used instead of fidaxomicin for *Clostridioides difficile* infection?
NG199_Rationale and impact: Choice of antibiotic - Part 3,NG199,What are the recommended treatments for recurrent *Clostridioides difficile* infection and how should the choice between vancomycin and fidaxomicin be made?
NG199_Rationale and impact: Choice of antibiotic - Part 4,NG199,What are the recommended antibiotic treatments for *Clostridioides difficile* infection when first- and second-line therapies fail?
NG199_Rationale and impact: Choice of antibiotic - Part 5,NG199,Why is metronidazole not recommended as first-line treatment for *C. difficile* infection according to NICE guidelines?
NG199_Rationale and impact: Choice of antibiotic - Part 6,NG199,What is the recommended dosage and administration route for oral vancomycin in treating *Clostridioides difficile* infection?
NG199_Rationale and impact: Choice of antibiotic - Part 7 & Rationale and impact: Preventing C. difficile infection,NG199,What are the recommended strategies for preventing Clostridioides difficile infection in children?
NG199_Rationale and impact: Preventing *C. difficile* infection - Part 1,NG199,What are the recommended strategies for preventing *Clostridium difficile* infection in healthcare settings?
NG199_Rationale and impact: Preventing *C. difficile* infection - Part 2 & Context,NG199,Should probiotics be recommended to prevent *Clostridioides difficile* infection in people taking antibiotics?
NG199_Summary of the evidence: Treating initial or first recurrent *C. difficile* infection in adults - Part 1,NG199,What is the most effective antibiotic for treating initial or first recurrent *Clostridioides difficile* infection in adults?
NG199_Summary of the evidence: Treating initial or first recurrent *C. difficile* infection in adults - Part 2,NG199,What is the most effective treatment for initial or recurrent Clostridioides difficile infection?
NG199_Summary of the evidence: Treating initial or first recurrent *C. difficile* infection in adults - Part 3 & Summary of the evidence: Preventing recurrence in people with C. difficile infection in adults,NG199,What are the most effective strategies for preventing recurrence of Clostridioides difficile infection in adults?
NG199_Summary of the evidence: Preventing recurrence in people with *C. difficile* infection in adults - Part 1,NG199,What are the recommended strategies to prevent recurrence of *Clostridioides difficile* infection in adults?
NG199_Summary of the evidence: Preventing recurrence in people with *C. difficile* infection in adults - Part 2,NG199,What is the effectiveness of bezlotoxumab in preventing recurrent *Clostridioides difficile* infection?
NG199_Summary of the evidence: Preventing recurrence in people with *C. difficile* infection in adults - Part 3 & Summary of the evidence: Treating initial or recurrent C. difficile infection in children and young people,NG199,What are the recommended treatments for initial or recurrent *Clostridioides difficile* infection in children and young people?
NG199_Summary of the evidence: Treating initial or recurrent *C. difficile* infection in children and young people & Summary of the evidence: Preventing C. difficile infection in adults without infection,NG199,What are the recommended antibiotic treatments for initial or recurrent *Clostridioides difficile* infection in children and young people?
NG199_Summary of the evidence: Preventing *C. difficile* infection in adults without infection - Part 1,NG199,What are the recommendations for preventing *C. difficile* infection in adults without current infection?
NG199_Summary of the evidence: Preventing *C. difficile* infection in adults without infection - Part 2 & Summary of the evidence: Preventing C. difficile infection in children and young people without infection,NG199,What are the recommended strategies for preventing Clostridioides difficile infection in children and young people without current infection?
NG199_Summary of the evidence: Preventing *C. difficile* infection in children and young people without infection,NG199,What is the evidence for using probiotics to prevent *C. difficile* infection in children and young people receiving antibiotics?
NG199_Other considerations: Medicines safety,NG199,"What are the safety considerations and monitoring requirements for using vancomycin, fidaxomicin, and faecal microbiota transplant in treating Clostridioides difficile infection?"
"NG19_Diabetic foot problems: prevention and management & Overview & Recommendations: 1.1 Care within 24 hours of a person with diabetic foot problems being admitted to hospital, or the detection of diabetic foot problems (if the person is already in hospital)",NG19,What are the recommended actions within 24 hours for managing diabetic foot problems in hospitalized patients?
"NG19_Recommendations: 1.1 Care within 24 hours of a person with diabetic foot problems being admitted to hospital, or the detection of diabetic foot problems (if the person is already in hospital)",NG19,What is the recommended timeframe for initial assessment and referral of diabetic foot problems in hospitalized patients?
NG19_Recommendations: 1.2 Care across all settings,NG19,What are the recommended multidisciplinary foot care services for managing diabetic foot problems?
NG19_Recommendations: 1.3 Assessing the risk of developing a diabetic foot problem - Part 1,NG19,How often should foot risk assessments be performed for adults with diabetes?
NG19_Recommendations: 1.3 Assessing the risk of developing a diabetic foot problem - Part 2,NG19,How should healthcare professionals assess and manage the risk of diabetic foot problems in patients with diabetes?
NG19_Recommendations: 1.3 Assessing the risk of developing a diabetic foot problem - Part 3,NG19,What are the recommended assessment and follow-up intervals for diabetic foot risk management?
NG19_Recommendations: 1.3 Assessing the risk of developing a diabetic foot problem - Part 4,NG19,What information should be provided to people with diabetes about foot care and risk of foot problems?
NG19_Recommendations: 1.4 Diabetic foot problems,NG19,What are the recommended referral procedures for diabetic foot problems according to NICE guidelines?
NG19_Recommendations: 1.5 Diabetic foot ulcer - Part 1,NG19,What are the recommended assessment and treatment options for diabetic foot ulcers according to NICE guidelines?
NG19_Recommendations: 1.5 Diabetic foot ulcer - Part 2,NG19,What are the recommended wound management strategies for diabetic foot ulcers according to NICE guidelines?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 1,NG19,What are the recommended investigations and antibiotic treatment strategies for diabetic foot infections?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 2,NG19,What is the recommended antibiotic treatment for mild diabetic foot infections in adults?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 3,NG19,What are the recommended oral antibiotics for penicillin allergy or when flucloxacillin is unsuitable?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 4,NG19,What are the recommended antibiotics and dosages for treating moderate or severe diabetic foot infections in adults?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 5,NG19,What is the recommended duration of antibiotic treatment for osteomyelitis according to NICE guidelines?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 6,NG19,When should intravenous antibiotics be switched to oral antibiotics in diabetic foot infections?
NG19_Recommendations: 1.6 Diabetic foot infection - Part 7,NG19,What are the NICE recommendations for antibiotic use and management of diabetic foot infections?
NG19_Recommendations: 1.7 Charcot arthropathy,NG19,What are the recommended investigations and management strategies for acute Charcot arthropathy in people with diabetes?
NG19_Recommendations: Terms used in this guideline,NG19,"What are the criteria for diagnosing mild, moderate, and severe diabetic foot infections?"
NG19_Recommendations for research: Key recommendations for research - Part 1,NG19,What is the effectiveness and cost-effectiveness of digital technologies for assessing and preventing diabetic foot problems?
NG19_Recommendations for research: Key recommendations for research - Part 2,NG19,What are the recommended criteria for referring diabetic patients to foot protection and multidisciplinary foot care services?
NG19_Recommendations for research: Other recommendations for research,NG19,When should patients with diabetic foot problems be referred to specialist services?
NG19_Rationale and impact: Assessing the risk of a diabetic foot problem - Part 1,NG19,What is the most accurate risk assessment tool for predicting diabetic foot ulcers?
NG19_Rationale and impact: Assessing the risk of a diabetic foot problem - Part 2,NG19,What are the recommended methods for assessing foot deformity in diabetic foot risk evaluation?
NG19_Rationale and impact: Managing the risk of developing a diabetic foot problem,NG19,What is the recommended frequency for diabetic foot risk assessments to prevent foot problems?
NG19_Rationale and impact: Treatment,NG19,What is the recommended timing for starting antibiotics in diabetic foot infections?
"NG19_Rationale and impact: Choice of antibiotic, dose frequency, route of administration and course length - Part 1",NG19,What are the recommended antibiotic choices and dosing for diabetic foot infections in adults?
"NG19_Rationale and impact: Choice of antibiotic, dose frequency, route of administration and course length - Part 2",NG19,What are the recommended antibiotic treatment durations and routes for managing diabetic foot infections?
NG19_Rationale and impact: Advice & Rationale and impact: Reassessment & Rationale and impact: Prevention,NG19,What are the recommended safety netting and reassessment procedures for diabetic foot infections?
NG19_Context - Part 1,NG19,What are the recommended strategies for preventing foot ulcers in people with diabetes?
NG19_Context - Part 2,NG19,What are the best practices for preventing diabetic foot ulcers and amputations in people with diabetes?
NG1_Gastro-oesophageal reflux disease in children and young people: diagnosis and management & Overview & Introduction - Part 1,NG1,What are the diagnostic criteria and management options for gastro-oesophageal reflux disease in children and young people?
NG1_Introduction - Part 2,NG1,What are the signs and management strategies for gastro-oesophageal reflux disease in children with neurodisabilities?
NG1_Key priorities for implementation - Part 1,NG1,What are the recommended management strategies for gastro-oesophageal reflux in infants and children?
NG1_Key priorities for implementation - Part 2,NG1,When should thickened formula or medication be used to manage infant regurgitation according to NICE guidelines?
NG1_Recommendations: Terms used in this guideline,NG1,What is the difference between gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants and children?
NG1_Recommendations: 1.1 Diagnosing and investigating GORD - Part 1,NG1,What are the red flag symptoms indicating disorders other than gastro-oesophageal reflux in infants?
NG1_Recommendations: 1.1 Diagnosing and investigating GORD - Part 2,NG1,What are the causes and management of gastrointestinal symptoms in infants and children?
NG1_Recommendations: 1.1 Diagnosing and investigating GORD - Part 3,NG1,What are the systemic signs and symptoms indicating serious underlying conditions in children?
NG1_Recommendations: 1.1 Diagnosing and investigating GORD - Part 4,NG1,What are the symptoms and investigation options for gastro-oesophageal reflux in children and young people?
NG1_Recommendations: 1.1 Diagnosing and investigating GORD - Part 5,NG1,What are the indications for upper GI contrast studies and endoscopy in children with suspected GORD?
NG1_Recommendations: 1.2 Initial management of GOR and GORD,NG1,What are the recommended initial management strategies for gastro-oesophageal reflux in infants?
NG1_Recommendations: 1.3 Pharmacological treatment of GORD - Part 1,NG1,What are the recommendations for pharmacological treatment of gastro-oesophageal reflux disease in children?
NG1_Recommendations: 1.3 Pharmacological treatment of GORD - Part 2,NG1,When should I consider prescribing PPIs or H2RAs for children with reflux oesophagitis?
NG1_Recommendations: 1.4 Enteral tube feeding for GORD & Recommendations: 1.5 Surgery for GORD,NG1,What are the indications and considerations for enteral tube feeding and surgical intervention in infants and children with GORD?
NG1_Recommendations for research,NG1,"What are the symptoms of gastro-oesophageal reflux disease in infants, children, and young people with neurodisability?"
NG1_Finding more information and resources,NG1,Where can I find more information and resources on NICE guidance for gastro-oesophageal reflux and Barrett's oesophagus?
NG201_Antenatal care & Overview,NG201,What are the recommended routine antenatal care practices for pregnant women?
NG201_Recommendations: 1.1 Organisation and delivery of antenatal care - Part 1,NG201,What are the recommended timings for the first antenatal appointment according to NICE guidelines?
NG201_Recommendations: 1.1 Organisation and delivery of antenatal care - Part 2,NG201,What are the recommended antenatal appointment schedules and considerations for women booking late in pregnancy?
NG201_Recommendations: 1.1 Organisation and delivery of antenatal care - Part 3,NG201,What are the NICE recommendations for involving partners in antenatal care?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 1,NG201,"What questions should be asked during the first antenatal appointment to assess a woman's medical, obstetric, mental health, and social history?"
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 2,NG201,How can healthcare providers address disparities in stillbirth rates among different ethnic and socioeconomic groups during pregnancy?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 3,NG201,What are the recommended antenatal risk assessments and investigations during pregnancy?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 4,NG201,What are the recommended ultrasound scans and blood tests during pregnancy according to NICE guidelines?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 5,NG201,What are the recommended risk assessments for venous thromboembolism and gestational diabetes during pregnancy?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 6,NG201,What are the recommended timing and procedures for gestational diabetes screening during pregnancy?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 7,NG201,What are the recommended procedures for managing hypertension and fetal growth monitoring in pregnant women?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 8,NG201,What are the recommended methods for monitoring fetal growth and wellbeing during antenatal care?
NG201_Recommendations: 1.2 Routine antenatal clinical care - Part 9,NG201,What are the recommended management options for breech presentation after 36 weeks of pregnancy?
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 1,NG201,What are the recommended approaches for communicating and providing information to pregnant women and their partners during antenatal care?
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 2,NG201,What information should be provided to women and their partners during the first antenatal appointment?
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 3,NG201,"What information should healthcare providers give about pregnancy changes, infections, immunisations, and lifestyle advice during antenatal care?"
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 4,NG201,"What information should be provided to pregnant women about emotional changes, bonding, and birth planning during antenatal care?"
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 5,NG201,What are the recommended discussions and support options during antenatal care for women at risk of preterm labor or prolonged pregnancy?
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 6,NG201,What topics are recommended to be included in antenatal classes for first-time and experienced mothers?
NG201_Recommendations: 1.3 Information and support for pregnant women and their partners - Part 7,NG201,What are the recommended approaches to peer support and sleep position advice for pregnant women to reduce the risk of stillbirth?
NG201_Recommendations: 1.4 Interventions for common problems during pregnancy - Part 1,NG201,What are the recommended interventions for nausea and vomiting during pregnancy?
NG201_Recommendations: 1.4 Interventions for common problems during pregnancy - Part 2,NG201,When should inpatient care be considered for vomiting in pregnancy?
NG201_Recommendations: 1.4 Interventions for common problems during pregnancy - Part 3,NG201,What are the recommended treatments for symptomatic vaginal discharge in pregnancy?
NG201_Recommendations: 1.4 Interventions for common problems during pregnancy - Part 4,NG201,What is the recommended management for unexplained vaginal bleeding after 13 weeks of pregnancy?
NG201_Recommendations: Terms used in this guideline - Part 1,NG201,What is the definition of bonding and emotional attachment in maternity care?
NG201_Recommendations: Terms used in this guideline - Part 2,NG201,What is the role of partner support and shared decision making in antenatal care?
NG201_Recommendations for research: Key recommendations for research - Part 1,NG201,What is the clinical and cost effectiveness of hospitalisation versus outpatient management for pregnant women with unexplained vaginal bleeding?
NG201_Recommendations for research: Key recommendations for research - Part 2,NG201,What is the clinical and cost effectiveness of routine ultrasound at 36 weeks for identifying breech presentation?
NG201_Rationale and impact: Starting antenatal care,NG201,What are the recommended timings and methods for initiating antenatal care in pregnant women?
NG201_Rationale and impact: Antenatal appointments - Part 1,NG201,What is the recommended timing for the first antenatal appointment?
NG201_Rationale and impact: Antenatal appointments - Part 2,NG201,What are the benefits of continuity of midwifery care throughout pregnancy and postnatal period?
NG201_Rationale and impact: Involving partners,NG201,How can antenatal services effectively involve partners in pregnancy care?
NG201_Rationale and impact: Taking and recording the woman's history - Part 1,NG201,What questions should be asked when taking a woman's obstetric and medical history during antenatal care?
NG201_Rationale and impact: Taking and recording the woman's history - Part 2,NG201,"What strategies can healthcare professionals use to address disparities in maternal and perinatal outcomes among women from black, Asian, and deprived backgrounds?"
NG201_Rationale and impact: Taking and recording the woman's history - Part 3,NG201,What are the recommended methods for screening and identifying cardiac problems in pregnant women at increased risk?
NG201_Rationale and impact: Examinations and investigations,NG201,What are the recommended timing and purpose of ultrasound scans in fetal anomaly screening?
NG201_Rationale and impact: Venous thromboembolism & Rationale and impact: Gestational diabetes,NG201,What are the risk assessment methods for venous thromboembolism in pregnancy?
NG201_Rationale and impact: Pre-eclampsia and hypertension in pregnancy,NG201,What is the recommended frequency for blood pressure monitoring and proteinuria testing in pregnant women at routine antenatal appointments?
NG201_Rationale and impact: Monitoring fetal growth and wellbeing - Part 1,NG201,What are the recommended methods for monitoring fetal growth and wellbeing during pregnancy?
NG201_Rationale and impact: Monitoring fetal growth and wellbeing - Part 2,NG201,What are the current recommendations for managing reduced fetal movements during pregnancy?
NG201_Rationale and impact: Breech presentation,NG201,What are the current recommendations for managing breech presentation at or after 36 weeks?
NG201_Rationale and impact: Communication – key principles,NG201,What are the key principles for effective communication and information sharing with pregnant women during antenatal care?
NG201_Rationale and impact: Information about antenatal care - Part 1,NG201,What information should be provided to women during antenatal care appointments?
NG201_Rationale and impact: Information about antenatal care - Part 2,NG201,What are the recommended timings and topics for discussing birth options and emotional attachment during pregnancy?
NG201_Rationale and impact: Antenatal classes,NG201,What are the benefits of attending antenatal classes for first-time and multiparous women?
NG201_Rationale and impact: Peer support,NG201,What is the role of peer support in antenatal care for women from vulnerable or minority groups?
NG201_Rationale and impact: Sleep position,NG201,What are the recommended sleep positions for pregnant women after 28 weeks to reduce the risk of stillbirth?
NG201_Rationale and impact: Nausea and vomiting - Part 1,NG201,What are the recommended treatments for nausea and vomiting in pregnancy?
NG201_Rationale and impact: Nausea and vomiting - Part 2,NG201,What are the recommended treatments for moderate-to-severe nausea and vomiting in pregnancy?
NG201_Rationale and impact: Heartburn,NG201,What are the recommended treatments for heartburn in pregnancy?
NG201_Rationale and impact: Symptomatic vaginal discharge,NG201,What are the recommended treatments for symptomatic vaginal discharge during pregnancy?
NG201_Rationale and impact: Pelvic girdle pain & Rationale and impact: Unexplained vaginal bleeding after 13 weeks,NG201,What are the recommended management options for unexplained vaginal bleeding after 13 weeks of pregnancy?
NG201_Rationale and impact: Unexplained vaginal bleeding after 13 weeks,NG201,What is the recommended management for unexplained vaginal bleeding after 13 weeks of pregnancy?
NG201_Context,NG201,What are the recommended practices for routine antenatal care and appointment scheduling?
NG202_Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s & Overview,NG202,What are the recommended diagnosis and management strategies for obstructive sleep apnoea and obesity hypoventilation syndrome in people over 16?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.1 Initial assessment for OSAHS - Part 1,NG202,What are the signs and risk factors for suspecting obstructive sleep apnoea hypopnoea syndrome (OSAHS)?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.1 Initial assessment for OSAHS - Part 2,NG202,What are the recommended assessment tools for suspected obstructive sleep apnoea hypopnoea syndrome?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.2 Prioritising people for rapid assessment by a sleep service,NG202,What are the criteria for prioritising patients with suspected OSAHS for rapid assessment in a sleep service?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.3 Diagnostic tests for OSAHS,NG202,What are the recommended diagnostic tests for obstructive sleep apnoea hypopnoea syndrome (OSAHS)?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.4 Lifestyle advice for all severities of OSAHS,NG202,What lifestyle changes are recommended for managing obstructive sleep apnoea hypopnoea syndrome (OSAHS)?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.5 Treatments for mild OSAHS - Part 1,NG202,What are the recommended treatments for mild obstructive sleep apnoea/hypopnoea syndrome?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.5 Treatments for mild OSAHS - Part 2,NG202,What precautions are recommended to reduce infection transmission when using CPAP therapy?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.6 Treatments for moderate and severe OSAHS - Part 1,NG202,What are the recommended treatments and management options for moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) according to NICE guidelines?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.7 Further treatment options for OSAHS,NG202,What are the treatment options for obstructive sleep apnoea hypopnoea syndrome (OSAHS) in patients who cannot tolerate CPAP?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.8 Managing rhinitis in people with OSAHS,NG202,What are the recommended treatments for rhinitis in people with obstructive sleep apnoea and how does it affect CPAP therapy?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.9 Follow-up and monitoring for people with OSAHS - Part 1,NG202,What are the recommended follow-up procedures for patients with obstructive sleep apnoea hypopnoea syndrome (OSAHS) undergoing CPAP therapy or surgical treatment?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.9 Follow-up and monitoring for people with OSAHS - Part 2,NG202,What are the recommended follow-up procedures for assessing treatment effectiveness in patients with obstructive sleep apnoea/hypopnoea syndrome (OSAHS)?
NG202_1 Obstructive sleep apnoea/hypopnoea syndrome: 1.10 Supporting adherence to treatment for OSAHS,NG202,What strategies can improve adherence to CPAP and mandibular advancement devices in patients with obstructive sleep apnoea?
NG202_2 Obesity hypoventilation syndrome: 2.1 Initial assessment for OHS,NG202,What are the criteria for assessing suspected obesity hypoventilation syndrome (OHS) in patients with high BMI?
NG202_2 Obesity hypoventilation syndrome: 2.2 Prioritising people for rapid assessment by a sleep service,NG202,What factors determine priority for rapid assessment in suspected obstructive hypoventilation syndrome (OHS) patients?
NG202_2 Obesity hypoventilation syndrome: 2.3 Diagnostic tests for OHS,NG202,What are the recommended diagnostic tests for obstructive hypoventilation syndrome (OHS)?
NG202_2 Obesity hypoventilation syndrome: 2.4 Lifestyle advice for OHS,NG202,What lifestyle changes are recommended for managing occupational hypersensitivity syndrome?
NG202_2 Obesity hypoventilation syndrome: 2.5 Treatments for OHS - Part 1,NG202,What are the recommended treatments for obstructive hypoventilation syndrome (OHS) according to NICE guidelines?
NG202_2 Obesity hypoventilation syndrome: 2.5 Treatments for OHS - Part 2,NG202,When should non-invasive ventilation be restarted after decompensation in patients using CPAP for obstructive sleep apnoea?
NG202_2 Obesity hypoventilation syndrome: 2.6 Managing rhinitis in people with OHS,NG202,What is the recommended management of rhinitis in people with obesity hypoventilation syndrome?
NG202_2 Obesity hypoventilation syndrome: 2.7 Follow-up and monitoring for people with OHS - Part 1,NG202,What are the recommended follow-up intervals for patients with obesity hypoventilation syndrome on non-invasive ventilation or CPAP?
NG202_2 Obesity hypoventilation syndrome: 2.7 Follow-up and monitoring for people with OHS - Part 2,NG202,How is treatment effectiveness monitored in people with obesity hypoventilation syndrome (OHS) using CPAP or non-invasive ventilation?
NG202_2 Obesity hypoventilation syndrome: 2.8 Supporting adherence to treatment for OHS,NG202,How can adherence to CPAP and non-invasive ventilation be improved in patients with obstructive hypoventilation syndrome?
NG202_3 COPD–OSAHS overlap syndrome: 3.1 Initial assessment for COPD–OSAHS overlap syndrome - Part 1,NG202,What are the criteria for suspecting COPD–OSAHS overlap syndrome in patients with COPD?
NG202_3 COPD–OSAHS overlap syndrome: 3.1 Initial assessment for COPD–OSAHS overlap syndrome - Part 2,NG202,When should spirometry be used to assess COPD–OSAHS overlap syndrome and what infection control measures are recommended during the procedure?
NG202_3 COPD–OSAHS overlap syndrome: 3.2 Prioritising people for rapid assessment by a sleep service,NG202,What are the criteria for prioritising patients with suspected COPD–OSAHS overlap syndrome for rapid assessment by a sleep service?
NG202_3 COPD–OSAHS overlap syndrome: 3.3 Diagnostic tests for COPD–OSAHS overlap syndrome,NG202,What are the recommended diagnostic tests for COPD–OSAHS overlap syndrome?
NG202_3 COPD–OSAHS overlap syndrome: 3.4 Lifestyle advice for COPD–OSAHS overlap syndrome & 3 COPD–OSAHS overlap syndrome: 3.5 Treatments for COPD–OSAHS overlap syndrome - Part 1,NG202,What are the recommended treatments and lifestyle advice for managing COPD–OSAHS overlap syndrome?
NG202_3 COPD–OSAHS overlap syndrome: 3.5 Treatments for COPD–OSAHS overlap syndrome - Part 2 & 3 COPD–OSAHS overlap syndrome: 3.6 Managing rhinitis in people with COPD–OSAHS overlap syndrome,NG202,What are the guidelines for oxygen therapy in patients with COPD-OSAHS overlap syndrome?
NG202_3 COPD–OSAHS overlap syndrome: 3.7 Follow-up and monitoring for people with COPD–OSAHS overlap syndrome - Part 1,NG202,What are the recommended follow-up procedures for patients with COPD–OSAHS overlap syndrome on non-invasive ventilation or CPAP?
NG202_3 COPD–OSAHS overlap syndrome: 3.7 Follow-up and monitoring for people with COPD–OSAHS overlap syndrome - Part 2,NG202,How is the effectiveness of CPAP or non-invasive ventilation monitored in patients with COPD–OSAHS overlap syndrome?
NG202_3 COPD–OSAHS overlap syndrome: 3.8 Supporting adherence to treatment for COPD–OSAHS overlap syndrome,NG202,What strategies are effective for improving adherence to CPAP and non-invasive ventilation in patients with COPD–OSAHS overlap syndrome?
"NG202_4 Information for people with OSAHS, OHS or COPD–OSAHS overlap syndrome: 4.1.1 & 4 Information for people with OSAHS, OHS or COPD–OSAHS overlap syndrome: 4.1.2",NG202,"What information should be provided to patients with suspected sleep apnoea or overlap syndrome about diagnosis, treatment options, and driving safety?"
"NG202_4 Information for people with OSAHS, OHS or COPD–OSAHS overlap syndrome: 4.1.3 & 4 Information for people with OSAHS, OHS or COPD–OSAHS overlap syndrome: 4.1.4",NG202,"What information should be provided to patients starting CPAP or non-invasive ventilation regarding its use, maintenance, and infection control precautions?"
"NG202_4 Information for people with OSAHS, OHS or COPD–OSAHS overlap syndrome: 4.1.5",NG202,What information should be provided to patients starting mandibular advancement splint therapy for sleep apnea?
NG202_Terms used in this guideline - Part 1,NG202,What is the role of mandibular advancement splints in treating sleep-related breathing disorders?
NG202_Terms used in this guideline - Part 2,NG202,What are the criteria for diagnosing and managing sleep apnea based on the apnoea–hypopnoea index (AHI) and sleep study types?
NG202_Recommendations for research: Key recommendations for research - Part 1,NG202,"What is the effectiveness of auto- and fixed-level CPAP therapy for mild, moderate, and severe obstructive sleep apnoea/hypopnoea syndrome?"
NG202_Recommendations for research: Key recommendations for research - Part 2,NG202,"What are the most effective interventions to improve adherence to CPAP therapy in patients with OSAHS, obesity hypoventilation syndrome, and COPD–OSAHS overlap syndrome?"
NG202_Recommendations for research: Key recommendations for research - Part 3,NG202,What is the effectiveness of mandibular advancement splints for severe obstructive sleep apnoea hypopnoea syndrome?
NG202_Recommendations for research: Other recommendations for research,NG202,What is the effectiveness of upper airway surgery or nocturnal oxygen therapy for patients with obstructive sleep apnoea who cannot tolerate CPAP?
NG202_Rationale and impact: When to suspect OSAHS,NG202,When should I suspect obstructive sleep apnoea/hypopnoea syndrome based on symptoms?
NG202_Rationale and impact: Assessment scales for suspected OSAHS,NG202,How are the Epworth Sleepiness Scale and STOP-Bang Questionnaire used in assessing suspected obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Prioritising people for rapid assessment by a sleep service - Part 1,NG202,Which patients should be prioritized for rapid assessment and treatment in sleep services for suspected COPD–OSAHS overlap syndrome?
NG202_Rationale and impact: Prioritising people for rapid assessment by a sleep service - Part 2,NG202,What are the priority groups for assessment and treatment of obstructive sleep apnoea hypopnoea syndrome (OSAHS) according to NICE guidelines?
NG202_Rationale and impact: Diagnostic tests for OSAHS - Part 1,NG202,What are the recommended diagnostic tests for obstructive sleep apnoea hypopnoea syndrome (OSAHS)?
NG202_Rationale and impact: Diagnostic tests for OSAHS - Part 2,NG202,When should polysomnography be used after a negative respiratory polygraphy in suspected obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Lifestyle advice for all severities of OSAHS,NG202,What lifestyle changes are recommended for managing obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Treatments for mild OSAHS - Part 1,NG202,What are the recommended treatments for mild obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Treatments for mild OSAHS - Part 2,NG202,What are the recommended treatment options for mild obstructive sleep apnoea syndrome?
NG202_Rationale and impact: Treatments for mild OSAHS - Part 3,NG202,What are the benefits and limitations of custom-made mandibular advancement splints for treating mild obstructive sleep apnoea?
NG202_Rationale and impact: Treatments for moderate and severe OSAHS - Part 1,NG202,What are the recommended treatments for moderate and severe obstructive sleep apnoea/hypopnoea syndrome?
NG202_Rationale and impact: Treatments for moderate and severe OSAHS - Part 2,NG202,What are the recommended treatment options for patients with moderate to severe obstructive sleep apnoea who cannot tolerate CPAP therapy?
NG202_Rationale and impact: Positional modifiers for OSAHS,NG202,What are the recommended positional modifiers for treating mild or moderate obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Surgery for OSAHS - Part 1,NG202,When is surgery recommended for obstructive sleep apnoea hypopnoea syndrome (OSAHS) in adults?
NG202_Rationale and impact: Surgery for OSAHS - Part 2 & Rationale and impact: Oxygen therapy for OSAHS,NG202,What are the criteria for referring patients with obstructive sleep apnoea hypopnoea syndrome for surgery?
NG202_Rationale and impact: Managing rhinitis in people with OSAHS,NG202,What are the recommended approaches for managing rhinitis in people with obstructive sleep apnoea/hypopnoea syndrome?
NG202_Rationale and impact: Follow-up for people with OSAHS - Part 1,NG202,What is the recommended follow-up approach for patients using CPAP therapy for obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Follow-up for people with OSAHS - Part 2,NG202,"What are the recommended follow-up methods for patients using CPAP, mandibular advancement splints, or positional devices for obstructive sleep apnea?"
NG202_Rationale and impact: Follow-up for people with OSAHS - Part 3,NG202,What are the recommended follow-up procedures for patients after surgery for obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Monitoring treatment efficacy in people with OSAHS,NG202,How should the effectiveness of treatment be monitored in people with obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: Supporting adherence to treatment for OSAHS,NG202,What strategies improve adherence to CPAP therapy for obstructive sleep apnoea hypopnoea syndrome?
NG202_Rationale and impact: When to suspect OHS,NG202,When should I suspect obesity hypoventilation syndrome in patients with obesity and sleep-related symptoms?
NG202_Rationale and impact: Assessment scales for suspected OHS,NG202,What assessment tools are recommended for suspected obesity hypoventilation syndrome?
NG202_Rationale and impact: Diagnostic tests for OHS - Part 1,NG202,What are the recommended diagnostic tests for obesity hypoventilation syndrome?
NG202_Rationale and impact: Diagnostic tests for OHS - Part 2,NG202,What are the recommended diagnostic methods for detecting obstructive sleep apnoea hypopnoea syndrome and nocturnal hypoventilation in obesity hypoventilation syndrome?
NG202_Rationale and impact: Lifestyle advice for OHS,NG202,What lifestyle changes are recommended for managing obesity hypoventilation syndrome?
NG202_Rationale and impact: Treatments for OHS - Part 1,NG202,What are the recommended treatments for obesity hypoventilation syndrome?
NG202_Rationale and impact: Treatments for OHS - Part 2,NG202,What are the guidelines for oxygen therapy in patients with obesity hypoventilation syndrome?
NG202_Rationale and impact: Managing rhinitis in people with OHS,NG202,What are the recommended approaches for managing rhinitis in people with obesity hypoventilation syndrome?
NG202_Rationale and impact: Follow-up for people with OHS - Part 1,NG202,What is the recommended follow-up schedule for patients with obesity hypoventilation syndrome on CPAP or non-invasive ventilation?
NG202_Rationale and impact: Follow-up for people with OHS - Part 2,NG202,What are the recommended follow-up intervals for drivers with obstructive sleep apnoea syndrome according to NICE guidelines?
NG202_Rationale and impact: Monitoring treatment efficacy for people with OHS & Rationale and impact: Supporting adherence to treatment for OHS,NG202,What are the recommended methods for monitoring treatment effectiveness in people with obesity hypoventilation syndrome?
NG202_Rationale and impact: When to suspect COPD–OSAHS overlap syndrome,NG202,What are the signs and symptoms to suspect COPD–OSAHS overlap syndrome in patients?
NG202_Rationale and impact: Assessment scales and tests for suspected COPD–OSAHS overlap syndrome,NG202,What assessment tools are recommended for diagnosing COPD–OSAHS overlap syndrome?
NG202_Rationale and impact: Diagnostic tests for COPD–OSAHS overlap syndrome - Part 1,NG202,What are the recommended diagnostic tests for detecting ventilatory failure in COPD–OSAHS overlap syndrome?
NG202_Rationale and impact: Diagnostic tests for COPD–OSAHS overlap syndrome - Part 2,NG202,What are the recommended diagnostic methods for detecting OSAHS and nocturnal hypoventilation in COPD–OSAHS overlap syndrome?
NG202_Rationale and impact: Treatments for COPD–OSAHS overlap syndrome - Part 1,NG202,What are the recommended treatments for COPD–OSAHS overlap syndrome based on hypercapnia levels?
NG202_Rationale and impact: Treatments for COPD–OSAHS overlap syndrome - Part 2,NG202,What are the recommended oxygen therapy options for patients with COPD–OSAHS overlap syndrome during sleep?
NG202_Rationale and impact: Follow-up for people with COPD–OSAHS overlap syndrome - Part 1,NG202,What is the recommended follow-up and monitoring for people with COPD-OSAHS overlap syndrome on CPAP therapy?
NG202_Rationale and impact: Monitoring treatment efficacy for people with COPD–OSAHS overlap syndrome - Part 1,NG202,How should the effectiveness of CPAP or non-invasive ventilation be monitored in patients with COPD–OSAHS overlap syndrome?
NG202_Rationale and impact: Monitoring treatment efficacy for people with COPD–OSAHS overlap syndrome - Part 2 & Rationale and impact: Supporting adherence to treatment for people with COPD–OSAHS overlap syndrome,NG202,When should supplemental oxygen therapy be reviewed in patients with COPD–OSAHS overlap syndrome receiving non-invasive ventilation or CPAP?
"NG202_Rationale and impact: Information for people with OSAHS, OHS and COPD–OSAHS overlap syndrome",NG202,"What information should be provided to patients with OSAHS, OHS, or COPD–OSAHS overlap syndrome to improve understanding and treatment adherence?"
NG202_Context - Part 1,NG202,"What are the recommended approaches for diagnosing and managing obstructive sleep apnoea, obesity hypoventilation syndrome, and COPD overlap syndrome?"
NG202_Context - Part 2,NG202,What are the recommended management strategies for obstructive sleep apnoea hypopnoea syndrome and overlap syndrome with COPD?
NG203_Chronic kidney disease: assessment and management & Overview,NG203,What are the recommended strategies for managing anemia and hyperphosphataemia in patients with chronic kidney disease?
NG203_Recommendations: 1.1 Investigations for chronic kidney disease - Part 1,NG203,What are the recommended methods for estimating glomerular filtration rate in adults with chronic kidney disease?
NG203_Recommendations: 1.1 Investigations for chronic kidney disease - Part 2,NG203,What are the recommended procedures for testing kidney function and proteinuria in adults?
NG203_Recommendations: 1.1 Investigations for chronic kidney disease - Part 3,NG203,What are the recommended methods for testing proteinuria and haematuria in patients with suspected CKD?
NG203_Recommendations: 1.1 Investigations for chronic kidney disease - Part 4,NG203,What are the recommended tests and follow-up procedures for detecting and managing persistent invisible haematuria in children and young people?
NG203_Recommendations: 1.1 Investigations for chronic kidney disease - Part 5,NG203,When should children and young people be tested for chronic kidney disease using eGFR and ACR?
NG203_Recommendations: 1.2 Classification of CKD in adults - Part 1,NG203,How is chronic kidney disease classified using GFR and ACR categories?
NG203_Recommendations: 1.2 Classification of CKD in adults - Part 2,NG203,What are the indications for renal ultrasound in adults with chronic kidney disease?
NG203_Recommendations: 1.3 Frequency of monitoring - Part 1,NG203,How often should kidney function be monitored in patients with chronic kidney disease?
NG203_Recommendations: 1.3 Frequency of monitoring - Part 2,NG203,What are the recommended monitoring intervals for kidney function based on GFR and albuminuria categories?
NG203_Recommendations: 1.3 Frequency of monitoring - Part 3,NG203,What are the criteria for accelerated progression of chronic kidney disease in adults?
NG203_Recommendations: 1.4 Information and education for people with CKD - Part 1,NG203,What information and education should be provided to people with CKD and their families?
NG203_Recommendations: 1.4 Information and education for people with CKD - Part 2,NG203,What information and support are recommended for adults with CKD to help them manage their condition?
"NG203_Recommendations: 1.5 Risk assessment, referral criteria and shared care - Part 1",NG203,What are the criteria for referral to a specialist for adults with chronic kidney disease?
"NG203_Recommendations: 1.5 Risk assessment, referral criteria and shared care - Part 2",NG203,When should children and young people with chronic kidney disease be referred to specialist services?
NG203_Recommendations: 1.6 Pharmacotherapy - Part 1,NG203,What are the blood pressure targets for adults with CKD and different levels of albuminuria according to NICE guidelines?
NG203_Recommendations: 1.6 Pharmacotherapy - Part 2,NG203,What is the recommended use of ACE inhibitors or ARBs for managing hypertension and proteinuria in adults and young people with chronic kidney disease?
NG203_Recommendations: 1.6 Pharmacotherapy - Part 3,NG203,What are the recommendations for using ACE inhibitors or ARBs to reduce proteinuria in children and young people with CKD?
NG203_Recommendations: 1.6 Pharmacotherapy - Part 4,NG203,What are the recommended monitoring and dosing strategies for renin–angiotensin system antagonists in adults with chronic kidney disease?
NG203_Recommendations: 1.6 Pharmacotherapy - Part 5,NG203,What are the recommended monitoring and management strategies for renal function when prescribing renin–angiotensin system antagonists in adults?
NG203_Recommendations: 1.7 Diagnosing and assessing anaemia - Part 1,NG203,When should anaemia be investigated in patients with chronic kidney disease based on haemoglobin levels and eGFR?
NG203_Recommendations: 1.7 Diagnosing and assessing anaemia - Part 2,NG203,What are the recommended diagnostic tests for assessing iron deficiency and predicting response to iron therapy in chronic kidney disease-related anemia?
NG203_Recommendations: 1.8 Managing anaemia - Part 1,NG203,What are the recommendations for starting and monitoring erythropoietic stimulating agent therapy in patients with anemia of chronic kidney disease?
NG203_Recommendations: 1.8 Managing anaemia - Part 2,NG203,What are the recommended treatments for anemia in adults with stage 3 to 5 CKD not on dialysis?
NG203_Recommendations: 1.8 Managing anaemia - Part 3,NG203,What information should be provided to patients about ESA therapy for anemia of CKD?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 1,NG203,What are the recommended management strategies for anemia in chronic kidney disease patients according to NICE guidelines?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 2,NG203,What are the recommended dosing and monitoring strategies for erythropoiesis-stimulating agents in managing anemia of chronic kidney disease?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 3,NG203,What are the recommended hemoglobin targets and ESA dosing guidelines for managing anemia in children and young people with CKD?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 4,NG203,What are the recommended high-dose intravenous iron regimens for adults and children with stage 5 CKD on haemodialysis?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 5,NG203,What are the recommendations for maintaining and monitoring iron levels in patients with CKD receiving ESA therapy?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 6,NG203,What are the recommended iron therapy options for patients with CKD who are iron deficient and on ESA treatment?
NG203_Recommendations: 1.9 Assessing and optimising erythropoiesis in people with anaemia - Part 7,NG203,What are the recommended iron therapy options for anemia in chronic kidney disease patients?
NG203_Recommendations: 1.10 Monitoring anaemia treatment - Part 1,NG203,How should iron and hemoglobin levels be monitored in patients with anemia of chronic kidney disease?
NG203_Recommendations: 1.10 Monitoring anaemia treatment - Part 2,NG203,What are the causes and management strategies for ESA resistance in patients with anemia of CKD?
NG203_Recommendations: 1.11 Hyperphosphataemia in people with CKD stage 4 or 5 - Part 1,NG203,What are the dietary management strategies for hyperphosphataemia in people with CKD stage 4 or 5?
NG203_Recommendations: 1.11 Hyperphosphataemia in people with CKD stage 4 or 5 - Part 2,NG203,What are the recommended phosphate binders for children and adults with CKD stage 4 or 5?
NG203_Recommendations: 1.11 Hyperphosphataemia in people with CKD stage 4 or 5 - Part 3,NG203,What are the recommended phosphate binders for CKD patients not on dialysis according to NICE guidelines?
NG203_Recommendations: 1.11 Hyperphosphataemia in people with CKD stage 4 or 5 - Part 4,NG203,What are the recommended combinations of phosphate binders for adults with advanced CKD to control serum phosphate levels?
NG203_Recommendations: 1.12 Other complications in adults - Part 1,NG203,"When should calcium, phosphate, and parathyroid hormone levels be measured in adults with chronic kidney disease?"
NG203_Recommendations: 1.12 Other complications in adults - Part 2,NG203,What are the recommended treatments for vitamin D deficiency and mineral bone disorders in chronic kidney disease?
NG203_Recommendations: Terms used in this guideline - Part 1,NG203,What is the definition and classification of chronic kidney disease (CKD) according to NICE guidelines?
NG203_Recommendations: Terms used in this guideline - Part 2,NG203,How is the 4-variable Kidney Failure Risk Equation used to estimate 5-year risk of renal replacement therapy?
NG203_Recommendations for research: Key recommendations for research - Part 1,NG203,"What are the most accurate creatinine-based eGFR calculations for assessing CKD in black, Asian, and minority ethnic groups in the UK?"
NG203_Recommendations for research: Key recommendations for research - Part 2,NG203,What are the optimal hemoglobin targets for children and young people with CKD to manage anemia safely?
NG203_Recommendations for research: Other recommendations for research - Part 1,NG203,What is the accuracy of cystatin-C equations for estimating GFR in children and adults with CKD?
NG203_Recommendations for research: Other recommendations for research - Part 2,NG203,Which phosphate binders are most effective and cost-efficient for managing serum phosphate in adults and children with stage 4 or 5 CKD not on dialysis?
NG203_Rationale and impact: Creatinine-based estimate of glomerular filtration rate (GFR) - Part 1,NG203,Why are ethnicity adjustments not recommended for creatinine-based eGFR calculations in the UK?
NG203_Rationale and impact: Creatinine-based estimate of glomerular filtration rate (GFR) - Part 2,NG203,Should cystatin-c equations be used for diagnosing chronic kidney disease in adults?
NG203_Rationale and impact: Investigations for proteinuria,NG203,What are the recommended methods for measuring proteinuria in children and young people with chronic kidney disease?
NG203_Rationale and impact: Reagent strips for proteinuria and haematuria,NG203,What are the recommendations for using reagent strips to detect proteinuria and haematuria in children and young people?
NG203_Rationale and impact: Who should be tested for CKD,NG203,Who should be tested for chronic kidney disease in children and adults?
NG203_Rationale and impact: Frequency of monitoring,NG203,What is the recommended frequency of eGFR and ACR monitoring in patients with chronic kidney disease?
"NG203_Rationale and impact: Risk assessment, referral criteria and shared care - Part 1",NG203,How is the 4-variable Kidney Failure Risk Equation used for referral in adult CKD patients?
"NG203_Rationale and impact: Risk assessment, referral criteria and shared care - Part 2",NG203,How should healthcare professionals communicate kidney failure risk to patients with CKD?
NG203_Rationale and impact: Pharmacotherapy for blood pressure control,NG203,What are the recommended blood pressure targets for adults and children with chronic kidney disease according to NICE guidelines?
NG203_Rationale and impact: Pharmacotherapy for proteinuria and choice of antihypertensive agent,NG203,What is the recommended pharmacotherapy for proteinuria in patients with hypertension and diabetes?
NG203_Rationale and impact: Diagnostic role of glomerular filtration rate - Part 1,NG203,When should glomerular filtration rate be used to diagnose anemia caused by chronic kidney disease?
NG203_Rationale and impact: Diagnostic role of glomerular filtration rate - Part 2,NG203,"What is the diagnostic accuracy of eGFR thresholds of 30, 45, and 60 ml/min/1.73 m2 for detecting anemia related to chronic kidney disease?"
NG203_Rationale and impact: Optimal Hb levels,NG203,What are the recommended haemoglobin targets for children and young people with anemia?
NG203_Rationale and impact: Correcting iron deficiency,NG203,What is the recommended intravenous iron dosing for correcting iron deficiency in patients with stage 5 CKD on haemodialysis?
NG203_Rationale and impact: Hyperphosphataemia in people with CKD stage 4 or 5 - Part 1,NG203,What are the recommended phosphate binders for managing hyperphosphataemia in children and adults with CKD stages 4 and 5?
NG203_Rationale and impact: Hyperphosphataemia in people with CKD stage 4 or 5 - Part 2,NG203,What is the most cost-effective sequence of phosphate binders for managing hyperphosphataemia in adults with chronic kidney disease?
NG203_Context - Part 1,NG203,What are the management strategies for hyperphosphataemia in patients with chronic kidney disease?
NG203_Context - Part 2,NG203,What are the recommended investigations and management strategies for anemia in patients with chronic kidney disease?
"NG204_Babies, children and young people's experience of healthcare & Overview",NG204,"What are the key recommendations for improving the healthcare experience of babies, children, and young people in NHS services?"
NG204_Introduction from the young people involved in the development of this guideline,NG204,"How can healthcare professionals improve the experience of babies, children, and young people during medical consultations?"
NG204_Context,NG204,What strategies can improve the healthcare experience and communication for children and young people in NHS services?
NG204_Recommendations: 1.1 Overarching principles - Part 1,NG204,What are the legal and ethical considerations for involving children and young people in healthcare decision making?
NG204_Recommendations: 1.1 Overarching principles - Part 2,NG204,"How should healthcare providers ensure accessible communication and shared decision-making for children, young people, and their families who cannot access digital resources?"
NG204_Recommendations: 1.2 Communication and information - Part 1,NG204,What are best practices for communicating effectively with children and young people in healthcare settings?
NG204_Recommendations: 1.2 Communication and information - Part 2,NG204,How can healthcare professionals effectively communicate with children and young people with additional communication needs?
NG204_Recommendations: 1.2 Communication and information - Part 3,NG204,"What are effective communication strategies for assessing pain and providing information to babies, children, and young people in healthcare settings?"
NG204_Recommendations: 1.2 Communication and information - Part 4,NG204,How should healthcare professionals communicate health information to children and young people?
NG204_Recommendations: 1.2 Communication and information - Part 5,NG204,How should healthcare professionals communicate and provide information to children and young people about their care?
NG204_Recommendations: 1.3 Planning healthcare - Part 1,NG204,How can healthcare professionals effectively involve children and young people in shared decision making about their healthcare?
NG204_Recommendations: 1.3 Planning healthcare - Part 2,NG204,How should healthcare professionals involve parents and children in shared decision-making about healthcare risks and benefits?
NG204_Recommendations: 1.3 Planning healthcare - Part 3,NG204,How should healthcare professionals communicate risks and benefits to children and young people?
"NG204_Recommendations: 1.4 Consent, privacy and confidentiality - Part 1",NG204,How should healthcare professionals handle consent and confidentiality discussions with children and young people?
"NG204_Recommendations: 1.4 Consent, privacy and confidentiality - Part 2",NG204,How should healthcare professionals ensure privacy and confidentiality when discussing sensitive topics with children and young people?
NG204_Recommendations: 1.5 Advocacy and support - Part 1,NG204,How should healthcare professionals involve parents and young people in decision-making about children's healthcare?
NG204_Recommendations: 1.5 Advocacy and support - Part 2,NG204,How can healthcare staff support children and young people in expressing their preferences and needs during healthcare visits?
NG204_Recommendations: 1.5 Advocacy and support - Part 3,NG204,How can healthcare providers support self-advocacy in children and young people?
NG204_Recommendations: 1.5 Advocacy and support - Part 4,NG204,What are the recommended digital health tools and advocacy support options for children and young people in healthcare?
NG204_Recommendations: 1.5 Advocacy and support - Part 5,NG204,What are the NICE recommendations for providing independent advocacy to children and young people in healthcare?
NG204_Recommendations: 1.6 Improving healthcare experience - Part 1,NG204,What strategies can be used to reduce pain-related anxiety in children during healthcare procedures?
NG204_Recommendations: 1.6 Improving healthcare experience - Part 2,NG204,What are the recommended practices for assessing and managing pain in children with cerebral palsy or sickle cell disease?
NG204_Recommendations: 1.7 Involvement in improving healthcare experience - Part 1,NG204,"How should healthcare services be designed to involve children, young people, and their families effectively?"
NG204_Recommendations: 1.7 Involvement in improving healthcare experience - Part 2,NG204,"How can healthcare providers effectively collect and use feedback from children, young people, and their families to improve healthcare experiences?"
NG204_Recommendations: 1.8 Healthcare environment,NG204,"What are the recommended standards for creating a child-friendly healthcare environment that supports privacy, safety, and family involvement?"
NG204_Recommendations: 1.9 Maintaining usual activities - Part 1,NG204,How can healthcare providers support children and young people in maintaining their usual activities during treatment?
NG204_Recommendations: 1.9 Maintaining usual activities - Part 2,NG204,How can healthcare providers support children and young people in maintaining their usual activities and support networks during treatment?
"NG204_Recommendations: 1.10 Accessibility, continuity and coordination - Part 1",NG204,What information should be provided to children and young people to help them access healthcare services?
"NG204_Recommendations: 1.10 Accessibility, continuity and coordination - Part 2",NG204,What strategies can improve access and continuity of healthcare for children and young people?
"NG204_Recommendations: 1.10 Accessibility, continuity and coordination - Part 3",NG204,How can healthcare providers improve communication and information sharing for children and young people across different services?
NG204_Recommendations: Terms used in this guideline - Part 1,NG204,What does it mean for a child to be Gillick competent in healthcare decision-making?
NG204_Recommendations: Terms used in this guideline - Part 2,NG204,What are the best practices for involving parents and carers in children's healthcare decisions?
NG204_Recommendations for research,NG204,What are effective methods for measuring and improving the healthcare experience of children and young people?
NG204_Rationale and impact: Overarching principles,NG204,What are the principles for safeguarding and making reasonable adjustments in children's healthcare?
NG204_Rationale and impact: Communication by healthcare staff,NG204,What are effective communication strategies for healthcare staff when working with children and young people with additional communication needs?
NG204_Rationale and impact: Providing information,NG204,"What are the best ways for healthcare professionals to provide age-appropriate and understandable information to children, young people, and their families?"
NG204_Rationale and impact: Shared decision making,NG204,How should healthcare professionals involve children and young people in shared decision making?
NG204_Rationale and impact: Risks and benefits,NG204,How should healthcare professionals discuss risks and benefits with children and young people during clinical decisions?
"NG204_Rationale and impact: Consent, privacy and confidentiality",NG204,"What are the NICE guidelines on consent, privacy, and confidentiality for children and young people in healthcare?"
NG204_Rationale and impact: Involvement of parents or carers,NG204,How should healthcare professionals involve parents or carers in supporting children and young people during consultations?
NG204_Rationale and impact: Support from healthcare staff,NG204,How can healthcare professionals effectively support children and young people's preferences and build trust?
NG204_Rationale and impact: Self-advocacy,NG204,What strategies can healthcare professionals use to support self-advocacy in children and young people?
NG204_Rationale and impact: Independent advocates,NG204,What are the NICE recommendations for providing independent advocacy to children and young people in healthcare settings?
NG204_Rationale and impact: Improving healthcare experience,NG204,What strategies can improve the healthcare experience for children and young people?
NG204_Rationale and impact: Design of healthcare services,NG204,How can healthcare services effectively involve children and young people in service design?
NG204_Rationale and impact: Measuring experience,NG204,What are the recommended methods for measuring children and young people's experience of healthcare services?
NG204_Rationale and impact: Healthcare environment,NG204,What are the recommended features of a child-friendly healthcare environment according to NICE guidelines?
NG204_Rationale and impact: Maintaining usual activities,NG204,What strategies can help children and young people maintain their usual activities during illness or treatment?
NG204_Rationale and impact: Accessing healthcare,NG204,What strategies can improve access to healthcare for children and young people facing practical and psychological barriers?
NG204_Rationale and impact: Continuity and coordination of care,NG204,What are the best practices for ensuring continuity and coordination of care for children and young people?
NG205_Looked-after children and young people & Overview,NG205,What are the best practices for supporting the well-being of looked-after children and young people?
NG205_Context - Part 1,NG205,What are the recommended strategies for supporting the mental health of looked-after children and young people?
NG205_Context - Part 2,NG205,What are the educational and care support strategies for looked-after children to improve outcomes?
NG205_Context - Part 3,NG205,What support is recommended for care leavers transitioning to independent living and adulthood?
NG205_Context - Part 4,NG205,What are the legal requirements for supporting the health and education needs of looked-after children?
NG205_Context - Part 5,NG205,What are the recommended interventions to improve outcomes for looked-after children and young people according to NICE guidelines?
NG205_Recommendations: 1.1 Diversity,NG205,"What strategies can be used to address additional disadvantages faced by looked-after children from minority ethnic, refugee, disabled, or LGBTQ+ groups?"
NG205_Recommendations: 1.2 Supporting positive relationships - Part 1,NG205,What strategies promote positive relationships between looked-after children and their carers or siblings?
NG205_Recommendations: 1.2 Supporting positive relationships - Part 2,NG205,What are best practices for supervising contact between looked-after children and their birth families?
NG205_Recommendations: 1.2 Supporting positive relationships - Part 3,NG205,What strategies can improve placement stability and support for looked-after children and young people?
NG205_Recommendations: 1.2 Supporting positive relationships - Part 4,NG205,What strategies can help identify children and young people likely to present out-of-hours support needs?
NG205_Recommendations: 1.2 Supporting positive relationships - Part 5,NG205,What strategies support care placement stability and positive relationships for looked-after children and young people?
NG205_Recommendations: 1.3 Valuing carers - Part 1,NG205,What are the recommended ways to support and involve carers in the care of looked-after children?
NG205_Recommendations: 1.3 Valuing carers - Part 2,NG205,What training should be provided to carers of looked-after children according to NICE guidelines?
NG205_Recommendations: 1.3 Valuing carers - Part 3,NG205,What training and support are recommended for carers and professionals working with looked-after children to promote wellbeing and meet individual needs?
NG205_Recommendations: 1.3 Valuing carers - Part 4,NG205,What training is recommended for trauma-informed care and attachment understanding for carers?
NG205_Recommendations: 1.4 Safeguarding - Part 1,NG205,What are the recommended practices for safeguarding looked-after children and young people?
NG205_Recommendations: 1.4 Safeguarding - Part 2,NG205,What training and review strategies are recommended to help practitioners recognize critical moments and early signs of risk in looked-after children?
NG205_Recommendations: 1.5 Health and wellbeing - Part 1,NG205,What training and awareness programs are recommended for practitioners working with looked-after children to address trauma and attachment issues?
NG205_Recommendations: 1.5 Health and wellbeing - Part 2,NG205,What are the recommended procedures for conducting health assessments for looked-after children and young people?
NG205_Recommendations: 1.5 Health and wellbeing - Part 3,NG205,What are the recommended health assessment procedures for unaccompanied asylum-seeking children?
NG205_Recommendations: 1.5 Health and wellbeing - Part 4,NG205,What mental health support and referral options are available for looked-after children and young people?
NG205_Recommendations: 1.5 Health and wellbeing - Part 5,NG205,What are the recommended practices for implementing life story work for looked-after children and young people?
NG205_Recommendations: 1.5 Health and wellbeing - Part 6,NG205,How should life story work be conducted to support the identity and wellbeing of looked-after children and young people?
NG205_Recommendations: 1.5 Health and wellbeing - Part 7,NG205,"How can primary carers support the social, emotional, and mental wellbeing of looked-after children through relationship building and activities?"
NG205_Recommendations: 1.6 Learning and education - Part 1,NG205,What strategies support the transition to school for looked-after children and young people?
NG205_Recommendations: 1.6 Learning and education - Part 2,NG205,What are the responsibilities of teachers and virtual schools in supporting the educational and health needs of looked-after children?
NG205_Recommendations: 1.6 Learning and education - Part 3,NG205,What strategies can virtual schools use to support the educational and health needs of looked-after children?
NG205_Recommendations: 1.6 Learning and education - Part 4,NG205,What strategies are recommended for supporting language development and educational inclusion of unaccompanied asylum-seeking children?
NG205_Recommendations: 1.6 Learning and education - Part 5,NG205,How can virtual schools support looked-after young people in accessing higher education and training?
NG205_Recommendations: 1.7 Transition between care placements and to permanent placements - Part 1,NG205,What are best practices for supporting transition between care placements and promoting reunification for looked-after children?
NG205_Recommendations: 1.7 Transition between care placements and to permanent placements - Part 2,NG205,What are best practices for supporting children during transition to permanent placements?
NG205_Recommendations: 1.7 Transition between care placements and to permanent placements - Part 3,NG205,What are best practices for supporting social connections and providing comprehensive background information during placement transitions for looked-after children?
NG205_Recommendations: 1.7 Transition between care placements and to permanent placements - Part 4,NG205,"What are best practices for ensuring continuity of care, education, and support for children and young people transitioning between care placements?"
NG205_Recommendations: 1.7 Transition between care placements and to permanent placements - Part 5,NG205,What are best practices for supporting looked-after children during transition to new carers?
NG205_Recommendations: 1.8 Transition out of care to independence - Part 1,NG205,What are the recommended support services for young people transitioning out of care to independence?
NG205_Recommendations: 1.8 Transition out of care to independence - Part 2,NG205,What support and services are recommended for care leavers to promote independence and well-being?
NG205_Recommendations: 1.8 Transition out of care to independence - Part 3,NG205,What support is recommended for care leavers in higher education to ensure smooth transition and social inclusion?
NG205_Recommendations: 1.8 Transition out of care to independence - Part 4,NG205,What are effective ways to gather and incorporate feedback from looked-after young people to improve care services?
NG205_Recommendations: 1.9 Forum for strategic leadership and best practice,NG205,How can forums improve leadership and best practice in the care of looked-after children and young people?
NG205_Recommendations: Terms used in this guideline - Part 1,NG205,What is the purpose of the Ages and Stages Questionnaire in child development assessment?
NG205_Recommendations: Terms used in this guideline - Part 2,NG205,What are the requirements and procedures for initial health assessments for looked-after children?
NG205_Recommendations: Terms used in this guideline - Part 3,NG205,What are the key components of family therapy and permanency planning for children in care?
NG205_Recommendations: Terms used in this guideline - Part 4,NG205,What is the role of shared decision making in care planning for looked-after children?
NG205_Recommendations for research: Key recommendations for research - Part 1,NG205,What interventions are effective in supporting the mental health of unaccompanied asylum-seeking children?
NG205_Recommendations for research: Key recommendations for research - Part 2,NG205,How does social media use affect contact arrangements for looked-after children and what safeguarding measures are recommended?
NG205_Recommendations for research: Other recommendations for research,NG205,What are effective strategies to support the physical and mental health of care leavers?
NG205_Rationale and impact: Diversity,NG205,What strategies can be used to ensure that looked-after children with protected characteristics are not marginalized?
NG205_Rationale and impact: Supporting positive relationships - Part 1,NG205,How can positive relationships between looked-after children and their carers be supported effectively?
NG205_Rationale and impact: Supporting positive relationships - Part 2,NG205,What are the recommended strategies for promoting positive sibling relationships and contact arrangements in looked-after children?
NG205_Rationale and impact: Supporting positive relationships - Part 3,NG205,What are best practices for safeguarding and supporting social media contact for unaccompanied asylum-seeking children?
NG205_Rationale and impact: Supporting positive relationships - Part 4,NG205,What strategies can help reduce social worker burnout and improve continuity of care for looked-after children?
NG205_Rationale and impact: Supporting positive relationships - Part 5,NG205,What strategies can improve communication about professional transitions to primary carers in social care?
NG205_Rationale and impact: Supporting positive relationships - Part 6,NG205,What are effective interventions to support placement stability and manage behavioural challenges in looked-after children and young people?
NG205_Rationale and impact: Supporting positive relationships - Part 7,NG205,What are the recommended interventions and practice changes for supporting attachment and trauma in looked-after children and young people?
NG205_Rationale and impact: Supporting positive relationships - Part 8,NG205,What are effective and cost-efficient ways to support sibling relationships and contact for children in care?
NG205_Rationale and impact: Supporting and involving carers - Part 1,NG205,What are the recommended ways to support and involve carers of children and young people in care?
NG205_Rationale and impact: Supporting and involving carers - Part 2,NG205,What are the best practices for providing effective respite care to prevent placement breakdown in looked-after children?
NG205_Rationale and impact: Supporting and involving carers - Part 3,NG205,What are cost-effective alternatives to on-call social workers for out-of-hours support in child social care?
NG205_Rationale and impact: Training for carers - Part 1,NG205,What training should be provided to foster carers to improve behaviour management and educational advocacy?
NG205_Rationale and impact: Training for carers - Part 2,NG205,What training is recommended for carers of looked-after children with special educational needs or trauma?
NG205_Rationale and impact: Training for carers - Part 3,NG205,What training is recommended for foster carers to support trauma-informed and culturally sensitive care?
NG205_Rationale and impact: Safeguarding - Part 1,NG205,What are the best practices for multiagency safeguarding of looked-after children at risk of exploitation or going missing?
NG205_Rationale and impact: Safeguarding - Part 2,NG205,What are effective strategies for safeguarding looked-after children from exploitation and going missing?
NG205_Rationale and impact: Safeguarding - Part 3,NG205,What are the recommended approaches for providing tailored safeguarding support to vulnerable looked-after young people at risk of exploitation?
NG205_Rationale and impact: Building expertise about trauma and raising awareness,NG205,What training is recommended for practitioners working with traumatized looked-after children and unaccompanied asylum-seeking minors?
NG205_Rationale and impact: Physical and mental health and wellbeing assessments - Part 1,NG205,What are the recommended procedures for health and wellbeing assessments for looked-after children and young people?
NG205_Rationale and impact: Physical and mental health and wellbeing assessments - Part 2,NG205,What are the key components of an initial health assessment for looked-after children and young people?
NG205_Rationale and impact: Physical and mental health and wellbeing assessments - Part 3,NG205,What are the recommended procedures for mental health assessment and follow-up in looked-after children?
NG205_Rationale and impact: Mental health and child and adolescent mental health services - Part 1,NG205,What are the recommended approaches for providing timely mental health support to looked-after children and young people?
NG205_Rationale and impact: Mental health and child and adolescent mental health services - Part 2,NG205,What are effective mental health support strategies for unaccompanied asylum-seeking children?
NG205_Rationale and impact: Life story work for identity and wellbeing - Part 1,NG205,What are the best practices for implementing life story work to support identity and wellbeing in looked-after children?
NG205_Rationale and impact: Life story work for identity and wellbeing - Part 2,NG205,How can social worker oversight improve the quality of life story work for looked-after children?
NG205_Rationale and impact: Relationships and wellbeing activities - Part 1,NG205,What is the role of physical affection in promoting emotional wellbeing for looked-after children?
NG205_Rationale and impact: Relationships and wellbeing activities - Part 2,NG205,How can activities and peer support improve emotional well-being and lifestyle in looked-after children and young people?
NG205_Rationale and impact: Readiness for starting or changing school,NG205,What are effective strategies for supporting looked-after children during school transitions?
NG205_Rationale and impact: Support in schools - Part 1,NG205,What support and advocacy are recommended for looked-after children in schools to improve their educational outcomes?
NG205_Rationale and impact: Support in schools - Part 2,NG205,What are the key principles for designated teachers to effectively advocate for looked-after children in schools?
NG205_Rationale and impact: Virtual schools - Part 1,NG205,What are the recommended features and staffing requirements for virtual schools supporting looked-after children?
NG205_Rationale and impact: Virtual schools - Part 2,NG205,How should virtual school heads be empowered to improve multiagency collaboration for looked-after children?
NG205_Rationale and impact: Improving educational outcomes - Part 1,NG205,What are effective interventions to improve educational outcomes for looked-after children?
NG205_Rationale and impact: Improving educational outcomes - Part 2,NG205,"What are effective therapeutic interventions to improve educational, social, and emotional outcomes for unaccompanied asylum-seeking children in schools?"
"NG205_Rationale and impact: Data collection, sharing and publication in education",NG205,What are the recommended practices for collecting and publishing data on education for looked-after children?
NG205_Rationale and impact: Further and higher education - Part 1,NG205,What interventions support looked-after young people in accessing and succeeding in higher education?
NG205_Rationale and impact: Further and higher education - Part 2,NG205,What support is recommended for looked-after young people to access higher education and training?
NG205_Rationale and impact: Before transition between care placements and to permanent placements - Part 1,NG205,What are best practices for transition planning between care placements to ensure stable and supportive permanency for looked-after children?
NG205_Rationale and impact: Before transition between care placements and to permanent placements - Part 2,NG205,What are effective interventions to support reunification for families involved in substance misuse?
NG205_Rationale and impact: During transition between care placements and to permanent placements - Part 1,NG205,What are the best practices for supporting transition between care placements and to permanent placements for looked-after children?
NG205_Rationale and impact: During transition between care placements and to permanent placements - Part 2,NG205,What information should be provided to new carers of looked-after children to support safeguarding and placement success?
NG205_Rationale and impact: During transition between care placements and to permanent placements - Part 3,NG205,What are best practices for ensuring continuity of education and healthcare during the transition of looked-after children to new placements?
NG205_Rationale and impact: After transition between care placements and to permanent placements - Part 1,NG205,What are best practices for supporting children and carers during transitions between care placements and permanent placements?
NG205_Rationale and impact: After transition between care placements and to permanent placements - Part 2,NG205,How can peer support groups improve the stability and long-term outcomes of permanent placements for children and young people in care?
NG205_Rationale and impact: Transition out of care to independence - Part 1,NG205,What are the recommended practices for supporting care leavers' transition to independence?
NG205_Rationale and impact: Transition out of care to independence - Part 2,NG205,What are the recommended independent living services and support strategies for care leavers transitioning to adulthood?
NG205_Rationale and impact: Transition out of care to independence - Part 3,NG205,What support services are recommended for care leavers to improve housing stability and independence?
NG205_Rationale and impact: Transition out of care to independence - Part 4,NG205,What are the recommended quality assessment procedures for pathway plans for care leavers?
NG205_Rationale and impact: Support for care leavers in further and higher education,NG205,What support is recommended for care leavers in higher and further education?
NG205_Rationale and impact: Feedback to improve services,NG205,How can services effectively incorporate feedback from looked-after children and care leavers to improve care?
NG205_Rationale and impact: Forum for strategic leadership and best practice,NG205,What are the benefits of establishing multiagency forums for improving care coordination for looked-after children?
NG206_Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management & Overview,NG206,What are the recommended diagnostic criteria and management strategies for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)?
NG206_Recommendations: Box 1 Severity of ME/CFS,NG206,What are the different levels of severity in ME/CFS and their implications for care?
NG206_Recommendations: 1.1 Principles of care for people with ME/CFS - Part 1,NG206,What are the principles of care for people with ME/CFS?
NG206_Recommendations: 1.1 Principles of care for people with ME/CFS - Part 2,NG206,How should healthcare professionals involve children and young people with ME/CFS in their care decisions?
NG206_Recommendations: 1.2 Suspecting ME/CFS - Part 1,NG206,What are the clinical criteria and recommended assessments for suspecting and diagnosing ME/CFS?
NG206_Recommendations: 1.2 Suspecting ME/CFS - Part 2,NG206,What are the common symptoms associated with ME/CFS that should prompt clinical suspicion?
NG206_Recommendations: 1.3 Advice for people with suspected ME/CFS,NG206,What advice should be given to people with suspected ME/CFS regarding activity management and symptom management?
NG206_Recommendations: 1.4 Diagnosis,NG206,"What are the diagnostic criteria and referral process for ME/CFS in children, young people, and adults?"
NG206_Recommendations: 1.5 Assessment and care and support planning by an ME/CFS specialist team - Part 1,NG206,What are the recommended assessments and care planning approaches for people with ME/CFS?
NG206_Recommendations: 1.5 Assessment and care and support planning by an ME/CFS specialist team - Part 2,NG206,What are the recommended strategies for managing flare-ups and relapses in ME/CFS?
NG206_Recommendations: 1.6 Information and support - Part 1,NG206,What information and support should be provided to people with ME/CFS and their families?
NG206_Recommendations: 1.6 Information and support - Part 2,NG206,What self-management strategies are recommended for managing flare-ups and relapses in ME/CFS?
NG206_Recommendations: 1.6 Information and support - Part 3,NG206,What support and assessment rights are available for families and carers of children with ME/CFS?
NG206_Recommendations: 1.7 Safeguarding - Part 1,NG206,How should healthcare professionals approach safeguarding assessments for patients with ME/CFS?
NG206_Recommendations: 1.7 Safeguarding - Part 2,NG206,How should healthcare professionals monitor and review care plans for children and young people with ME/CFS?
NG206_Recommendations: 1.8 Access to care and support - Part 1,NG206,How can healthcare providers improve access and support for people with ME/CFS in community and hospital settings?
NG206_Recommendations: 1.8 Access to care and support - Part 2,NG206,How can families and carers access training and resources for caring for someone with ME/CFS?
"NG206_Recommendations: 1.9 Supporting people with ME/CFS in work, education and training - Part 1",NG206,What support and adjustments are recommended for people with ME/CFS in the workplace and educational settings?
"NG206_Recommendations: 1.9 Supporting people with ME/CFS in work, education and training - Part 2",NG206,"What information should be provided to parents and carers about education, health, and care plans for children with ME/CFS?"
NG206_Recommendations: 1.10 Multidisciplinary care - Part 1,NG206,How should multidisciplinary care be coordinated for people with ME/CFS?
NG206_Recommendations: 1.10 Multidisciplinary care - Part 2,NG206,How should the transition from children's to adults' services be managed for young adults with ME/CFS?
NG206_Recommendations: 1.11 Managing ME/CFS - Part 1,NG206,What are the recommended approaches for managing symptoms of ME/CFS?
NG206_Recommendations: 1.11 Managing ME/CFS - Part 2,NG206,What are the recommended strategies for energy management and activity pacing in people with ME/CFS?
NG206_Recommendations: 1.11 Managing ME/CFS - Part 3,NG206,What are the recommended approaches for incorporating physical activity and exercise into the management of ME/CFS?
NG206_Recommendations: 1.11 Managing ME/CFS - Part 4,NG206,What are the recommended approaches for physical activity and exercise in managing ME/CFS?
NG206_Recommendations: 1.11 Managing ME/CFS - Part 5,NG206,How should physical activity be adjusted during flare-ups in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 1,NG206,What are the recommended strategies for managing sleep and rest in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 2,NG206,What strategies can help maintain and prevent deterioration of mobility in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 3,NG206,What are the recommended treatments for orthostatic intolerance in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 4,NG206,What are the recommended approaches for medication management and dietary strategies in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 5,NG206,What is the NICE guidance on vitamin D supplementation and management for people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 6,NG206,How is cognitive behavioural therapy used to support symptom management in people with ME/CFS?
NG206_Recommendations: 1.12 Symptom management for people with ME/CFS - Part 7,NG206,What does cognitive behavioural therapy (CBT) involve for managing ME/CFS?
NG206_Recommendations: 1.13 Managing coexisting conditions,NG206,How should coexisting conditions such as thyroid disease or irritable bowel syndrome be managed in patients with ME/CFS?
NG206_Recommendations: 1.14 Managing flare-ups in symptoms and relapse - Part 1,NG206,How should flare-ups and relapses be managed in people with ME/CFS?
NG206_Recommendations: 1.14 Managing flare-ups in symptoms and relapse - Part 2,NG206,How should care plans be reviewed and adjusted after a relapse in ME/CFS?
NG206_Recommendations: 1.15 Review in primary care - Part 1,NG206,What are the recommended review intervals and key discussion points for managing adults and children with ME/CFS in primary care?
NG206_Recommendations: 1.15 Review in primary care - Part 2,NG206,What are the recommended procedures for reviewing and monitoring patients with ME/CFS?
NG206_Recommendations: 1.16 Training for health and social care professionals,NG206,What training should health and social care professionals receive to effectively support people with ME/CFS?
NG206_Recommendations: 1.17 Care for people with severe or very severe ME/CFS - Part 1,NG206,What are the recommended care considerations for people with severe or very severe ME/CFS?
NG206_Recommendations: 1.17 Care for people with severe or very severe ME/CFS - Part 2,NG206,What are the recommended approaches for providing personal care and hospital support to people with severe or very severe ME/CFS?
NG206_Recommendations: 1.17 Care for people with severe or very severe ME/CFS - Part 3,NG206,What are the recommended approaches for energy and symptom management in severe or very severe ME/CFS?
NG206_Recommendations: 1.17 Care for people with severe or very severe ME/CFS - Part 4,NG206,What are the recommended non-pharmacological management strategies for ME/CFS?
NG206_Recommendations: Terms used in this guideline - Part 1,NG206,What is energy management and how can it help people with ME/CFS?
NG206_Recommendations: Terms used in this guideline - Part 2,NG206,What are the symptoms and management strategies for flare-ups and orthostatic intolerance in ME/CFS?
NG206_Recommendations: Terms used in this guideline - Part 3,NG206,What are safe physical activity guidelines for people with ME/CFS to avoid post-exertional malaise?
NG206_Recommendations for research: Key recommendations for research,NG206,What are the recommended diagnostic tests and criteria for diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)?
NG206_Recommendations for research: Other recommendations for research,NG206,"What is the effectiveness of self-monitoring, sleep, and dietary management strategies for ME/CFS?"
NG206_Rationale and impact: Principles of care for people with ME/CFS,NG206,What are the principles of care for people with ME/CFS to improve understanding and trust in healthcare?
NG206_Rationale and impact: Suspecting ME/CFS - Part 1,NG206,What are the key symptoms and diagnostic criteria for suspecting ME/CFS in adults and children?
NG206_Rationale and impact: Suspecting ME/CFS - Part 2,NG206,What are the recommended diagnostic tests and assessment procedures for suspected ME/CFS?
NG206_Rationale and impact: Advice for people with suspected ME/CFS,NG206,What advice should be given to people with suspected ME/CFS for early symptom management?
NG206_Rationale and impact: Diagnosis,NG206,How can early diagnosis of ME/CFS be achieved within 3 months of symptom onset?
NG206_Rationale and impact: Assessment and care and support planning by an ME/CFS specialist team,NG206,What are the recommended approaches for assessment and care planning in ME/CFS specialist teams?
NG206_Rationale and impact: Information and support,NG206,What information and support are recommended for people with ME/CFS and their families?
NG206_Rationale and impact: Safeguarding,NG206,What are the NICE guidelines for safeguarding children and young people with ME/CFS?
NG206_Rationale and impact: Access to care and support,NG206,How can healthcare services improve access and support for people with ME/CFS?
"NG206_Rationale and impact: Supporting people with ME/CFS in work, education and training",NG206,What support and educational adjustments are recommended for children and young people with ME/CFS in school settings?
NG206_Rationale and impact: Multidisciplinary care,NG206,What is the recommended multidisciplinary team approach for managing ME/CFS?
NG206_Rationale and impact: Managing ME/CFS,NG206,What are the recommended management strategies for ME/CFS according to NICE guidelines?
NG206_Rationale and impact: Energy management,NG206,What are the recommended strategies for energy management in people with ME/CFS?
NG206_Rationale and impact: Incorporating physical activity and exercise,NG206,What are the recommended guidelines for physical activity and exercise in people with ME/CFS?
NG206_Rationale and impact: Rest and sleep,NG206,What are the recommended sleep management strategies for people with ME/CFS?
NG206_Rationale and impact: Physical functioning and mobility,NG206,What are the recommended assessments and support strategies for maintaining mobility in people with ME/CFS?
NG206_Rationale and impact: Orthostatic intolerance,NG206,What are the signs and when should patients with orthostatic intolerance be referred to secondary care in ME/CFS?
NG206_Rationale and impact: Pain,NG206,What are the recommended approaches for managing pain in people with ME/CFS?
NG206_Rationale and impact: Medicines,NG206,What are the recommended approaches to using medicines for symptom management in ME/CFS?
NG206_Rationale and impact: Dietary management and strategies,NG206,What dietary strategies are recommended for managing symptoms in people with ME/CFS?
NG206_Rationale and impact: Lightning Process,NG206,What are the risks and concerns associated with using the Lightning Process for ME/CFS?
NG206_Rationale and impact: Cognitive behavioural therapy & Rationale and impact: Managing coexisting conditions,NG206,What is the role of cognitive behavioural therapy in managing ME/CFS symptoms?
NG206_Rationale and impact: Managing flare-ups in symptoms and relapse,NG206,How can I recognize and manage flare-ups and relapses in ME/CFS symptoms?
NG206_Rationale and impact: Review in primary care,NG206,What is the recommended frequency for primary care review of adults and children with ME/CFS?
NG206_Rationale and impact: Training for health and social care professionals,NG206,What training is recommended for health and social care professionals to improve care for people with ME/CFS?
NG206_Rationale and impact: Care for people with severe or very severe ME/CFS - Part 1,NG206,What are the recommended care and support strategies for people with severe or very severe ME/CFS?
NG206_Rationale and impact: Care for people with severe or very severe ME/CFS - Part 2,NG206,What are the recommended energy management strategies for people with severe or very severe ME/CFS?
NG206_Context - Part 1,NG206,What are the clinical features and impact of ME/CFS on patients' quality of life?
NG206_Context - Part 2,NG206,What are the current recommendations for diagnosing and managing ME/CFS according to NICE guidelines?
NG207_Inducing labour & Overview,NG207,What are the indications and methods for inducing labour according to NICE guidelines?
NG207_Recommendations: 1.1 Information and decision making - Part 1,NG207,What should women know about the risks and considerations of induction of labour?
NG207_Recommendations: 1.1 Information and decision making - Part 2,NG207,What information should be provided to women about induction of labour and their options?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 1,NG207,What are the risks of continuing pregnancy beyond 41 weeks?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 2,NG207,What are the options and considerations for women choosing expectant management versus induction of labour after 41 weeks?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 3,NG207,What are the recommended management options for preterm prelabour rupture of membranes before 34 weeks?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 4,NG207,What are the recommended management options for women with prelabour rupture of membranes at term?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 5,NG207,What are the recommendations for induction of labour in women with breech presentation or fetal growth restriction according to NICE guidelines?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 6,NG207,What are the recommended management options for intrauterine fetal death?
NG207_Recommendations: 1.2 Induction of labour in specific circumstances - Part 7,NG207,What are the recommended methods for inducing labour after intrauterine fetal death in women with a previous caesarean section?
NG207_Recommendations: 1.3 Methods for induction of labour - Part 1,NG207,What are the methods for induction of labour and their associated risks?
NG207_Recommendations: 1.3 Methods for induction of labour - Part 2,NG207,What are the recommended methods for inducing labour in women with a Bishop score of 6 or less?
NG207_Recommendations: 1.4 Methods that are not recommended for induction of labour,NG207,What methods are not recommended for induction of labour according to NICE guidelines?
"NG207_Recommendations: 1.5 Assessment before induction, monitoring and pain relief - Part 1",NG207,What are the recommended assessments and monitoring procedures before and during induction of labour?
"NG207_Recommendations: 1.5 Assessment before induction, monitoring and pain relief - Part 2",NG207,What are the recommended pain relief options during induction of labour according to NICE guidelines?
NG207_Recommendations: 1.6 Outpatient induction,NG207,What are the safety and monitoring requirements for outpatient induction of labour with dinoprostone?
NG207_Recommendations: 1.7 Prevention and management of complications - Part 1,NG207,What are the recommended management strategies for uterine hyperstimulation during labour induction?
NG207_Recommendations: 1.7 Prevention and management of complications - Part 2,NG207,What are the recommended procedures for fetal assessment and monitoring during labour induction?
NG207_Recommendations: Terms used in this guideline - Part 1,NG207,What is the significance of the Bishop score in assessing cervical readiness for labour induction?
NG207_Recommendations: Terms used in this guideline - Part 2,NG207,What are the management options for expectant management during pregnancy?
NG207_Recommendations for research: 1 Prevention of prolonged pregnancy & Recommendations for research: 2 Prevention of prolonged pregnancy & Recommendations for research: 3 Preterm prelabour rupture of membranes,NG207,When should induction of labour be offered for prolonged pregnancy?
NG207_Recommendations for research: 4 Intrauterine fetal death after previous caesarean birth & Recommendations for research: 5 Membrane sweeping,NG207,How should labour be induced in women with intrauterine fetal death and previous caesarean who choose induction?
NG207_Recommendations for research: 6 Vaginal dinoprostone & Recommendations for research: 7 Setting for induction of labour,NG207,What is the effectiveness and safety of different vaginal dinoprostone regimens for labour induction based on clinical indications and patient history?
NG207_Rationale and impact: Induction of labour for pregnancy lasting longer than 41 weeks,NG207,What are the recommended timings and considerations for inducing labour in pregnancies lasting longer than 41 weeks?
NG207_Rationale and impact: Induction of labour for prelabour rupture of the membranes,NG207,What are the guidelines for inducing labour after prelabour rupture of membranes at term or preterm?
NG207_Rationale and impact: Induction of labour for suspected fetal macrosomia,NG207,What are the benefits and risks of inducing labour for suspected fetal macrosomia in women without diabetes?
NG207_Rationale and impact: Induction of labour for intrauterine fetal death after previous caesarean birth,NG207,What are the recommended methods for inducing labour after intrauterine fetal death in women with a previous caesarean section?
NG207_Rationale and impact: Methods for induction of labour - Part 1,NG207,What are the recommended pharmacological methods for induction of labour and their associated risks?
NG207_Rationale and impact: Methods for induction of labour - Part 2,NG207,What are the recommended mechanical methods for induction of labour and their safety profiles?
NG207_Context,NG207,What are the indications and methods for induction of labour according to NICE guidelines?
NG208_Heart valve disease presenting in adults: investigation and management & Overview,NG208,What are the recommended investigations and management strategies for adult heart valve disease?
NG208_Recommendations: 1.1 Referral for echocardiography and specialist assessment - Part 1,NG208,What are the indications for referral for echocardiography in adults with heart murmurs?
NG208_Recommendations: 1.1 Referral for echocardiography and specialist assessment - Part 2,NG208,What are the NICE guidelines for referral and assessment of adults with murmur and syncope?
NG208_Recommendations: 1.1 Referral for echocardiography and specialist assessment - Part 3,NG208,What precautions should be taken for women with valve disease during pregnancy?
NG208_Recommendations: 1.2 Pharmacological management,NG208,What is the recommended pharmacological management for heart failure in patients with valve disease?
NG208_Recommendations: 1.3 Indications for interventions - Part 1,NG208,What are the indications for intervention in adults with severe aortic stenosis?
NG208_Recommendations: 1.3 Indications for interventions - Part 2,NG208,What are the criteria for intervention in adults with severe aortic regurgitation based on echocardiographic findings?
NG208_Recommendations: 1.3 Indications for interventions - Part 3,NG208,When should adults with asymptomatic severe primary mitral regurgitation be referred for intervention?
NG208_Recommendations: 1.4 Monitoring when there is no current need for intervention,NG208,How often should adults with asymptomatic severe valve disease be monitored with echocardiography?
NG208_Recommendations: 1.5 Interventions - Part 1,NG208,What factors should be considered when discussing valve intervention options with adults?
NG208_Recommendations: 1.5 Interventions - Part 2,NG208,What are the recommended surgical and transcatheter treatment options for severe aortic stenosis and mitral stenosis?
NG208_Recommendations: 1.5 Interventions - Part 3,NG208,What are the recommended surgical options for treating severe primary mitral regurgitation in adults?
NG208_Recommendations: 1.5 Interventions - Part 4,NG208,When should surgical repair or replacement be considered for secondary mitral regurgitation during other cardiac surgeries?
NG208_Recommendations: 1.6 Repeat intervention,NG208,When should transcatheter or surgical reintervention be considered for adults with failed biological aortic valve prostheses?
NG208_Recommendations: 1.7 Anticoagulation and antiplatelet therapy,NG208,When should anticoagulation or antiplatelet therapy be used after biological valve replacement?
NG208_Recommendations: 1.8 Monitoring after an intervention,NG208,What are the recommended monitoring strategies after valve repair or replacement for adults?
NG208_Recommendations: 1.9 Information and advice,NG208,What information and support should be provided to adults with valve disease regarding prognosis and treatment options?
NG208_Recommendations: Terms used in this guideline,NG208,What criteria determine suitability for transcatheter aortic valve implantation and edge-to-edge repair?
NG208_Recommendations for research: Key recommendations for research - Part 1,NG208,What is the most effective monitoring approach for adults with asymptomatic mild or moderate heart valve disease?
NG208_Recommendations for research: Key recommendations for research - Part 2,NG208,What is the most effective timing and approach for follow-up after heart valve intervention?
NG208_Recommendations for research: Other recommendations for research - Part 1,NG208,What is the prognostic value of stress testing and advanced imaging techniques in assessing the need for intervention in adults with valvular heart disease?
NG208_Recommendations for research: Other recommendations for research - Part 2,NG208,What are the most effective management and monitoring strategies for adults with severe heart valve disease?
NG208_Rationale and impact: Referral for echocardiography,NG208,When should I refer a patient with a heart murmur for echocardiography?
NG208_Rationale and impact: Referral for urgent specialist assessment or urgent echocardiography,NG208,When should urgent echocardiography or specialist assessment be performed for suspected severe valve disease?
NG208_Rationale and impact: Referral to a specialist after echocardiography,NG208,When should patients with mild or moderate valve disease be referred to a cardiologist after echocardiography?
"NG208_Rationale and impact: Information, referral and specialist assessment for pregnant women and women considering pregnancy",NG208,When should women with valve disease be referred to a cardiologist before pregnancy?
NG208_Rationale and impact: Pharmacological management to improve prognosis,NG208,What is the role of pharmacological management in improving prognosis for adults with heart valve disease?
NG208_Rationale and impact: Pharmacological management of heart failure in heart valve disease & Rationale and impact: Indications for interventions,NG208,What is the role of beta-blockers in managing heart failure in patients with mitral stenosis?
NG208_Rationale and impact: Indications for interventions for adults with aortic stenosis - Part 1,NG208,What are the indications for intervention in adults with asymptomatic severe aortic stenosis based on echocardiography and stress testing?
NG208_Rationale and impact: Indications for interventions for adults with aortic stenosis - Part 2,NG208,What are the indications for intervention in low-flow low-gradient aortic stenosis based on dobutamine stress testing and valve area?
NG208_Rationale and impact: Indications for intervention for adults with aortic regurgitation,NG208,When should intervention be considered for adults with severe aortic regurgitation based on echocardiographic findings?
NG208_Rationale and impact: Indications for intervention for adults with mitral regurgitation,NG208,What are the echocardiographic indicators for intervention in asymptomatic severe mitral regurgitation?
NG208_Rationale and impact: Monitoring when there is no current need for intervention,NG208,What is the recommended frequency of echocardiographic monitoring for asymptomatic severe aortic stenosis?
NG208_Rationale and impact: Decisions about interventions,NG208,How should shared decision making be incorporated into choosing between minimally invasive and standard valve replacement surgery?
NG208_Rationale and impact: Interventions for aortic valve disease - Part 1,NG208,What are the differences between transcatheter aortic valve implantation and surgery for treating aortic stenosis?
NG208_Rationale and impact: Interventions for aortic valve disease - Part 2,NG208,What are the benefits and risks of transcatheter aortic valve implantation (TAVI) for inoperable severe aortic stenosis?
NG208_Rationale and impact: Interventions for aortic valve disease - Part 3,NG208,What are the current recommendations for managing aortic valve disease with TAVI versus surgical replacement?
NG208_Rationale and impact: Interventions for mitral stenosis,NG208,What are the recommended interventions for severe rheumatic mitral stenosis in adults?
NG208_Rationale and impact: Interventions for mitral regurgitation - Part 1,NG208,What are the recommended surgical options for treating severe mitral regurgitation?
NG208_Rationale and impact: Interventions for mitral regurgitation - Part 2,NG208,What is the effectiveness of transcatheter mitral valve repair compared to medical management for primary mitral regurgitation when surgery is not suitable?
NG208_Rationale and impact: Interventions for mitral regurgitation - Part 3,NG208,What is the cost-effectiveness of transcatheter mitral valve repair with MitraClip for secondary mitral regurgitation?
NG208_Rationale and impact: Interventions for tricuspid regurgitation,NG208,What are the recommended interventions for severe tricuspid regurgitation in high-risk patients?
NG208_Rationale and impact: Repeat intervention,NG208,What are the indications for repeat surgical or transcatheter intervention in patients with failing biological prosthetic aortic valves?
NG208_Rationale and impact: Anticoagulation and antiplatelet therapy - Part 1,NG208,What are the recommendations for anticoagulation therapy after surgical biological valve replacement?
NG208_Rationale and impact: Anticoagulation and antiplatelet therapy - Part 2,NG208,What is the recommended antiplatelet therapy after transcatheter aortic valve implantation (TAVI)?
NG208_Rationale and impact: Monitoring after an intervention,NG208,What is the recommended follow-up schedule for patients with mechanical or biological heart valve replacements?
NG208_Rationale and impact: Information and advice,NG208,What information and support should be provided to patients with heart valve disease to improve understanding and reduce anxiety?
NG208_Context,NG208,What are the symptoms and management options for heart valve disease in older adults?
"NG209_Tobacco: preventing uptake, promoting quitting and treating dependence & Overview",NG209,What are the recommended strategies for preventing smoking uptake among children and young people?
"NG209_Preventing uptake: 1.1 Organising and planning national, regional or local mass-media campaigns",NG209,What are the recommended strategies for designing and implementing mass-media campaigns to prevent smoking among young people?
NG209_Preventing uptake: 1.2 Campaign strategies to prevent uptake and denormalise tobacco use,NG209,What strategies are recommended for local authorities to prevent tobacco uptake and denormalise tobacco use?
NG209_Preventing uptake: 1.3 Helping retailers avoid illegal tobacco sales & Preventing uptake: 1.4 Coordinated approach to school-based interventions,NG209,What are the recommended strategies for preventing illegal tobacco sales to minors?
NG209_Preventing uptake: 1.5 Whole-school or organisation-wide smokefree policies,NG209,What are the key components of a whole-school smokefree policy according to NICE guidelines?
NG209_Preventing uptake: 1.6 Adult-led interventions in schools - Part 1,NG209,What are the recommended strategies for teaching about the health effects of tobacco and e-cigarettes in schools?
NG209_Preventing uptake: 1.6 Adult-led interventions in schools - Part 2 & Preventing uptake: 1.7 Peer-led interventions in schools,NG209,What are effective strategies for implementing school-based smoking prevention interventions for children and young people?
NG209_Promoting quitting: 1.8 Using medicinally licensed nicotine-containing products - Part 1,NG209,What are the benefits of using medicinally licensed nicotine-containing products for smoking cessation?
NG209_Promoting quitting: 1.8 Using medicinally licensed nicotine-containing products - Part 2,NG209,What are the safety and effectiveness of medicinally licensed nicotine-containing products for smoking cessation?
NG209_Promoting quitting: 1.9 Promoting stop-smoking support - Part 1,NG209,What are effective strategies for promoting stop-smoking support through community and workplace campaigns?
NG209_Promoting quitting: 1.9 Promoting stop-smoking support - Part 2,NG209,What are the recommended employer responsibilities for supporting employees to stop smoking?
NG209_Promoting quitting: 1.10 Promoting support for people to stop using smokeless tobacco - Part 1,NG209,What are effective strategies for promoting smokeless tobacco cessation in South Asian communities?
NG209_Promoting quitting: 1.10 Promoting support for people to stop using smokeless tobacco - Part 2,NG209,How can culturally sensitive approaches be used to reduce smokeless tobacco use in South Asian communities?
NG209_Treating tobacco dependence: 1.11 Identifying and quantifying people's smoking - Part 1,NG209,What are the recommended methods for identifying and assessing smoking behavior in healthcare settings?
NG209_Treating tobacco dependence: 1.11 Identifying and quantifying people's smoking - Part 2,NG209,What are the recommended strategies for healthcare professionals to support smoking cessation among patients and their household members?
NG209_Treating tobacco dependence: 1.12 Stop-smoking interventions - Part 1,NG209,What are the recommended stop-smoking interventions and support options for adults and young people?
NG209_Treating tobacco dependence: 1.12 Stop-smoking interventions - Part 2,NG209,What are the recommended smoking cessation options and support for adults and young people according to NICE guidelines?
NG209_Treating tobacco dependence: 1.12 Stop-smoking interventions - Part 3,NG209,What are the recommended pharmacotherapies for smoking cessation according to NICE guidelines?
NG209_Treating tobacco dependence: 1.12 Stop-smoking interventions - Part 4,NG209,How should I use nicotine-containing e-cigarettes safely to stop smoking?
NG209_Treating tobacco dependence: 1.12 Stop-smoking interventions - Part 5,NG209,How should healthcare professionals advise adults using nicotine-containing e-cigarettes to manage withdrawal symptoms?
NG209_Treating tobacco dependence: 1.13 Support to stop smoking in primary care and community settings,NG209,What are the recommended stop-smoking interventions in primary care and community settings?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 1,NG209,What information should healthcare professionals provide to patients about smoking cessation support before hospital admission?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 2,NG209,What are the NICE recommendations for supporting smoking cessation in acute and mental health services?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 3,NG209,What are the recommended strategies for supporting smoking cessation during hospital admission and outpatient care?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 4,NG209,What are the NICE guidelines for supporting smoking cessation in mental health services?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 5,NG209,What behavioral support is recommended for smoking cessation in secondary care settings?
NG209_Treating tobacco dependence: 1.14 Support to stop smoking in secondary care services - Part 6,NG209,What strategies can support staff in secondary care to stop or reduce smoking while at work?
"NG209_Treating tobacco dependence: 1.15 Supporting people who do not want, or are not ready, to stop smoking in one go to reduce their harm from smoking - Part 1",NG209,What are the harm-reduction strategies for people not ready to stop smoking abruptly?
"NG209_Treating tobacco dependence: 1.15 Supporting people who do not want, or are not ready, to stop smoking in one go to reduce their harm from smoking - Part 2",NG209,What are the recommended strategies for reducing smoking and using nicotine replacement therapy according to NICE guidelines?
"NG209_Treating tobacco dependence: 1.15 Supporting people who do not want, or are not ready, to stop smoking in one go to reduce their harm from smoking - Part 3",NG209,What are effective strategies for using medicinal nicotine products to reduce smoking?
NG209_Treating tobacco dependence: 1.16 Stopping use of smokeless tobacco - Part 1,NG209,What are the recommended strategies for healthcare professionals to support patients in stopping smokeless tobacco use?
NG209_Treating tobacco dependence: 1.16 Stopping use of smokeless tobacco - Part 2,NG209,What are effective strategies for supporting smokeless tobacco cessation in South Asian communities?
NG209_Treating tobacco dependence: 1.16 Stopping use of smokeless tobacco - Part 3,NG209,How can public health services improve smokeless tobacco cessation support for South Asian communities?
NG209_Treating tobacco dependence: 1.16 Stopping use of smokeless tobacco - Part 4,NG209,What are the recommended strategies for integrating smokeless tobacco cessation services into local tobacco control programs?
NG209_Treating tobacco dependence: 1.17 Adherence and relapse prevention - Part 1,NG209,What strategies can help prevent relapse in people trying to stop smoking?
NG209_Treating tobacco dependence: 1.17 Adherence and relapse prevention - Part 2,NG209,What are the recommended strategies for preventing smoking relapse using licensed nicotine products?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.18 Stop-smoking support in pregnancy: identification and referral - Part 1,NG209,What is the recommended approach for smoking cessation support during pregnancy according to NICE guidelines?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.18 Stop-smoking support in pregnancy: identification and referral - Part 2,NG209,What are the recommended actions for managing elevated carbon monoxide levels in pregnant women who do not smoke?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.19 Following up on referrals for stop-smoking support made during pregnancy,NG209,What are the recommended follow-up procedures for pregnant women referred to stop-smoking support services?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.20 Providing support to stop smoking - Part 1,NG209,What is the recommended support for pregnant women to stop smoking?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.20 Providing support to stop smoking - Part 2,NG209,What are the recommendations for using nicotine replacement therapy during pregnancy?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.20 Providing support to stop smoking - Part 3,NG209,What are the recommended incentive schemes to support smoking cessation in pregnant women according to NICE guidelines?
NG209_Treating tobacco dependence during pregnancy and in the first year after childbirth: 1.20 Providing support to stop smoking - Part 4,NG209,"What strategies are recommended to improve access to stop-smoking support for pregnant women, including trans and non-binary people?"
"NG209_Policy, commissioning and training: 1.21 Policy - Part 1",NG209,What are the key components of a smokefree grounds policy in secondary care settings?
"NG209_Policy, commissioning and training: 1.21 Policy - Part 2",NG209,How should healthcare staff communicate and enforce smokefree policies in secondary care settings?
"NG209_Policy, commissioning and training: 1.21 Policy - Part 3",NG209,What are the recommended strategies for implementing tobacco control and smoking cessation support in secondary care services?
"NG209_Policy, commissioning and training: 1.22 Commissioning and designing services - Part 1",NG209,What are the recommended strategies for commissioning and designing stop-smoking support services?
"NG209_Policy, commissioning and training: 1.22 Commissioning and designing services - Part 2",NG209,What strategies are recommended for supporting high-risk populations and workplaces in smoking cessation efforts?
"NG209_Policy, commissioning and training: 1.22 Commissioning and designing services - Part 3",NG209,What are the NICE recommendations for providing stop-smoking support and medicinal nicotine products in secondary care settings?
"NG209_Policy, commissioning and training: 1.22 Commissioning and designing services - Part 4",NG209,What are the recommended strategies for secondary care providers to support smoking cessation?
"NG209_Policy, commissioning and training: 1.22 Commissioning and designing services - Part 5",NG209,What are the recommended performance targets for monitoring stop-smoking services?
"NG209_Policy, commissioning and training: 1.23 Training - Part 1",NG209,What training is recommended for healthcare professionals to support smoking cessation in children and young people?
"NG209_Policy, commissioning and training: 1.23 Training - Part 2",NG209,What training should healthcare professionals receive to support smoking cessation in pregnant women?
"NG209_Policy, commissioning and training: 1.23 Training - Part 3",NG209,What training is recommended for midwives and healthcare professionals to effectively support pregnant women in stopping smoking?
NG209_Terms used in this guideline - Part 1,NG209,What is behavioural support for smoking cessation according to NICE guidelines?
NG209_Terms used in this guideline - Part 2,NG209,What are the regulations and safety considerations for using nicotine-containing e-cigarettes?
NG209_Terms used in this guideline - Part 3,NG209,What are the recommended nicotine replacement therapies for smoking cessation?
NG209_Terms used in this guideline - Part 4,NG209,What are the recommended strategies for supporting South Asian individuals to quit smokeless tobacco?
NG209_Recommendations for research: Key recommendations for research - Part 1,NG209,What are the current recommendations for smoking cessation interventions in pregnant women and under-served populations?
NG209_Recommendations for research: Key recommendations for research - Part 2,NG209,What are effective strategies to support people with mental health conditions in quitting smoking?
NG209_Recommendations for research: Other recommendations for research - Part 1,NG209,What is the effectiveness and safety of nicotine-containing e-cigarettes for harm reduction when used alongside tobacco?
NG209_Recommendations for research: Other recommendations for research - Part 2,NG209,What is the evidence on the effectiveness of e-cigarettes and nicotine replacement therapy in preventing smoking relapse?
NG209_Recommendations for research: Other recommendations for research - Part 3,NG209,What are the best strategies to prevent smoking relapse after discharge from a smokefree inpatient or treatment setting?
NG209_Rationale and impact: Adult-led interventions in schools,NG209,What are effective school-based interventions to prevent e-cigarette use among young people?
NG209_Rationale and impact: Stop-smoking interventions - Part 1,NG209,What are the most effective stop-smoking interventions with behavioral support according to NICE guidelines?
NG209_Rationale and impact: Stop-smoking interventions - Part 2,NG209,What is the cost-effectiveness of cytisinicline for smoking cessation?
NG209_Rationale and impact: Stop-smoking interventions - Part 3,NG209,Is Allen Carr's Easyway effective and cost-effective for smoking cessation through NHS programs?
NG209_Rationale and impact: Stop-smoking interventions - Part 4,NG209,What are the recommended strategies for combining behavioral support with nicotine-containing stop-smoking products?
NG209_Rationale and impact: Advice on nicotine-containing e-cigarettes - Part 1,NG209,What is the effectiveness of nicotine-containing e-cigarettes for smoking cessation?
NG209_Rationale and impact: Advice on nicotine-containing e-cigarettes - Part 2,NG209,What are the current NICE recommendations on the use of e-cigarettes for smoking cessation?
NG209_Rationale and impact: Stop-smoking support in mental health services & Rationale and impact: Nicotine-containing e-cigarettes for harm reduction,NG209,What are the recommended strategies for stop-smoking support in mental health services for people with severe mental health conditions?
NG209_Rationale and impact: Supporting people trying to stop smoking,NG209,What strategies are recommended to prevent relapse in people trying to stop smoking?
"NG209_Rationale and impact: Reviewing the approach for people trying to stop smoking, cutting down or stopping temporarily",NG209,What is the recommended approach for reviewing and supporting people who are trying to stop smoking or reduce harm?
NG209_Rationale and impact: Stop-smoking support in pregnancy: identification and referral,NG209,What is the recommended process for identifying and referring pregnant women for stop-smoking support based on NICE guidelines?
NG209_Rationale and impact: Nicotine replacement therapy and other pharmacological support - Part 1,NG209,What are the current recommendations for using nicotine replacement therapy to support smoking cessation during pregnancy?
NG209_Rationale and impact: Nicotine replacement therapy and other pharmacological support - Part 2,NG209,What is the current evidence on the safety and effectiveness of nicotine replacement therapy for pregnant women who smoke?
NG209_Rationale and impact: Incentives to stop smoking,NG209,What are the recommended incentives to help pregnant women stop smoking according to NICE guidelines?
NG209_Rationale and impact: Commissioning and designing services - Part 1,NG209,What are the recommended strategies for commissioning and designing stop-smoking services according to NICE guidelines?
NG209_Rationale and impact: Commissioning and designing services - Part 2 & Rationale and impact: Stop-smoking support in secondary care,NG209,What strategies are effective for engaging under-served populations in stop-smoking support?
NG209_Context - Part 1,NG209,What are the recommended interventions for smoking cessation in adults?
NG209_Context - Part 2,NG209,What are the current NICE recommendations on harm reduction strategies for smoking cessation?
"NG20_Coeliac disease: recognition, assessment and management & Overview",NG20,What are the recommended methods for diagnosing and managing coeliac disease in children and adults?
NG20_Recommendations: 1.1 Recognition of coeliac disease,NG20,What are the indications for serological testing for coeliac disease in adults and children?
NG20_Recommendations: 1.2 Serological testing for coeliac disease,NG20,What are the recommended serological tests for diagnosing coeliac disease in adults and children?
NG20_Recommendations: 1.3 Referral of people with suspected coeliac disease,NG20,When should patients with suspected coeliac disease be referred to a specialist for diagnosis?
NG20_Recommendations: 1.4 Monitoring in people with coeliac disease,NG20,What are the recommended monitoring and follow-up procedures for people with coeliac disease?
NG20_Recommendations: 1.5 Non‑responsive and refractory coeliac disease,NG20,What are the management strategies for non-responsive or refractory coeliac disease?
NG20_Recommendations: 1.6 Information and support,NG20,What information and support should be provided to people with coeliac disease and their families?
NG20_Recommendations: 1.7 Advice on dietary management & Recommendations: Terms used in this guideline,NG20,What dietary management advice is recommended for people with coeliac disease?
NG20_Context,NG20,What is the recommended management for coeliac disease and how does a gluten-free diet improve outcomes?
NG20_Recommendations for research: 1 Serological testing in people who have IgA deficiency,NG20,"What are the accuracy and reliability of IgG tTG, IgG EMA, and IgG DGP tests for diagnosing coeliac disease in people with IgA deficiency?"
NG20_Recommendations for research: 2 Serological testing in people who test negative for anti‑transglutaminase & Recommendations for research: 3 Dietary supplements,NG20,What are the sensitivity and specificity of IgA EMA and IgA DGP tests in detecting coeliac disease in patients who test negative for IgA tTG?
NG20_Recommendations for research: 4 Dietitian contribution to patient management & Recommendations for research: 5 Frequency of monitoring,NG20,How can dietitians improve adherence to a gluten-free diet in patients with coeliac disease?
NG20_Implementation: getting started: The challenge: making sure laboratories offer testing for tissue transglutaminase and endomysial antibodies,NG20,What are the recommended laboratory testing procedures for tissue transglutaminase and endomysial antibodies in diagnosing coeliac disease?
NG20_Implementation: getting started: The challenge: making sure people have access to a healthcare professional trained to give specialist dietetic advice in relation to coeliac disease,NG20,What are effective strategies to improve access to specialist dietetic advice for people with coeliac disease?
NG210_Pelvic floor dysfunction: prevention and non-surgical management & Overview,NG210,What are the recommended non-surgical management strategies for pelvic floor dysfunction in women?
NG210_Recommendations: 1.1 Raising awareness of pelvic floor dysfunction for all women - Part 1,NG210,What are the key recommendations for raising awareness and providing information about pelvic floor dysfunction to women?
NG210_Recommendations: 1.1 Raising awareness of pelvic floor dysfunction for all women - Part 2,NG210,What are the recommended approaches for discussing pelvic floor dysfunction with women during postnatal and primary care visits?
NG210_Recommendations: 1.2 Risk factors for pelvic floor dysfunction - Part 1,NG210,What are the risk factors for pelvic floor dysfunction in women?
NG210_Recommendations: 1.2 Risk factors for pelvic floor dysfunction - Part 2,NG210,What are the benefits and risks of vaginal versus caesarean birth regarding pelvic floor dysfunction?
NG210_Recommendations: 1.3 Preventing pelvic floor dysfunction - Part 1,NG210,What lifestyle changes can help prevent pelvic floor dysfunction in women?
NG210_Recommendations: 1.3 Preventing pelvic floor dysfunction - Part 2,NG210,What are the recommendations for pelvic floor muscle training during and after pregnancy to prevent pelvic floor dysfunction?
NG210_Recommendations: 1.3 Preventing pelvic floor dysfunction - Part 3,NG210,What are the recommended practices for supervising pelvic floor muscle training after childbirth?
NG210_Recommendations: 1.4 Communicating with and providing information to women with pelvic floor dysfunction - Part 1,NG210,What are recommended communication strategies for discussing pelvic floor dysfunction with women?
NG210_Recommendations: 1.4 Communicating with and providing information to women with pelvic floor dysfunction - Part 2,NG210,How should information about pelvic floor dysfunction be tailored for women at different life stages?
NG210_Recommendations: 1.5 Assessment in primary care - Part 1,NG210,What are the recommended assessment procedures for pelvic floor dysfunction in primary care?
NG210_Recommendations: 1.5 Assessment in primary care - Part 2,NG210,What are the recommended assessments for urinary incontinence and pelvic organ prolapse in women?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 1,NG210,What are the recommended non-surgical management strategies for pelvic floor dysfunction in primary care?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 2,NG210,What are the recommended weight loss and dietary interventions for managing pelvic floor dysfunction in women?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 3,NG210,What are the recommended durations for supervised pelvic floor muscle training for pelvic organ prolapse and urinary incontinence?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 4,NG210,What are the recommended review and supplementation strategies for pelvic floor muscle training in women with pelvic floor dysfunction?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 5,NG210,What are the recommended psychological and behavioral interventions for managing pelvic floor dysfunction in women?
NG210_Recommendations: 1.6 Non-surgical management of pelvic floor dysfunction - Part 6,NG210,What are the recommended behavioral and medicinal interventions for managing urinary and faecal incontinence in women?
NG210_Recommendations: Terms used in this guideline & Recommendations for research: Key recommendations for research - Part 1,NG210,What is the most effective way to provide pelvic floor muscle training to prevent pelvic floor dysfunction?
NG210_Recommendations for research: Key recommendations for research - Part 2,NG210,What are the benefits of pelvic floor muscle training in preventing pelvic floor dysfunction during pregnancy in high-risk women?
NG210_Recommendations for research: Key recommendations for research - Part 3,NG210,Is pelvic floor muscle training effective for preventing pelvic floor dysfunction in women aged 65 and over or during menopause?
NG210_Recommendations for research: Other recommendations for research - Part 1,NG210,What is the effectiveness of pelvic floor muscle training in preventing bowel symptoms related to pelvic floor dysfunction?
NG210_Recommendations for research: Other recommendations for research - Part 2,NG210,What dietary changes can help improve symptoms of pelvic floor dysfunction?
NG210_Recommendations for research: Other recommendations for research - Part 3,NG210,What community strategies are effective in raising awareness about pelvic floor dysfunction prevention?
NG210_Recommendations for research: Other recommendations for research - Part 4,NG210,What are the most effective methods for providing information about pelvic floor dysfunction to young women aged 12 to 17 and to groups protected under the Equality Act?
NG210_Recommendations for research: Other recommendations for research - Part 5,NG210,What is the effectiveness of virtual versus in-person pelvic floor muscle training sessions?
NG210_Rationale and impact: Raising awareness of pelvic floor dysfunction for all women - Part 1,NG210,What are effective strategies for raising awareness of pelvic floor dysfunction among women?
NG210_Rationale and impact: Raising awareness of pelvic floor dysfunction for all women - Part 2,NG210,How can midwives effectively raise awareness of pelvic floor dysfunction during pregnancy?
NG210_Rationale and impact: Risk factors for pelvic floor dysfunction - Part 1,NG210,What are the risk factors for pelvic floor dysfunction and how can they be modified?
NG210_Rationale and impact: Risk factors for pelvic floor dysfunction - Part 2,NG210,What are the risk factors and coexisting conditions associated with pelvic floor dysfunction?
NG210_Rationale and impact: Physical activity and diet and other modifiable risk factors,NG210,What lifestyle modifications can help prevent pelvic floor dysfunction?
NG210_Rationale and impact: Pelvic floor muscle training for preventing pelvic floor dysfunction - Part 1,NG210,What are the benefits of pelvic floor muscle training for preventing pelvic floor dysfunction in women?
NG210_Rationale and impact: Pelvic floor muscle training for preventing pelvic floor dysfunction - Part 2,NG210,What is the evidence for the effectiveness of supervised pelvic floor muscle training in preventing pelvic floor dysfunction?
NG210_Rationale and impact: Pelvic floor muscle training for preventing pelvic floor dysfunction - Part 3,NG210,What are the current NICE recommendations for pelvic floor muscle training to prevent pelvic floor dysfunction during and after pregnancy?
NG210_Rationale and impact: Communicating with and providing information to women with pelvic floor dysfunction - Part 1,NG210,What are effective communication strategies for discussing pelvic floor dysfunction with women?
NG210_Rationale and impact: Communicating with and providing information to women with pelvic floor dysfunction - Part 2,NG210,"What are effective strategies for providing information and support to women with pelvic floor dysfunction, especially young women and those with disabilities?"
NG210_Rationale and impact: Assessment in primary care,NG210,What are the recommended initial assessments for pelvic floor dysfunction in primary care?
NG210_Rationale and impact: Community-based multidisciplinary teams,NG210,What are the recommended team-based approaches for managing pelvic floor dysfunction in community settings?
NG210_Rationale and impact: Lifestyle changes - Part 1,NG210,What are effective strategies for encouraging women to make lifestyle changes to improve pelvic floor health?
NG210_Rationale and impact: Lifestyle changes - Part 2,NG210,"What lifestyle modifications, including diet and physical activity, are recommended for managing pelvic floor dysfunction?"
NG210_Rationale and impact: Lifestyle changes - Part 3,NG210,What is the evidence for supervised physical activity improving symptoms of pelvic floor dysfunction in women?
NG210_Rationale and impact: Pelvic floor muscle training for managing pelvic floor dysfunction - Part 1,NG210,What is the recommended duration for pelvic floor muscle training to manage pelvic organ prolapse and urinary incontinence?
NG210_Rationale and impact: Pelvic floor muscle training for managing pelvic floor dysfunction - Part 2,NG210,What are the benefits of group versus individual pelvic floor muscle training for women with pelvic floor dysfunction?
NG210_Rationale and impact: Intravaginal devices and pessaries - Part 1,NG210,When should intravaginal devices be considered for managing urinary leakage in women?
NG210_Rationale and impact: Intravaginal devices and pessaries - Part 2,NG210,What are the benefits and risks of using pessaries for pelvic organ prolapse?
NG210_Rationale and impact: Psychological interventions,NG210,What psychological interventions are recommended for managing the psychological impact of pelvic floor dysfunction?
NG210_Rationale and impact: Behavioural approaches,NG210,What are the recommended behavioral techniques for managing pelvic floor dysfunction symptoms?
NG210_Rationale and impact: Medicines,NG210,What are the recommended medicines for managing pelvic floor dysfunction in women?
NG210_Context,NG210,What are the recommended prevention and management strategies for pelvic floor dysfunction in women?
NG211_Rehabilitation after traumatic injury & Overview & How to use this guideline - Part 1,NG211,What are the key principles for coordinating rehabilitation care after traumatic injury in hospital?
NG211_How to use this guideline - Part 2,NG211,What are the key considerations for coordinating rehabilitation services after traumatic injury?
NG211_Recommendations: 1.1 Initial assessment and early interventions for people with complex rehabilitation needs - Part 1,NG211,What are the recommended initial assessment and early intervention strategies for people with complex rehabilitation needs after traumatic injury?
NG211_Recommendations: 1.1 Initial assessment and early interventions for people with complex rehabilitation needs - Part 2,NG211,"What are the recommended assessments and interventions for managing trauma patients' cognitive, nutritional, and safeguarding needs?"
NG211_Recommendations: 1.1 Initial assessment and early interventions for people with complex rehabilitation needs - Part 3,NG211,What are the recommended approaches for assessment and early intervention in people with complex rehabilitation needs after traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 1,NG211,What are the key components of a multidisciplinary team rehabilitation needs assessment for traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 2,NG211,What are the recommended components of a multidisciplinary rehabilitation needs assessment after traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 3,NG211,How should healthcare professionals assess and support patients' rehabilitation needs after traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 4,NG211,What are the recommended assessments for physical functioning and rehabilitation needs after traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 5,NG211,What are the recommended assessments for physical and cognitive functioning in people with traumatic injuries?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 6,NG211,What are the recommended assessments for cognitive problems after traumatic injury?
NG211_Recommendations: 1.2 Multidisciplinary team rehabilitation needs assessment - Part 7,NG211,What are the recommended methods for assessing psychological functioning after traumatic injury?
NG211_Recommendations: 1.3 Setting rehabilitation goals,NG211,How should rehabilitation goals be set and reviewed for people with complex needs after traumatic injury?
NG211_Recommendations: 1.4 Developing a rehabilitation plan and making referrals - Part 1,NG211,How should a rehabilitation plan be developed and shared for patients recovering from injury?
NG211_Recommendations: 1.4 Developing a rehabilitation plan and making referrals - Part 2,NG211,What are the recommended steps for managing rehabilitation and preventing future injuries in adults with fragility fractures or traumatic injuries?
NG211_Recommendations: 1.4 Developing a rehabilitation plan and making referrals - Part 3,NG211,What are the recommended approaches for developing a rehabilitation plan and making referrals after traumatic injury?
NG211_Recommendations: 1.5 Rehabilitation programmes of therapies and treatments - Part 1,NG211,What are the key principles for developing effective rehabilitation programmes according to NICE guidelines?
NG211_Recommendations: 1.5 Rehabilitation programmes of therapies and treatments - Part 2,NG211,What are the recommended practices for implementing guided self-managed rehabilitation after traumatic injury?
NG211_Recommendations: 1.5 Rehabilitation programmes of therapies and treatments - Part 3,NG211,What are the benefits of guided self-managed rehabilitation for traumatic injury recovery?
NG211_Recommendations: 1.5 Rehabilitation programmes of therapies and treatments - Part 4,NG211,What are the recommended methods for monitoring progress and supporting shared decision making during adult and pediatric rehabilitation after traumatic injury?
NG211_Recommendations: 1.6 Principles for sharing information and involving family and carers - Part 1,NG211,How should healthcare professionals involve family and carers in the rehabilitation process after traumatic injury?
NG211_Recommendations: 1.6 Principles for sharing information and involving family and carers - Part 2,NG211,What are the rights of people lacking mental capacity to receive advocacy and support?
NG211_Recommendations: 1.7 Coordination of rehabilitation care in hospital - Part 1,NG211,What are the recommended practices for coordinating rehabilitation care in hospital settings?
NG211_Recommendations: 1.7 Coordination of rehabilitation care in hospital - Part 2,NG211,What information should be shared during patient transfers between rehabilitation services?
NG211_Recommendations: 1.7 Coordination of rehabilitation care in hospital - Part 3,NG211,What are effective service coordination strategies for inpatient and outpatient rehabilitation after traumatic injury?
NG211_Recommendations: 1.8 Coordination of rehabilitation care at discharge - Part 1,NG211,How should discharge planning and multidisciplinary coordination be managed for patients undergoing rehabilitation?
NG211_Recommendations: 1.8 Coordination of rehabilitation care at discharge - Part 2,NG211,What are best practices for planning post-discharge rehabilitation and support for patients with ongoing needs?
NG211_Recommendations: 1.8 Coordination of rehabilitation care at discharge - Part 3,NG211,What are the recommended practices for coordinating discharge and community rehabilitation for patients after traumatic injury?
NG211_Recommendations: 1.8 Coordination of rehabilitation care at discharge - Part 5,NG211,What are the recommendations for transition from children's to adult health or social care services for young people?
"NG211_Recommendations: 1.9 Supporting access and participation in education, work and community (adjustment and goal setting) - Part 1",NG211,"How can healthcare professionals support access to education, work, and community participation after a traumatic injury?"
"NG211_Recommendations: 1.9 Supporting access and participation in education, work and community (adjustment and goal setting) - Part 2",NG211,How can employers and educational settings support the rehabilitation and return to work or school for individuals recovering from traumatic injury?
"NG211_Recommendations: 1.9 Supporting access and participation in education, work and community (adjustment and goal setting) - Part 3",NG211,What are effective psychological and social interventions for people with complex rehabilitation needs after traumatic injury?
NG211_Recommendations: 1.10 Commissioning and organisation of rehabilitation services - Part 1,NG211,How should rehabilitation services be commissioned and organized for patients after traumatic injury?
NG211_Recommendations: 1.10 Commissioning and organisation of rehabilitation services - Part 2,NG211,How can care networks and online directories improve coordination of rehabilitation services after traumatic injury?
NG211_Recommendations: 1.10 Commissioning and organisation of rehabilitation services - Part 3,NG211,What training and expertise should rehabilitation staff have for managing complex traumatic injuries?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 1,NG211,What are the recommended early physical rehabilitation interventions for traumatic injury patients?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 2,NG211,What are the recommended early weight-bearing and exercise interventions after traumatic injury?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 3,NG211,What are recommended gait training and exercise interventions after traumatic injury?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 4,NG211,What are the recommended manual therapies and splinting practices for maintaining joint range of movement after traumatic injury?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 5,NG211,What are the recommendations for using spinal orthoses and managing swelling and scars after traumatic injury?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 6,NG211,What are recommended scar management techniques after traumatic injury?
NG211_Recommendations: 1.11 Physical rehabilitation - Part 7,NG211,What are the recommended dietary and nutritional interventions for patients with severe kidney impairment or fragility fractures?
NG211_Recommendations: 1.12 Cognitive rehabilitation,NG211,What are the NICE recommendations for cognitive rehabilitation after traumatic injury?
NG211_Recommendations: 1.13 Psychological rehabilitation - Part 1,NG211,What are the recommended psychological support strategies for patients recovering from traumatic injury?
NG211_Recommendations: 1.13 Psychological rehabilitation - Part 2,NG211,"What are the recommended psychological treatments for PTSD, anxiety, and depression in adults and young people according to NICE guidelines?"
"NG211_Recommendations: 1.14 Rehabilitation after limb reconstruction, limb loss or amputation - Part 1",NG211,What are the recommended rehabilitation strategies after limb reconstruction or amputation according to NICE guidelines?
"NG211_Recommendations: 1.14 Rehabilitation after limb reconstruction, limb loss or amputation - Part 2",NG211,What are the recommended early rehabilitation interventions after limb reconstruction or amputation?
"NG211_Recommendations: 1.14 Rehabilitation after limb reconstruction, limb loss or amputation - Part 3",NG211,What are the recommended pain management strategies after limb amputation according to NICE guidelines?
"NG211_Recommendations: 1.14 Rehabilitation after limb reconstruction, limb loss or amputation - Part 4",NG211,What are the recommended practices for managing residual limb swelling and early rehabilitation after limb amputation?
"NG211_Recommendations: 1.14 Rehabilitation after limb reconstruction, limb loss or amputation - Part 6",NG211,What are the key components of a rehabilitation plan after limb amputation or reconstruction?
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 1,NG211,What are the recommended rehabilitation procedures for patients after spinal cord injury?
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 2,NG211,What are the recommended practices for managing bladder and bowel function after spinal cord injury?
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 3,NG211,"What are the recommended assessments and interventions for respiratory, swallowing, and speech difficulties in patients with spinal cord injury?"
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 4,NG211,What are the recommended strategies for preventing skin complications and autonomic dysreflexia in patients with spinal cord injury?
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 5,NG211,What are the recommended interventions and treatments for improving mobility and managing spasticity after spinal cord injury?
NG211_Recommendations: 1.15 Rehabilitation after spinal cord injury - Part 6,NG211,What psychological support is recommended for people with spinal cord injury during rehabilitation?
NG211_Recommendations: 1.16 Rehabilitation after nerve injury - Part 1,NG211,What are the recommended rehabilitation strategies for nerve injury recovery?
NG211_Recommendations: 1.16 Rehabilitation after nerve injury - Part 2,NG211,What are recommended therapies and psychological support options for nerve injury rehabilitation?
NG211_Recommendations: 1.17 Rehabilitation after chest injury - Part 1,NG211,What are the recommended rehabilitation strategies after chest injury to improve respiratory function and prevent complications?
NG211_Recommendations: 1.17 Rehabilitation after chest injury - Part 2,NG211,What are recommended strategies for preventing upper limb stiffness and maintaining function after chest injury?
NG211_Recommendations: Terms used in this guideline - Part 1,NG211,What is the role of a key worker in complex rehabilitation care?
NG211_Recommendations: Terms used in this guideline - Part 2,NG211,What are the key components of a rehabilitation plan for patients with complex traumatic injuries?
NG211_Recommendations for research: 1 Effectiveness of intensive rehabilitation in adults & Recommendations for research: 2 Effectiveness of intensive rehabilitation in children and young people & Recommendations for research: 3 Thoracic lumbar sacral orthoses in older people,NG211,What is the effectiveness of intensive rehabilitation programs for adults and children after traumatic injury?
NG211_Recommendations for research: 4 Self-management materials & Recommendations for research: 5 Length of bed rest after spinal cord injury,NG211,What is the effectiveness of self-management materials combined with rehabilitation programs for people with complex rehabilitation needs after traumatic injury?
NG211_Rationale and impact: Initial assessment and early interventions for people with complex rehabilitation needs,NG211,What are the recommended initial assessment and early intervention strategies for people with complex rehabilitation needs after traumatic injury?
NG211_Rationale and impact: Multidisciplinary team rehabilitation needs assessment,NG211,What are the recommended approaches for multidisciplinary team rehabilitation needs assessments after traumatic injury?
NG211_Rationale and impact: Assessing physical functioning,NG211,What are the recommended methods for assessing physical functioning after traumatic injury?
NG211_Rationale and impact: Assessing cognitive functioning,NG211,What are the recommended methods for assessing cognitive functioning after a traumatic injury?
NG211_Rationale and impact: Assessing psychological functioning & Rationale and impact: Setting rehabilitation goals,NG211,What are the recommended approaches for assessing psychological functioning and setting rehabilitation goals after trauma?
NG211_Rationale and impact: Developing a rehabilitation plan and making referrals,NG211,What are the key components of an effective rehabilitation plan and referral process for traumatic injury?
NG211_Rationale and impact: General principles for rehabilitation programmes,NG211,How should rehabilitation programmes be tailored to individual needs and goals?
NG211_Rationale and impact: Intensive rehabilitation programmes,NG211,What are the key principles and considerations for implementing intensive rehabilitation programmes for severe injuries?
NG211_Rationale and impact: Guided self-managed rehabilitation,NG211,What are the benefits and implementation considerations of guided self-managed rehabilitation programs?
"NG211_Rationale and impact: Monitoring progress against the rehabilitation plan, goals and programme of therapies and treatments",NG211,What are effective methods for monitoring progress in rehabilitation programs?
NG211_Rationale and impact: Principles for sharing information and involving family and carers,NG211,What are the best practices for involving family and carers in patient rehabilitation communication?
NG211_Rationale and impact: Coordination of rehabilitation care in hospital,NG211,How can early coordination and communication improve rehabilitation outcomes in hospital settings?
NG211_Rationale and impact: Coordination of rehabilitation care at discharge - Part 1,NG211,What are the best practices for coordinating rehabilitation care at hospital discharge?
NG211_Rationale and impact: Coordination of rehabilitation care at discharge - Part 2,NG211,What are the best practices for discharge planning and home-based rehabilitation after hospital stay?
"NG211_Rationale and impact: A single point of contact, key contact and key worker after discharge",NG211,What is the recommended role of a single point of contact or key worker after hospital discharge?
"NG211_Rationale and impact: Supporting access and participation in education, work and community after discharge (adjustment and goal setting)",NG211,What strategies can support social participation and goal setting after discharge from rehabilitation?
NG211_Rationale and impact: Commissioning,NG211,What are the NICE recommendations for commissioning and organizing rehabilitation services?
NG211_Rationale and impact: Organisation,NG211,What are the benefits of establishing care networks and pathways for stroke rehabilitation?
"NG211_Rationale and impact: Rehabilitation skills, knowledge and expertise in the workforce",NG211,What training is recommended for non-specialist healthcare professionals to improve rehabilitation support?
NG211_Rationale and impact: Physical rehabilitation – early interventions and principles,NG211,What are the recommended principles for early physical rehabilitation after trauma?
NG211_Rationale and impact: Early weight-bearing,NG211,What are the guidelines for early weight-bearing after traumatic injury?
NG211_Rationale and impact: Aerobic and strengthening interventions,NG211,What are the recommendations for aerobic and strengthening exercises in trauma rehabilitation?
NG211_Rationale and impact: Gait training and re-education,NG211,What is the role of gait re-education in improving mobility after injury or surgery?
NG211_Rationale and impact: Manual therapies and maintaining joint range of movement,NG211,What are the recommended manual therapies and exercises for maintaining joint range of movement during rehabilitation?
NG211_Rationale and impact: Splinting and orthotics,NG211,What are the best practices for fitting and monitoring splints and orthoses in trauma rehabilitation?
"NG211_Rationale and impact: Management of swelling and oedema, and scars",NG211,"What are the recommended methods for managing swelling, oedema, and scars after traumatic injury?"
NG211_Rationale and impact: Nutritional supplementation,NG211,What are the guidelines for nutritional supplementation after traumatic injury and burns?
NG211_Rationale and impact: Cognitive rehabilitation,NG211,What are the recommended approaches for cognitive rehabilitation after trauma?
NG211_Rationale and impact: Psychological rehabilitation,NG211,What are the recommended approaches for psychological rehabilitation after trauma?
"NG211_Rationale and impact: Rehabilitation after limb-threatening injury – early assessment, decision making and support & Rationale and impact: Rehabilitation after limb reconstruction",NG211,What is the recommended approach to psychological support and early rehabilitation after limb reconstruction or amputation?
NG211_Rationale and impact: Rehabilitation after limb loss or amputation,NG211,What is the recommended timing for starting rehabilitation after limb amputation?
NG211_Rationale and impact: Pain management after limb loss or amputation,NG211,What are the recommended pain management strategies after limb amputation?
NG211_Rationale and impact: Residual limb oedema and shaping after limb loss or amputation & Rationale and impact: Range of movement and strengthening after limb loss or amputation,NG211,What are the recommended practices for managing residual limb oedema and shaping after limb amputation?
NG211_Rationale and impact: Functional independence after limb loss or amputation,NG211,What is the recommended timing for starting rehabilitation after limb amputation to improve functional independence?
"NG211_Rationale and impact: Psychological support after limb loss, amputation or limb reconstruction",NG211,What psychological support is recommended for children and young people after limb loss or amputation?
"NG211_Rationale and impact: Continuing rehabilitation after limb reconstruction, limb loss or amputation and after discharge",NG211,What are the recommended practices for ongoing rehabilitation after limb reconstruction or amputation?
"NG211_Rationale and impact: Rehabilitation after spinal cord injury – referral, assessment and general principles",NG211,What are the key principles for rehabilitation after spinal cord injury?
NG211_Rationale and impact: Bladder and bowel function,NG211,What are the recommended practices for monitoring bladder and bowel function in patients undergoing rehabilitation?
"NG211_Rationale and impact: Respiratory function, swallowing and speech",NG211,"What are the recommended assessments for respiratory function, swallowing, and speech in people with spinal cord injury?"
NG211_Rationale and impact: Preventing complications,NG211,What are the best practices for preventing complications after spinal cord injury?
NG211_Rationale and impact: Maintaining mobility and movement,NG211,What are the recommended approaches for maintaining mobility and managing spasticity after a spinal cord injury?
NG211_Rationale and impact: Low mood and psychological support,NG211,What psychological support is recommended for people with spinal cord injury experiencing low mood?
NG211_Rationale and impact: Rehabilitation after nerve injury – general principles,NG211,What are the principles for rehabilitation after nerve injury?
NG211_Rationale and impact: Therapies and referral,NG211,What are the recommended rehabilitation therapies and referral criteria for peripheral nerve injury recovery?
NG211_Rationale and impact: Rehabilitation after chest injury,NG211,What are the recommended approaches for rehabilitation after chest injury to prevent respiratory complications and improve recovery?
NG211_Context - Part 1,NG211,What are the key considerations for rehabilitation assessment and interventions after traumatic injury?
NG211_Context - Part 2,NG211,What are the recommended approaches for managing complex rehabilitation needs after traumatic injury?
NG212_Mental wellbeing at work & Overview,NG212,What strategies can employers implement to promote mental wellbeing at work?
NG212_Recommendations: 1.1 Strategic approaches to improving mental wellbeing in the workplace - Part 1,NG212,What strategies can organizations implement to improve mental wellbeing in the workplace?
NG212_Recommendations: 1.1 Strategic approaches to improving mental wellbeing in the workplace - Part 2,NG212,What are the validated measures for assessing mental wellbeing in the workplace?
NG212_Recommendations: 1.2 Supportive work environment - Part 1,NG212,What strategies can healthcare organizations implement to create a supportive and inclusive work environment that promotes mental wellbeing?
NG212_Recommendations: 1.2 Supportive work environment - Part 2,NG212,What are the recommended leadership and organisational practices to promote mental wellbeing at work according to NICE guidelines?
NG212_Recommendations: 1.3 External sources of support - Part 1,NG212,What external resources and support services are available for employees with mental health issues?
NG212_Recommendations: 1.3 External sources of support - Part 2,NG212,What resources and evidence-informed sources are recommended for supporting mental wellbeing in the workplace?
NG212_Recommendations: 1.4 Organisation-wide approaches - Part 1,NG212,What strategies can organizations implement to reduce workplace stress and improve employee mental wellbeing?
NG212_Recommendations: 1.4 Organisation-wide approaches - Part 2,NG212,What are recommended strategies for supporting employee mental health after traumatic workplace incidents?
NG212_Recommendations: 1.5 Training and support for managers - Part 1,NG212,What training and support should managers receive to promote mental wellbeing in the workplace?
NG212_Recommendations: 1.5 Training and support for managers - Part 2,NG212,How does mental health training for managers impact employee wellbeing and workplace mental health outcomes?
NG212_Recommendations: 1.6 Individual-level approaches - Part 1,NG212,What strategies can managers use to support employee mental wellbeing and reduce work-related stress?
NG212_Recommendations: 1.6 Individual-level approaches - Part 2,NG212,What are the recommended approaches for improving mental wellbeing at work according to NICE guidelines?
NG212_Recommendations: 1.7 Approaches for employees who have or are at risk of poor mental health - Part 1,NG212,What are effective workplace approaches for supporting employees at risk of poor mental health?
NG212_Recommendations: 1.7 Approaches for employees who have or are at risk of poor mental health - Part 2,NG212,What are NICE recommendations for supporting employees' choices regarding mental health interventions at work?
NG212_Recommendations: 1.8 Organisational-level approaches for high-risk occupations,NG212,What organizational strategies are recommended to support mental wellbeing in high-risk occupations after traumatic events?
NG212_Recommendations: 1.9 Engaging with employees and their representatives,NG212,What are effective strategies for engaging employees and their representatives in mental wellbeing interventions at work?
NG212_Recommendations: 1.10 Local and regional strategies and plans - Part 1,NG212,How can local authorities promote mental wellbeing at work and support employers in implementing mental health strategies?
NG212_Recommendations: 1.10 Local and regional strategies and plans - Part 2,NG212,How can incentives and procurement strategies promote employer participation in mental wellbeing support programs?
NG212_Recommendations: 1.11 Making this guideline relevant for small and medium-sized enterprises (including micro-enterprises) - Part 1,NG212,How can small and medium-sized enterprises promote mental wellbeing among employees?
NG212_Recommendations: 1.11 Making this guideline relevant for small and medium-sized enterprises (including micro-enterprises) - Part 2,NG212,What are the recommended workplace mental health support services for employees according to NICE guidelines?
NG212_Recommendations: Terms used in this guideline,NG212,What is the definition of psychological safety in the workplace according to NICE guidelines?
NG212_Recommendations for research: Key recommendations for research - Part 1,NG212,What is the long-term effectiveness of manager training on employee mental wellbeing?
NG212_Recommendations for research: Key recommendations for research - Part 2,NG212,"What are the mental wellbeing promotion strategies recommended for micro, small, and medium-sized enterprises?"
NG212_Recommendations for research: Key recommendations for research - Part 3,NG212,What mental wellbeing and productivity outcomes should be included in a core outcome set for workplace mental health research?
NG212_Recommendations for research: Other recommendations for research - Part 1,NG212,What tools are available to identify employees at risk of poor mental wellbeing in the workplace?
NG212_Recommendations for research: Other recommendations for research - Part 2,NG212,What are the effective strategies to address the mental wellbeing needs of employees from diverse demographic groups at work?
NG212_Recommendations for research: Other recommendations for research - Part 3,NG212,What are the key reporting characteristics for research on workplace mental wellbeing interventions?
NG212_Rationale and impact: Strategic approaches to improving mental wellbeing in the workplace - Part 1,NG212,What are the recommended strategic approaches to improving mental wellbeing in the workplace?
NG212_Rationale and impact: Strategic approaches to improving mental wellbeing in the workplace - Part 2,NG212,What are the recommended strategies for supporting mental wellbeing in the workplace according to NICE guidelines?
NG212_Rationale and impact: Supportive work environment,NG212,What are the key elements of creating a supportive and inclusive work environment to promote mental wellbeing?
NG212_Rationale and impact: External sources of support,NG212,What external resources are available to support workplace mental wellbeing?
NG212_Rationale and impact: Organisation-wide approaches - Part 1,NG212,What organizational strategies are recommended to improve mental wellbeing and reduce stress in the workplace?
NG212_Rationale and impact: Organisation-wide approaches - Part 2,NG212,What are effective organizational strategies to support employee mental wellbeing in small and medium-sized enterprises?
NG212_Rationale and impact: Training and support for managers - Part 1,NG212,What training and support should managers receive to promote mental health in the workplace?
NG212_Rationale and impact: Training and support for managers - Part 2,NG212,What are the recommended strategies for supporting mental wellbeing of employees during and after COVID-19 in the workplace?
NG212_Rationale and impact: Individual-level approaches,NG212,What are effective individual-level interventions to improve mental wellbeing in the workplace?
NG212_Rationale and impact: Approaches for employees who have or are at risk of poor mental health - Part 1,NG212,What strategies can organizations use to support employees at risk of poor mental health while maintaining confidentiality?
NG212_Rationale and impact: Approaches for employees who have or are at risk of poor mental health - Part 2,NG212,What are effective strategies for supporting employees at risk of poor mental wellbeing in the workplace?
NG212_Rationale and impact: Organisational-level approaches for high-risk occupations,NG212,What organizational strategies are recommended for supporting mental wellbeing in high-risk occupations?
NG212_Rationale and impact: Engaging with employees and their representatives,NG212,What are best practices for engaging employees and their representatives in workplace mental wellbeing interventions?
NG212_Rationale and impact: Local and regional strategies and plans,NG212,What are the recommended strategies for local and regional authorities to promote mental wellbeing in workplaces?
NG212_Rationale and impact: Making this guideline relevant for small and medium-sized enterprises (including micro-enterprises) - Part 1,NG212,What resources are available to help small and medium-sized enterprises promote mental wellbeing at work?
NG212_Rationale and impact: Making this guideline relevant for small and medium-sized enterprises (including micro-enterprises) - Part 2,NG212,What are effective mental wellbeing interventions for small and medium-sized enterprises?
NG212_Context,NG212,What are the recommended workplace interventions to promote mental wellbeing in employees aged 16 and over?
"NG213_Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education & Overview",NG213,What are the recommended approaches for integrated service delivery for disabled children and young people with severe complex needs up to age 25?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 1",NG213,"What are the principles for involving children, young people, and their families in planning and decision-making for health and social care?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 2",NG213,How can healthcare professionals support children and young people to participate in decision-making about their care?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 3",NG213,"How can healthcare professionals communicate effectively and empathetically with children, young people, and their families about assessment, diagnosis, and support options?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 4",NG213,What support and information services are available for children and young people with special educational needs and disabilities (SEND)?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 5",NG213,How should practitioners prepare for and conduct meetings with children and young people to ensure their meaningful participation?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 6",NG213,What are best practices for conducting child and young person meetings in health and social care settings?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 7",NG213,What are the recommended practices for recording and involving children and young people in meetings according to NICE guidelines?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 8",NG213,"What are effective strategies for ensuring consistent collaboration among education, health, and social care services for children and young people?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 9",NG213,How should healthcare professionals involve young people aged 16 or over in decision-making about their support and education?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.1 Principles for working with children, young people and their families - Part 10",NG213,How should information sharing be managed for children and young people with complex care plans?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.2 Identifying needs and involving other services - Part 1,NG213,"What are the recommended steps for involving health, social care, and educational services when a child or young person is identified as having complex health needs or disabilities?"
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.2 Identifying needs and involving other services - Part 2,NG213,What are the recommended procedures for referring disabled children to social care services?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.3 Education, health and care needs assessment - Part 1",NG213,"How do I request an education, health and care (EHC) needs assessment for a child or young person?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.3 Education, health and care needs assessment - Part 2",NG213,What information should be provided to families during an EHC needs assessment process?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.3 Education, health and care needs assessment - Part 3",NG213,"What are the best practices for conducting a needs assessment to develop an education, health and care plan for children with special educational needs?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.3 Education, health and care needs assessment - Part 4",NG213,What are the timescales and procedures for conducting an EHC needs assessment according to NICE guidelines?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.4 Education, health and care plans - Part 1",NG213,"How should outcomes be defined and agreed upon in education, health and care plans for children with complex needs?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.4 Education, health and care plans - Part 2",NG213,How should practitioners contribute to and use information in EHC plans to support children and young people's outcomes?
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.4 Education, health and care plans - Part 3",NG213,"How can I ensure that the child's or young person's voice is accurately preserved and understood in their education, health, and care plan?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.4 Education, health and care plans - Part 4",NG213,"How often should education, health, and social care practitioners review a child's progress and needs in relation to EHC plans?"
"NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.4 Education, health and care plans - Part 5",NG213,What are the NICE recommendations on funding and support for children and young people with EHC plans?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.5 Personal budgets and direct payments - Part 1,NG213,How can families of children with complex needs access and use personal health budgets and direct payments?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.5 Personal budgets and direct payments - Part 2,NG213,What are the requirements for personal budgets and direct payments under the Care Act 2014?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.6 Supporting parents and carers - Part 1,NG213,What support and training are available for parents and carers of children with special educational needs and disabilities?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.6 Supporting parents and carers - Part 2,NG213,What are recommended strategies for providing flexible and effective training and support for parents and carers of children with disabilities?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.7 Social participation - Part 1,NG213,What are effective strategies for improving social participation for children with severe complex needs?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.7 Social participation - Part 2,NG213,"How can health, education, and social care services support social participation for children and young people with additional needs?"
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.8 Transition from children's to adults' services - Part 1,NG213,What are the best practices for transitioning young people from children's to adult health and social care services?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.8 Transition from children's to adults' services - Part 2,NG213,What are best practices for transitioning young people from children's to adult health and social care services?
NG213_Recommendations on support for all disabled children and young people with severe complex needs: 1.8 Transition from children's to adults' services - Part 3,NG213,What are the recommended strategies for supporting young people and their families during the transition from children's to adult health services?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.9 Palliative care and end of life care - Part 1,NG213,What are the key considerations for developing palliative and end of life care plans for children and young people with complex needs?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.9 Palliative care and end of life care - Part 2,NG213,What training is recommended for education and social care practitioners in pediatric palliative and end of life care?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.10 Communication aids - Part 1,NG213,What are the best practices for assessing and supporting communication aids for children and young people?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.10 Communication aids - Part 2,NG213,What are the eligibility criteria for accessing augmentative and alternative communication services for children and young people?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.11 Environmental adaptations - Part 1,NG213,What are the recommended practices for assessing and implementing environmental adaptations for disabled children with complex needs?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.11 Environmental adaptations - Part 2,NG213,What are the recommended procedures for transferring environmental control equipment when moving a child or young person to a new setting?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.11 Environmental adaptations - Part 3,NG213,What are the recommended accessibility assessments for environments serving children and young people with disabilities?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.12 Travel training,NG213,What are the recommended travel training practices for supporting disabled children and young people with complex needs?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.13 Employment - Part 1,NG213,What are the recommended practices for supporting employment for young people with disabilities according to NICE guidelines?
NG213_Recommendations on specialist support for disabled children and young people with particular needs: 1.13 Employment - Part 2,NG213,What strategies are recommended to support disabled young people in preparing for employment and working effectively?
"NG213_Recommendations on service organisation, integration and commissioning: 1.14 All education, health and social care practitioners",NG213,"What are best practices for collaboration and communication among education, health, and social care practitioners supporting children with complex needs?"
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 1",NG213,What are the recommended practices for providing key working support to disabled children with complex needs?
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 2",NG213,What are the best practices for key working support in multidisciplinary child and young person services?
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 3",NG213,What training is recommended for practitioners to improve joined-up care and support for children and young people with complex needs?
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 4",NG213,"What training and observational opportunities are recommended for practitioners across education, health, and social care sectors to improve support for children and young people?"
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 5",NG213,What are the recommended training and competency requirements for support workers delegated clinical tasks in healthcare settings?
"NG213_Recommendations on service organisation, integration and commissioning: 1.15 Education, health and social care services - Part 6",NG213,What training and support should be provided to parents and family members delegated clinical tasks in healthcare?
"NG213_Recommendations on service organisation, integration and commissioning: 1.16 Interagency teams",NG213,How should interagency teams be organized to effectively meet the needs of children and young people with disabilities?
"NG213_Recommendations on service organisation, integration and commissioning: 1.17 Local authorities and health commissioners - Part 1",NG213,"What are the NICE recommendations for commissioning education, health, and social care services for disabled children with complex needs?"
"NG213_Recommendations on service organisation, integration and commissioning: 1.17 Local authorities and health commissioners - Part 2",NG213,How can services be designed to better involve disabled children and young people in their review and planning processes?
"NG213_Recommendations on service organisation, integration and commissioning: 1.17 Local authorities and health commissioners - Part 3",NG213,What training is recommended for practitioners on developing and contributing to EHC plans?
"NG213_Recommendations on service organisation, integration and commissioning: 1.17 Local authorities and health commissioners - Part 4",NG213,"What support is available for disabled children and young people to participate in leisure, social activities, and employment?"
"NG213_Recommendations on service organisation, integration and commissioning: 1.18 Improving how local authorities, commissioners and services work together",NG213,How can local authorities and healthcare providers improve collaboration to support disabled children with complex needs?
NG213_Terms used in this guideline - Part 1,NG213,What are the eligibility criteria for specialised augmentative and alternative communication services for children with severe complex needs?
NG213_Terms used in this guideline - Part 2,NG213,What are the key components of end of life and palliative care for children and young people with complex needs?
NG213_Terms used in this guideline - Part 3,NG213,What is parallel planning in end-of-life care for children with life-limiting conditions?
NG213_Recommendations for research: Key recommendations for research - Part 1,NG213,"What is the effectiveness of assistive technology in enabling disabled children with complex needs to communicate with education, health, and social care services?"
NG213_Recommendations for research: Key recommendations for research - Part 2,NG213,What are the most effective models for commissioning and delivering services to support disabled children with complex needs close to home?
NG213_Recommendations for research: Other recommendations for research,NG213,What is the evidence on the effectiveness of telehealth for communicating with disabled children with complex needs?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Principles for working with children, young people and their families - Part 1",NG213,What are the principles for supporting children and young people with special educational needs and disabilities in decision-making?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Principles for working with children, young people and their families - Part 2",NG213,"How can practitioners effectively involve children, young people, and families in decision-making about support for severe complex needs?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Communication formats and providing information - Part 1,NG213,What are effective communication strategies for supporting children and young people with complex needs and their families?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Communication formats and providing information - Part 2,NG213,What are the recommended approaches for providing information and support to children and young people with special educational needs and disabilities?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Preparing for and running meetings with children and young people - Part 1,NG213,How can I prepare children and young people to participate effectively in meetings about their care?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Preparing for and running meetings with children and young people - Part 2,NG213,What strategies can improve children and young people's participation and communication in care planning meetings?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Preparing for and running meetings with children and young people - Part 3,NG213,How can effective interagency collaboration improve support for children and young people with complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Using a consistent approach,NG213,What are the benefits of using a consistent approach when supporting children and young people with complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Decision making,NG213,What are the NICE recommendations for involving disabled children and young people in decision making about their care?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Information sharing and privacy - Part 1,NG213,How can healthcare and social care services improve information sharing while respecting children's privacy and confidentiality?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Information sharing and privacy - Part 2,NG213,"How should behaviour management plans be shared with children, young people, and their families in healthcare and social care settings?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Identifying needs and involving other services - Part 1,NG213,What are the recommended procedures for identifying needs and involving services for children with severe complex disabilities?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Identifying needs and involving other services - Part 2,NG213,What are the recommended practices for making social care referrals for children with complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Requesting a needs assessment - Part 1,NG213,What are the best practices for requesting a needs assessment for children with complex special educational needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Requesting a needs assessment - Part 2,NG213,How can practitioners better support families during the EHC needs assessment process?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Supporting children, young people and their families during a needs assessment - Part 1",NG213,How can children and young people and their families be better supported and informed during the EHC needs assessment process?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Supporting children, young people and their families during a needs assessment - Part 2",NG213,How can early interagency support prevent crises in children and young people with special educational needs and disabilities?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Carrying out the needs assessment, timescales for the assessment, and when parents or carers decline an assessment - Part 1",NG213,How should needs assessments be carried out for children and young people with complex needs?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Carrying out the needs assessment, timescales for the assessment, and when parents or carers decline an assessment - Part 2",NG213,"What are the recommended procedures and timescales for Education, Health and Care (EHC) needs assessments and plans according to NICE guidelines?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Agreeing on outcomes for the EHC plan,NG213,"What are best practices for setting meaningful outcomes in Education, Health and Care plans for children with severe complex needs?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Providing information and advice for the EHC plan - Part 1,NG213,What are the best practices for providing information and advice in EHC plans for children with complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Providing information and advice for the EHC plan - Part 2,NG213,"How can EHC plans be improved to clearly specify support responsibilities and ensure they are understandable for children, young people, and families?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Providing information and advice for the EHC plan - Part 3,NG213,"How should practitioners involve children, young people, and their families in the development of EHC plans?"
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Reviewing progress and needs, and coordinating with EHC plan reviews",NG213,What are the recommended practices for reviewing and updating EHC plans for children and young people with severe complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Funding,NG213,What are the funding requirements for supporting children and young people with severe and complex needs according to NICE guidelines?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: If children, young people and their families decline an EHC plan",NG213,"What should practitioners do if parents decline an Education, Health and Care plan for their child?"
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Personal budgets and direct payments - Part 1,NG213,What information should local authorities provide to families about personal budgets and direct payments for children with special educational needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Personal budgets and direct payments - Part 2,NG213,What are the best practices for assessing full costs of services when implementing personal budgets and direct payments for children and young people?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Supporting parents and carers, and training - Part 1",NG213,What are effective strategies for supporting parents and carers of children with severe complex needs?
"NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Supporting parents and carers, and training - Part 2",NG213,How should parent and carer training be tailored and delivered to meet individual family needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Social participation - Part 1,NG213,What strategies can support social participation for disabled children and young people with severe complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Social participation - Part 2,NG213,How can collaboration between health and education services improve social participation for children with severe complex needs?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Transition from children's to adults' services - Part 1,NG213,What are the best practices for transitioning children with special educational needs to adult services?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Transition from children's to adults' services - Part 2,NG213,What are the best practices for coordinating transition from paediatric to adult health services for young people?
NG213_Rationale and impact for recommendations on supporting all disabled children and young people with severe complex needs: Transition from children's to adults' services - Part 3,NG213,What are best practices for involving parents and young people in transition planning from children's to adult health services?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Palliative care and end of life care - Part 1,NG213,What are best practices for coordinating palliative and end of life care for children and young people?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Palliative care and end of life care - Part 2,NG213,How should EHC plans be reviewed and updated for children receiving palliative or end-of-life care?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Communication aids - Part 1,NG213,What are the best practices for providing and maintaining communication aids for children and young people with communication needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Communication aids - Part 2,NG213,What are the best practices for training families and practitioners to use communication aids for children with complex needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Environmental adaptations - Part 1,NG213,What are best practices for providing environmental adaptations and assistive technology support for disabled children and young people?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Environmental adaptations - Part 2,NG213,What are the best practices for training staff to use environmental control equipment for children with disabilities?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Environmental accessibility - Part 1,NG213,What are the recommended practices for assessing environmental accessibility in health and social care services for disabled children and young people?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Environmental accessibility - Part 2,NG213,What are best practices for conducting accessibility assessments in public places for disabled children and young people?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Travel training - Part 1,NG213,What are the recommended approaches for travel training to promote independence in disabled children and young people with complex needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Travel training - Part 2,NG213,What are the local authority responsibilities for travel training for disabled children and young people with special educational needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Employment - Part 1,NG213,What are the recommended approaches for supporting employment outcomes in disabled children and young people with complex needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Employment - Part 2,NG213,What are the recommended roles and training requirements for lead employment practitioners supporting young people with complex needs?
NG213_Rationale and impact for recommendations on specialist support for disabled children and young people with particular needs: Employment - Part 3,NG213,What support services are available for young people with SEND in the local area according to the SEND Local Offer?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: All education, health and social care practitioners - Part 1",NG213,How can healthcare professionals improve collaboration and communication when working with children and young people?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: All education, health and social care practitioners - Part 2 & Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Working culture",NG213,"What are effective strategies for improving interagency collaboration and coordination among education, health, and social care practitioners?"
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Key working support - Part 1",NG213,What are the best practices for providing effective key working support for children and young people with special educational needs and disabilities?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Key working support - Part 2",NG213,What are the best practices for implementing key working support in services for children and young people with special educational needs and disabilities?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Making processes easier to understand",NG213,"How can services improve transparency and understanding of education, health, and care plan processes for children and young people?"
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Training for practitioners - Part 1",NG213,What training is recommended for practitioners to improve joint working and understanding of complex needs in disabled children and young people?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Training for practitioners - Part 2",NG213,What are the benefits of joint interagency training for practitioners working with disabled children and young people?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Delegated clinical tasks and feedback",NG213,What are the recommended practices for delegating clinical tasks to support staff in caring for children with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Interagency teams - Part 1",NG213,What are the best practices for establishing effective interagency teams to support children and young people with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Interagency teams - Part 2",NG213,How can interagency teams improve collaboration and knowledge sharing to better support children with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Local authorities and health commissioners - Part 1",NG213,What are the recommended strategies for local authorities and health commissioners to provide community-based care for disabled children with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Local authorities and health commissioners - Part 2",NG213,How can integrated service planning improve support for disabled children and young people?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Local authorities and health commissioners - Part 3",NG213,"What are effective strategies for implementing flexible, child-centered services for children with special educational needs and disabilities?"
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Coordinating EHC plan process changes with local services, training and short breaks - Part 1",NG213,How can local services improve coordination and training for EHC plan processes to better support children with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Coordinating EHC plan process changes with local services, training and short breaks - Part 2",NG213,What evidence is available on the effectiveness of different types of short breaks for children and young people with special educational needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: What to include in the SEND Local Offer - Part 1",NG213,What information should be included in the SEND Local Offer to ensure accessibility and compliance with regulations?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: What to include in the SEND Local Offer - Part 2",NG213,What information should local authorities include in the SEND Local Offer to support social inclusion and preparation for adulthood for disabled children and young people?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Improving how local authorities, commissioners and services work together - Part 1",NG213,How can local authorities and clinical commissioning groups improve joint working and interagency collaboration for supporting children with complex needs?
"NG213_Rationale and impact for recommendations on working culture, training, service organisation, integration and commissioning: Improving how local authorities, commissioners and services work together - Part 2",NG213,How can joint commissioning frameworks improve integrated care for children and young people with disabilities?
NG213_Context,NG213,"What are best practices for delivering integrated education, health, and social care services for disabled children with severe complex needs?"
NG214_Integrated health and social care for people experiencing homelessness & 3 more sections,NG214,How can health and social care services be effectively integrated for people experiencing homelessness?
NG214_Context - Part 1,NG214,What strategies can improve access to health and social care for people experiencing homelessness?
NG214_Context - Part 2,NG214,What are effective strategies to improve healthcare access and outcomes for people experiencing homelessness?
NG214_Context - Part 3,NG214,What are effective models of service provision to prevent and address homelessness?
NG214_Recommendations & Recommendations: 1.1 General principles & Recommendations: 1.1 General principles - Part 1,NG214,What strategies can improve engagement and trust between healthcare providers and people experiencing homelessness?
NG214_Recommendations: 1.1 General principles - Part 2,NG214,What strategies can help healthcare providers re-engage people experiencing homelessness with health and social care services?
NG214_Recommendations: 1.1 General principles - Part 3 & Recommendations: 1.2 Planning and commissioning,NG214,How should health and social care services communicate effectively with people experiencing homelessness to meet their individual needs and preferences?
NG214_Recommendations: 1.2 Planning and commissioning - Part 1,NG214,How should commissioners plan and develop integrated health and social care services for people experiencing homelessness?
NG214_Recommendations: 1.2 Planning and commissioning - Part 2 & Recommendations: 1.3 Models of multidisciplinary service provision,NG214,What are recommended models of multidisciplinary service provision for supporting people experiencing homelessness?
NG214_Recommendations: 1.3 Models of multidisciplinary service provision - Part 1,NG214,What are the key components and roles of multidisciplinary teams in providing care for people experiencing homelessness?
NG214_Recommendations: 1.3 Models of multidisciplinary service provision - Part 2 & Recommendations: 1.4 The role of peers,NG214,What are the recommended roles of peers in supporting people experiencing homelessness according to NICE guidelines?
NG214_Recommendations: 1.4 The role of peers & Recommendations: 1.5 Improving access to and engagement with health and social care,NG214,How can peer support improve access to and engagement with health and social care for people experiencing homelessness?
NG214_Recommendations: 1.5 Improving access to and engagement with health and social care - Part 1,NG214,How can health and social care services improve access and engagement for people experiencing homelessness?
NG214_Recommendations: 1.5 Improving access to and engagement with health and social care - Part 2,NG214,How can healthcare providers improve access to health and social care for people experiencing homelessness?
NG214_Recommendations: 1.5 Improving access to and engagement with health and social care - Part 3 & Recommendations: 1.6 Assessing individual needs,NG214,"What are the recommended outreach services for supporting people experiencing homelessness with healthcare, mental health, and substance use needs?"
NG214_Recommendations: 1.6 Assessing individual needs - Part 1,NG214,What are the key components of assessing individual needs for people experiencing homelessness according to NICE guidelines?
NG214_Recommendations: 1.6 Assessing individual needs - Part 2 & Recommendations: 1.7 Intermediate care,NG214,How should healthcare professionals conduct holistic needs assessments for people experiencing homelessness during hospital admissions?
NG214_Recommendations: 1.7 Intermediate care & Recommendations: 1.8 Transitions between different settings,NG214,What are the recommended intermediate care services for people experiencing homelessness who cannot be safely managed in the community?
NG214_Recommendations: 1.8 Transitions between different settings - Part 1,NG214,What are the recommended practices for supporting people experiencing homelessness during transitions between care settings?
NG214_Recommendations: 1.8 Transitions between different settings - Part 2 & Recommendations: 1.9 Housing with health and social care support,NG214,What are the NICE recommendations for housing with health and social care support?
NG214_Recommendations: 1.9 Housing with health and social care support & Recommendations: 1.10 Safeguarding,NG214,What are the recommended housing and support strategies for people experiencing homelessness to improve health and social care engagement?
NG214_Recommendations: 1.10 Safeguarding & Recommendations: 1.11 Long-term support,NG214,What are the NICE recommendations for safeguarding and safeguarding adults boards in supporting people experiencing homelessness?
NG214_Recommendations: 1.11 Long-term support & Recommendations: 1.12 Staff support and development,NG214,What strategies are recommended for building long-term engagement and trust with people experiencing homelessness?
NG214_Recommendations: 1.12 Staff support and development & Recommendations: Terms used in this guideline,NG214,What training and support are recommended for healthcare staff working with people experiencing homelessness?
NG214_Recommendations: Terms used in this guideline - Part 1,NG214,What is the role of assertive outreach in engaging people who are initially unwilling to participate in health and social care services?
NG214_Recommendations: Terms used in this guideline - Part 2,NG214,What are effective outreach strategies for engaging people experiencing homelessness in health and social care services?
NG214_Recommendations: Terms used in this guideline - Part 3,NG214,What are the key principles of safeguarding adults and managing severe and multiple disadvantage?
NG214_Recommendations: Terms used in this guideline - Part 4 & Recommendations for research,NG214,What are the key principles of trauma-informed care in social services?
NG214_Recommendations for research & Rationale and impact,NG214,What research is available on the effectiveness of psychologically informed environments for people experiencing homelessness?
NG214_Rationale and impact: General principles & Rationale and impact: General principles - Part 1,NG214,What are effective strategies for involving people experiencing homelessness in service design and delivery?
NG214_Rationale and impact: General principles - Part 2,NG214,What strategies can improve engagement and trust between healthcare providers and people experiencing homelessness?
NG214_Rationale and impact: General principles - Part 3,NG214,How can healthcare services improve engagement and re-engagement with people experiencing homelessness?
NG214_Rationale and impact: Communication and information & Rationale and impact: Communication and information - Part 1,NG214,What are effective communication strategies for healthcare providers working with people experiencing homelessness?
NG214_Rationale and impact: Communication and information - Part 2 & Rationale and impact: Planning and commissioning,NG214,What are the recommended strategies for providing advocacy and information to improve access to health and social care for people experiencing homelessness?
NG214_Rationale and impact: Planning and commissioning - Part 1,NG214,What are the recommended approaches for planning and commissioning integrated health and social care services for people experiencing homelessness?
NG214_Rationale and impact: Planning and commissioning - Part 2,NG214,What are best practices for safeguarding adults and developing integrated services for people experiencing homelessness?
NG214_Rationale and impact: Planning and commissioning - Part 3,NG214,What strategies can improve access to healthcare for people experiencing homelessness?
NG214_Rationale and impact: Planning and commissioning - Part 4,NG214,What strategies can improve access and integration of health and social care services for people experiencing homelessness?
NG214_Rationale and impact: Planning and commissioning - Part 5,NG214,How can joint strategic needs assessments improve service provision for people experiencing homelessness?
NG214_Rationale and impact: Models of multidisciplinary service provision - Part 1,NG214,What are the recommended models for multidisciplinary services to support people experiencing homelessness?
NG214_Rationale and impact: Models of multidisciplinary service provision - Part 2,NG214,What is the role of multidisciplinary teams in supporting people experiencing homelessness?
NG214_Rationale and impact: Models of multidisciplinary service provision - Part 3 & Rationale and impact: The role of peers,NG214,What are the benefits of multidisciplinary teams for addressing homelessness in healthcare services?
NG214_Rationale and impact: The role of peers - Part 1,NG214,What is the role of peer support in improving hepatitis C screening and services for people experiencing homelessness?
NG214_Rationale and impact: The role of peers - Part 2 & Rationale and impact: Supporting access to and engagement with services,NG214,How can peer support be effectively integrated into mental health and homelessness services to improve engagement and outcomes?
NG214_Rationale and impact: Supporting access to and engagement with services - Part 1,NG214,What strategies improve access and engagement with health and social care for people experiencing homelessness?
NG214_Rationale and impact: Supporting access to and engagement with services - Part 2,NG214,What strategies can improve access to healthcare for people experiencing homelessness and reduce missed appointments?
NG214_Rationale and impact: Supporting access to and engagement with services - Part 3,NG214,What are the legal requirements and best practices for healthcare providers to register and engage with people experiencing homelessness?
NG214_Rationale and impact: Supporting access to and engagement with services - Part 4,NG214,How can flexible appointment systems and travel support improve access and reduce costs for homeless patients?
NG214_Rationale and impact: Supporting access to and engagement with services - Part 5 & Rationale and impact: Outreach services,NG214,How can outreach services improve access and engagement with health and social care for people experiencing homelessness?
NG214_Rationale and impact: Outreach services - Part 1,NG214,What are the benefits and best practices of outreach services for people experiencing homelessness?
NG214_Rationale and impact: Outreach services - Part 2 & Rationale and impact: Assessing people's needs,NG214,What are effective strategies for assessing the needs of homeless individuals to improve engagement with health and social care services?
NG214_Rationale and impact: Assessing people's needs - Part 1,NG214,What are the recommended approaches for assessing individual health and social care needs in adults?
NG214_Rationale and impact: Assessing people's needs - Part 2,NG214,How can involving peers and advocates improve the assessment process for people experiencing homelessness?
NG214_Rationale and impact: Assessing people's needs - Part 3 & Rationale and impact: Intermediate care,NG214,How should ongoing support needs be reviewed for people with complex health and social care requirements?
NG214_Rationale and impact: Intermediate care & Rationale and impact: Transitions between different settings,NG214,What are the benefits of intermediate care services for preventing hospital admissions and supporting recovery in people experiencing homelessness?
NG214_Rationale and impact: Transitions between different settings - Part 1,NG214,What are effective strategies for supporting transitions between healthcare settings for people experiencing homelessness?
NG214_Rationale and impact: Transitions between different settings - Part 2,NG214,How can hospitals prevent self-discharge and ensure safe transfer of care for people experiencing homelessness with opioid dependence?
NG214_Rationale and impact: Housing with health and social care support - Part 1,NG214,What are the best practices for providing housing with integrated health and social care support to improve patient outcomes?
NG214_Rationale and impact: Housing with health and social care support - Part 2 & Rationale and impact: Safeguarding,NG214,How can tailored support and risk assessment improve outcomes during the transition to independent accommodation?
NG214_Rationale and impact: Safeguarding - Part 1,NG214,What is the role of social workers in safeguarding adults experiencing homelessness?
NG214_Rationale and impact: Safeguarding - Part 2 & Rationale and impact: Long-term support,NG214,What are the safeguarding responsibilities and best practices for health and social care staff working with people experiencing homelessness?
NG214_Rationale and impact: Long-term support - Part 1,NG214,What are effective strategies for providing long-term support to people experiencing homelessness?
NG214_Rationale and impact: Long-term support - Part 2 & Rationale and impact: Staff support and development,NG214,How can long-term support and palliative care be improved for people experiencing homelessness and severe disadvantage?
NG214_Rationale and impact: Staff support and development - Part 1,NG214,What training is recommended for healthcare professionals to improve support for people experiencing homelessness and address social determinants of health?
NG215_Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults & Overview & Recommendations: 1.1 Supporting people taking a dependence-forming medicine or antidepressant,NG215,What are best practices for managing withdrawal from dependence-forming medicines like benzodiazepines and opioids?
NG215_Recommendations: 1.2 Making decisions about prescribing and taking a dependence-forming medicine or antidepressant - Part 1,NG215,What factors increase the risk of dependence when prescribing antidepressants or opioids?
NG215_Recommendations: 1.2 Making decisions about prescribing and taking a dependence-forming medicine or antidepressant - Part 2,NG215,What should prescribers do if they believe a medicine is not in a patient's best interests but cannot reach shared decision-making?
NG215_Recommendations: 1.2 Making decisions about prescribing and taking a dependence-forming medicine or antidepressant - Part 3,NG215,What are the key principles for safe prescribing and decision making when working with individuals who may lack mental capacity?
NG215_Recommendations: 1.3 Starting a dependence-forming medicine or antidepressant - Part 1,NG215,What information should be provided to patients when starting dependence-forming medicines or antidepressants?
NG215_Recommendations: 1.3 Starting a dependence-forming medicine or antidepressant - Part 2,NG215,What are the recommended strategies for regular review and safe prescribing of dependence-forming medicines?
NG215_Recommendations: 1.3 Starting a dependence-forming medicine or antidepressant - Part 3,NG215,How should responsibility for prescribing and reviewing medicines be managed during transfer from secondary to primary care?
NG215_Recommendations: 1.4 Reviewing a dependence-forming medicine or antidepressant - Part 1,NG215,What are the recommended review intervals for patients taking dependence-forming medicines or antidepressants?
NG215_Recommendations: 1.4 Reviewing a dependence-forming medicine or antidepressant - Part 2,NG215,How should healthcare professionals review and adjust medicines during patient consultations?
NG215_Recommendations: 1.5 Withdrawing a dependence-forming medicine or antidepressant - Part 1,NG215,How should healthcare professionals approach withdrawing dependence-forming medicines or antidepressants through shared decision-making?
NG215_Recommendations: 1.5 Withdrawing a dependence-forming medicine or antidepressant - Part 2,NG215,What are the recommended approaches for dose reduction during medication withdrawal?
NG215_Recommendations: 1.5 Withdrawing a dependence-forming medicine or antidepressant - Part 3,NG215,"How should healthcare professionals manage gradual dose reduction and withdrawal from opioids, benzodiazepines, Z-drugs, antidepressants, or gabapentinoids?"
NG215_Recommendations: 1.5 Withdrawing a dependence-forming medicine or antidepressant - Part 4,NG215,How can healthcare professionals distinguish between withdrawal symptoms and re‑emergence of underlying conditions during medication tapering?
NG215_Recommendations: 1.5 Withdrawing a dependence-forming medicine or antidepressant - Part 5,NG215,What are the recommended strategies for safely reducing or stopping dependence-forming medicines?
NG215_Recommendations for research: Key recommendations for research - Part 1,NG215,What are the most effective strategies and interventions to support medication withdrawal and manage dependence?
NG215_Recommendations for research: Key recommendations for research - Part 2,NG215,"What information and support should be provided to family members and carers of people taking opioids, benzodiazepines, Z-drugs, antidepressants, or gabapentinoids?"
NG215_Recommendations for research: Other recommendations for research - Part 1,NG215,What are the most effective strategies for supporting withdrawal from benzodiazepines using cognitive behavioural therapy?
NG215_Recommendations for research: Other recommendations for research - Part 2,NG215,What are the most effective acupuncture and withdrawal support strategies for opioid and gabapentinoid dependence?
NG215_Rationale and impact: Supporting people taking a dependence-forming medicine or antidepressant,NG215,What strategies improve support for patients taking dependence-forming medicines or antidepressants?
NG215_Rationale and impact: Making decisions about prescribing and taking a dependence-forming medicine or antidepressant - Part 1,NG215,What factors should healthcare professionals consider when prescribing dependence-forming medicines or antidepressants?
NG215_Rationale and impact: Making decisions about prescribing and taking a dependence-forming medicine or antidepressant - Part 2,NG215,How can healthcare professionals support shared decision-making to prevent dependence on medicines?
NG215_Rationale and impact: Starting a dependence-forming medicine or antidepressant - Part 1,NG215,What information should be provided to patients when starting a dependence-forming medicine or antidepressant?
NG215_Rationale and impact: Starting a dependence-forming medicine or antidepressant - Part 2,NG215,What are the recommended strategies for safe long-term opioid prescribing and dose management?
NG215_Rationale and impact: Starting a dependence-forming medicine or antidepressant - Part 3,NG215,How can effective communication between primary and secondary care improve prescribing continuity?
NG215_Rationale and impact: Reviewing a dependence-forming medicine or antidepressant,NG215,How often should dependence-forming medicines or antidepressants be reviewed in clinical practice?
NG215_Rationale and impact: Withdrawing a dependence-forming medicine or antidepressant - Part 1,NG215,What are the recommended strategies for safely withdrawing from dependence-forming medicines or antidepressants?
NG215_Rationale and impact: Withdrawing a dependence-forming medicine or antidepressant - Part 2,NG215,"What are the best practices for dose reduction schedules and managing withdrawal symptoms in opioid, benzodiazepine, and antidepressant withdrawal?"
NG215_Rationale and impact: Withdrawing a dependence-forming medicine or antidepressant - Part 3,NG215,What psychological interventions are effective to support benzodiazepine withdrawal?
NG215_Rationale and impact: Withdrawing a dependence-forming medicine or antidepressant - Part 4,NG215,What are the recommended strategies and service models for supporting withdrawal from prescribed medicines like opioids and benzodiazepines?
NG215_Context,NG215,"What are the best practices for managing dependence and withdrawal symptoms in patients prescribed medicines like benzodiazepines, opioids, or gabapentin?"
NG216_Social work with adults experiencing complex needs & Overview,NG216,What are best practices for social work interventions with adults who have complex needs?
NG216_Recommendations: 1.1 Principles of social work for adults with complex needs - Part 1,NG216,What are the principles of respectful and person-centred social work for adults with complex needs?
NG216_Recommendations: 1.1 Principles of social work for adults with complex needs - Part 2,NG216,What are the recommended practices for social workers when discussing a person's life history and experiences to inform care planning?
NG216_Recommendations: 1.1 Principles of social work for adults with complex needs - Part 3,NG216,What are the NICE recommendations for social workers managing caseloads involving adults with complex needs?
NG216_Recommendations: 1.1 Principles of social work for adults with complex needs - Part 4,NG216,"What training do social workers need to effectively address equality, diversity, and legal literacy in social care?"
NG216_Recommendations: 1.1 Principles of social work for adults with complex needs - Part 5,NG216,How can social workers promote an open learning culture to support wellbeing and rights of individuals and communities?
NG216_Recommendations: 1.2 Assessment - Part 1,NG216,What are best practices for informing and preparing individuals for a needs assessment under the Care Act 2014?
NG216_Recommendations: 1.2 Assessment - Part 2,NG216,What are the recommended practices for social workers when arranging and conducting assessments for people with complex needs?
NG216_Recommendations: 1.2 Assessment - Part 3,NG216,How should social workers ensure the accuracy and completeness of supported self-assessment in adult needs assessments?
NG216_Recommendations: 1.2 Assessment - Part 4,NG216,What information should social workers provide to people with complex needs and their families about the complaints procedure?
NG216_Recommendations: 1.2 Assessment - Part 5,NG216,How should social workers conduct risk assessments for individuals with complex needs?
NG216_Recommendations: 1.2 Assessment - Part 6,NG216,How should social workers assess mental capacity and risk in decision-making for individuals with potential cognitive or executive dysfunction?
NG216_Recommendations: 1.2 Assessment - Part 7,NG216,What are the recommended practices for social workers when respecting decision-making capacity and sharing information under the NICE guidelines?
NG216_Recommendations: 1.2 Assessment - Part 8,NG216,How should social workers conduct and review risk assessments for individuals at potential risk of serious harm?
NG216_Recommendations: 1.2 Assessment - Part 9,NG216,What organizational strategies support staff safety and risk assessment in managing people with complex needs?
NG216_Recommendations: 1.3 Individual or family casework - Part 1,NG216,What are the principles of social work for adults with complex needs in individual or family casework?
NG216_Recommendations: 1.3 Individual or family casework - Part 2,NG216,What training and support are recommended for social workers to promote the rights and wellbeing of individuals and families?
NG216_Recommendations: 1.4 Helping people to connect with local communities and reduce isolation - Part 1,NG216,How can social workers help people with complex needs connect with local community groups and reduce social isolation?
NG216_Recommendations: 1.4 Helping people to connect with local communities and reduce isolation - Part 2,NG216,What information should organizations provide about their services and community resources for people with complex needs?
"NG216_Recommendations: 1.5 Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 1",NG216,What are the key principles for supporting care planning and decision-making for people with complex needs?
"NG216_Recommendations: 1.5 Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 2",NG216,What are the key requirements for social workers when developing and reviewing care plans for individuals receiving social support?
"NG216_Recommendations: 1.5 Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 3",NG216,What are the recommended practices for planning transitions between inpatient and community care settings?
"NG216_Recommendations: 1.6 Responding to an escalation of need, including urgent support - Part 1",NG216,What are the recommended actions for social workers when responding to an unplanned escalation of a person's care needs?
"NG216_Recommendations: 1.6 Responding to an escalation of need, including urgent support - Part 2",NG216,What are the recommended practices for social workers responding to escalation of need in mental health crises?
"NG216_Recommendations: 1.7 Social workers and multidisciplinary teams: communication, support and collaboration - Part 1",NG216,What are best practices for effective communication and collaboration within multidisciplinary health and social care teams?
"NG216_Recommendations: 1.7 Social workers and multidisciplinary teams: communication, support and collaboration - Part 2",NG216,What strategies can improve collaboration and role clarity for social workers in multidisciplinary healthcare teams?
NG216_Recommendations: Terms used in this guideline - Part 1,NG216,What is the meaning of debriefing and how is it used in social work practice?
NG216_Recommendations: Terms used in this guideline - Part 2 & Recommendations for research: 1 Needs assessment,NG216,What are the benefits and challenges of using strengths and asset-based approaches in social care assessments?
NG216_Recommendations for research: 2 Risk assessment & 3 more sections,NG216,What are effective social work interventions for supporting people with complex needs during an escalation of risk?
NG216_Rationale and impact: Principles of social work for adults with complex needs - Part 1,NG216,What are the principles of social work for adults with complex needs according to NICE guidelines?
NG216_Rationale and impact: Principles of social work for adults with complex needs - Part 2,NG216,How can social workers effectively address communication barriers and cultural differences during needs assessments?
NG216_Rationale and impact: Principles of social work for adults with complex needs - Part 3,NG216,How can social workers build trusting relationships to address healthcare inequalities related to cultural differences and individual circumstances?
NG216_Rationale and impact: Principles of social work for adults with complex needs - Part 4,NG216,What are the key principles for social work practice with adults who have complex health and social care needs?
NG216_Rationale and impact: Principles of social work for adults with complex needs - Part 5,NG216,How can social workers be supported to address social and personal identities to reduce inequalities in care?
NG216_Rationale and impact: Assessment – needs assessment - Part 1,NG216,What are the recommended practices for providing information to individuals undergoing social work needs assessments under the Care Act 2014?
NG216_Rationale and impact: Assessment – needs assessment - Part 2,NG216,What are best practices for conducting social work needs assessments to minimise stress and support person-centred involvement?
NG216_Rationale and impact: Assessment – needs assessment - Part 3,NG216,How do NICE recommendations on initial contact and assessment impact social work practice?
NG216_Rationale and impact: Assessment – needs assessment - Part 4,NG216,What are the key considerations for social workers when conducting needs assessments under the Care Act 2014?
NG216_Rationale and impact: Assessment – needs assessment - Part 5,NG216,What are the recommended practices for recording disagreements and providing information during needs assessments for people with complex needs?
NG216_Rationale and impact: Assessment – risk assessment - Part 1,NG216,What are the best practices for conducting risk assessments for people with complex needs?
NG216_Rationale and impact: Assessment – risk assessment - Part 2,NG216,How should social workers conduct risk assessments to fully understand individual circumstances and environment?
NG216_Rationale and impact: Assessment – risk assessment - Part 3,NG216,What are the best practices for conducting risk assessments in social care to ensure safety and respect for mental capacity?
NG216_Rationale and impact: Assessment – risk assessment - Part 4,NG216,How should risk assessments be conducted for people with complex mental health needs to ensure understanding and respect for their autonomy?
NG216_Rationale and impact: Assessment – risk assessment - Part 5,NG216,What are best practices for assessing and recording risk severity and likelihood in social work?
NG216_Rationale and impact: Assessment – risk assessment - Part 6,NG216,What are the best practices for sharing risk assessment information among agencies while complying with UK GDPR?
NG216_Rationale and impact: Individual or family casework - Part 1,NG216,What are effective social work approaches for goal setting and problem solving in individual and family casework?
NG216_Rationale and impact: Individual or family casework - Part 2,NG216,How can social workers effectively involve family members in casework while safeguarding the rights and wellbeing of the individual?
NG216_Rationale and impact: Helping people to connect with local communities and reduce isolation - Part 1,NG216,What strategies do NICE guidelines recommend for social workers to help reduce social isolation and improve community connections?
NG216_Rationale and impact: Helping people to connect with local communities and reduce isolation - Part 2,NG216,How can social workers effectively support individuals in connecting with community resources to reduce social isolation?
"NG216_Rationale and impact: Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 1",NG216,What are the best practices for supporting care planning and future decision-making for people with complex needs?
"NG216_Rationale and impact: Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 2",NG216,"What are best practices for involving family, carers, and community networks in care planning for adults with complex needs?"
"NG216_Rationale and impact: Supporting people to plan for the future, including considering changing needs, wishes and capabilities - Part 3",NG216,What are the recommended practices for reviewing care and support plans for adults with complex needs?
"NG216_Rationale and impact: Responding to an escalation of need, including urgent support - Part 1",NG216,What are the recommended practices for social workers responding to an escalation of need in adults with complex needs?
"NG216_Rationale and impact: Responding to an escalation of need, including urgent support - Part 2",NG216,What are the recommendations for using advance statements and out-of-hours mental health services?
"NG216_Rationale and impact: Social workers and multidisciplinary teams: communication, support and collaboration - Part 1",NG216,What are effective strategies for improving communication and collaboration among social workers and multidisciplinary healthcare teams?
"NG216_Rationale and impact: Social workers and multidisciplinary teams: communication, support and collaboration - Part 2",NG216,How can multidisciplinary team training and effective communication improve support for people with complex needs?
"NG216_Rationale and impact: Social workers and multidisciplinary teams: communication, support and collaboration - Part 3",NG216,What strategies can improve integrated working and referral efficiency in multidisciplinary healthcare teams?
NG216_Context - Part 1,NG216,What are the key considerations for supporting adults with complex needs through social care services?
NG216_Context - Part 2,NG216,What are evidence-based social work practices for adults with complex needs?
NG216_Context - Part 3,NG216,How do NICE guidelines for adults with complex needs align with legal duties and statutory guidance?
"NG217_Epilepsies in children, young people and adults & Overview - Part 1",NG217,What are the current NICE recommendations for managing epilepsy in children and adults?
NG217_Overview - Part 2,NG217,What are the current safety recommendations for prescribing valproate and topiramate to women and girls of childbearing potential?
NG217_1 Diagnosis and assessment of epilepsy: 1.1 Referral after a first seizure or remission and assessing risk of a second seizure - Part 1,NG217,What are the recommended referral procedures and risk assessments after a first seizure?
NG217_1 Diagnosis and assessment of epilepsy: 1.1 Referral after a first seizure or remission and assessing risk of a second seizure - Part 2,NG217,"What information should be provided to patients and families after a first seizure regarding risk factors, recognition, and safety?"
NG217_1 Diagnosis and assessment of epilepsy: 1.2 Specialist assessment and diagnosis - Part 1,NG217,What are the recommended assessments for diagnosing a first suspected seizure according to NICE guidelines?
NG217_1 Diagnosis and assessment of epilepsy: 1.2 Specialist assessment and diagnosis - Part 2,NG217,What is the role of EEG in diagnosing epilepsy after a first seizure?
NG217_1 Diagnosis and assessment of epilepsy: 1.3 Neuroimaging,NG217,What are the recommendations for neuroimaging in the diagnosis and management of epilepsy?
NG217_1 Diagnosis and assessment of epilepsy: 1.4 Genetic testing,NG217,What are the recommendations for genetic testing in people with epilepsy?
NG217_1 Diagnosis and assessment of epilepsy: 1.5 Antibody testing & 5 more sections,NG217,What are the recommendations for antibody testing in suspected autoimmune encephalitis in people with new-onset epilepsy?
NG217_2 Information and support: 2.1.6 & 4 more sections,NG217,What information should be provided to people with epilepsy during their first appointment?
NG217_2 Information and support: 2.1.11 - Part 1,NG217,What topics should be discussed with people with epilepsy and their families during clinical appointments?
NG217_2 Information and support: 2.1.11 - Part 2,NG217,What are the recommended considerations for contraception and pregnancy management in women with epilepsy?
NG217_3 Referral to tertiary specialist services,NG217,What are the criteria for referring patients with suspected or confirmed epilepsy to tertiary specialist services?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.1 Treatment with antiseizure medications - Part 1",NG217,What are the recommended approaches for individualizing antiseizure medication treatment in epilepsy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.1 Treatment with antiseizure medications - Part 2",NG217,How should add-on antiseizure treatments be adjusted if they do not reduce seizures?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.1 Treatment with antiseizure medications - Part 3",NG217,What are the most effective antiseizure therapies for treating juvenile myoclonic epilepsy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.2 When to start antiseizure medication - Part 1",NG217,When should antiseizure medication be started after a first unprovoked seizure?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.3 Safety considerations - Part 1",NG217,What safety considerations should be taken into account when prescribing antiseizure medications?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.3 Safety considerations - Part 2",NG217,What are the considerations for prescribing antiseizure medications to women of childbearing potential regarding pregnancy risks and contraception interactions?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.3 Safety considerations - Part 3",NG217,What are the safety considerations and evidence for antiseizure medications in women and girls?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.4 Monitoring and review - Part 1",NG217,What is the recommended frequency for epilepsy monitoring reviews in adults and children?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.4 Monitoring and review - Part 2",NG217,When should antiseizure medication levels be monitored in people with epilepsy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.5 Support and monitoring - Part 1",NG217,What are the recommended monitoring and support strategies for women and men with epilepsy planning pregnancy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.5 Support and monitoring - Part 2",NG217,What are the recommendations for monitoring and adjusting antiseizure medication doses in pregnant women with epilepsy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.6 Discontinuing antiseizure medication - Part 1",NG217,How should clinicians approach discontinuing antiseizure medication in patients with epilepsy?
"NG217_4 Principles of treatment, safety, monitoring and withdrawal: 4.6 Discontinuing antiseizure medication - Part 2",NG217,How should antiseizure medications be safely discontinued in epilepsy patients?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.1 Generalised tonic-clonic seizures - Part 1",NG217,What are the recommended first-line treatments for generalised tonic-clonic seizures?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.1 Generalised tonic-clonic seizures - Part 2",NG217,What are the recommended second-line add-on treatments for generalized tonic-clonic seizures if first-line therapies fail?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.2 Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 1",NG217,What are the recommended first-line and second-line monotherapy options for focal seizures according to NICE guidelines?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.2 Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 2",NG217,What are the recommended first-line and second-line add-on treatments for focal seizures when monotherapy is unsuccessful?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.2 Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 3",NG217,What are the third-line add-on treatment options for focal seizures when second-line therapies are unsuccessful?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.3 Absence seizures - Part 1",NG217,What is the recommended first-line treatment for absence seizures according to NICE guidelines?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.3 Absence seizures - Part 2",NG217,What are the recommended first-line treatments for absence seizures with other seizure types according to NICE guidelines?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.4 Myoclonic seizures - Part 1",NG217,What are the recommended first-line treatments for myoclonic seizures in children?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.4 Myoclonic seizures - Part 2",NG217,Which antiseizure medications are recommended or contraindicated for treating myoclonic seizures?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.5 Tonic or atonic seizures - Part 1",NG217,What are the recommended treatments for tonic or atonic seizures according to NICE guidelines?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.5 Tonic or atonic seizures - Part 2",NG217,What are the recommended treatment options for tonic or atonic seizures in children when first-line therapies fail?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.6 Idiopathic generalised epilepsies - Part 1",NG217,What are the recommended second-line treatments for idiopathic generalised epilepsies?
"NG217_5 Treating epileptic seizures in children, young people and adults: 5.6 Idiopathic generalised epilepsies - Part 2",NG217,What are the second-line treatment options for idiopathic generalised epilepsy?
NG217_6 Treating childhood-onset epilepsies: 6.1 Dravet syndrome - Part 1,NG217,What are the recommended treatment options for managing Dravet syndrome in children and adults?
NG217_6 Treating childhood-onset epilepsies: 6.1 Dravet syndrome - Part 2,NG217,What are the recommended medication options and precautions for managing seizures in Dravet syndrome?
NG217_6 Treating childhood-onset epilepsies: 6.2 Lennox–Gastaut syndrome - Part 1,NG217,What are the recommended treatment options for Lennox–Gastaut syndrome?
NG217_6 Treating childhood-onset epilepsies: 6.2 Lennox–Gastaut syndrome - Part 2,NG217,What are the recommended treatment options and considerations for managing Lennox–Gastaut syndrome?
NG217_6 Treating childhood-onset epilepsies: 6.3 Infantile spasms syndrome - Part 1,NG217,What is the recommended initial treatment for infantile spasms in children under 2 years?
NG217_6 Treating childhood-onset epilepsies: 6.3 Infantile spasms syndrome - Part 2,NG217,What are the recommended second-line treatments for infantile spasms according to NICE guidelines?
NG217_6 Treating childhood-onset epilepsies: 6.4 Self-limited epilepsy with centrotemporal spikes - Part 1,NG217,What are the recommended treatment options for self-limited epilepsy with centrotemporal spikes in children?
NG217_6 Treating childhood-onset epilepsies: 6.4 Self-limited epilepsy with centrotemporal spikes - Part 2,NG217,"What are the considerations for using carbamazepine, oxcarbazepine, and lamotrigine in children with self-limited epilepsy with centrotemporal spikes?"
NG217_6 Treating childhood-onset epilepsies: 6.5 Epilepsy with myoclonic-atonic seizures (Doose syndrome) - Part 1,NG217,What are the recommended treatment options for epilepsy with myoclonic-atonic seizures in children?
NG217_6 Treating childhood-onset epilepsies: 6.5 Epilepsy with myoclonic-atonic seizures (Doose syndrome) - Part 2,NG217,What are the recommended third-line treatments for epilepsy with myoclonic-atonic seizures according to NICE guidelines?
"NG217_7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures: 7.1 Status epilepticus - Part 1",NG217,What is the recommended initial emergency treatment for convulsive status epilepticus in adults and children?
"NG217_7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures: 7.1 Status epilepticus - Part 2",NG217,What are the recommended second- and third-line treatments for convulsive status epilepticus according to NICE guidelines?
"NG217_7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures: 7.2 Repeated seizures or cluster seizures",NG217,What is the recommended emergency management for repeated or cluster seizures?
"NG217_7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures: 7.3 Prolonged seizures",NG217,What is the recommended emergency management for prolonged convulsive seizures?
NG217_8 Non-pharmacological treatments: 8.1 Ketogenic diet,NG217,What are the indications for using a ketogenic diet in children with drug-resistant epilepsy?
NG217_8 Non-pharmacological treatments: 8.2 Resective epilepsy surgery,NG217,What are the criteria for referring patients with drug-resistant epilepsy for resective epilepsy surgery assessment?
NG217_8 Non-pharmacological treatments: 8.3 Vagus nerve stimulation,NG217,What are the benefits and risks of vagus nerve stimulation for drug-resistant epilepsy?
"NG217_9 Psychological, neurobehavioural, cognitive and developmental comorbidities in epilepsy: 9.1 Providing coordinated care",NG217,How should care be coordinated for people with epilepsy and mental health or learning disabilities?
"NG217_9 Psychological, neurobehavioural, cognitive and developmental comorbidities in epilepsy: 9.2 Support and treatment - Part 1",NG217,How should mental health and social wellbeing be managed in people with epilepsy?
"NG217_9 Psychological, neurobehavioural, cognitive and developmental comorbidities in epilepsy: 9.2 Support and treatment - Part 2",NG217,What are the recommended psychological treatments for adults with epilepsy and comorbid anxiety or psychosis?
NG217_10 Reducing the risk of epilepsy-related death including sudden unexpected death in epilepsy: 10.1 Risk factors,NG217,What are the risk factors for sudden unexpected death in epilepsy (SUDEP) and how can they be minimized?
NG217_10 Reducing the risk of epilepsy-related death including sudden unexpected death in epilepsy: 10.2 Interventions,NG217,What are recommended interventions to reduce the risk of epilepsy-related death?
NG217_11 Service provision and transition: 11.1 Epilepsy specialist nurses,NG217,What is the role of epilepsy specialist nurses in supporting patients with epilepsy?
NG217_11 Service provision and transition: 11.2 Transition from children's to adults' epilepsy services - Part 1,NG217,How should the transition from children's to adult epilepsy services be managed for young people?
NG217_11 Service provision and transition: 11.2 Transition from children's to adults' epilepsy services - Part 2,NG217,What topics should be discussed when transitioning from paediatric to adult epilepsy services?
NG217_Terms used in this guideline,NG217,What is the definition of drug-resistant epilepsy according to NICE guidelines?
NG217_Recommendations for research: Key recommendations for research - Part 1,NG217,What are the effective antibody testing methods for autoimmune epilepsy?
NG217_Recommendations for research: Key recommendations for research - Part 2,NG217,What are the recommended approaches for risk prediction of epilepsy-related death and SUDEP?
NG217_Recommendations for research: Key recommendations for research - Part 3,NG217,What is the evidence for the effectiveness of vagus nerve stimulation in treating epilepsy?
NG217_Recommendations for research: Other recommendations for research - Part 1,NG217,What is the effectiveness of therapeutic drug monitoring for antiseizure medications in women and girls with epilepsy?
NG217_Recommendations for research: Other recommendations for research - Part 2,NG217,What is the effectiveness and tolerability of ketogenic diets for managing drug-resistant epilepsy in adults and children?
NG217_Rationale and impact: Referral after a first seizure or remission and assessing risk of a second seizure - Part 1,NG217,What are the criteria for urgent referral after a first seizure and how is the risk of a second seizure assessed?
NG217_Rationale and impact: Referral after a first seizure or remission and assessing risk of a second seizure - Part 2,NG217,What are the recommended assessment procedures for identifying risk factors after a first seizure?
NG217_Rationale and impact: Specialist assessment and diagnosis - Part 1,NG217,What is the role of clinical history and neuroimaging in diagnosing epilepsy?
NG217_Rationale and impact: Specialist assessment and diagnosis - Part 2,NG217,How should EEG be used to diagnose epilepsy effectively?
NG217_Rationale and impact: Neuroimaging - Part 1,NG217,What are the recommended neuroimaging procedures for diagnosing epilepsy?
NG217_Rationale and impact: Neuroimaging - Part 2,NG217,What are the recommended practices for reporting and repeating MRI scans in epilepsy diagnosis and management?
NG217_Rationale and impact: Genetic testing - Part 1,NG217,What are the indications for genetic testing in epilepsy patients?
NG217_Rationale and impact: Genetic testing - Part 2,NG217,When should genetic testing be considered for children with early-onset or syndromic epilepsy?
NG217_Rationale and impact: Antibody testing,NG217,What is the role of antibody testing in diagnosing autoimmune encephalitis in new-onset epilepsy?
NG217_Rationale and impact: Information and support,NG217,What information and support should be provided to people with epilepsy and their carers at diagnosis?
NG217_Rationale and impact: New technologies,NG217,Why is there limited evidence supporting the use of digital health technologies for epilepsy management?
NG217_Rationale and impact: Referral to tertiary specialist services - Part 1,NG217,What are the criteria for referral to tertiary specialist services for epilepsy patients?
NG217_Rationale and impact: Referral to tertiary specialist services - Part 2,NG217,What are the criteria for urgent referral of children with suspected epilepsy to tertiary services?
NG217_Rationale and impact: Treatment with antiseizure medications - Part 1,NG217,What are the principles for selecting antiseizure medications in epilepsy treatment?
NG217_Rationale and impact: Treatment with antiseizure medications - Part 2,NG217,What are the recommended strategies for switching or adding antiseizure medications in epilepsy treatment?
NG217_Rationale and impact: When to start antiseizure medication,NG217,When should antiseizure medication be started after a first unprovoked seizure?
NG217_Rationale and impact: Safety considerations - Part 1,NG217,What safety considerations should be taken into account when prescribing antiseizure medications for epilepsy?
NG217_Rationale and impact: Safety considerations - Part 2,NG217,What are the current NICE recommendations for contraception and pregnancy management in women and girls with epilepsy?
NG217_Rationale and impact: Monitoring and review - Part 1,NG217,What are the recommended monitoring and review practices for people with epilepsy on long-term antiseizure medication?
NG217_Rationale and impact: Monitoring and review - Part 2,NG217,When should therapeutic drug monitoring be used for people with epilepsy?
NG217_Rationale and impact: Support and monitoring,NG217,What are the recommended practices for monitoring antiseizure medication levels in women planning pregnancy or during pregnancy?
NG217_Rationale and impact: Discontinuing antiseizure medication,NG217,What are the best practices for safely discontinuing antiseizure medication in people with epilepsy?
NG217_Rationale and impact: Generalised tonic-clonic seizures - Part 1,NG217,What are the recommended first-line treatments for generalised tonic-clonic seizures in adults and children?
NG217_Rationale and impact: Generalised tonic-clonic seizures - Part 2,NG217,Which add-on medications are recommended for treating generalised tonic-clonic seizures that do not respond to initial monotherapy?
NG217_Rationale and impact: Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 1,NG217,What are the recommended first-line treatments for focal seizures with or without evolution to bilateral tonic-clonic seizures?
NG217_Rationale and impact: Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 2,NG217,What are the recommended add-on treatments for focal epilepsy after monotherapy failure?
NG217_Rationale and impact: Focal seizures with or without evolution to bilateral tonic-clonic seizures - Part 3,NG217,What are the current NICE recommendations for antiseizure medication choices and considerations for different patient backgrounds?
NG217_Rationale and impact: Absence seizures - Part 1,NG217,What are the recommended treatments for absence seizures in children and adults?
NG217_Rationale and impact: Absence seizures - Part 2,NG217,What are the recommended first-line treatments for absence seizures with other seizure types according to NICE guidelines?
NG217_Rationale and impact: Myoclonic seizures - Part 1,NG217,What are the recommended first-line treatments for myoclonic seizures in adults and children?
NG217_Rationale and impact: Myoclonic seizures - Part 2,NG217,Which antiseizure medications are recommended as second-line treatments for myoclonic seizures according to NICE guidelines?
NG217_Rationale and impact: Tonic or atonic seizures - Part 1,NG217,What are the recommended treatments for tonic or atonic seizures in epilepsy?
NG217_Rationale and impact: Tonic or atonic seizures - Part 2,NG217,What are the recommended second-line treatments for tonic and atonic seizures in epilepsy?
NG217_Rationale and impact: Idiopathic generalised epilepsies - Part 1,NG217,What are the recommended first-line treatments for idiopathic generalised epilepsies and their associated risks?
NG217_Rationale and impact: Idiopathic generalised epilepsies - Part 2,NG217,What are the recommended first-line and second-line treatments for epilepsy in women and girls of childbearing potential?
NG217_Rationale and impact: Dravet syndrome - Part 1,NG217,What are the recommended treatments for managing seizures in children with confirmed Dravet syndrome?
NG217_Rationale and impact: Dravet syndrome - Part 2,NG217,What are the recommended treatment options for managing seizures in children with Dravet syndrome who do not respond to first-line therapy?
NG217_Rationale and impact: Lennox–Gastaut syndrome - Part 1,NG217,What are the recommended treatments for Lennox–Gastaut syndrome in children?
NG217_Rationale and impact: Lennox–Gastaut syndrome - Part 2,NG217,What are the recommended add-on treatments for Lennox–Gastaut syndrome when first- and second-line therapies are not tolerated or ineffective?
NG217_Rationale and impact: Infantile spasms syndrome - Part 1,NG217,What is the recommended treatment for infantile spasms in children under 2 years old?
NG217_Rationale and impact: Infantile spasms syndrome - Part 2,NG217,What information should be provided to parents about the side effects of steroids in children under 2 years?
NG217_Rationale and impact: Self-limited epilepsy with centrotemporal spikes - Part 1,NG217,What are the recommended first-line treatments for self-limited epilepsy with centrotemporal spikes in children?
NG217_Rationale and impact: Self-limited epilepsy with centrotemporal spikes - Part 2,NG217,What are the safety considerations and monitoring requirements for carbamazepine and related medicines in children of different ethnic backgrounds?
NG217_Rationale and impact: Epilepsy with myoclonic-atonic seizures (Doose syndrome) - Part 1,NG217,What are the recommended treatments for epilepsy with myoclonic-atonic seizures in children?
NG217_Rationale and impact: Epilepsy with myoclonic-atonic seizures (Doose syndrome) - Part 2,NG217,What are the recommended treatments for epilepsy with myoclonic-atonic seizures?
NG217_Rationale and impact: Status epilepticus - Part 1,NG217,What is the recommended initial treatment for convulsive status epilepticus in hospital and community settings?
NG217_Rationale and impact: Status epilepticus - Part 2,NG217,What are the recommended second-line treatments for status epilepticus after benzodiazepines?
NG217_Rationale and impact: Repeated or cluster seizures,NG217,What are the recommended treatments for managing repeated or cluster seizures in epilepsy?
NG217_Rationale and impact: Prolonged seizures,NG217,What is the recommended management for prolonged convulsive seizures lasting more than 2 minutes?
NG217_Rationale and impact: Ketogenic diet,NG217,What is the evidence for the effectiveness of ketogenic diets in managing drug-resistant epilepsy?
NG217_Rationale and impact: Resective epilepsy surgery - Part 1,NG217,What are the benefits and risks of resective epilepsy surgery for drug-resistant focal epilepsy?
NG217_Rationale and impact: Resective epilepsy surgery - Part 2,NG217,What are the criteria for referring patients with drug-resistant epilepsy for resective surgery?
NG217_Rationale and impact: Vagus nerve stimulation,NG217,What are the indications and effectiveness of vagus nerve stimulation for treatment-resistant epilepsy?
"NG217_Rationale and impact: Psychological, neurobehavioural, cognitive and developmental comorbidities in epilepsy - Part 1",NG217,What are the recommended psychological and neurobehavioural interventions for people with epilepsy and comorbid mental health conditions?
"NG217_Rationale and impact: Psychological, neurobehavioural, cognitive and developmental comorbidities in epilepsy - Part 2",NG217,What is the evidence for the cost-effectiveness of psychological interventions for people with epilepsy?
NG217_Rationale and impact: Reducing the risk of epilepsy-related death including sudden unexpected death in epilepsy - Part 1,NG217,What are the current recommendations for reducing the risk of epilepsy-related death and sudden unexpected death in epilepsy (SUDEP)?
NG217_Rationale and impact: Reducing the risk of epilepsy-related death including sudden unexpected death in epilepsy - Part 2,NG217,What are the risk factors for sudden unexpected death in epilepsy (SUDEP) and how can they be reduced?
NG217_Rationale and impact: Reducing the risk of epilepsy-related death including sudden unexpected death in epilepsy - Part 3,NG217,What are the recommended strategies to reduce the risk of epilepsy-related death and SUDEP?
NG217_Rationale and impact: Epilepsy specialist nurses - Part 1,NG217,What is the role of epilepsy specialist nurses in supporting people with epilepsy?
NG217_Rationale and impact: Epilepsy specialist nurses - Part 2,NG217,What are the benefits of epilepsy specialist nurse interventions for ongoing seizure management?
NG217_Rationale and impact: Transition from children's to adults' epilepsy services - Part 1,NG217,What are the best practices for transitioning young people with epilepsy from children's to adult services?
NG217_Rationale and impact: Transition from children's to adults' epilepsy services - Part 2,NG217,What information should be provided to young people with epilepsy and their families during transition to adult services?
NG217_Context,NG217,What are the recommended treatment options and management strategies for epilepsy?
NG218_Vaccine uptake in the general population & Overview,NG218,How can healthcare providers improve vaccine uptake among eligible populations?
NG218_Recommendations: 1.1 Service organisation - Part 1,NG218,What are the responsibilities of a named vaccination lead in healthcare organizations?
NG218_Recommendations: 1.1 Service organisation - Part 2,NG218,What strategies can improve access and uptake of routine vaccines in low-coverage populations?
NG218_Recommendations: 1.1 Service organisation - Part 3,NG218,What strategies can improve COVID-19 vaccine uptake among minority ethnic groups and vulnerable populations?
NG218_Recommendations: 1.1 Service organisation - Part 4,NG218,What are the recommended strategies for increasing vaccine uptake through extended access and service coordination?
NG218_Recommendations: 1.1 Service organisation - Part 5,NG218,What training and education should healthcare practitioners receive to effectively promote and administer vaccinations?
NG218_Recommendations: 1.1 Service organisation - Part 6,NG218,When should vaccination be contraindicated and how can healthcare professionals address individual barriers to vaccine uptake?
"NG218_Recommendations: 1.2 Identifying eligibility, giving vaccinations and recording vaccination status - Part 1",NG218,What are the recommended processes for recording and updating vaccination status in primary care and child health information services?
"NG218_Recommendations: 1.2 Identifying eligibility, giving vaccinations and recording vaccination status - Part 2",NG218,What are the recommended ways for general practices to identify and record vaccination eligibility?
"NG218_Recommendations: 1.2 Identifying eligibility, giving vaccinations and recording vaccination status - Part 3",NG218,How can healthcare providers ensure patients have access to and are prompted about their vaccination records?
"NG218_Recommendations: 1.2 Identifying eligibility, giving vaccinations and recording vaccination status - Part 4",NG218,What are the recommended practices for recording vaccination offers and patient responses in medical records?
"NG218_Recommendations: 1.2 Identifying eligibility, giving vaccinations and recording vaccination status - Part 5",NG218,What are the recommended procedures for recording and reporting vaccination administration according to NICE guidelines?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 1",NG218,What are the NICE recommendations for invitations and reminders to improve vaccination uptake?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 2",NG218,How should healthcare providers invite pregnant women to receive routine vaccinations?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 3",NG218,How can I ensure that care home residents and housebound individuals receive home visits for vaccination?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 4",NG218,What strategies can healthcare providers use to improve vaccination uptake in neonatal and early childhood populations?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 5",NG218,"What strategies can be used to improve vaccination uptake among pregnant women, older people, and transient populations?"
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 6",NG218,What are the NICE recommendations for vaccinating children and young people who are not registered with a GP practice?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 7",NG218,What are the best practices for obtaining informed consent for vaccination in children and young people?
"NG218_Recommendations: 1.3 Invitations, reminders and escalation of contact - Part 8",NG218,What strategies are recommended to improve catch-up vaccination rates among school-aged children and young people?
NG218_Recommendations: Terms used in this guideline - Part 1,NG218,"What is the definition of ""housebound"" according to NICE guidelines?"
NG218_Recommendations: Terms used in this guideline - Part 2,NG218,What are the criteria for classifying someone as housebound according to NICE guidelines?
NG218_Recommendations for research: Key recommendations for research - Part 1,NG218,What strategies are effective in increasing vaccination uptake among populations with low coverage in the UK?
NG218_Recommendations for research: Key recommendations for research - Part 2,NG218,What are the most effective strategies for increasing vaccine uptake through tailored immunisation programmes in the UK?
NG218_Recommendations for research: Other recommendations for research - Part 1,NG218,What are the most effective strategies to increase vaccination uptake among older adults in the UK?
NG218_Recommendations for research: Other recommendations for research - Part 2,NG218,What is the effectiveness of provider incentives in increasing immunisation rates in the UK?
NG218_Rationale and impact: Named vaccination leads - Part 1,NG218,What is the role of a named vaccination lead in improving vaccination uptake and coordination?
NG218_Rationale and impact: Named vaccination leads - Part 2,NG218,What are effective strategies for ensuring vaccination invitations are responded to in supported living and care home settings?
NG218_Rationale and impact: Designing and raising awareness of payment schemes,NG218,How can healthcare commissioners effectively raise awareness of vaccination funding streams and avoid unintended consequences of provider incentives?
NG218_Rationale and impact: Making vaccination services accessible and tailoring to local needs - Part 1,NG218,How can local healthcare providers improve vaccine accessibility and address low uptake in specific communities?
NG218_Rationale and impact: Making vaccination services accessible and tailoring to local needs - Part 2,NG218,What strategies can improve vaccine uptake among populations with low access or acceptance?
NG218_Rationale and impact: Making vaccination services accessible and tailoring to local needs - Part 3,NG218,"What strategies can improve vaccine access and uptake among immigrant and Traveller, Roma, Gypsy communities?"
NG218_Rationale and impact: Audit and feedback - Part 1,NG218,What is the effectiveness of audit and feedback in increasing vaccination uptake among healthcare providers?
NG218_Rationale and impact: Audit and feedback - Part 2,NG218,How can vaccination initiatives during the COVID-19 pandemic be evaluated for their effectiveness in increasing vaccine uptake?
NG218_Rationale and impact: Training and education for health and social care practitioners - Part 1,NG218,What training and education are recommended for health and social care practitioners to improve vaccine uptake and address vaccine hesitancy?
NG218_Rationale and impact: Training and education for health and social care practitioners - Part 2,NG218,What training is recommended for healthcare and social care staff to improve vaccination conversations and signposting?
NG218_Rationale and impact: Appointments and consultations,NG218,What is the recommended duration for vaccination appointments to ensure informed consent and address patient concerns?
NG218_Rationale and impact: Using compatible systems and processes,NG218,What are effective compatible processes for sharing vaccination records between healthcare providers?
NG218_Rationale and impact: Keeping records up to date - Part 1,NG218,How can general practices ensure their vaccination records are kept accurate and up to date?
NG218_Rationale and impact: Keeping records up to date - Part 2,NG218,How can general practices improve the accuracy of vaccination records and contact details to enhance vaccine uptake?
NG218_Rationale and impact: Identifying people eligible for vaccination and opportunistic vaccination - Part 1,NG218,How can healthcare providers identify and vaccinate people who are outside the healthcare system or at risk of missing routine vaccinations?
NG218_Rationale and impact: Identifying people eligible for vaccination and opportunistic vaccination - Part 2,NG218,What are the recommended methods for identifying and verifying vaccination status in adults and pregnant women?
NG218_Rationale and impact: Identifying people eligible for vaccination and opportunistic vaccination - Part 3,NG218,How can healthcare providers increase opportunistic vaccination uptake using existing records and contact opportunities?
NG218_Rationale and impact: Recording vaccination offers and administration - Part 1,NG218,What information should be recorded when administering vaccinations according to NICE guidelines?
NG218_Rationale and impact: Recording vaccination offers and administration - Part 2,NG218,What are the best practices for recording and updating vaccination information in electronic health records?
NG218_Rationale and impact: System organisation and accessibility issues - Part 1,NG218,What strategies can improve the effectiveness of vaccination invitations and reminders for diverse populations?
NG218_Rationale and impact: System organisation and accessibility issues - Part 2,NG218,How can healthcare providers improve access and understanding of vaccination schedules for people from abroad?
NG218_Rationale and impact: Initial invitations - Part 1,NG218,What are the recommended methods for inviting people to receive routine vaccinations?
NG218_Rationale and impact: Initial invitations - Part 2,NG218,What information should be included in vaccination invitations to improve uptake and address barriers?
NG218_Rationale and impact: Initial invitations - Part 3,NG218,How can healthcare providers improve communication to increase vaccination uptake and address concerns about vaccine safety and timing?
NG218_Rationale and impact: Initial invitations - Part 4,NG218,"What are effective strategies to increase vaccination uptake among pregnant women, older adults, and low-coverage communities?"
NG218_Rationale and impact: Reminders and escalation of contact - Part 1,NG218,What are effective strategies for escalating contact to improve vaccination uptake?
NG218_Rationale and impact: Reminders and escalation of contact - Part 2,NG218,What are effective and cost-effective strategies for increasing vaccination uptake in hesitant or hard-to-reach populations?
NG218_Rationale and impact: Reminders and escalation of contact - Part 3,NG218,How can multidisciplinary approaches and home visits improve vaccination uptake in underserved populations?
NG218_Rationale and impact: People who are not registered with a GP practice - Part 1,NG218,"What strategies can be used to ensure vaccination access for people not registered with a GP practice, such as Travellers, homeless individuals, and immigrants?"
NG218_Rationale and impact: People who are not registered with a GP practice - Part 2,NG218,How can local authorities improve vaccination access for people not registered with a GP practice?
NG218_Rationale and impact: Vaccinations for school-aged children and young people - Part 1,NG218,What are the NICE recommendations for vaccinating school-aged children and young people in schools?
NG218_Rationale and impact: Vaccinations for school-aged children and young people - Part 2,NG218,What strategies can improve the return rate of consent forms for school vaccinations?
NG218_Rationale and impact: Vaccinations for school-aged children and young people - Part 3,NG218,What are the best practices for assessing Gillick competence in young people for vaccination consent?
NG218_Rationale and impact: Vaccinations for school-aged children and young people - Part 4,NG218,What are effective strategies to increase vaccination uptake among school-aged children and young people?
NG218_Rationale and impact: Vaccinations for school-aged children and young people - Part 5,NG218,What are effective strategies for increasing vaccination uptake among school-aged children?
NG218_Context,NG218,What strategies can improve vaccination uptake among populations with low coverage?
NG219_Gout: diagnosis and management & Overview & Recommendations: 1.1 Diagnosis and assessment - Part 1,NG219,What are the key signs and symptoms used to diagnose gout?
NG219_Recommendations: 1.1 Diagnosis and assessment - Part 2,NG219,What is the recommended approach for diagnosing gout using serum urate levels and joint aspiration?
NG219_Recommendations: 1.2 Information and support,NG219,What information should be provided to patients and families about managing gout and preventing flares?
NG219_Recommendations: 1.3 Managing gout flares - Part 1,NG219,What are the recommended first-line treatments for managing gout flares?
NG219_Recommendations: 1.3 Managing gout flares - Part 2,NG219,What are the recommended follow-up procedures after a gout flare?
NG219_Recommendations: 1.4 Diet and lifestyle,NG219,What lifestyle changes are recommended for managing gout symptoms?
NG219_Recommendations: 1.5 Long-term management of gout - Part 1,NG219,When should urate-lowering therapy be started in people with gout?
NG219_Recommendations: 1.5 Long-term management of gout - Part 2,NG219,What is the recommended treat-to-target serum urate level for gout management according to NICE guidelines?
NG219_Recommendations: 1.5 Long-term management of gout - Part 3,NG219,What are the recommended second-line treatments for gout when first-line urate-lowering therapy is not tolerated or effective?
NG219_Recommendations: 1.5 Long-term management of gout - Part 4,NG219,What are the recommended approaches to prevent gout flares when initiating urate-lowering therapy?
NG219_Recommendations: 1.6 Referral to specialist services,NG219,When should I refer a patient with gout to a specialist rheumatology service?
NG219_Recommendations for research: Key recommendations for research - Part 1,NG219,What is the clinical and cost effectiveness of colchicine compared to corticosteroids for managing gout flares?
NG219_Recommendations for research: Key recommendations for research - Part 2,NG219,What is the recommended target serum urate level for treating gout in patients with CKD?
NG219_Recommendations for research: Other recommendations for research & Rationale and impact: Symptoms and signs of gout,NG219,What are the best practices for initiating urate-lowering therapy during a gout flare?
NG219_Rationale and impact: Diagnosis,NG219,What are the recommended methods for diagnosing gout in clinical practice?
NG219_Rationale and impact: Information and support,NG219,What information should healthcare professionals provide to patients about gout management and long-term treatment options?
NG219_Rationale and impact: Managing gout flares,NG219,What are the recommended pharmacological treatments for managing gout flares?
NG219_Rationale and impact: Follow-up after a gout flare,NG219,What is the recommended follow-up approach after a gout flare to improve long-term management?
NG219_Rationale and impact: Diet and lifestyle,NG219,What dietary modifications are recommended for managing gout?
NG219_Rationale and impact: Management of gout with urate-lowering therapies - Part 1,NG219,What are the recommendations for long-term urate-lowering therapy in gout management?
NG219_Rationale and impact: Management of gout with urate-lowering therapies - Part 2,NG219,When is the best time to start urate-lowering therapy after a gout flare?
NG219_Rationale and impact: Treat-to-target strategy,NG219,What is the effectiveness of treat-to-target strategies for gout management?
NG219_Rationale and impact: Target serum urate level,NG219,What is the recommended target serum urate level for gout management?
NG219_Rationale and impact: Urate-lowering therapies - Part 1,NG219,What are the differences between allopurinol and febuxostat for urate-lowering therapy in gout management?
NG219_Rationale and impact: Urate-lowering therapies - Part 2,NG219,What are the recommended first-line and second-line urate-lowering therapies for patients with major cardiovascular disease?
NG219_Rationale and impact: Preventing gout flares when starting or titrating ULT,NG219,What are the recommended options for preventing gout flares during initiation or titration of urate-lowering therapy?
NG219_Rationale and impact: Monitoring serum urate level,NG219,What is the recommended frequency for monitoring serum urate levels in people on urate-lowering therapy?
NG219_Rationale and impact: Referral to specialist services - Part 1,NG219,When should patients with gout be referred to a specialist rheumatologist or gout services?
NG219_Rationale and impact: Referral to specialist services - Part 2,NG219,What are the indications for surgical removal of tophi in gout patients?
NG219_Context,NG219,What are the recommended management strategies for gout in patients with chronic kidney disease?
NG21_Home care: delivering personal care and practical support to older people living in their own homes & Overview & Recommendations: 1.1 Ensuring care is person centred,NG21,How can home care services ensure person-centred support that promotes independence and respects patient preferences?
NG21_Recommendations: 1.2 Providing information about care and support options - Part 1,NG21,What information should be provided to people using home care services about funding options and support available?
NG21_Recommendations: 1.2 Providing information about care and support options - Part 2,NG21,What information should home care services provide to help patients and carers make informed choices about care?
NG21_Recommendations: 1.3 Planning and reviewing home care and support - Part 1,NG21,What are the best practices for planning and coordinating home care for older people?
NG21_Recommendations: 1.3 Planning and reviewing home care and support - Part 2,NG21,How can I ensure person-centered planning and support in home care services?
NG21_Recommendations: 1.3 Planning and reviewing home care and support - Part 3,NG21,What are the key components of effective home care planning for adults requiring social care support?
NG21_Recommendations: 1.3 Planning and reviewing home care and support - Part 4,NG21,How should home care plans and care diaries be managed and reviewed for people receiving home care services?
NG21_Recommendations: 1.4 Delivering home care - Part 1,NG21,What are the NICE recommendations for delivering person-centred home care and contracting home care services?
NG21_Recommendations: 1.4 Delivering home care - Part 2,NG21,What are the best practices for managing complaints and ensuring continuity of care in home care services?
NG21_Recommendations: 1.4 Delivering home care - Part 3 & Recommendations: 1.5 Joint working between health and social care,NG21,What are best practices for managing missed or late home visits and ensuring effective telecare use?
NG21_Recommendations: 1.6 Ensuring safety and safeguarding people using home care services,NG21,What are the recommended procedures for safeguarding and reporting abuse in home care services?
"NG21_Recommendations: 1.7 Recruiting, training and supporting home care workers - Part 1",NG21,What training and support should home care workers receive to ensure safe and compassionate care?
"NG21_Recommendations: 1.7 Recruiting, training and supporting home care workers - Part 2 & Recommendations: Terms used in this guideline",NG21,What are the key components of safe care policies and procedures in home care services?
NG21_Recommendations for research: 1 Intensity of home care packages & Recommendations for research: 2 Telecare,NG21,What is the effectiveness and cost effectiveness of different intensities of home care packages and telecare components for older adults with complex care needs?
NG21_Recommendations for research: 3 Training & Recommendations for research: 4 Specialist dementia support,NG21,What is the most effective way to support people with dementia living at home?
"NG21_Recommendations for research: 5 Safety and safeguarding & Home care implementation: getting started: The challenge: delivering services that support the aspirations, goals and priorities of the person",NG21,What are the most effective safeguarding practices to improve safety and wellbeing in adult social care?
NG21_Home care implementation: getting started: The challenge: working together to ensure care and support is coordinated,NG21,How can care coordination improve outcomes and support for people receiving home care?
NG21_Home care implementation: getting started: The challenge: strategic partnership working to deliver high quality and integrated home care & Home care implementation: getting started: Need more help?,NG21,"How can healthcare organizations improve partnership working to deliver high-quality, integrated home care?"
NG21_Context,NG21,What are the best practices for delivering person-centred home care for older people?
NG220_Multiple sclerosis in adults: management & Overview,NG220,What are the recommended management strategies for multiple sclerosis in adults?
NG220_Recommendations: 1.1 Diagnosing multiple sclerosis - Part 1,NG220,What are the key clinical features and diagnostic criteria for diagnosing multiple sclerosis?
NG220_Recommendations: 1.1 Diagnosing multiple sclerosis - Part 2,NG220,What are the diagnostic criteria for relapsing–remitting multiple sclerosis according to NICE guidelines?
NG220_Recommendations: 1.2 Providing information and support - Part 1,NG220,What information and support should be provided to people with multiple sclerosis at diagnosis and during ongoing care?
NG220_Recommendations: 1.2 Providing information and support - Part 2,NG220,What information and support should be provided to people with MS planning to have children or who are pregnant?
NG220_Recommendations: 1.2 Providing information and support - Part 3,NG220,How can I support a child with MS and manage fatigue and other symptoms?
NG220_Recommendations: 1.3 Coordination of care,NG220,What is the recommended approach for coordinating care for people with multiple sclerosis?
NG220_Recommendations: 1.4 Modifiable risk factors for relapse or progression of MS,NG220,What lifestyle modifications can help reduce the risk of MS relapse or progression?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 1,NG220,What are the recommended approaches for managing fatigue in people with multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 2,NG220,What are the recommended non-pharmacological and pharmacological options for managing fatigue in people with multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 3,NG220,What are the safety considerations and monitoring requirements for using modafinil in patients planning pregnancy?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 4,NG220,What are the current recommendations for pharmacological management of fatigue and mobility problems in multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 5,NG220,What are non-pharmacological options for managing mobility problems and fatigue in people with multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 6,NG220,What are the guidelines for using gabapentin as a second-line treatment for spasticity in multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 7,NG220,What are the recommended treatments for oscillopsia according to NICE guidelines?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 8,NG220,What are the recommended treatments for oscillopsia in people with multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 9,NG220,What are the recommended approaches for managing pain and cognitive problems in people with multiple sclerosis?
NG220_Recommendations: 1.5 MS symptom management and rehabilitation - Part 10,NG220,What are the recommended non-pharmacological management strategies for cognitive impairments in multiple sclerosis?
NG220_Recommendations: 1.6 Comprehensive review - Part 1,NG220,What should be included in a comprehensive annual review for people with multiple sclerosis?
NG220_Recommendations: 1.6 Comprehensive review - Part 2,NG220,What are the recommended assessments and reviews for managing multiple sclerosis according to NICE guidelines?
NG220_Recommendations: 1.7 Relapse and exacerbation - Part 1,NG220,How should an MS relapse be diagnosed and treated according to NICE guidelines?
NG220_Recommendations: 1.7 Relapse and exacerbation - Part 2,NG220,Should people with MS be prescribed steroids to self-administer during relapses?
NG220_Recommendations: 1.8 Other treatments & Recommendations: Terms used in this guideline,NG220,Should vitamin D or omega fatty acids be offered to treat multiple sclerosis?
NG220_Recommendations for research: Key recommendations for research,NG220,What are the most effective care coordination strategies and non-pharmacological interventions for improving outcomes in adults with multiple sclerosis?
NG220_Recommendations for research: Other recommendations for research - Part 1,NG220,What are the most effective pharmacological treatments for spasticity in adults with multiple sclerosis?
NG220_Recommendations for research: Other recommendations for research - Part 2,NG220,What is the clinical and cost effectiveness of pharmacological treatments for fatigue in adults with multiple sclerosis?
NG220_Rationale and impact: Diagnosing multiple sclerosis,NG220,What are the updated criteria for diagnosing multiple sclerosis according to NICE guidelines?
NG220_Rationale and impact: Providing information and support - Part 1,NG220,What information and support should be provided to people with multiple sclerosis and their carers?
NG220_Rationale and impact: Providing information and support - Part 2,NG220,What information and support are available for people with multiple sclerosis planning a family or approaching end of life?
NG220_Rationale and impact: Coordination of care,NG220,What are the best practices for coordinating care for people with multiple sclerosis?
NG220_Rationale and impact: Assessment and non-pharmacological management of fatigue - Part 1,NG220,What are the recommended non-pharmacological strategies for managing fatigue in multiple sclerosis?
NG220_Rationale and impact: Assessment and non-pharmacological management of fatigue - Part 2,NG220,Why is hyperbaric oxygen not recommended for managing MS-related fatigue according to NICE guidelines?
NG220_Rationale and impact: Pharmacological management of fatigue - Part 1,NG220,What are the considerations for pharmacological treatment of fatigue in multiple sclerosis?
NG220_Rationale and impact: Pharmacological management of fatigue - Part 2 & Rationale and impact: Pharmacological management of mobility problems,NG220,What are the recommended pharmacological treatments for managing fatigue and mobility problems in multiple sclerosis?
NG220_Rationale and impact: Spasticity - Part 1,NG220,What are the current recommendations for managing spasticity in multiple sclerosis?
NG220_Rationale and impact: Spasticity - Part 2,NG220,What are the recommended approaches for escalating pharmacological treatment of spasticity in multiple sclerosis?
NG220_Rationale and impact: Pain,NG220,What are the recommended approaches for diagnosing and managing pain in people with multiple sclerosis?
NG220_Rationale and impact: Cognitive and memory problems - Part 1,NG220,What are the recommended approaches for assessing cognitive and memory problems in multiple sclerosis patients?
NG220_Rationale and impact: Cognitive and memory problems - Part 2 & Rationale and impact: Pharmacological management of ataxia and tremor,NG220,What are the current recommendations for cognitive assessment and management in multiple sclerosis?
NG220_Context,NG220,What are the current NICE recommendations for diagnosing and managing multiple sclerosis?
NG221_Reducing sexually transmitted infections & Overview,NG221,What are the recommended interventions to reduce sexually transmitted infections in people aged 16 and over?
NG221_Recommendations: 1.1 Reducing the risk of people getting and transmitting sexually transmitted infections (STIs) - Part 1,NG221,What strategies can improve access to sexual health services for underserved communities?
NG221_Recommendations: 1.1 Reducing the risk of people getting and transmitting sexually transmitted infections (STIs) - Part 2,NG221,How can interventions be targeted to reduce STI transmission among high-risk groups with greater sexual health or access needs?
NG221_Recommendations: 1.1 Reducing the risk of people getting and transmitting sexually transmitted infections (STIs) - Part 3,NG221,What are effective strategies for co-producing culturally competent interventions to reduce STI transmission?
NG221_Recommendations: 1.1 Reducing the risk of people getting and transmitting sexually transmitted infections (STIs) - Part 4,NG221,"What are effective strategies for co-producing STI prevention interventions that consider behaviour change, safety concerns, and community preferences?"
NG221_Recommendations: 1.1 Reducing the risk of people getting and transmitting sexually transmitted infections (STIs) - Part 5,NG221,What are effective ways to deliver culturally sensitive and peer-led interventions for STI prevention?
NG221_Recommendations: 1.2 Improving uptake and increasing the frequency of STI testing - Part 1,NG221,What are effective strategies to improve uptake and frequency of STI testing through self-sampling?
NG221_Recommendations: 1.2 Improving uptake and increasing the frequency of STI testing - Part 2,NG221,How can interventions be tailored to increase STI testing among high-risk groups?
"NG221_Recommendations: 1.3 Partner notification & Recommendations: 1.4 HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men",NG221,What are the recommended methods for partner notification of sexually transmitted infections?
"NG221_Recommendations: 1.4 HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men - Part 1",NG221,"What are the recommendations for HPV, hepatitis A and B vaccination in gay, bisexual, and other men who have sex with men?"
"NG221_Recommendations: 1.4 HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men - Part 2",NG221,"How can healthcare providers improve HPV and hepatitis vaccination rates among gay, bisexual, and other men who have sex with men?"
NG221_Recommendations: 1.5 Pre-exposure prophylaxis for HIV - Part 1,NG221,What are the NICE recommendations for raising awareness and promoting access to HIV pre-exposure prophylaxis (PrEP) among high-risk populations?
NG221_Recommendations: 1.5 Pre-exposure prophylaxis for HIV - Part 2,NG221,"How can PrEP services be designed to ensure accessibility, awareness, and effective referral pathways for all eligible populations?"
NG221_Recommendations: 1.5 Pre-exposure prophylaxis for HIV - Part 3,NG221,What are the NICE guidelines for prescribing PrEP to high-risk individuals?
NG221_Recommendations: Terms used in this guideline,NG221,What are effective sex-positive approaches to improve sexual health and access for diverse populations?
NG221_Recommendations for research: Key recommendations for research - Part 1,NG221,What are the best strategies for integrating sexual health services with other healthcare services such as drug and alcohol treatment?
NG221_Recommendations for research: Key recommendations for research - Part 2,NG221,How can outreach services be tailored to improve access and STI testing uptake among high-risk and underserved groups?
NG221_Recommendations for research: Key recommendations for research - Part 3,NG221,What are the most effective strategies to reduce stigma associated with accessing sexual health services?
NG221_Recommendations for research: Other recommendations for research - Part 1,NG221,"What factors influence completion rates of hepatitis A, hepatitis B, and HPV vaccination courses and how can adherence be improved?"
NG221_Recommendations for research: Other recommendations for research - Part 2,NG221,What is the cost-effectiveness of offering PrEP to individuals without recent condomless sex?
NG221_Recommendations for research: Other recommendations for research - Part 3,NG221,"What strategies are effective in increasing the uptake and frequency of STI testing among high-risk groups, including online testing options?"
NG221_Rationale and impact: Accessing sexual health services,NG221,How can healthcare services improve access to sexual health services for high-risk and minority groups?
NG221_Rationale and impact: Meeting the needs of groups with greater sexual health or access needs - Part 1,NG221,What strategies are recommended for improving sexual health services for groups with greater access needs and social disadvantages?
NG221_Rationale and impact: Meeting the needs of groups with greater sexual health or access needs - Part 2,NG221,What are effective strategies for tailoring sexual health outreach services to underserved and high-risk groups?
NG221_Rationale and impact: Co-producing interventions to reduce STI transmission - Part 1,NG221,What are effective strategies for co-producing culturally sensitive interventions to reduce STI transmission?
NG221_Rationale and impact: Co-producing interventions to reduce STI transmission - Part 2,NG221,What are effective strategies for promoting correct and consistent condom use to prevent sexually transmitted infections?
NG221_Rationale and impact: Delivering and evaluating interventions to reduce STI transmission - Part 1,NG221,What are effective strategies for delivering and evaluating interventions to reduce sexually transmitted infection transmission?
NG221_Rationale and impact: Delivering and evaluating interventions to reduce STI transmission - Part 2,NG221,How should healthcare providers document and respect patients' gender identities and pronouns in sexual health records?
NG221_Rationale and impact: Self-sampling to improve the uptake and increase the frequency of STI testing - Part 1,NG221,What are the benefits and challenges of using self-sampling kits for STI testing outside clinical settings?
NG221_Rationale and impact: Self-sampling to improve the uptake and increase the frequency of STI testing - Part 2,NG221,What are the best practices for self-sampling for sexually transmitted infections and blood-borne viruses?
NG221_Rationale and impact: Self-sampling to improve the uptake and increase the frequency of STI testing - Part 3,NG221,What are effective strategies to increase STI testing uptake and ensure prompt treatment?
NG221_Rationale and impact: Tailoring interventions to improve the uptake and increase the frequency of STI testing,NG221,How can interventions be tailored to improve STI testing uptake among different communities?
NG221_Rationale and impact: Partner notification - Part 1,NG221,What are the recommended methods for partner notification in sexually transmitted infection management?
NG221_Rationale and impact: Partner notification - Part 2,NG221,What are effective methods for maintaining anonymity in partner notification for sexually transmitted infections?
"NG221_Rationale and impact: HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men - Part 1",NG221,"What are the current recommendations for HPV and hepatitis A and B vaccination in gay, bisexual, and other men who have sex with men?"
"NG221_Rationale and impact: HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men - Part 2",NG221,"How can healthcare professionals improve vaccination uptake among gay, bisexual, and other men who have sex with men?"
NG221_Rationale and impact: Raising awareness of pre-exposure prophylaxis for HIV - Part 1,NG221,What are effective strategies for raising awareness and increasing uptake of pre-exposure prophylaxis (PrEP) for HIV among at-risk populations?
NG221_Rationale and impact: Raising awareness of pre-exposure prophylaxis for HIV - Part 2,NG221,What are the safety considerations and drug interactions between PrEP and gender-affirming hormones in transgender individuals?
NG221_Rationale and impact: Service design for PrEP services,NG221,What training is recommended for healthcare professionals to improve access to PrEP services in primary care and community settings?
NG221_Rationale and impact: Access to PrEP services,NG221,What are the recommended strategies for improving access to PrEP services and referral pathways?
NG221_Rationale and impact: Prescribing PrEP - Part 1,NG221,What are the NICE recommendations for prescribing PrEP for HIV prevention?
NG221_Rationale and impact: Prescribing PrEP - Part 2,NG221,"What are the considerations for monitoring and managing adverse effects of PrEP, including kidney health and bone density?"
NG221_Context,NG221,What are the current recommendations for screening and management of sexually transmitted infections in young people and high-risk populations?
NG222_Depression in adults: treatment and management & Overview & Recommendations: 1.1 Principles of care,NG222,What are the recommended treatments for adults with depression according to NICE guidelines?
NG222_Recommendations: 1.2 Recognition and assessment - Part 1,NG222,What are the recommended methods for recognizing and assessing depression in people with physical health problems or communication difficulties?
NG222_Recommendations: 1.2 Recognition and assessment - Part 2,NG222,How should depression be comprehensively assessed and managed according to NICE guidelines?
NG222_Recommendations: 1.2 Recognition and assessment - Part 3,NG222,What are the recommended management strategies for depression in patients at risk of suicide?
NG222_Recommendations: 1.3 Choice of treatments,NG222,What are the NICE-recommended treatment options for depression and how should patient preferences be incorporated?
NG222_Recommendations: 1.4 Delivery of treatments - Part 1,NG222,What are the recommended approaches for delivering and monitoring treatment for depression?
NG222_Recommendations: 1.4 Delivery of treatments - Part 2,NG222,What are the recommended psychological and psychosocial interventions for depression according to NICE guidelines?
NG222_Recommendations: 1.4 Delivery of treatments - Part 3,NG222,"What information should be provided to patients starting antidepressant medication regarding effects, review timing, and withdrawal symptoms?"
NG222_Recommendations: 1.4 Delivery of treatments - Part 4,NG222,What are the best strategies for safely stopping antidepressant medication to minimize withdrawal symptoms?
NG222_Recommendations: 1.4 Delivery of treatments - Part 5,NG222,What are the recommended strategies for safely stopping or reducing antidepressant medication to manage withdrawal symptoms?
NG222_Recommendations: 1.4 Delivery of treatments - Part 6,NG222,What are the recommended monitoring and risk management strategies for patients starting antidepressant treatment?
NG222_Recommendations: 1.4 Delivery of treatments - Part 7,NG222,What are the recommended monitoring and dosing guidelines for lithium therapy in adults?
NG222_Recommendations: 1.4 Delivery of treatments - Part 8,NG222,What are the recommended monitoring procedures for patients on oral antipsychotics used as augmentation for depression?
NG222_Recommendations: 1.4 Delivery of treatments - Part 9,NG222,What are the safety considerations and recommended uses of St John's Wort for depression management?
NG222_Recommendations: 1.5 Treatment for a new episode of less severe depression - Part 1,NG222,What are the recommended first-line treatments for less severe depression according to NICE guidelines?
NG222_Recommendations: 1.5 Treatment for a new episode of less severe depression - Part 2,NG222,What are the recommended treatment options for less severe depression according to NICE guidelines?
NG222_Recommendations: 1.5 Treatment for a new episode of less severe depression - Part 3 & Recommendations: 1.5 Treatment for a new episode of less severe depression - Part 4 & Recommendations: 1.6 Treatment for a new episode of more severe depression - Part 1,NG222,What are the recommended treatment options for a new episode of more severe depression according to NICE guidelines?
NG222_Recommendations: 1.6 Treatment for a new episode of more severe depression - Part 2,NG222,What are the recommended treatment options for severe depression according to NICE guidelines?
NG222_Recommendations: 1.6 Treatment for a new episode of more severe depression - Part 3 & Recommendations: 1.7 Behavioural couples therapy for depression,NG222,What is the effectiveness of behavioural couples therapy for treating depression with relationship problems?
NG222_Recommendations: 1.8 Preventing relapse - Part 1,NG222,What are the recommendations for preventing relapse in depression according to NICE guidelines?
NG222_Recommendations: 1.8 Preventing relapse - Part 2,NG222,What are the recommended relapse prevention strategies for people in remission from depression?
NG222_Recommendations: 1.8 Preventing relapse - Part 3,NG222,What are the recommended strategies for preventing relapse in depression after treatment?
NG222_Recommendations: 1.9 Further-line treatment - Part 1,NG222,What are the recommended further-line treatment options for depression after initial treatments have failed?
NG222_Recommendations: 1.9 Further-line treatment - Part 2,NG222,How should antidepressant therapy be adjusted if there is a limited response to initial treatment?
NG222_Recommendations: 1.9 Further-line treatment - Part 3,NG222,What are the risks and considerations of combining different antidepressant medications in treatment-resistant depression?
NG222_Recommendations: 1.10 Chronic depressive symptoms - Part 1,NG222,What are the recommended treatment options for chronic depressive symptoms with significant impairment?
NG222_Recommendations: 1.10 Chronic depressive symptoms - Part 2,NG222,What are the treatment options for chronic depression when SSRIs are not tolerated or ineffective?
NG222_Recommendations: 1.10 Chronic depressive symptoms - Part 3,NG222,What are recommended approaches for managing chronic depression that does not respond to initial treatments?
NG222_Recommendations: 1.11 Depression in people with a diagnosis of personality disorder,NG222,What are the recommended treatments for depression in people with coexisting personality disorder?
NG222_Recommendations: 1.12 Psychotic depression - Part 1,NG222,What are the recommended treatment options for psychotic depression according to NICE guidelines?
NG222_Recommendations: 1.12 Psychotic depression - Part 2,NG222,How should depression with psychotic symptoms be monitored and managed with antipsychotic medication?
NG222_Recommendations: 1.13 Electroconvulsive therapy for depression - Part 1,NG222,When is electroconvulsive therapy recommended for severe depression?
NG222_Recommendations: 1.13 Electroconvulsive therapy for depression - Part 2 & Recommendations: 1.14 Transcranial magnetic stimulation for depression,NG222,What are the NICE guidelines for providing electroconvulsive therapy for depression?
NG222_Recommendations: 1.15 Treatment-resistant depression,NG222,What are the recommended treatment options for treatment-resistant depression according to NICE guidelines?
"NG222_Recommendations: 1.16 Access, coordination and delivery of care - Part 1",NG222,What are the recommended models and pathways for accessing and coordinating care for people with depression?
"NG222_Recommendations: 1.16 Access, coordination and delivery of care - Part 2",NG222,What strategies can improve access and retention of mental health services for people with depression?
"NG222_Recommendations: 1.16 Access, coordination and delivery of care - Part 3",NG222,What are the recommended care pathways for severe depression requiring specialist and crisis intervention?
"NG222_Recommendations: 1.16 Access, coordination and delivery of care - Part 4",NG222,What are the recommended crisis management and treatment planning strategies for people with depression receiving community or inpatient care?
NG222_Recommendations: Terms used in this guideline - Part 1,NG222,What is the definition of chronic depressive symptoms according to NICE guidelines?
NG222_Recommendations: Terms used in this guideline - Part 2,NG222,What are the clinical features and diagnostic criteria for depression according to NICE guidelines?
NG222_Recommendations: Terms used in this guideline - Part 3,NG222,What are the recommended approaches for managing moderate to severe depression according to NICE guidelines?
NG222_Recommendations for research: Key recommendations for research - Part 1,NG222,What is the incidence and severity of withdrawal symptoms after stopping antidepressants?
NG222_Recommendations for research: Key recommendations for research - Part 2,NG222,"What are the benefits and harms of further-line psychological, pharmacological, and physical treatments for adults with depression who do not respond to initial psychological therapy?"
NG222_Recommendations for research: Other recommendations for research - Part 1,NG222,What is the effectiveness of peer support as a stand-alone or adjunct treatment for less severe depression?
NG222_Recommendations for research: Other recommendations for research - Part 2,NG222,What are the most effective treatments for psychotic depression and relapse prevention with electroconvulsive therapy?
NG222_Rationale and impact: Choice of treatments,NG222,How should healthcare professionals involve patients in choosing treatment options for depression?
NG222_Rationale and impact: Starting and stopping antidepressants & Rationale and impact: Use of lithium as augmentation,NG222,What are the best practices for starting and stopping antidepressants safely?
NG222_Rationale and impact: Use of oral antipsychotics as augmentation & Rationale and impact: Activities to help wellbeing,NG222,What are the NICE recommendations on using oral antipsychotics as augmentation therapy in psychosis?
NG222_Rationale and impact: Treatment for a new episode of less severe depression - Part 1,NG222,What are the recommended psychological treatments for less severe depression according to NICE guidelines?
NG222_Rationale and impact: Treatment for a new episode of less severe depression - Part 2,NG222,What are the recommended treatment options for less severe depression according to NICE guidelines?
NG222_Rationale and impact: Treatment for a new episode of more severe depression - Part 1,NG222,What are the recommended treatment options for a new episode of severe depression?
NG222_Rationale and impact: Treatment for a new episode of more severe depression - Part 2 & Rationale and impact: Behavioural couples therapy,NG222,What are the recommended treatment options for depression that include therapist contact or group interventions?
NG222_Rationale and impact: Preventing relapse,NG222,What are the recommended strategies for preventing relapse in depression?
NG222_Rationale and impact: Further-line treatment - Part 1,NG222,What are the recommended further-line treatments for depression after failure of initial therapies?
NG222_Rationale and impact: Further-line treatment - Part 2,NG222,What are the current NICE recommendations for using electroconvulsive therapy in the treatment of depression?
NG222_Rationale and impact: Chronic depressive symptoms,NG222,What are the recommended treatment options for managing chronic depressive symptoms according to NICE guidelines?
NG222_Rationale and impact: Depression in people with a diagnosis of personality disorder,NG222,What are the recommended treatment options for depression in people with personality disorder?
NG222_Rationale and impact: Psychotic depression,NG222,What are the recommended treatment options for psychotic depression involving antidepressant and antipsychotic combination therapy?
NG222_Rationale and impact: Access to services,NG222,What are effective strategies to improve access to depression treatment for underserved and underrepresented groups?
NG222_Rationale and impact: Collaborative care and specialist care,NG222,What are the benefits of collaborative care for depression management?
"NG222_Rationale and impact: Crisis care, home treatment and inpatient care",NG222,What are the benefits of crisis resolution and home treatment teams for severe depression?
NG222_Context,NG222,What are the recommended approaches for diagnosing and managing depression in adults?
"NG223_Social, emotional and mental wellbeing in primary and secondary education & Overview",NG223,"What strategies can be used to support social, emotional, and mental wellbeing in children and young people in schools?"
NG223_Recommendations: 1.1 Whole-school approach - Part 1,NG223,What are the key components of a whole-school approach to promoting mental wellbeing in primary and secondary education?
NG223_Recommendations: 1.1 Whole-school approach - Part 2,NG223,What strategies can schools use to promote staff wellbeing and psychological safety?
NG223_Recommendations: 1.1 Whole-school approach - Part 3,NG223,What is the recommended 'step up–step down' approach for supporting children's mental health in schools?
NG223_Recommendations: 1.2 Universal curriculum content - Part 1,NG223,"What are effective strategies for integrating social, emotional, and mental wellbeing education into the school curriculum?"
NG223_Recommendations: 1.2 Universal curriculum content - Part 2,NG223,What are recommended universal interventions for promoting mental health and well-being in schools?
"NG223_Recommendations: 1.3 Identifying children and young people at risk of poor social, emotional and mental wellbeing - Part 1",NG223,"How can healthcare professionals identify children and young people at risk of poor social, emotional, and mental wellbeing?"
"NG223_Recommendations: 1.3 Identifying children and young people at risk of poor social, emotional and mental wellbeing - Part 2",NG223,"What are the recommended tools for assessing social, emotional, and mental wellbeing in children and young people?"
NG223_Recommendations: 1.4 Targeted support - Part 1,NG223,"How should healthcare professionals identify and provide targeted social, emotional, and mental health support for children and young people?"
NG223_Recommendations: 1.4 Targeted support - Part 2,NG223,What are effective strategies for providing targeted social and emotional support to children and young people?
NG223_Recommendations: 1.5 Support with school-related transitions and other life changes - Part 1,NG223,What strategies can help children and young people manage school transitions and related life changes effectively?
NG223_Recommendations: 1.5 Support with school-related transitions and other life changes - Part 2,NG223,How can schools support children and young people during transitions to promote their wellbeing and sense of belonging?
NG223_Recommendations: Terms used in this guideline - Part 1,NG223,What are the key principles of relational approaches to managing challenging behaviour in children?
NG223_Recommendations: Terms used in this guideline - Part 2,NG223,What are effective trauma-informed approaches for supporting children with mental health difficulties in schools?
NG223_Recommendations for research: Key recommendations for research - Part 1,NG223,"What are the early signs and risk factors of poor social, emotional, and mental wellbeing in children and young people?"
NG223_Recommendations for research: Key recommendations for research - Part 2,NG223,"What is the effectiveness of targeted interventions for children and young people with mental health needs considering social, cultural, and personal factors?"
NG223_Recommendations for research: Key recommendations for research - Part 3,NG223,"What are effective and cost-effective interventions to promote social, emotional, and mental wellbeing in children and young people?"
NG223_Recommendations for research: Other recommendations for research - Part 1,NG223,What are the potential harms and unintended consequences of targeted mental health interventions for children and young people with special educational needs?
NG223_Recommendations for research: Other recommendations for research - Part 2,NG223,What are effective strategies to support children and young people during transitions in education and mental health care?
NG223_Recommendations for research: Other recommendations for research - Part 3,NG223,What are the long-term effects of COVID-19 on the mental health of children and young people?
NG223_Rationale and impact: Whole-school approach - Part 1,NG223,What is a whole-school approach to promoting children and young people's mental health and wellbeing?
NG223_Rationale and impact: Whole-school approach - Part 2,NG223,What are effective strategies for implementing a whole-school relational approach to improve children and young people's mental health?
NG223_Rationale and impact: Whole-school approach - Part 3,NG223,What strategies can schools use to support staff wellbeing and involve families in promoting mental health?
NG223_Rationale and impact: Whole-school approach - Part 4,NG223,"How can schools effectively implement a whole-school approach to improve children's social, emotional, and mental wellbeing?"
NG223_Rationale and impact: Universal curriculum content - Part 1,NG223,"What are the recommended components of universal curriculum content to promote social, emotional, and mental wellbeing in schools?"
NG223_Rationale and impact: Universal curriculum content - Part 2,NG223,"What are effective school-based interventions to improve social, emotional, and mental wellbeing in children and young people?"
"NG223_Rationale and impact: Identifying children and young people at risk of poor social, emotional and mental wellbeing - Part 1",NG223,"What are the risk factors for poor social, emotional, and mental wellbeing in children and young people?"
"NG223_Rationale and impact: Identifying children and young people at risk of poor social, emotional and mental wellbeing - Part 2",NG223,What are effective strategies for school staff to identify mental health issues in children and young people?
"NG223_Rationale and impact: Identifying children and young people at risk of poor social, emotional and mental wellbeing - Part 3",NG223,"What factors should be considered when selecting tools to assess social, emotional, and mental wellbeing in children and young people?"
NG223_Rationale and impact: Targeted support - Part 1,NG223,What are effective targeted support strategies for children and young people with mental health needs in secondary and primary schools?
NG223_Rationale and impact: Targeted support - Part 2,NG223,"What are best practices for providing targeted social, emotional, and mental health support in schools?"
NG223_Rationale and impact: Support with school-related transitions and other life changes - Part 1,NG223,What strategies are effective for supporting children and young people during school transitions and life changes?
NG223_Rationale and impact: Support with school-related transitions and other life changes - Part 2,NG223,What strategies can schools use to support children and young people during transitions between educational settings?
NG223_Context,NG223,What strategies do NICE guidelines recommend for promoting mental health and wellbeing in schools?
NG224_Urinary tract infection in under 16s: diagnosis and management & Overview,NG224,What are the recommended methods for diagnosing urinary tract infections in children under 16?
NG224_Recommendations: 1.1 Diagnosis - Part 1,NG224,What are the indications for urine testing in children suspected of having a urinary tract infection?
NG224_Recommendations: 1.1 Diagnosis - Part 2,NG224,When should urine testing be considered for children under 5 with fever and no obvious cause?
NG224_Recommendations: 1.1 Diagnosis - Part 3,NG224,What are the recommended management strategies for bacterial infections in babies up to 28 days old according to NICE guidelines?
NG224_Recommendations: 1.1 Diagnosis - Part 4,NG224,What is the recommended method for urine collection in children suspected of urinary tract infection?
NG224_Recommendations: 1.1 Diagnosis - Part 5,NG224,What are the recommended urine dipstick testing strategies for diagnosing urinary tract infections in children aged 3 years and older?
NG224_Recommendations: 1.1 Diagnosis - Part 6,NG224,What are the criteria for interpreting microscopy results in diagnosing urinary tract infections in children?
NG224_Recommendations: 1.2 Acute management - Part 1,NG224,What is the recommended management and antibiotic treatment for urinary tract infections in babies and children?
NG224_Recommendations: 1.2 Acute management - Part 2,NG224,What are the recommended management strategies for urinary tract infections in babies and children according to NICE guidelines?
NG224_Recommendations: 1.3 Imaging tests - Part 1,NG224,When should imaging tests be performed for children with urinary tract infections?
NG224_Recommendations: 1.3 Imaging tests - Part 2,NG224,When should imaging be performed after a child's urinary tract infection?
NG224_Recommendations: 1.3 Imaging tests - Part 3 & Recommendations: 1.4 Surgical intervention,NG224,What is the recommended imaging schedule for diagnosing urinary tract infections in children aged 6 months to under 3 years?
NG224_Recommendations: 1.5 Follow up,NG224,What are the recommended follow-up procedures for children after urinary tract infection investigations?
NG224_Recommendations: 1.6 Information and advice & Recommendations: Terms used in this guideline,NG224,What information should healthcare professionals provide to children and parents about urinary tract infections in young people?
NG224_Recommendations for research: 1 Symptoms and signs of urinary tract infection in children and young people aged 5 years and above but under 16 years & Recommendations for research: 2 Long-term risk of renal scarring and impaired renal function & Recommendations for research: 3 Symptoms and signs of recurrent UTI,NG224,What are the symptoms and signs of urinary tract infection in children aged 5 to 15 years?
NG224_Recommendations for research: 4 Symptoms and signs of long-term (chronic) UTI,NG224,What are the symptoms and signs of long-term urinary tract infection in children and young people?
NG224_Rationale and impact: Symptoms and signs - Part 1,NG224,What are the key symptoms and signs used to diagnose urinary tract infections in children?
NG224_Rationale and impact: Symptoms and signs - Part 2,NG224,When should urine testing be performed to diagnose urinary tract infection in children?
NG224_Rationale and impact: Symptoms and signs - Part 3,NG224,What are the current recommendations for diagnosing urinary tract infections in babies and children?
NG224_Rationale and impact: Urine testing,NG224,When should urine dipstick testing be used to diagnose urinary tract infections in children aged 3 months to 3 years?
NG224_Context,NG224,What are the current recommendations for diagnosing and managing urinary tract infections in children?
"NG225_Self-harm: assessment, management and preventing recurrence & Overview",NG225,What are the recommended approaches for assessing and managing self-harm to prevent recurrence?
NG225_Recommendations: 1.1 Information and support - Part 1,NG225,What information and support should be provided to individuals who have self-harmed and their families?
NG225_Recommendations: 1.1 Information and support - Part 2,NG225,How should information and support be tailored for individuals who have self-harmed based on their circumstances and needs?
NG225_Recommendations: 1.2 Consent and confidentiality,NG225,What are the best practices for obtaining consent and maintaining confidentiality when working with individuals who self-harm?
NG225_Recommendations: 1.3 Safeguarding,NG225,What are the safeguarding procedures for staff managing patients who self-harm?
NG225_Recommendations: 1.4 Involving family members and carers,NG225,How should healthcare professionals involve family members and carers in the care of individuals who have self-harmed?
NG225_Recommendations: 1.5 Psychosocial assessment and care by mental health professionals - Part 1,NG225,What are the recommended practices for psychosocial assessment after self-harm?
NG225_Recommendations: 1.5 Psychosocial assessment and care by mental health professionals - Part 2,NG225,What are the key components of psychosocial assessment for individuals who self-harm?
NG225_Recommendations: 1.5 Psychosocial assessment and care by mental health professionals - Part 3,NG225,How should a care plan be developed and reviewed for individuals who self-harm?
NG225_Recommendations: 1.6 Risk assessment tools and scales,NG225,Should risk assessment tools be used to predict future self-harm or determine treatment eligibility in mental health care?
NG225_Recommendations: 1.7 Assessment and care by healthcare professionals and social care practitioners - Part 1,NG225,What are the recommended assessment and care procedures for healthcare professionals following an episode of self-harm?
NG225_Recommendations: 1.7 Assessment and care by healthcare professionals and social care practitioners - Part 2,NG225,What are the recommended steps for assessing and managing self-harm in primary care and emergency settings according to NICE guidelines?
NG225_Recommendations: 1.7 Assessment and care by healthcare professionals and social care practitioners - Part 3,NG225,"What are the recommended procedures for managing self-harm in emergency departments, including mental health assessments and safeguarding?"
NG225_Recommendations: 1.7 Assessment and care by healthcare professionals and social care practitioners - Part 4,NG225,What are the recommended policies and procedures for managing self-harm patients in emergency and hospital settings?
NG225_Recommendations: 1.7 Assessment and care by healthcare professionals and social care practitioners - Part 5,NG225,What is the recommended social care approach for supporting individuals who have self-harmed?
NG225_Recommendations: 1.8 Assessment and care by professionals from other sectors - Part 1,NG225,What should non-health professionals do when someone self-harms in a criminal justice or educational setting?
NG225_Recommendations: 1.8 Assessment and care by professionals from other sectors - Part 2,NG225,What are the recommended policies and procedures for supporting students who self-harm in educational settings?
NG225_Recommendations: 1.8 Assessment and care by professionals from other sectors - Part 3,NG225,What are the recommended practices for supporting staff wellbeing and managing self-harm in criminal justice and secure settings?
NG225_Recommendations: 1.9 Admission to and discharge from hospital,NG225,What are the NICE guidelines for hospital admission and discharge procedures following self-harm?
NG225_Recommendations: 1.10 Initial aftercare after an episode of self-harm,NG225,What are the recommended initial aftercare procedures following an episode of self-harm?
NG225_Recommendations: 1.11 Interventions for self-harm - Part 1,NG225,What are the recommended interventions for managing self-harm in patients with coexisting mental health conditions?
NG225_Recommendations: 1.11 Interventions for self-harm - Part 2,NG225,What are the recommended psychological interventions for adults who self-harm according to NICE guidelines?
NG225_Recommendations: 1.11 Interventions for self-harm - Part 3,NG225,What are the recommended approaches for developing and sharing a safety plan for self-harm management?
NG225_Recommendations: 1.11 Interventions for self-harm - Part 4,NG225,What are the recommended interventions and assessment strategies for managing self-harm?
NG225_Recommendations: 1.12 Supporting people to be safe after self-harm,NG225,What are best practices for ensuring safety and continuity of care for people who have self-harmed?
NG225_Recommendations: 1.13 Safer prescribing and dispensing - Part 1,NG225,What are the best practices for prescribing and dispensing medicines to individuals at risk of self-harm?
NG225_Recommendations: 1.13 Safer prescribing and dispensing - Part 2,NG225,What are the warning signs of self-harm community pharmacy staff should be aware of?
NG225_Recommendations: 1.14 Training - Part 1,NG225,What training is recommended for staff working with people who self-harm?
NG225_Recommendations: 1.14 Training - Part 2,NG225,What training is recommended for staff managing self-harm cases according to NICE guidelines?
NG225_Recommendations: 1.15 Supervision,NG225,What are the recommended supervision practices for staff working with people who self-harm?
NG225_Terms used in this guideline - Part 1,NG225,What is the role of a designated lead in supporting student mental health in educational settings?
NG225_Terms used in this guideline - Part 2 & Recommendations for research: 1 Models of care,NG225,What are the most effective models of care for children and young people who self-harm?
NG225_Recommendations for research: 2 Assessment in non-specialist settings & Recommendations for research: 3 Routine admission to hospital,NG225,What are the most effective assessment strategies for non-specialist settings in managing self-harm?
NG225_Recommendations for research: 4 Psychological interventions & Recommendations for research: 5 Harm minimisation,NG225,What is the effectiveness of digital versus face-to-face psychological interventions for self-harm?
NG225_Rationale and impact: Information and support,NG225,What information and support should be provided to people who have self-harmed and their families?
NG225_Rationale and impact: Consent and confidentiality,NG225,What are the NICE guidelines on consent and confidentiality when managing self-harm?
NG225_Rationale and impact: Safeguarding,NG225,What are the recommended safeguarding procedures for healthcare staff when managing patients who have self-harmed?
NG225_Rationale and impact: Involving family members and carers,NG225,What are the NICE recommendations for involving family members and carers in the care of people who have self-harmed?
NG225_Rationale and impact: Psychosocial assessment and care by mental health professionals - Part 1,NG225,What are the recommended practices for psychosocial assessment and care by mental health professionals?
NG225_Rationale and impact: Psychosocial assessment and care by mental health professionals - Part 2,NG225,What are the recommended practices for assessing and managing self-harm in mental health services?
NG225_Rationale and impact: Risk assessment tools and scales,NG225,Why should risk assessment tools not be used to determine care for self-harm or suicide risk?
NG225_Rationale and impact: Assessment and care by healthcare professionals and social care practitioners - Part 1,NG225,What are the recommended approaches for assessment and care of individuals who have self-harmed?
NG225_Rationale and impact: Assessment and care by healthcare professionals and social care practitioners - Part 2,NG225,What are the recommended approaches for assessing and managing self-harm in primary care and emergency settings?
NG225_Rationale and impact: Assessment and care by healthcare professionals and social care practitioners - Part 3,NG225,What are the recommended practices for liaison psychiatry and mental health assessment in emergency departments for patients who have self-harmed?
NG225_Rationale and impact: Assessment and care by healthcare professionals and social care practitioners - Part 4,NG225,What are the NICE recommendations for assessing and managing self-harm in hospital and social care settings?
NG225_Rationale and impact: Assessment and care by professionals from other sectors - Part 1,NG225,What are the recommended approaches for assessment and care of individuals who have self-harmed in non-healthcare settings?
NG225_Rationale and impact: Assessment and care by professionals from other sectors - Part 2,NG225,How can staff in secure settings improve assessment and support for individuals who self-harm?
NG225_Rationale and impact: Admission to and discharge from hospital,NG225,What are the current NICE recommendations for hospital admission and discharge after self-harm?
NG225_Rationale and impact: Initial aftercare after an episode of self-harm - Part 1,NG225,What is the recommended timing and approach for initial aftercare following an episode of self-harm?
NG225_Rationale and impact: Initial aftercare after an episode of self-harm - Part 2,NG225,What is the impact of continuity of personnel on engagement and repeat self-harm after mental health assessment?
NG225_Rationale and impact: Interventions for self-harm - Part 1,NG225,What are the recommended psychosocial interventions for self-harm in adults and adolescents?
NG225_Rationale and impact: Interventions for self-harm - Part 2,NG225,What are the recommended approaches for safety planning and psychosocial interventions to prevent self-harm?
NG225_Rationale and impact: Interventions for self-harm - Part 3,NG225,What are the recommended psychological interventions for self-harm prevention?
NG225_Rationale and impact: Interventions for self-harm - Part 4,NG225,What is therapeutic risk taking and how is it used in managing self-harm?
NG225_Rationale and impact: Supporting people to be safe after self-harm - Part 1,NG225,What are the best practices for supporting safety after self-harm in healthcare settings?
NG225_Rationale and impact: Supporting people to be safe after self-harm - Part 2,NG225,How should mental health inpatient units balance safety measures and patient autonomy for individuals who have self-harmed?
NG225_Rationale and impact: Safer prescribing and dispensing,NG225,What are the recommended practices for safer prescribing and dispensing after an episode of self-harm?
NG225_Rationale and impact: Training,NG225,What training is recommended for healthcare staff working with people who self-harm?
NG225_Rationale and impact: Supervision - Part 1,NG225,What are the recommended supervision practices for staff caring for people who self-harm?
NG225_Rationale and impact: Supervision - Part 2,NG225,What are the recommended approaches for providing emotional support and supervision to staff working with people who self-harm?
NG225_Context,NG225,What are the recommended management strategies for self-harm in emergency and primary care settings?
NG226_Osteoarthritis in over 16s: diagnosis and management & 6 more sections,NG226,What are the clinical criteria for diagnosing osteoarthritis without imaging in people over 45?
NG226_Recommendations: 1.2 Information and support & Recommendations: 1.3 Non-pharmacological management,NG226,What are the recommended non-pharmacological management strategies for osteoarthritis?
NG226_Recommendations: 1.3 Non-pharmacological management - Part 1,NG226,What are the recommended non-pharmacological management strategies for osteoarthritis?
NG226_Recommendations: 1.3 Non-pharmacological management - Part 2,NG226,What are the recommended non-pharmacological treatments for osteoarthritis management according to NICE guidelines?
NG226_Recommendations: 1.3 Non-pharmacological management - Part 3 & Recommendations: 1.4 Pharmacological management,NG226,What are the recommended electrotherapy treatments for osteoarthritis and their effectiveness?
NG226_Recommendations: 1.4 Pharmacological management - Part 1,NG226,What are the recommended pharmacological treatments for osteoarthritis management?
NG226_Recommendations: 1.4 Pharmacological management - Part 2 & Recommendations: 1.5 Follow-up and review,NG226,What are the recommendations for intra-articular injections in osteoarthritis management?
NG226_Recommendations: 1.5 Follow-up and review & Recommendations: 1.6 Referral for joint replacement,NG226,What are the NICE guidelines for referral for joint replacement in osteoarthritis management?
NG226_Recommendations: 1.6 Referral for joint replacement & Recommendations: 1.7 Arthroscopic procedures,NG226,What are the indications for referring patients with osteoarthritis for joint replacement surgery?
NG226_Recommendations: 1.7 Arthroscopic procedures & 4 more sections,NG226,What is the evidence on the effectiveness of arthroscopic lavage or debridement for osteoarthritis management?
NG226_Recommendations for research: Key recommendations for research - Part 1 & Recommendations for research: Other recommendations for research,NG226,"What is the clinical and cost effectiveness of exercise, devices, and topical medicines for managing osteoarthritis?"
NG226_Recommendations for research: Other recommendations for research - Part 1,NG226,What is the effectiveness of manual therapy and electroacupuncture for managing osteoarthritis?
NG226_Recommendations for research: Other recommendations for research - Part 2,NG226,What is the clinical and cost effectiveness of extracorporeal shockwave therapy for osteoarthritis management?
NG226_Recommendations for research: Other recommendations for research - Part 3,NG226,What is the effectiveness of intra-articular corticosteroids and stem cell injections for osteoarthritis management?
NG226_Recommendations for research: Other recommendations for research - Part 4 & Rationale and impact,NG226,What are the criteria for referring osteoarthritis patients for joint replacement surgery?
NG226_Rationale and impact: Diagnosis & Rationale and impact: Diagnosis & Rationale and impact: Information and support,NG226,Should imaging be used routinely for diagnosing osteoarthritis?
NG226_Rationale and impact: Information and support & Rationale and impact: Therapeutic exercise,NG226,What information should be provided to patients with osteoarthritis about self-management and the role of therapeutic exercise?
NG226_Rationale and impact: Therapeutic exercise & Rationale and impact: Weight management,NG226,What are the benefits of supervised therapeutic exercise for managing osteoarthritis?
NG226_Rationale and impact: Weight management & Rationale and impact: Manual therapy,NG226,What are the benefits of weight loss for people with osteoarthritis?
NG226_Rationale and impact: Manual therapy & Rationale and impact: Acupuncture,NG226,What is the effectiveness of manual therapy combined with exercise for treating hip and knee osteoarthritis?
NG226_Rationale and impact: Acupuncture & Rationale and impact: Electrotherapy,NG226,What is the evidence for the effectiveness of electroacupuncture in treating osteoarthritis?
NG226_Rationale and impact: Electrotherapy & Rationale and impact: Devices,NG226,What is the evidence for the effectiveness of electrotherapy in managing osteoarthritis?
"NG226_Rationale and impact: Devices & Rationale and impact: Topical, oral and transdermal medicines",NG226,What is the evidence for using walking aids to improve quality of life in people with lower limb osteoarthritis?
"NG226_Rationale and impact: Topical, oral and transdermal medicines - Part 1",NG226,What are the recommended uses and safety considerations for topical NSAIDs in osteoarthritis treatment?
"NG226_Rationale and impact: Topical, oral and transdermal medicines - Part 2",NG226,What are the safety considerations and recommended use of NSAIDs and opioids for osteoarthritis pain management?
"NG226_Rationale and impact: Topical, oral and transdermal medicines - Part 3 & Rationale and impact: Intra-articular injections",NG226,What are the recommended pharmacological treatments for osteoarthritis management?
NG226_Rationale and impact: Intra-articular injections & Rationale and impact: Follow-up and review,NG226,What are the current NICE recommendations on intra-articular injections for osteoarthritis treatment?
NG226_Rationale and impact: Follow-up and review & Rationale and impact: Imaging for management of osteoarthritis,NG226,What are the recommended follow-up strategies for managing osteoarthritis?
NG226_Rationale and impact: Imaging for management of osteoarthritis & Rationale and impact: Referral for joint replacement,NG226,Should imaging be routinely used to guide non-surgical management of osteoarthritis?
NG226_Rationale and impact: Referral for joint replacement - Part 1,NG226,What are the clinical criteria for referring patients with osteoarthritis for joint replacement?
NG226_Rationale and impact: Referral for joint replacement - Part 2 & Rationale and impact: Arthroscopic procedures,NG226,Should BMI or other factors prevent patients from being referred for joint replacement surgery?
NG226_Rationale and impact: Arthroscopic procedures & 3 more sections,NG226,Should arthroscopic procedures be used for osteoarthritis management?
NG227_Advocacy services for adults with health and social care needs & 3 more sections,NG227,What are the key principles for commissioning and delivering effective advocacy services for adults with health and social care needs?
NG227_Context - Part 1,NG227,What is independent advocacy and how does it support people with health and social care needs?
NG227_Context - Part 2 & Recommendations,NG227,What are the standards for independent advocacy services in health and social care?
NG227_Recommendations: 1.1 Legal right to advocacy - Part 1,NG227,What are the legal requirements for providing advocacy services under the Care Act 2014 and Mental Capacity Act 2005?
NG227_Recommendations: 1.1 Legal right to advocacy - Part 2,NG227,When is an independent advocate required during adult care assessments and safeguarding processes?
NG227_Recommendations: 1.1 Legal right to advocacy - Part 3 & Recommendations: 1.2 Who else may benefit from advocacy,NG227,Who is eligible for independent advocacy services under the Health and Social Care Act 2012?
NG227_Recommendations: 1.2 Who else may benefit from advocacy & Recommendations: 1.3 Information about effective advocacy and signposting to services,NG227,What are the recommended strategies for providing advocacy and signposting to services for individuals who cannot fully express their views?
NG227_Recommendations: 1.3 Information about effective advocacy and signposting to services - Part 1,NG227,What information should local authorities provide about advocacy services for adults?
NG227_Recommendations: 1.3 Information about effective advocacy and signposting to services - Part 2 & Recommendations: 1.4 Improving access to advocacy,NG227,How should health and social care providers ensure patients are informed about advocacy services at key points in their care?
NG227_Recommendations: 1.4 Improving access to advocacy - Part 1,NG227,What are the recommended practices for improving access to advocacy services in health and social care settings?
NG227_Recommendations: 1.4 Improving access to advocacy - Part 2 & Recommendations: 1.5 Enabling and supporting effective advocacy,NG227,How can advocacy organisations ensure early and regular access to IMHA for people who need it?
NG227_Recommendations: 1.5 Enabling and supporting effective advocacy - Part 1,NG227,What are the best practices for supporting effective advocacy in health and social care?
NG227_Recommendations: 1.5 Enabling and supporting effective advocacy - Part 2 & Recommendations: 1.6 Effective advocacy,NG227,What are the recommended practices for health and social care providers to ensure effective advocacy and safeguard vulnerable adults?
NG227_Recommendations: 1.6 Effective advocacy - Part 1,NG227,What are best practices for providing accessible and person-centred advocacy services?
NG227_Recommendations: 1.6 Effective advocacy - Part 2,NG227,What are the principles for providing person-centred and independent advocacy in health and social care?
"NG227_Recommendations: 1.6 Effective advocacy - Part 3 & Recommendations: 1.7 Partnership working and relationships with families, friends and carers, commissioners and providers",NG227,What are the recommended practices for advocacy services to ensure cultural competence and effective communication?
"NG227_Recommendations: 1.7 Partnership working and relationships with families, friends and carers, commissioners and providers - Part 1",NG227,"How should advocacy providers collaborate with families, carers, and commissioners to support individuals effectively?"
"NG227_Recommendations: 1.7 Partnership working and relationships with families, friends and carers, commissioners and providers - Part 2 & Recommendations: 1.8 Planning and commissioning services for advocacy",NG227,How should advocacy services be planned and commissioned to ensure cultural appropriateness and effective partnership working?
NG227_Recommendations: 1.8 Planning and commissioning services for advocacy - Part 1,NG227,How should advocacy services be planned and commissioned to address local needs and promote independence?
NG227_Recommendations: 1.8 Planning and commissioning services for advocacy - Part 2,NG227,What are best practices for commissioning advocacy services to ensure person-centered support and address health inequalities?
"NG227_Recommendations: 1.8 Planning and commissioning services for advocacy - Part 3 & Recommendations: 1.9 Training, skills and support for advocates",NG227,What training and support are recommended for advocates to ensure effective safeguarding?
"NG227_Recommendations: 1.9 Training, skills and support for advocates - Part 1",NG227,What training and skills are recommended for advocates supporting people with diverse needs in health and social care?
"NG227_Recommendations: 1.9 Training, skills and support for advocates - Part 2 & Recommendations: 1.10 Training and skills for health and social care practitioners who work with advocates",NG227,What training and skills are recommended for health and social care practitioners working with advocates?
NG227_Recommendations: 1.10 Training and skills for health and social care practitioners who work with advocates - Part 1,NG227,What training should health and social care practitioners receive about advocacy and supporting people's rights?
NG227_Recommendations: 1.10 Training and skills for health and social care practitioners who work with advocates - Part 2 & Recommendations: 1.11 Monitoring services and collecting data for quality improvement,NG227,What are the recommended training methods for health and social care practitioners on advocacy skills?
NG227_Recommendations: 1.11 Monitoring services and collecting data for quality improvement - Part 1,NG227,What are the recommended methods for monitoring and measuring outcomes in advocacy services according to NICE guidelines?
NG227_Recommendations: 1.11 Monitoring services and collecting data for quality improvement - Part 2,NG227,How can advocacy services effectively collect and evaluate data on user outcomes and satisfaction?
NG227_Recommendations: 1.11 Monitoring services and collecting data for quality improvement - Part 3 & Terms used in this guideline,NG227,How should safeguarding advocates be monitored and included in safeguarding processes?
NG227_Terms used in this guideline - Part 1,NG227,What is anti-oppressive practice and how does it relate to healthcare?
NG227_Terms used in this guideline - Part 2 & Recommendations for research,NG227,What is the purpose of opt-out systems in advocacy services for mental health?
NG227_Recommendations for research & 3 more sections,NG227,What are the most effective approaches to providing advocacy services in healthcare settings?
NG227_Rationale and impact: Who else may benefit from advocacy,NG227,Who may benefit from non-statutory advocacy services in healthcare?
NG227_Rationale and impact: Information about effective advocacy and signposting to services - Part 1,NG227,What information should be provided about advocacy and support services to ensure accessible access for all?
NG227_Rationale and impact: Information about effective advocacy and signposting to services - Part 2 & Rationale and impact: Improving access to advocacy,NG227,What are the recommended practices for providing information and signposting to advocacy services in healthcare settings?
NG227_Rationale and impact: Improving access to advocacy - Part 1,NG227,What are the recommended ways to improve access to advocacy services for mental health patients?
NG227_Rationale and impact: Improving access to advocacy - Part 2,NG227,What are effective strategies to improve access and continuity of advocacy services in mental health care?
NG227_Rationale and impact: Improving access to advocacy - Part 3,NG227,What are the best practices for providing advocacy services to individuals who cannot ask for support?
NG227_Rationale and impact: Improving access to advocacy - Part 4,NG227,How can removing blanket restrictions and increasing access to independent mental health advocacy services improve resource use and patient outcomes?
NG227_Rationale and impact: Enabling and supporting effective advocacy - Part 1,NG227,What are the best practices for timely and effective advocacy support in healthcare decision-making?
NG227_Rationale and impact: Enabling and supporting effective advocacy - Part 2,NG227,How can advocacy services be effectively integrated into health and social care to improve patient outcomes?
NG227_Rationale and impact: Enabling and supporting effective advocacy - Part 3,NG227,What are best practices for providing effective advocacy support in health and social care?
NG227_Rationale and impact: Enabling and supporting effective advocacy - Part 4 & Rationale and impact: Effective advocacy,NG227,What are the best practices for safeguarding advocacy in adult social care services?
NG227_Rationale and impact: Effective advocacy - Part 1,NG227,What are the best practices for providing accessible and person-centred advocacy services?
NG227_Rationale and impact: Effective advocacy - Part 2,NG227,"How can advocacy services ensure independence, continuity, and cultural relevance for people with health inequalities?"
NG227_Rationale and impact: Effective advocacy - Part 3,NG227,What are best practices for culturally sensitive and accessible advocacy services to address health inequalities?
NG227_Rationale and impact: Effective advocacy - Part 4,NG227,What are the recommended practices for promoting shared learning and collaboration among advocacy service providers?
"NG227_Rationale and impact: Partnership working and relationships with families, friends and carers, commissioners and providers - Part 1",NG227,"How can advocacy services improve collaboration with families, carers, and commissioners to support people with communication challenges?"
"NG227_Rationale and impact: Partnership working and relationships with families, friends and carers, commissioners and providers - Part 2",NG227,What are the best practices for developing protocols to ensure effective and culturally appropriate advocacy services?
"NG227_Rationale and impact: Partnership working and relationships with families, friends and carers, commissioners and providers - Part 3",NG227,How can advocacy services improve partnership working and monitoring under the Mental Health Act?
NG227_Rationale and impact: Planning and commissioning services for advocacy - Part 1,NG227,What are the recommended approaches for planning and commissioning advocacy services to ensure they meet local needs and promote equality?
NG227_Rationale and impact: Planning and commissioning services for advocacy - Part 2,NG227,What are the best practices for commissioning and providing advocacy services in mental health care?
NG227_Rationale and impact: Planning and commissioning services for advocacy - Part 3,NG227,What are the key principles for developing person-centred advocacy services according to NICE guidelines?
NG227_Rationale and impact: Planning and commissioning services for advocacy - Part 4,NG227,How can long-term planning and commissioning improve advocacy services in health and social care?
"NG227_Rationale and impact: Training, skills and support for advocates - Part 1",NG227,What training and support are recommended for advocates to ensure effective advocacy services?
"NG227_Rationale and impact: Training, skills and support for advocates - Part 2",NG227,What training and support are recommended for advocates providing non-instructed advocacy in health and social care?
NG227_Rationale and impact: Training and skills for health and social care practitioners who work with advocates - Part 1,NG227,What training is recommended for health and social care practitioners to understand advocacy and referral processes?
NG227_Rationale and impact: Training and skills for health and social care practitioners who work with advocates - Part 2,NG227,How can involving people with lived experience improve advocacy training for health and social care practitioners?
NG227_Rationale and impact: Monitoring services and collecting data for quality improvement - Part 1,NG227,What are the recommended data collection practices for monitoring advocacy services to improve quality?
NG227_Rationale and impact: Monitoring services and collecting data for quality improvement - Part 2,NG227,What are the recommended methods for collecting and evaluating data on advocacy services to improve quality and reduce inequalities?
NG228_Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management & Overview,NG228,What are the recommended diagnostic and management strategies for aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.1 Assessment and diagnosis - Part 1,NG228,What are the recommended assessment and diagnostic procedures for suspected subarachnoid haemorrhage?
NG228_Recommendations: 1.1 Assessment and diagnosis - Part 2,NG228,What are the recommended steps for diagnosing suspected subarachnoid haemorrhage in emergency settings?
NG228_Recommendations: 1.1 Assessment and diagnosis - Part 3,NG228,What are the recommended diagnostic procedures for suspected subarachnoid hemorrhage?
NG228_Recommendations: 1.1 Assessment and diagnosis - Part 4,NG228,What are the recommended imaging techniques for diagnosing aneurysmal subarachnoid hemorrhage?
NG228_Recommendations: 1.2 Managing a confirmed aneurysmal subarachnoid haemorrhage - Part 1,NG228,What are the recommended medical management strategies for confirmed aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.2 Managing a confirmed aneurysmal subarachnoid haemorrhage - Part 2,NG228,How should interventional treatment for intracranial aneurysm be timed to prevent rebleeding?
NG228_Recommendations: 1.3 Monitoring and managing complications - Part 1,NG228,When should transcranial Doppler monitoring be used in the management of aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.3 Monitoring and managing complications - Part 2,NG228,What are the recommended management strategies for delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.4 Follow-up care - Part 1,NG228,What is the recommended follow-up care and neuroimaging strategy after aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.4 Follow-up care - Part 2,NG228,What are the recommended management strategies for hypertension after hospital discharge?
NG228_Recommendations: 1.4 Follow-up care - Part 3,NG228,How should blood pressure be managed in adults after aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.4 Follow-up care - Part 4,NG228,What are the recommendations for screening relatives of patients with aneurysmal subarachnoid haemorrhage?
NG228_Recommendations: 1.5 Information and support - Part 1,NG228,What information should be provided to patients and families about aneurysmal subarachnoid haemorrhage and its complications?
NG228_Recommendations: 1.5 Information and support - Part 2,NG228,What are the common symptoms and follow-up care recommendations for patients after a subarachnoid haemorrhage?
NG228_Recommendations: Terms used in this guideline & Recommendations for research: Key recommendations for research - Part 1,NG228,What is the recommended role of senior clinical decision-makers in diagnosing subarachnoid haemorrhage?
NG228_Recommendations for research: Key recommendations for research - Part 2,NG228,What is the effectiveness of endovascular devices like coated coils and flow diverters in treating aneurysmal subarachnoid haemorrhage?
NG228_Recommendations for research: Other recommendations for research - Part 1,NG228,What is the effectiveness of interventions to prevent rebleeding in patients with severe neurological deficits after aneurysmal subarachnoid hemorrhage?
NG228_Recommendations for research: Other recommendations for research - Part 2,NG228,What are the recommended management strategies for intracranial hypertension in patients with aneurysmal subarachnoid haemorrhage?
NG228_Recommendations for research: Other recommendations for research - Part 3,NG228,What is the effectiveness of blood pressure targets in preventing delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage?
NG228_Rationale and impact: Assessment and referral for diagnostic investigation - Part 1,NG228,What are the clinical features and signs that indicate the need for urgent investigation for suspected subarachnoid haemorrhage?
NG228_Rationale and impact: Assessment and referral for diagnostic investigation - Part 2 & Rationale and impact: Pain relief and neurological assessment,NG228,What is the recommended timing for non-contrast CT head scans to rule out subarachnoid haemorrhage?
NG228_Rationale and impact: Diagnosing a subarachnoid haemorrhage - Part 1,NG228,When should a lumbar puncture be performed to diagnose subarachnoid hemorrhage?
NG228_Rationale and impact: Diagnosing a subarachnoid haemorrhage - Part 2,NG228,What are the current recommendations for transferring patients with suspected subarachnoid haemorrhage to neurosurgical centres?
NG228_Rationale and impact: Detecting an aneurysm,NG228,What is the most accurate imaging method for detecting cerebral aneurysms in suspected subarachnoid haemorrhage?
NG228_Rationale and impact: Medical management - Part 1,NG228,What is the current evidence for using nimodipine in the management of aneurysmal subarachnoid haemorrhage?
NG228_Rationale and impact: Medical management - Part 2,NG228,When should intravenous nimodipine be used instead of oral or crushed tablets in patients with aneurysmal subarachnoid haemorrhage?
NG228_Rationale and impact: Managing the culprit aneurysm - Part 1,NG228,What are the recommended management options for securing a culprit aneurysm after subarachnoid haemorrhage?
NG228_Rationale and impact: Managing the culprit aneurysm - Part 2,NG228,What are the current NICE recommendations for treating ruptured intracranial aneurysms with endovascular coiling versus neurosurgical clipping?
NG228_Rationale and impact: Monitoring and investigating for deterioration,NG228,What are the recommended methods for monitoring and investigating neurological deterioration in patients with aneurysmal subarachnoid haemorrhage?
NG228_Rationale and impact: Hydrocephalus,NG228,What are the recommended methods for diagnosing and managing acute and chronic hydrocephalus after subarachnoid haemorrhage?
NG228_Rationale and impact: Intracranial hypertension,NG228,What are the best methods for diagnosing and managing intracranial hypertension in critically ill patients?
NG228_Rationale and impact: Delayed cerebral ischaemia & Rationale and impact: Follow-up care plan,NG228,What are the current management strategies for delayed cerebral ischaemia after subarachnoid haemorrhage?
NG228_Rationale and impact: Follow-up neuroimaging & Rationale and impact: Managing non-culprit (unruptured) aneurysms,NG228,What is the recommended follow-up imaging schedule for unruptured cerebral aneurysms?
NG228_Rationale and impact: Managing other conditions after discharge from hospital - Part 1,NG228,What are the recommended blood pressure targets for patients after aneurysmal subarachnoid haemorrhage?
NG228_Rationale and impact: Managing other conditions after discharge from hospital - Part 2,NG228,What is the recommended management for headaches and seizures after aneurysmal subarachnoid haemorrhage?
NG228_Rationale and impact: Investigations to detect aneurysms in relatives,NG228,Should first-degree relatives of people with aneurysmal subarachnoid haemorrhage be screened for intracranial aneurysms?
NG228_Rationale and impact: Information and support,NG228,What information and support should be provided to patients after aneurysmal subarachnoid haemorrhage?
NG228_Context,NG228,What are the recommended diagnostic and management strategies for subarachnoid haemorrhage?
NG229_Fetal monitoring in labour & 6 more sections,NG229,What are the recommended methods for fetal monitoring during labour according to NICE guidelines?
NG229_Recommendations: 1.2 Assessment during labour and methods for fetal monitoring - Part 1,NG229,What are the recommended methods for fetal monitoring during labour according to NICE guidelines?
NG229_Recommendations: 1.2 Assessment during labour and methods for fetal monitoring - Part 2,NG229,What are the recommended methods for fetal heart rate monitoring during labour for low-risk women?
NG229_Recommendations: 1.2 Assessment during labour and methods for fetal monitoring - Part 3,NG229,What are the recommended procedures for monitoring fetal well-being during labour according to NICE guidelines?
NG229_Recommendations: 1.2 Assessment during labour and methods for fetal monitoring - Part 4 & Recommendations: 1.3 Indications for continuous cardiotocography monitoring in labour,NG229,What are the indications for continuous cardiotocography monitoring during labour?
NG229_Recommendations: 1.3 Indications for continuous cardiotocography monitoring in labour - Part 1,NG229,What are the indications for continuous cardiotocography monitoring during labour according to NICE guidelines?
NG229_Recommendations: 1.3 Indications for continuous cardiotocography monitoring in labour - Part 2,NG229,What are the indications for continuous CTG monitoring during labor according to NICE guidelines?
NG229_Recommendations: 1.3 Indications for continuous cardiotocography monitoring in labour - Part 3 & Recommendations: 1.4 Use of cardiotocography for monitoring during labour,NG229,What are the indications for using cardiotocography during labour according to NICE guidelines?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 1,NG229,How is cardiotocography used to monitor fetal well-being during labour?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 2,NG229,What are the recommended steps for interpreting and managing cardiotocography (CTG) traces during labour?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 3,NG229,What is the recommended method for assessing baseline fetal heart rate and variability during labor according to NICE guidelines?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 4,NG229,What are the criteria for categorising fetal heart rate variability using CTG tracings according to NICE guidelines?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 5,NG229,What are the characteristics and classification of fetal heart rate decelerations during labor?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 6,NG229,What are the recommended actions for managing variable decelerations during labour according to NICE guidelines?
NG229_Recommendations: 1.4 Use of cardiotocography for monitoring during labour - Part 7 & Recommendations: 1.5 Making care decisions based on the cardiotocography trace,NG229,What are the recommended practices for interpreting cardiotocography traces during the second stage of labour?
NG229_Recommendations: 1.5 Making care decisions based on the cardiotocography trace - Part 1,NG229,What are the recommended management steps for interpreting cardiotocography (CTG) traces during labour?
NG229_Recommendations: 1.5 Making care decisions based on the cardiotocography trace - Part 2,NG229,What are the recommended management strategies for pathological CTG traces during labor?
NG229_Recommendations: 1.5 Making care decisions based on the cardiotocography trace - Part 3 & Recommendations: 1.6 Fetal scalp stimulation,NG229,What are the recommended conservative measures for fetal wellbeing concerns during labor?
NG229_Recommendations: 1.6 Fetal scalp stimulation & 3 more sections,NG229,What are the recommended practices for record keeping of cardiotocography during fetal monitoring?
NG229_Recommendations: 1.8 Record keeping for cardiotocography & Recommendations: Terms used in this guideline,NG229,What are the recommended procedures for record keeping and storage of cardiotocography traces during intrapartum monitoring?
NG229_Recommendations: Terms used in this guideline & Rationale and impact,NG229,"What are the definitions and clinical significance of early, late, and variable decelerations in fetal heart rate monitoring?"
NG229_Rationale and impact: Information and supported decision-making & Rationale and impact: Information and supported decision-making & Rationale and impact: Assessment during labour and methods for fetal monitoring,NG229,What are the recommended practices for fetal monitoring and decision-making during labour?
NG229_Rationale and impact: Indications for continuous cardiotocography monitoring in labour,NG229,When should continuous cardiotocography monitoring be used during labour based on risk factors?
NG229_Rationale and impact: Use of cardiotocography for monitoring during labour - Part 1,NG229,What are the NICE recommendations for using cardiotocography to monitor fetal well-being during labour?
NG229_Rationale and impact: Use of cardiotocography for monitoring during labour - Part 2 & Rationale and impact: Making care decisions based on the cardiotocography trace,NG229,What are the guidelines for interpreting fetal heart rate variability and decelerations on CTG during labour?
NG229_Rationale and impact: Fetal blood sampling & Rationale and impact: Fetal blood sampling & Context,NG229,Should fetal blood sampling be used during labor for fetal monitoring?
NG22_Older people with social care needs and multiple long-term conditions & Overview & Recommendations: 1.1 Identifying and assessing social care needs - Part 1,NG22,What are the recommended approaches for assessing social care needs in older people with multiple long-term conditions?
NG22_Recommendations: 1.1 Identifying and assessing social care needs - Part 2,NG22,What support and assessments are available for older people with social care needs and multiple long-term conditions?
NG22_Recommendations: 1.2 Care planning - Part 1,NG22,What are the best practices for care planning and coordination for older people with multiple long-term conditions?
NG22_Recommendations: 1.2 Care planning - Part 2,NG22,What are the key components to include in a care plan for managing medicines and supporting social participation in older people with long-term conditions?
NG22_Recommendations: 1.3 Supporting carers,NG22,How can healthcare professionals support carers of people with multiple long-term conditions?
NG22_Recommendations: 1.4 Integrating health and social care planning,NG22,How should health and social care services coordinate for older adults with complex needs?
NG22_Recommendations: 1.5 Delivering care - Part 1,NG22,What are the recommended strategies for providing person-centred support and information to people with long-term conditions?
NG22_Recommendations: 1.5 Delivering care - Part 2,NG22,What are the key responsibilities of care coordinators in supporting older people with long-term conditions in care homes?
NG22_Recommendations: 1.6 Preventing social isolation,NG22,How can health and social care practitioners prevent social isolation in older people with long-term conditions?
NG22_Recommendations: 1.7 Training health and social care practitioners,NG22,What training and competencies should health and social care practitioners have to effectively manage medicines and support older people with complex health needs?
NG22_Recommendations: Terms used in this guideline,NG22,What is the role of a named care coordinator in managing multiple long-term conditions?
NG22_Older people with social care needs and multiple long‑term conditions implementation: getting started: The challenge: empowering older people with social care needs and multiple long‑term conditions and their carers to choose and manage their own support,NG22,What are the best practices for supporting older people to choose and manage their own social care support?
NG22_Older people with social care needs and multiple long‑term conditions implementation: getting started: The challenge: empowering practitioners to deliver person‑centred care,NG22,How can health and social care practitioners develop skills to deliver person-centred care for older people with multiple long-term conditions?
NG22_Older people with social care needs and multiple long‑term conditions implementation: getting started: The challenge: integrating different care and support options to enable person‑centred care,NG22,What are effective strategies for integrating health and social care to support older people with long-term conditions?
NG22_Context - Part 1,NG22,What are the recommended approaches for providing integrated care to people with multiple long-term conditions?
NG22_Context - Part 2,NG22,What are the best practices for person-centred social care for older people with multiple long-term conditions?
NG22_Recommendations for research: 1 Older people's experiences & Recommendations for research: 2 Service delivery models,NG22,What are effective service delivery models for supporting older people with social care needs and multiple long-term conditions?
NG22_Recommendations for research: 3 Supporting people in care homes to stay active & Recommendations for research: 4 Developing a 'risk positive' approach in care homes,NG22,What are effective strategies to support social participation and positive risk-taking for older people in care homes?
NG230_Thyroid cancer: assessment and management & Overview,NG230,What are the recommended approaches for the diagnosis and management of thyroid cancer in adults?
NG230_Recommendations: 1.1 Information and support - Part 1,NG230,"What information should be provided to patients with suspected or diagnosed thyroid cancer about diagnosis, treatment options, and support services?"
NG230_Recommendations: 1.1 Information and support - Part 2,NG230,What are the long-term monitoring requirements and follow-up care for people treated for thyroid cancer?
NG230_Recommendations: 1.2 Assessment and diagnosis - Part 1,NG230,What are the recommended blood tests and ultrasound procedures for assessing suspected thyroid nodules?
NG230_Recommendations: 1.2 Assessment and diagnosis - Part 2,NG230,What are the recommended procedures for performing and reporting fine needle aspiration cytology in thyroid nodule assessment?
NG230_Recommendations: 1.2 Assessment and diagnosis - Part 3,NG230,What are the recommended management options after initial fine-needle aspiration cytology for thyroid nodules?
NG230_Recommendations: 1.2 Assessment and diagnosis - Part 4,NG230,When should imaging with CT or MRI be used for staging thyroid cancer?
NG230_Recommendations: 1.3 Initial treatment of differentiated thyroid cancer - Part 1,NG230,What are the recommended surgical options for treating differentiated thyroid cancer?
NG230_Recommendations: 1.3 Initial treatment of differentiated thyroid cancer - Part 2,NG230,What are the guidelines for using thyrotropin alfa and radioactive iodine in the treatment of thyroid cancer?
NG230_Recommendations: 1.3 Initial treatment of differentiated thyroid cancer - Part 3,NG230,What is the recommended activity of radioactive iodine for initial ablation in high-risk thyroid cancer patients?
NG230_Recommendations: 1.4 Ongoing treatment with thyroid stimulating hormone suppression for differentiated thyroid cancer - Part 1,NG230,What are the guidelines for TSH suppression therapy in differentiated thyroid cancer management?
NG230_Recommendations: 1.4 Ongoing treatment with thyroid stimulating hormone suppression for differentiated thyroid cancer - Part 2,NG230,What are the recommendations for long-term TSH suppression in thyroid cancer management?
NG230_Recommendations: 1.5 Post-thyroidectomy monitoring of differentiated thyroid cancer - Part 1,NG230,How is thyroglobulin monitoring used in post-thyroidectomy follow-up for differentiated thyroid cancer?
NG230_Recommendations: 1.5 Post-thyroidectomy monitoring of differentiated thyroid cancer - Part 2,NG230,What are the indications for stimulated and highly sensitive thyroglobulin testing after thyroidectomy and radioactive iodine treatment?
NG230_Recommendations: 1.6 Follow up of differentiated thyroid cancer,NG230,What are the recommended follow-up procedures for patients after thyroid cancer surgery according to NICE guidelines?
NG230_Recommendations: Terms used in this guideline,NG230,What does active surveillance involve in the management of thyroid cancer?
NG230_Recommendations for research: Key recommendations for research,NG230,What is the clinical and cost effectiveness of molecular testing for thyroid cancer in indeterminate FNAC samples?
NG230_Recommendations for research: Other recommendations for research - Part 1,NG230,What is the clinical and cost effectiveness of radioactive iodine therapy after total thyroidectomy for T2 thyroid cancer?
NG230_Recommendations for research: Other recommendations for research - Part 2,NG230,"What is the clinical and cost effectiveness of CT, MRI, or F-18 FDG PET-CT scans for staging extensive local spread in differentiated thyroid cancer?"
NG230_Rationale and impact: Information and support,NG230,What information should healthcare professionals provide to patients diagnosed with thyroid cancer?
NG230_Rationale and impact: Blood tests - Part 1,NG230,When should calcitonin testing be used in the diagnosis of thyroid cancer?
NG230_Rationale and impact: Blood tests - Part 2,NG230,When should thyroid peroxidase antibody testing be used to interpret indeterminate thyroid cytology?
NG230_Rationale and impact: Ultrasound,NG230,What are the recommended ultrasound grading systems for assessing thyroid nodules?
NG230_Rationale and impact: Performing and reporting FNAC,NG230,What are the recommended techniques and reporting systems for performing fine-needle aspiration cytology (FNAC)?
NG230_Rationale and impact: Management and further sampling after initial FNAC - Part 1,NG230,What is the recommended approach for managing inadequate or benign thyroid FNAC results?
NG230_Rationale and impact: Management and further sampling after initial FNAC - Part 2,NG230,"What are the recommended management options for Thy3a, Thy3f, Thy4, and Thy5 thyroid cytology results?"
NG230_Rationale and impact: Management and further sampling after initial FNAC - Part 3,NG230,How does the use of molecular testing impact the management of indeterminate thyroid cytology results?
NG230_Rationale and impact: Radioisotope scans,NG230,When should radioisotope scans be used in the initial diagnosis of thyroid cancer?
NG230_Rationale and impact: Imaging for further staging,NG230,When should cross-sectional imaging be used for staging in thyroid cancer patients?
NG230_Rationale and impact: Surgery and active surveillance for primary tumours - Part 1,NG230,What are the indications for choosing total thyroidectomy versus hemithyroidectomy in thyroid cancer management?
NG230_Rationale and impact: Surgery and active surveillance for primary tumours - Part 2,NG230,What are the recommended management options for small thyroid microcarcinomas?
NG230_Rationale and impact: Surgery and active surveillance for primary tumours - Part 3,NG230,What are the current recommendations for prophylactic lymph node dissection in thyroid cancer surgery?
NG230_Rationale and impact: Thyrotropin alfa - Part 1,NG230,What are the benefits and considerations of using thyrotropin alfa instead of thyroid hormone withdrawal for radioactive iodine treatment?
NG230_Rationale and impact: Thyrotropin alfa - Part 2,NG230,What are the risks and benefits of using thyrotropin alfa versus thyroid hormone withdrawal in radioactive iodine treatment?
NG230_Rationale and impact: RAI for initial ablation,NG230,When should radioactive iodine therapy be offered after thyroidectomy for thyroid cancer?
NG230_Rationale and impact: RAI activity for initial ablation,NG230,What is the recommended activity level of radioactive iodine for initial ablation in thyroid cancer patients?
NG230_Rationale and impact: External beam radiotherapy,NG230,When should external beam radiotherapy be considered for thyroid cancer treatment?
NG230_Rationale and impact: Thyroid stimulating hormone suppression - Part 1,NG230,When should thyroid stimulating hormone suppression be used in thyroid cancer management?
NG230_Rationale and impact: Thyroid stimulating hormone suppression - Part 2,NG230,How should TSH suppression be managed in patients with thyroid cancer to optimize treatment outcomes?
NG230_Rationale and impact: Long-term duration of TSH suppression,NG230,What is the recommended duration of TSH suppression therapy in thyroid cancer management?
NG230_Rationale and impact: Measuring thyroglobulin and thyroglobulin antibodies - Part 1,NG230,How should thyroglobulin and thyroglobulin antibody levels be measured and interpreted after thyroidectomy for thyroid cancer?
NG230_Rationale and impact: Measuring thyroglobulin and thyroglobulin antibodies - Part 2,NG230,When should thyroglobulin and thyroglobulin antibody levels be measured in thyroid cancer follow-up?
NG230_Rationale and impact: Stimulated thyroglobulin and highly sensitive thyroglobulin testing,NG230,What are the guidelines for using stimulated and highly sensitive thyroglobulin testing in thyroid cancer follow-up?
NG230_Rationale and impact: Follow up - Part 1,NG230,What is the recommended follow-up strategy for different stages of thyroid cancer after surgery?
NG230_Rationale and impact: Follow up - Part 2,NG230,What are the recommended follow-up protocols for patients after total or completion thyroidectomy and radioactive iodine treatment?
NG230_Context,NG230,What are the recommended management strategies for small and intermediate thyroid nodules suspected of cancer?
NG231_Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management & 6 more sections,NG231,What are the recommended pharmacological treatments for managing Barrett's oesophagus and stage 1 oesophageal adenocarcinoma?
NG231_Recommendations: 1.2 Pharmacological interventions & Recommendations: 1.3 Endoscopic surveillance,NG231,What are the recommended pharmacological interventions for symptom control and disease progression prevention in Barrett's oesophagus?
NG231_Recommendations: 1.3 Endoscopic surveillance & Recommendations: 1.4 Staging for suspected stage 1 oesophageal adenocarcinoma,NG231,What are the recommended staging procedures for suspected stage 1 oesophageal adenocarcinoma according to NICE guidelines?
NG231_Recommendations: 1.4 Staging for suspected stage 1 oesophageal adenocarcinoma & Recommendations: 1.5 Managing Barrett's oesophagus with dysplasia,NG231,What are the recommended management strategies for Barrett's oesophagus with dysplasia according to NICE guidelines?
NG231_Recommendations: 1.5 Managing Barrett's oesophagus with dysplasia & Recommendations: 1.6 Managing stage 1 oesophageal adenocarcinoma,NG231,What are the recommended endoscopic treatments for managing Barrett's oesophagus with dysplasia?
NG231_Recommendations: 1.6 Managing stage 1 oesophageal adenocarcinoma & Recommendations: 1.7 Non-surgical treatment for T1b oesophageal adenocarcinoma,NG231,What are the non-surgical treatment options for T1b oesophageal adenocarcinoma?
NG231_Recommendations: 1.7 Non-surgical treatment for T1b oesophageal adenocarcinoma & Recommendations: 1.8 Anti-reflux surgery,NG231,What are the recommended non-surgical treatments for T1b oesophageal adenocarcinoma?
NG231_Recommendations: 1.8 Anti-reflux surgery & Recommendations: Terms used in this guideline,NG231,Should anti-reflux surgery be offered to patients with Barrett's oesophagus to prevent progression to dysplasia or cancer?
NG231_Recommendations: Terms used in this guideline & 6 more sections,NG231,What are the indications and outcomes of oesophagectomy for early-stage Barrett's oesophagus-related adenocarcinoma?
NG231_Recommendations for research: 3 Oesophagectomy & 3 more sections,NG231,What is the recommended frequency and duration of endoscopic follow-up for patients with Barrett's oesophagus or early oesophageal adenocarcinoma?
NG231_Recommendations for research: 5 Frequency and duration of endoscopic follow-up & Rationale and impact,NG231,What is the recommended frequency and duration of endoscopic follow-up after treatment for Barrett's oesophagus with dysplasia or stage 1 oesophageal adenocarcinoma?
NG231_Rationale and impact: Information and support & Rationale and impact: Information and support & Rationale and impact: Pharmacological interventions,NG231,What information and support should be provided to patients after a diagnosis of Barrett's oesophagus?
NG231_Rationale and impact: Pharmacological interventions & Rationale and impact: Endoscopic surveillance,NG231,What is the evidence for using proton pump inhibitors or aspirin to prevent progression of Barrett's oesophagus to oesophageal cancer?
NG231_Rationale and impact: Endoscopic surveillance - Part 1,NG231,What is the recommended frequency of endoscopic surveillance for Barrett's oesophagus based on segment length?
NG231_Rationale and impact: Endoscopic surveillance - Part 2,NG231,What are the current recommendations for endoscopic surveillance intervals in Barrett's oesophagus?
NG231_Rationale and impact: Staging for suspected stage 1 oesophageal adenocarcinoma - Part 1,NG231,What is the recommended staging approach for suspected stage 1 oesophageal adenocarcinoma?
NG231_Rationale and impact: Staging for suspected stage 1 oesophageal adenocarcinoma - Part 2,NG231,When should endoscopic ultrasonography be used for staging suspected T1 oesophageal adenocarcinoma?
NG231_Rationale and impact: Managing Barrett's oesophagus with dysplasia - Part 1,NG231,What are the recommended endoscopic treatments for high-grade dysplasia in Barrett's oesophagus?
NG231_Rationale and impact: Managing Barrett's oesophagus with dysplasia - Part 2,NG231,What are the criteria for selecting patients for radiofrequency ablation in Barrett's oesophagus with low-grade dysplasia?
NG231_Rationale and impact: Managing stage 1 oesophageal adenocarcinoma - Part 1,NG231,What are the recommended treatment options for stage 1 oesophageal adenocarcinoma?
NG231_Rationale and impact: Managing stage 1 oesophageal adenocarcinoma - Part 2,NG231,What is the recommended treatment approach for high-risk T1b oesophageal adenocarcinoma?
NG231_Rationale and impact: Non-surgical treatment for T1b oesophageal adenocarcinoma & Rationale and impact: Anti-reflux surgery,NG231,What are the recommended non-surgical treatments for T1b oesophageal adenocarcinoma?
NG231_Rationale and impact: Anti-reflux surgery & Context,NG231,When is anti-reflux surgery recommended for gastro-oesophageal reflux disease?
NG232_Head injury: assessment and early management & Overview & Recommendations: 1.1 Decision making and mental capacity,NG232,What are the recommended assessment and early management steps for head injury in adults and children?
"NG232_Recommendations: 1.2 Pre-hospital assessment, advice and referral to hospital - Part 1",NG232,What are the criteria for emergency referral after a head injury according to NICE guidelines?
"NG232_Recommendations: 1.2 Pre-hospital assessment, advice and referral to hospital - Part 2",NG232,What are the criteria for referring a patient with head injury to emergency services according to NICE guidelines?
"NG232_Recommendations: 1.2 Pre-hospital assessment, advice and referral to hospital - Part 3",NG232,What are the criteria for referring a child with head injury to emergency services according to NICE guidelines?
NG232_Recommendations: 1.3 Immediate management at the scene and transport to hospital - Part 1,NG232,What is the recommended initial assessment and management for head injury patients using the Glasgow Coma Scale?
NG232_Recommendations: 1.3 Immediate management at the scene and transport to hospital - Part 2,NG232,What are the recommended pre-hospital management procedures for paediatric head injuries?
NG232_Recommendations: 1.3 Immediate management at the scene and transport to hospital - Part 3,NG232,What are the recommended treatments for head injury patients with low GCS scores according to NICE guidelines?
NG232_Recommendations: 1.3 Immediate management at the scene and transport to hospital - Part 4,NG232,Should patients with head injury and suspected extracranial bleeding receive haemostatic agents?
NG232_Recommendations: 1.4 Assessment in the emergency department - Part 1,NG232,What are the emergency assessment procedures for patients with head injury and impaired consciousness?
NG232_Recommendations: 1.4 Assessment in the emergency department - Part 2,NG232,What are the recommended procedures for assessing and managing head injuries in emergency departments?
NG232_Recommendations: 1.4 Assessment in the emergency department - Part 3,NG232,What are the recommended procedures for initial assessment and safeguarding in patients with head injury in the emergency department?
NG232_Recommendations: 1.5 Investigating clinically important traumatic brain injuries - Part 1,NG232,What are the criteria for performing a CT head scan within 1 hour after a head injury in people aged 16 and over?
NG232_Recommendations: 1.5 Investigating clinically important traumatic brain injuries - Part 2,NG232,What are the criteria for urgent CT head scanning in children and adults after head injury according to NICE guidelines?
NG232_Recommendations: 1.5 Investigating clinically important traumatic brain injuries - Part 3,NG232,What are the criteria for performing a CT head scan after a head injury in children and adults?
NG232_Recommendations: 1.5 Investigating clinically important traumatic brain injuries - Part 4,NG232,What is the recommended timeframe for providing a provisional radiology report after a CT scan?
NG232_Recommendations: 1.6 Investigating injuries to the cervical spine - Part 1,NG232,What are the criteria for performing a CT cervical spine scan in adults with head injury?
NG232_Recommendations: 1.6 Investigating injuries to the cervical spine - Part 2,NG232,What are the criteria for performing a CT cervical spine scan in children under 16 after head injury?
NG232_Recommendations: 1.6 Investigating injuries to the cervical spine - Part 3,NG232,When should cervical spine X-rays be performed in children with head injury and neck pain?
NG232_Recommendations: 1.7 Information and support for families and carers,NG232,What information and support should be provided to families and carers of patients with head injury?
NG232_Recommendations: 1.8 Transfer from hospital to a neuroscience unit - Part 1,NG232,What are the recommended procedures for transferring patients with severe traumatic brain injury to a neuroscience unit?
NG232_Recommendations: 1.8 Transfer from hospital to a neuroscience unit - Part 2,NG232,What are the guidelines for intubation and ventilation during transfer of critically ill patients?
NG232_Recommendations: 1.8 Transfer from hospital to a neuroscience unit - Part 3,NG232,What are the recommended practices for transferring children under 16 with head injuries?
NG232_Recommendations: 1.9 Admission and observation - Part 1,NG232,What are the criteria for admitting patients with head injury to hospital?
NG232_Recommendations: 1.9 Admission and observation - Part 2,NG232,What are the criteria for hospital admission and observation for patients with concussion symptoms and normal brain imaging?
NG232_Recommendations: 1.9 Admission and observation - Part 3,NG232,What are the recommended investigations and observation protocols for hypopituitarism after head injury?
NG232_Recommendations: 1.9 Admission and observation - Part 4,NG232,What are the recommended observation and assessment procedures for patients with head injury according to NICE guidelines?
NG232_Recommendations: 1.10 Discharge and follow up - Part 1,NG232,When is it safe to discharge a patient after a head injury with normal imaging and GCS score?
NG232_Recommendations: 1.10 Discharge and follow up - Part 2,NG232,What are the discharge and supervision recommendations for patients with head injury?
NG232_Recommendations: 1.10 Discharge and follow up - Part 3,NG232,What information should be provided to patients and families after a head injury?
NG232_Recommendations: 1.10 Discharge and follow up - Part 4,NG232,When should hypopituitarism be investigated in patients after head injury with persistent symptoms?
NG232_Recommendations: Terms used in this guideline - Part 1,NG232,What is a closed head injury and how is it diagnosed?
NG232_Recommendations: Terms used in this guideline - Part 2,NG232,What are the symptoms and management of hypopituitarism?
NG232_Recommendations: Terms used in this guideline - Part 3,NG232,What are the common symptoms and signs of traumatic brain injury and skull fractures?
NG232_Recommendations for research: Key recommendations for research - Part 1,NG232,What are the criteria for hospital admission in patients with mild head injury and abnormal CT findings?
NG232_Recommendations for research: Key recommendations for research - Part 2,NG232,What is the risk of intracranial bleeding in patients with pre-injury coagulopathy after head injury?
NG232_Recommendations for research: Other recommendations for research - Part 1,NG232,What are the criteria for selecting patients for imaging more than 24 hours after a head injury?
NG232_Recommendations for research: Other recommendations for research - Part 2 & Rationale and impact: Decision making and mental capacity,NG232,What is the accuracy of biomarkers and MRI in predicting post-concussion syndrome after head injury?
NG232_Rationale and impact: Transport to hospital,NG232,What is the evidence for transporting head injury patients to specialist neuroscience centres versus non-specialist hospitals?
NG232_Rationale and impact: Tranexamic acid - Part 1,NG232,What is the recommended use of tranexamic acid for traumatic brain injury in adults?
NG232_Rationale and impact: Tranexamic acid - Part 2,NG232,What is the recommended use of tranexamic acid for traumatic brain injury?
NG232_Rationale and impact: Tranexamic acid - Part 3,NG232,What is the recommended dose of tranexamic acid for children under 16 with traumatic brain injury?
NG232_Rationale and impact: Direct access from the community to imaging & Rationale and impact: Assessment in the emergency department,NG232,Should community healthcare providers have direct access to imaging for head injury assessment?
NG232_Rationale and impact: Criteria for doing a CT head scan - Part 1,NG232,What are the criteria for performing a CT head scan in patients with head injury?
NG232_Rationale and impact: Criteria for doing a CT head scan - Part 2,NG232,What is the current NICE guidance on clinical decision rules for head injury imaging in people under 16?
NG232_Rationale and impact: Criteria for doing a CT head scan - Part 3,NG232,What are the current recommendations for CT imaging in patients on anticoagulants or antiplatelets after head injury?
NG232_Rationale and impact: Criteria for doing a CT head scan - Part 4,NG232,What are the recommendations for managing head injury in people with liver or coagulopathy disorders?
NG232_Rationale and impact: Criteria for doing a CT head scan - Part 5,NG232,What are the current recommendations for imaging in people with recurrent head injuries or presenting more than 24 hours after a head injury?
NG232_Rationale and impact: Post-concussion syndrome,NG232,What is the evidence for using biomarkers or MRI to predict post-concussion syndrome after mild traumatic brain injury?
NG232_Rationale and impact: Investigating injuries to the cervical spine,NG232,What is the recommended imaging approach for cervical spine injuries in adults with head trauma?
NG232_Rationale and impact: Admission and observation - Part 1,NG232,What are the criteria for admitting patients with mild head injury and abnormal CT findings?
NG232_Rationale and impact: Admission and observation - Part 2,NG232,What are the management recommendations for isolated skull fractures in children and adults?
NG232_Rationale and impact: Admission and observation - Part 3,NG232,Should anticoagulation or antiplatelet use influence admission decisions after a negative head CT?
NG232_Rationale and impact: Early diagnosis of hypopituitarism,NG232,What are the recommended signs and symptoms to screen for hypopituitarism after a head injury?
NG232_Rationale and impact: Discharge and follow up,NG232,What are the recommended discharge and follow-up procedures for patients with pre-existing cognitive impairment after a head injury?
NG232_Rationale and impact: Follow up,NG232,What follow-up assessments are recommended for persistent symptoms after a head injury?
NG232_Rationale and impact: Investigations for hypopituitarism,NG232,What are the recommended investigations for diagnosing hypopituitarism after head injury?
NG232_Context,NG232,What are the indications for CT head scans and imaging in patients with head injury?
NG233_Otitis media with effusion in under 12s & Overview,NG233,What are the recommended management strategies for otitis media with effusion in children under 12?
NG233_Recommendations: 1.1 Information and advice - Part 1,NG233,What information should I give to parents about managing otitis media with effusion in children?
NG233_Recommendations: 1.1 Information and advice - Part 2,NG233,What are effective strategies for supporting children with OME and hearing loss in educational settings?
NG233_Recommendations: 1.2 Recognition and assessment - Part 1,NG233,What are the clinical features and associated signs of otitis media with effusion in children?
NG233_Recommendations: 1.2 Recognition and assessment - Part 2,NG233,What are the recommended assessment procedures for diagnosing otitis media with effusion in children?
NG233_Recommendations: 1.3 Reassessment - Part 1,NG233,What is the recommended timing for hearing reassessment in children with otitis media with effusion?
NG233_Recommendations: 1.3 Reassessment - Part 2,NG233,What are the recommended management options for hearing loss associated with otitis media with effusion?
NG233_Recommendations: 1.4 Management of hearing loss,NG233,What are the recommended hearing aid options for children with OME-related hearing loss?
NG233_Recommendations: 1.5 Non-surgical management of otitis media with effusion - Part 1,NG233,What are the recommended non-surgical treatments for otitis media with effusion in children?
NG233_Recommendations: 1.5 Non-surgical management of otitis media with effusion - Part 2,NG233,"Why are homeopathy, cranial osteopathy, acupuncture, dietary modification, and massage not recommended for managing otitis media with effusion in children?"
NG233_Recommendations: 1.6 Surgical management of otitis media with effusion - Part 1,NG233,What are the recommended surgical options for managing otitis media with effusion in children?
NG233_Recommendations: 1.6 Surgical management of otitis media with effusion - Part 2,NG233,What are the recommended treatments for otorrhoea after grommet surgery in children?
NG233_Recommendations: 1.6 Surgical management of otitis media with effusion - Part 3,NG233,What is the recommended follow-up after grommet removal for persistent otorrhoea in children?
NG233_Recommendations: Terms used in this guideline,NG233,What are the indications for using bone conduction devices in hearing loss management?
NG233_Recommendations for research: Key recommendations for research - Part 1,NG233,What is the clinical and cost effectiveness of hearing aids and grommets for otitis media with effusion in children under 12 years?
NG233_Recommendations for research: Key recommendations for research - Part 2,NG233,What are the best water precautions to prevent otorrhoea after grommet surgery in children with OME?
NG233_Recommendations for research: Other recommendations for research,NG233,What are the recommended follow-up strategies after surgical treatment for OME-related hearing loss in children under 12?
NG233_Rationale and impact: Information and advice - Part 1,NG233,What information should healthcare professionals provide to parents and children about otitis media with effusion?
NG233_Rationale and impact: Information and advice - Part 2,NG233,How should healthcare professionals communicate information about otitis media with effusion to children and their parents to ensure understanding and support?
NG233_Rationale and impact: Recognition and assessment - Part 1,NG233,What are the clinical features and parent-reported signs associated with otitis media with effusion in children?
NG233_Rationale and impact: Recognition and assessment - Part 2,NG233,What are the recommended methods for diagnosing otitis media with effusion in children?
NG233_Rationale and impact: Reassessment - Part 1,NG233,What is the recommended follow-up schedule for children with otitis media with effusion and hearing loss?
NG233_Rationale and impact: Reassessment - Part 2,NG233,When should hearing loss be considered for intervention in children with bilateral hearing loss at 3 months?
NG233_Rationale and impact: Management of hearing loss - Part 1,NG233,What are the considerations for choosing hearing aids for children with otitis media with effusion?
NG233_Rationale and impact: Management of hearing loss - Part 2,NG233,What are the safety considerations and benefits of bone conduction hearing aids compared to air conduction hearing aids in children?
NG233_Rationale and impact: Auto-inflation,NG233,What is the effectiveness of auto-inflation in improving short-term hearing outcomes in children with ear conditions?
NG233_Rationale and impact: Antibiotics,NG233,Should antibiotics be used to treat otitis media with effusion in children?
NG233_Rationale and impact: Non-antimicrobial pharmacological interventions - Part 1,NG233,Should nasal or oral steroids be used to treat otitis media with effusion in children?
NG233_Rationale and impact: Non-antimicrobial pharmacological interventions - Part 2 & Rationale and impact: Other non-surgical interventions,NG233,What are the current recommendations for pharmacological treatment of otitis media with effusion in children under 12?
NG233_Rationale and impact: Grommets - Part 1,NG233,When should grommet insertion be considered for children with otitis media with effusion and hearing loss?
NG233_Rationale and impact: Grommets - Part 2,NG233,What are the benefits and risks of grommet insertion for children with OME-related hearing loss?
NG233_Rationale and impact: Adenoidectomy,NG233,When should adenoidectomy be considered for children with otitis media with effusion?
NG233_Rationale and impact: Prevention of otorrhoea,NG233,What is the effectiveness of intraoperative ciprofloxacin ear drops in preventing otorrhoea after grommet insertion in children?
NG233_Rationale and impact: Treatment of infection after grommet insertion - Part 1,NG233,What is the recommended treatment for otorrhoea after grommet insertion?
NG233_Rationale and impact: Treatment of infection after grommet insertion - Part 2,NG233,When should grommets be removed in children with recurrent otorrhoea?
NG233_Rationale and impact: Follow up after surgical treatment - Part 1,NG233,What is the recommended follow-up schedule after grommet surgery in children?
NG233_Rationale and impact: Follow up after surgical treatment - Part 2,NG233,What are the recommended follow-up procedures after surgical treatment for OME-related hearing loss in children?
NG233_Context,NG233,What are the recommended management options for persistent otitis media with effusion in children?
NG234_Spinal metastases and metastatic spinal cord compression & Overview,NG234,What are the recommended approaches for early diagnosis and management of spinal metastases and metastatic spinal cord compression?
NG234_Recommendations: 1.1 Organising and delivering services - Part 1,NG234,What are the recommended roles and responsibilities of cancer alliances and service commissioners in managing spinal metastases and MSCC?
NG234_Recommendations: 1.1 Organising and delivering services - Part 2,NG234,What are the key components of a coordinated MSCC and spinal metastases service?
NG234_Recommendations: 1.1 Organising and delivering services - Part 3,NG234,What are the recommended systems for recording data and investigating incidents in MSCC services?
NG234_Recommendations: 1.1 Organising and delivering services - Part 4,NG234,What are the recommendations for providing urgent imaging and radiotherapy services for spinal metastases and MSCC?
NG234_Recommendations: 1.1 Organising and delivering services - Part 5,NG234,What are the recommended urgent imaging and radiotherapy services for suspected spinal cord compression?
NG234_Recommendations: 1.1 Organising and delivering services - Part 6,NG234,What are the recommended components of discharge planning and support for patients with MSCC?
NG234_Recommendations: 1.2 Information and support - Part 1,NG234,How should healthcare professionals provide information and support to patients with suspected or confirmed spinal metastases or MSCC and their families?
NG234_Recommendations: 1.2 Information and support - Part 2,NG234,What is the recommended approach for conducting a holistic needs assessment after an initial diagnosis?
NG234_Recommendations: 1.2 Information and support - Part 3,NG234,What support and information should be provided to patients with spinal metastases or MSCC and their families regarding end-of-life care and post-discharge management?
NG234_Recommendations: 1.3 Recognising spinal metastases or MSCC - Part 1,NG234,What are the signs and symptoms indicating spinal metastases or spinal cord compression in cancer patients?
NG234_Recommendations: 1.3 Recognising spinal metastases or MSCC - Part 2,NG234,What are the recommended initial care steps for suspected spinal metastases or MSCC according to NICE guidelines?
NG234_Recommendations: 1.4 Immobilisation,NG234,What are the recommended practices for immobilisation in patients with suspected or confirmed spinal metastases or MSCC?
NG234_Recommendations: 1.5 Imaging investigations - Part 1,NG234,What are the recommended MRI imaging protocols for suspected spinal metastases and MSCC?
NG234_Recommendations: 1.5 Imaging investigations - Part 2,NG234,What are the recommended imaging techniques for diagnosing and managing suspected spinal metastases or MSCC?
NG234_Recommendations: 1.6 Mobilisation and assessment of spinal stability,NG234,What are the recommended procedures for mobilising and assessing spinal stability in patients with suspected spinal injuries?
NG234_Recommendations: 1.7 Pain management - Part 1,NG234,What are the recommended approaches for individualised pain assessment and management in patients with suspected or confirmed spinal metastases or MSCC?
NG234_Recommendations: 1.7 Pain management - Part 2,NG234,What are the recommended approaches for prescribing and managing analgesic medications in adults with cancer-related pain?
NG234_Recommendations: 1.7 Pain management - Part 3,NG234,When should bisphosphonates be used for managing spinal metastases in cancer patients?
NG234_Recommendations: 1.8 Corticosteroid therapy - Part 1,NG234,When should corticosteroids be administered for spinal cord compression in cancer patients?
NG234_Recommendations: 1.8 Corticosteroid therapy - Part 2,NG234,What are the recommended corticosteroid treatments for spinal metastases in haematological malignancies?
NG234_Recommendations: 1.9 Tools for assessing spinal stability and prognosis,NG234,What are the recommended tools for assessing spinal stability and prognosis in patients with spinal metastases?
NG234_Recommendations: 1.10 Radiotherapy - Part 1,NG234,What are the considerations for radiotherapy and fertility preservation in cancer patients?
NG234_Recommendations: 1.10 Radiotherapy - Part 2,NG234,What are the NICE guidelines for radiotherapy management of metastatic spinal cord compression?
NG234_Recommendations: 1.10 Radiotherapy - Part 3,NG234,What are the recommendations for postoperative and further radiotherapy in patients with spinal metastases or MSCC?
NG234_Recommendations: 1.11 Invasive interventions - Part 1,NG234,What are the recommended timing and options for invasive interventions in managing spinal metastases with or without MSCC?
NG234_Recommendations: 1.11 Invasive interventions - Part 2,NG234,What are the recommended surgical and non-surgical interventions for spinal metastases with MSCC?
NG234_Recommendations: 1.12 Rehabilitation and supportive care - Part 1,NG234,What are the recommended approaches for rehabilitation and supportive care for patients with spinal metastases or MSCC?
NG234_Recommendations: 1.12 Rehabilitation and supportive care - Part 2,NG234,What are the recommended interventions for preventing venous thromboembolism in patients undergoing elective spinal or cranial surgery?
NG234_Recommendations: Terms used in this guideline,NG234,What is a holistic needs assessment in cancer care?
NG234_Recommendations for research,NG234,What are the current research priorities for radiotherapy and immobilisation in the management of metastatic spinal cord compression?
NG234_Rationale and impact: Organising and delivering services - Part 1,NG234,What are the recommended organizational structures for coordinated spinal metastases and MSCC services?
NG234_Rationale and impact: Organising and delivering services - Part 2,NG234,What is the role of the MSCC coordinator in improving access and outcomes for spinal cord compression services?
NG234_Rationale and impact: Organising and delivering services - Part 3,NG234,What are the recommended strategies for improving coordination and data sharing in MSCC services to enhance patient outcomes?
NG234_Rationale and impact: Organising and delivering services - Part 4,NG234,What are the recommended roles and responsibilities in a coordinated MSCC and spinal metastases service?
NG234_Rationale and impact: Organising and delivering services - Part 5,NG234,What are the recommended timeframes for MRI and radiotherapy for suspected or confirmed spinal metastases according to NICE guidelines?
NG234_Rationale and impact: Organising and delivering services - Part 6,NG234,What are the best practices for providing support and rehabilitation services for people with MSCC after hospital discharge?
NG234_Rationale and impact: Information and support - Part 1,NG234,What are the best ways to improve communication and provide support for patients with spinal metastases or MSCC?
NG234_Rationale and impact: Information and support - Part 2,NG234,What are the recommended approaches for providing emotional and psychological support to people with spinal metastases or MSCC?
NG234_Rationale and impact: Information and support - Part 3,NG234,What are the recommended practices for providing holistic needs assessments and support to patients with spinal metastases or MSCC during hospital discharge?
NG234_Rationale and impact: Recognising spinal metastases or MSCC - Part 1,NG234,What are the early signs and symptoms of spinal metastases and MSCC that require urgent medical attention?
NG234_Rationale and impact: Recognising spinal metastases or MSCC - Part 2,NG234,What are the recommended urgent assessment procedures for suspected spinal metastases in cancer patients?
NG234_Rationale and impact: Immobilisation,NG234,What are the recommended practices for immobilisation and positioning in patients with suspected spinal instability?
NG234_Rationale and impact: Imaging investigations – radiologist involvement and MRI assessment - Part 1,NG234,What is the recommended timing and process for MRI imaging in suspected spinal metastases or MSCC?
NG234_Rationale and impact: Imaging investigations – radiologist involvement and MRI assessment - Part 2,NG234,What are the recommended MRI protocols and timing for suspected spinal metastases?
NG234_Rationale and impact: Imaging investigations – other imaging techniques for diagnosis and management - Part 1,NG234,When should CT scan or myelography be used instead of MRI for diagnosing spinal metastases or spinal cord compression?
NG234_Rationale and impact: Imaging investigations – other imaging techniques for diagnosis and management - Part 2,NG234,When should MRI or CT scans be used for detecting spinal cord compression in patients with spinal metastases?
NG234_Rationale and impact: Mobilisation and assessment of spinal stability,NG234,What are the recommended approaches for mobilising patients with suspected spinal stability in cancer care?
NG234_Rationale and impact: Individualised pain assessment and management plan,NG234,What are the key components of an individualised pain assessment and management plan according to NICE guidelines?
NG234_Rationale and impact: Analgesic medication - Part 1,NG234,What are the current NICE recommendations for analgesic medication in cancer pain management?
NG234_Rationale and impact: Analgesic medication - Part 2,NG234,How should pain medication dosages and titration be managed and reviewed in patients with neuropathic pain or inadequate pain relief?
NG234_Rationale and impact: Bisphosphonates and denosumab,NG234,What are the current NICE recommendations for bisphosphonate and denosumab use in osteoporosis and cancer-related bone disease?
NG234_Rationale and impact: Corticosteroid therapy - Part 1,NG234,What are the current recommendations for corticosteroid use in managing spinal cord compression due to metastatic cancer?
NG234_Rationale and impact: Corticosteroid therapy - Part 2,NG234,What are the recommended corticosteroid treatments for haematological malignancy with spinal infiltration according to NICE guidelines?
NG234_Rationale and impact: Tools for assessing spinal stability and prognosis - Part 1,NG234,What are the recommended tools for assessing spinal stability and prognosis in patients with spinal neoplasms?
NG234_Rationale and impact: Tools for assessing spinal stability and prognosis - Part 2,NG234,How should prognostic scoring systems be used alongside clinical assessment to guide treatment decisions?
NG234_Rationale and impact: Radiotherapy and fertility,NG234,How should fertility preservation be discussed and managed in patients undergoing radiotherapy for metastatic spinal cord compression?
NG234_Rationale and impact: Radiotherapy to treat painful spinal metastases and prevent MSCC - Part 1,NG234,What is the recommended radiotherapy approach for treating painful spinal metastases without MSCC?
NG234_Rationale and impact: Radiotherapy to treat painful spinal metastases and prevent MSCC - Part 2,NG234,What are the risks of radiotherapy for spinal metastatic disease in patients with haematological conditions?
NG234_Rationale and impact: Radiotherapy to treat MSCC,NG234,What is the recommended radiotherapy approach for treating malignant spinal cord compression?
NG234_Rationale and impact: Radiotherapy for asymptomatic spinal metastases,NG234,When should radiotherapy be considered for asymptomatic spinal metastases?
NG234_Rationale and impact: Postoperative radiotherapy and further radiotherapy treatment,NG234,When should postoperative radiotherapy be offered to patients with spinal metastases or MSCC?
NG234_Rationale and impact: Timing of invasive interventions,NG234,What is the recommended timing for surgical intervention in malignant spinal cord compression?
NG234_Rationale and impact: Options for invasive interventions - Part 1,NG234,What are the recommended invasive interventions for spinal metastases without cord compression?
NG234_Rationale and impact: Options for invasive interventions - Part 2,NG234,What are the recommended surgical interventions for spinal metastases with MSCC?
NG234_Rationale and impact: Rehabilitation and supportive care,NG234,What are the key components of effective rehabilitation and supportive care services?
NG234_Context,NG234,What are the current recommendations for managing spinal metastases and metastatic spinal cord compression?
NG235_Intrapartum care & Overview,NG235,What are the recommended practices for intrapartum care for women giving birth at term?
NG235_Recommendations: 1.1 Antenatal education about labour,NG235,What information should be provided to women antenatally about labour and birth options?
NG235_Recommendations: 1.2 Service organisation,NG235,What are the recommended service organization and transfer protocols for different birth settings according to NICE guidelines?
NG235_Recommendations: 1.3 Planning place of birth - Part 1,NG235,What information should healthcare professionals provide to women when planning their place of birth?
NG235_Recommendations: 1.3 Planning place of birth - Part 2,NG235,What are the factors affecting access to midwifery care and transfer to obstetric units during labour?
NG235_Recommendations: 1.3 Planning place of birth - Part 3,NG235,How does BMI above 35 affect the choice of place of birth and associated risks?
NG235_Recommendations: 1.3 Planning place of birth - Part 4,NG235,"What are the outcomes and intervention rates for low-risk multiparous women planning birth at home, midwifery units, or obstetric units?"
NG235_Recommendations: 1.3 Planning place of birth - Part 5,NG235,What are the maternal and neonatal outcomes associated with different planned birth settings for low-risk nulliparous women?
NG235_Recommendations: 1.3 Planning place of birth - Part 6,NG235,What are the risks and transfer rates associated with planning a home birth compared to hospital birth for low-risk women?
NG235_Recommendations: 1.3 Planning place of birth - Part 7,NG235,What factors should be considered when choosing the planned place of birth for low-risk nulliparous women?
NG235_Recommendations: 1.3 Planning place of birth - Part 8,NG235,What are the medical conditions and pregnancy factors that indicate the need for planned birth at an obstetric unit?
NG235_Recommendations: 1.3 Planning place of birth - Part 9,NG235,What medical conditions require individual assessment when planning the place of birth?
NG235_Recommendations: 1.4 Care throughout labour in all birth settings - Part 1,NG235,What are the recommendations for providing care throughout labour in all birth settings?
NG235_Recommendations: 1.4 Care throughout labour in all birth settings - Part 2,NG235,What are best practices for effective communication and informed decision-making during labour?
NG235_Recommendations: 1.4 Care throughout labour in all birth settings - Part 3,NG235,What are the recommended practices for supporting a woman's labour and birth preferences according to NICE guidelines?
NG235_Recommendations: 1.5 Transfer of care and changing place of birth - Part 1,NG235,What are the recommended procedures for transferring care between midwifery-led and obstetric-led services during labour?
NG235_Recommendations: 1.5 Transfer of care and changing place of birth - Part 2,NG235,What are the recommended procedures for transferring a woman in labour to another location?
NG235_Recommendations: 1.6 Pain relief during labour - Part 1,NG235,What are the recommended non-pharmacological pain relief options during labour according to NICE guidelines?
NG235_Recommendations: 1.6 Pain relief during labour - Part 2,NG235,What are the recommended pain relief options during labour according to NICE guidelines?
NG235_Recommendations: 1.6 Pain relief during labour - Part 3,NG235,What are the guidelines for using remifentanil patient-controlled analgesia during labour?
NG235_Recommendations: 1.6 Pain relief during labour - Part 4,NG235,What are the safety guidelines and considerations for using regional analgesia during labour?
NG235_Recommendations: 1.6 Pain relief during labour - Part 5,NG235,What are the recommended monitoring and observation practices for women receiving regional analgesia during labour?
NG235_Recommendations: 1.6 Pain relief during labour - Part 6,NG235,What are the recommended techniques and medications for establishing and maintaining epidural analgesia during labour?
NG235_Recommendations: 1.7 Prelabour rupture of membranes at term - Part 1,NG235,What are the recommended management steps for suspected prelabour rupture of membranes at term?
NG235_Recommendations: 1.7 Prelabour rupture of membranes at term - Part 2,NG235,What are the management options and recommendations for women with prelabour rupture of membranes at term?
NG235_Recommendations: 1.7 Prelabour rupture of membranes at term - Part 3,NG235,How should fetal movement and heart rate be monitored after rupture of membranes?
NG235_Recommendations: 1.8 First stage of labour - Part 1,NG235,What are the recommended assessments and care procedures during the first stage of labour?
NG235_Recommendations: 1.8 First stage of labour - Part 2,NG235,What are the recommended steps for initial assessment of a woman in labour according to NICE guidelines?
NG235_Recommendations: 1.8 First stage of labour - Part 3,NG235,What are the recommended procedures and considerations for performing vaginal examinations during labour according to NICE guidelines?
NG235_Recommendations: 1.8 First stage of labour - Part 4,NG235,What are the indications for fetal monitoring and assessment during labour according to NICE guidelines?
NG235_Recommendations: 1.8 First stage of labour - Part 5,NG235,What are the recommendations for fluid intake and monitoring during labour?
NG235_Recommendations: 1.8 First stage of labour - Part 6,NG235,What are the key signs and observations indicating the need for urgent medical intervention during labour?
NG235_Recommendations: 1.8 First stage of labour - Part 7,NG235,What are the recommended practices for bladder care and fluid management during labour?
NG235_Recommendations: 1.8 First stage of labour - Part 8,NG235,What are the recommendations for managing hyponatraemia and fluid balance in pregnant women during the peripartum period?
NG235_Recommendations: 1.8 First stage of labour - Part 9,NG235,What are the recommendations for transfer of care and management of meconium-stained amniotic fluid during labour?
NG235_Recommendations: 1.8 First stage of labour - Part 10,NG235,What are the recommended assessments and management options for suspected delay in the first stage of labour?
NG235_Recommendations: 1.8 First stage of labour - Part 11,NG235,What are the recommendations for using oxytocin in the first stage of labour?
NG235_Recommendations: 1.8 First stage of labour - Part 12,NG235,When should oxytocin be restarted during the first stage of labour according to NICE guidelines?
NG235_Recommendations: 1.9 Second stage of labour - Part 1,NG235,What are the recommended practices for assessing progress during the second stage of labour?
NG235_Recommendations: 1.9 Second stage of labour - Part 2,NG235,What are the recommended practices for fetal monitoring and maternal positioning during the second stage of labour?
NG235_Recommendations: 1.9 Second stage of labour - Part 3,NG235,What are the recommended pushing techniques for women with an epidural during labor?
NG235_Recommendations: 1.9 Second stage of labour - Part 4,NG235,What is the recommended management of episiotomy and perineal trauma during vaginal birth?
NG235_Recommendations: 1.9 Second stage of labour - Part 5,NG235,What are the recommended management steps for the second stage of labour in women without epidurals or with epidurals?
NG235_Recommendations: 1.9 Second stage of labour - Part 6,NG235,What are the recommended management steps for delay in the second stage of labour in multiparous women with an epidural?
NG235_Recommendations: 1.9 Second stage of labour - Part 7,NG235,What are the recommended procedures for using oxytocin during the second stage of labour?
NG235_Recommendations: 1.9 Second stage of labour - Part 8,NG235,What are the recommended pain relief options for birth with forceps or ventouse?
NG235_Recommendations: 1.10 Third stage of labour - Part 1,NG235,What are the differences between active and physiological management of the third stage of labour?
NG235_Recommendations: 1.10 Third stage of labour - Part 2,NG235,What are the outcomes of active management versus physiological management of the third stage of labour?
NG235_Recommendations: 1.10 Third stage of labour - Part 3,NG235,What are the recommended management options for the third stage of labour according to NICE guidelines?
NG235_Recommendations: 1.10 Third stage of labour - Part 4,NG235,What are the recommended uterotonics and antiemetics for managing the third stage of labour?
NG235_Recommendations: 1.10 Third stage of labour - Part 5,NG235,What are the recommended practices for timing and management of cord clamping during the third stage of labour?
NG235_Recommendations: 1.10 Third stage of labour - Part 6,NG235,What are the recommended management steps for retained placenta and postpartum haemorrhage?
NG235_Recommendations: 1.10 Third stage of labour - Part 7,NG235,What are the risk factors for postpartum haemorrhage during labour and how should they be managed?
NG235_Recommendations: 1.10 Third stage of labour - Part 8,NG235,What is the recommended first-line treatment for postpartum haemorrhage according to NICE guidelines?
NG235_Recommendations: 1.10 Third stage of labour - Part 9,NG235,What are the recommended uterotonic and adjunct treatments for postpartum haemorrhage according to NICE guidelines?
NG235_Recommendations: 1.10 Third stage of labour - Part 10,NG235,What are the recommended pharmacological management strategies for postpartum haemorrhage?
NG235_Recommendations: 1.11 Care of the newborn baby - Part 1,NG235,What are the recommended procedures for initial newborn assessment and promoting mother–baby bonding after birth?
NG235_Recommendations: 1.11 Care of the newborn baby - Part 2,NG235,What are the recommended postnatal procedures and monitoring for babies exposed to antidepressants during pregnancy?
NG235_Recommendations: 1.11 Care of the newborn baby - Part 3,NG235,What are the recommended procedures for neonatal resuscitation in babies with meconium-stained amniotic fluid?
NG235_Recommendations: 1.11 Care of the newborn baby - Part 4,NG235,What are the recommended observations and assessment criteria for newborns with meconium-stained amniotic fluid?
NG235_Recommendations: 1.11 Care of the newborn baby - Part 5,NG235,What are the signs of neonatal sepsis and when should a baby be referred to a specialist?
NG235_Recommendations: 1.12 Care of the woman after birth - Part 1,NG235,What are the recommended postnatal assessments and care procedures for women after birth according to NICE guidelines?
NG235_Recommendations: 1.12 Care of the woman after birth - Part 2,NG235,What are the classifications and assessment procedures for perineal tears during childbirth?
NG235_Recommendations: 1.12 Care of the woman after birth - Part 3,NG235,What are the recommended practices for perineal trauma assessment and repair during childbirth?
NG235_Recommendations: 1.12 Care of the woman after birth - Part 4,NG235,What are the recommended techniques and materials for perineal repair after second-degree trauma?
NG235_Recommendations: Terms used in this guideline,NG235,What does hyperstimulation of the uterus mean during labour?
NG235_Recommendations for research: Key recommendations for research - Part 1,NG235,What is the most effective method of perineal care during the second stage of labour to reduce trauma?
NG235_Recommendations for research: Key recommendations for research - Part 2,NG235,What are the best practices for managing postpartum haemorrhage to support breastfeeding and patient satisfaction?
NG235_Recommendations for research: Other recommendations for research - Part 1,NG235,What are the long-term health and psychological outcomes for women and children based on the setting of birth?
NG235_Recommendations for research: Other recommendations for research - Part 2,NG235,What is the most effective treatment for primary postpartum haemorrhage?
NG235_Rationale and impact: Antenatal education about labour & Rationale and impact: Planning place of birth & Rationale and impact: Care throughout labour in all birth settings,NG235,What information should be provided to women during antenatal education about labour options?
NG235_Rationale and impact: Communication & Rationale and impact: Transfer of care and changing place of birth & Rationale and impact: Attitudes to pain and pain relief in childbirth,NG235,What are the recommended communication strategies and considerations for supporting decision making in maternity care?
NG235_Rationale and impact: Care and observations for women with regional analgesia & 3 more sections,NG235,What are the recommended practices for bladder care and urine monitoring during labour?
NG235_Rationale and impact: Fluid balance and hyponatraemia - Part 1,NG235,What are the recommended practices for managing fluid balance to prevent hyponatraemia in women during labour?
NG235_Rationale and impact: Fluid balance and hyponatraemia - Part 2,NG235,What are the indications for fluid balance monitoring during labour to prevent hyponatraemia?
NG235_Rationale and impact: Presence of meconium & 3 more sections,NG235,What are the guidelines for managing meconium presence and delayed second stage of labour?
NG235_Rationale and impact: Risk factors for postpartum haemorrhage & Rationale and impact: Initial assessment of the newborn baby,NG235,What medications increase the risk of postpartum haemorrhage according to NICE guidelines?
NG235_Rationale and impact: Optimal positioning during skin-to-skin contact & Rationale and impact: Additional monitoring for babies exposed to antidepressants in utero & Rationale and impact: Care of the woman after birth,NG235,What are the recommended practices for safe positioning during skin-to-skin contact after birth?
NG235_Rationale and impact: Impact of BMI on choice of place of birth,NG235,What is the impact of BMI on the safety of different birth settings?
NG235_Rationale and impact: Initial assessment of women reporting prelabour rupture of membranes,NG235,What are the initial assessment criteria for women reporting prelabour rupture of membranes at term?
NG235_Rationale and impact: Sterile water injections,NG235,What are the benefits and risks of sterile water injections for back pain in labour?
NG235_Rationale and impact: Remifentanil patient-controlled analgesia,NG235,What are the safety considerations and recommended monitoring protocols for using remifentanil patient-controlled analgesia during labor?
NG235_Rationale and impact: Programmed intermittent epidural bolus,NG235,What are the benefits of programmed intermittent epidural bolus compared to continuous infusion during labour?
NG235_Rationale and impact: Use of oxytocin in the first or second stage of labour,NG235,What are the current NICE recommendations for the use of oxytocin in the first and second stages of labour?
NG235_Rationale and impact: Position for birth,NG235,What is the recommended maternal position during the second stage of labour for women with an epidural?
NG235_Rationale and impact: Pushing techniques,NG235,What are the recommended pushing techniques during the second stage of labour for women with and without epidurals?
NG235_Rationale and impact: Interventions to reduce perineal trauma,NG235,What are the benefits of using warm compresses during labour to reduce perineal trauma?
NG235_Rationale and impact: Prophylactic antibiotics for birth with forceps or ventouse,NG235,What are the recommended prophylactic antibiotics to prevent infection after birth with forceps or ventouse?
NG235_Rationale and impact: Management of the third stage of labour - Part 1,NG235,What are the recommended management options for the third stage of labour to prevent postpartum haemorrhage?
NG235_Rationale and impact: Management of the third stage of labour - Part 2,NG235,What are the recommended uterotonics for preventing postpartum hemorrhage after caesarean birth?
NG235_Rationale and impact: Position of the baby during cord clamping,NG235,What is the optimal position of the baby during cord clamping to improve neonatal outcomes?
NG235_Rationale and impact: Management of postpartum haemorrhage,NG235,What are the recommended pharmacological treatments for postpartum haemorrhage?
NG235_Rationale and impact: Uterotonics for postpartum haemorrhage - Part 1,NG235,What are the recommended uterotonics for managing postpartum haemorrhage according to NICE guidelines?
NG235_Rationale and impact: Uterotonics for postpartum haemorrhage - Part 2,NG235,When should a second dose of ergometrine be administered for postpartum haemorrhage in home birth settings?
NG235_Context - Part 1,NG235,What are the recommended practices for supporting women during labour at term?
NG236_Stroke rehabilitation in adults & 4 more sections,NG236,What are the recommended strategies for organizing health and social care for stroke rehabilitation in adults?
NG236_Recommendations: 1.1 Organising health and social care for people needing rehabilitation after stroke - Part 1,NG236,What are the recommended components of a specialist stroke rehabilitation team and their roles?
NG236_Recommendations: 1.1 Organising health and social care for people needing rehabilitation after stroke - Part 2,NG236,What are the recommended practices for assessing care and support needs after a stroke?
NG236_Recommendations: 1.1 Organising health and social care for people needing rehabilitation after stroke - Part 3,NG236,What are the key considerations for early supported discharge and care planning after stroke?
NG236_Recommendations: 1.1 Organising health and social care for people needing rehabilitation after stroke - Part 4 & Recommendations: 1.2 Planning and delivering stroke rehabilitation,NG236,What are the recommended procedures for transferring stroke patients from hospital to care homes and ensuring continuity of rehabilitation services?
NG236_Recommendations: 1.2 Planning and delivering stroke rehabilitation - Part 1,NG236,What are the recommended screening and assessment procedures for stroke rehabilitation?
NG236_Recommendations: 1.2 Planning and delivering stroke rehabilitation - Part 2,NG236,What are the recommended practices for goal-setting and rehabilitation planning after stroke according to NICE guidelines?
NG236_Recommendations: 1.2 Planning and delivering stroke rehabilitation - Part 3,NG236,What are the recommended components and planning considerations for stroke rehabilitation?
NG236_Recommendations: 1.2 Planning and delivering stroke rehabilitation - Part 4 & Recommendations: 1.3 Telerehabilitation,NG236,What are the recommendations for involving families and carers in stroke rehabilitation sessions?
NG236_Recommendations: 1.3 Telerehabilitation & Recommendations: 1.4 Providing support and information,NG236,When should telerehabilitation be used instead of face-to-face therapy after a stroke?
NG236_Recommendations: 1.4 Providing support and information & Recommendations: 1.5 Cognitive functioning,NG236,How should healthcare professionals support cognitive functioning and provide information to stroke survivors and their families?
NG236_Recommendations: 1.5 Cognitive functioning & Recommendations: 1.6 Psychological functioning,NG236,What are the recommended assessments and interventions for cognitive and psychological impairments after stroke?
NG236_Recommendations: 1.6 Psychological functioning & Recommendations: 1.7 Fatigue,NG236,What are the recommended approaches for assessing and managing psychological functioning and emotional health after stroke?
NG236_Recommendations: 1.7 Fatigue & Recommendations: 1.8 Vision,NG236,What are the recommended tools for assessing fatigue in people after stroke during early rehabilitation and at 6-month review?
NG236_Recommendations: 1.8 Vision & Recommendations: 1.9 Hearing,NG236,"What assessments and interventions are recommended for visual problems, such as hemianopia, after stroke?"
NG236_Recommendations: 1.9 Hearing & Recommendations: 1.10 Mouth care,NG236,What are the recommended mouth care practices for stroke patients?
NG236_Recommendations: 1.10 Mouth care & Recommendations: 1.11 Swallowing,NG236,What are the recommended mouth care practices for people after stroke?
NG236_Recommendations: 1.11 Swallowing - Part 1,NG236,What are the recommended strategies for managing swallowing difficulties after stroke?
NG236_Recommendations: 1.11 Swallowing - Part 2 & Recommendations: 1.12 Communication,NG236,What are the recommended practices for monitoring and supporting people with dysphagia after stroke?
NG236_Recommendations: 1.12 Communication - Part 1,NG236,What are the recommended approaches for screening and managing communication difficulties after stroke?
NG236_Recommendations: 1.12 Communication - Part 2 & Recommendations: 1.13 Movement,NG236,What are the recommended strategies for supporting communication and language recovery in stroke patients with aphasia or dysarthria?
NG236_Recommendations: 1.13 Movement - Part 1,NG236,What are the recommended physiotherapy interventions for improving movement after stroke?
NG236_Recommendations: 1.13 Movement - Part 2,NG236,What are the recommended interventions for upper limb rehabilitation after stroke according to NICE guidelines?
NG236_Recommendations: 1.13 Movement - Part 3,NG236,What are the recommended rehabilitation strategies for improving walking and upper limb function after stroke?
NG236_Recommendations: 1.13 Movement - Part 4 & Recommendations: 1.14 Managing shoulder pain,NG236,What are the recommended approaches for managing shoulder pain after a stroke?
NG236_Recommendations: 1.14 Managing shoulder pain & Recommendations: 1.15 Spasticity,NG236,What are the recommended management strategies for shoulder pain after stroke?
NG236_Recommendations: 1.15 Spasticity - Part 1,NG236,What are the management options for spasticity after stroke?
NG236_Recommendations: 1.15 Spasticity - Part 2 & Recommendations: 1.16 Self-care,NG236,When should patients with post-stroke spasticity be referred to a specialist spasticity service?
NG236_Recommendations: 1.16 Self-care - Part 1,NG236,What occupational therapy interventions are recommended for improving activities of daily living after stroke?
NG236_Recommendations: 1.16 Self-care - Part 2 & Recommendations: 1.17 Long-term health and social support,NG236,What are the NICE guidelines for long-term health and social support after stroke?
NG236_Recommendations: 1.17 Long-term health and social support - Part 1,NG236,What support and information should be provided to people after stroke to help them achieve their life goals?
NG236_Recommendations: 1.17 Long-term health and social support - Part 2 & Recommendations: Terms used in this guideline,NG236,What are the benefits of community participation programmes for stroke rehabilitation?
NG236_Recommendations: Terms used in this guideline & Recommendations for research,NG236,What are the definitions and roles of community participation programmes and telerehabilitation in stroke care?
NG236_Recommendations for research: Key recommendations for research & Recommendations for research: Key recommendations for research - Part 1,NG236,What is the clinical and cost effectiveness of delivering stroke rehabilitation therapy 7 days a week compared to 5 days a week?
NG236_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG236,What is the effectiveness of computer-based speech and language therapy for post-stroke communication problems?
NG236_Recommendations for research: Other recommendations for research - Part 1,NG236,What is the clinical and cost effectiveness of tools for assessing fatigue in people after stroke?
NG236_Recommendations for research: Other recommendations for research - Part 2,NG236,What is the clinical and cost effectiveness of self-management interventions for stroke recovery?
NG236_Recommendations for research: Other recommendations for research - Part 3,NG236,What is the clinical and cost effectiveness of neuromuscular electrical stimulation for improving swallowing after stroke?
NG236_Recommendations for research: Other recommendations for research - Part 4,NG236,What is the effectiveness of acupuncture and electroacupuncture in treating spasticity after stroke?
"NG236_Rationale and impact & Rationale and impact: Transfer of care from hospital to community, including early supported discharge & Rationale and impact: Transfer of care from hospital to community, including early supported discharge - Part 1",NG236,What are the benefits and risks of early supported discharge after hospital rehabilitation?
"NG236_Rationale and impact: Transfer of care from hospital to community, including early supported discharge - Part 2 & Rationale and impact: Intensity of stroke rehabilitation",NG236,What is the recommended intensity of stroke rehabilitation after early supported discharge?
NG236_Rationale and impact: Intensity of stroke rehabilitation - Part 1,NG236,What is the recommended intensity and duration of stroke rehabilitation therapy?
NG236_Rationale and impact: Intensity of stroke rehabilitation - Part 2 & Rationale and impact: Telerehabilitation,NG236,What are the current NICE recommendations on the duration and intensity of stroke rehabilitation therapies?
NG236_Rationale and impact: Telerehabilitation & Rationale and impact: Fatigue,NG236,What are the best practices for implementing telerehabilitation after stroke?
NG236_Rationale and impact: Fatigue & Rationale and impact: Vision,NG236,What are the recommended tools for assessing fatigue in stroke rehabilitation?
NG236_Rationale and impact: Vision & Rationale and impact: Hearing,NG236,What are the recommended methods for assessing eyesight problems in stroke patients before discharge?
NG236_Rationale and impact: Hearing & Rationale and impact: Mouth care,NG236,What are the recommended procedures for hearing screening and assessment in stroke patients?
NG236_Rationale and impact: Mouth care & Rationale and impact: Swallowing,NG236,What are the recommended mouth care practices for people after stroke to prevent pneumonia?
NG236_Rationale and impact: Swallowing - Part 1,NG236,What are the recommended interventions for managing dysphagia after stroke?
NG236_Rationale and impact: Swallowing - Part 2 & Rationale and impact: Communication,NG236,What is the evidence for neuromuscular electrical stimulation and free water protocols in managing dysphagia?
NG236_Rationale and impact: Communication & Rationale and impact: Robot-assisted arm training,NG236,What is the evidence for using computer-based speech and language therapy to improve word finding after stroke?
NG236_Rationale and impact: Robot-assisted arm training & Rationale and impact: Walking therapies and group circuit training,NG236,What is the evidence for the effectiveness of robot-assisted arm training after stroke?
NG236_Rationale and impact: Walking therapies and group circuit training - Part 1,NG236,What are the benefits of group circuit training and walking therapies for stroke rehabilitation?
NG236_Rationale and impact: Walking therapies and group circuit training - Part 2 & Rationale and impact: Mirror therapy for the upper or lower limb,NG236,What is the effectiveness of mirror therapy for improving upper or lower limb function after stroke?
NG236_Rationale and impact: Mirror therapy for the upper or lower limb - Part 1,NG236,What is the effectiveness of mirror therapy for improving activities of daily living after stroke?
NG236_Rationale and impact: Mirror therapy for the upper or lower limb - Part 2 & Rationale and impact: Music therapy and interventions,NG236,What is the recommended supervision and implementation process for mirror therapy in stroke rehabilitation?
NG236_Rationale and impact: Music therapy and interventions & Rationale and impact: Managing shoulder pain,NG236,What is the evidence for the effectiveness of music therapy in improving outcomes after a stroke?
NG236_Rationale and impact: Managing shoulder pain & Rationale and impact: Spasticity,NG236,What are the recommended treatments for managing shoulder pain caused by spasticity after stroke?
NG236_Rationale and impact: Spasticity - Part 1,NG236,What are the recommended treatments for focal spasticity after stroke?
NG236_Rationale and impact: Spasticity - Part 2,NG236,"What are the recommended treatments for focal spasticity, including botulinum toxin A and electrical stimulation therapies?"
NG236_Rationale and impact: Spasticity - Part 3 & Rationale and impact: Returning to work,NG236,What are the recommended treatments and management options for generalised spasticity?
NG236_Rationale and impact: Returning to work & 3 more sections,NG236,What are the benefits of return-to-work programmes for stroke survivors?
NG236_Rationale and impact: Community participation programmes & Context,NG236,What are the benefits of community participation programmes for people after stroke?
NG237_Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management & 4 more sections,NG237,What is the initial assessment and management for suspected acute respiratory infection in patients aged 16 and over?
NG237_Recommendations: 1.1 All first contact with NHS services & Recommendations: 1.2 Remote contact with NHS services at first presentation,NG237,What are the recommendations for managing first contact with NHS services for patients with suspected acute respiratory infection?
NG237_Recommendations: 1.2 Remote contact with NHS services at first presentation - Part 1,NG237,What are the criteria for remote assessment and management of suspected acute respiratory infections in NHS services?
NG237_Recommendations: 1.2 Remote contact with NHS services at first presentation - Part 2 & Recommendations: 1.3 In-person contact with NHS services at first presentation,NG237,When should remote consultations be used instead of face-to-face appointments for initial NHS contact?
NG237_Recommendations: 1.3 In-person contact with NHS services at first presentation - Part 1,NG237,What is the recommended approach for assessing and managing suspected acute respiratory infections in primary care?
NG237_Recommendations: 1.3 In-person contact with NHS services at first presentation - Part 2,NG237,How should clinicians use the CRB65 score to assess pneumonia severity and determine appropriate care settings?
NG237_Recommendations: 1.3 In-person contact with NHS services at first presentation - Part 3 & Recommendations: Terms used in this guideline,NG237,What are the risk stratification criteria for mortality in patients aged 65 and over with acute respiratory infections?
NG237_Recommendations: Terms used in this guideline & Recommendations for research & Recommendations for research: 1 Early warning scores in different settings,NG237,What are the recommended early warning scores for detecting deterioration in patients across different healthcare settings?
NG237_Recommendations for research: 1 Early warning scores in different settings & Recommendations for research: 2 Point-of-care microbiological tests,NG237,What is the accuracy and clinical utility of point-of-care microbiological tests for diagnosing acute respiratory infections?
NG237_Recommendations for research: 2 Point-of-care microbiological tests & 4 more sections,NG237,What is the effectiveness of point-of-care microbiological tests in managing acute respiratory infections?
NG237_Rationale and impact: Remote contact with NHS services at first presentation - Part 1,NG237,What are the recommendations for remote assessment of suspected acute respiratory infections?
NG237_Rationale and impact: Remote contact with NHS services at first presentation - Part 2,NG237,What are the criteria for deciding when a face-to-face assessment is needed for suspected respiratory infections?
NG237_Rationale and impact: In-person contact with NHS services at first presentation - Part 1,NG237,What are the recommended approaches for in-person assessment of suspected acute respiratory infections at first presentation?
NG237_Rationale and impact: In-person contact with NHS services at first presentation - Part 2,NG237,What is the role of CRP testing in managing respiratory infections and prescribing antibiotics?
NG237_Rationale and impact: In-person contact with NHS services at first presentation - Part 3 & Context,NG237,How is the CRB65 score used to assess pneumonia severity and guide management decisions?
"NG238_Cardiovascular disease: risk assessment and reduction, including lipid modification & Overview",NG238,What are the recommended strategies for cardiovascular risk assessment and lipid modification in adults?
NG238_Recommendations: 1.1 Identifying and assessing cardiovascular disease risk for people without established cardiovascular disease - Part 1,NG238,What is the recommended approach for assessing cardiovascular disease risk in primary care?
NG238_Recommendations: 1.1 Identifying and assessing cardiovascular disease risk for people without established cardiovascular disease - Part 2,NG238,What are the criteria for assessing cardiovascular disease risk in people with chronic kidney disease and inherited lipid disorders?
NG238_Recommendations: 1.1 Identifying and assessing cardiovascular disease risk for people without established cardiovascular disease - Part 3,NG238,What are the recommended approaches for discussing cardiovascular risk assessment and management options with patients?
NG238_Recommendations: 1.2 Aspirin for primary prevention of cardiovascular disease,NG238,Should aspirin be used for primary prevention of cardiovascular disease in adults?
NG238_Recommendations: 1.3 Lifestyle changes for the primary and secondary prevention of cardiovascular disease - Part 1,NG238,What lifestyle changes are recommended for preventing cardiovascular disease in high-risk individuals?
NG238_Recommendations: 1.3 Lifestyle changes for the primary and secondary prevention of cardiovascular disease - Part 2,NG238,What are the NICE recommendations for promoting physical activity and lifestyle modifications to reduce cardiovascular risk?
NG238_Recommendations: 1.4 Initial lipid measurement and referral for specialist review,NG238,What are the recommended initial lipid measurement and referral criteria for assessing cardiovascular risk?
NG238_Recommendations: 1.5 Discussions and assessment before starting statins - Part 1,NG238,What should be included in the assessment and discussion before starting statin therapy?
NG238_Recommendations: 1.5 Discussions and assessment before starting statins - Part 2,NG238,What are the guidelines for prescribing statins in patients with elevated liver transaminase levels?
NG238_Recommendations: 1.6 Statins for primary prevention of cardiovascular disease - Part 1,NG238,What are the NICE recommendations for using statins in primary prevention of cardiovascular disease?
NG238_Recommendations: 1.6 Statins for primary prevention of cardiovascular disease - Part 2,NG238,What are the NICE recommendations for prescribing statins to people aged 85 and older?
NG238_Recommendations: 1.7 Lipid-lowering treatment for secondary prevention of cardiovascular disease - Part 1,NG238,What is the recommended LDL cholesterol target for secondary prevention of cardiovascular disease?
NG238_Recommendations: 1.7 Lipid-lowering treatment for secondary prevention of cardiovascular disease - Part 2,NG238,When should I consider lowering the dose of atorvastatin due to drug interactions or risk of side effects?
NG238_Recommendations: 1.7 Lipid-lowering treatment for secondary prevention of cardiovascular disease - Part 3,NG238,What factors should be considered when adjusting lipid-lowering treatment for secondary prevention of cardiovascular disease?
NG238_Recommendations: 1.8 Statins for primary and secondary prevention of cardiovascular disease in people with chronic kidney disease,NG238,What is the recommended use of atorvastatin for preventing cardiovascular disease in people with chronic kidney disease?
NG238_Recommendations: 1.9 Optimising treatment for people on statins,NG238,What are the recommended strategies for managing adverse effects of high-intensity statins?
NG238_Recommendations: 1.10 Statins are contraindicated or not tolerated,NG238,What are the recommended alternatives to statins for secondary prevention of cardiovascular disease when statins are contraindicated or not tolerated?
NG238_Recommendations: 1.11 Assessing response to treatment - Part 1,NG238,When should liver function tests and creatine kinase levels be measured during lipid-lowering treatment?
NG238_Recommendations: 1.11 Assessing response to treatment - Part 2,NG238,What is the recommended frequency for annual lipid profile and medication review in patients on lipid-lowering therapy?
NG238_Recommendations: 1.12 Lipid-lowering treatments that should not be used or not used routinely - Part 1,NG238,Which lipid-lowering treatments should not be routinely used for preventing cardiovascular disease?
NG238_Recommendations: 1.12 Lipid-lowering treatments that should not be used or not used routinely - Part 2,NG238,Should omega 3 fatty acid compounds be used to prevent cardiovascular disease?
NG238_Recommendations: Terms used in this guideline,NG238,What is included in a full lipid profile and how is it performed?
NG238_Recommendations for research,NG238,What is the evidence for the effectiveness of lipid-lowering treatments in people with type 1 diabetes?
NG238_Rationale and impact: Full formal risk assessment - Part 1,NG238,What is the recommended method for full formal cardiovascular risk assessment using QRISK3?
NG238_Rationale and impact: Full formal risk assessment - Part 2,NG238,What is the recommended approach for recording gender and calculating cardiovascular risk in transgender individuals according to NICE guidelines?
NG238_Rationale and impact: Full formal risk assessment - Part 3,NG238,How should clinicians interpret and use CVD risk scores like QRISK2 and QRISK3 in practice?
"NG238_Rationale and impact: Communication about risk assessment, lifestyle changes and treatment",NG238,How should healthcare professionals communicate lifetime cardiovascular risk to patients to encourage lifestyle changes?
NG238_Rationale and impact: Aspirin for primary prevention of cardiovascular disease & Rationale and impact: Cardioprotective diet,NG238,What are the current NICE recommendations on using aspirin for primary prevention of cardiovascular disease?
NG238_Rationale and impact: Discussions and assessment before starting statins,NG238,What should be discussed with patients before starting statin therapy regarding potential adverse effects?
NG238_Rationale and impact: Statins for primary prevention of cardiovascular disease - Part 1,NG238,What is the recommended starting dose of atorvastatin for primary prevention of cardiovascular disease?
NG238_Rationale and impact: Statins for primary prevention of cardiovascular disease - Part 2,NG238,What are the current NICE recommendations for using statins in primary prevention of cardiovascular disease based on QRISK scores?
NG238_Rationale and impact: Statins for secondary prevention of cardiovascular disease & Rationale and impact: Optimising treatment for people on statins,NG238,What are the current NICE recommendations for using high-intensity statins in secondary prevention of cardiovascular disease?
NG238_Rationale and impact: Lipid target for secondary prevention of cardiovascular disease - Part 1,NG238,What are the lipid targets for secondary prevention of cardiovascular disease according to NICE guidelines?
NG238_Rationale and impact: Lipid target for secondary prevention of cardiovascular disease - Part 2,NG238,What is the recommended LDL cholesterol target for cost-effective treatment escalation in patients on high-intensity statins?
NG238_Rationale and impact: Lipid target for secondary prevention of cardiovascular disease - Part 3,NG238,What are the recommended treatment options for patients who are statin intolerant or contraindicated for statins?
NG238_Rationale and impact: Lipid target for secondary prevention of cardiovascular disease - Part 4,NG238,"What is the recommended LDL cholesterol target for people on lipid-lowering treatment, including those who are statin intolerant?"
NG238_Rationale and impact: Assessing response to treatment,NG238,What is the recommended timing for blood tests to assess lipid response after starting or changing high-intensity statin therapy?
NG238_Context,NG238,What are the current recommendations for lipid-lowering treatment in patients at high risk of cardiovascular disease?
NG239_Vitamin B12 deficiency in over 16s: diagnosis and management & Overview & Recommendations: 1.1 Information and support - Part 1,NG239,What are the recommended approaches for diagnosing and managing vitamin B12 deficiency in adults?
NG239_Recommendations: 1.1 Information and support - Part 2,NG239,What are the recommended treatment approaches for vitamin B12 deficiency?
NG239_Recommendations: 1.2 Recognising vitamin B12 deficiency - Part 1,NG239,What are the indications for testing for vitamin B12 deficiency in patients with neurological or hematological symptoms?
NG239_Recommendations: 1.2 Recognising vitamin B12 deficiency - Part 2,NG239,What are the risk factors for vitamin B12 deficiency?
NG239_Recommendations: 1.3 Diagnosing vitamin B12 deficiency - Part 1,NG239,What factors can affect the accuracy of total or active B12 test results in diagnosing vitamin B12 deficiency?
NG239_Recommendations: 1.3 Diagnosing vitamin B12 deficiency - Part 2,NG239,"What factors can affect the accuracy of vitamin B12, MMA, and homocysteine test results in diagnosing deficiency?"
NG239_Recommendations: 1.3 Diagnosing vitamin B12 deficiency - Part 3,NG239,When should vitamin B12 replacement be started in patients with indeterminate B12 test results?
NG239_Recommendations: 1.4 Identifying the cause of vitamin B12 deficiency - Part 1,NG239,When should anti-intrinsic factor antibody testing be used to diagnose vitamin B12 deficiency due to autoimmune gastritis?
NG239_Recommendations: 1.4 Identifying the cause of vitamin B12 deficiency - Part 2,NG239,What tests are recommended to diagnose autoimmune gastritis and vitamin B12 deficiency?
NG239_Recommendations: 1.5 Managing vitamin B12 deficiency - Part 1,NG239,What are the recommended management strategies for vitamin B12 deficiency caused by malabsorption?
NG239_Recommendations: 1.5 Managing vitamin B12 deficiency - Part 2,NG239,What are the recommended management strategies for vitamin B12 deficiency caused by medication or recreational nitrous oxide use?
NG239_Recommendations: 1.5 Managing vitamin B12 deficiency - Part 3,NG239,What are the recommended dietary sources and supplementation options for vitamin B12 deficiency?
NG239_Recommendations: 1.5 Managing vitamin B12 deficiency - Part 4,NG239,"What are the considerations for oral vitamin B12 replacement in patients with adherence issues due to age, cognitive impairment, or social factors?"
NG239_Recommendations: 1.6 Ongoing care and follow up - Part 1,NG239,What is the recommended follow-up schedule for patients on vitamin B12 replacement therapy?
NG239_Recommendations: 1.6 Ongoing care and follow up - Part 2,NG239,When should vitamin B12 treatment be switched from oral to intramuscular injections?
NG239_Recommendations: 1.6 Ongoing care and follow up - Part 3,NG239,How should vitamin B12 deficiency be monitored and managed during ongoing treatment?
NG239_Recommendations: 1.7 Monitoring for gastric cancer in people with suspected or confirmed autoimmune gastritis,NG239,What are the recommended monitoring strategies for gastric cancer in patients with autoimmune gastritis?
NG239_Recommendations: Terms used in this guideline,NG239,What are the differences between reversible and irreversible causes of vitamin B12 deficiency?
NG239_Recommendations for research: Key recommendations for research - Part 1,NG239,What is the effectiveness of vitamin B12 replacement therapy for deficiency management?
NG239_Recommendations for research: Key recommendations for research - Part 2,NG239,"What are the recommended follow-up procedures for patients with vitamin B12 deficiency, including those with autoimmune gastritis?"
NG239_Recommendations for research: Other recommendations for research - Part 1,NG239,Which medications and dietary factors increase the risk of vitamin B12 deficiency?
NG239_Recommendations for research: Other recommendations for research - Part 2,NG239,What are the recommended methods for diagnosing the cause of vitamin B12 deficiency?
NG239_Rationale and impact: Information and support,NG239,"What information should be provided to patients about vitamin B12 deficiency, its symptoms, causes, and diagnostic limitations?"
NG239_Rationale and impact: Recognising vitamin B12 deficiency - Part 1,NG239,When should I test for vitamin B12 deficiency in patients with unexplained fatigue or mental health issues?
NG239_Rationale and impact: Recognising vitamin B12 deficiency - Part 2,NG239,"What are the symptoms, risk factors, and signs of vitamin B12 deficiency during pregnancy and breastfeeding?"
NG239_Rationale and impact: Recognising vitamin B12 deficiency - Part 3,NG239,Which medications and gastrointestinal surgeries increase the risk of vitamin B12 deficiency?
NG239_Rationale and impact: Initial tests - Part 1,NG239,What are the recommended initial tests for diagnosing vitamin B12 deficiency?
NG239_Rationale and impact: Initial tests - Part 2,NG239,When should vitamin B12 replacement be started in patients with suspected deficiency and neurological symptoms?
NG239_Rationale and impact: Factors that can affect total or active B12 test results,NG239,How do over-the-counter vitamin B12 supplements and hormonal changes affect B12 test results?
NG239_Rationale and impact: Thresholds for initial test results - Part 1,NG239,What are the recommended thresholds for diagnosing vitamin B12 deficiency based on blood test results?
NG239_Rationale and impact: Thresholds for initial test results - Part 2,NG239,When should serum MMA testing be used to diagnose vitamin B12 deficiency?
NG239_Rationale and impact: Identifying the cause of vitamin B12 deficiency - Part 1,NG239,When should anti-intrinsic factor antibody testing be used to identify the cause of vitamin B12 deficiency?
NG239_Rationale and impact: Identifying the cause of vitamin B12 deficiency - Part 2,NG239,What are the most effective investigations for diagnosing autoimmune gastritis in patients with vitamin B12 deficiency?
NG239_Rationale and impact: Managing vitamin B12 deficiency,NG239,What are the recommended management strategies for vitamin B12 deficiency?
NG239_Rationale and impact: Managing vitamin B12 deficiency when malabsorption is the confirmed or suspected cause,NG239,What is the recommended management of vitamin B12 deficiency caused by malabsorption?
NG239_Rationale and impact: Managing medicine-induced vitamin B12 deficiency,NG239,What are the recommended approaches for treating medicine-induced vitamin B12 deficiency?
NG239_Rationale and impact: Managing vitamin B12 deficiency caused by recreational nitrous oxide use,NG239,What is the recommended management for vitamin B12 deficiency caused by recreational nitrous oxide use?
NG239_Rationale and impact: Managing dietary vitamin B12 deficiency - Part 1,NG239,How can dietary changes effectively treat vitamin B12 deficiency?
NG239_Rationale and impact: Managing dietary vitamin B12 deficiency - Part 2,NG239,What are the recommended vitamin B12 replacement options during pregnancy and for people with adherence issues?
NG239_Rationale and impact: Managing vitamin B12 deficiency when the cause is unknown & Rationale and impact: Self-administration of vitamin B12 replacement,NG239,What is the recommended management of vitamin B12 deficiency when the cause is unknown and malabsorption is not suspected?
NG239_Rationale and impact: Ongoing care and follow up - Part 1,NG239,What are the recommended follow-up procedures for vitamin B12 deficiency treatment?
NG239_Rationale and impact: Ongoing care and follow up - Part 2,NG239,How should vitamin B12 deficiency be monitored and managed when symptoms worsen or new symptoms develop?
NG239_Rationale and impact: Ongoing care and follow up - Part 3,NG239,How should follow-up and ongoing treatment be managed for patients with vitamin deficiency to ensure effective symptom control?
NG239_Rationale and impact: Monitoring for gastric cancer in people with suspected or confirmed autoimmune gastritis,NG239,What are the recommended monitoring strategies for gastric cancer in patients with autoimmune gastritis?
NG239_Context,NG239,What are the recommended approaches for diagnosing and treating vitamin B12 deficiency in primary care?
NG23_Menopause: identification and management & Overview & Recommendations: 1.1 Individualised care,NG23,What are the best practices for individualised management of menopause symptoms?
NG23_Recommendations: 1.2 Information and support - Part 1,NG23,What information should be provided to women about menopause symptoms and management?
NG23_Recommendations: 1.2 Information and support - Part 2,NG23,What advice should I give to women about maintaining bone health during menopause?
NG23_Recommendations: 1.3 Identifying perimenopause and menopause - Part 1,NG23,How can perimenopause and menopause be identified without laboratory tests in women aged 45 and over?
NG23_Recommendations: 1.3 Identifying perimenopause and menopause - Part 2,NG23,When should serum FSH levels be used to confirm menopause in women aged 40 to 45 or under 40 with suspected early menopause?
NG23_Recommendations: 1.4 Discussing management options with people aged 40 or over - Part 1,NG23,What are the benefits and risks of different hormone replacement therapy options for menopause management in women aged 40 and over?
NG23_Recommendations: 1.4 Discussing management options with people aged 40 or over - Part 2,NG23,What are the recommendations for discussing hormone replacement therapy and cognitive behavioural therapy options for menopause management?
NG23_Recommendations: 1.4 Discussing management options with people aged 40 or over - Part 3,NG23,What should I know about the safety and effectiveness of unregulated herbal remedies for menopause symptoms?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 1,NG23,What are the recommended management options for vasomotor and genitourinary symptoms of menopause in women aged 40 or over?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 2,NG23,What are the treatment options for genitourinary symptoms of menopause and their safety considerations?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 3,NG23,What are the recommended treatments for genitourinary symptoms in women with a history of breast cancer?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 4,NG23,What are the safety considerations for using vaginal oestrogens in women with a history of breast cancer?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 5,NG23,Should vaginal laser treatment be offered for genitourinary symptoms of menopause?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 6,NG23,What are the recommended management options for sleep problems related to menopause?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 7,NG23,What are the guidelines for prescribing hormone replacement therapy in women with a history of coronary heart disease or stroke?
NG23_Recommendations: 1.5 Managing symptoms associated with menopause in people aged 40 or over - Part 8,NG23,What are the recommended discussions about fertility and menopause before and after medical or surgical treatments that may cause menopause?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 1,NG23,What are the benefits and risks of hormone replacement therapy for women aged 45 or over?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 2,NG23,How should healthcare professionals discuss the benefits and risks of hormone replacement therapy with patients?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 3,NG23,What are the health risks associated with combined hormone replacement therapy (HRT) compared to no HRT?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 4 & Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 5,NG23,What are the risks and benefits of combined versus oestrogen-only hormone replacement therapy (HRT) in women aged 45 or over?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 6,NG23,What are the different oestrogen-only HRT options and their associated benefits and risks?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 9 & Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 10,NG23,Should combined or oestrogen-only HRT be used for preventing cardiovascular disease or dementia?
NG23_Recommendations: 1.6 Effects of hormone replacement therapy on specific health outcomes in people aged 40 or over - Part 11,NG23,What are the benefits and risks of hormone replacement therapy for women aged 40 to 44 experiencing early menopause?
NG23_Recommendations: 1.7 Diagnosing and managing premature ovarian insufficiency in people under 40 - Part 1,NG23,What are the diagnostic criteria for premature ovarian insufficiency in women under 40?
NG23_Recommendations: 1.7 Diagnosing and managing premature ovarian insufficiency in people under 40 - Part 2,NG23,What are the recommended hormone replacement options for managing premature ovarian insufficiency?
NG23_Recommendations: 1.8 Starting and stopping hormone replacement therapy for anyone - Part 1,NG23,What are the guidelines for starting and stopping hormone replacement therapy in menopausal women?
NG23_Recommendations: 1.8 Starting and stopping hormone replacement therapy for anyone - Part 2 & Recommendations: 1.9 Reviewing treatment for anyone,NG23,What are the recommended approaches for stopping or reducing hormone replacement therapy in women with menopause symptoms?
NG23_Recommendations: Terms used in this guideline - Part 1,NG23,What is combined hormone replacement therapy (HRT) and how is it used for menopausal symptoms?
NG23_Recommendations: Terms used in this guideline - Part 2,NG23,What qualifications are required for healthcare professionals managing complex menopause cases with hormone therapy?
NG23_Recommendations for research: Key recommendations for research - Part 1,NG23,How does the mode of administration of hormone replacement therapy affect health outcomes in women?
NG23_Recommendations for research: Key recommendations for research - Part 2,NG23,"What is the impact of different administration methods of combined and oestrogen-only HRT on breast cancer, cardiovascular disease, and dementia risks?"
NG23_Recommendations for research: Key recommendations for research - Part 3,NG23,What is the safety of using vaginal oestrogen for longer than 12 months?
NG23_Recommendations for research: Key recommendations for research - Part 4,NG23,What is the impact of age at menopause and timing of HRT initiation on long-term coronary heart disease risk?
NG23_Recommendations for research: Key recommendations for research - Part 5,NG23,"What is the impact of hormone replacement therapy on cardiovascular disease, stroke, cancer, dementia, and mortality in trans men, non-binary people, and ethnic minority groups?"
NG23_Recommendations for research: Other recommendations for research & Rationale and impact: Psychological support for early menopause,NG23,What are the recommended psychological support options for women experiencing early menopause?
NG23_Rationale and impact: Identifying perimenopause and menopause,NG23,How can healthcare professionals better identify menopause in women from ethnic minority groups or with lifelong conditions?
NG23_Rationale and impact: Discussing management options with people aged 40 or over - Part 1,NG23,What are the considerations for discussing hormone replacement therapy options with women aged 40 or over?
NG23_Rationale and impact: Discussing management options with people aged 40 or over - Part 2,NG23,What should be discussed regarding the duration of hormone replacement therapy and options for cognitive behavioural therapy in menopause management?
NG23_Rationale and impact: Cognitive behavioural therapy for vasomotor symptoms - Part 1,NG23,What is the effectiveness of cognitive behavioural therapy for managing vasomotor symptoms during menopause?
NG23_Rationale and impact: Cognitive behavioural therapy for vasomotor symptoms - Part 2,NG23,What are the benefits and considerations of using menopause-specific cognitive behavioral therapy alongside hormone replacement therapy?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with no personal history of breast cancer - Part 1,NG23,What are the safety considerations for long-term use of vaginal oestrogen in menopause-related genitourinary symptoms?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with no personal history of breast cancer - Part 2,NG23,What are the safety considerations and effectiveness of vaginal oestrogen for menopausal genitourinary symptoms?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with no personal history of breast cancer - Part 3,NG23,What are the recommended second-line treatments for genitourinary symptoms of menopause when vaginal oestrogen is ineffective or not tolerated?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with a personal history of breast cancer - Part 1,NG23,What are the recommended management options for genitourinary symptoms in women with a history of breast cancer?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with a personal history of breast cancer - Part 2,NG23,What are the safety considerations of using vaginal oestrogen in women taking aromatase inhibitors after breast cancer?
NG23_Rationale and impact: Genitourinary symptoms associated with menopause in people with a personal history of breast cancer - Part 3,NG23,What are the safety considerations for using vaginal oestrogen in women with a history of breast cancer?
NG23_Rationale and impact: Vaginal laser treatment,NG23,What are the current NICE recommendations on vaginal laser treatment for menopausal genitourinary symptoms?
NG23_Rationale and impact: Management options for depressive symptoms or depression in people with menopause-associated symptoms,NG23,What are the recommended management options for depressive symptoms in women experiencing menopause?
NG23_Rationale and impact: Cognitive behavioural therapy for sleep problems associated with menopause - Part 1,NG23,What is the effectiveness of cognitive behavioural therapy for sleep problems related to menopause?
NG23_Rationale and impact: Cognitive behavioural therapy for sleep problems associated with menopause - Part 2,NG23,What is the effectiveness of menopause-specific cognitive behavioural therapy for managing sleep problems and vasomotor symptoms?
NG23_Rationale and impact: Taking medical history of coronary heart disease or stroke into account before offering treatment,NG23,What factors should be considered when prescribing hormone replacement therapy for women with a history of coronary heart disease or stroke?
NG23_Rationale and impact: Managing menopause-associated symptoms in people who have taken gender-affirming hormone therapy in the past - Part 1,NG23,What considerations are there for managing menopause symptoms in trans men and non-binary people who have previously taken gender-affirming hormone therapy?
NG23_Rationale and impact: Managing menopause-associated symptoms in people who have taken gender-affirming hormone therapy in the past - Part 2,NG23,How should menopause management be tailored for trans men and non-binary people who have undergone gender-affirming hormone therapy?
NG23_Rationale and impact: Effect of HRT on life expectancy in people aged 45 and over,NG23,What is the effect of hormone replacement therapy on life expectancy in women aged 45 and over?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 1,NG23,What are the risks and benefits of combined hormone replacement therapy on breast cancer and cardiovascular health in women aged 45 and over?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 2,NG23,What is the risk of breast cancer associated with combined hormone replacement therapy (HRT) use?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 3,NG23,What is the risk of endometrial and ovarian cancer associated with different types of hormone replacement therapy?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 4,NG23,What is the risk of ovarian cancer and coronary heart disease associated with hormone replacement therapy?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 5,NG23,What is the risk of stroke associated with different modes of hormone replacement therapy (HRT) administration?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 6,NG23,What is the impact of the timing of hormone replacement therapy initiation on cardiovascular disease risk?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 7,NG23,What is the evidence on the association between hormone replacement therapy and dementia risk?
NG23_Rationale and impact: Effect of combined HRT on specific health outcomes in people aged 45 or over - Part 8,NG23,What are the risks of developing dementia associated with hormone replacement therapy started after age 65?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 1,NG23,What are the effects of oestrogen-only HRT on breast cancer risk in women aged 45 and over?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 2,NG23,What is the impact of oestrogen-only HRT duration on breast cancer risk and mortality?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 3,NG23,What is the risk of endometrial and ovarian cancer associated with long-term oestrogen-only HRT use?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 4,NG23,What is the impact of age at first hormone replacement therapy use on the risk of coronary heart disease?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 5,NG23,What is the risk of stroke associated with oral versus transdermal oestrogen-only HRT?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 6,NG23,What is the impact of different modes of administration of oestrogen-only HRT on coronary heart disease risk?
NG23_Rationale and impact: Effect of oestrogen-only HRT on specific health outcomes in people aged 45 or over - Part 7,NG23,What is the evidence on the risk of dementia associated with oestrogen-only hormone replacement therapy?
NG23_Rationale and impact: Cardiovascular disease prevention & Rationale and impact: Dementia prevention,NG23,Should hormone replacement therapy be used for preventing cardiovascular disease or dementia?
NG23_Rationale and impact: Effects of HRT use in early menopause on specific health outcomes - Part 1,NG23,What are the health outcomes associated with hormone replacement therapy in women experiencing early menopause aged 40 to 44?
NG23_Rationale and impact: Effects of HRT use in early menopause on specific health outcomes - Part 2,NG23,What are the health risks and benefits of hormone replacement therapy in women with early menopause?
NG23_Rationale and impact: Starting and stopping HRT for anyone - Part 1,NG23,What are the recommended types of hormone replacement therapy for women with a uterus versus those who have had a hysterectomy?
NG23_Rationale and impact: Starting and stopping HRT for anyone - Part 2,NG23,When should HRT be discontinued in patients diagnosed with breast cancer?
NG23_Implementation,NG23,What are the recommended strategies for improving access to menopause specialist healthcare and therapies?
NG23_Context,NG23,What are the current recommendations for managing menopause and hormone replacement therapy?
"NG240_Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management & Overview",NG240,What are the key signs and symptoms of bacterial meningitis and meningococcal disease in different age groups?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 1,NG240,What are the key signs and symptoms to suspect bacterial meningitis and meningococcal disease?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 2,NG240,When should bacterial meningitis be suspected based on clinical symptoms and signs?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 3,NG240,"What are the key symptoms and signs that may indicate bacterial meningitis in babies, children, and young people?"
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 4,NG240,What are the key signs and symptoms indicating bacterial meningitis in adults?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 5,NG240,What are the risk factors for bacterial meningitis?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 6 & Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 7,NG240,How can I identify signs of meningococcal disease and when should I suspect it?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 8,NG240,What are the symptoms and signs that indicate meningococcal disease in different age groups?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 9,NG240,What are the risk factors for meningococcal disease that require heightened clinical suspicion?
NG240_Recommendations: 1.1 Recognising bacterial meningitis and meningococcal disease - Part 10,NG240,What are the key symptoms and signs that differentiate bacterial meningitis and meningococcal disease from other serious conditions?
NG240_Recommendations: 1.2 Transfer to hospital and antibiotics before arrival at hospital - Part 1,NG240,What is the recommended management for suspected bacterial meningitis and meningococcal disease before hospital transfer?
NG240_Recommendations: 1.2 Transfer to hospital and antibiotics before arrival at hospital - Part 2,NG240,What are the recommended timings for antibiotic administration in bacterial meningitis and meningococcal disease?
NG240_Recommendations: 1.3 Information and support for people with suspected bacterial meningitis or meningococcal disease - Part 1,NG240,What information and support should be provided to patients and families when bacterial meningitis or meningococcal disease is suspected?
NG240_Recommendations: 1.3 Information and support for people with suspected bacterial meningitis or meningococcal disease - Part 2,NG240,"What are the recommended ways for healthcare staff to communicate and provide information to babies, children, and young people with suspected bacterial meningitis?"
NG240_Recommendations: 1.4 Investigating suspected bacterial meningitis in hospital - Part 1,NG240,What are the recommended procedures and timing for investigations and antibiotic administration in suspected bacterial meningitis?
NG240_Recommendations: 1.4 Investigating suspected bacterial meningitis in hospital - Part 2,NG240,What are the recommended blood tests and procedures for diagnosing bacterial meningitis?
NG240_Recommendations: 1.4 Investigating suspected bacterial meningitis in hospital - Part 3,NG240,When should neuroimaging be performed before lumbar puncture in suspected meningitis?
NG240_Recommendations: 1.4 Investigating suspected bacterial meningitis in hospital - Part 4,NG240,What are the signs and investigations for suspected bacterial meningitis in adults?
NG240_Recommendations: 1.4 Investigating suspected bacterial meningitis in hospital - Part 5,NG240,What cerebrospinal fluid tests are recommended for diagnosing bacterial meningitis?
NG240_Recommendations: 1.5 Investigating suspected meningococcal disease in hospital - Part 1,NG240,What are the recommended investigations and timing for diagnosing suspected meningococcal disease in hospital?
NG240_Recommendations: 1.5 Investigating suspected meningococcal disease in hospital - Part 2,NG240,How is meningococcal disease diagnosed based on blood tests and clinical features?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 1,NG240,What are the recommended antibiotic treatments for bacterial meningitis in hospital settings?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 2,NG240,What is the recommended antibiotic treatment for suspected bacterial meningitis when the causative organism is unknown?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 3,NG240,What are the recommended timing and choice of antibiotics for bacterial meningitis in different age groups and causative organisms?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 4,NG240,"What are the recommended antibiotic treatments for bacterial meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b?"
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 5,NG240,What is the recommended antibiotic treatment for group B streptococcal meningitis?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 6,NG240,What is the recommended antibiotic treatment for Neisseria meningitidis meningitis?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 7,NG240,What are the recommended antibiotic options for bacterial meningitis in patients with antibiotic allergy?
NG240_Recommendations: 1.6 Antibiotics for bacterial meningitis in hospital - Part 8,NG240,What are the recommended antibiotic treatments for bacterial meningitis in patients with a penicillin allergy?
NG240_Recommendations: 1.7 Antibiotics for meningococcal disease in hospital,NG240,What are the recommended antibiotics and treatment duration for meningococcal disease in hospital?
NG240_Recommendations: 1.8 Corticosteroids for bacterial meningitis and meningococcal disease - Part 1,NG240,What are the NICE recommendations for using corticosteroids in bacterial meningitis treatment?
NG240_Recommendations: 1.8 Corticosteroids for bacterial meningitis and meningococcal disease - Part 2,NG240,When should corticosteroids be used in the treatment of meningococcal disease?
"NG240_Recommendations: 1.9 Fluid restriction, osmotic agents and intracranial pressure monitoring for confirmed bacterial meningitis - Part 1",NG240,What are the recommended fluid management and intracranial pressure monitoring practices for bacterial meningitis?
"NG240_Recommendations: 1.9 Fluid restriction, osmotic agents and intracranial pressure monitoring for confirmed bacterial meningitis - Part 2",NG240,When should intracranial pressure monitoring be considered in bacterial meningitis?
NG240_Recommendations: 1.10 Assessing for immunodeficiency and recurrence risk in people with bacterial meningitis or meningococcal disease,NG240,What are the recommended tests and assessments for immunodeficiency and recurrence risk in patients with bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.11 Information and support after diagnosis - Part 1,NG240,What information and support should be provided to patients and families after a diagnosis of bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.11 Information and support after diagnosis - Part 2,NG240,What psychological support is recommended for patients recovering from bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.12 Preparing for hospital discharge - Part 1,NG240,What are the recommended follow-up procedures and specialist referrals after hospital discharge for patients who had bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.12 Preparing for hospital discharge - Part 2,NG240,What follow-up care and psychosocial support are recommended after discharge for patients who have had bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.12 Preparing for hospital discharge - Part 3,NG240,Should children and young people who have had bacterial meningitis or meningococcal disease receive education and psychosocial support after hospital discharge?
NG240_Recommendations: 1.13 Care after hospital discharge - Part 1,NG240,What is the recommended follow-up care after hospital discharge for children and young people who had bacterial meningitis or meningococcal disease?
NG240_Recommendations: 1.13 Care after hospital discharge - Part 2,NG240,What follow-up care is recommended for children and young people after meningitis or meningococcal disease?
NG240_Recommendations: 1.14 Recurrent bacterial meningitis and meningococcal disease - Part 1,NG240,What are the risk factors and management strategies for recurrent bacterial meningitis and meningococcal disease?
NG240_Recommendations: 1.14 Recurrent bacterial meningitis and meningococcal disease - Part 2,NG240,What are the recommended investigations and management strategies for recurrent bacterial meningitis?
NG240_Recommendations: Terms used in this guideline,NG240,What are the definitions of age groups and terms used in the NICE guideline for infectious diseases?
NG240_Recommendations for research: 1 Long-term outcomes of bacterial meningitis & Recommendations for research: 2 Novel diagnostic techniques applied to blood or cerebrospinal fluid,NG240,What are the long-term outcomes for infants after bacterial meningitis?
NG240_Recommendations for research: 3 Duration of antibiotic treatment for meningitis caused by Enterobacterales (coliforms) & Recommendations for research: 4 Intracranial pressure monitoring,NG240,What is the optimal duration of antibiotic treatment for Enterobacterales meningitis in newborns?
NG240_Recommendations for research: 5 Corticosteroids for newborn babies with bacterial meningitis & Rationale and impact: Recognising bacterial meningitis and meningococcal disease,NG240,What is the evidence for using corticosteroids as an adjunct to antibiotics in newborns with bacterial meningitis?
NG240_Rationale and impact: When to suspect bacterial meningitis,NG240,What are the key signs and symptoms to suspect bacterial meningitis?
NG240_Rationale and impact: When to suspect meningococcal disease,NG240,What are the key signs and symptoms to suspect meningococcal disease?
NG240_Rationale and impact: Safety netting and alternative causes,NG240,What are the safety netting strategies for patients with suspected bacterial meningitis or meningococcal disease?
NG240_Rationale and impact: Transfer to hospital and antibiotics before arrival at hospital,NG240,When should antibiotics be given before hospital transfer for suspected bacterial meningitis or meningococcal disease?
NG240_Rationale and impact: Information and support for people with suspected bacterial meningitis or meningococcal disease & Rationale and impact: Timing of investigations and antibiotics for bacterial meningitis,NG240,What information and support should be provided to people with suspected bacterial meningitis or meningococcal disease?
NG240_Rationale and impact: Bacterial throat swabs and blood tests for bacterial meningitis,NG240,What are the recommended blood tests and throat swab procedures for diagnosing bacterial meningitis?
NG240_Rationale and impact: Neuroimaging,NG240,When should neuroimaging be performed before lumbar puncture in suspected meningitis cases?
NG240_Rationale and impact: Lumbar puncture,NG240,What is the recommended timing for performing a lumbar puncture in suspected bacterial meningitis?
NG240_Rationale and impact: Cerebrospinal fluid investigations,NG240,What are the recommended cerebrospinal fluid investigations for diagnosing bacterial meningitis?
NG240_Rationale and impact: Investigating suspected meningococcal disease in hospital,NG240,What are the recommended investigations for suspected meningococcal disease in hospital?
NG240_Rationale and impact: Antibiotics for bacterial meningitis in hospital - Part 1,NG240,What is the recommended time frame for administering antibiotics in suspected bacterial meningitis in hospital?
NG240_Rationale and impact: Antibiotics for bacterial meningitis in hospital - Part 2,NG240,What are the recommended antibiotic treatments and durations for bacterial meningitis according to NICE guidelines?
"NG240_Rationale and impact: Antibiotics for bacterial meningitis in hospital, when the causative organism is known",NG240,What are the recommended antibiotics and treatment durations for bacterial meningitis when the causative organism is identified?
NG240_Rationale and impact: Antibiotic allergy with bacterial meningitis,NG240,What is the recommended antibiotic treatment for bacterial meningitis in patients with antibiotic allergy?
NG240_Rationale and impact: Antibiotics for meningococcal disease in hospital,NG240,What is the recommended antibiotic treatment for meningococcal disease in hospital?
NG240_Rationale and impact: Corticosteroids for bacterial meningitis and meningococcal disease - Part 1,NG240,What is the recommended use of corticosteroids in the treatment of bacterial meningitis in different age groups?
NG240_Rationale and impact: Corticosteroids for bacterial meningitis and meningococcal disease - Part 2,NG240,What is the current guidance on using corticosteroids in newborns with bacterial meningitis?
"NG240_Rationale and impact: Fluid restriction, osmotic agents and intracranial pressure monitoring for confirmed bacterial meningitis - Part 1",NG240,What are the recommendations for fluid management and use of osmotic agents in bacterial meningitis?
"NG240_Rationale and impact: Fluid restriction, osmotic agents and intracranial pressure monitoring for confirmed bacterial meningitis - Part 2",NG240,What are the current recommendations for intracranial pressure monitoring in bacterial meningitis?
NG240_Rationale and impact: Assessing for immunodeficiency and recurrence risk in people with bacterial meningitis or meningococcal disease,NG240,What are the recommended assessments for immunodeficiency and recurrence risk in patients with bacterial meningitis or meningococcal disease?
NG240_Rationale and impact: Information and support after diagnosis,NG240,What information and support should be provided to patients and families after a diagnosis of bacterial meningitis or meningococcal disease?
NG240_Rationale and impact: Identifying and managing complications,NG240,What are the recommended follow-up assessments for long-term complications after bacterial meningitis?
NG240_Rationale and impact: Planning for care after discharge,NG240,What are the recommended arrangements for follow-up care and psychosocial support after meningitis discharge?
NG240_Rationale and impact: Care after hospital discharge,NG240,What is the recommended timing and process for post-discharge review of patients who have had meningitis?
NG240_Rationale and impact: Recurrent bacterial meningitis and meningococcal disease,NG240,What are the risk factors and recommended management strategies for recurrent bacterial meningitis?
NG240_Context,NG240,What are the recommended management and treatment protocols for bacterial meningitis and meningococcal disease in different healthcare settings?
NG241_Ovarian cancer: identifying and managing familial and genetic risk & Overview,NG241,What are the recommendations for assessing familial and genetic risk of ovarian cancer in women?
NG241_Recommendations: 1.1 Organisation of services - Part 1,NG241,What are the recommended referral pathways for genetic assessment in ovarian cancer risk?
NG241_Recommendations: 1.1 Organisation of services - Part 2,NG241,What are the recommended practices for genetic counseling and testing in familial ovarian cancer management?
NG241_Recommendations: 1.2 Information and support - Part 1,NG241,What information and support should healthcare professionals provide to individuals at familial or genetic risk of ovarian cancer?
NG241_Recommendations: 1.2 Information and support - Part 2,NG241,What information and support should healthcare professionals provide to patients referred for familial ovarian cancer assessment?
NG241_Recommendations: 1.2 Information and support - Part 3,NG241,What information and support should healthcare professionals provide to patients regarding genetic testing and risk assessment for familial ovarian cancer?
NG241_Recommendations: 1.2 Information and support - Part 4,NG241,How should genetic counselling be offered to individuals at risk of cancer based on NICE guidelines?
NG241_Recommendations: 1.2 Information and support - Part 5,NG241,What information and support should specialist services provide to individuals with a pathogenic variant or strong family history of ovarian cancer?
NG241_Recommendations: 1.2 Information and support - Part 6,NG241,What are the potential psychosocial and sexual effects of risk-reducing surgery for ovarian cancer?
NG241_Recommendations: 1.3 Assessing the risk of having a pathogenic variant - Part 1,NG241,What are the criteria for genetic testing for ovarian cancer risk?
NG241_Recommendations: 1.3 Assessing the risk of having a pathogenic variant - Part 2,NG241,What are the recommended methods for assessing the probability of having a pathogenic genetic variant in clinical practice?
NG241_Recommendations: 1.4 Criteria for genetic counselling and genetic testing (in genetics services or in gynaecology oncology multidisciplinary services) - Part 1,NG241,What are the criteria for genetic testing and counselling for ovarian cancer risk based on family history?
NG241_Recommendations: 1.4 Criteria for genetic counselling and genetic testing (in genetics services or in gynaecology oncology multidisciplinary services) - Part 2,NG241,When should genetic counselling and testing be offered for ovarian cancer risk in people with distant relatives or from high-risk populations?
NG241_Recommendations: 1.4 Criteria for genetic counselling and genetic testing (in genetics services or in gynaecology oncology multidisciplinary services) - Part 3,NG241,What are the recommended genetic testing protocols for women with ovarian cancer?
NG241_Recommendations: 1.5 Gene panel testing,NG241,How is gene panel testing selected and used for assessing hereditary cancer risk?
NG241_Recommendations: 1.6 Assessing the risk of developing ovarian cancer - Part 1,NG241,What are the recommended methods for assessing ovarian cancer risk in women and people with female reproductive organs?
NG241_Recommendations: 1.6 Assessing the risk of developing ovarian cancer - Part 2,NG241,How should healthcare professionals communicate a person's risk of developing ovarian cancer and incorporate shared decision making?
NG241_Recommendations: 1.7 Primary preventive medicines,NG241,What are the recommendations for using aspirin and combined oral contraceptives to reduce ovarian cancer risk?
NG241_Recommendations: 1.8 Risk-reducing surgery - Part 1,NG241,What are the criteria for offering risk-reducing surgery for ovarian cancer in women and trans/non-binary people?
NG241_Recommendations: 1.8 Risk-reducing surgery - Part 2,NG241,What are the recommended ages for risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 pathogenic variants?
NG241_Recommendations: 1.8 Risk-reducing surgery - Part 3,NG241,What are the recommended criteria for risk-reducing hysterectomy and salpingo-oophorectomy in individuals with PMS2 pathogenic variants?
NG241_Recommendations: 1.8 Risk-reducing surgery - Part 4,NG241,What are the recommendations for ovarian cancer surveillance and risk-reducing surgery options for women at familial risk?
NG241_Recommendations: 1.8 Risk-reducing surgery - Part 5,NG241,"What are the recommended surveillance protocols for individuals with BRCA1, BRCA2, or RAD51C/D, BRIP1, PALB2 pathogenic variants who choose to delay or avoid risk-reducing surgery?"
NG241_Recommendations: 1.9 Pathology protocol for handling specimens from risk-reducing surgery,NG241,What is the recommended pathology protocol for handling specimens from risk-reducing ovarian and fallopian tube surgery?
NG241_Recommendations: 1.10 Hormone replacement therapy after risk-reducing surgery,NG241,What are the NICE recommendations for hormone replacement therapy after risk-reducing bilateral salpingo-oophorectomy?
NG241_Recommendations: Terms used in this guideline - Part 1,NG241,What does bilateral salpingo-oophorectomy involve in hereditary ovarian cancer management?
NG241_Recommendations: Terms used in this guideline - Part 2,NG241,What is the role of pre-test counselling and genetic testing for mismatch repair gene mutations in ovarian cancer risk assessment?
NG241_Recommendations for research: Key recommendations for research - Part 1,NG241,What are the most effective psychological interventions to support decision making for genetic testing?
NG241_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG241,What are the benefits and risks of ovarian cancer surveillance for individuals at increased genetic risk?
NG241_Rationale and impact: Organisation of services - Part 1,NG241,What are the recommended referral pathways for genetic services in ovarian cancer risk assessment?
NG241_Rationale and impact: Organisation of services - Part 2,NG241,What are the referral criteria for genetics services in ovarian cancer patients?
NG241_Rationale and impact: Organisation of services - Part 3,NG241,What is the recommended multidisciplinary team approach for familial ovarian cancer management?
NG241_Rationale and impact: Information and support - Part 1,NG241,What information and support should be provided to individuals at risk of familial ovarian cancer in healthcare settings?
NG241_Rationale and impact: Information and support - Part 2,NG241,What are the recommended approaches for providing information and support about familial ovarian cancer risk assessment and genetic testing?
NG241_Rationale and impact: Information and support - Part 3,NG241,What are the benefits and limitations of using decision aids alongside genetic counselling for cancer risk assessment?
NG241_Rationale and impact: Information and support - Part 4,NG241,What information and psychological support should be provided to individuals with a pathogenic variant or strong family history of ovarian cancer?
NG241_Rationale and impact: Assessing the risk of having a pathogenic variant - Part 1,NG241,What are the criteria for referring individuals for genetic testing for BRCA1 and BRCA2 pathogenic variants?
NG241_Rationale and impact: Assessing the risk of having a pathogenic variant - Part 2,NG241,What are the recommended tools and criteria for assessing BRCA1 and BRCA2 mutation risk in ovarian cancer families?
NG241_Rationale and impact: Criteria for genetic testing - Part 1,NG241,What are the criteria for genetic testing in individuals with a family history of ovarian cancer?
NG241_Rationale and impact: Criteria for genetic testing - Part 2,NG241,What are the recommendations for genetic testing and counselling for BRCA mutations in Ashkenazi and Sephardi Jewish populations?
NG241_Rationale and impact: Criteria for genetic testing - Part 3,NG241,What are the recommendations for genetic testing in people with different types of ovarian cancer?
NG241_Rationale and impact: Gene panel testing,NG241,What genes are included in the gene panel testing for ovarian cancer risk according to NICE guidelines?
NG241_Rationale and impact: Assessing the risk of developing ovarian cancer - Part 1,NG241,What are the recommended methods for assessing ovarian cancer risk?
NG241_Rationale and impact: Assessing the risk of developing ovarian cancer - Part 2,NG241,What are the recommended methods for assessing ovarian cancer risk in clinical practice?
NG241_Rationale and impact: Primary preventive medicines,NG241,What are the current recommendations for primary preventive medicines to reduce ovarian cancer risk?
NG241_Rationale and impact: Risk-reducing surgery - Part 1,NG241,What factors should be considered when offering risk-reducing surgery for ovarian cancer prevention?
NG241_Rationale and impact: Risk-reducing surgery - Part 2,NG241,"What are the recommended risk-reducing surgical options for ovarian and endometrial cancer in individuals with BRCA, Lynch syndrome, or other genetic variants?"
NG241_Rationale and impact: Risk-reducing surgery - Part 3,NG241,What are the recommended criteria and timing for risk-reducing hysterectomy and oophorectomy in carriers of pathogenic variants associated with endometrial and ovarian cancer?
NG241_Rationale and impact: Risk-reducing surgery - Part 4,NG241,What are the recommended practices for peritoneal washing during risk-reducing surgery for ovarian cancer?
NG241_Rationale and impact: Risk-reducing surgery - Part 5,NG241,What are the recommended protocols for ovarian cancer surveillance using CA125 testing and risk algorithms?
NG241_Rationale and impact: Pathology protocol for handling specimens from risk-reducing surgery - Part 1,NG241,What is the recommended pathology protocol for examining specimens from risk-reducing salpingo-oophorectomy?
NG241_Rationale and impact: Pathology protocol for handling specimens from risk-reducing surgery - Part 2,NG241,How should surgical specimens from adnexal and endometrial tissues be labeled and submitted for accurate pathological reporting?
NG241_Rationale and impact: Hormone replacement therapy after risk-reducing surgery - Part 1,NG241,Should hormone replacement therapy be offered after risk-reducing salpingo-oophorectomy in women without a history of breast cancer?
NG241_Rationale and impact: Hormone replacement therapy after risk-reducing surgery - Part 2,NG241,What are the guidelines for prescribing hormone replacement therapy after risk-reducing salpingo-oophorectomy?
NG241_Context,NG241,What are the criteria for genetic testing for familial ovarian cancer risk?
NG242_Diabetic retinopathy: management and monitoring & Overview,NG242,What are the recommended management and monitoring strategies for diabetic retinopathy in hospital eye services?
NG242_Recommendations: 1.1 Managing diabetes to support best eye care - Part 1,NG242,What information should be available to healthcare professionals caring for patients with diabetic retinopathy?
NG242_Recommendations: 1.1 Managing diabetes to support best eye care - Part 2,NG242,What are the recommended blood pressure management strategies for preventing diabetic retinopathy progression in people with diabetes?
NG242_Recommendations: 1.1 Managing diabetes to support best eye care - Part 3,NG242,Should fenofibrate be used to slow the progression of diabetic retinopathy in people with type 2 diabetes?
NG242_Recommendations: 1.2 Cataract surgery for people with diabetic retinopathy or diabetic macular oedema,NG242,What are the recommended management strategies for cataract surgery in patients with diabetic retinopathy or diabetic macular oedema?
NG242_Recommendations: 1.3 Treating all active pathologies in each eye,NG242,How should active diabetic retinopathy be treated and monitored in each eye?
NG242_Recommendations: 1.4 Non-proliferative diabetic retinopathy: monitoring frequencies,NG242,What are the recommended monitoring intervals for non-proliferative diabetic retinopathy?
NG242_Recommendations: 1.5 Proliferative diabetic retinopathy - Part 1,NG242,What are the recommended treatment options for proliferative diabetic retinopathy and their benefits and risks?
NG242_Recommendations: 1.5 Proliferative diabetic retinopathy - Part 2,NG242,What are the current licensed anti-VEGF treatments for proliferative diabetic retinopathy?
NG242_Recommendations: 1.5 Proliferative diabetic retinopathy - Part 3,NG242,What are the indications for vitrectomy in proliferative diabetic retinopathy?
NG242_Recommendations: 1.5 Proliferative diabetic retinopathy - Part 4,NG242,What are the recommended imaging techniques for monitoring diabetic retinopathy and diabetic macular oedema?
NG242_Recommendations: 1.5 Proliferative diabetic retinopathy - Part 5,NG242,What are the recommended monitoring intervals for patients with proliferative diabetic retinopathy who do not show disease regression?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 1,NG242,What are the recommended treatment options for clinically significant diabetic macular oedema?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 2,NG242,What are the recommended treatment options for centre-involving diabetic macular oedema with good or impaired vision?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 3,NG242,What are the recommended treatment options for centre-involving diabetic macular oedema with central retinal thickness less than 400 micrometres?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 4,NG242,When should I assess response to anti-VEGF treatment for diabetic macular oedema and consider switching or adding treatments?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 5,NG242,What are the treatment options for diabetic macular oedema when non-corticosteroid therapy is not suitable?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 6,NG242,What are the recommended imaging techniques and monitoring frequencies for diabetic macular oedema after treatment?
NG242_Recommendations: 1.6 Diabetic macular oedema - Part 7,NG242,When should vitrectomy be considered for diabetic macular oedema unresponsive to anti-VEGF therapy?
NG242_Recommendations: Terms used in this guideline - Part 1,NG242,What are the criteria for diagnosing clinically significant diabetic macular oedema?
NG242_Recommendations: Terms used in this guideline - Part 2,NG242,What are the criteria for diabetic retinopathy regression and management of high-risk proliferative diabetic retinopathy?
NG242_Recommendations for research: Key recommendations for research - Part 1,NG242,What are the clinical features indicating when to switch or stop treatment for diabetic macular oedema?
NG242_Recommendations for research: Key recommendations for research - Part 2,NG242,What is the risk of short-term diabetic retinopathy progression after rapid HbA1c reduction?
NG242_Recommendations for research: Other recommendations for research - Part 1,NG242,What is the effectiveness of different treatment thresholds for non-proliferative diabetic retinopathy?
NG242_Recommendations for research: Other recommendations for research - Part 2,NG242,What is the most effective method of delivering panretinal photocoagulation for proliferative diabetic retinopathy?
NG242_Recommendations for research: Other recommendations for research - Part 3,NG242,What is the recommended monitoring frequency for non-proliferative diabetic retinopathy in patients not receiving treatment?
NG242_Rationale and impact: Working with the person,NG242,What are the benefits of intensive blood glucose management for preventing diabetic retinopathy progression?
NG242_Rationale and impact: Effects of a rapid reduction in HbA1c,NG242,Should patients have an eye review before starting intensive glycaemic control to prevent early worsening of diabetic retinopathy?
NG242_Rationale and impact: Information that should be available to all people involved in the care of people with diabetic retinopathy - Part 1,NG242,What information should be shared with healthcare professionals managing diabetic retinopathy regarding blood pressure and HbA1c levels?
NG242_Rationale and impact: Information that should be available to all people involved in the care of people with diabetic retinopathy - Part 2,NG242,What are the prognostic factors for progression of non-proliferative diabetic retinopathy?
NG242_Rationale and impact: Blood pressure management,NG242,What are the blood pressure management strategies for patients with hypertension and diabetic retinopathy?
NG242_Rationale and impact: Fenofibrate & Rationale and impact: Statins,NG242,What is the evidence for using fenofibrate to prevent progression of diabetic retinopathy in people with type 2 diabetes?
NG242_Rationale and impact: Cataract surgery for people with diabetic retinopathy or diabetic macular oedema - Part 1,NG242,What are the considerations for cataract surgery in patients with diabetic retinopathy or diabetic macular oedema?
NG242_Rationale and impact: Cataract surgery for people with diabetic retinopathy or diabetic macular oedema - Part 2,NG242,What is the recommended timing for anti-VEGF treatment in patients with proliferative diabetic retinopathy undergoing cataract surgery?
NG242_Rationale and impact: Treating all active pathologies in each eye,NG242,How should active pathologies be treated in each eye for diabetic eye disease?
NG242_Rationale and impact: Treatment strategies for non-proliferative and proliferative diabetic retinopathy - Part 1,NG242,What are the recommended treatment options for proliferative diabetic retinopathy according to NICE guidelines?
NG242_Rationale and impact: Treatment strategies for non-proliferative and proliferative diabetic retinopathy - Part 2,NG242,What is the recommended timing for panretinal photocoagulation in proliferative diabetic retinopathy?
NG242_Rationale and impact: Treatment strategies for non-proliferative and proliferative diabetic retinopathy - Part 3,NG242,What are the recommended treatment timing and options for proliferative diabetic retinopathy?
NG242_Rationale and impact: Treatment strategies for non-proliferative and proliferative diabetic retinopathy - Part 4,NG242,What are the recommended treatments for proliferative diabetic retinopathy when panretinal photocoagulation is ineffective or cannot be performed?
NG242_Rationale and impact: Treatment strategies for non-proliferative and proliferative diabetic retinopathy - Part 5,NG242,What are the most effective combination treatments for proliferative diabetic retinopathy?
NG242_Rationale and impact: Discussing and offering treatment for diabetic macular oedema,NG242,What are the recommended treatment options for diabetic macular oedema?
NG242_Rationale and impact: Treatment strategies for non-centre-involving clinically significant diabetic macular oedema,NG242,What are the recommended treatment options for non-centre-involving diabetic macular oedema?
NG242_Rationale and impact: Treatment strategies for centre-involving diabetic macular oedema - Part 1,NG242,What are the treatment options for centre-involving diabetic macular oedema in patients with good vision?
NG242_Rationale and impact: Treatment strategies for centre-involving diabetic macular oedema - Part 2,NG242,What are the treatment options for centre-involving diabetic macular oedema in patients with good vision?
NG242_Rationale and impact: Treatment strategies for centre-involving diabetic macular oedema - Part 3,NG242,What are the treatment options for macular oedema with central retinal thickness of 400 micrometres or more?
NG242_Rationale and impact: Treatment strategies for centre-involving diabetic macular oedema - Part 4,NG242,What are the recommended treatment options for central-involving diabetic macular oedema in patients with thinner retinas?
NG242_Rationale and impact: When non-corticosteroid treatment is not possible,NG242,What are the alternative intravitreal treatments for macular oedema when anti-VEGF therapy is not suitable?
"NG242_Rationale and impact: When to add, switch or stop treatment - Part 1",NG242,When should I consider switching or stopping anti-VEGF treatment for diabetic macular oedema?
"NG242_Rationale and impact: When to add, switch or stop treatment - Part 2",NG242,How should response to anti-VEGF treatment be assessed in diabetic macular oedema patients?
NG242_Rationale and impact: When to assess disease status and how often to monitor - Part 1,NG242,What are the recommended monitoring frequencies for non-proliferative diabetic retinopathy based on disease severity?
NG242_Rationale and impact: When to assess disease status and how often to monitor - Part 2,NG242,What are the recommended monitoring intervals for proliferative diabetic retinopathy after treatment?
NG242_Rationale and impact: When to assess disease status and how often to monitor - Part 3,NG242,What are the recommended monitoring frequencies for diabetic retinopathy in people under 18 or pregnant women?
NG242_Rationale and impact: Imaging techniques for monitoring diabetic retinopathy and diabetic macular oedema - Part 1,NG242,What are the recommended imaging techniques for monitoring diabetic retinopathy progression?
NG242_Rationale and impact: Imaging techniques for monitoring diabetic retinopathy and diabetic macular oedema - Part 2,NG242,What is the recommended use of optical coherence tomography for diagnosing and monitoring diabetic macular oedema?
NG242_Rationale and impact: Vitrectomy - Part 1,NG242,What are the indications and benefits of vitrectomy for proliferative diabetic retinopathy and diabetic macular oedema?
NG242_Rationale and impact: Vitrectomy - Part 2,NG242,When should vitrectomy be considered for proliferative diabetic retinopathy with vitreous haemorrhage or tractional retinal detachment?
NG242_Rationale and impact: Vitrectomy - Part 3,NG242,What are the recommended treatments for proliferative retinopathy without retinal detachment and diabetic macular oedema?
NG242_Context,NG242,What are the recommended management and treatment options for diabetic retinopathy and diabetic macular oedema?
"NG243_Adrenal insufficiency: identification and management & Overview & Recommendations: 1.1 Information, support and decision making - Part 1",NG243,What are the key considerations for communicating and supporting patients with adrenal insufficiency?
"NG243_Recommendations: 1.1 Information, support and decision making - Part 2",NG243,What are the key management strategies and emergency precautions for patients on long-term glucocorticoid therapy?
"NG243_Recommendations: 1.1 Information, support and decision making - Part 3",NG243,How should healthcare professionals review and provide information and support for children with adrenal insufficiency during transition and life events?
NG243_Recommendations: 1.2 Initial identification and referral - Part 1,NG243,What are the signs and risk factors for suspecting adrenal insufficiency in adults and children?
NG243_Recommendations: 1.2 Initial identification and referral - Part 2,NG243,What are the initial tests and interpretation criteria for diagnosing adrenal insufficiency?
NG243_Recommendations: 1.2 Initial identification and referral - Part 3 & Recommendations: 1.3 Routine pharmacological management - Part 1,NG243,How should serum cortisol levels be interpreted in diagnosing adrenal insufficiency in infants and adults?
NG243_Recommendations: 1.3 Routine pharmacological management - Part 2,NG243,What is the recommended corticosteroid replacement therapy for adults with primary adrenal insufficiency?
NG243_Recommendations: 1.3 Routine pharmacological management - Part 3,NG243,What is the recommended hydrocortisone dosing for children with adrenal insufficiency?
NG243_Recommendations: 1.3 Routine pharmacological management - Part 4,NG243,What is the recommended initial dose of fludrocortisone for adrenal insufficiency in adults and children?
NG243_Recommendations: 1.3 Routine pharmacological management - Part 5,NG243,What should be included in an emergency management kit for adrenal insufficiency?
NG243_Recommendations: 1.4 Management during physiological stress - Part 1,NG243,What is the recommended glucocorticoid management during physiological stress in adrenal insufficiency?
NG243_Recommendations: 1.4 Management during physiological stress - Part 2,NG243,What are the recommended glucocorticoid management strategies for patients undergoing surgery or invasive procedures?
NG243_Recommendations: 1.4 Management during physiological stress - Part 3,NG243,What is the recommended management of adrenal insufficiency during pregnancy?
NG243_Recommendations: 1.4 Management during physiological stress - Part 4,NG243,What are the NICE guidelines for corticosteroid management during pregnancy labor and postpartum?
NG243_Recommendations: 1.5 Management during psychological stress - Part 1,NG243,What is the recommended pharmacological management for psychological stress in children and adults?
NG243_Recommendations: 1.5 Management during psychological stress - Part 2,NG243,What are recommended non-pharmacological strategies to manage psychological stress in people with adrenal insufficiency?
NG243_Recommendations: 1.6 When to suspect adrenal crisis,NG243,When should adrenal crisis be suspected in critically ill patients?
NG243_Recommendations: 1.7 Emergency management of adrenal crisis - Part 1,NG243,What is the emergency management protocol for adrenal crisis in adults?
NG243_Recommendations: 1.7 Emergency management of adrenal crisis - Part 2,NG243,What is the recommended emergency management for adrenal crisis in children and young people?
NG243_Recommendations: 1.8 Ongoing care and monitoring - Part 1,NG243,What are the recommended frequency and components of ongoing reviews for people with adrenal insufficiency?
NG243_Recommendations: 1.8 Ongoing care and monitoring - Part 2,NG243,What are the signs of glucocorticoid under- or over-replacement in adrenal insufficiency?
NG243_Recommendations: 1.8 Ongoing care and monitoring - Part 3,NG243,Should cortisol day series be routinely performed to check hydrocortisone dosing in adrenal insufficiency?
NG243_Recommendations: 1.9 Managing glucocorticoid withdrawal to prevent adrenal insufficiency - Part 1,NG243,What are the recommended glucocorticoid tapering protocols to prevent adrenal insufficiency?
NG243_Recommendations: 1.9 Managing glucocorticoid withdrawal to prevent adrenal insufficiency - Part 2,NG243,When should I test for adrenal insufficiency during glucocorticoid tapering?
NG243_Recommendations: 1.9 Managing glucocorticoid withdrawal to prevent adrenal insufficiency - Part 3,NG243,What are the serum cortisol level thresholds for managing glucocorticoid withdrawal?
NG243_Recommendations: Terms used in this guideline,NG243,What is the recommended management of adrenal crisis using an emergency management kit?
NG243_Recommendations for research: 1 Initial investigations for people with suspected adrenal insufficiency & Recommendations for research: 2 Glucocorticoid withdrawal & Recommendations for research: 3 Adrenal crisis,NG243,What are the recommended initial tests for diagnosing adrenal insufficiency?
NG243_Recommendations for research: 4 Routine pharmacological management in secondary and tertiary adrenal insufficiency & Recommendations for research: 5 Pharmacological management of physiological stress,NG243,What is the effectiveness of glucocorticoids in managing secondary and tertiary adrenal insufficiency?
"NG243_Rationale and impact: Information, support and decision making",NG243,What information and support are recommended for adults and children with adrenal insufficiency?
NG243_Rationale and impact: When to suspect adrenal insufficiency,NG243,What are the clinical signs and symptoms that should raise suspicion of adrenal insufficiency?
NG243_Rationale and impact: Initial investigations for adrenal insufficiency - Part 1,NG243,What is the recommended timing for serum cortisol testing in suspected adrenal insufficiency?
NG243_Rationale and impact: Initial investigations for adrenal insufficiency - Part 2,NG243,What are the recommended initial tests for diagnosing adrenal insufficiency in patients with hyponatraemia?
NG243_Rationale and impact: Routine pharmacological management - Part 1,NG243,What is the recommended pharmacological management for adrenal insufficiency with hydrocortisone?
NG243_Rationale and impact: Routine pharmacological management - Part 2,NG243,What are the recommended glucocorticoid treatments for adrenal insufficiency in adults and children?
NG243_Rationale and impact: Routine pharmacological management - Part 3,NG243,What are the recommended treatments for hyponatraemia in primary adrenal insufficiency?
NG243_Rationale and impact: Pharmacological management during physiological stress - Part 1,NG243,What are the recommended pharmacological strategies for managing physiological stress in patients requiring glucocorticoid therapy?
NG243_Rationale and impact: Pharmacological management during physiological stress - Part 2,NG243,What are the current NICE recommendations for sick-day dosing of glucocorticoids in children with adrenal insufficiency?
NG243_Rationale and impact: Non-pharmacological management during physiological stress,NG243,What are the non-pharmacological strategies for managing adrenal insufficiency during physiological stress?
NG243_Rationale and impact: Pregnancy care,NG243,What are the recommended management strategies for adrenal insufficiency during pregnancy?
NG243_Rationale and impact: Pharmacological management during psychological stress,NG243,What is the recommended pharmacological management of psychological stress in patients with adrenal insufficiency?
NG243_Rationale and impact: Non-pharmacological management during psychological stress,NG243,What strategies can help reduce psychological stress to prevent adrenal crisis in patients with adrenal insufficiency?
NG243_Rationale and impact: When to suspect adrenal crisis,NG243,What are the clinical signs and risk factors for suspecting adrenal crisis in critically unwell patients?
NG243_Rationale and impact: Emergency management of adrenal crisis - Part 1,NG243,What is the emergency management protocol for adrenal crisis including hydrocortisone and fluid administration?
NG243_Rationale and impact: Emergency management of adrenal crisis - Part 2,NG243,What are the recommended emergency management protocols for adrenal crisis in children and adults?
NG243_Rationale and impact: Ongoing care and monitoring - Part 1,NG243,What are the recommended approaches for ongoing monitoring of adrenal insufficiency?
NG243_Rationale and impact: Ongoing care and monitoring - Part 2,NG243,What are the recommended monitoring and emergency management strategies for patients with adrenal insufficiency?
NG243_Rationale and impact: Managing glucocorticoid withdrawal to prevent adrenal insufficiency - Part 1,NG243,What are the recommended strategies for tapering glucocorticoids to prevent adrenal insufficiency?
NG243_Rationale and impact: Managing glucocorticoid withdrawal to prevent adrenal insufficiency - Part 2,NG243,What are the recommended practices for tapering and switching glucocorticoids in adults and children?
NG243_Context,NG243,What are the recommended management strategies for adrenal insufficiency and prevention of adrenal crisis?
"NG244_Asthma pathway (BTS, NICE, SIGN) & Overview",NG244,What are the current NICE guidelines for diagnosing and managing asthma in adults and children?
NG244_Diagnosis & Monitoring asthma control,NG244,What are the recommended objective tests for diagnosing asthma in children aged 5 and over?
NG244_Managing chronic asthma: Pharmacological management - Part 1,NG244,What are the pharmacological management recommendations for asthma in people aged 12 years and over?
NG244_Managing chronic asthma: Pharmacological management - Part 2 & Managing chronic asthma: Non-pharmacological management,NG244,What are the pharmacological management recommendations for children aged 5 to 11 with asthma?
NG244_Managing acute asthma,NG244,What are the recommended management strategies for acute asthma attacks?
NG244_Managing difficult and severe asthma,NG244,What are the recommended specialist therapies for severe asthma?
"NG244_Managing asthma in pregnancy, during labour and when breastfeeding & 5 more sections",NG244,"What are the recommended management strategies for asthma during pregnancy, labour, and breastfeeding?"
"NG245_Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) & Overview",NG245,What are the current recommendations for diagnosing and monitoring asthma in adults and children?
NG245_Recommendations: 1.1 Initial clinical assessment - Part 1,NG245,What are the key components of initial clinical assessment for suspected asthma?
NG245_Recommendations: 1.1 Initial clinical assessment - Part 2,NG245,What are the recommended initial assessments and objective tests for diagnosing asthma in acute settings?
"NG245_Recommendations: 1.2 Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 1",NG245,What are the objective tests for diagnosing asthma in adults and children aged 5 to 16?
"NG245_Recommendations: 1.2 Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 2",NG245,What are the recommended objective tests for diagnosing asthma in children aged 5 to 16?
"NG245_Recommendations: 1.2 Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 3",NG245,What should be done if there is uncertainty in diagnosing asthma in children?
"NG245_Recommendations: 1.2 Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 4",NG245,What are the most accurate tests for diagnosing asthma?
NG245_Recommendations: 1.3 Diagnosing asthma in children under 5,NG245,How is asthma diagnosed in children under 5 years old?
NG245_Recommendations: 1.4 Diagnosing occupational asthma,NG245,How can I identify occupational asthma in adults with poorly controlled or recurrent asthma?
NG245_Recommendations: 1.5 Monitoring asthma control,NG245,How should asthma control be monitored during patient reviews?
NG245_Recommendations: 1.6 Principles of pharmacological treatment - Part 1,NG245,What are the principles for pharmacological treatment and prescribing inhalers for asthma management?
NG245_Recommendations: 1.6 Principles of pharmacological treatment - Part 2,NG245,How often should asthma treatment response be reviewed after starting or adjusting medication?
NG245_Recommendations: 1.6 Principles of pharmacological treatment - Part 3,NG245,How should inhaler technique be checked and managed in asthma patients?
NG245_Recommendations: 1.7 Pharmacological management in people aged 12 and over - Part 1,NG245,What is the recommended pharmacological management for newly diagnosed asthma in people aged 12 and over?
NG245_Recommendations: 1.7 Pharmacological management in people aged 12 and over - Part 2,NG245,What are the recommended medication options and sequencing for asthma management in people aged 12 and over who are not controlled on low-dose or moderate-dose MART?
NG245_Recommendations: 1.7 Pharmacological management in people aged 12 and over - Part 3,NG245,What are the recommended treatment options for uncontrolled asthma despite using LTRA or LAMA therapy?
NG245_Recommendations: 1.7 Pharmacological management in people aged 12 and over - Part 4,NG245,When should treatment be escalated from low- or moderate-dose ICS or ICS/LABA to MART in asthma management?
NG245_Recommendations: 1.8 Pharmacological management in children aged 5 to 11 - Part 1,NG245,What is the recommended pharmacological management for children aged 5 to 11 with asthma according to NICE guidelines?
NG245_Recommendations: 1.8 Pharmacological management in children aged 5 to 11 - Part 2,NG245,What are the current NICE recommendations for using low-dose MART in children with asthma?
NG245_Recommendations: 1.8 Pharmacological management in children aged 5 to 11 - Part 3,NG245,What is the recommended asthma management for children aged 5 to 11 who are not controlled on low-dose ICS plus SABA?
NG245_Recommendations: 1.9 Pharmacological management in children under 5 - Part 1,NG245,What is the recommended pharmacological management for children under 5 with suspected or confirmed asthma?
NG245_Recommendations: 1.9 Pharmacological management in children under 5 - Part 2,NG245,What is the recommended management for acute asthma episodes in children under 5 according to NICE guidelines?
NG245_Recommendations: 1.10 Decreasing maintenance therapy & Recommendations: 1.11 Adherence,NG245,What are the recommended steps for safely decreasing maintenance therapy in asthma patients?
NG245_Recommendations: 1.12 Asthma in pregnancy and breastfeeding,NG245,What are the recommended asthma medications during pregnancy and breastfeeding?
NG245_Recommendations: 1.13 Asthma in adolescents,NG245,"What are the recommendations for managing asthma in adolescents, including transition to adult services and smoking cessation?"
NG245_Recommendations: 1.14 Self-management - Part 1,NG245,What are the recommended self-management strategies and action plans for adults and children with asthma?
NG245_Recommendations: 1.14 Self-management - Part 2,NG245,How should I increase inhaled corticosteroid dose in asthma management according to NICE guidelines?
NG245_Recommendations: 1.15 Risk-stratified care & Recommendations: 1.16 Organisation and delivery of care,NG245,What are the risk factors for poor outcomes in asthma management according to NICE guidelines?
NG245_Recommendations: Terms used in this guideline - Part 1,NG245,What is the role of AIR therapy in managing asthma symptoms?
NG245_Recommendations: Terms used in this guideline - Part 2,NG245,What are the recommended treatments for managing uncontrolled asthma?
NG245_Recommendations for research: Key recommendations for research - Part 1,NG245,What is the most effective initial inhaler strategy for managing asthma in children aged 5 to 11?
NG245_Recommendations for research: Key recommendations for research - Part 2,NG245,What is the cost-effectiveness of the NICE diagnostic pathways for asthma in children and adults?
NG245_Recommendations for research: Key recommendations for research - Part 3,NG245,What are the most accurate diagnostic tests for asthma in children?
NG245_Recommendations for research: Key recommendations for research - Part 4,NG245,What are effective strategies to improve adherence to asthma inhalers and monitor inhaler technique?
NG245_Recommendations for research: Other recommendations for research,NG245,Is increasing inhaled corticosteroid dose beneficial for children and young people with asthma during self-management when control worsens?
"NG245_Rationale and impact: Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 1",NG245,What are the recommended objective tests for diagnosing asthma in children aged 5 to 16?
"NG245_Rationale and impact: Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 2",NG245,What are the recommended methods for measuring bronchodilator reversibility and FeNO levels in asthma diagnosis?
"NG245_Rationale and impact: Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 3",NG245,What is the recommended diagnostic pathway for asthma in adults and children according to NICE guidelines?
"NG245_Rationale and impact: Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 4",NG245,What are the recommended initial and follow-up tests for diagnosing asthma in children according to NICE guidelines?
"NG245_Rationale and impact: Objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma - Part 5",NG245,What are the recommended diagnostic approaches for asthma in children under 5 years old?
NG245_Rationale and impact: Monitoring asthma control - Part 1,NG245,What are the recommended methods for monitoring asthma control in adults and children?
NG245_Rationale and impact: Monitoring asthma control - Part 2,NG245,How is FeNO monitoring used to manage asthma in adults and children?
NG245_Rationale and impact: Principles of pharmacological treatment,NG245,Why should short-acting beta2 agonists not be used alone in asthma treatment?
NG245_Rationale and impact: Digital inhalers,NG245,What is the effectiveness and cost-effectiveness of digital inhalers for asthma management?
NG245_Rationale and impact: Medicines for the initial management of newly diagnosed asthma in people aged 12 and over,NG245,What is the recommended initial inhaler treatment for newly diagnosed asthma in people aged 12 and over?
NG245_Rationale and impact: Medicine combination and sequencing in people aged 12 and over - Part 1,NG245,What is the most effective combination and sequencing of asthma medications for people aged 12 and over?
NG245_Rationale and impact: Medicine combination and sequencing in people aged 12 and over - Part 2,NG245,What are the recommended options for escalating asthma treatment when control is inadequate on MART therapy?
NG245_Rationale and impact: Transferring people aged 12 and over from other treatment pathways,NG245,How should clinicians transfer patients aged 12 and over from other asthma treatment pathways to MART?
NG245_Rationale and impact: Medicines for initial management in children aged 5 to 11,NG245,What is the recommended initial inhaler treatment for children aged 5 to 11 with asthma?
NG245_Rationale and impact: Medicine combination and sequencing in children aged 5 to 11 - Part 1,NG245,What is the recommended asthma treatment combination and sequencing for children aged 5 to 11?
NG245_Rationale and impact: Medicine combination and sequencing in children aged 5 to 11 - Part 2,NG245,What are the recommended treatment options for children with uncontrolled asthma on low-dose inhaled corticosteroids?
NG245_Rationale and impact: Pharmacological management in children under 5,NG245,What are the recommended pharmacological treatments for asthma in children under 5 years old?
NG245_Rationale and impact: Self-management,NG245,What are the recommended self-management strategies for children and young people with asthma?
NG245_Rationale and impact: Risk-stratified care,NG245,What are effective methods for risk stratification in asthma management in primary care?
NG245_Context,NG245,What are the current NICE recommendations for diagnosing and managing asthma in adults?
NG246_Overweight and obesity management & Overview,NG246,What are the recommended strategies for managing overweight and obesity in adults and children?
NG246_General principles of care: 1.1 General principles for all ages - Part 1,NG246,What factors should healthcare professionals consider when discussing overweight and obesity with patients of different ages and backgrounds?
NG246_General principles of care: 1.1 General principles for all ages - Part 2,NG246,How should healthcare professionals discuss overweight and obesity with patients in a sensitive and person-centred way?
NG246_General principles of care: 1.1 General principles for all ages - Part 3,NG246,What are effective strategies for having sensitive conversations about weight with adults and children?
NG246_General principles of care: 1.2 Additional principles for children and young people - Part 1,NG246,What are effective strategies for creating a supportive environment for weight management in children and young people?
NG246_General principles of care: 1.2 Additional principles for children and young people - Part 2,NG246,What are the recommended referral pathways for managing obesity and related comorbidities in children and young people?
"NG246_Preventing overweight, obesity and central adiposity: 1.3 Information and support to help people maintain a healthier weight - Part 1",NG246,What strategies can help people maintain a healthier weight and avoid disordered eating behaviors?
"NG246_Preventing overweight, obesity and central adiposity: 1.3 Information and support to help people maintain a healthier weight - Part 2",NG246,What are effective ways to monitor and improve physical activity and dietary habits in children and young people?
"NG246_Preventing overweight, obesity and central adiposity: 1.3 Information and support to help people maintain a healthier weight - Part 3",NG246,What strategies can help families support healthy eating and activity in children and young people?
"NG246_Preventing overweight, obesity and central adiposity: 1.4 Healthcare professionals - Part 1",NG246,What strategies are recommended for healthcare professionals to promote physical activity and healthy diet in community and clinical settings?
"NG246_Preventing overweight, obesity and central adiposity: 1.4 Healthcare professionals - Part 2",NG246,What are effective strategies for supporting behavioral change to increase physical activity and healthy eating in children and families?
"NG246_Preventing overweight, obesity and central adiposity: 1.5 Local or regional strategic partnerships - Part 1",NG246,What strategies are recommended for local partnerships to prevent and manage obesity effectively?
"NG246_Preventing overweight, obesity and central adiposity: 1.5 Local or regional strategic partnerships - Part 2",NG246,What strategies can be used to create safe and inclusive spaces for promoting physical activity in local communities?
"NG246_Preventing overweight, obesity and central adiposity: 1.6 Schools, nurseries and childcare facilities - Part 1",NG246,What strategies can schools and nurseries use to promote healthy eating and physical activity in children?
"NG246_Preventing overweight, obesity and central adiposity: 1.6 Schools, nurseries and childcare facilities - Part 2",NG246,What are the recommended practices for promoting healthy eating and physical activity in schools and early-years settings?
"NG246_Preventing overweight, obesity and central adiposity: 1.6 Schools, nurseries and childcare facilities - Part 3",NG246,How can schools adapt activities to support children and young people with SEND in promoting healthy weight and physical activity?
"NG246_Preventing overweight, obesity and central adiposity: 1.7 Workplaces",NG246,What strategies can workplaces implement to prevent and manage overweight and obesity among staff?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.8 Specific advice for people from ethnic minority backgrounds",NG246,How should healthcare professionals address the increased risk of central adiposity and weight-related health conditions in ethnic minority populations?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.9 Identifying and assessing overweight and obesity in adults - Part 1",NG246,What are the recommended methods for measuring and recording overweight and obesity in adults?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.9 Identifying and assessing overweight and obesity in adults - Part 2",NG246,How can adults with a BMI below 35 kg/m² measure their waist-to-height ratio accurately?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.9 Identifying and assessing overweight and obesity in adults - Part 3",NG246,What are the recommended methods for measuring overweight and obesity in adults?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.9 Identifying and assessing overweight and obesity in adults - Part 4",NG246,What are the BMI thresholds for overweight and obesity in different ethnic groups according to NICE guidelines?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.9 Identifying and assessing overweight and obesity in adults - Part 5",NG246,What is the recommended waist-to-height ratio threshold for assessing health risks related to central adiposity?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.10 Identifying and assessing overweight and obesity in children and young people - Part 1",NG246,What are the recommended procedures for measuring and assessing overweight and obesity in children and young people?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.10 Identifying and assessing overweight and obesity in children and young people - Part 2",NG246,What are the recommended methods for measuring and interpreting BMI in children and young people for overweight and obesity assessment?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.10 Identifying and assessing overweight and obesity in children and young people - Part 3",NG246,What is the recommended method for assessing adiposity in children and young people?
"NG246_Identifying and assessing overweight, obesity and central adiposity: 1.10 Identifying and assessing overweight and obesity in children and young people - Part 4",NG246,What is the recommended waist-to-height ratio threshold for assessing health risks in children and young people?
NG246_Discussing results and referral: 1.11 Discussing results and referral for adults - Part 1,NG246,What information should healthcare professionals provide to adults about the health risks of overweight and obesity?
NG246_Discussing results and referral: 1.11 Discussing results and referral for adults - Part 2,NG246,What are the recommended behavioral interventions for managing overweight and obesity tailored to individual needs and cultural backgrounds?
NG246_Discussing results and referral: 1.11 Discussing results and referral for adults - Part 3,NG246,What are the recommended community support options for adults managing overweight and obesity?
NG246_Discussing results and referral: 1.11 Discussing results and referral for adults - Part 4,NG246,What should I do if an adult declines referral to weight management services?
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 1,NG246,"How should healthcare professionals discuss overweight and obesity results with children, young people, and their families?"
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 2,NG246,What are recommended strategies for managing overweight and obesity in children and young people?
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 3,NG246,"How should healthcare professionals involve children, young people, and their families in decision-making about obesity management interventions?"
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 4,NG246,What are the recommended long-term behavioral interventions for overweight and obesity management in children and young people?
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 5,NG246,When should children and young people with obesity be referred to specialist weight management services?
NG246_Discussing results and referral: 1.12 Discussing results and referral for children and young people - Part 6,NG246,What should be done if a child or young person declines referral to weight management interventions?
NG246_Behavioural overweight and obesity management interventions: 1.13 Behavioural overweight and obesity management interventions for adults - Part 1,NG246,How can healthcare providers support adherence to behavioural overweight and obesity management interventions in adults?
NG246_Behavioural overweight and obesity management interventions: 1.13 Behavioural overweight and obesity management interventions for adults - Part 2,NG246,What are the NICE recommendations for submitting audit data on overweight and obesity management interventions in adults?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 1,NG246,What are the recommended components of behavioral overweight and obesity management interventions for children and young people?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 2,NG246,What are the recommended assessments and interventions for managing overweight and obesity in children and young people?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 3,NG246,What are the recommended strategies for involving families in childhood weight management programs?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 4,NG246,What are effective strategies for involving families in overweight and obesity management for children and young people?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 5,NG246,How should healthcare providers support families facing barriers to participation in childhood weight management interventions?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 6,NG246,What are the recommended ongoing support strategies for children and young people managing overweight and obesity?
NG246_Behavioural overweight and obesity management interventions: 1.14 Behavioural overweight and obesity management interventions for children and young people - Part 7,NG246,What support should children and young people with overweight or obesity receive from specialist services?
NG246_Physical activity and diet: 1.15 Physical activity approaches - Part 1,NG246,What are the recommended physical activity guidelines for adults to prevent obesity and maintain weight?
NG246_Physical activity and diet: 1.15 Physical activity approaches - Part 2,NG246,What are the recommended physical activity guidelines for children and young people to improve health?
NG246_Physical activity and diet: 1.16 Dietary approaches - Part 1,NG246,What are effective dietary approaches for managing overweight and obesity in adults and children?
NG246_Physical activity and diet: 1.16 Dietary approaches - Part 2,NG246,What are the recommended uses and limitations of low-energy and very-low-energy diets for weight management?
NG246_Physical activity and diet: 1.16 Dietary approaches - Part 3,NG246,What are the recommendations for using low-energy and very-low-energy diets in weight management?
NG246_Medicines and surgery: 1.17 Medicines for overweight and obesity - Part 1,NG246,What are the recommended medicines for weight management in adults according to NICE guidelines?
NG246_Medicines and surgery: 1.17 Medicines for overweight and obesity - Part 2,NG246,What are the NICE recommended medicines for weight management in adults with obesity?
NG246_Medicines and surgery: 1.17 Medicines for overweight and obesity - Part 3,NG246,What are the NICE recommendations for prescribing weight management medicines in adults and children?
NG246_Medicines and surgery: 1.17 Medicines for overweight and obesity - Part 4,NG246,When is orlistat appropriate for use in children aged 12 years and older?
NG246_Medicines and surgery: 1.18 Surgical interventions - Part 1,NG246,What are the criteria for referring adults for bariatric surgery assessment according to NICE guidelines?
NG246_Medicines and surgery: 1.18 Surgical interventions - Part 2,NG246,What are the criteria and considerations for assessing eligibility for bariatric surgery in people from diverse ethnic backgrounds?
NG246_Medicines and surgery: 1.18 Surgical interventions - Part 3,NG246,"What information should be provided to patients after bariatric surgery regarding diet, nutritional monitoring, and long-term support?"
NG246_Medicines and surgery: 1.18 Surgical interventions - Part 4,NG246,What are the recommended follow-up care procedures after bariatric surgery?
NG246_Medicines and surgery: 1.18 Surgical interventions - Part 5 & Digital technologies for delivering multidisciplinary weight-management services to adults,NG246,What are the recommended components of a multidisciplinary team for paediatric bariatric surgery?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 1,NG246,What are the recommended components of effective overweight and obesity management interventions?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 2,NG246,What are the recommended strategies for developing sustainable weight management interventions for adults?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 3,NG246,How can local businesses support obesity prevention and promote healthy lifestyles?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 4,NG246,What equipment and facilities are recommended for weighing and monitoring people with severe obesity in healthcare settings?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 5,NG246,What strategies can be used to raise awareness of overweight and obesity management interventions among health and social care professionals and the general public?
NG246_Planning and delivering overweight and obesity services and interventions: 1.19 Planning and commissioning services and interventions for all ages - Part 6,NG246,What are the recommended strategies for monitoring and evaluating the effectiveness of overweight and obesity management interventions?
NG246_Planning and delivering overweight and obesity services and interventions: 1.20 Planning and commissioning interventions for children and young people - Part 1,NG246,What are the recommended components and team members involved in planning and delivering obesity interventions for children and young people?
NG246_Planning and delivering overweight and obesity services and interventions: 1.20 Planning and commissioning interventions for children and young people - Part 2,NG246,What are the recommended practices for measuring and recording BMI in children and young people undergoing weight management interventions?
NG246_Monitoring and evaluating services and interventions: 1.21 Data to collect & Monitoring and evaluating services and interventions: 1.22 Sharing and using the results,NG246,What outcomes should be measured to evaluate the effectiveness of obesity prevention interventions?
NG246_Monitoring and evaluating services and interventions: 1.23 Additional principles on monitoring provision for children and young people,NG246,What are the recommended monitoring practices for children's and young people's interventions according to NICE guidelines?
NG246_Terms used in this guideline - Part 1,NG246,What are effective behavioral interventions for managing overweight and obesity in adults?
NG246_Terms used in this guideline - Part 2,NG246,What are the different levels of overweight and obesity management services available?
NG246_Recommendations for research: Key recommendations for research - Part 1,NG246,What are effective and acceptable methods for identifying overweight and obesity in people from ethnic minority backgrounds?
NG246_Recommendations for research: Key recommendations for research - Part 2,NG246,What is the effectiveness and cost effectiveness of bariatric surgery for weight loss and treatment outcomes in people unable to receive other treatments or from ethnic minority backgrounds?
NG246_Recommendations for research: Key recommendations for research - Part 3,NG246,What are the most appropriate anthropometric measurements and cutoff values for assessing health risks related to overweight and obesity in adults from diverse ethnic backgrounds?
NG246_Recommendations for research: Other recommendations for research - Part 1,NG246,"What is the effectiveness of psychological therapies in reducing weight stigma in children, young people, and adults?"
NG246_Recommendations for research: Other recommendations for research - Part 2,NG246,What is the effectiveness of behavioural interventions with long-term support for weight management in children and young people?
NG246_Recommendations for research: Other recommendations for research - Part 3,NG246,What are the adverse events associated with different dietary approaches for weight management in overweight and obese adults?
NG246_Recommendations for research: Other recommendations for research - Part 4,NG246,What are the long-term effects of very-low-calorie diets on weight maintenance and quality of life in people with a BMI of 40 or higher?
NG246_Recommendations for research: Other recommendations for research - Part 5,NG246,How can I effectively communicate the results of the National Child Measurement Programme to families without causing distress?
NG246_Rationale and impact: General principles for all ages - Part 1,NG246,How should healthcare professionals approach discussions about overweight and obesity with patients to ensure sensitivity and respect?
NG246_Rationale and impact: General principles for all ages - Part 2,NG246,How can healthcare professionals have sensitive and non-stigmatising conversations about weight with patients?
NG246_Rationale and impact: Additional principles for children and young people,NG246,When should children and young people be empowered to manage their overweight or obesity?
"NG246_Rationale and impact: All early-years settings, nurseries, other childcare facilities and schools - Part 1",NG246,What are the recommended strategies for preventing obesity in early-years and school settings?
"NG246_Rationale and impact: All early-years settings, nurseries, other childcare facilities and schools - Part 2",NG246,What are effective strategies for preventing obesity in children and young people in school settings?
NG246_Rationale and impact: Specific advice for people from ethnic minority backgrounds,NG246,What are the BMI thresholds for assessing overweight and obesity in people from ethnic minority backgrounds?
NG246_Rationale and impact: When to take and record measurements in adults,NG246,When should healthcare professionals measure and record weight and waist circumference in adults during consultations?
"NG246_Rationale and impact: How to take measurements and measures of overweight, obesity and central adiposity in adults - Part 1",NG246,"What are the recommended methods for measuring overweight, obesity, and central adiposity in adults?"
"NG246_Rationale and impact: How to take measurements and measures of overweight, obesity and central adiposity in adults - Part 2",NG246,How can healthcare professionals effectively measure waist-to-height ratio for obesity assessment?
"NG246_Rationale and impact: Classifying overweight, obesity and central adiposity in adults - Part 1",NG246,What are the BMI thresholds and considerations for assessing overweight and obesity in adults from different ethnic backgrounds?
"NG246_Rationale and impact: Classifying overweight, obesity and central adiposity in adults - Part 2",NG246,How should obesity thresholds be adjusted for different ethnic groups according to NICE guidelines?
"NG246_Rationale and impact: Classifying overweight, obesity and central adiposity in adults - Part 3",NG246,What are the recommended methods for measuring obesity and assessing health risks in adults from diverse ethnic backgrounds?
NG246_Rationale and impact: When to take and record measurements in children and young people - Part 1,NG246,When should measurements for overweight and obesity be taken and recorded in children and young people?
NG246_Rationale and impact: When to take and record measurements in children and young people - Part 2,NG246,What are the recommended methods for measuring and recording growth and obesity in children and young people?
"NG246_Rationale and impact: Measures of overweight, obesity and central adiposity in children and young people - Part 1",NG246,What are the best measures to assess overweight and obesity in children and young people?
"NG246_Rationale and impact: Measures of overweight, obesity and central adiposity in children and young people - Part 2",NG246,What are the recommended methods for assessing overweight and obesity in children and young people with disabilities?
"NG246_Rationale and impact: Classifying overweight, obesity and central adiposity in children and young people - Part 1",NG246,What are the clinical definitions and assessment methods for overweight and obesity in children and young people?
"NG246_Rationale and impact: Classifying overweight, obesity and central adiposity in children and young people - Part 2",NG246,What is the recommended waist-to-height ratio cutoff for assessing overweight in children and young people?
NG246_Rationale and impact: Discussing the results with adults,NG246,How should healthcare professionals discuss overweight and obesity management options with adults to support person-centred care?
NG246_Rationale and impact: Choosing interventions with adults - Part 1,NG246,What are effective strategies for tailoring overweight and obesity interventions to diverse adult populations?
NG246_Rationale and impact: Choosing interventions with adults - Part 2,NG246,How can healthcare professionals address cost barriers to improve participation in obesity interventions?
NG246_Rationale and impact: Referring adults to specialist services,NG246,What are the criteria for referring adults with obesity or weight-related comorbidities to specialist services?
NG246_Rationale and impact: If an adult declines referral,NG246,What should healthcare professionals do if an adult declines referral for overweight or obesity management?
"NG246_Rationale and impact: Asking permission from children and young people, and their families and carers",NG246,How should healthcare professionals obtain permission from children and young people before discussing overweight or obesity?
"NG246_Rationale and impact: Discussing the results with children and young people, and their families and carers - Part 1",NG246,"What are effective ways to discuss overweight and obesity management with children, young people, and their families?"
"NG246_Rationale and impact: Discussing the results with children and young people, and their families and carers - Part 2",NG246,What are the recommended approaches for setting person-centred health goals in managing overweight and obesity in children and young people?
"NG246_Rationale and impact: Choosing interventions with children and young people, and their families and carers - Part 1",NG246,What factors should be considered when selecting overweight and obesity interventions for children and young people?
"NG246_Rationale and impact: Choosing interventions with children and young people, and their families and carers - Part 2",NG246,How should healthcare professionals tailor interventions for children with overweight or obesity considering individual factors?
NG246_Rationale and impact: Specialist services,NG246,What specialist services are available for children and young people with obesity-related comorbidities?
NG246_Rationale and impact: If a child or young person declines referral,NG246,What should healthcare professionals do if a child or young person declines referral for overweight or obesity management?
NG246_Rationale and impact: Encouraging adherence to behavioural overweight and obesity management interventions for adults & Rationale and impact: Submitting audit data for adults,NG246,How can healthcare professionals improve adherence to behavioral weight management interventions in adults?
NG246_Rationale and impact: Core components of behavioural overweight and obesity management interventions for children and young people,NG246,What are effective behavioural interventions for managing overweight and obesity in children and young people?
NG246_Rationale and impact: Developing a tailored plan to meet individual needs & Rationale and impact: Encouraging adherence to behavioural overweight and obesity management interventions for children and young people,NG246,How can tailored plans improve adherence to behavioral overweight and obesity interventions in children and young people?
NG246_Rationale and impact: Ongoing support from providers of overweight and obesity management interventions,NG246,What is the recommended approach for providing ongoing support in overweight and obesity management for children and young people?
NG246_Rationale and impact: Ongoing support from healthcare and other professionals & Rationale and impact: Submitting audit data for children and young people,NG246,What is the recommended approach for ongoing support and monitoring of children and young people with overweight or obesity?
NG246_Rationale and impact: Psychological therapies to address the effect of weight stigma (no recommendations),NG246,What is the evidence for psychological therapies to reduce weight stigma in adults and children?
NG246_Rationale and impact: Dietary approaches for all ages,NG246,What are the recommended dietary approaches for promoting healthy weight management across all age groups?
NG246_Rationale and impact: Intermittent fasting in adults (no recommendations),NG246,Why does NICE not recommend intermittent fasting for adults?
NG246_Rationale and impact: Low-energy and very-low-energy diets for adults - Part 1,NG246,What are the recommended durations and effectiveness of low-energy and very-low-energy diets for weight management in adults with obesity or type 2 diabetes?
NG246_Rationale and impact: Low-energy and very-low-energy diets for adults - Part 2,NG246,What are the considerations and support strategies for using very-low-energy diets in weight management?
NG246_Rationale and impact: Low-energy and very-low-energy diets for adults - Part 3,NG246,What are the considerations for assessing and supporting mental health when prescribing low-energy diets for obesity?
NG246_Rationale and impact: Surgical interventions - Part 1,NG246,When should adults be referred for assessment for bariatric surgery based on BMI and obesity-related health conditions?
NG246_Rationale and impact: Surgical interventions - Part 2,NG246,What are the recommended assessment procedures for bariatric surgery in people from ethnic minority backgrounds?
NG246_Rationale and impact: Surgical interventions - Part 3,NG246,What are the recommended multidisciplinary team members for assessing eligibility for bariatric surgery?
NG246_Rationale and impact: Planning and funding services and interventions,NG246,Should overweight and obesity management services have age or BMI limits for referrals?
NG246_Rationale and impact: Raising awareness of overweight and obesity management options,NG246,How can healthcare providers effectively raise awareness of overweight and obesity management options among the public and professionals?
NG246_Rationale and impact: Involving a multidisciplinary team for children and young people,NG246,What is the recommended composition of a multidisciplinary team for managing childhood obesity?
NG246_Context,NG246,What are the recommended management strategies for overweight and obesity in adults and children according to NICE guidelines?
"NG247_Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years",NG247,What are the recommended strategies for nutrition and weight management during pregnancy and in children up to 5 years?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 1,NG247,What are the recommendations for folic acid supplementation before and during pregnancy?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 2,NG247,What is the recommended folic acid intake for women planning pregnancy or in early pregnancy according to NICE guidelines?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 3,NG247,What are the folic acid supplementation recommendations for women planning pregnancy with a history of neural tube defects or certain health conditions?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 4,NG247,"What are the recommendations for vitamin D and other vitamin supplements during pregnancy, breastfeeding, and for children under 5?"
NG247_Recommendations: 1.1 Vitamin supplementation - Part 5,NG247,What are the recommended vitamin D supplementation guidelines for pregnant and breastfeeding women?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 6,NG247,What are the recommended vitamin supplements for pregnant women and children under 5 according to NICE guidelines?
NG247_Recommendations: 1.1 Vitamin supplementation - Part 7,NG247,"Should pregnant women, breastfeeding mothers, and young children be offered free vitamin D supplements based on ethnicity or sunlight exposure?"
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 1",NG247,What are the key dietary recommendations for healthy eating during pregnancy?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 2",NG247,What are effective strategies to support healthy eating in pregnancy for women with diverse needs and social backgrounds?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 3",NG247,What are the recommended strategies for promoting physical activity and healthy weight management during pregnancy?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 4",NG247,What are the recommended practices for measuring BMI and providing weight management advice during pregnancy?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 5",NG247,Should I routinely weigh pregnant women during pregnancy?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 6",NG247,What interventions are recommended to support healthy weight gain during pregnancy?
"NG247_Recommendations: 1.2 Healthy eating, physical activity and weight management during pregnancy - Part 7 & Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth",NG247,What are the recommendations for breastfeeding and formula feeding beyond 8 weeks postpartum?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 1,NG247,What strategies can healthcare professionals use to support continued breastfeeding beyond 8 weeks postpartum?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 2,NG247,What are the best strategies to support and maintain breastfeeding for new mothers?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 3,NG247,What strategies are recommended to support continued breastfeeding after returning to work or study?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 4,NG247,How can I balance breastfeeding with returning to work or education and what support is available?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 5,NG247,What are the recommended workplace accommodations to support breastfeeding employees?
NG247_Recommendations: 1.3 Breastfeeding and formula feeding beyond 8 weeks after birth - Part 6,NG247,What are the recommended practices for safe and appropriate formula feeding in infants?
NG247_Recommendations: 1.4 Weighing babies and young children & Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years,NG247,What are the recommended practices for weighing babies and young children according to NICE guidelines?
NG247_Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years - Part 1,NG247,What is the recommended age to introduce solid foods to babies according to NICE guidelines?
NG247_Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years - Part 2,NG247,What are the recommended guidelines for introducing solid foods to babies around 6 months old?
NG247_Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years - Part 3,NG247,What are the recommended approaches for discussing healthy eating and drinking with families of children aged 1 to 5 years?
NG247_Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years - Part 4,NG247,What are effective strategies to promote healthy eating practices for children aged 1 to 5 years?
NG247_Recommendations: 1.5 Healthy eating behaviours in babies and children from 6 months and up to 5 years - Part 5,NG247,What strategies can early years settings use to promote healthy eating and drinking among children aged 1 to 5 years?
NG247_Recommendations for research: Key recommendations for research - Part 1,NG247,What is the recommended dose of vitamin D during pregnancy for women with overweight or obesity?
NG247_Recommendations for research: Key recommendations for research - Part 2,NG247,What are the recommended dietary interventions during pregnancy for managing gestational diabetes?
NG247_Rationale and impact: Folic acid before and during pregnancy - Part 1,NG247,What is the recommended dose of folic acid before and during pregnancy for women at increased risk of neural tube defects?
"NG247_Rationale and impact: Folic acid before and during pregnancy - Part 2 & Rationale and impact: Vitamin D and other vitamin supplements during and after pregnancy, and for babies and children under 5",NG247,What are the current recommendations for folic acid supplementation before and during pregnancy for women with overweight or obesity?
"NG247_Rationale and impact: Vitamin D and other vitamin supplements during and after pregnancy, and for babies and children under 5",NG247,What are the current NICE recommendations for vitamin D supplementation during pregnancy and for children under 5?
NG247_Rationale and impact: Healthy eating in pregnancy,NG247,What are the NICE recommendations for promoting healthy eating in pregnancy?
NG247_Rationale and impact: Physical activity in pregnancy,NG247,What are the benefits of physical activity during pregnancy for maternal and fetal health?
NG247_Rationale and impact: Weight management in pregnancy,NG247,What are the NICE guidelines on weight management and BMI assessment during pregnancy?
NG247_Rationale and impact: Low weight gain in pregnancy & Rationale and impact: Excessive weight gain in pregnancy,NG247,What are the risks of low or excessive weight gain during pregnancy for fetal and maternal health?
NG247_Rationale and impact: Gestational diabetes,NG247,What is the most effective dietary intervention for managing gestational diabetes?
NG247_Rationale and impact: Discussing babies' feeding and supporting continued breastfeeding - Part 1,NG247,What are effective ways to support and discuss breastfeeding with new mothers during healthcare visits?
NG247_Rationale and impact: Discussing babies' feeding and supporting continued breastfeeding - Part 2,NG247,What strategies are effective for increasing breastfeeding rates among low-income families?
NG247_Rationale and impact: Supporting continued breastfeeding after returning to work or study,NG247,What strategies can healthcare professionals recommend to support continued breastfeeding after returning to work or study?
NG247_Rationale and impact: Supporting safe and appropriate formula feeding & Rationale and impact: Introducing solid foods (complementary feeding) for babies between 6 months and 1 year,NG247,What are the best practices for supporting safe and appropriate formula feeding in infants?
NG247_Rationale and impact: Introducing solid foods (complementary feeding) for babies between 6 months and 1 year,NG247,What is the recommended timing and approach for introducing solid foods to babies aged 6 months to 1 year?
NG247_Rationale and impact: Healthy eating and drinking for children from 1 to 5 years & Rationale and impact: Healthy eating and drinking for children from 1 to 5 years,NG247,What strategies can healthcare professionals use to promote healthy eating in children aged 1 to 5 years from disadvantaged backgrounds?
NG247_Context - Part 1,NG247,What are the recommended strategies to improve nutritional health and supplement uptake during pregnancy?
NG247_Context - Part 2,NG247,What are the NICE recommendations for supporting breastfeeding and infant feeding beyond 8 weeks?
"NG248_Gambling-related harms: identification, assessment and management & Overview",NG248,What are the recommended approaches for identifying and managing gambling-related harms in healthcare settings?
"NG248_Recommendations: 1.1 Case identification, initial support, referral and assessment - Part 1",NG248,How should healthcare professionals ask about gambling during patient assessments to identify gambling-related harms?
"NG248_Recommendations: 1.1 Case identification, initial support, referral and assessment - Part 2",NG248,What questions should I ask to identify gambling-related harms in patients at risk?
"NG248_Recommendations: 1.1 Case identification, initial support, referral and assessment - Part 3",NG248,What are effective strategies for supporting someone with gambling-related harms and preventing suicide?
"NG248_Recommendations: 1.1 Case identification, initial support, referral and assessment - Part 4",NG248,What are the recommended referral pathways and support options for individuals experiencing gambling-related harms?
"NG248_Recommendations: 1.1 Case identification, initial support, referral and assessment - Part 5",NG248,What are the recommended methods for assessing gambling behavior and related harms in clinical practice?
NG248_Recommendations: 1.2 Information and support - Part 1,NG248,What information and support should be provided to individuals experiencing gambling-related harms?
NG248_Recommendations: 1.2 Information and support - Part 2,NG248,How can I access support and practical help for gambling-related harms?
NG248_Recommendations: 1.3 Models of care and service delivery - Part 1,NG248,What are the recommended models of care for gambling treatment and support services?
NG248_Recommendations: 1.3 Models of care and service delivery - Part 2,NG248,What are the recommended approaches for providing multidisciplinary support for gambling-related harms?
NG248_Recommendations: 1.4 Improving access to treatment - Part 1,NG248,What strategies can healthcare providers use to reduce stigma and improve access to gambling treatment services?
NG248_Recommendations: 1.4 Improving access to treatment - Part 2,NG248,What are the recommended ways to improve access and engagement in gambling treatment services?
NG248_Recommendations: 1.5 Treatment of gambling-related harms - Part 1,NG248,What are the recommended approaches for treating gambling-related harms?
NG248_Recommendations: 1.5 Treatment of gambling-related harms - Part 2,NG248,What are recommended psychological interventions for gambling-related harms according to NICE guidelines?
NG248_Recommendations: 1.5 Treatment of gambling-related harms - Part 3,NG248,What are the recommended psychological and pharmacological treatments for gambling addiction?
NG248_Recommendations: 1.5 Treatment of gambling-related harms - Part 4,NG248,How should naltrexone be initiated and monitored for treating gambling disorder?
NG248_Recommendations: 1.6 Relapse and ongoing support,NG248,What strategies are recommended to prevent relapse in gambling treatment?
NG248_Recommendations: 1.7 Interventions and support for families and affected others,NG248,What support and interventions are recommended for families and affected others of individuals with gambling-related harms?
NG248_Terms used in this guideline,NG248,What are the definitions of gambling-related harms and affected others according to NICE guidelines?
NG248_Recommendations for research: Key recommendations for research - Part 1,NG248,What is the effectiveness of care models for gambling-related harms?
NG248_Recommendations for research: Key recommendations for research - Part 2,NG248,What is the effectiveness of pharmacological and psychological interventions for treating gambling-related harms?
NG248_Recommendations for research: Other recommendations for research - Part 1,NG248,What are the most effective psychological or psychosocial interventions for treating gambling-related harms?
NG248_Recommendations for research: Other recommendations for research - Part 2,NG248,What is the effectiveness of pharmacological treatments for gambling-related harms in people with comorbid mental health conditions?
NG248_Rationale and impact: Asking about gambling,NG248,What are the recommended questions for healthcare professionals to ask about gambling in primary care settings?
NG248_Rationale and impact: Initial support for people experiencing gambling-related harms,NG248,What are the recommended initial support strategies for individuals experiencing gambling-related harms?
NG248_Rationale and impact: Referral and triage,NG248,What are the recommended procedures for referral and triage in gambling-related harm treatment?
NG248_Rationale and impact: Assessment of gambling that harms,NG248,What are the recommended tools for assessing gambling-related harms in treatment services?
NG248_Rationale and impact: Information and support - Part 1,NG248,What information and support are recommended for people experiencing gambling-related harms?
NG248_Rationale and impact: Information and support - Part 2,NG248,What are the best ways to access information and support for gambling-related harms?
NG248_Rationale and impact: Models of care and service delivery - Part 1,NG248,What are the recommended models of care and service delivery for gambling treatment and support services?
NG248_Rationale and impact: Models of care and service delivery - Part 2,NG248,What are the NICE recommendations for commissioning and delivering gambling treatment and support services?
NG248_Rationale and impact: Improving access to treatment - Part 1,NG248,What strategies can improve access to gambling treatment services and reduce stigma?
NG248_Rationale and impact: Improving access to treatment - Part 2,NG248,How can gambling treatment services be made more accessible and acceptable for women and people with mental health issues?
NG248_Rationale and impact: Treatment of gambling-related harms: general principles and peer support - Part 1,NG248,What are the principles for treating gambling-related harms and how does peer support fit into the approach?
NG248_Rationale and impact: Treatment of gambling-related harms: general principles and peer support - Part 2,NG248,What are the recommended competencies for practitioners delivering gambling treatment services?
NG248_Rationale and impact: Psychological interventions for gambling that harms - Part 1,NG248,What are the recommended psychological interventions for treating gambling-related harm?
NG248_Rationale and impact: Psychological interventions for gambling that harms - Part 2,NG248,What are the current NICE recommendations for psychological treatments for gambling-related harms?
NG248_Rationale and impact: Pharmacological treatment of gambling that harms - Part 1,NG248,What are the recommended pharmacological treatments for gambling harm?
NG248_Rationale and impact: Pharmacological treatment of gambling that harms - Part 2,NG248,Should naltrexone be used as a first-line treatment for gambling disorder or only after psychological therapies have failed?
NG248_Rationale and impact: Relapse and ongoing support,NG248,What are effective strategies for relapse prevention in gambling treatment?
NG248_Rationale and impact: Interventions for families and affected others,NG248,What interventions are effective for supporting families and affected others of individuals with gambling-related harms?
NG248_Context - Part 1,NG248,What are the recommended interventions for problem gambling and its mental health impacts?
NG248_Context - Part 2,NG248,What are the health and social impacts of gambling-related harms?
NG248_Context - Part 3,NG248,What are the recommended approaches for identifying and treating gambling-related harm in adults?
NG249_Falls: assessment and prevention in older people and in people 50 and over at higher risk & Recommendations: 1.1 Identifying people at risk of falls for further assessment - Part 1,NG249,What are the recommended methods for assessing fall risk in older adults and people over 50 at higher risk?
NG249_Recommendations: 1.1 Identifying people at risk of falls for further assessment - Part 2,NG249,What are the recommended assessments and interventions for falls prevention in older adults?
NG249_Recommendations: 1.1 Identifying people at risk of falls for further assessment - Part 3,NG249,What are the recommended assessments for identifying fall risk in hospital and residential care patients?
NG249_Recommendations: 1.2 Comprehensive falls assessment - Part 1,NG249,What does a comprehensive falls assessment include for older adults in community and care settings?
NG249_Recommendations: 1.2 Comprehensive falls assessment - Part 2,NG249,What are the recommended assessments and interventions to reduce fall risk in older adults?
NG249_Recommendations: 1.3 Interventions to reduce the risk of falls - Part 1,NG249,What are effective interventions to reduce fall risk in community-dwelling adults?
NG249_Recommendations: 1.3 Interventions to reduce the risk of falls - Part 2,NG249,What are the recommended interventions to prevent falls in community-dwelling adults at risk?
NG249_Recommendations: 1.3 Interventions to reduce the risk of falls - Part 3,NG249,What are effective interventions for preventing falls in hospital inpatient settings?
NG249_Recommendations: 1.3 Interventions to reduce the risk of falls - Part 4,NG249,What strategies can help prevent falls in hospital and residential care settings?
NG249_Recommendations: 1.3 Interventions to reduce the risk of falls - Part 5,NG249,What are the recommended strategies for reducing fall risk in older adults taking psychotropic medications?
NG249_Recommendations: 1.4 Maximising ongoing participation in falls prevention interventions,NG249,How can I improve participation in falls prevention exercise programs?
NG249_Recommendations: 1.5 Information and education for people receiving falls assessment or interventions - Part 1,NG249,What information and education should be provided to patients receiving falls assessment or interventions in different healthcare settings?
NG249_Recommendations: 1.5 Information and education for people receiving falls assessment or interventions - Part 2,NG249,What are the best practices for preventing falls and promoting safety for patients and residents in hospital and residential care settings?
NG249_Recommendations: Terms used in this guideline,NG249,What is a comprehensive falls assessment and how is it conducted in community settings?
NG249_Recommendations for research: Key recommendations for research - Part 1,NG249,What is the effectiveness of supervision interventions in reducing falls among hospital inpatients?
NG249_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG249,What are the most effective interventions to prevent falls in care home residents with dementia?
NG249_Rationale and impact: Falls risk prediction tools,NG249,Are falls risk assessment tools effective in predicting falls in hospital and community settings?
NG249_Rationale and impact: Identifying people at risk of falls for further assessment,NG249,What are the recommended methods for assessing fall risk in community settings?
NG249_Rationale and impact: Comprehensive falls assessment,NG249,What are the recommended components of a comprehensive falls assessment for older adults?
NG249_Rationale and impact: Interventions to reduce the risk of falls – community settings - Part 1,NG249,What interventions are recommended to reduce fall risk in community-dwelling older adults?
NG249_Rationale and impact: Interventions to reduce the risk of falls – community settings - Part 2,NG249,What are the recommended practices for home hazard assessments and fall prevention interventions?
NG249_Rationale and impact: Interventions to reduce the risk of falls – community settings - Part 3,NG249,What are the recommended interventions for fall prevention in people with gait or balance impairments?
NG249_Rationale and impact: Interventions to reduce the risk of falls – hospital inpatient settings,NG249,What are effective interventions to reduce falls risk among hospital inpatients?
NG249_Rationale and impact: Interventions to reduce the risk of falls – residential care settings - Part 1,NG249,What are the recommended strategies for medication review to reduce fall risk in residential care settings?
NG249_Rationale and impact: Interventions to reduce the risk of falls – residential care settings - Part 2,NG249,What are effective exercise interventions to reduce falls in residents of care homes?
NG249_Rationale and impact: Maximising ongoing participation in falls prevention interventions,NG249,How can participation and adherence to falls prevention exercise programs be maximized in community settings?
NG249_Rationale and impact: Information and education for people receiving falls assessment or interventions - Part 1,NG249,What information and education should be provided to people at risk of falls to promote safety and empowerment?
NG249_Rationale and impact: Information and education for people receiving falls assessment or interventions - Part 2,NG249,What information should be provided to older adults about safe exercise and falls prevention in different care settings?
NG249_Context,NG249,What are the best strategies for fall prevention in adults aged 50 and over at risk of falling?
NG24_Blood transfusion & Overview & Recommendations: Blood transfusion algorithm,NG24,What are the guidelines for assessing and managing blood transfusions in adults and children over 1 year old?
NG24_Recommendations: 1.1 Alternatives to blood transfusion for patients having surgery,NG24,What are the recommended alternatives to blood transfusion for patients undergoing surgery according to NICE guidelines?
NG24_Recommendations: 1.2 Red blood cells,NG24,What are the recommended transfusion thresholds and targets for red blood cell transfusions in different patient groups?
NG24_Recommendations: 1.3 Platelets - Part 1,NG24,What are the recommended platelet transfusion thresholds for patients with thrombocytopenia?
NG24_Recommendations: 1.3 Platelets - Part 2,NG24,When should prophylactic platelet transfusions be given to patients undergoing surgery or invasive procedures?
NG24_Recommendations: 1.4 Fresh frozen plasma,NG24,When should fresh frozen plasma be used for patients with abnormal coagulation and bleeding risk?
NG24_Recommendations: 1.5 Cryoprecipitate,NG24,When should cryoprecipitate be used to treat bleeding or prepare for surgery based on fibrinogen levels?
NG24_Recommendations: 1.6 Prothrombin complex concentrate & Recommendations: 1.7 Patient safety,NG24,What are the indications for using prothrombin complex concentrate to reverse warfarin anticoagulation in emergency situations?
NG24_Recommendations: 1.8 Patient information & Recommendations: 1.9 Blood transfusions for patients with acute upper gastrointestinal bleeding,NG24,What information should be provided to patients about blood transfusions and their risks?
NG24_Recommendations: Terms used in this guideline - Part 1,NG24,What is the definition of major haemorrhage in adults and children according to NICE guidelines?
NG24_Recommendations: Terms used in this guideline - Part 2 & Recommendations for research: 1 Red blood cell transfusion thresholds for patients with chronic cardiovascular disease,NG24,What are the recommended red blood cell transfusion thresholds for patients with chronic cardiovascular disease?
NG24_Recommendations for research: 2 Electronic Decision Support & Recommendations for research: 3 Post‑operative cell salvage for patients having cardiac surgery with a significant risk of post‑operative blood loss,NG24,What is the clinical and cost effectiveness of electronic decision support systems in reducing inappropriate blood transfusions?
NG24_Recommendations for research: 4 Fresh frozen plasma for patients with abnormal haemostasis who are having invasive procedures or surgery,NG24,What is the most effective dose of fresh frozen plasma to prevent bleeding in patients with abnormal haemostasis undergoing invasive procedures?
NG24_Implementation: getting started: The challenge: Using tranexamic acid as an alternative to transfusion,NG24,How can hospitals improve the use of tranexamic acid to reduce blood transfusions during surgery?
NG24_Implementation: getting started: The challenge: using electronic patient identification systems - Part 1,NG24,What are the benefits of using electronic patient identification systems during blood transfusions?
NG24_Implementation: getting started: The challenge: using electronic patient identification systems - Part 2,NG24,How can hospitals effectively implement blood transfusion safety systems with support from patient safety representatives and the Hospital Transfusion Committee?
NG24_Context - Part 1,NG24,What are the best practices for ensuring patient safety during blood transfusions?
NG24_Context - Part 2,NG24,What are the principles and recommendations for appropriate blood transfusion practice in adults?
NG25_Preterm labour and birth & Overview,NG25,What are the recommended interventions to prevent or delay preterm labour in women with singleton pregnancies?
NG25_Recommendations: 1.1 Information and support - Part 1,NG25,What information and support should be provided to women at risk of preterm labour?
NG25_Recommendations: 1.1 Information and support - Part 2 & Recommendations: Care of women at risk of preterm labour,NG25,What are the recommended care strategies for women at risk of preterm labour?
NG25_Recommendations: 1.2 Prophylactic vaginal progesterone and prophylactic cervical cerclage - Part 1,NG25,What are the options for preventing preterm birth in women with a short cervix or previous preterm delivery?
NG25_Recommendations: 1.2 Prophylactic vaginal progesterone and prophylactic cervical cerclage - Part 2,NG25,What are the guidelines for using vaginal progesterone and cervical cerclage to prevent preterm birth?
NG25_Recommendations: 1.3 Diagnosing preterm prelabour rupture of membranes (P-PROM),NG25,How is preterm prelabour rupture of membranes (P-PROM) diagnosed and managed according to NICE guidelines?
NG25_Recommendations: 1.4 Antenatal prophylactic antibiotics for women with P-PROM & Recommendations: 1.5 Identifying infection in women with P-PROM,NG25,What is the recommended antibiotic prophylaxis for women with preterm prelabour rupture of membranes?
NG25_Recommendations: 1.6 Emergency cervical cerclage & Recommendations: Care of women with suspected or established preterm labour,NG25,When should emergency cervical cerclage be considered for women with cervical dilation and exposed membranes?
NG25_Recommendations: 1.7 Diagnosing preterm labour for women with intact membranes - Part 1,NG25,What are the recommended clinical assessment and diagnostic tests for preterm labour in women with intact membranes?
NG25_Recommendations: 1.7 Diagnosing preterm labour for women with intact membranes - Part 2,NG25,When should fetal fibronectin testing be used to assess preterm labour risk in women 30 weeks pregnant or more?
NG25_Recommendations: 1.8 Tocolysis,NG25,What are the recommended medications for tocolysis in preterm labor according to NICE guidelines?
NG25_Recommendations: 1.9 Maternal corticosteroids - Part 1,NG25,What are the guidelines for administering maternal corticosteroids in preterm labor between 22 and 36 weeks of pregnancy?
NG25_Recommendations: 1.9 Maternal corticosteroids - Part 2,NG25,What are the recommendations for administering repeat courses of maternal corticosteroids in preterm birth?
NG25_Recommendations: 1.10 Magnesium sulfate for neuroprotection - Part 1,NG25,What are the guidelines for using magnesium sulfate for neuroprotection in preterm labor between 23 and 24 weeks?
NG25_Recommendations: 1.10 Magnesium sulfate for neuroprotection - Part 2 & Recommendations: 1.11 Intrapartum antibiotics,NG25,What are the recommendations for using intravenous magnesium sulfate for fetal neuroprotection in preterm labor?
NG25_Recommendations: 1.12 Fetal monitoring - Part 1,NG25,What are the recommended fetal monitoring options for women in preterm labor?
NG25_Recommendations: 1.12 Fetal monitoring - Part 2,NG25,What are the guidelines for using fetal scalp electrodes and fetal blood sampling in pregnancies before 34 weeks?
NG25_Recommendations: 1.13 Mode of birth & Recommendations: 1.14 Timing of cord clamping for preterm babies (born vaginally or by caesarean birth),NG25,What are the considerations for choosing caesarean versus vaginal birth in preterm labour?
NG25_Recommendations: Terms used in this guideline,NG25,What is the definition of suspected preterm labour according to NICE guidelines?
NG25_Recommendations for research: Key recommendations for research - Part 1,NG25,What is the evidence for using vaginal progesterone to prevent preterm birth in women with a short cervix but no other risk factors?
NG25_Recommendations for research: Key recommendations for research - Part 2,NG25,What is the recommended timing for starting and stopping prophylactic vaginal progesterone to prevent preterm birth?
NG25_Recommendations for research: Other recommendations for research,NG25,What is the diagnostic accuracy of serial C-reactive protein testing for detecting chorioamnionitis in women with preterm prelabour rupture of membranes?
NG25_Rationale and impact: Prophylactic vaginal progesterone - Part 1,NG25,What are the recommendations for using vaginal progesterone to prevent preterm birth in women with a history of preterm birth or a short cervix?
NG25_Rationale and impact: Prophylactic vaginal progesterone - Part 2,NG25,What are the criteria for administering vaginal progesterone to women at risk of preterm birth?
NG25_Rationale and impact: Emergency cervical cerclage,NG25,What are the guidelines for suture removal after emergency cervical cerclage?
NG25_Rationale and impact: Repeat courses of maternal corticosteroids,NG25,What are the guidelines for repeat courses of maternal corticosteroids in preterm labor?
NG25_Context,NG25,What are the best management strategies for women presenting with symptoms of preterm labour?
"NG26_Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care & Overview",NG26,What are the best practices for assessing attachment difficulties in children adopted from care?
NG26_Key priorities for implementation: Principles of care in all contexts & Key priorities for implementation: Supporting children with attachment difficulties in schools,NG26,What are the principles for providing equitable attachment support to children and young people in care settings?
NG26_Key priorities for implementation: Assessing attachment difficulties in children and young people in all health and social care settings & Key priorities for implementation: Interventions for children and young people on the edge of care,NG26,How can health and social care professionals assess and support attachment difficulties in children and young people?
"NG26_Key priorities for implementation: Interventions for attachment difficulties in children and young people in the care system, subject to special guardianship orders and adopted from care",NG26,What interventions are recommended for attachment difficulties in children and young people in care with special guardianship or adoption?
NG26_Recommendations: 1.1 Principles of care in all contexts - Part 1,NG26,What are the principles for ensuring consistent and equitable care for children and young people with attachment difficulties in care settings?
NG26_Recommendations: 1.1 Principles of care in all contexts - Part 2,NG26,What are the recommended practices for arranging kinship placements and supporting children with attachment difficulties?
NG26_Recommendations: 1.1 Principles of care in all contexts - Part 3,NG26,What are the recommended practices for supporting children and young people through adoption and safeguarding their personal history?
NG26_Recommendations: 1.2 Supporting children and young people with attachment difficulties in schools and other education settings (including early years) - Part 1,NG26,What training should school staff receive to support children with attachment difficulties?
NG26_Recommendations: 1.2 Supporting children and young people with attachment difficulties in schools and other education settings (including early years) - Part 2,NG26,What training should designated teachers have to support children in care with attachment and mental health difficulties?
NG26_Recommendations: 1.3 Assessing attachment difficulties in children and young people in all health and social care settings - Part 2,NG26,What are the recommended assessment tools for diagnosing attachment difficulties in children and young people?
NG26_Recommendations: 1.4 Interventions for attachment difficulties in children and young people on the edge of care - Part 1,NG26,What are effective interventions for attachment difficulties in children on the edge of care?
NG26_Recommendations: 1.4 Interventions for attachment difficulties in children and young people on the edge of care - Part 2,NG26,What are the recommended interventions to improve parental sensitivity and attachment in at-risk preschool children?
NG26_Recommendations: 1.4 Interventions for attachment difficulties in children and young people on the edge of care - Part 3,NG26,What are effective interventions for improving attachment in children and young people at risk of maltreatment?
"NG26_Recommendations: 1.5 Interventions for attachment difficulties in children and young people in the care system, subject to special guardianship orders and adopted from care - Part 1",NG26,What interventions are recommended for attachment difficulties in children and young people in the care system?
"NG26_Recommendations: 1.5 Interventions for attachment difficulties in children and young people in the care system, subject to special guardianship orders and adopted from care - Part 2",NG26,What are recommended group-based training programs for foster carers and young people in care to support social skills and stability?
NG26_Recommendations: 1.6 Interventions for attachment difficulties in children and young people in residential care,NG26,What interventions are recommended for attachment difficulties in children and young people in residential care?
NG26_Recommendations: Terms used in this guideline - Part 1,NG26,What is the definition of maltreatment in the context of child care guidelines?
NG26_Recommendations: Terms used in this guideline - Part 2,NG26,What is the role of a personal adviser in supporting children leaving care?
NG26_Recommendations for research: 1 Screening assessment tools,NG26,What are validated screening assessment tools for attachment and sensitivity in children and young people?
NG26_Recommendations for research: 2 Attachment-focused interventions,NG26,What are effective attachment-focused interventions for children over 5 years and young people in care or adoption?
NG26_Recommendations for research: 3 Evaluation of extensively used interventions & Recommendations for research: 4 Interventions in a school setting,NG26,What evidence is available for the effectiveness of attachment-based interventions in school settings for children and young people in care or at risk of care?
NG26_Recommendations for research: 5 Relationship between attachment difficulties and complex trauma,NG26,What is the prevalence of attachment difficulties and complex trauma among children in the care system in the UK?
NG26_Children's attachment implementation: getting started: The challenge: stability of care - Part 1,NG26,How can care placement stability be improved for children in the care system?
NG26_Children's attachment implementation: getting started: The challenge: stability of care - Part 2,NG26,What factors influence placement stability and how can local authorities improve care placement options for children in the care system?
NG26_Children's attachment implementation: getting started: The challenge: stability of care - Part 3,NG26,How can children's services improve placement stability and continuity of relationships for children in care?
NG26_Children's attachment implementation: getting started: The challenge: assessing attachment difficulties,NG26,What are the recommended methods and training for assessing attachment difficulties in children and young people?
NG26_Children's attachment implementation: getting started: The challenge: using video feedback programmes - Part 1,NG26,What training is available for health and social care workers to deliver video feedback programmes for improving parent-child attachment?
NG26_Children's attachment implementation: getting started: The challenge: using video feedback programmes - Part 2,NG26,What are the best practices for obtaining consent and ensuring confidentiality when using video feedback in clinical interventions?
NG26_Context - Part 1,NG26,What are the signs of insecure attachment in children and how can they be addressed?
NG26_Context - Part 2,NG26,What are the recommended approaches for assessing and treating attachment difficulties in children and young people in care settings?
NG27_Transition between inpatient hospital settings and community or care home settings for adults with social care needs & Overview,NG27,What are the recommended practices for transitioning adults with social care needs between hospital and community or care home settings?
NG27_Recommendations: 1.1 Overarching principles of care and support during transition,NG27,What are the principles for person-centred care and effective communication during healthcare transitions?
NG27_Recommendations: 1.2 Before admission to hospital,NG27,What should health and social care practitioners include in a care plan to prevent hospital admission for adults with social care needs?
NG27_Recommendations: 1.3 Admission to hospital - Part 1,NG27,What are the recommended communication procedures for hospital admission and information sharing?
NG27_Recommendations: 1.3 Admission to hospital - Part 2,NG27,What are the recommended practices for assessing and supporting older people with complex needs during hospital admission?
NG27_Recommendations: 1.4 During hospital stay,NG27,What are the recommended practices for multidisciplinary assessments and patient communication during hospital stays?
NG27_Recommendations: 1.5 Discharge from hospital - Part 1,NG27,What are the key principles for effective discharge planning from hospital?
NG27_Recommendations: 1.5 Discharge from hospital - Part 2,NG27,How can hospitals ensure safe and coordinated discharge planning for older patients with complex needs?
NG27_Recommendations: 1.5 Discharge from hospital - Part 3,NG27,"What are the recommended practices for discharge planning and support for patients with end-of-life, mental health, or social care needs?"
NG27_Recommendations: 1.5 Discharge from hospital - Part 4,NG27,What support and training should be provided to carers of stroke patients after hospital discharge?
NG27_Recommendations: 1.6 Supporting infrastructure,NG27,What community and social care services are recommended to support patients after hospital discharge?
NG27_Recommendations: 1.7 Training and development,NG27,What training should hospital staff receive on the discharge process and community care coordination?
NG27_Recommendations: Terms used in this guideline,NG27,What is the role of a community-based multidisciplinary team in caring for older people with complex needs?
NG27_Implementation: getting started: The challenge: improving understanding of person‑centred care - Part 1,NG27,What are the key principles of person-centred care in hospital and community settings?
NG27_Implementation: getting started: The challenge: improving understanding of person‑centred care - Part 2,NG27,What strategies can health and social care professionals use to improve personalised care and support during care transitions?
NG27_Implementation: getting started: The challenge: ensuring health and social care practitioners communicate effectively - Part 1,NG27,How can health and social care practitioners improve communication and information sharing to enhance patient outcomes?
NG27_Implementation: getting started: The challenge: ensuring health and social care practitioners communicate effectively - Part 2,NG27,What are best practices for health and social care managers to improve information sharing and use technology effectively?
"NG27_Implementation: getting started: The challenge: changing how community‑ and hospital‑based staff work together to ensure coordinated, person‑centred support - Part 1",NG27,How can community and hospital staff improve coordination to support person-centred care during patient transitions?
"NG27_Implementation: getting started: The challenge: changing how community‑ and hospital‑based staff work together to ensure coordinated, person‑centred support - Part 2",NG27,What strategies can health and social care managers use to improve integrated working and reduce delayed transfers of care?
NG27_Context,NG27,How can hospital discharge processes be improved to ensure timely and coordinated care transitions for adults with social care needs?
NG27_Recommendations for research: 1 Training for hospital and social care practitioners,NG27,What is the impact of hospital discharge training for health and social care practitioners on patient outcomes and readmission rates?
NG27_Recommendations for research: 2 Self‑management support for people with mental health difficulties,NG27,What interventions support self-management for people with mental health difficulties during hospital transitions and how effective are they?
NG27_Recommendations for research: 3 Mental health interventions to support discharge from general inpatient hospital settings,NG27,What are the cost-effective mental health interventions to support discharge for patients with dementia or delirium from general hospital inpatient settings?
NG27_Recommendations for research: 4 Geriatric assessment and care & Recommendations for research: 5 Assessment at home to improve hospital discharge success rates,NG27,What is the cost-effectiveness of comprehensive geriatric assessment and care in specialist units compared to general wards?
NG27_Glossary,NG27,What is included in an advance care plan and how is it used in patient care?
NG28_Type 2 diabetes in adults: management & Overview & Recommendations: 1.1 Individualised care,NG28,What is the recommended approach to individualised management of type 2 diabetes in adults?
NG28_Recommendations: 1.2 Education,NG28,What are the key components of effective structured education programs for adults with type 2 diabetes?
NG28_Recommendations: 1.3 Dietary advice and bariatric surgery - Part 1,NG28,What are the recommended dietary advice and weight loss targets for adults with type 2 diabetes?
NG28_Recommendations: 1.3 Dietary advice and bariatric surgery - Part 2 & Recommendations: 1.4 Diagnosing and managing hypertension,NG28,What dietary advice should be given to adults with type 2 diabetes regarding carbohydrate intake and sucrose consumption?
NG28_Recommendations: 1.5 Antiplatelet therapy,NG28,Should antiplatelet therapy be offered to adults with type 2 diabetes without cardiovascular disease?
NG28_Recommendations: 1.6 Blood glucose management - Part 1,NG28,What are the recommended HbA1c measurement intervals and targets for adults with type 2 diabetes?
NG28_Recommendations: 1.6 Blood glucose management - Part 2,NG28,What is the recommended HbA1c target for adults with type 2 diabetes on different treatment regimens?
NG28_Recommendations: 1.6 Blood glucose management - Part 3,NG28,What are the NICE recommendations for self-monitoring of capillary blood glucose in adults with type 2 diabetes?
NG28_Recommendations: 1.6 Blood glucose management - Part 4,NG28,When should intermittently scanned continuous glucose monitoring be offered to adults with type 2 diabetes on insulin?
NG28_Recommendations: 1.6 Blood glucose management - Part 5,NG28,What are the recommended options for blood glucose monitoring in adults with type 2 diabetes who cannot or do not want to use continuous glucose monitoring devices?
NG28_Recommendations: 1.7 Drug treatment - Part 1,NG28,What are the recommended drug treatment options and considerations for managing type 2 diabetes?
NG28_Recommendations: 1.7 Drug treatment - Part 2,NG28,What is the recommended first-line drug treatment for adults with type 2 diabetes?
NG28_Recommendations: 1.7 Drug treatment - Part 3,NG28,What is the recommended approach for initiating dual therapy with metformin and SGLT2 inhibitors in adults with type 2 diabetes?
NG28_Recommendations: 1.7 Drug treatment - Part 4,NG28,What precautions should be taken before prescribing SGLT2 inhibitors to prevent diabetic ketoacidosis?
NG28_Recommendations: 1.7 Drug treatment - Part 5,NG28,When should SGLT2 inhibitors be continued or discontinued in adults with type 2 diabetes based on age and cardiovascular risk?
NG28_Recommendations: 1.7 Drug treatment - Part 6,NG28,What are the recommended combination therapy options for adults with type 2 diabetes when monotherapy fails to control HbA1c?
NG28_Recommendations: 1.7 Drug treatment - Part 7,NG28,When should insulin-based treatment be considered for adults with type 2 diabetes who do not tolerate dual oral therapy?
NG28_Recommendations: 1.7 Drug treatment - Part 8,NG28,What are the recommended approaches for initiating insulin therapy in adults with type 2 diabetes?
NG28_Recommendations: 1.7 Drug treatment - Part 9,NG28,When should insulin detemir or insulin glargine be considered as alternatives to NPH insulin in adults with type 2 diabetes?
NG28_Recommendations: 1.7 Drug treatment - Part 10,NG28,What is the recommended approach for choosing a biosimilar insulin to minimize medication errors?
NG28_Recommendations: 1.8 Managing complications - Part 1,NG28,What are the recommended management strategies for periodontitis in adults with type 2 diabetes?
NG28_Recommendations: 1.8 Managing complications - Part 2,NG28,What are the recommended treatments and safety considerations for managing gastroparesis-related vomiting in adults with type 2 diabetes?
NG28_Recommendations: 1.8 Managing complications - Part 3,NG28,What are the recommended management strategies for autonomic neuropathy in adults with type 2 diabetes?
NG28_Recommendations: 1.8 Managing complications - Part 4,NG28,When should SGLT2 inhibitors be prescribed for adults with type 2 diabetes and chronic kidney disease?
NG28_Recommendations: 1.8 Managing complications - Part 5,NG28,What are the recommended management and referral procedures for erectile dysfunction and eye disease in people with type 2 diabetes?
NG28_Recommendations: Terms used in this guideline - Part 1,NG28,What is the definition of atherosclerotic cardiovascular disease according to NICE guidelines?
NG28_Recommendations: Terms used in this guideline - Part 2,NG28,What are the risk factors for cardiovascular disease according to NICE guidelines?
NG28_Recommendations for research: Key recommendations for research - Part 1,NG28,What are the effects of stopping or switching drug treatments for blood glucose control in adults with type 2 diabetes?
NG28_Recommendations for research: Key recommendations for research - Part 2,NG28,What blood glucose lowering therapies are recommended when blood glucose is not controlled by three oral antidiabetic drugs or insulin combinations?
NG28_Recommendations for research: Other recommendations for research - Part 1,NG28,What is the effectiveness of SGLT2 inhibitors in different ethnic groups with type 2 diabetes and chronic kidney disease?
NG28_Recommendations for research: Other recommendations for research - Part 2,NG28,What are the long-term effects of blood glucose lowering agents like SGLT2 inhibitors and DPP-4 inhibitors in adults with type 2 diabetes?
NG28_Rationale and impact: Continuous glucose monitoring - Part 1,NG28,What are the indications for using continuous glucose monitoring in adults with type 2 diabetes on insulin?
NG28_Rationale and impact: Continuous glucose monitoring - Part 2,NG28,When should continuous glucose monitoring be offered to people with diabetes?
NG28_Rationale and impact: Continuous glucose monitoring - Part 3,NG28,What are the recommendations for using continuous glucose monitoring in people with type 2 diabetes?
NG28_Rationale and impact: First-line drug treatment - Part 1,NG28,What are the first-line drug treatment options for people with type 2 diabetes at different levels of cardiovascular risk?
NG28_Rationale and impact: First-line drug treatment - Part 2,NG28,Which SGLT2 inhibitors are recommended for cardiovascular benefit in diabetes management?
NG28_Rationale and impact: First-line drug treatment - Part 3,NG28,What is the recommended first-line treatment for adults with type 2 diabetes and established cardiovascular disease?
NG28_Rationale and impact: First-line drug treatment - Part 4,NG28,What are the safety considerations and risk factors for using SGLT2 inhibitors in adults with type 2 diabetes?
NG28_Rationale and impact: First-line drug treatment - Part 5,NG28,What are the current NICE recommendations for using SGLT2 inhibitors with metformin in the treatment of type 2 diabetes and cardiovascular disease?
NG28_Rationale and impact: Reviewing drug treatments - Part 1,NG28,How should I review and optimise existing drug treatments for type 2 diabetes?
NG28_Rationale and impact: Reviewing drug treatments - Part 2,NG28,When should SGLT2 inhibitors be considered for patients with type 2 diabetes and high cardiovascular risk or heart failure?
NG28_Rationale and impact: Treatment options if further interventions are needed - Part 1,NG28,What are the recommended treatment options for patients requiring further intervention in cardiovascular disease management according to NICE guidelines?
NG28_Rationale and impact: Treatment options if further interventions are needed - Part 2,NG28,What are the current NICE recommendations for the use of GLP‑1 mimetics in blood glucose management?
NG28_Rationale and impact: Long-acting insulin & Rationale and impact: SGLT2 inhibitors for adults with type 2 diabetes and chronic kidney disease,NG28,What are the NICE recommendations for using SGLT2 inhibitors in adults with type 2 diabetes and chronic kidney disease?
NG28_Rationale and impact: SGLT2 inhibitors for adults with type 2 diabetes and chronic kidney disease - Part 1,NG28,What are the recommendations for using SGLT2 inhibitors in adults with type 2 diabetes and chronic kidney disease?
NG28_Rationale and impact: SGLT2 inhibitors for adults with type 2 diabetes and chronic kidney disease - Part 2,NG28,What is the evidence for using SGLT2 inhibitors in patients with a urine albumin-to-creatinine ratio below 3 mg/mol?
NG28_Rationale and impact: Periodontitis,NG28,What is the importance of routine oral health reviews for people with diabetes to prevent periodontitis?
NG28_Context,NG28,What are the recommended management strategies for type 2 diabetes in adults?
NG29_Intravenous fluid therapy in children and young people in hospital & Overview & Key priorities for implementation: Assessment and monitoring,NG29,What are the best practices for assessing and monitoring intravenous fluid therapy in children and young people in hospital?
NG29_Key priorities for implementation: Fluid resuscitation & Key priorities for implementation: Routine maintenance,NG29,"What are the recommended practices for IV fluid resuscitation and maintenance in children, young people, and neonates according to NICE guidelines?"
NG29_Key priorities for implementation: Replacement and redistribution & Key priorities for implementation: Managing hyponatraemia that develops during intravenous fluid therapy,NG29,How should hyponatraemia be managed in children receiving intravenous fluids?
NG29_Recommendations: 1.1 Principles and protocols for intravenous fluid therapy,NG29,What are the principles and protocols for administering intravenous fluid therapy in children and young people?
NG29_Recommendations: 1.2 Assessment and monitoring - Part 1,NG29,How should IV fluid and electrolyte needs be assessed and monitored in neonates and children?
NG29_Recommendations: 1.2 Assessment and monitoring - Part 2,NG29,What are the clinical features used to diagnose dehydration and hypovolaemic shock in children?
NG29_Recommendations: 1.4 Routine maintenance - Part 1,NG29,How do I calculate routine maintenance IV fluid rates for children and neonates according to NICE guidelines?
NG29_Recommendations: 1.4 Routine maintenance - Part 2,NG29,What are the recommended IV fluid compositions for term neonates aged over 8 days?
NG29_Recommendations: 1.5 Replacement and redistribution,NG29,"What are the recommended IV fluid options for fluid replacement and redistribution in neonates, children, and young people?"
NG29_Recommendations: 1.6 Managing hypernatraemia that develops during intravenous fluid therapy,NG29,How should hypernatraemia be managed during intravenous fluid therapy in neonates and children?
NG29_Recommendations: 1.8 Training and education - Part 1,NG29,What are the recommended types of isotonic crystalloids for intravenous fluid therapy in children and young people?
NG29_Recommendations: 1.8 Training and education - Part 2 & Recommendations: Terms used in this guideline,NG29,What are the recommended types of isotonic and hypotonic fluids containing sodium for intravenous hydration?
NG29_Recommendations for research: 1 Complications of IV fluid therapy & Recommendations for research: 2 Glucose concentration,NG29,What are the recommended glucose concentrations in IV fluids for children and young people of different ages?
NG29_Recommendations for research: 3 Fluid balance charts,NG29,Does using a standardized national fluid balance chart reduce complications and prescription errors in children receiving IV fluids?
NG29_Recommendations for research: 4 Training and education of healthcare professionals,NG29,How does training healthcare professionals in pediatric IV fluid management impact complication rates and healthcare costs?
NG29_Rationale,NG29,What are current NICE recommendations for intravenous fluids for routine maintenance in term neonates in the first 48 hours?
NG29_Intravenous fluid therapy in children and young people in hospital implementation: getting started: The challenge: assessment and monitoring,NG29,What are the recommended components to include on fluid balance and prescription charts for children receiving IV fluid therapy?
NG29_Intravenous fluid therapy in children and young people in hospital implementation: getting started: The challenge: identifying fluids for fluid resuscitation and routine maintenance,NG29,What are the recommended intravenous fluids for fluid resuscitation and routine maintenance in clinical practice?
NG29_Intravenous fluid therapy in children and young people in hospital implementation: getting started: The challenge: lack of training and education in IV fluid therapy in children and young people & Intravenous fluid therapy in children and young people in hospital implementation: getting started: Need more help?,NG29,What training and education resources are available to improve IV fluid management in children and young people?
NG29_Context - Part 1,NG29,What are the recommended practices for administering intravenous fluid therapy in children and young people?
NG29_Context - Part 2,NG29,What are the recommended practices for prescribing and monitoring IV fluids in children and young people?
NG2_Bladder cancer: diagnosis and management & Overview,NG2,What are the recommended diagnostic and management strategies for bladder cancer in adults?
NG2_Introduction,NG2,What are the recommended diagnostic and management strategies for suspected bladder cancer in adults?
NG2_Key priorities for implementation: Information and support for people with bladder cancer & Key priorities for implementation: Diagnosing and staging bladder cancer,NG2,What are the recommended diagnostic and staging procedures for bladder cancer according to NICE guidelines?
NG2_Key priorities for implementation: Treating non-muscle-invasive bladder cancer,NG2,What are the treatment options and prognostic factors for high-risk non-muscle-invasive bladder cancer?
NG2_Key priorities for implementation: Follow-up after treatment for non-muscle-invasive bladder cancer & Key priorities for implementation: Treating muscle-invasive bladder cancer,NG2,What are the follow-up recommendations for low-risk non-muscle-invasive bladder cancer after initial treatment?
NG2_Recommendations: 1.1 Information and support for people with bladder cancer - Part 1,NG2,What support and information should be provided to patients with bladder cancer?
NG2_Recommendations: 1.1 Information and support for people with bladder cancer - Part 2,NG2,What are the recommended strategies for managing complications and providing support for patients undergoing bladder cancer treatment?
NG2_Recommendations: 1.2 Diagnosing and staging bladder cancer - Part 1,NG2,What are the recommended diagnostic procedures and staging methods for bladder cancer?
NG2_Recommendations: 1.2 Diagnosing and staging bladder cancer - Part 2,NG2,When should repeat TURBT be performed for bladder cancer staging?
NG2_Recommendations: 1.3 Treating non-muscle-invasive bladder cancer - Part 1,NG2,What are the risk classification criteria and prognostic markers for non-muscle-invasive bladder cancer?
NG2_Recommendations: 1.3 Treating non-muscle-invasive bladder cancer - Part 2,NG2,What are the treatment options and considerations for high-risk non-muscle-invasive bladder cancer?
NG2_Recommendations: 1.3 Treating non-muscle-invasive bladder cancer - Part 3,NG2,What are the indications for intravesical BCG therapy in non-muscle-invasive bladder cancer?
NG2_Recommendations: 1.4 Follow-up after treatment for non-muscle-invasive bladder cancer - Part 1,NG2,What is the recommended follow-up protocol for low-risk non-muscle-invasive bladder cancer?
NG2_Recommendations: 1.4 Follow-up after treatment for non-muscle-invasive bladder cancer - Part 2,NG2,What is the recommended follow-up schedule for patients with intermediate-risk non-muscle-invasive bladder cancer?
NG2_Recommendations: 1.5 Treating muscle-invasive bladder cancer - Part 1,NG2,What are the treatment options and considerations for muscle-invasive bladder cancer?
NG2_Recommendations: 1.5 Treating muscle-invasive bladder cancer - Part 2,NG2,What are the recommended management strategies for bladder cancer patients undergoing radical cystectomy and radiotherapy?
NG2_Recommendations: 1.6 Follow-up after treatment for muscle-invasive bladder cancer,NG2,What is the recommended follow-up protocol after radical cystectomy or radiotherapy for muscle-invasive bladder cancer?
NG2_Recommendations: 1.7 Managing locally advanced or metastatic muscle-invasive bladder cancer - Part 1,NG2,What are the recommended first- and second-line chemotherapy options for locally advanced or metastatic bladder cancer?
NG2_Recommendations: 1.7 Managing locally advanced or metastatic muscle-invasive bladder cancer - Part 2,NG2,What are the recommended second-line chemotherapy options for advanced urothelial bladder cancer?
NG2_Recommendations: 1.7 Managing locally advanced or metastatic muscle-invasive bladder cancer - Part 3,NG2,What are the recommended management options for symptoms and complications in advanced bladder cancer?
NG2_Recommendations: 1.8 Specialist palliative care for people with incurable bladder cancer,NG2,What are the recommended palliative care approaches for patients with incurable bladder cancer?
NG2_Recommendations for research: 1 Patient satisfaction,NG2,What are the factors contributing to low patient satisfaction in bladder cancer care?
NG2_Recommendations for research: 2 BCG or primary cystectomy in high-risk non-muscle-invasive bladder cancer,NG2,Is primary radical cystectomy more effective than BCG immunotherapy for high-risk non-muscle-invasive bladder cancer in terms of survival and quality of life?
NG2_Recommendations for research: 3 Follow-up of high-risk non-muscle-invasive bladder cancer & Recommendations for research: 4 Biomarkers for treatment selection,NG2,What is the most effective follow-up schedule for high-risk non-muscle-invasive bladder cancer to detect progression and minimize patient discomfort?
NG2_Recommendations for research: 5 Follow-up after radical treatment for organ-confined muscle-invasive bladder cancer,NG2,What is the effectiveness of symptom-based follow-up compared to scheduled follow-up after radical treatment for organ-confined muscle-invasive bladder cancer?
NG30_Oral health promotion: general dental practice & Overview & Recommendations: 1.1 Oral health advice given by dentists and dental care professionals,NG30,What oral health advice should dental professionals provide to patients during dental examinations?
NG30_Recommendations: 1.2 How dentists and dental care professionals can adopt a patient‑centred approach,NG30,How can dental care professionals adopt a patient-centred approach to improve oral health outcomes?
NG30_Recommendations: Terms used in this guideline & Implementation: getting started: 1 The challenge: delivering patient‑centred oral health advice - Part 1,NG30,What training is recommended for dental professionals to deliver patient-centred oral health advice?
NG30_Implementation: getting started: 1 The challenge: delivering patient‑centred oral health advice - Part 2,NG30,What are effective communication strategies for dental professionals to promote oral health and address health inequalities?
NG30_Implementation: getting started: 2 The challenge: developing new incentives for general dental teams to improve people's oral health,NG30,How can dental practices be incentivized to adopt a more preventive approach to improving oral health?
NG30_Context - Part 1,NG30,What are the recommended intervals for oral health reviews according to NICE guidelines?
NG30_Context - Part 2,NG30,What are the current NHS guidelines for preventing tooth decay in children and adults?
NG30_Recommendations for research: 2 Reducing use of emergency dental care & 4 more sections,NG30,What strategies are effective in encouraging people to use general dental services regularly instead of emergency dental care?
NG31_Care of dying adults in the last days of life & Overview,NG31,What are the best practices for managing symptoms and maintaining dignity in the last days of life for adults?
NG31_Context - Part 1,NG31,What are the recommended practices for caring for adults in the last 2 to 3 days of life in NHS settings?
NG31_Context - Part 2,NG31,How can healthcare professionals support communication and decision-making for patients in the last days of life with fluctuating mental capacity?
NG31_Recommendations: 1.1 Recognising when a person may be in the last days of life,NG31,What are the key clinical signs and assessments to recognise when a person is entering the last days of life?
NG31_Recommendations: 1.2 Communication,NG31,What are the recommended communication strategies for discussing prognosis with adults at the end of life?
NG31_Recommendations: 1.3 Shared decision-making - Part 1,NG31,What are best practices for shared decision-making in end-of-life care?
NG31_Recommendations: 1.3 Shared decision-making - Part 2,NG31,How should healthcare professionals develop and update individualised care plans for dying patients?
NG31_Recommendations: 1.4 Maintaining hydration - Part 1,NG31,What are the best practices for maintaining hydration and managing dry mouth in dying patients?
NG31_Recommendations: 1.4 Maintaining hydration - Part 2,NG31,What factors should be considered when deciding to initiate or continue clinically assisted hydration in a dying person?
NG31_Recommendations: 1.5 Pharmacological interventions - Part 1,NG31,What are the recommended pharmacological interventions for managing pain in end-of-life care?
NG31_Recommendations: 1.5 Pharmacological interventions - Part 2,NG31,"What are the recommended non-pharmacological approaches for managing pain, breathlessness, and nausea in people in the last days of life?"
NG31_Recommendations: 1.5 Pharmacological interventions - Part 3,NG31,What are the recommended treatments for nausea and vomiting in the last days of life?
NG31_Recommendations: 1.5 Pharmacological interventions - Part 4,NG31,What are the recommended pharmacological and non-pharmacological options for managing noisy respiratory secretions at the end of life?
NG31_Recommendations: 1.6 Anticipatory prescribing,NG31,How should anticipatory prescribing be managed for symptom control in the last days of life?
NG31_Implementation: getting started: The challenge: recognising dying and communicating effectively - Part 1,NG31,What are the key signs to recognise when a person is in the last days of life?
NG31_Implementation: getting started: The challenge: recognising dying and communicating effectively - Part 2,NG31,What training and resources are available for healthcare professionals to improve end-of-life communication skills?
NG31_Implementation: getting started: The challenge: maintaining hydration,NG31,What are the best practices for providing clinically assisted hydration to dying patients?
NG31_Implementation: getting started: The challenge: anticipatory prescribing & Implementation: getting started: Need more help?,NG31,What are best practices for anticipatory prescribing at the end of life?
NG31_Recommendations for research: 1 Recognising dying,NG31,How can multidisciplinary team interventions reduce uncertainty in recognising the last days of life to improve communication and decision-making?
NG31_Recommendations for research: 2 Agitation and delirium,NG31,What are the best strategies for managing delirium and agitation in dying patients without causing excessive sedation or shortening life?
NG31_Recommendations for research: 3 Noisy respiratory secretions,NG31,What is the effectiveness of antisecretory anti-muscarinic drugs compared to nursing interventions alone in reducing noisy respiratory secretions at the end of life?
NG31_Recommendations for research: 4 Anticipatory prescribing,NG31,What is the clinical and cost effectiveness of anticipatory prescribing for end-of-life symptom management in patients at home?
NG32_Older people: independence and mental wellbeing & Overview & Recommendations: 1.1 Principles of good practice,NG32,What strategies can support older people's independence and mental wellbeing?
NG32_Recommendations: 1.2 Group-based activities & Recommendations: 1.3 One-to-one activities,NG32,What are effective group and one-to-one activities to support social engagement and mental wellbeing in older adults?
NG32_Recommendations: 1.4 Volunteering & Recommendations: 1.5 Identifying those most at risk of a decline in their independence and mental wellbeing,NG32,What strategies can encourage older adults to participate in volunteering to improve their mental wellbeing and social engagement?
NG32_Recommendations: Terms used in this guideline,NG32,What is the definition of age-related disability according to NICE guidelines?
NG32_Implementation: getting started: Area 1: planning and partnerships,NG32,How can local partnerships effectively promote older people's mental wellbeing and independence?
NG32_Implementation: getting started: Area 2: local assets and needs assessment,NG32,What are effective methods for conducting a local assets and needs assessment for older people's health and wellbeing?
NG32_Implementation: getting started: Area 3: local coordination,NG32,What are the best practices for implementing local coordinator roles to support older people's independence and wellbeing?
NG32_Implementation: getting started: Area 4: getting older people involved in activities - Part 1,NG32,How can community organizations improve access and engagement for older people in social activities?
NG32_Implementation: getting started: Area 4: getting older people involved in activities - Part 2,NG32,What strategies can improve access and participation of older people in community activities and volunteering programs?
NG32_Implementation: getting started: Area 5: training,NG32,What training is recommended for healthcare staff to identify and support older people at risk of decline in independence and mental wellbeing?
NG32_Implementation: getting started: Area 6: evaluating effectiveness - Part 1,NG32,How can local authorities and service providers effectively evaluate the impact and cost-effectiveness of services for older people?
NG32_Implementation: getting started: Area 6: evaluating effectiveness - Part 2 & Implementation: getting started: Need more help?,NG32,How can community projects effectively evaluate their impact on older people's mental wellbeing and social engagement?
NG32_Recommendations for research: Key recommendations for research - Part 1,NG32,What are the most effective and cost-effective activity-based interventions to support independence and mental wellbeing in at-risk older people in the UK?
NG32_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG32,What are the most effective and cost-effective interventions to promote independence and mental wellbeing among older adults in the UK?
NG32_Context - Part 1,NG32,What are the healthcare considerations for managing age-related disabilities in people aged 85 and older?
NG32_Context - Part 2,NG32,What strategies can help reduce loneliness and improve mental wellbeing in older adults?
NG33_Tuberculosis & Overview,NG33,What are the recommended strategies for preventing and managing latent and active tuberculosis in adults and children?
NG33_Recommendations: 1.1 Preventing TB - Part 1,NG33,What are effective strategies for raising awareness of tuberculosis among healthcare professionals and high-risk populations?
NG33_Recommendations: 1.1 Preventing TB - Part 2,NG33,What are the recommended strategies for raising awareness of tuberculosis among high-risk and underserved groups?
NG33_Recommendations: 1.1 Preventing TB - Part 3,NG33,What are the recommended strategies for increasing public awareness of tuberculosis through multidisciplinary teams and community engagement?
NG33_Recommendations: 1.1 Preventing TB - Part 4,NG33,What are the recommended strategies for identifying and vaccinating infants and high-risk groups against tuberculosis according to NICE guidelines?
NG33_Recommendations: 1.1 Preventing TB - Part 5,NG33,What are the NICE guidelines for BCG vaccination in neonates and children at risk of tuberculosis?
NG33_Recommendations: 1.1 Preventing TB - Part 6,NG33,What are the recommended strategies to improve BCG vaccination uptake among eligible groups in primary care settings?
NG33_Recommendations: 1.1 Preventing TB - Part 7,NG33,What are the NICE guidelines for BCG vaccination and TB screening for healthcare workers in the NHS?
NG33_Recommendations: 1.1 Preventing TB - Part 8,NG33,What are the recommended TB screening and vaccination protocols for healthcare workers in the NHS?
NG33_Recommendations: 1.1 Preventing TB - Part 9,NG33,How should NHS trusts screen healthcare workers for tuberculosis in non-NHS settings?
NG33_Recommendations: 1.2 Latent TB - Part 1,NG33,What are the recommended methods for diagnosing latent tuberculosis in immunocompromised adults?
NG33_Recommendations: 1.2 Latent TB - Part 2,NG33,What are the recommended TB screening and testing procedures for immunocompromised adults and healthcare workers?
NG33_Recommendations: 1.2 Latent TB - Part 3,NG33,What are the recommended screening and testing procedures for latent TB in healthcare workers and children?
NG33_Recommendations: 1.2 Latent TB - Part 4,NG33,When should a child be tested for latent tuberculosis infection after exposure and how is the testing interpreted?
NG33_Recommendations: 1.2 Latent TB - Part 5,NG33,What is the recommended testing approach for diagnosing latent tuberculosis infection in children and young people?
NG33_Recommendations: 1.2 Latent TB - Part 6,NG33,What are the criteria for TB testing and management in people who misuse substances or are in high-incidence areas?
NG33_Recommendations: 1.2 Latent TB - Part 7,NG33,What are the recommended drug regimens for latent tuberculosis infection in people under 65 with HIV?
NG33_Recommendations: 1.2 Latent TB - Part 8,NG33,What are the recommendations for managing latent tuberculosis in adults and children?
NG33_Recommendations: 1.3 Active TB - Part 1,NG33,What are the recommended diagnostic procedures for active pulmonary tuberculosis?
NG33_Recommendations: 1.3 Active TB - Part 2,NG33,When should rapid nucleic acid amplification tests be used for diagnosing tuberculosis in children and young people?
NG33_Recommendations: 1.3 Active TB - Part 3,NG33,What are the recommended diagnostic approaches for tuberculosis in children and extrapulmonary TB?
NG33_Recommendations: 1.3 Active TB - Part 4,NG33,What are the recommended investigations for diagnosing pleural and central nervous system tuberculosis?
NG33_Recommendations: 1.3 Active TB - Part 5,NG33,What are the recommended investigations for diagnosing central nervous system and extrapulmonary tuberculosis?
NG33_Recommendations: 1.3 Active TB - Part 6,NG33,What are the recommended site-specific investigations for diagnosing gastrointestinal tuberculosis?
NG33_Recommendations: 1.3 Active TB - Part 7,NG33,What are the recommended site-specific investigations for diagnosing disseminated tuberculosis?
NG33_Recommendations: 1.3 Active TB - Part 8,NG33,What is the recommended process for referring suspected active TB cases from emergency departments to multidisciplinary TB teams?
NG33_Recommendations: 1.3 Active TB - Part 9,NG33,What is the recommended treatment regimen for active tuberculosis in adults and children?
NG33_Recommendations: 1.3 Active TB - Part 10,NG33,What are the recommended investigations and treatment approaches for disseminated or miliary tuberculosis with neurological symptoms?
NG33_Recommendations: 1.3 Active TB - Part 11,NG33,What is the recommended duration of treatment for HIV-associated TB with and without central nervous system involvement?
NG33_Recommendations: 1.3 Active TB - Part 12,NG33,What is the recommended use of corticosteroids in children with active central nervous system tuberculosis?
NG33_Recommendations: 1.4 Drug resistant TB - Part 1,NG33,What are the recommended diagnostic and treatment strategies for multidrug-resistant tuberculosis?
NG33_Recommendations: 1.4 Drug resistant TB - Part 2,NG33,What are the recommended management strategies for suspected multidrug-resistant tuberculosis when initial rapid nucleic acid amplification tests are negative?
NG33_Recommendations: 1.4 Drug resistant TB - Part 3,NG33,What are the recommended treatment options for drug-resistant tuberculosis without central nervous system involvement?
NG33_Recommendations: 1.5 Infection control - Part 1,NG33,What are the infection control measures for managing tuberculosis in healthcare settings?
NG33_Recommendations: 1.5 Infection control - Part 2,NG33,What are the infection control precautions for managing pulmonary tuberculosis in hospital settings?
NG33_Recommendations: 1.5 Infection control - Part 3,NG33,What are the criteria for discharging patients with pulmonary TB from hospital?
NG33_Recommendations: 1.5 Infection control - Part 4,NG33,What are the infection control measures for managing multidrug-resistant tuberculosis in hospital settings?
NG33_Recommendations: 1.6 Case finding - Part 1,NG33,What are the recommended contact tracing procedures for tuberculosis?
NG33_Recommendations: 1.6 Case finding - Part 2,NG33,"What are the recommendations for contact tracing and informing contacts of people with TB in different settings such as workplaces, aircraft, and schools?"
NG33_Recommendations: 1.6 Case finding - Part 3,NG33,What are the recommended procedures for contact tracing and infection control in schools and healthcare settings after a TB diagnosis?
NG33_Recommendations: 1.6 Case finding - Part 4,NG33,What are the criteria for contact tracing and testing for tuberculosis in healthcare settings?
NG33_Recommendations: 1.6 Case finding - Part 5,NG33,What are the recommended approaches for screening and managing latent tuberculosis infection in vulnerable migrant populations and homeless individuals?
NG33_Recommendations: 1.6 Case finding - Part 6,NG33,What strategies can improve TB screening attendance among homeless people and substance users?
NG33_Recommendations: 1.6 Case finding - Part 7,NG33,What are the recommended procedures for contact investigations in active tuberculosis cases?
NG33_Recommendations: 1.6 Case finding - Part 8,NG33,What are the recommended procedures for managing tuberculosis incidents in congregate settings?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 1",NG33,What strategies are recommended to improve adherence to tuberculosis treatment?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 2",NG33,What are the key considerations for re-evaluating directly observed therapy in tuberculosis treatment?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 3",NG33,What strategies can help improve adherence to tuberculosis treatment plans?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 4",NG33,What are the recommended strategies for managing tuberculosis treatment in prisons and detention centers?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 5",NG33,What are the recommended procedures for ensuring continuity of TB treatment in prisoners and detainees after release?
"NG33_Recommendations: 1.7 Adherence, treatment completion and follow‑up - Part 6",NG33,What are the recommended monitoring and follow-up procedures for patients on anti-TB drugs with low hepatotoxicity and risk of cutaneous reactions?
NG33_Recommendations: 1.8 Service organisation - Part 1,NG33,What are the recommended organizational structures for TB prevention and control services?
NG33_Recommendations: 1.8 Service organisation - Part 2,NG33,What are the key components of effective tuberculosis prevention and control programmes according to NICE guidelines?
NG33_Recommendations: 1.8 Service organisation - Part 3,NG33,What are the recommended roles and responsibilities of TB control boards in developing and overseeing TB prevention and control programs?
NG33_Recommendations: 1.8 Service organisation - Part 4,NG33,What are the recommended strategies for managing multidrug-resistant tuberculosis and ensuring effective TB control in low-incidence areas?
NG33_Recommendations: 1.8 Service organisation - Part 5,NG33,What are the recommended strategies for managing multidrug-resistant tuberculosis within regional networks?
NG33_Recommendations: 1.8 Service organisation - Part 6,NG33,What are the recommended organizational and support factors for delivering effective tuberculosis services in rural areas?
NG33_Recommendations: 1.8 Service organisation - Part 7,NG33,What are the recommended methods for monitoring treatment outcomes and contact investigations in tuberculosis control programs?
NG33_Recommendations: 1.8 Service organisation - Part 8,NG33,What are the recommended practices for cohort review meetings and multidisciplinary team involvement in tuberculosis management?
NG33_Recommendations: 1.8 Service organisation - Part 9,NG33,What are the recommended resources and multidisciplinary team requirements for managing latent and active tuberculosis in underserved populations?
NG33_Recommendations: 1.8 Service organisation - Part 10,NG33,What are the recommended staffing ratios and non-clinical roles for tuberculosis services according to NICE guidelines?
NG33_Recommendations: 1.8 Service organisation - Part 11,NG33,What are the recommended referral pathways and processes for rapid-access tuberculosis services?
NG33_Recommendations: 1.8 Service organisation - Part 12,NG33,What are the recommended procedures for managing active tuberculosis in prisons and detention centers?
NG33_Recommendations: 1.8 Service organisation - Part 13,NG33,What are the recommended procedures for providing accommodation to homeless people with active pulmonary TB who are ineligible for public funds?
NG33_Recommendations: Terms used in this guideline - Part 1,NG33,What is the process for contact investigation and contact tracing in tuberculosis management?
NG33_Recommendations: Terms used in this guideline - Part 2,NG33,What are the recommended management strategies for disseminated and extrapulmonary tuberculosis?
NG33_Recommendations: Terms used in this guideline - Part 3,NG33,What are the criteria for defining homelessness in TB control guidelines?
NG33_Recommendations: Terms used in this guideline - Part 4,NG33,What are the criteria for defining someone as lost to follow-up in TB management?
NG33_Recommendations: Terms used in this guideline - Part 5,NG33,What are the criteria for identifying under-served groups and children at risk of tuberculosis?
NG33_Context - Part 1,NG33,What are the recommended treatments for latent and active tuberculosis?
NG33_Context - Part 2,NG33,What are the current strategies for reducing tuberculosis incidence and improving TB control in England?
NG33_Recommendations for research: 1 Universal compared with risk‑based approach to using rapid diagnostic tests & Recommendations for research: 2 Diagnosis in children,NG33,What is the clinical and cost-effectiveness of universal versus risk-based use of rapid nucleic acid amplification tests for suspected tuberculosis?
NG33_Recommendations for research: 3 Treating isoniazid‑resistant TB & Recommendations for research: 4 Impact of infection control measures on quality of life,NG33,What is the most effective treatment regimen for isoniazid-resistant tuberculosis to reduce mortality and morbidity?
NG33_Recommendations for research: 5 Treatment interruptions caused by adverse events (specifically hepatotoxicity),NG33,What is the most effective approach to re-establishing TB treatment after hepatotoxicity-induced interruption to reduce mortality and relapse?
NG34_Sunlight exposure: risks and benefits & Overview,NG34,What are the recommended strategies for communicating the risks and benefits of sunlight exposure to prevent skin cancer and vitamin D deficiency?
NG34_Recommendations: At‑risk groups,NG34,Which groups are at increased risk of skin damage and skin cancer from sun exposure?
NG34_Recommendations: Message content,NG34,What are the recommended strategies for healthcare professionals to advise patients on safe sunlight exposure and skin cancer prevention?
NG34_Recommendations: Mass media campaigns - Part 1,NG34,What are the key recommendations for public health campaigns on sunlight exposure?
NG34_Recommendations: Mass media campaigns - Part 2,NG34,How can public health campaigns effectively promote sun safety and skin cancer prevention across diverse communities?
NG34_Recommendations: Local strategic approach,NG34,How can local authorities develop a multiagency strategy to promote safe sunlight exposure and skin health?
NG34_Recommendations: Terms used in this guideline,NG34,What is considered low vitamin D status and how is it measured?
NG34_Supporting information for practitioners: Risks and benefits of sunlight exposure - Part 1,NG34,How can I safely enjoy sunlight exposure to improve vitamin D levels while minimizing the risk of sunburn?
NG34_Supporting information for practitioners: Risks and benefits of sunlight exposure - Part 2,NG34,What are the recommended sun protection measures for children and young people in the UK during the summer months?
NG34_Supporting information for practitioners: Risks and benefits of sunlight exposure - Part 3,NG34,What are the recommended vitamin D supplement guidelines for children under 5 and people with different skin types?
NG34_Supporting information for practitioners: Risks and benefits of sunlight exposure - Part 4,NG34,What are the recommended practices for applying and reapplying sunscreen to prevent sunburn and skin damage?
NG34_Who should take action? & Implementation: Approaches in different settings - Part 1,NG34,What are the recommended policies for managing sun exposure risks in workplaces and educational settings?
NG34_Implementation: Approaches in different settings - Part 2,NG34,How can early years and school staff develop effective policies to protect children from sunburn and skin damage?
NG34_Implementation: Approaches in different settings - Part 3 & Implementation: Training,NG34,What are the recommended practices for managing sunlight exposure in workplaces and care settings according to NICE guidelines?
NG34_Implementation: Evaluation & Implementation: Need more help?,NG34,How can public health agencies evaluate the effectiveness of policies and campaigns to improve sunlight exposure awareness?
NG34_Implementation: Other guidance and policies,NG34,What other policies and guidance should be considered alongside this NICE guideline?
NG34_Context - Part 1,NG34,What are the recommendations for balancing sun exposure to maintain vitamin D levels while minimizing skin cancer risk?
NG34_Context - Part 2,NG34,What are the recommended sun protection strategies to prevent skin cancer and photoaging?
NG34_Context - Part 3,NG34,What are the recommended strategies for preventing vitamin D deficiency in at-risk populations?
NG34_Context - Part 4,NG34,What are the current NICE guidelines for the diagnosis and management of melanoma and non-melanoma skin cancers?
NG34_Recommendations for research,NG34,What are effective strategies for communicating the risks and benefits of sunlight exposure to different populations?
NG35_Myeloma: diagnosis and management & Overview,NG35,What are the recommended diagnostic and management strategies for myeloma according to NICE guideline NG35?
NG35_Recommendations: 1.1 Communication and support,NG35,What information and support should be provided to patients with myeloma and their families throughout their treatment journey?
NG35_Recommendations: 1.2 Laboratory investigations,NG35,What are the recommended laboratory investigations for diagnosing and assessing prognosis in suspected myeloma?
NG35_Recommendations: 1.3 Imaging investigations,NG35,What are the recommended imaging investigations for diagnosing and assessing myeloma?
NG35_Recommendations: 1.4 Service organisation,NG35,What are the recommended service organization and multidisciplinary team requirements for myeloma treatment facilities?
NG35_Recommendations: 1.5 Managing newly diagnosed myeloma - Part 1,NG35,What are the recommended first-line treatments for newly diagnosed multiple myeloma according to NICE guidelines?
NG35_Recommendations: 1.5 Managing newly diagnosed myeloma - Part 2,NG35,What are the criteria for assessing suitability for autologous and allogeneic stem cell transplantation in multiple myeloma?
NG35_Recommendations: 1.6 Managing acute renal disease caused by myeloma,NG35,What is the recommended treatment for acute renal disease caused by myeloma?
NG35_Recommendations: 1.7 Preventing and managing bone disease - Part 1,NG35,What are the recommended treatments for preventing and managing bone disease in people with myeloma?
NG35_Recommendations: 1.7 Preventing and managing bone disease - Part 2,NG35,What are the recommended treatments for spinal bone disease in myeloma patients according to NICE guidelines?
NG35_Recommendations: 1.8 Preventing and managing complications - Part 1,NG35,What are the recommended strategies for preventing infections and managing peripheral neuropathy in people with myeloma?
NG35_Recommendations: 1.8 Preventing and managing complications - Part 2,NG35,How should neuropathy be managed in myeloma patients receiving chemotherapy?
NG35_Recommendations: 1.9 Monitoring,NG35,How should patients with smouldering myeloma be monitored and what tests are recommended?
NG35_Recommendations: 1.10 Managing relapsed myeloma - Part 1,NG35,"What are the NICE recommendations for managing relapsed multiple myeloma, including the use of bortezomib monotherapy and second autologous stem cell transplantation?"
NG35_Recommendations: 1.10 Managing relapsed myeloma - Part 2,NG35,What are the current NICE recommendations for treating relapsed multiple myeloma with lenalidomide and pomalidomide?
NG35_Recommendations: Terms used in this guideline & Recommendations for research: 1 Diagnostic investigations to predict treatment outcomes & Recommendations for research: 2 Imaging investigations for newly diagnosed myeloma,NG35,What are the prognostic and imaging investigations recommended for diagnosing and predicting treatment outcomes in smouldering myeloma?
NG35_Recommendations for research: 3 Management of smouldering myeloma,NG35,"What are the most effective risk stratification methods for smouldering myeloma using FISH, molecular technologies, and other diagnostic tools?"
NG35_Recommendations for research: 4 Allogeneic stem cell transplantation & Recommendations for research: 5 Bisphosphonates for the prevention of bone disease,NG35,What is the comparative effectiveness of autologous–allogeneic versus autologous stem cell transplantation in multiple myeloma treatment?
NG35_Context,NG35,What are the recommended diagnostic and management strategies for myeloma and related plasma cell disorders?
NG36_Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over & Overview,NG36,What are the recommended assessment and management strategies for upper aerodigestive tract cancers in adults?
NG36_Recommendations: 1.1 Information and support,NG36,What information and support should be provided to people with upper aerodigestive tract cancer and their carers?
NG36_Recommendations: 1.2 Investigation,NG36,What are the recommended investigations for diagnosing and staging neck lumps suspected of being upper aerodigestive tract cancer?
NG36_Recommendations: 1.3 Treatment of early stage disease,NG36,What are the recommended treatment options for early-stage squamous cell carcinoma of the larynx and oropharynx?
NG36_Recommendations: 1.4 Treatment of advanced disease - Part 1,NG36,What are the recommended treatment options for T3 and T4a squamous cell carcinoma of the larynx?
NG36_Recommendations: 1.4 Treatment of advanced disease - Part 2,NG36,What are the recommended treatment options for patients with upper aerodigestive tract cancer who are unsuitable for chemotherapy?
NG36_Recommendations: 1.5 Response assessment after chemoradiotherapy,NG36,What is the recommended timing for FDG PET-CT scans after chemoradiotherapy for head and neck cancers?
NG36_Recommendations: 1.6 HPV‑related disease,NG36,What are the recommended methods for testing HPV status in oropharyngeal squamous cell carcinomas?
NG36_Recommendations: 1.7 Less common upper aerodigestive tract cancers,NG36,What are the recommended treatments for locally advanced nasopharyngeal carcinoma?
NG36_Recommendations: 1.8 Optimising rehabilitation and function,NG36,What are the recommended strategies for optimizing rehabilitation and function in patients undergoing head and neck cancer treatment?
NG36_Recommendations: 1.9 Follow‑up of people with cancer of the upper aerodigestive tract and management of osteoradionecrosis,NG36,What are the recommended follow-up protocols for detecting recurrence in patients with upper aerodigestive tract cancer?
NG36_Recommendations for research: Key recommendations for research - Part 1,NG36,What is the recommended management of nodal metastasis in nasopharynx cancer following chemoradiotherapy?
NG36_Recommendations for research: Key recommendations for research - Part 2,NG36,What is the evidence for using FDG PET-CT to guide follow-up in head and neck cancer patients after chemoradiotherapy?
NG36_Recommendations for research: Other recommendations for research - Part 1,NG36,What clinical factors influence the decision to provide enteral nutrition to patients with upper aerodigestive tract cancer?
NG36_Recommendations for research: Other recommendations for research - Part 2,NG36,What are the recommended follow-up strategies for patients who are disease-free after treatment for upper aerodigestive tract cancer?
NG36_Rationale and impact: Response assessment after chemoradiotherapy - Part 1,NG36,When should FDG PET-CT be used to assess response after chemoradiotherapy in head and neck cancer patients?
NG36_Rationale and impact: Response assessment after chemoradiotherapy - Part 2,NG36,How should FDG PET-CT scans be timed and interpreted in the management of head and neck cancer after chemoradiotherapy?
NG36_Context,NG36,What are the recommended investigations and management strategies for suspected upper aerodigestive tract cancers?
NG37_Fractures (complex): assessment and management & Overview,NG37,What are the recommended assessment and management protocols for complex pelvic and ankle fractures in emergency care?
NG37_Recommendations: 1.1 Pre-hospital settings - Part 1,NG37,What are the recommended pre-hospital management strategies for open fractures and pelvic trauma?
NG37_Recommendations: 1.1 Pre-hospital settings - Part 2,NG37,What is the recommended pre-hospital management for open fractures and suspected long bone fractures?
NG37_Recommendations: 1.2 Hospital settings - Part 1,NG37,What are the recommended management strategies for vascular injury and compartment syndrome in hospital settings?
NG37_Recommendations: 1.2 Hospital settings - Part 2,NG37,When should a pelvic binder be removed in patients with pelvic fractures?
NG37_Recommendations: 1.2 Hospital settings - Part 3,NG37,When should pelvic binders be removed in patients with suspected pelvic fractures?
NG37_Recommendations: 1.2 Hospital settings - Part 4,NG37,What are the recommended timing and multidisciplinary approaches for surgical management of open fractures?
NG37_Recommendations: 1.2 Hospital settings - Part 5,NG37,What is the recommended timing for surgery in adults with displaced pilon fractures?
NG37_Recommendations: 1.3 Documentation,NG37,What are the recommended documentation practices for trauma care and open fracture wounds according to NICE guidelines?
"NG37_Recommendations: 1.4 Information and support for patients, family members and carers - Part 1",NG37,"What are the recommended ways to communicate with patients, family members, and carers following major trauma?"
"NG37_Recommendations: 1.4 Information and support for patients, family members and carers - Part 2",NG37,What information should be provided to patients and their families about fracture management and transfer procedures?
NG37_Recommendations: 1.5 Training and skills & Recommendations: Terms used in this guideline,NG37,What training and skills are recommended for healthcare professionals managing trauma and fracture care?
NG37_Recommendations for research: 1 Temporary dressings for up to 72 hours between wound excision and definitive soft tissue cover,NG37,"What is the most effective temporary dressing for open fractures after wound excision to minimize dressing changes, bedding changes, pain, and nursing time?"
NG37_Recommendations for research: 2 Cystourethrogram,NG37,How accurate is the initial contrast-enhanced CT scan in detecting bladder injuries after trauma?
NG37_Recommendations for research: 3 Pilon fractures,NG37,What is the most effective method of fixation for adult closed pilon fractures in terms of clinical outcomes and complication rates at 2 years?
NG37_Rationale and impact: Temporary dressings for open fractures after wound excision but before definitive soft tissue cover - Part 1,NG37,What are the recommended temporary dressings for open fractures after wound excision before definitive soft tissue coverage?
NG37_Rationale and impact: Temporary dressings for open fractures after wound excision but before definitive soft tissue cover - Part 2,NG37,What are the recommended temporary dressings for open fractures before definitive soft tissue coverage?
NG37_Context,NG37,What are the recommended management strategies for complex fractures in adults and children?
NG38_Fractures (non-complex): assessment and management & Overview,NG38,What is the recommended assessment and management for non-complex fractures in emergency and orthopaedic settings?
NG38_Recommendations: 1.1 Initial pain management and immobilisation - Part 1,NG38,What are the recommended initial pain management strategies for adults with suspected long bone fractures?
NG38_Recommendations: 1.1 Initial pain management and immobilisation - Part 2 & Recommendations: 1.2 Acute stage assessment and diagnostic imaging,NG38,What is the recommended initial pain management for children under 16 with suspected long bone fractures?
NG38_Recommendations: 1.3 Management in the emergency department & Recommendations: 1.4 Ongoing orthopaedic management - Part 1,NG38,What are the recommended management strategies for distal radius fractures in adults and children according to NICE guidelines?
NG38_Recommendations: 1.4 Ongoing orthopaedic management - Part 2,NG38,What are the recommended treatments for distal femoral fractures after surgery?
NG38_Recommendations: 1.5 Documentation,NG38,What are the recommended documentation practices for trauma patients with fractures according to NICE guidelines?
"NG38_Recommendations: 1.6 Information and support for patients, family members and carers - Part 1",NG38,"What are the recommended practices for communicating with patients, family members, and carers in major trauma services?"
"NG38_Recommendations: 1.6 Information and support for patients, family members and carers - Part 2 & Recommendations: 1.7 Non-accidental injury",NG38,What information should be provided to patients with fractures about their treatment outcomes and rehabilitation?
NG38_Recommendations: 1.8 Training and skills & 3 more sections,NG38,What training and skills are recommended for healthcare professionals managing trauma and fracture care?
NG38_Recommendations for research: 4 Treatment of torus fractures,NG38,What is the effectiveness of no treatment versus splints or bandages for managing torus fractures of the distal radius in children?
NG38_Context,NG38,What is the recommended management for non‑complex fractures in adults and children?
NG39_Major trauma: assessment and initial management & Overview & Recommendations: 1.1 Immediate destination after injury,NG39,What is the recommended destination for patients with major trauma?
NG39_Recommendations: 1.2 Airway management in pre‑hospital and hospital settings,NG39,What are the recommended airway management strategies for major trauma patients in pre-hospital settings?
NG39_Recommendations: 1.3 Management of chest trauma in pre‑hospital settings,NG39,What are the recommended pre-hospital management strategies for chest trauma and pneumothorax?
NG39_Recommendations: 1.4 Management of chest trauma in hospital settings,NG39,What are the recommended imaging and management procedures for chest trauma and tension pneumothorax in hospital settings?
NG39_Recommendations: 1.5 Management of haemorrhage in pre‑hospital and hospital settings - Part 1,NG39,"What are the recommended management strategies for haemorrhage in trauma patients, including use of dressings, tourniquets, pelvic binders, and anticoagulant reversal?"
NG39_Recommendations: 1.5 Management of haemorrhage in pre‑hospital and hospital settings - Part 2,NG39,What are the recommended procedures for managing major trauma with active bleeding in children under 16?
NG39_Recommendations: 1.5 Management of haemorrhage in pre‑hospital and hospital settings - Part 3,NG39,What are the recommended fluid resuscitation strategies for patients with haemorrhagic shock and traumatic brain injury?
NG39_Recommendations: 1.5 Management of haemorrhage in pre‑hospital and hospital settings - Part 4 & Recommendations: 1.6 Reducing heat loss in pre‑hospital and hospital settings,NG39,When should I perform a CT scan in patients with suspected major trauma and haemorrhage?
NG39_Recommendations: 1.7 Pain management in pre‑hospital and hospital settings,NG39,What are the recommended pain assessment and management strategies for patients with major trauma in pre-hospital and hospital settings?
NG39_Recommendations: 1.8 Documentation in pre‑hospital and hospital settings - Part 1,NG39,What information should be documented in pre-hospital and hospital settings for major trauma patients?
NG39_Recommendations: 1.8 Documentation in pre‑hospital and hospital settings - Part 2,NG39,What are the recommended procedures for documenting and sharing trauma patient information in hospital settings?
"NG39_Recommendations: 1.9 Information and support for patients, family members and carers - Part 1",NG39,"What are the recommendations for providing information and support to patients, families, and carers in major trauma services?"
"NG39_Recommendations: 1.9 Information and support for patients, family members and carers - Part 2",NG39,How should healthcare professionals communicate and provide information to families and carers of children and vulnerable adults during injury management and transfer?
NG39_Recommendations: 1.10 Training and skills,NG39,What training and skills are recommended for healthcare professionals managing trauma patients according to NICE guidelines?
NG39_Recommendations for research: 1 Point-of-care coagulation testing & Recommendations for research: 2 Lactate level for monitoring severity of shock,NG39,What is the clinical and cost effectiveness of point-of-care ROTEM or TEG testing for managing coagulopathy in trauma patients?
NG39_Recommendations for research: 3 Morphine compared with ketamine for first‑line management of pain & Recommendations for research: 4 Warming in patients with major trauma,NG39,What is the clinical and cost effectiveness of morphine versus ketamine as first‑line analgesia for major trauma?
NG39_Context,NG39,What are the recommended initial assessment and management procedures for major trauma patients?
NG3_Diabetes in pregnancy: management from preconception to the postnatal period & Overview & Recommendations: Blood glucose and plasma glucose,NG3,What are the recommended blood glucose management strategies for women with diabetes during pregnancy?
NG3_Recommendations: 1.1 Preconception planning and care - Part 1,NG3,What information should be provided to women with diabetes planning pregnancy to reduce risks for mother and baby?
NG3_Recommendations: 1.1 Preconception planning and care - Part 2,NG3,What advice is given to women with diabetes regarding contraception and pregnancy planning?
NG3_Recommendations: 1.1 Preconception planning and care - Part 3,NG3,What blood glucose targets should women with diabetes aim for before pregnancy?
NG3_Recommendations: 1.1 Preconception planning and care - Part 4,NG3,What are the recommended safety precautions for using diabetes medications during pregnancy?
NG3_Recommendations: 1.1 Preconception planning and care - Part 5,NG3,What preconception advice and assessments are recommended for women with diabetes planning pregnancy?
NG3_Recommendations: 1.2 Gestational diabetes - Part 1,NG3,What are the recommended tests for diagnosing gestational diabetes in pregnant women with risk factors?
NG3_Recommendations: 1.2 Gestational diabetes - Part 2,NG3,What are the diagnostic criteria and management options for gestational diabetes?
NG3_Recommendations: 1.2 Gestational diabetes - Part 3,NG3,What are the recommended management strategies for women diagnosed with gestational diabetes?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 1,NG3,What are the recommended blood glucose monitoring targets for pregnant women with diabetes?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 2,NG3,What are the recommended management strategies for insulin-treated diabetes in pregnant women?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 3,NG3,What are the recommendations for continuous glucose monitoring in pregnant women with diabetes?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 4,NG3,"What are the recommended assessments and management strategies for pregnant women with diabetes regarding ketonaemia, retinopathy, and renal function?"
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 5,NG3,What are the recommended antenatal monitoring and screening protocols for pregnant women with diabetes?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 6,NG3,What are the recommended antenatal care and screening schedules for pregnant women with diabetes?
NG3_Recommendations: 1.3 Antenatal care for women with diabetes - Part 7 & Recommendations: 1.4 Intrapartum care - Part 1,NG3,What are the recommended timings and modes of birth for women with diabetes during pregnancy?
NG3_Recommendations: 1.4 Intrapartum care - Part 2,NG3,What are the recommended blood glucose monitoring and management strategies during labour for women with diabetes?
NG3_Recommendations: 1.5 Neonatal care - Part 1,NG3,What are the neonatal care and admission criteria for babies born to women with diabetes?
NG3_Recommendations: 1.5 Neonatal care - Part 2,NG3,What are the recommended practices for managing neonatal hypoglycaemia in babies of women with diabetes?
NG3_Recommendations: 1.6 Postnatal care - Part 1,NG3,What are the postnatal blood glucose management recommendations for women with pre-existing diabetes who are breastfeeding?
NG3_Recommendations: 1.6 Postnatal care - Part 2,NG3,What are the postnatal testing and follow-up recommendations for women with a history of gestational diabetes?
NG3_Recommendations: 1.6 Postnatal care - Part 3,NG3,What are the postnatal HbA1c testing recommendations for women with gestational diabetes?
NG3_Recommendations: Terms used in this guideline,NG3,What is continuous glucose monitoring and how does it differ between real-time and flash systems?
NG3_Recommendations for research: 1 Preconception care for women with diabetes: insulin pump therapy and real-time continuous glucose monitoring,NG3,What is the role of insulin pump therapy and real-time continuous glucose monitoring in preconception blood glucose management for women with diabetes?
NG3_Recommendations for research: 2 Testing for gestational diabetes,NG3,When should screening for gestational diabetes be performed during pregnancy?
NG3_Recommendations for research: 3 Barriers to achieving blood glucose targets before and during pregnancy & Recommendations for research: 4 Risk of fetal death for women with diabetes,NG3,What are the barriers to achieving blood glucose targets in women with diabetes during pregnancy?
NG3_Recommendations for research: 5 Postnatal treatment for women diagnosed with gestational diabetes,NG3,Are there effective postnatal pharmacological or lifestyle interventions to prevent type 2 diabetes in women with a history of gestational diabetes?
NG3_Rationale and impact: Continuous glucose monitoring - Part 1,NG3,What are the benefits of real-time continuous glucose monitoring compared to intermittently scanned CGM in pregnant women with type 1 diabetes?
NG3_Rationale and impact: Continuous glucose monitoring - Part 2,NG3,What are the current NICE recommendations for using continuous glucose monitoring in pregnant women with diabetes?
NG3_Context,NG3,What are the recommended management strategies for women with pre-existing or gestational diabetes during pregnancy?
NG40_Major trauma: service delivery & Overview,NG40,What are the key components of major trauma service delivery in pre-hospital and hospital settings?
NG40_Recommendations: 1.1 Pre‑hospital triage,NG40,What is the recommended pre-hospital triage tool for identifying major trauma patients?
NG40_Recommendations: 1.2 Transferring patients with major trauma,NG40,What are the recommended procedures for transferring patients with major trauma to a trauma centre?
NG40_Recommendations: 1.3 Pre‑alert procedures,NG40,What are the recommended pre-alert procedures for trauma patients in emergency care?
NG40_Recommendations: 1.4 Procedures for receiving patients in trauma units and major trauma centres & Recommendations: 1.5 Transfer between emergency departments,NG40,What are the recommended procedures for activating trauma teams and transferring major trauma patients?
NG40_Recommendations: 1.6 Organisation of hospital major trauma services & Recommendations: 1.7 Documentation,NG40,What are the key components of hospital major trauma service organization and documentation standards?
"NG40_Recommendations: 1.8 Monitoring and audit & Recommendations: 1.9 Information and support for patients, family members and carers",NG40,What are the recommended procedures for monitoring trauma service performance and providing information and support to patients and families in major trauma care?
NG40_Recommendations: 1.10 Training and skills,NG40,What training and skills are recommended for healthcare professionals managing major trauma patients according to NICE guidelines?
NG40_Recommendations: 1.11 Access to major trauma services,NG40,What are the recommended procedures for access to major trauma services and interventions in emergency care?
NG40_Recommendations for research: 1 Audit & Recommendations for research: 2 Rehabilitation & Recommendations for research: 3 Dedicated transfer service,NG40,What are the benefits and challenges of implementing a dedicated transfer service for major trauma patients?
NG40_Context,NG40,What are the recommended procedures for pre-hospital triage and hospital organisation in major trauma care?
NG41_Spinal injury: assessment and initial management & Overview,NG41,What is the initial assessment and management of suspected spinal injury in emergency settings?
NG41_Recommendations: 1.1 Assessment and management in pre‑hospital settings - Part 1,NG41,What are the recommended assessment procedures for suspected spinal injury in pre-hospital settings?
NG41_Recommendations: 1.1 Assessment and management in pre‑hospital settings - Part 2,NG41,What are the criteria for assessing low risk of cervical spine injury after trauma?
NG41_Recommendations: 1.1 Assessment and management in pre‑hospital settings - Part 3,NG41,When should full in-line spinal immobilisation be used for suspected cervical spine injuries?
NG41_Recommendations: 1.1 Assessment and management in pre‑hospital settings - Part 4,NG41,What are the recommended procedures for spinal immobilisation and extrication in prehospital care?
NG41_Recommendations: 1.2 Pain management in pre‑hospital and hospital settings,NG41,What are the recommended pain management strategies for patients with spinal injury in pre-hospital and hospital settings?
NG41_Recommendations: 1.3 Immediate destination after injury,NG41,What is the recommended destination for patients with suspected traumatic spinal cord injury?
NG41_Recommendations: 1.4 Emergency department assessment and management - Part 1,NG41,What is the recommended assessment process for suspected spinal injuries in the emergency department?
NG41_Recommendations: 1.4 Emergency department assessment and management - Part 2,NG41,When should full in-line spinal immobilisation and imaging be performed after suspected cervical spine injury?
NG41_Recommendations: 1.5 Diagnostic imaging - Part 1,NG41,What are the recommended imaging procedures for suspected spinal injuries in children and adults?
NG41_Recommendations: 1.5 Diagnostic imaging - Part 2,NG41,What are the recommended imaging procedures for adults with suspected cervical spine injury after head trauma?
NG41_Recommendations: 1.6 Communication with tertiary services & Recommendations: 1.7 Early management in the emergency department after traumatic spinal cord injury,NG41,What are the recommended communication protocols and early management guidelines for traumatic spinal cord injury in emergency settings?
"NG41_Recommendations: 1.8 Information and support for patients, family members and carers - Part 1",NG41,"What are the recommended communication and support strategies for patients, families, and carers in major trauma services?"
"NG41_Recommendations: 1.8 Information and support for patients, family members and carers - Part 2",NG41,What information should be provided to family members and carers of children and vulnerable adults after injury?
NG41_Recommendations: 1.9 Documentation in pre‑hospital and hospital settings - Part 1,NG41,What are the recommended documentation practices for pre-hospital and hospital settings in major trauma cases?
NG41_Recommendations: 1.9 Documentation in pre‑hospital and hospital settings - Part 2,NG41,What are the recommended procedures for recording and sharing trauma and hospital admission information according to NICE guidelines?
NG41_Recommendations: 1.10 Training and skills,NG41,What training and skills are recommended for healthcare professionals managing major trauma patients?
NG41_Recommendations for research,NG41,What are the current recommendations for research on early treatment of neuropathic pain in spinal cord injury?
NG41_Context,NG41,What are the recommended initial management and imaging protocols for traumatic spinal cord injuries?
NG42_Motor neurone disease: assessment and management & Overview,NG42,What are the recommended approaches for assessing and managing motor neurone disease?
NG42_Recommendations: 1.1 Recognition and referral,NG42,What are the early signs and symptoms of motor neurone disease (MND) that should prompt referral?
NG42_Recommendations: 1.2 Information and support at diagnosis - Part 1,NG42,What information and support should be provided to patients at diagnosis of motor neurone disease (MND)?
NG42_Recommendations: 1.2 Information and support at diagnosis - Part 2,NG42,What are the recommended steps for initial diagnosis and multidisciplinary care in motor neurone disease?
NG42_Recommendations: 1.3 Cognitive assessments & Recommendations: 1.4 Prognostic factors,NG42,What are the recommended cognitive assessment procedures for people with motor neurone disease and frontotemporal dementia?
NG42_Recommendations: 1.5 Organisation of care - Part 1,NG42,What is the recommended organization of care for people with motor neurone disease (MND) according to NICE guidelines?
NG42_Recommendations: 1.5 Organisation of care - Part 2,NG42,What are the recommended components of a multidisciplinary team for managing motor neurone disease?
NG42_Recommendations: 1.5 Organisation of care - Part 3,NG42,How should multidisciplinary team assessments be tailored and managed for people with motor neurone disease?
NG42_Recommendations: 1.6 Psychological and social care support - Part 1,NG42,What psychological and social support options are recommended for people with motor neurone disease and their families?
NG42_Recommendations: 1.6 Psychological and social care support - Part 2,NG42,What support and resources are available for family carers of people with motor neurone disease?
NG42_Recommendations: 1.7 Planning for end of life - Part 1,NG42,What are the recommended discussions and planning strategies for end-of-life care in people with motor neurone disease?
NG42_Recommendations: 1.7 Planning for end of life - Part 2,NG42,When should advance care planning and discussions about DNACPR and Lasting Power of Attorney be initiated for people with motor neurone disease?
NG42_Recommendations: 1.8 Managing symptoms - Part 1,NG42,What are the recommended pharmacological treatments for muscle cramps and spasticity in motor neuron disease?
NG42_Recommendations: 1.8 Managing symptoms - Part 2,NG42,What are the recommended exercise programs for managing muscle problems in motor neurone disease?
NG42_Recommendations: 1.8 Managing symptoms - Part 3 & Recommendations: 1.9 Disease-modifying treatment,NG42,What are the recommended first-line treatments for sialorrhoea in people with MND?
NG42_Recommendations: 1.10 Equipment and adaptations to aid activities of daily living and mobility,NG42,What equipment and home adaptations are recommended to support daily living and mobility in people with motor neurone disease?
NG42_Recommendations: 1.11 Nutrition and gastrostomy - Part 1,NG42,What are the recommended assessments and interventions for nutrition and swallowing difficulties in adults?
NG42_Recommendations: 1.11 Nutrition and gastrostomy - Part 2,NG42,What are the considerations for early gastrostomy discussion and decision-making in motor neurone disease?
NG42_Recommendations: 1.12 Communication,NG42,What are the recommended strategies for communication support in people with motor neurone disease?
NG42_Recommendations: 1.13 Respiratory function and respiratory symptoms,NG42,What are the recommended approaches for managing respiratory symptoms and impairment in people with motor neurone disease?
NG42_Recommendations: 1.14 Cough effectiveness,NG42,What are the recommended cough augmentation techniques for people with motor neuron disease?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 1,NG42,What should I know about non-invasive ventilation for respiratory support in motor neurone disease?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 2,NG42,What are the recommended assessments and monitoring strategies for respiratory impairment in patients with motor neuron disease?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 3,NG42,What are the recommended respiratory assessments and referral criteria for people with motor neurone disease and respiratory impairment?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 4,NG42,When should patients with respiratory impairment or frontotemporal dementia be referred for respiratory ventilation assessment?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 5,NG42,What are the indications and considerations for initiating non-invasive ventilation in people with motor neurone disease?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 6,NG42,What are the criteria for continuing or withdrawing non-invasive ventilation in patients with neurological or cognitive impairments?
NG42_Recommendations: 1.15 Non-invasive ventilation - Part 7,NG42,What are the recommended procedures for stopping non-invasive ventilation in patients with motor neurone disease?
NG42_Context - Part 1,NG42,What are the clinical features and progression of motor neurone disease (MND)?
NG42_Context - Part 2 & Recommendations for research: 1 Organisation of care,NG42,Is a network-based multidisciplinary care model as effective as a clinic-based model for managing motor neurone disease?
NG42_Recommendations for research: 2 Cognitive assessment & Recommendations for research: 3 Prognostic tools,NG42,What is the value of cognitive and behavioural assessments in managing motor neuron disease and how often should they be repeated?
NG42_Recommendations for research: 4 Saliva & Recommendations for research: 5 Nutrition & Recommendations for research: 6 Augmentative and alternative communication,NG42,What are the recommended management options for sialorrhoea in people with motor neuron disease?
NG43_Transition from children’s to adults’ services for young people using health or social care services & Overview,NG43,What are the best practices for transitioning young people from children's to adults' health and social care services?
NG43_Recommendations: 1.1 Overarching principles - Part 1,NG43,What are the principles for involving young people and their carers in transition support?
NG43_Recommendations: 1.1 Overarching principles - Part 2,NG43,What are the recommended practices for supporting transition and housing options for young people with special needs?
NG43_Recommendations: 1.2 Transition planning - Part 1,NG43,What are the recommended practices for transition planning for young people with special educational needs?
NG43_Recommendations: 1.2 Transition planning - Part 2,NG43,What is the role of a named worker in supporting young people's transition to adult services?
NG43_Recommendations: 1.2 Transition planning - Part 3,NG43,How can healthcare professionals support young people with disabilities in their transition to adult services?
NG43_Recommendations: 1.2 Transition planning - Part 4,NG43,How should parents and carers be involved in the transition to adult services for looked-after children?
NG43_Recommendations: 1.3 Support before transfer - Part 1,NG43,What support should be provided to young people and their families before transferring from children's to adult services?
NG43_Recommendations: 1.3 Support before transfer - Part 2,NG43,What are the recommended steps for supporting young people during the transition to adult health and social care services?
NG43_Recommendations: 1.4 Support after transfer,NG43,How should healthcare providers support young people who do not engage with adult health and social care services after transfer?
NG43_Recommendations: 1.5 Supporting infrastructure - Part 1,NG43,What are the recommended responsibilities for leadership roles in supporting transition between children's and adults' health and social care services?
NG43_Recommendations: 1.5 Supporting infrastructure - Part 2,NG43,How should services be planned and coordinated for young people transitioning from children's to adult healthcare?
NG43_Recommendations: Terms used in this guideline - Part 1,NG43,What is meant by developmentally appropriate care for young people in healthcare?
NG43_Recommendations: Terms used in this guideline - Part 2,NG43,What are the key principles of pooled budgets and strengths-based approaches in health and social care?
NG43_Implementation: getting started: The challenge: adults' services taking joint responsibility with children's services for transition,NG43,What are best practices for joint responsibility in transition from children's to adults' health and social care services?
"NG43_Implementation: getting started: The challenge: joint planning, development and commissioning of services involved in transition across children's and adults' health and social care - Part 1",NG43,What are best practices for joint planning and commissioning of transition services from children's to adult healthcare?
"NG43_Implementation: getting started: The challenge: joint planning, development and commissioning of services involved in transition across children's and adults' health and social care - Part 2",NG43,What are best practices for managing transitions of young people from children's to adult health and social care services?
NG43_Implementation: getting started: The challenge: improving front‑line practice with young people through training in developmentally appropriate services and person‑centred practice - Part 1,NG43,How can practitioners improve transition support for young people through developmentally appropriate and person-centred care?
NG43_Implementation: getting started: The challenge: improving front‑line practice with young people through training in developmentally appropriate services and person‑centred practice - Part 2,NG43,What are best practices for involving families and carers in supporting young people's independence and transition to adult services?
NG43_Implementation: getting started: The challenge: maximising opportunities for young people who have become disengaged or who are not eligible for adults' services to access care and support - Part 1,NG43,What strategies can health and social care professionals use to improve transition support for young people disengaged from services?
NG43_Implementation: getting started: The challenge: maximising opportunities for young people who have become disengaged or who are not eligible for adults' services to access care and support - Part 2,NG43,How can services effectively support young people transitioning to adulthood and ensure they have access to appropriate care and support?
NG43_Context - Part 1,NG43,What are best practices for supporting young people through the transition from children's to adult health and social care services?
NG43_Context - Part 2 & Recommendations for research: 1 Transition support for young adults,NG43,What are the most effective and cost-effective approaches to supporting young people transitioning from children's to adult health and social care services?
NG43_Recommendations for research: 2 The role of families in supporting young adults discharged from children's services & Recommendations for research: 3 The role of primary care in supporting young people discharged from children's services,NG43,What are the best ways for families and primary care to support young adults transitioning from children's to adult healthcare services?
NG43_Recommendations for research: 4 The consequences and costs of poor transition & 3 more sections,NG43,What are the best practices for supporting young offenders during transition from children's to adult health and social care services?
NG44_Community engagement: improving health and wellbeing and reducing health inequalities & Overview,NG44,How can community engagement reduce health inequalities and improve health and wellbeing?
NG44_Recommendations: 1.1 Overarching principles of good practice - Part 1,NG44,What are the principles of effective community engagement in health and wellbeing initiatives?
NG44_Recommendations: 1.1 Overarching principles of good practice - Part 2,NG44,How can I effectively involve local communities in health and wellbeing initiatives?
NG44_Recommendations: 1.2 Developing collaborations and partnerships to meet local needs and priorities,NG44,How can public health directors develop effective community partnerships to improve health and reduce inequalities?
NG44_Recommendations: 1.3 Involving people in peer and lay roles to represent local needs and priorities,NG44,How can public health initiatives effectively involve community members in peer and lay roles to address local health needs?
NG44_Recommendations: 1.4 Local approach to making community engagement an integral part of health and wellbeing initiatives - Part 1,NG44,What are effective strategies for integrating community engagement into local health and wellbeing initiatives?
NG44_Recommendations: 1.4 Local approach to making community engagement an integral part of health and wellbeing initiatives - Part 2,NG44,What strategies are recommended for engaging local communities to address health inequalities according to NICE guidelines?
NG44_Recommendations: 1.5 Making it as easy as possible for people to get involved,NG44,How can healthcare providers improve community involvement in health and wellbeing initiatives?
NG44_Recommendations: Terms used in this guideline,NG44,What is an asset-based approach in community health initiatives?
NG44_Implementation: getting started: Identifying the resources needed & Implementation: getting started: Learning and training,NG44,What resources and training are recommended to support community engagement in local health and wellbeing initiatives?
NG44_Implementation: getting started: Evaluation and feedback & Implementation: getting started: Need more help?,NG44,How can community engagement be effectively evaluated to improve health and wellbeing initiatives?
NG44_Context - Part 1,NG44,What are effective strategies for community engagement to reduce health inequalities?
NG44_Context - Part 2,NG44,What are the statutory obligations for community engagement in health and social care?
NG44_Recommendations for research,NG44,What are effective community engagement strategies for improving health outcomes and reducing health inequalities?
NG45_Routine preoperative tests for elective surgery & 5 more sections,NG45,What are the recommended preoperative tests for elective surgery in adults?
NG45_Recommendations: 1.4 Sickle cell disease or sickle cell trait tests & 5 more sections,NG45,"What are the recommended preoperative tests for sickle cell disease, HbA1c, urine analysis, chest X-ray, and echocardiography?"
"NG45_Recommendations: Recommendations for specific surgery grades (minor, intermediate, and major or complex) and ASA grades - Part 1",NG45,What are the recommended preoperative assessments for different surgery and ASA grades?
"NG45_Recommendations: Recommendations for specific surgery grades (minor, intermediate, and major or complex) and ASA grades - Part 2",NG45,When should kidney function tests be performed before intermediate surgery in patients at risk of acute kidney injury?
"NG45_Recommendations: Recommendations for specific surgery grades (minor, intermediate, and major or complex) and ASA grades - Part 3",NG45,What preoperative tests are recommended for patients undergoing major or complex surgery based on ASA classification?
NG45_Context,NG45,What are the current NICE recommendations on preoperative testing for elective surgery?
NG45_Recommendations for research,NG45,What is the evidence for preoperative screening and treatment of obstructive sleep apnoea to improve surgical outcomes?
NG46_Controlled drugs: safe use and management & Overview,NG46,What are the best practices for the safe use and management of controlled drugs in NHS settings?
NG46_Recommendations: 1.1 Developing and establishing systems and processes for organisations - Part 1,NG46,What are the key governance and policy requirements for managing controlled drugs in healthcare organizations?
NG46_Recommendations: 1.1 Developing and establishing systems and processes for organisations - Part 2,NG46,What are the recommended procedures for storing and auditing controlled drugs in healthcare settings?
NG46_Recommendations: 1.1 Developing and establishing systems and processes for organisations - Part 3,NG46,"What are the recommended procedures for auditing, transporting, and disposing of controlled drugs in healthcare settings?"
NG46_Recommendations: 1.2 Record keeping for organisations,NG46,What are the record-keeping requirements for controlled drugs in healthcare organizations according to NICE guidelines?
NG46_Recommendations: 1.3 Risk assessment for organisations & Recommendations: 1.4 Processes for reporting controlled drug‑related incidents,NG46,What are the recommended procedures for risk assessment and incident reporting for controlled drugs in healthcare organizations?
NG46_Recommendations: 1.5 Prescribing controlled drugs - Part 1,NG46,What are the recommended practices for prescribing and managing controlled drugs in clinical settings?
NG46_Recommendations: 1.5 Prescribing controlled drugs - Part 2,NG46,How should controlled drugs be prescribed and documented to ensure safe use and effective communication among healthcare providers?
NG46_Recommendations: 1.5 Prescribing controlled drugs - Part 3,NG46,What information should be provided to patients and carers when prescribing controlled drugs?
NG46_Recommendations: 1.6 Obtaining and supplying controlled drugs - Part 1,NG46,What are the recommended procedures for supplying and recording controlled drugs in primary care?
NG46_Recommendations: 1.6 Obtaining and supplying controlled drugs - Part 2,NG46,What are the requirements for requisitioning controlled drugs in primary care?
NG46_Recommendations: 1.7 Administering controlled drugs,NG46,What are the safety and record-keeping requirements for administering controlled drugs?
NG46_Recommendations: 1.8 Handling controlled drugs - Part 1,NG46,What are the recommended procedures for recording and witnessing the destruction of controlled drugs?
NG46_Recommendations: 1.8 Handling controlled drugs - Part 2,NG46,What are the recommended procedures for witnessing and recording the destruction of controlled drugs in primary care?
NG46_Recommendations: 1.9 Monitoring the use of controlled drugs,NG46,What are the recommended procedures for monitoring and reporting concerns about controlled drugs in healthcare settings?
NG46_Recommendations: Terms used in this guideline - Part 1,NG46,What is the role of an authorised person in the destruction of controlled drugs?
NG46_Recommendations: Terms used in this guideline - Part 2,NG46,What is the difference between external and internal pharmacy services in healthcare settings?
NG46_Recommendations: Terms used in this guideline - Part 3,NG46,What are the responsibilities of the NHS England lead controlled drugs accountable officer?
NG46_Context - Part 1,NG46,What are the best practices for managing and prescribing controlled drugs safely in healthcare settings?
NG46_Context - Part 2,NG46,What are the legal requirements for managing controlled drugs in healthcare settings according to NICE guidelines?
NG47_Haematological cancers: improving outcomes & Overview,NG47,What are the recommended diagnostic reporting procedures for haematological cancers in adults and children?
NG47_Recommendations: 1.1 Integrated diagnostic reporting - Part 1,NG47,What are the key components and organizational requirements for establishing an effective integrated haematological malignancy diagnostic service?
NG47_Recommendations: 1.1 Integrated diagnostic reporting - Part 2,NG47,What are the requirements for laboratory information systems in specialized haematological malignancy diagnostic services?
NG47_Recommendations: 1.2 Staffing and facilities (levels of care) for adults and young people who are having high-intensity non-transplant chemotherapy - Part 1,NG47,What are the recommended staffing levels and facility requirements for adults and young people receiving high-intensity non-transplant chemotherapy for haematological malignancies?
NG47_Recommendations: 1.2 Staffing and facilities (levels of care) for adults and young people who are having high-intensity non-transplant chemotherapy - Part 2,NG47,What are recommended inpatient isolation facilities for adults with haematological malignancies at risk of prolonged neutropenia?
NG47_Recommendations: 1.2 Staffing and facilities (levels of care) for adults and young people who are having high-intensity non-transplant chemotherapy - Part 3,NG47,What are the key components of standard operating procedures for ambulatory haematology care?
NG47_Recommendations: 1.2 Staffing and facilities (levels of care) for adults and young people who are having high-intensity non-transplant chemotherapy - Part 4,NG47,What are the staffing and specialist support requirements for haematology units caring for patients on high‑intensity chemotherapy?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 1,NG47,What are the recommended roles and responsibilities of multidisciplinary teams in the management of haematological cancers?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 2,NG47,What are the recommended core members and team composition for a haemato-oncology multidisciplinary team?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 3,NG47,What specialists should be involved in a haemato-oncology multidisciplinary team?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 4,NG47,What are the recommended procedures for reviewing and discontinuing treatment in multidisciplinary teams managing haematological cancers?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 5,NG47,What are the recommended practices for effective multidisciplinary team meetings in haemato-oncology?
NG47_Recommendations: 1.3 Multidisciplinary teams - Part 6 & Recommendations: 1.4 Recommendations from the 2003 cancer service guidance,NG47,What are the recommended arrangements for high-intensity chemotherapy services in haematology and oncology teams?
NG47_Recommendations: Terms used in this guideline,NG47,What is the definition of high-intensity chemotherapy in NICE guidelines for haematological cancers?
NG47_Context,NG47,What are the current diagnostic and management recommendations for haematological malignancies according to NICE guidelines?
NG48_Oral health for adults in care homes & Overview,NG48,What are the recommended oral health care practices for adults in care homes?
NG48_Recommendations: 1.1 Care home policies on oral health and providing residents with support to access dental services,NG48,What are the recommended policies for care homes to support residents' oral health and access to dental services?
NG48_Recommendations: 1.2 Oral health assessment and mouth care plans,NG48,What are the recommended procedures for oral health assessment and mouth care planning in care home residents?
NG48_Recommendations: 1.3 Daily mouth care,NG48,What are the recommended practices for daily mouth care in care home residents?
NG48_Recommendations: 1.4 Care staff knowledge and skills,NG48,What training do care staff need to effectively support residents' oral health and mouth care?
NG48_Recommendations: 1.5 Availability of local oral health services,NG48,What are the recommended strategies for ensuring adequate local oral health services for care home residents?
NG48_Recommendations: 1.6 Oral health promotion services & Recommendations: 1.7 General dental practices and community dental services,NG48,What are the recommended strategies for oral health promotion in care homes?
NG48_Context - Part 1,NG48,What are the recommended oral health assessments and preventive care for older adults in care homes?
NG48_Context - Part 2,NG48,What are the recommended strategies for improving oral health care in residents with dementia in care homes?
NG48_Recommendations for research: 2 Effectiveness and costs of oral health interventions for care home residents & Recommendations for research: 3 Measuring improvements in care home residents' oral health & Recommendations for research: 4 Daily mouth care for residents,NG48,What are the benefits and cost-effectiveness of oral health interventions for care home residents?
NG48_Recommendations for research: 5 Reducing demands on health and social care services & Recommendations for research: 6 Facilitators and barriers to carrying out daily mouth care and oral health assessments for adults in care homes & Glossary,NG48,What are the barriers and facilitators to implementing daily oral care and assessments in care homes?
NG49_Non-alcoholic fatty liver disease (NAFLD): assessment and management & Overview & Recommendations: 1.1 Assessment for NAFLD,NG49,What are the recommended methods for diagnosing non-alcoholic fatty liver disease in children and young people?
NG49_Recommendations: 1.2 Assessment for advanced liver fibrosis in people with NAFLD - Part 1,NG49,What are the recommended methods for assessing advanced liver fibrosis in people with NAFLD?
NG49_Recommendations: 1.2 Assessment for advanced liver fibrosis in people with NAFLD - Part 2 & Recommendations: 1.3 People with NAFLD who are taking statins,NG49,What are the recommended monitoring and lifestyle management strategies for adults with NAFLD?
NG49_Recommendations: 1.4 Pharmacological treatment,NG49,What are the considerations for prescribing pioglitazone or vitamin E for advanced liver fibrosis?
NG49_Context,NG49,What are the current recommendations for diagnosing and managing non-alcoholic fatty liver disease (NAFLD) in primary care?
NG49_Recommendations for research: 1 Non-invasive tests for diagnosing NAFLD in adults,NG49,What are the most accurate and cost-effective non-invasive tests for diagnosing NAFLD in adults with risk factors?
NG49_Recommendations for research: 2 Non-invasive tests for diagnosing NASH,NG49,What are the most accurate non-invasive tests for diagnosing NASH in patients with NAFLD?
NG49_Recommendations for research: 3 Non-invasive tests for diagnosing NAFLD and advanced liver fibrosis in children and young people & Recommendations for research: 4 Probiotic and prebiotic supplements,NG49,What are the most accurate non-invasive tests for diagnosing NAFLD and advanced liver fibrosis in children and young people?
NG4_Safe midwifery staffing for maternity settings & Overview - Part 1,NG4,What are the recommended staffing levels for safe midwifery care in maternity units?
NG4_Overview - Part 2,NG4,What are the recommended staffing levels for maternity units to ensure safe and effective care?
NG4_Introduction - Part 1,NG4,What are the NICE guidelines for safe midwifery staffing in maternity services?
NG4_Introduction - Part 2,NG4,What are the recommended staffing ratios for midwives during established labour?
NG4_Introduction - Part 3,NG4,What are the recommended staffing levels for woman- and baby-centred maternity care?
NG4_Recommendations: 1.1 Organisational requirements - Part 1,NG4,What are the organizational requirements for staffing and service provision in maternity care?
NG4_Recommendations: 1.1 Organisational requirements - Part 2,NG4,What are the recommended practices for staffing and escalation planning in maternity services according to NICE guidelines?
NG4_Recommendations: 1.1 Organisational requirements - Part 3,NG4,How should midwifery staffing levels be reviewed and adjusted in maternity services?
NG4_Recommendations: 1.2 Setting the midwifery staffing establishment - Part 1,NG4,How should midwifery staffing levels be determined and reviewed in maternity services?
NG4_Recommendations: 1.2 Setting the midwifery staffing establishment - Part 2,NG4,How should maternity care staffing levels be calculated considering local service configuration and staff skill mix?
NG4_Recommendations: 1.2 Setting the midwifery staffing establishment - Part 3,NG4,How should midwifery staffing levels be determined based on risk assessment and activity peaks in maternity services?
NG4_Recommendations: 1.2 Setting the midwifery staffing establishment - Part 4,NG4,What are the recommended routine and additional care activities during the intrapartum and postnatal periods according to NICE guidelines?
NG4_Recommendations: 1.3 Assessing differences in the number and skill mix of midwives needed and the number of midwives available - Part 1,NG4,How should midwives assess staffing levels and skill mix for maternity services?
NG4_Recommendations: 1.3 Assessing differences in the number and skill mix of midwives needed and the number of midwives available - Part 2,NG4,What are the indicators of midwifery red flag events and how should they be managed?
NG4_Recommendations: 1.4 Monitoring and evaluating midwifery staffing requirements - Part 1,NG4,How can midwifery staffing levels be monitored and evaluated to ensure safe maternity care?
NG4_Recommendations: 1.4 Monitoring and evaluating midwifery staffing requirements - Part 2,NG4,What are the recommended data collection practices for monitoring maternity care quality and staffing levels according to NICE guidelines?
NG4_Recommendations: Terms used in this guideline - Part 1,NG4,What are midwifery red flag events and how should they be managed during maternity care?
NG4_Recommendations: Terms used in this guideline - Part 2,NG4,What are the recommended staffing requirements and skill mix for midwifery services in maternity care?
NG4_Evidence - Part 1,NG4,What evidence supports effective methods for determining midwife staffing requirements and skill mix at a local level?
NG4_Evidence - Part 2,NG4,What factors influence safe midwife staffing levels and skill mix in maternity units?
NG4_Gaps in the evidence,NG4,What is the evidence on the impact of midwifery staffing levels and skill mix on maternal and neonatal outcomes?
NG4_Recommendations for research: 1 Relationship between midwifery staffing and outcomes,NG4,What is the impact of midwifery staffing levels on maternal and neonatal outcomes in maternity care?
NG4_Recommendations for research: 2 Decision support methods,NG4,What is the effectiveness of Birthrate Plus compared to other decision support methods for determining midwifery staffing requirements in maternity services?
NG4_Contributors and declarations of interest: Safe Staffing Advisory Committee,NG4,What is the role of the Safe Staffing Advisory Committee in NHS workforce planning?
NG4_Contributors and declarations of interest: NICE team - Part 1,NG4,Who are the members of the NICE team responsible for developing the safe staffing guidelines?
NG4_Contributors and declarations of interest: NICE team - Part 2,NG4,What are the NICE guidelines for managing conflicts of interest in healthcare committees?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: outcome measures reported by women in maternity services - Part 1,NG4,What are the recommended standards for midwifery staffing to ensure women’s positive experiences during maternity care?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: outcome measures reported by women in maternity services - Part 2,NG4,What are the recommended practices for supporting breastfeeding and postnatal mental health in maternity care?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: booking appointment within 13 weeks of pregnancy (or sooner) & Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: booking appointment within 13 weeks of pregnancy (or sooner),NG4,What is the recommended timing for booking appointments with a midwife during pregnancy?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: breastfeeding & Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: antenatal and postnatal admissions and readmissions within 28 days,NG4,What are the recommended staffing levels to support breastfeeding initiation and continuation in maternity services?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: antenatal and postnatal admissions and readmissions within 28 days - Part 1,NG4,What are the recommended staffing levels for managing antenatal and postnatal inpatient admissions within 28 days according to NICE guidelines?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: antenatal and postnatal admissions and readmissions within 28 days - Part 2,NG4,How are hospital readmission rates within 28 days measured and interpreted for antenatal and postnatal mothers?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: incidence of genital tract trauma,NG4,What are the recommended practices for monitoring and reducing genital tract trauma during labour?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: birth place of choice,NG4,What are the recommended practices for recording and analyzing birth place of choice in maternity services?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: staff-reported measures - Part 1,NG4,What are the recommended staffing levels to prevent missed breaks and reduce overtime for midwives in maternity settings?
NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: staff-reported measures - Part 2,NG4,"What are the recommended outcome measures for assessing midwife staff experience, including sickness and morale in maternity services?"
"NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: midwifery establishment measures & Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: the number of women in established labour and the number of midwifery staff available over a specified period, for example 24 hours",NG4,What are the recommended staffing levels for midwives during shifts in maternity units?
"NG4_Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: the number of women in established labour and the number of midwifery staff available over a specified period, for example 24 hours & Indicators for safe midwifery staffing: Safe midwifery staffing for maternity settings indicator: compliance with any mandatory training",NG4,What are the recommended staffing levels and training requirements for midwives in maternity services?
NG4_Finding more information,NG4,Where can I find more information and resources on NICE intrapartum care guidelines?
NG50_Cirrhosis in over 16s: assessment and management & Overview,NG50,What are the recommended approaches for assessing and managing cirrhosis in adults?
NG50_Recommendations: 1.1 Diagnosis - Part 1,NG50,"What are the recommended tests for diagnosing cirrhosis in patients with hepatitis C, alcohol-related liver disease, or NAFLD?"
NG50_Recommendations: 1.1 Diagnosis - Part 2,NG50,When should liver biopsy be considered for diagnosing cirrhosis in patients unable to undergo transient elastography?
NG50_Recommendations: 1.2 Monitoring - Part 1,NG50,How should patients with cirrhosis be monitored for complications and hepatocellular carcinoma?
NG50_Recommendations: 1.2 Monitoring - Part 2,NG50,When should upper gastrointestinal endoscopy be performed for surveillance of oesophageal varices in patients without varices on previous endoscopy?
NG50_Recommendations: 1.3 Managing complications - Part 1,NG50,How should carvedilol and propranolol be safely prescribed for patients with cirrhosis to prevent variceal bleeding?
NG50_Recommendations: 1.3 Managing complications - Part 2,NG50,What are the recommended strategies for preventing bleeding from medium or large oesophageal varices in patients with cirrhosis?
NG50_Recommendations: 1.3 Managing complications - Part 3,NG50,What are the recommended treatments for medium or large oesophageal varices in cirrhosis patients?
NG50_Recommendations: 1.3 Managing complications - Part 4,NG50,When should antibiotics be used to prevent spontaneous bacterial peritonitis in patients with cirrhosis and ascites?
NG50_Recommendations for research: Key recommendations for research - Part 1,NG50,What is the effectiveness of antibiotic prophylaxis for preventing spontaneous bacterial peritonitis in patients with cirrhosis and ascites?
NG50_Recommendations for research: Key recommendations for research - Part 2,NG50,What is the effectiveness of non-selective beta-blockers in preventing decompensation in patients with compensated cirrhosis and portal hypertension?
NG50_Recommendations for research: Other recommendations for research - Part 1,NG50,What is the effectiveness of non-selective beta-blockers in preventing first variceal bleeding and improving survival in patients with cirrhosis and small oesophageal varices?
NG50_Recommendations for research: Other recommendations for research - Part 2,NG50,What is the impact of transjugular intrahepatic portosystemic stent (TIPS) on quality of life in patients with cirrhosis?
NG50_Recommendations for research: Other recommendations for research - Part 3,NG50,Does managing the precipitating factors alone improve hepatic encephalopathy in cirrhosis patients without specific treatments?
NG50_Rationale and impact: Oesophageal varices,NG50,What are the current recommendations for managing oesophageal varices in patients with portal hypertension?
NG50_Rationale and impact: Safe prescribing and use of carvedilol and propranolol in people with cirrhosis,NG50,What precautions should be taken when prescribing carvedilol or propranolol to patients with cirrhosis?
NG50_Rationale and impact: Primary prevention of decompensation,NG50,What are the current recommendations for using non-selective beta-blockers to prevent decompensation in clinically significant portal hypertension?
NG50_Rationale and impact: Preventing bleeding from medium or large oesophageal varices,NG50,What are the most effective options for preventing bleeding from medium or large oesophageal varices?
NG50_Rationale and impact: Preventing spontaneous bacterial peritonitis - Part 1,NG50,Should antibiotics be used to prevent spontaneous bacterial peritonitis in patients with cirrhosis and ascites?
NG50_Rationale and impact: Preventing spontaneous bacterial peritonitis - Part 2,NG50,What are the current recommendations for antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in cirrhosis patients?
NG50_Context,NG50,What are the best practices for diagnosing and managing cirrhosis in adults?
"NG51_Suspected sepsis: recognition, diagnosis and early management & Overview",NG51,What are the key steps for early recognition and management of suspected sepsis?
NG51_Could this be sepsis?: 1.1 When to suspect sepsis - Part 1,NG51,When should I suspect sepsis in a patient with non-specific symptoms?
NG51_Could this be sepsis?: 1.1 When to suspect sepsis - Part 2,NG51,When should an early warning score be used to assess suspected sepsis in different patient groups?
NG51_Could this be sepsis?: 1.2 People who are most vulnerable to sepsis - Part 1,NG51,Which groups are most at risk of developing sepsis?
NG51_Could this be sepsis?: 1.2 People who are most vulnerable to sepsis - Part 2,NG51,What are the risk factors for early-onset neonatal infection during pregnancy and delivery?
NG51_Face to face assessment: 1.3 Initial assessment and examination - Part 1,NG51,What are the initial assessment and examination procedures for suspected sepsis in children and adults?
NG51_Face to face assessment: 1.3 Initial assessment and examination - Part 2,NG51,What questions should I ask to assess for sepsis in a patient?
NG51_Face to face assessment: 1.4 Interpreting findings - Part 1,NG51,How should vital signs be interpreted when assessing suspected sepsis?
NG51_Face to face assessment: 1.4 Interpreting findings - Part 2,NG51,How should changes in mental and cognitive state be assessed in suspected sepsis?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.5 Evaluating risk level - Part 1,NG51,How should clinicians assess the risk of severe illness or death from sepsis in children under 16?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.5 Evaluating risk level - Part 2,NG51,What are the risk criteria for suspected sepsis in children aged 12 to 15?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.5 Evaluating risk level - Part 3,NG51,What are the clinical criteria for assessing sepsis risk in children under 5 years old?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.5 Evaluating risk level - Part 4,NG51,What are the criteria for assessing sepsis risk in children aged 5 to 11 years?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.5 Evaluating risk level - Part 5,NG51,What are the risk criteria for sepsis in children aged 12 to 15 and adults in community or non-acute settings?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.6 Managing suspected sepsis outside acute hospital settings - Part 1,NG51,What are the criteria for immediate transfer of children under 16 with suspected sepsis to hospital?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.6 Managing suspected sepsis outside acute hospital settings - Part 2,NG51,What are the recommended actions for ambulance services when transferring children with suspected sepsis in remote areas?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.7 Managing suspected sepsis in acute hospital settings - Part 1,NG51,What are the recommended initial investigations and antibiotic management for suspected sepsis in children under 16 in hospital settings?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.7 Managing suspected sepsis in acute hospital settings - Part 2,NG51,What are the intravenous fluid management recommendations for children with suspected sepsis based on age and lactate levels?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.7 Managing suspected sepsis in acute hospital settings - Part 3,NG51,What are the recommended monitoring and escalation procedures for children under 16 with suspected sepsis?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.7 Managing suspected sepsis in acute hospital settings - Part 4,NG51,What are the recommended investigations and management for children aged 12 to 15 with suspected sepsis?
NG51_Under 16s: evaluating risk and managing suspected sepsis: 1.7 Managing suspected sepsis in acute hospital settings - Part 5,NG51,What is the recommended management and review process for children under 12 with suspected sepsis meeting only one moderate to high risk criterion?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.8 Evaluating risk level - Part 2,NG51,What are the risk stratification criteria for sepsis in pregnant women aged 16 or over?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.9 Managing suspected sepsis outside acute hospital settings - Part 1,NG51,What are the criteria for immediate transfer and pre-hospital management of suspected sepsis in pregnant women outside hospital settings?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.9 Managing suspected sepsis outside acute hospital settings - Part 2,NG51,What are the recommendations for administering antibiotics to suspected sepsis patients in remote or rural settings?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.10 Managing suspected sepsis in acute hospital settings - Part 2,NG51,What are the recommended management steps for suspected sepsis in pregnant women with high lactate levels?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.10 Managing suspected sepsis in acute hospital settings - Part 3,NG51,What are the NICE guidelines for managing suspected sepsis in pregnant or recently pregnant women with high or moderate risk criteria?
NG51_Pregnant or recently pregnant people: evaluating risk and managing suspected sepsis: 1.10 Managing suspected sepsis in acute hospital settings - Part 4,NG51,What are the recommended actions for managing suspected sepsis in pregnant women with moderate to high risk criteria?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.11 Evaluating risk level - Part 1,NG51,How should healthcare professionals assess the risk of severe sepsis in adults in community and custodial settings?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.11 Evaluating risk level - Part 2,NG51,How should clinicians assess the risk of severe sepsis in adults using NEWS2 scores and clinical signs?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.11 Evaluating risk level - Part 3,NG51,When should the NEWS2 score be recalculated for patients with suspected sepsis according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.12 Managing suspected sepsis outside acute hospital settings - Part 1,NG51,What are the criteria for immediate transfer of suspected sepsis patients in community and mental health settings?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.12 Managing suspected sepsis outside acute hospital settings - Part 2,NG51,What are the recommendations for managing suspected sepsis in remote and rural settings with transfer times over one hour?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.12 Managing suspected sepsis outside acute hospital settings - Part 3,NG51,What are the NICE guidelines for administering antibiotics to people with suspected sepsis in ambulance and community settings?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.12 Managing suspected sepsis outside acute hospital settings - Part 4,NG51,What are the recommended procedures for assessing and managing suspected sepsis in acute mental health settings?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 2,NG51,What are the recommended initial assessments and antibiotic treatments for high-risk sepsis patients aged 16 and over?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 3,NG51,What are the current NICE recommendations for intravenous fluid administration in adults with suspected sepsis?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 4,NG51,What are the recommended actions for managing suspected sepsis in adults at high or moderate risk according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 5,NG51,What are the recommended investigations and management steps for moderate risk sepsis in adults according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 6,NG51,What are the current NICE recommendations for managing suspected sepsis in adults at high and moderate risk?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 7,NG51,What are the recommended management steps for low-risk suspected sepsis in adults according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 8,NG51,How should clinicians manage antibiotic timing and assessment for low-risk suspected sepsis patients according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 9,NG51,What are the recommended management and escalation procedures for patients at very low risk of sepsis according to NICE guidelines?
NG51_Over 16s (not pregnant or recently pregnant): evaluating risk and managing suspected sepsis: 1.13 Managing suspected sepsis in acute hospital settings - Part 10,NG51,What information should be provided to patients at discharge after suspected sepsis assessment?
"NG51_Antibiotic therapy, intravenous fluid and oxygen: 1.14 Choice of antibiotic therapy for people with suspected sepsis - Part 1",NG51,What is the recommended antibiotic management for suspected sepsis in newborns under 28 days?
"NG51_Antibiotic therapy, intravenous fluid and oxygen: 1.14 Choice of antibiotic therapy for people with suspected sepsis - Part 2",NG51,What is the recommended antibiotic treatment for suspected sepsis in newborns under 28 days?
"NG51_Antibiotic therapy, intravenous fluid and oxygen: 1.15 Intravenous fluids for people with suspected sepsis - Part 1",NG51,What are the recommended intravenous fluid types and volumes for resuscitation in patients with suspected sepsis across different age groups?
"NG51_Antibiotic therapy, intravenous fluid and oxygen: 1.15 Intravenous fluids for people with suspected sepsis - Part 2",NG51,What are the recommended practices for fluid resuscitation in patients with suspected sepsis according to NICE guidelines?
"NG51_Antibiotic therapy, intravenous fluid and oxygen: 1.16 Using oxygen for people with suspected sepsis",NG51,What are the recommended oxygen saturation targets for treating suspected sepsis in adults and children?
NG51_Finding and controlling the source of infection: 1.17 Everyone & Finding and controlling the source of infection: 1.18 Children aged 3 months or less,NG51,When should lumbar puncture be performed in children under 3 months with suspected sepsis?
NG51_Information and support for all people with suspected sepsis: 1.19 Communicating and sharing information,NG51,What are best practices for communicating with patients and families about suspected sepsis to support shared decision making?
"NG51_Information and support for all people with suspected sepsis: 1.20 People who have sepsis and their families and carers & Information and support for all people with suspected sepsis: 1.21 Information at discharge for people assessed for suspected sepsis, but not diagnosed with sepsis",NG51,"What information should be provided to families and carers of patients with sepsis regarding diagnosis, treatment, and support?"
NG51_Information and support for all people with suspected sepsis: 1.22 Information at discharge for people at increased risk of sepsis & Information and support for all people with suspected sepsis: 1.23 Information at discharge for people who have had sepsis,NG51,What information should be provided to patients and carers at discharge after sepsis treatment?
NG51_Training and education,NG51,What training is recommended for healthcare staff to identify and manage sepsis effectively?
NG51_Terms used in this guideline & Recommendations for research: 1 Epidemiological study on presentation and management of sepsis in England,NG51,"What is the incidence, presentation, and management of sepsis in the UK?"
"NG51_Recommendations for research: 2 Association between NEWS2 bands (0, 1 to 4, 5 to 6, 7 or above) and risk of severe illness or death & Recommendations for research: 3 Derivation of clinical decision rules in suspected sepsis",NG51,What is the relationship between NEWS2 scores and the risk of severe illness or death in adults with suspected sepsis?
NG51_Rationale and impact: People with neutropenia or immunosuppression & Rationale and impact: Initial assessment and examination,NG51,What are the recommended initial assessment procedures for identifying sepsis in people with neutropenia or immunosuppression?
"NG51_Rationale and impact: Evaluating risk level in people with suspected sepsis in acute hospital settings, acute mental health settings and ambulances - Part 1",NG51,How is the NEWS2 score used to assess sepsis risk in acute hospital and mental health settings?
"NG51_Rationale and impact: Evaluating risk level in people with suspected sepsis in acute hospital settings, acute mental health settings and ambulances - Part 2",NG51,Should a NEWS2 score of 0 be considered safe for discharging patients with infection?
NG51_Rationale and impact: Outside acute hospital settings - Part 1,NG51,What are the recommendations for managing suspected sepsis outside acute hospital settings?
NG51_Rationale and impact: Outside acute hospital settings - Part 2,NG51,What are the criteria for transferring patients at risk of sepsis in mental health settings?
NG51_Rationale and impact: Managing suspected sepsis in acute hospital settings - Part 1,NG51,What is the recommended timing for antibiotic administration in suspected sepsis based on risk level?
NG51_Rationale and impact: Managing suspected sepsis in acute hospital settings - Part 2,NG51,When should antibiotics be administered for suspected sepsis based on initial NEWS2 assessment?
NG51_Rationale and impact: Managing suspected sepsis in acute hospital settings - Part 3,NG51,What are the recommended escalation pathways for managing suspected sepsis in high and moderate risk patients?
NG51_Rationale and impact: Managing suspected sepsis in acute hospital settings - Part 4,NG51,What are the discharge criteria for patients with suspected sepsis at low or very low risk of severe illness?
NG51_Rationale and impact: Finding and controlling the source of infection,NG51,What are the recommended approaches for finding and controlling the source of infection in sepsis management?
NG51_Context - Part 1,NG51,What are the early signs and initial management steps for suspected sepsis in adults?
NG51_Context - Part 2,NG51,What are the current clinical parameters for early identification and risk stratification of sepsis and septic shock?
NG52_Non-Hodgkin’s lymphoma: diagnosis and management & Overview,NG52,What are the recommended diagnostic tests and treatment options for non-Hodgkin's lymphoma?
NG52_Recommendations: 1.1 Diagnosis,NG52,What are the recommended biopsy procedures for diagnosing non-Hodgkin's lymphoma?
NG52_Recommendations: 1.2 Staging using FDG‑PET‑CT (fluorodeoxyglucose‑positron emission tomography‑CT),NG52,When should FDG-PET-CT be used to confirm staging and assess treatment response in non-Hodgkin's lymphoma?
NG52_Recommendations: 1.3 Management of follicular lymphoma - Part 1,NG52,What is the recommended management for stage IIA follicular lymphoma?
NG52_Recommendations: 1.3 Management of follicular lymphoma - Part 2,NG52,What are the recommended treatment options for stage III–IV follicular lymphoma according to NICE guidelines?
NG52_Recommendations: 1.3 Management of follicular lymphoma - Part 3,NG52,What are the NICE recommendations for using rituximab as maintenance therapy in relapsed follicular non-Hodgkin's lymphoma?
NG52_Recommendations: 1.4 Management of MALT lymphoma - Part 1,NG52,What is the recommended management for gastric MALT lymphoma after Helicobacter pylori eradication therapy?
NG52_Recommendations: 1.4 Management of MALT lymphoma - Part 2,NG52,What are the treatment options for progressive gastric MALT lymphoma?
NG52_Recommendations: 1.4 Management of MALT lymphoma - Part 3,NG52,What are the recommended management options for non-gastric MALT lymphoma?
NG52_Recommendations: 1.5 Management of mantle cell lymphoma - Part 1,NG52,What are the recommended first-line treatments for advanced-stage mantle cell lymphoma?
NG52_Recommendations: 1.5 Management of mantle cell lymphoma - Part 2,NG52,What are the NICE recommendations for maintenance rituximab in mantle cell lymphoma?
NG52_Recommendations: 1.6 Management of diffuse large B‑cell lymphoma - Part 1,NG52,"What are the recommended management strategies for diffuse large B-cell lymphoma, including radiotherapy and CNS prophylaxis?"
NG52_Recommendations: 1.6 Management of diffuse large B‑cell lymphoma - Part 2,NG52,What are the recommendations for central nervous system prophylaxis and stem cell transplantation in diffuse large B-cell lymphoma?
NG52_Recommendations: 1.7 Management of Burkitt lymphoma & Recommendations: 1.8 Management of peripheral T‑cell lymphoma,NG52,What is the recommended first-line treatment for Burkitt lymphoma and peripheral T-cell lymphoma?
NG52_Recommendations: 1.9 Information and support,NG52,"What information and support should be provided to patients with non-Hodgkin's lymphoma regarding diagnosis, treatment options, and lifestyle?"
NG52_Recommendations: 1.10 Follow‑up for people with diffuse large B‑cell lymphoma & Recommendations: 1.11 Survivorship,NG52,What is the recommended follow-up protocol for detecting relapse in patients with diffuse large B-cell lymphoma after treatment?
NG52_Recommendations for research: 1 Baseline FDG‑PET‑CT imaging for people with diffuse large B‑cell lymphoma stage II or above,NG52,What are the benefits of baseline FDG‑PET‑CT compared to baseline CT scan in interpreting end‑of‑treatment FDG‑PET‑CT for diffuse large B‑cell lymphoma?
NG52_Recommendations for research: 2 Factors predicting outcomes for people with high‑grade transformation of follicular lymphoma,NG52,What clinical and molecular factors predict good outcomes with immunochemotherapy in high-grade transformation of follicular lymphoma?
NG52_Recommendations for research: 3 Radiotherapy in first‑line treatment of diffuse large B‑cell lymphoma,NG52,What is the effectiveness of radiotherapy to bulky disease sites after chemotherapy in first-line treatment of diffuse large B-cell lymphoma?
NG52_Context,NG52,What are the current diagnostic and management strategies for non-Hodgkin's lymphoma?
NG53_Transition between inpatient mental health settings and community or care home settings & Overview,NG53,What are the best practices for transitioning patients between inpatient mental health settings and community or care home environments?
NG53_Recommendations: 1.1 Overarching principles,NG53,What are the principles for supporting people in mental health transition care?
NG53_Recommendations: 1.2 Before hospital admission - Part 1,NG53,What are the recommended practices for planning and assessing mental health admissions for people with complex needs?
NG53_Recommendations: 1.2 Before hospital admission - Part 2,NG53,What should be included in admission planning and crisis plans for mental health patients?
NG53_Recommendations: 1.3 Hospital admission - Part 1,NG53,What are the key principles for hospital admission and early engagement in mental health care?
NG53_Recommendations: 1.3 Hospital admission - Part 2,NG53,What are the recommended procedures for managing out-of-area psychiatric admissions and ensuring patient safety?
NG53_Recommendations: 1.3 Hospital admission - Part 3,NG53,What are the key considerations for managing restrictions and providing support during admission to mental health wards?
"NG53_Recommendations: 1.4 Support for families, parents and carers throughout admission - Part 1",NG53,What strategies can healthcare professionals use to support families and carers during a child's hospital admission?
"NG53_Recommendations: 1.4 Support for families, parents and carers throughout admission - Part 2",NG53,What information should be provided to families and carers during a patient's hospital admission and discharge?
NG53_Recommendations: 1.5 Hospital discharge - Part 1,NG53,What are best practices for planning hospital discharge to ensure continuity of care and community links?
NG53_Recommendations: 1.5 Hospital discharge - Part 2,NG53,What are the recommended discharge planning and psychoeducation strategies for people with mental health conditions to prevent relapse and homelessness?
NG53_Recommendations: 1.5 Hospital discharge - Part 3,NG53,What are the recommended components of a discharge care plan for mental health patients?
NG53_Recommendations: 1.5 Hospital discharge - Part 4,NG53,What are the key considerations for discharge planning and assessment in mental health services?
NG53_Recommendations: 1.6 Follow-up support - Part 1,NG53,What follow-up support should be arranged after hospital discharge for mental health patients?
NG53_Recommendations: 1.6 Follow-up support - Part 2,NG53,What are the recommended follow-up procedures and legal considerations for patients discharged after self-harm or suicide risk assessment?
NG53_Terms used in this guideline,NG53,What are effective coping strategies for managing mental health symptoms?
NG53_Implementation: getting started: Challenges for implementation - Part 1,NG53,How can mental health services improve person-centred and recovery-focused transitions for patients?
NG53_Implementation: getting started: Challenges for implementation - Part 2,NG53,What are effective communication strategies for multidisciplinary teams involved in mental health transitions?
NG53_Implementation: getting started: Challenges for implementation - Part 3,NG53,How can healthcare practitioners effectively co-produce and review personalized care plans to support seamless transitions for people with mental health conditions?
NG53_Recommendations for research: 1 Care and support for people with dementia,NG53,What interventions support people with dementia during transition from inpatient mental health settings to community or care homes?
NG53_Recommendations for research: 2 People with complex needs other than dementia,NG53,What are effective interventions to support people with complex mental and physical health needs during transition from inpatient mental health settings to community or care homes?
NG53_Recommendations for research: 3 Children and young people in transition between settings,NG53,What interventions support children and young people during transition from inpatient mental health settings to community or care home settings?
NG53_Context - Part 1,NG53,What are the best practices for ensuring effective transition from inpatient mental health services to community care?
NG53_Context - Part 2,NG53,What are best practices for discharge planning and transition management in mental health inpatient care?
"NG54_Mental health problems in people with learning disabilities: prevention, assessment and management & Overview & Recommendations: 1.1 Using this guideline with other NICE guidelines",NG54,What are the recommended approaches for preventing and managing mental health problems in people with learning disabilities?
NG54_Recommendations: 1.2 Organisation and delivery of care and support - Part 1,NG54,What are the key components of effective care organization for people with learning disabilities and mental health problems according to NICE guidelines?
NG54_Recommendations: 1.2 Organisation and delivery of care and support - Part 2,NG54,What are the recommended approaches for inpatient mental health treatment for people with learning disabilities?
NG54_Recommendations: 1.3 Support and interventions for family members and carers & Recommendations: 1.4 Social and physical environment interventions,NG54,What support and interventions are recommended for family members and carers of people with learning disabilities and mental health problems?
NG54_Recommendations: 1.5 Annual health check,NG54,What should be included in an annual health check for adults with learning disabilities?
NG54_Recommendations: 1.6 Identification and referral,NG54,How should staff identify and refer mental health problems in people with learning disabilities?
NG54_Recommendations: 1.7 Assessment - Part 1,NG54,How should a mental health assessment be conducted for people with learning disabilities?
NG54_Recommendations: 1.7 Assessment - Part 2,NG54,What are the recommended methods for conducting mental health assessments and risk evaluations in people with learning disabilities?
NG54_Recommendations: 1.7 Assessment - Part 3,NG54,How should risk assessments and management plans be conducted and reviewed for people with learning disabilities and mental health problems?
NG54_Recommendations: 1.8 Psychological interventions - Part 1,NG54,What are the recommended principles for delivering psychological interventions to people with learning disabilities?
NG54_Recommendations: 1.8 Psychological interventions - Part 2,NG54,What are effective psychological interventions for managing depression and anxiety in people with learning disabilities?
NG54_Recommendations: 1.9 Pharmacological interventions - Part 1,NG54,What are the NICE recommendations for prescribing medication for mental health problems in people with learning disabilities?
NG54_Recommendations: 1.9 Pharmacological interventions - Part 2,NG54,How should clinicians monitor and review the benefits and side effects of mental health medications?
NG54_Recommendations: 1.10 Occupational interventions,NG54,What are recommended occupational interventions to support adults with learning disabilities in accessing community activities and employment?
NG54_Recommendations: Terms used in this guideline - Part 1,NG54,What are the roles and responsibilities of key workers in supporting people with learning disabilities?
NG54_Recommendations: Terms used in this guideline - Part 2,NG54,What support is recommended for people with learning disabilities to live independently and manage daily activities?
NG54_Recommendations for research: Key recommendations for research - Part 1,NG54,What are effective psychological interventions for internalising disorders in children and young people with learning disabilities?
NG54_Recommendations for research: Key recommendations for research - Part 2,NG54,What is the clinical and cost effectiveness of psychological and pharmacological interventions for depression and anxiety disorders in adults with learning disabilities?
NG54_Recommendations for research: Key recommendations for research - Part 3,NG54,What are the most effective pharmacological and psychosocial interventions for anxiety and mental health problems in people with learning disabilities and autism?
NG54_Recommendations for research: Other recommendations for research,NG54,What are the experiences of people with learning disabilities and mental health problems in mental health services and how do these experiences impact clinical outcomes?
NG54_Context,NG54,How can mental health problems be effectively identified and managed in people with learning disabilities?
NG55_Harmful sexual behaviour among children and young people & Overview,NG55,What are the recommended interventions for children and young people displaying harmful sexual behaviour?
NG55_Recommendations: 1.1 Multi-agency approach - Part 1,NG55,What are best practices for multi-agency teams in providing continuous care for children and young people?
NG55_Recommendations: 1.1 Multi-agency approach - Part 2,NG55,What are the recommended multi-agency safeguarding arrangements for harmful sexual behaviour in children and young people?
NG55_Recommendations: 1.1 Multi-agency approach - Part 3,NG55,What are the recommended procedures for reviewing and sharing care plans for children and young people in multidisciplinary teams?
NG55_Recommendations: 1.2 Named safeguarding leads in universal services,NG55,What are the recommended actions for safeguarding leads when a child displays sexualised behaviour?
NG55_Recommendations: 1.3 Early help assessment - Part 1,NG55,What are the recommended procedures for early help assessment of children displaying inappropriate sexualised behaviour?
NG55_Recommendations: 1.3 Early help assessment - Part 2,NG55,What are the recommended approaches for managing harmful sexual behaviour in children and young people?
NG55_Recommendations: 1.4 Risk assessment for children and young people referred to harmful sexual behaviour services,NG55,What are the recommended risk assessment tools for children and young people displaying harmful sexual behaviour?
NG55_Recommendations: 1.5 Engaging with families and carers before an intervention begins,NG55,How should healthcare professionals engage with families and carers before beginning intervention for harmful sexual behaviour in children and young people?
NG55_Recommendations: 1.6 Developing and managing a care plan for children and young people displaying harmful sexual behaviour,NG55,What are the key components of developing a care plan for children and young people with harmful sexual behaviour according to NICE guidelines?
NG55_Recommendations: 1.7 Developing interventions for children and young people displaying harmful sexual behaviour - Part 1,NG55,What are effective interventions for children and young people displaying harmful sexual behaviour?
NG55_Recommendations: 1.7 Developing interventions for children and young people displaying harmful sexual behaviour - Part 2,NG55,What are the recommended therapeutic approaches for children and young people with problematic sexual behaviour who are not living with their birth parents?
NG55_Recommendations: 1.7 Developing interventions for children and young people displaying harmful sexual behaviour - Part 3 & Recommendations: 1.8 Supporting a return to the community for 'accommodated' children and young people,NG55,What are the recommended strategies for maintaining family links and supporting reintegration for children and young people in care?
NG55_Recommendations: Terms used in this guideline,NG55,What is the definition of harmful sexual behaviour in children according to NICE guidelines?
NG55_Context,NG55,What are effective interventions for children and young people with harmful sexual behaviour?
NG55_Recommendations for research: Key recommendations for research - Part 1,NG55,What are the effective interventions for children and young people displaying harmful sexual behaviour?
NG55_Recommendations for research: Key recommendations for research - Part 2,NG55,What are the most effective interventions for families and carers of children and young people displaying harmful sexual behaviour?
NG55_Recommendations for research: Other recommendations for research & 10 more sections,NG55,What are effective interventions for harmful sexual behaviour in children and adolescents?
NG55_Glossary: Problematic sexual behaviour & 6 more sections,NG55,What are the recommended approaches for managing problematic sexual behaviour in children and young people?
NG56_Multimorbidity: clinical assessment and management & Overview & Recommendations: 1.1 General principles,NG56,What are the best practices for managing multimorbidity to reduce treatment burden and improve patient quality of life?
NG56_Recommendations: 1.2 Taking account of multimorbidity in tailoring the approach to care,NG56,How should care be tailored for patients with multimorbidity and complex health needs?
NG56_Recommendations: 1.3 How to identify people who may benefit from an approach to care that takes account of multimorbidity,NG56,What are the methods for identifying adults who may benefit from a multimorbidity-informed approach to care?
NG56_Recommendations: 1.4 How to assess frailty,NG56,What are the recommended methods for assessing frailty in primary care and hospital outpatient settings?
NG56_Recommendations: 1.5 Principles of an approach to care that takes account of multimorbidity,NG56,How should healthcare professionals develop an individualized care plan for patients with multimorbidity?
NG56_Recommendations: 1.6 Delivering an approach to care that takes account of multimorbidity - Part 1,NG56,How should healthcare professionals assess and address multimorbidity to improve patient quality of life?
NG56_Recommendations: 1.6 Delivering an approach to care that takes account of multimorbidity - Part 2,NG56,How should healthcare professionals involve patients and their families in treatment decisions and review medication effectiveness?
NG56_Recommendations: 1.6 Delivering an approach to care that takes account of multimorbidity - Part 3 & Recommendations: 1.7 Comprehensive assessment in hospital,NG56,What are the recommended approaches for discussing treatment continuation and goals with older adults with limited life expectancy or frailty?
NG56_Recommendations: Terms used in this guideline,NG56,What is the recommended approach to managing multimorbidity in adults?
NG56_Recommendations for research: 1 Organisation of care,NG56,What is the clinical and cost effectiveness of different approaches to organising primary care for people with multimorbidity?
NG56_Recommendations for research: 2 Holistic assessment in the community,NG56,What is the clinical and cost effectiveness of community holistic assessments for people with multimorbidity?
NG56_Recommendations for research: 3 Stopping preventive medicines,NG56,What is the clinical and cost effectiveness of stopping preventive medicines in people with multimorbidity?
NG56_Recommendations for research: 4 Predicting life expectancy,NG56,How can primary care data be used to predict life expectancy and inform treatment decisions?
NG56_Context,NG56,What are the recommended approaches for managing multimorbidity in primary care?
NG57_Physical health of people in prison & Overview,NG57,What are the recommended approaches for assessing and managing physical health problems in people in prison?
NG57_Recommendations: 1.1 Assessing health - Part 1,NG57,What should be included in the first-stage health assessment for new prisoners?
NG57_Recommendations: 1.1 Assessing health - Part 2,NG57,What questions should be asked during a first-stage health assessment in prison?
NG57_Recommendations: 1.1 Assessing health - Part 3 & Recommendations: 1.1 Assessing health - Part 4,NG57,What are the recommended steps for recording mental health assessments and transferring medical records when a person enters prison healthcare?
NG57_Recommendations: 1.1 Assessing health - Part 5,NG57,What are the recommended procedures for medicines reconciliation and tuberculosis screening in prison settings?
NG57_Recommendations: 1.1 Assessing health - Part 6,NG57,What are the recommended assessments for mental health and physical health in prison health evaluations?
NG57_Recommendations: 1.1 Assessing health - Part 7,NG57,"What are the recommended health advice and screening procedures for alcohol, substance misuse, exercise, diet, smoking cessation, and sexual health in prison populations?"
NG57_Recommendations: 1.1 Assessing health - Part 8,NG57,What are the recommended hepatitis B and C screening and vaccination protocols for people entering prison?
NG57_Recommendations: 1.2 Communication and coordination,NG57,How should communication and information sharing be managed for people with complex health and social care needs in prison?
NG57_Recommendations: 1.3 Promoting health and wellbeing,NG57,What health promotion strategies are recommended for improving lifestyle and wellbeing in prison settings?
NG57_Recommendations: 1.4 Managing medicines,NG57,What are the recommended practices for managing medicines and ensuring adherence in prison settings?
NG57_Recommendations: 1.5 Monitoring chronic conditions,NG57,What are the recommended monitoring protocols for chronic heart failure according to NICE guidelines?
NG57_Recommendations: 1.6 Managing deteriorating health and health emergencies,NG57,What are the recommended protocols for managing rapid health deterioration and emergencies in prison settings?
NG57_Recommendations: 1.7 Continuity of healthcare - Part 1,NG57,How can healthcare providers ensure continuity of care for prisoners during transfer and after release?
NG57_Recommendations: 1.7 Continuity of healthcare - Part 2,NG57,What are the recommended procedures for ensuring continuity of medicines and care planning for individuals released from prison?
NG57_Recommendations: 1.7 Continuity of healthcare - Part 3,NG57,What are the recommended practices for managing medication continuity when discharging prisoners?
NG57_Recommendations: Terms used in this guideline & Recommendations for research: 1 Subsequent health assessment,NG57,When should subsequent health assessments be conducted for people serving long-term sentences in prison?
NG57_Recommendations for research: 2 Chronic conditions & Recommendations for research: 3 Promoting health and wellbeing,NG57,What is the prevalence of chronic diseases among the UK prison population?
NG57_Recommendations for research: 4 Assessment tools for health promotion,NG57,What are the most effective assessment tools for identifying health promotion needs in prison populations?
NG57_Recommendations for research: 5 Access to medicines,NG57,"What is the effectiveness of directly observed supply of high-risk medicines in reducing diversion, abuse, and non-adherence in prison settings?"
NG57_Context,NG57,What are the key principles for providing equivalent healthcare to prisoners in line with NICE guidelines?
NG58_Coexisting severe mental illness and substance misuse: community health and social care services & Overview,NG58,What are the recommended community health and social care services for people with coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.1 First contact with services,NG58,What are the key considerations for first contact staff when supporting individuals with coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.2 Referral to secondary care mental health services - Part 1,NG58,What are the recommended practices for referral and care coordination in secondary mental health services for people with coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.2 Referral to secondary care mental health services - Part 2,NG58,What are the key components of developing a person-centered care plan for individuals with coexisting mental health and substance misuse issues?
"NG58_Recommendations: 1.3 The care plan: multi-agency approach to address physical health, social care, housing and other support needs - Part 1",NG58,What are the key components of a multi-agency care plan for individuals with complex health and social needs?
"NG58_Recommendations: 1.3 The care plan: multi-agency approach to address physical health, social care, housing and other support needs - Part 2",NG58,"How can healthcare providers support self-care, social engagement, and multi-agency coordination for individuals with complex health and social needs?"
"NG58_Recommendations: 1.3 The care plan: multi-agency approach to address physical health, social care, housing and other support needs - Part 3",NG58,What are the key considerations for discharge planning and transition of care in mental health services?
"NG58_Recommendations: 1.4 Partnership working between specialist services, health, social care and other support services and commissioners",NG58,"What are the recommended strategies for partnership working between mental health, substance misuse, and social care services to support people with coexisting severe mental illness and substance misuse?"
NG58_Recommendations: 1.5 Improving service delivery - Part 1,NG58,How can health and social care services be adapted to better support people with coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.5 Improving service delivery - Part 2,NG58,What are recommended interventions for supporting people with coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.6 Maintaining contact between services and people with coexisting severe mental illness and substance misuse who use them - Part 1,NG58,How can services improve engagement and maintain contact with people who have coexisting severe mental illness and substance misuse?
NG58_Recommendations: 1.6 Maintaining contact between services and people with coexisting severe mental illness and substance misuse who use them - Part 2,NG58,How should healthcare providers follow up with patients with coexisting mental illness and substance misuse who miss appointments?
NG58_Recommendations: Terms used in this guideline,NG58,What is the definition of contingency management in mental health treatment?
NG58_Recommendations for research: 1 Needs assessment,NG58,What is the prevalence and support needs of people with coexisting severe mental illness and substance misuse in the UK?
NG58_Recommendations for research: 2 What works? & Recommendations for research: 3 Costing tool,NG58,"What is the effectiveness and cost-effectiveness of peer support, contingency management, and text messaging interventions for people with coexisting severe mental illness and substance misuse?"
NG58_Recommendations for research: 4 Barriers and facilitators & Recommendations for research: 5 Care pathway,NG58,What are the barriers and facilitators to providing optimal care for people with coexisting severe mental illness and substance misuse?
NG58_Context,NG58,What are the recommended approaches for managing coexisting severe mental illness and substance misuse in adults and young people?
NG59_Low back pain and sciatica in over 16s: assessment and management & Overview,NG59,What are the recommended assessment and management strategies for low back pain and sciatica in adults?
NG59_Recommendations: 1.1 Assessment of low back pain and sciatica,NG59,What are the recommended approaches for assessing and managing low back pain and sciatica according to NICE guidelines?
NG59_Recommendations: 1.2 Non-invasive treatments for low back pain and sciatica - Part 1,NG59,What non-pharmacological treatments are recommended for managing low back pain and sciatica?
NG59_Recommendations: 1.2 Non-invasive treatments for low back pain and sciatica - Part 2,NG59,What are the recommended non-pharmacological treatments for low back pain with or without sciatica according to NICE guidelines?
NG59_Recommendations: 1.2 Non-invasive treatments for low back pain and sciatica - Part 3,NG59,"What are the recommended approaches for managing opioid, gabapentinoid, or benzodiazepine withdrawal in patients with sciatica?"
NG59_Recommendations: 1.2 Non-invasive treatments for low back pain and sciatica - Part 4,NG59,What are the recommended pharmacological treatments for low back pain according to NICE guidelines?
NG59_Recommendations: 1.3 Invasive treatments for low back pain and sciatica,NG59,When should spinal injections or surgical interventions be considered for low back pain and sciatica?
NG59_Recommendations: Terms used in this guideline & Recommendations for research,NG59,What is the clinical effectiveness of opioids for managing acute sciatica?
NG59_Rationale and impact: Pharmacological management of sciatica - Part 1,NG59,What are the recommended pharmacological treatments for managing sciatica?
NG59_Rationale and impact: Pharmacological management of sciatica - Part 2,NG59,What is the evidence for using antidepressants to treat sciatica?
NG59_Context,NG59,What are the recommended assessment and management strategies for non-specific low back pain and sciatica in adults?
NG5_Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes & Overview,NG5,What are the best practices for medicines reconciliation and review to ensure safe and effective medication use?
NG5_Introduction - Part 1,NG5,What are the best practices for managing polypharmacy in patients with long-term conditions?
NG5_Introduction - Part 2,NG5,What is the difference between appropriate and problematic polypharmacy according to NICE guidelines?
NG5_Introduction - Part 3,NG5,What are the best practices for involving patients in decisions about their medicines to improve safety and experience in NHS services?
NG5_Introduction - Part 4,NG5,What strategies are recommended to reduce medication errors during patient transfers between care settings?
NG5_Introduction - Part 5,NG5,What are the key principles of medicines optimisation to improve patient outcomes?
NG5_Introduction - Part 6,NG5,How can health and social care practitioners optimise medicines use through data and person-centred approaches?
NG5_Key priorities for implementation,NG5,What are best practices for communicating medication information during patient transfers between care settings?
"NG5_Recommendations: 1.1 Systems for identifying, reporting and learning from medicines‑related patient safety incidents - Part 1",NG5,How can healthcare organizations improve reporting and learning from medicines-related patient safety incidents?
"NG5_Recommendations: 1.1 Systems for identifying, reporting and learning from medicines‑related patient safety incidents - Part 2",NG5,What are the recommended strategies for reporting and reducing medicines-related patient safety incidents in healthcare settings?
NG5_Recommendations: 1.2 Medicines-related communication systems when patients move from one care setting to another - Part 1,NG5,What are the recommended processes for sharing medicines information during patient transfers between care settings?
NG5_Recommendations: 1.2 Medicines-related communication systems when patients move from one care setting to another - Part 2,NG5,What information should be communicated to patients and carers about their medicines during hospital discharge?
NG5_Recommendations: 1.3 Medicines reconciliation,NG5,What are the key steps and responsibilities involved in medicines reconciliation across different care settings?
NG5_Recommendations: 1.4 Medication review,NG5,How should healthcare professionals conduct a structured medication review for patients with polypharmacy or chronic conditions?
NG5_Recommendations: 1.5 Self-management plans,NG5,How should healthcare professionals develop and implement self-management plans for patients with long-term conditions?
NG5_Recommendations: 1.6 Patient decision aids used in consultations involving medicines - Part 1,NG5,How can healthcare professionals effectively involve patients in decision-making about their medicines using decision aids?
NG5_Recommendations: 1.6 Patient decision aids used in consultations involving medicines - Part 2,NG5,What are the best practices for using patient decision aids in consultations about medicines?
NG5_Recommendations: 1.7 Clinical decision support & Recommendations: 1.8 Medicines-related models of organisational and cross-sector working,NG5,What are the best practices for implementing and using computerised clinical decision support systems in prescribing?
NG5_Recommendations: Terms used in this guideline,NG5,What is an adverse drug reaction and how is it reported?
NG5_Recommendations for research: 1 Medication review in children – suboptimal use of medicines and medicines-related patient safety incidents - Part 1,NG5,What is the effectiveness of medication reviews in children for reducing medicines-related safety incidents compared to usual care?
NG5_Recommendations for research: 1 Medication review in children – suboptimal use of medicines and medicines-related patient safety incidents - Part 2,NG5,What is the effectiveness of medication reviews in children for improving clinical outcomes and reducing medication-related problems?
NG5_Recommendations for research: 2 Medication review – suboptimal use of medicines and patient‑reported outcomes - Part 1,NG5,What is the clinical and cost effectiveness of medication reviews carried out by different health professionals in reducing suboptimal medicine use and improving patient-reported outcomes?
NG5_Recommendations for research: 2 Medication review – suboptimal use of medicines and patient‑reported outcomes - Part 2,NG5,What is the effectiveness of medication reviews in improving patient outcomes and resource use in UK healthcare settings?
NG5_Recommendations for research: 3 Clinical decision support systems - Part 1,NG5,What is the clinical and cost effectiveness of clinical decision support systems in improving medication safety and patient outcomes in the UK?
NG5_Recommendations for research: 3 Clinical decision support systems - Part 2,NG5,What is the effectiveness of clinical decision support systems in improving patient outcomes and medication safety in all populations taking medicines?
NG5_Recommendations for research: 4 Cross-organisational working,NG5,"What models of cross-organisational working improve clinical and cost outcomes in the management of suboptimal prescribing across NHS, social care, and primary and secondary care settings?"
NG60_HIV testing: increasing uptake among people who may have undiagnosed HIV & Overview,NG60,How can healthcare services increase the uptake of HIV testing among people with undiagnosed HIV?
NG60_Recommendations: 1.1 Offering and recommending HIV testing in different settings - Part 1,NG60,What are the recommendations for offering HIV testing in different healthcare settings based on local prevalence?
NG60_Recommendations: 1.1 Offering and recommending HIV testing in different settings - Part 2,NG60,When should HIV testing be offered in healthcare settings and primary care?
NG60_Recommendations: 1.1 Offering and recommending HIV testing in different settings - Part 3,NG60,What are the recommended procedures for HIV testing and specimen collection in community and prison settings according to NICE guidelines?
NG60_Recommendations: 1.2 Increasing opportunities for HIV testing - Part 1,NG60,What are the recommendations for increasing HIV testing opportunities through point-of-care testing and self-sampling?
NG60_Recommendations: 1.2 Increasing opportunities for HIV testing - Part 2,NG60,What are the recommended frequency and strategies for HIV testing in high-risk populations?
NG60_Recommendations: 1.3 Promoting awareness and uptake of HIV testing - Part 1,NG60,What are effective strategies for promoting awareness and increasing HIV testing uptake in diverse communities?
NG60_Recommendations: 1.3 Promoting awareness and uptake of HIV testing - Part 2,NG60,What are effective strategies for promoting HIV testing and reducing stigma through health promotion materials?
NG60_Recommendations: 1.4 Reducing barriers to HIV testing,NG60,What are the recommended strategies for reducing barriers to HIV testing in healthcare settings?
NG60_Recommendations: Terms used in this guideline,NG60,What is chemsex and how does it relate to HIV risk?
NG60_Recommendations for research,NG60,What are effective strategies to increase HIV testing uptake among high-risk populations in the UK?
NG60_Context - Part 1,NG60,What are the recommended strategies for early diagnosis and testing for HIV in high-risk populations?
NG60_Context - Part 2,NG60,What are the current NICE recommendations for increasing HIV testing uptake among high-risk groups in the UK?
"NG61_End of life care for infants, children and young people with life-limiting conditions: planning and management & Overview",NG61,"What are the key principles for planning and managing end of life care for infants, children, and young people with life-limiting conditions?"
NG61_Recommendations: 1.1 General principles - Part 1,NG61,How can healthcare professionals support children and young people with life-limiting conditions and their families in decision-making and communication?
NG61_Recommendations: 1.1 General principles - Part 2,NG61,How should healthcare professionals communicate with children and young people with life-limiting conditions and their families?
NG61_Recommendations: 1.1 General principles - Part 3,NG61,What are best practices for communicating with children and young people about their life-limiting condition?
NG61_Recommendations: 1.2 Care planning and support throughout the child or young person's life - Part 1,NG61,What are the key components of advance care planning for children and young people with life-limiting conditions?
NG61_Recommendations: 1.2 Care planning and support throughout the child or young person's life - Part 2,NG61,How should healthcare professionals develop and review advance care plans for children and young people with life-limiting conditions?
NG61_Recommendations: 1.2 Care planning and support throughout the child or young person's life - Part 3,NG61,How should healthcare professionals discuss organ donation with children and young people with life-limiting conditions?
NG61_Recommendations: 1.2 Care planning and support throughout the child or young person's life - Part 4,NG61,"How can healthcare providers support the emotional, social, and spiritual needs of children with life-limiting conditions?"
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 1,NG61,What are the recommended practices for end-of-life care and advance care planning for children and young people with life-limiting conditions?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 2,NG61,What are the best practices for planning rapid transfer and end-of-life care for children and young people in their preferred place of death?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 3,NG61,What are effective strategies for managing pain and distress in children at the end of life?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 4,NG61,What is the recommended stepwise approach to managing pain with analgesics and opioids in children and young people?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 5,NG61,What are recommended approaches for managing agitation and delirium in children and young people approaching end of life?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 6,NG61,What are the recommended approaches for managing seizures and respiratory distress in children and young people approaching the end of life?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 7,NG61,How should respiratory distress and airway secretions be managed in children approaching the end of life?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 8,NG61,What are the signs indicating a child or young person is likely to die within hours or days?
NG61_Recommendations: 1.3 Care of the child or young person who is approaching the end of life - Part 9,NG61,What are the recommended communication strategies for discussing end-of-life care with children and young people?
"NG61_Recommendations: 1.4 Care and support for parents, carers and healthcare professionals in relation to the death of a child or young person",NG61,What are the recommended practices for providing care and support to parents and healthcare professionals after the death of a child or young person?
NG61_Recommendations: 1.5 Service delivery - Part 1,NG61,How should multidisciplinary teams be structured for caring for children and young people with life-limiting conditions?
NG61_Recommendations: 1.5 Service delivery - Part 2,NG61,What are the recommended arrangements for rapid transfer and home care for children with life-limiting conditions nearing end of life?
NG61_Recommendations: Terms used in this guideline,NG61,What is paediatric palliative care and how is it provided for children with life-limiting conditions?
NG61_Implementation: getting started - Part 1,NG61,How can healthcare organizations effectively implement NICE guidelines into practice?
NG61_Implementation: getting started - Part 2,NG61,How can healthcare organizations develop and implement an effective action plan to improve guideline adherence?
NG61_Recommendations for research: 1 Preferred place of care and place of death,NG61,What factors influence children's and young people's preferences for end-of-life care location and death setting?
NG61_Recommendations for research: 2 Perinatal palliative care,NG61,What are the effects of timely perinatal palliative care on parental experience and decision-making?
NG61_Recommendations for research: 3 Emotional and psychological support and interventions & Recommendations for research: 4 Managing breakthrough pain,NG61,What are the most effective and safe opioid options for managing breakthrough pain in children and young people receiving end-of-life care in the community?
NG61_Recommendations for research: 5 Recognising that a child or young person may be dying & Context - Part 1,NG61,What are the signs and symptoms indicating a child or young person with a life-limiting condition is approaching death?
NG61_Context - Part 2,NG61,How is paediatric palliative and end of life care provided to improve quality of life for children with life-limiting conditions?
NG62_Cerebral palsy in under 25s: assessment and management & Overview,NG62,What are the recommended assessment and management strategies for cerebral palsy in children and young people up to age 25?
NG62_Recommendations: 1.1 Risk factors,NG62,What are the risk factors for cerebral palsy in newborns and infants?
NG62_Recommendations: 1.2 Causes of cerebral palsy - Part 1,NG62,What are the main causes and brain abnormalities associated with cerebral palsy in children?
NG62_Recommendations: 1.2 Causes of cerebral palsy - Part 2,NG62,When should MRI be used to investigate the cause of cerebral palsy in children and young people?
NG62_Recommendations: 1.3 Looking for signs of cerebral palsy,NG62,What are the early signs and assessment methods for cerebral palsy in infants?
NG62_Recommendations: 1.4 Red flags for other neurological disorders,NG62,What are the red flags indicating a possible neurological disorder in children?
NG62_Recommendations: 1.5 Multidisciplinary care,NG62,What are the recommended multidisciplinary team services for children with cerebral palsy?
NG62_Recommendations: 1.6 Information and support - Part 1,NG62,What information and support should be provided to parents and carers of children with cerebral palsy?
NG62_Recommendations: 1.6 Information and support - Part 2,NG62,"What information should be provided to children with cerebral palsy and their families about communication, care planning, and local support services?"
NG62_Recommendations: 1.7 Information about prognosis,NG62,What is the prognosis for walking and speech development in children with cerebral palsy?
"NG62_Recommendations: 1.8 Eating, drinking and swallowing difficulties - Part 1",NG62,"What are the recommended assessment and management strategies for eating, drinking, and swallowing difficulties in children with cerebral palsy?"
"NG62_Recommendations: 1.8 Eating, drinking and swallowing difficulties - Part 2",NG62,"What are the recommended assessments and management strategies for eating, drinking, and swallowing difficulties in children with cerebral palsy?"
"NG62_Recommendations: 1.9 Speech, language and communication - Part 1",NG62,What are the recommended approaches for assessing and managing communication difficulties in children and young people with cerebral palsy?
"NG62_Recommendations: 1.9 Speech, language and communication - Part 2",NG62,What are effective communication interventions for children and young people with cerebral palsy?
NG62_Recommendations: 1.10 Optimising nutritional status,NG62,How should the nutritional status of children with cerebral palsy be monitored and managed?
NG62_Recommendations: 1.11 Managing saliva control - Part 1,NG62,What are the recommended medications for managing saliva control in children with cerebral palsy according to NICE guidelines?
NG62_Recommendations: 1.11 Managing saliva control - Part 2,NG62,What are the recommended treatments for saliva control in children with cerebral palsy according to NICE guidelines?
NG62_Recommendations: 1.12 Low bone mineral density,NG62,What are the recommended management strategies for low bone mineral density in children and young people with cerebral palsy?
"NG62_Recommendations: 1.13 Pain, discomfort and distress - Part 1",NG62,What are the recommended methods for assessing pain in children and young people with cerebral palsy?
"NG62_Recommendations: 1.13 Pain, discomfort and distress - Part 2",NG62,When should children with cerebral palsy be referred for specialist pain assessment?
NG62_Recommendations: 1.14 Sleep disturbances,NG62,What are the recommended approaches for managing sleep disturbances in children with cerebral palsy?
NG62_Recommendations: 1.15 Mental health problems - Part 1,NG62,What are the recommended approaches for identifying and managing mental health problems in children and young people with cerebral palsy?
NG62_Recommendations: 1.15 Mental health problems - Part 2,NG62,What are effective strategies for assessing and managing emotional and behavioural difficulties in children and young people with cerebral palsy?
NG62_Recommendations: 1.16 Registering and processing sensory information,NG62,What are effective strategies for supporting sensory processing difficulties in children with cerebral palsy?
NG62_Recommendations: 1.17 Information on other comorbidities - Part 1,NG62,What are the recommended assessments and management strategies for visual and hearing impairments in children with cerebral palsy?
NG62_Recommendations: 1.17 Information on other comorbidities - Part 2,NG62,"What are the common hearing, learning, and behavioral difficulties associated with cerebral palsy in children and young people?"
NG62_Recommendations: 1.17 Information on other comorbidities - Part 3,NG62,What are the recommended approaches for managing behavioural difficulties in children with cerebral palsy?
NG62_Recommendations: 1.18 Care needs,NG62,How should healthcare professionals assess and address the care needs of children with cerebral palsy and their families?
NG62_Recommendations: 1.19 Transition to adults' services,NG62,What are the recommended practices for transitioning young people with cerebral palsy from children's to adults' health and social care services?
NG62_Recommendations: Terms used in this guideline & Recommendations for research: 1 Optimising nutritional status in children with cerebral palsy & Recommendations for research: 2 Managing communication difficulties in children with cerebral palsy,NG62,What is the effectiveness of early nutritional interventions for improving growth and development in children with cerebral palsy?
NG62_Recommendations for research: 3 Recognition and early management of pain in children and young people with cerebral palsy & Recommendations for research: 4 Association between treating infections in pregnancy and rates of cerebral palsy,NG62,Does using pain assessment tools by parents or carers improve early recognition and management of pain in children with cerebral palsy in community settings?
NG62_Recommendations for research: 5 Prevalence of mental health problems in young people (up to the age of 25) with cerebral palsy & Recommendations for research: 5 Prevalence of mental health problems in young people (up to the age of 25) with cerebral palsy,NG62,What is the prevalence of mental health problems among young people with cerebral palsy?
NG62_Context,NG62,What are the recommended management strategies for developmental and clinical comorbidities in children with cerebral palsy?
NG63_Antimicrobial stewardship: changing risk-related behaviours in the general population & Overview,NG63,What strategies can effectively change public behaviour to reduce antimicrobial misuse and resistance?
NG63_Recommendations: 1.1 Overarching principles,NG63,What are the key principles for public health leaders to promote antimicrobial stewardship and infection prevention programs?
NG63_Recommendations: 1.2 Local system-wide approaches to reducing inappropriate antimicrobial demand and use - Part 1,NG63,What information should be provided to patients and the public to promote self-care and appropriate use of antimicrobials for self-limiting infections?
NG63_Recommendations: 1.2 Local system-wide approaches to reducing inappropriate antimicrobial demand and use - Part 2,NG63,What are the recommended precautions for the public to avoid misuse of prescription-only antimicrobials?
NG63_Recommendations: 1.3 Local system-wide approaches to preventing and limiting the spread of infection - Part 1,NG63,What are the recommended strategies for local authorities to promote infection prevention and control in the community?
NG63_Recommendations: 1.3 Local system-wide approaches to preventing and limiting the spread of infection - Part 2,NG63,What are the key food hygiene practices and handwashing tips to prevent infection?
NG63_Recommendations: 1.4 Childcare and education providers - Part 1,NG63,What are the recommended infection control practices for childcare and education providers?
NG63_Recommendations: 1.4 Childcare and education providers - Part 2,NG63,What are effective strategies for promoting infection prevention in schools and childcare settings?
NG63_Recommendations: 1.4 Childcare and education providers - Part 3,NG63,What information should be provided to young people about recognizing and managing self-limiting infections?
"NG63_Recommendations: 1.5 Prescribers, primary care and community pharmacy teams - Part 1",NG63,What is the recommended approach for managing self-limiting infections in primary care?
"NG63_Recommendations: 1.5 Prescribers, primary care and community pharmacy teams - Part 2",NG63,What information should healthcare professionals provide to patients about the appropriate use and safety of antimicrobials?
NG63_Recommendations: Terms used in this guideline - Part 1,NG63,What is antimicrobial stewardship and how does it help prevent antimicrobial resistance?
NG63_Recommendations: Terms used in this guideline - Part 2,NG63,What are the risks of inappropriate antimicrobial use and how can it lead to antimicrobial resistance?
NG63_Context - Part 1,NG63,What are the best practices for antimicrobial stewardship to prevent antimicrobial resistance?
NG63_Context - Part 2,NG63,What are the recommended strategies to reduce antibiotic resistance in the UK?
NG63_Recommendations for research: 2 Behavioural strategies and programmes & Recommendations for research: 3 High-risk groups & Recommendations for research: 4 Workplace,NG63,What are the most effective behavioral strategies and interventions to reduce antimicrobial demand and prevent infection spread in high-risk groups and workplace settings?
NG64_Drug misuse prevention: targeted interventions & Overview & Recommendations: 1.1 Delivering drug misuse prevention activities as part of existing services,NG64,What are the recommended targeted interventions for preventing drug misuse in at-risk populations?
NG64_Recommendations: 1.2 Assessment,NG64,What are the recommended approaches for assessing vulnerability to drug misuse during routine healthcare contacts?
NG64_Recommendations: 1.3 Children and young people assessed as vulnerable to drug misuse - Part 1,NG64,What are effective skills training strategies for children and young people vulnerable to drug misuse?
NG64_Recommendations: 1.3 Children and young people assessed as vulnerable to drug misuse - Part 2,NG64,"What are the recommended components and considerations for skills training programs for children, young people, and their carers?"
NG64_Recommendations: 1.4 Adults assessed as vulnerable to drug misuse,NG64,What are the recommended approaches for providing information and support to adults vulnerable to drug misuse?
NG64_Recommendations: 1.5 People at risk of using drugs,NG64,"What information should be provided to people at risk of drug use in settings like nightclubs, gyms, or supported accommodation?"
NG64_Recommendations: Terms used in this guideline - Part 1,NG64,What is the definition of care leavers and children and young people who are looked after according to NICE guidelines?
NG64_Recommendations: Terms used in this guideline - Part 2,NG64,What are the recommended strategies for preventing drug misuse among young people aged 10 to 25 with special educational needs?
NG64_Recommendations for research: Key recommendations for research - Part 1,NG64,What is known about the long-term health and social consequences of drug use?
NG64_Recommendations for research: Key recommendations for research - Part 2,NG64,What is the acceptability and effectiveness of digital interventions for drug misuse prevention among at-risk groups in the UK?
NG64_Recommendations for research: Other recommendations for research & 5 more sections,NG64,What are effective strategies to prevent and reduce the use of image- and performance-enhancing drugs?
NG64_Glossary: Motivational interviewing & Glossary: Psychoeducation & Glossary: Skills training,NG64,What is motivational interviewing and how is it used to reduce drug misuse?
NG64_Context - Part 1,NG64,What are the legal restrictions and classifications of controlled drugs under the Misuse of Drugs Act 1971 and Psychoactive Substances Act 2016 in the UK?
NG64_Context - Part 2,NG64,What are the current NICE recommendations for drug misuse treatment and prevention in young people?
NG65_Spondyloarthritis in over 16s: diagnosis and management & Overview,NG65,What are the recommended approaches for diagnosing and managing spondyloarthritis in adults over 16?
NG65_Recommendations: 1.1 Recognition and referral in non-specialist care settings - Part 1,NG65,What are the criteria for referring a patient with suspected axial spondyloarthritis to a rheumatologist?
NG65_Recommendations: 1.1 Recognition and referral in non-specialist care settings - Part 2,NG65,What are the criteria for referring a patient for spondyloarthritis assessment?
NG65_Recommendations: 1.1 Recognition and referral in non-specialist care settings - Part 3,NG65,When should I refer a patient with enthesitis or uveitis for spondyloarthritis assessment?
NG65_Recommendations: 1.2 Diagnosing spondyloarthritis in specialist care settings - Part 1,NG65,What are the diagnostic criteria and imaging recommendations for spondyloarthritis in specialist care?
NG65_Recommendations: 1.2 Diagnosing spondyloarthritis in specialist care settings - Part 2,NG65,How is MRI used to diagnose non-radiographic axial spondyloarthritis according to NICE guidelines?
NG65_Recommendations: 1.3 Information and support,NG65,What information and support should be provided to people with spondyloarthritis and their carers?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 1,NG65,What is the recommended pharmacological management for axial spondyloarthritis according to NICE guidelines?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 2,NG65,What are the treatment options for active ankylosing spondylitis and non-radiographic axial spondyloarthritis when NSAIDs are ineffective or not tolerated?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 3,NG65,What are the recommended treatments for active non-radiographic axial spondyloarthritis when TNF-alpha inhibitors are not suitable?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 4,NG65,What factors should be considered when choosing a standard DMARD for rheumatoid arthritis?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 5,NG65,What are the recommended biological DMARDs for treating active psoriatic arthritis when previous treatments are ineffective or not tolerated?
NG65_Recommendations: 1.4 Pharmacological management of spondyloarthritis - Part 6,NG65,What are the criteria for continuing biological DMARD treatment in adults with spondyloarthritis according to NICE guidelines?
NG65_Recommendations: 1.5 Non-pharmacological management of spondyloarthritis & Recommendations: 1.6 Surgery for spondyloarthritis,NG65,What are the recommended non-pharmacological management strategies for axial spondyloarthritis?
NG65_Recommendations: 1.7 Managing flares & Recommendations: 1.8 Long-term complications,NG65,How should flares be managed in primary care for patients with spondyloarthritis?
NG65_Recommendations: 1.9 Organisation of care,NG65,How should care be coordinated across primary and secondary settings for people with spondyloarthritis?
NG65_Terms used in this guideline,NG65,What is the definition of active psoriatic arthritis according to NICE guidelines?
NG65_Recommendations for research: 1 Referral criteria for people with suspected axial spondyloarthritis,NG65,What are the recommended referral criteria for suspected axial spondyloarthritis in primary care?
NG65_Recommendations for research: 2 Long-term complications of spondyloarthritis,NG65,"What is the risk of osteoporosis, cardiovascular disease, and metabolic syndrome in people with spondyloarthritis compared to the general population?"
NG65_Recommendations for research: 3 Educational intervention to improve healthcare professionals' awareness of spondyloarthritis,NG65,What is the effectiveness of educational interventions for healthcare professionals in reducing diagnosis delays of spondyloarthritis?
NG65_Recommendations for research: 4 Pharmacological management of peripheral spondyloarthritis,NG65,What is the effectiveness and cost-effectiveness of standard DMARDs in managing peripheral spondyloarthritis?
NG65_Recommendations for research: 5 Biological therapies for peripheral spondyloarthritis,NG65,What is the evidence for the effectiveness and cost-effectiveness of biological DMARDs in persistent peripheral spondyloarthritis?
NG65_Context,NG65,What are the early signs and symptoms of spondyloarthritis and how can it be diagnosed in primary care?
NG66_Mental health of adults in contact with the criminal justice system & Overview,NG66,What are the recommended approaches for assessing and managing mental health in adults involved with the criminal justice system?
NG66_Recommendations: 1.1 Using this guideline together with other NICE guidelines & Recommendations: 1.2 Principles of assessment,NG66,What are the key considerations for assessing and treating mental health problems in people involved with the criminal justice system?
NG66_Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 1,NG66,What are the recommended procedures for initial mental health assessment of new arrivals in prison?
NG66_Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 2,NG66,"What questions should be asked during a first-stage prison health assessment to evaluate physical health, mental health, substance misuse, and self-harm risk?"
NG66_Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 3 & Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 4 & Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 5,NG66,When should mental health screening be used during prison health assessments?
NG66_Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 6,NG66,What are the key components of a comprehensive mental health assessment for individuals in contact with the criminal justice system?
NG66_Recommendations: 1.3 Identification and assessment throughout the care pathway - Part 7,NG66,What are the recommended practices for reviewing and updating mental health assessments in people involved with the criminal justice system?
NG66_Recommendations: 1.4 Risk assessment and management - Part 1,NG66,How should mental health risk assessments be conducted for individuals in contact with the criminal justice system?
NG66_Recommendations: 1.4 Risk assessment and management - Part 2,NG66,What are the key components of an effective risk management plan for mental health patients?
NG66_Recommendations: 1.5 Care planning,NG66,What are the key components of an effective mental healthcare care planning process?
NG66_Recommendations: 1.6 Psychological interventions - Part 1,NG66,What are the recommended psychological interventions for adults with personality disorders in the criminal justice system?
NG66_Recommendations: 1.6 Psychological interventions - Part 2 & Recommendations: 1.7 Pharmacological interventions,NG66,What are the recommended psychological and pharmacological interventions for managing substance misuse and comorbid mental health conditions?
NG66_Recommendations: 1.8 Organisation of services,NG66,What are the recommended service structures and protocols for mental health assessment and care coordination in criminal justice settings?
NG66_Recommendations: 1.9 Staff training,NG66,"What training should staff in the criminal justice system receive to effectively manage mental health issues and ensure safe, respectful care?"
NG66_Recommendations: Terms used in this guideline - Part 1,NG66,What is the purpose and process of the ACCT system in reducing self-harm risk in custody?
NG66_Recommendations: Terms used in this guideline - Part 2,NG66,What are the roles and functions of liaison and diversion services in the criminal justice system?
NG66_Recommendations for research: Key recommendations for research - Part 1,NG66,What is the effectiveness and safety of psychological and pharmacological interventions for paraphilic disorders in criminal justice settings?
NG66_Recommendations for research: Key recommendations for research - Part 2,NG66,What are the most effective models for coordinating care to improve mental health outcomes and service uptake in people in contact with the criminal justice system?
NG66_Recommendations for research: Key recommendations for research - Part 3 & Recommendations for research: Other recommendations for research,NG66,What are the effective methods for identifying acquired cognitive impairment in individuals within the criminal justice system?
NG66_Context,NG66,What are the recommended approaches for recognizing and assessing mental health problems in adults in contact with the criminal justice system?
NG67_Managing medicines for adults receiving social care in the community & Overview,NG67,What are the best practices for supporting adults in the community to manage their medicines safely?
NG67_Recommendations: 1.1 Governance for managing medicines safely and effectively,NG67,What are the key components of governance arrangements for safe and effective medicines management in social care settings?
NG67_Recommendations: 1.2 Assessing and reviewing a person's medicines support needs - Part 1,NG67,How should healthcare professionals assess a patient's medicines support needs?
NG67_Recommendations: 1.2 Assessing and reviewing a person's medicines support needs - Part 2,NG67,How should healthcare professionals assess and document a patient's medicines management and support needs?
NG67_Recommendations: 1.3 Joint working between health and social care,NG67,What are the best practices for joint working between health and social care providers in supporting medication management?
NG67_Recommendations: 1.4 Sharing information about a person's medicines - Part 1,NG67,What are the best practices for sharing information about a person's medicines with family and care teams?
NG67_Recommendations: 1.4 Sharing information about a person's medicines - Part 2,NG67,What are the recommended communication procedures for changing a patient's medicines during care transitions according to NICE guidelines?
NG67_Recommendations: 1.5 Ensuring that records are accurate and up to date - Part 1,NG67,What are the requirements for maintaining accurate and up-to-date medicines records in social care settings?
NG67_Recommendations: 1.5 Ensuring that records are accurate and up to date - Part 2,NG67,What should be included in medicines administration records for social care?
NG67_Recommendations: 1.6 Managing concerns about medicines - Part 1,NG67,How can social care providers effectively manage and respond to medicines-related concerns and safeguarding incidents?
NG67_Recommendations: 1.6 Managing concerns about medicines - Part 2,NG67,How should care workers report concerns about a person's medicines to ensure safety and appropriate action?
NG67_Recommendations: 1.7 Supporting people to take their medicines - Part 1,NG67,What are the best practices for supporting people to take their medicines safely in social care settings?
NG67_Recommendations: 1.7 Supporting people to take their medicines - Part 2,NG67,What are the key requirements for care workers when administering medicines safely?
NG67_Recommendations: 1.8 Giving medicines to people without their knowledge (covert administration),NG67,What are the guidelines for covert administration of medicines under the Mental Capacity Act 2005?
NG67_Recommendations: 1.9 Ordering and supplying medicines - Part 1,NG67,What are the responsibilities of social care providers when ordering and supplying medicines?
NG67_Recommendations: 1.9 Ordering and supplying medicines - Part 2,NG67,What actions should social care providers take if there is a discrepancy between medicines ordered and supplied?
"NG67_Recommendations: 1.10 Transporting, storing and disposing of medicines - Part 1",NG67,How should medicines be transported stored and disposed of safely in home and social care settings?
"NG67_Recommendations: 1.10 Transporting, storing and disposing of medicines - Part 2 & Recommendations: 1.11 Training and competency",NG67,What are the recommended procedures for storing and disposing of medicines safely in social care settings?
NG67_Recommendations: Terms used in this guideline - Part 1,NG67,What is advance care planning and how is it implemented in health and social care?
NG67_Recommendations: Terms used in this guideline - Part 2,NG67,What are the legal considerations for making decisions about medical treatment under the Mental Capacity Act 2005?
NG67_Context - Part 1,NG67,What are the best practices for supporting adults in the community to manage their medicines safely?
NG67_Context - Part 2,NG67,How can care providers ensure safe and effective medicines support for adults with high staff turnover?
NG67_Context - Part 3,NG67,What are the legal requirements for storing and disposing of controlled drugs in healthcare settings?
NG68_Sexually transmitted infections: condom distribution schemes & Overview,NG68,What are the recommended strategies for implementing condom distribution schemes to reduce the risk of sexually transmitted infections?
NG68_Recommendations: 1.1 Targeting services,NG68,What are effective strategies for targeting condom distribution services to populations most at risk of sexually transmitted infections?
"NG68_Recommendations: 1.2 Multicomponent schemes for young people in health, education, youth and outreach settings - Part 1",NG68,What are best practices for implementing multicomponent condom schemes for young people up to age 25?
"NG68_Recommendations: 1.2 Multicomponent schemes for young people in health, education, youth and outreach settings - Part 2",NG68,What information should be provided to young people about condom use and sexual health?
NG68_Recommendations: 1.3 Single component schemes,NG68,What are the recommended strategies for distributing free condoms to at-risk populations?
"NG68_Recommendations: Terms used in this guideline & Recommendations for research: 1 What measures would make up an effective, standardised approach to evaluation of condom distribution schemes?",NG68,What are the key components of an effective framework for evaluating condom distribution schemes?
NG68_Recommendations for research: 2 How can the effectiveness and cost effectiveness of condom schemes in the UK be improved for people at most risk of STIs? & 3 more sections,NG68,How can the effectiveness and cost-effectiveness of condom schemes like the C‑Card be improved for high-risk populations in the UK?
NG68_Context - Part 1,NG68,What are the recommended strategies for STI prevention and management in sexual health services?
NG68_Context - Part 2,NG68,What are the recommended strategies for increasing condom use among young people in community settings?
NG68_Glossary,NG68,What is the definition of competence and how is it assessed in young people?
NG69_Eating disorders: recognition and treatment & Overview,NG69,What are the recommended assessment and treatment approaches for eating disorders according to NICE guideline NG69?
NG69_Recommendations: 1.1 General principles of care - Part 1,NG69,What are the best communication strategies for healthcare professionals when assessing and supporting people with eating disorders?
NG69_Recommendations: 1.1 General principles of care - Part 2,NG69,What training and competencies are recommended for professionals treating eating disorders across different age groups?
NG69_Recommendations: 1.2 Identification and assessment - Part 1,NG69,What are the key factors to consider when assessing for an eating disorder in young people?
NG69_Recommendations: 1.2 Identification and assessment - Part 2,NG69,What are the clinical signs and assessment criteria for diagnosing eating disorders in children and young people?
NG69_Recommendations: 1.3 Treating anorexia nervosa - Part 1,NG69,What are the recommended psychological treatments for adults with anorexia nervosa according to NICE guidelines?
NG69_Recommendations: 1.3 Treating anorexia nervosa - Part 2,NG69,What are the recommended psychological treatments for anorexia nervosa in children and young people according to NICE guidelines?
NG69_Recommendations: 1.3 Treating anorexia nervosa - Part 3,NG69,What is the recommended structure and approach for family therapy in treating anorexia nervosa in children and young people?
NG69_Recommendations: 1.3 Treating anorexia nervosa - Part 4,NG69,What are the recommended treatment approaches for anorexia nervosa in children and young people according to NICE guidelines?
NG69_Recommendations: 1.3 Treating anorexia nervosa - Part 5,NG69,What are the recommended approaches for supporting people with anorexia nervosa who are not receiving treatment?
NG69_Recommendations: 1.4 Treating binge eating disorder - Part 1,NG69,What are the recommended psychological treatments for binge eating disorder in adults?
NG69_Recommendations: 1.4 Treating binge eating disorder - Part 2,NG69,What are the recommended psychological treatments for binge eating disorder in adults and young people?
NG69_Recommendations: 1.5 Treating bulimia nervosa - Part 1,NG69,What are the recommended psychological treatments for bulimia nervosa in adults and young people?
NG69_Recommendations: 1.5 Treating bulimia nervosa - Part 2 & Recommendations: 1.6 Treating other specified feeding and eating disorders (OSFED),NG69,What are the recommended psychological and family support strategies for treating bulimia nervosa in children and young people?
NG69_Recommendations: 1.7 Physical therapy for any eating disorder & Recommendations: 1.8 Physical and mental health comorbidities - Part 1,NG69,What are the recommended approaches for managing physical and mental health comorbidities in people with eating disorders?
NG69_Recommendations: 1.8 Physical and mental health comorbidities - Part 2,NG69,What are the recommended blood glucose and ketone testing protocols for managing hypoglycaemia and hyperglycaemia in diabetes?
NG69_Recommendations: 1.8 Physical and mental health comorbidities - Part 3,NG69,What are the considerations for prescribing medication to patients with eating disorders and comorbid mental or physical health conditions?
NG69_Recommendations: 1.9 Conception and pregnancy for women with eating disorders,NG69,What advice should be given to women with eating disorders planning pregnancy to improve outcomes?
"NG69_Recommendations: 1.10 Physical health assessment, monitoring and management for eating disorders - Part 1",NG69,What are the recommended assessments and management strategies for physical health in people with eating disorders?
"NG69_Recommendations: 1.10 Physical health assessment, monitoring and management for eating disorders - Part 2",NG69,What are the recommended assessments and monitoring procedures for physical health in individuals with anorexia nervosa?
"NG69_Recommendations: 1.10 Physical health assessment, monitoring and management for eating disorders - Part 3",NG69,What are the recommended management strategies for low bone mineral density in people with anorexia nervosa?
NG69_Recommendations: 1.11 Inpatient and day patient treatment - Part 1,NG69,What are the criteria for inpatient or day patient admission for people with eating disorders?
NG69_Recommendations: 1.11 Inpatient and day patient treatment - Part 2,NG69,What are the recommended practices for inpatient care and discharge planning for people with eating disorders?
NG69_Recommendations: 1.12 Using the Mental Health Act and compulsory treatment & Recommendations: Terms used in this guideline,NG69,What are the legal requirements for compulsory treatment under the Mental Health Act for patients with eating disorders who refuse treatment?
NG69_Recommendations for research: 1 Psychological treatments for binge eating disorder,NG69,"What is the clinical and cost effectiveness of individual CBT‑ED compared to guided self-help and group CBT‑ED for binge eating disorder in adults, children, and young people?"
NG69_Recommendations for research: 2 Duration and intensity of psychological treatment,NG69,What is the effectiveness of reduced-duration and reduced-intensity psychological treatments for eating disorders compared to standard treatment?
NG69_Recommendations for research: 3 Predictors of acute physical risk,NG69,What are the most effective clinical and biochemical markers for predicting acute physical risk in people with eating disorders?
NG69_Recommendations for research: 4 Treating an eating disorder in people with a comorbidity & Recommendations for research: 5 Maintaining benefits after successful treatment of anorexia nervosa,NG69,What are the most effective treatment approaches for managing eating disorders in patients with comorbid mental or physical health conditions?
NG69_Context,NG69,What are the recommended approaches for diagnosing and managing eating disorders in adults and children?
NG6_Excess winter deaths and illness and the health risks associated with cold homes & Overview,NG6,What are the recommended strategies for reducing health risks associated with cold homes?
NG6_What is this guideline about?,NG6,What are the recommendations for reducing health risks associated with cold homes in vulnerable populations?
NG6_Recommendations: Recommendation 1 Develop a strategy,NG6,What are the key components of a strategy to address health risks from cold homes according to NICE guidelines?
NG6_Recommendations: Recommendation 2 Ensure there is a single‑point‑of‑contact health and housing referral service for people living in cold homes,NG6,What is the recommended approach for establishing a single-point-of-contact referral service for vulnerable people living in cold homes?
NG6_Recommendations: Recommendation 3 Provide tailored solutions via the single‑ point‑of‑contact health and housing referral service for people living in cold homes,NG6,What services are available to help improve housing insulation and heating for people living in cold homes?
NG6_Recommendations: Recommendation 4 Identify people at risk of ill health from living in a cold home,NG6,How can healthcare professionals identify patients at risk of health problems due to living in cold or hard-to-heat homes?
NG6_Recommendations: Recommendation 5 Make every contact count by assessing the heating needs of people who use primary health and home care services & Recommendations: Recommendation 6 Non-health and social care workers who visit people at home should assess their heating needs,NG6,What are the recommended practices for primary care providers to assess and address heating needs in vulnerable patients?
NG6_Recommendations: Recommendation 7 Discharge vulnerable people from health or social care settings to a warm home & Recommendations: Recommendation 8 Train health and social care practitioners to help people whose homes may be too cold,NG6,What are the recommended procedures for discharging vulnerable patients to ensure their home is warm enough?
"NG6_Recommendations: Recommendation 9 Train housing professionals and faith and voluntary sector workers to help people whose homes may be too cold for their health and wellbeing & Recommendations: Recommendation 10 Train heating engineers, meter installers and those providing building insulation to help vulnerable people at home & Recommendations: Recommendation 11 Raise awareness among practitioners and the public about how to keep warm at home",NG6,What training is recommended for housing and building professionals to help vulnerable people stay warm at home?
NG6_Recommendations: Recommendation 12 Ensure buildings meet ventilation and other building and trading standards,NG6,What are the building and ventilation standards required for housing compliance and safety?
NG6_Recommendations: Terms used in this guideline,NG6,What are effective strategies to reduce excess winter deaths in hard-to-heat homes?
NG6_Who should take action?: Introduction,NG6,What are the recommended actions for health and housing professionals to improve home heating and insulation?
NG6_Who should take action?: Who should take action in detail - Part 1,NG6,Who is responsible for assessing and addressing cold-related health risks in vulnerable populations?
NG6_Who should take action?: Who should take action in detail - Part 2,NG6,What training is recommended for health and social care practitioners to support people living in inadequate housing?
NG6_Context - Part 1,NG6,What are the health risks associated with cold weather and how can they be prevented?
NG6_Context - Part 2,NG6,What are the health risks associated with cold homes and how can housing conditions reduce winter mortality?
NG6_Context - Part 3,NG6,What factors influence the SAP ratings and energy efficiency of homes?
NG6_Context - Part 4,NG6,What are the health risks associated with living in a cold or fuel-poor home for vulnerable groups?
NG6_Context - Part 5,NG6,What are the current definitions and policies for identifying fuel poverty in England?
NG6_Considerations: Background - Part 1,NG6,What are effective interventions to reduce health risks associated with cold homes and winter-related illnesses?
NG6_Considerations: Background - Part 2,NG6,What are effective strategies to improve home insulation and ventilation to reduce cold-related health risks?
NG6_Considerations: Evidence,NG6,What are effective strategies for preventing cold-related deaths in vulnerable populations?
NG6_Considerations: Health economics,NG6,What is the cost-effectiveness of energy efficiency interventions for cold homes according to NICE guidelines?
NG6_Considerations: Equalities,NG6,What are the best ways to support vulnerable groups in managing cold homes and preventing cold-related health issues?
NG6_Considerations: Illness and deaths linked to the cold,NG6,What are the health risks associated with cold homes and cold weather?
NG6_Considerations: Services and policy - Part 1,NG6,What are effective strategies for healthcare professionals to identify and support patients living in cold homes?
NG6_Considerations: Services and policy - Part 2,NG6,What strategies can healthcare professionals use to help patients negotiate home insulation and heating improvements?
NG6_Considerations: Barriers,NG6,What are the barriers to addressing cold homes and how can they be overcome?
NG6_Recommendations for research,NG6,What are effective interventions to improve home energy efficiency and reduce cold-related health risks?
NG6_Gaps in the evidence,NG6,What is the impact of indoor and outdoor temperatures on cold-related health risks in the UK?
NG70_Air pollution: outdoor air quality and health & Overview,NG70,What are the health impacts of outdoor air pollution from road traffic?
NG70_Recommendations: 1.1 Planning,NG70,How should local government incorporate air pollution considerations into planning and development strategies?
NG70_Recommendations: 1.2 Development management,NG70,What strategies can be used to reduce road traffic-related air pollution in urban development management?
NG70_Recommendations: 1.3 Clean air zones - Part 1,NG70,What are the recommended strategies for implementing clean air zones to reduce air pollution and promote low-emission travel?
NG70_Recommendations: 1.3 Clean air zones - Part 2,NG70,What strategies can be implemented to reduce vehicle emissions within a clean air zone?
NG70_Recommendations: 1.4 Reducing emissions from public sector transport services and vehicle fleets,NG70,What are effective strategies for reducing vehicle emissions in public sector transport fleets?
NG70_Recommendations: 1.5 Smooth driving and speed reduction,NG70,What strategies can promote smooth driving and consistent speeds to improve road safety?
NG70_Recommendations: 1.6 Walking and cycling,NG70,What strategies can improve safety and reduce pollution exposure for cyclists on busy roads?
NG70_Recommendations: 1.7 Awareness raising - Part 1,NG70,What are effective strategies for raising awareness about road-traffic-related air pollution and its health impacts?
NG70_Recommendations: 1.7 Awareness raising - Part 2,NG70,What are effective strategies to raise public awareness about air pollution and protect vulnerable groups?
NG70_Recommendations: Terms used in this guideline,NG70,What is the impact of street canyon geometry on air pollution levels and vulnerable populations?
NG70_Context - Part 1,NG70,What are the health impacts of air pollution from road traffic in the UK?
NG70_Context - Part 2,NG70,What are the health impacts of PM2.5 and NO2 air pollution in the UK and how can they be reduced?
NG70_Recommendations for research: Key recommendations for research - Part 1,NG70,"What factors influence the effectiveness of vegetation, street trees, and clean air zones on improving urban air quality and health outcomes?"
NG70_Recommendations for research: Key recommendations for research - Part 2 & Recommendations for research: Other recommendations for research,NG70,What is the effectiveness of air pollution awareness alerts on public behavior and health outcomes?
NG70_Glossary,NG70,What is average speed technology and how does it help monitor vehicle speeds?
NG71_Parkinson’s disease in adults & Overview & Recommendations: 1.1 Communication with people with Parkinson's disease and their carers,NG71,What are the recommended communication strategies for healthcare professionals when supporting adults with Parkinson's disease?
NG71_Recommendations: 1.2 Diagnosing Parkinson's disease - Part 1,NG71,What are the recommended diagnostic criteria and procedures for diagnosing Parkinson's disease?
NG71_Recommendations: 1.2 Diagnosing Parkinson's disease - Part 2,NG71,Should PET scans or MRI be used to differentiate Parkinson's disease from other parkinsonian syndromes?
NG71_Recommendations: 1.3 Pharmacological management of motor symptoms - Part 1,NG71,What are the recommended pharmacological treatments for motor symptoms in Parkinson's disease?
NG71_Recommendations: 1.3 Pharmacological management of motor symptoms - Part 2,NG71,What are the recommended first-line treatments for Parkinson's disease according to NICE guidelines?
NG71_Recommendations: 1.3 Pharmacological management of motor symptoms - Part 3,NG71,"What are the benefits and risks of using dopamine agonists, MAO-B inhibitors, COMT inhibitors, and amantadine in Parkinson's disease management?"
NG71_Recommendations: 1.4 Managing and monitoring impulse control disorders as an adverse effect of dopaminergic therapy,NG71,What are the recommended strategies for managing impulse control disorders in Parkinson's disease patients on dopaminergic therapy?
NG71_Recommendations: 1.5 Pharmacological management of non-motor symptoms - Part 1,NG71,What are the recommended pharmacological treatments for daytime sleepiness and sleep disturbances in Parkinson's disease?
NG71_Recommendations: 1.5 Pharmacological management of non-motor symptoms - Part 2,NG71,What are the recommended treatments for nocturnal akinesia and orthostatic hypotension in Parkinson's disease?
NG71_Recommendations: 1.5 Pharmacological management of non-motor symptoms - Part 3,NG71,What are the recommended treatments for hallucinations and delusions in Parkinson's disease?
NG71_Recommendations: 1.5 Pharmacological management of non-motor symptoms - Part 4,NG71,Which medications should be avoided in Parkinson's disease to prevent worsening motor symptoms?
NG71_Recommendations: 1.5 Pharmacological management of non-motor symptoms - Part 5,NG71,What are the recommended management options for drooling of saliva in people with Parkinson's disease?
NG71_Recommendations: 1.6 Pharmacological neuroprotective therapy,NG71,What are the recommended neuroprotective pharmacological therapies for Parkinson's disease?
NG71_Recommendations: 1.7 Non-pharmacological management of motor and non-motor symptoms - Part 1,NG71,What non-pharmacological interventions are recommended for managing motor and non-motor symptoms in Parkinson's disease?
NG71_Recommendations: 1.7 Non-pharmacological management of motor and non-motor symptoms - Part 2,NG71,What strategies are recommended to improve swallowing safety and communication in Parkinson's disease?
NG71_Recommendations: 1.8 Treating advanced Parkinson's disease,NG71,What are the recommended treatments for advanced Parkinson's disease when medications are not effective?
NG71_Recommendations: 1.9 Palliative care,NG71,What information and support should be offered to people with Parkinson's disease and their families regarding palliative care?
NG71_Recommendations for research: 1 Combination treatment for Parkinson's disease dementia & Recommendations for research: 2 Orthostatic hypotension treatment,NG71,What is the effectiveness of combination therapy with cholinesterase inhibitors and memantine for Parkinson's disease dementia?
NG71_Recommendations for research: 3 Psychotic symptoms (hallucinations and delusions) & Recommendations for research: 4 Rapid eye movement sleep behaviour disorder treatment,NG71,What is the most effective treatment for psychotic symptoms in Parkinson's disease?
NG71_Recommendations for research: 5 Physiotherapy,NG71,Does early physiotherapy intervention in Parkinson's disease delay symptom onset or reduce severity?
NG71_Context,NG71,What are the clinical features and diagnosis criteria for Parkinson's disease?
NG72_Developmental follow-up of children and young people born preterm & Overview,NG72,What are the recommended developmental follow-up assessments for children born preterm?
NG72_Recommendations: 1.1 Information and support for parents and carers of all preterm babies - Part 1,NG72,What information and support should be provided to parents and carers of preterm babies regarding developmental outcomes and discharge planning?
NG72_Recommendations: 1.1 Information and support for parents and carers of all preterm babies - Part 2,NG72,What information and support should parents of preterm babies receive before and after discharge to promote development and manage care at home?
NG72_Recommendations: 1.2 Risk and prevalence of developmental problems and disorders - Part 1,NG72,What is the risk of developmental problems and cerebral palsy in children born preterm?
NG72_Recommendations: 1.2 Risk and prevalence of developmental problems and disorders - Part 2,NG72,What are the developmental and educational risks associated with preterm birth in children?
NG72_Recommendations: 1.2 Risk and prevalence of developmental problems and disorders - Part 3,NG72,What are the neurodevelopmental risks and early signs to monitor in children born preterm?
NG72_Recommendations: 1.2 Risk and prevalence of developmental problems and disorders - Part 4,NG72,"What are the feeding, sleep, visual, hearing, and developmental risks for children born preterm?"
NG72_Recommendations: 1.3 Enhanced developmental support and surveillance - Part 1,NG72,What are the criteria for providing enhanced developmental support and surveillance for preterm children up to 2 years old?
NG72_Recommendations: 1.3 Enhanced developmental support and surveillance - Part 2,NG72,What are the recommended developmental surveillance procedures for preterm children up to 2 years corrected age?
NG72_Recommendations: 1.3 Enhanced developmental support and surveillance - Part 3,NG72,What are the recommended developmental assessments for children born preterm at 2 and 4 years of age?
NG72_Recommendations: 1.3 Enhanced developmental support and surveillance - Part 4,NG72,What assessments are recommended at age 4 for children born very preterm to evaluate development and identify potential problems?
NG72_Recommendations: 1.4 Delivering enhanced developmental support and surveillance - Part 1,NG72,What are the recommended practices for providing developmental support and surveillance for preterm children?
NG72_Recommendations: 1.4 Delivering enhanced developmental support and surveillance - Part 2,NG72,Which healthcare professionals should be involved in developmental support and surveillance for children born preterm?
NG72_Recommendations: 1.5 Neonatal audit,NG72,What information should be recorded in the neonatal audit for preterm infants regarding developmental surveillance and outcomes?
NG72_Recommendations: Terms used in this guideline,NG72,What are the recommended interventions for developmental problems and disorders in children?
NG72_Context,NG72,What are the recommended developmental surveillance practices for children born preterm?
NG72_Recommendations for research: 1 Predictive accuracy of the WPPSI-IV at age 4 years (uncorrected) for children born preterm & Recommendations for research: 2 Predictive accuracy of the PARCA-R for children born preterm,NG72,What is the predictive accuracy of WPPSI-IV and PARCA-R assessments for identifying learning disabilities in children born preterm?
NG72_Recommendations for research: 3 Predictive accuracy of the ASQ-3 for children born preterm & 3 more sections,NG72,What is the accuracy of the ASQ-3 in detecting developmental delays in preterm children aged 2 to 4 years?
NG73_Endometriosis: diagnosis and management & Overview,NG73,What are the recommended approaches for diagnosing and managing endometriosis?
NG73_Recommendations: 1.1 Organisation of care,NG73,What are the recommended organizational structures and specialist services for managing endometriosis?
NG73_Recommendations: 1.2 Endometriosis information and support,NG73,What information and support should be provided to women with endometriosis?
NG73_Recommendations: 1.3 Endometriosis symptoms and signs,NG73,What are the common symptoms and signs of endometriosis to look for in women?
NG73_Recommendations: 1.4 Initial pharmacological treatment for women and people with suspected or confirmed endometriosis,NG73,What are the recommended pharmacological treatments for managing pain in women with endometriosis?
NG73_Recommendations: 1.5 Diagnosis and referral for women or people with suspected or confirmed endometriosis - Part 1,NG73,What are the recommended diagnostic and referral procedures for women with suspected endometriosis?
NG73_Recommendations: 1.5 Diagnosis and referral for women or people with suspected or confirmed endometriosis - Part 2,NG73,When should women with suspected endometriosis be referred to a specialist endometriosis service?
NG73_Recommendations: 1.5 Diagnosis and referral for women or people with suspected or confirmed endometriosis - Part 3 & Recommendations: 1.6 Staging systems,NG73,What are the recommended imaging options before diagnostic laparoscopy for suspected deep endometriosis?
NG73_Recommendations: 1.7 Monitoring for women with confirmed endometriosis & Recommendations: 1.8 Non-pharmacological management,NG73,When should women with confirmed endometriosis undergo outpatient follow-up for deep endometriosis or large endometriomas?
NG73_Recommendations: 1.9 Surgical management - Part 1,NG73,What are the recommended surgical management options for endometriosis according to NICE guidelines?
NG73_Recommendations: 1.9 Surgical management - Part 2,NG73,What are the recommended surgical and hormonal treatment options for endometriosis management?
NG73_Recommendations: 1.10 Management if fertility is a priority - Part 1,NG73,What are the recommended fertility management options for women with endometriosis who wish to conceive?
NG73_Recommendations: 1.10 Management if fertility is a priority - Part 2 & Recommendations: Terms used in this guideline,NG73,What are the benefits and risks of laparoscopic surgery for deep endometriosis in women trying to conceive?
NG73_Recommendations for research: 1 Pain management programmes,NG73,Are pain management programmes effective for treating endometriosis-related pain?
NG73_Recommendations for research: 2 Laparoscopic treatment of peritoneal endometriosis (excision or ablation),NG73,Is laparoscopic excision or ablation of isolated peritoneal endometriosis effective for reducing endometriosis-related pain?
NG73_Recommendations for research: 3 Lifestyle interventions (diet and exercise) & Recommendations for research: 4 Information and support,NG73,What is the effectiveness of lifestyle interventions such as diet and exercise in managing symptoms of endometriosis?
NG73_Recommendations for research: 5 Hormonal treatments for people with endometriosis where fertility is a priority & Rationale and impact: Endometriosis signs and symptoms,NG73,What is the impact of hormonal treatment timing and dosage on fertility outcomes in women with endometriosis undergoing surgery?
NG73_Rationale and impact: Diagnosis of endometriosis - Part 1,NG73,What is the role of ultrasound in diagnosing endometriosis and when should it be used?
NG73_Rationale and impact: Diagnosis of endometriosis - Part 2,NG73,What are the current recommendations for referral and imaging options in the diagnosis and management of endometriosis?
NG73_Rationale and impact: Diagnosis of endometriosis - Part 3,NG73,What is the role of diagnostic laparoscopy in detecting endometriosis when ultrasound and MRI results are normal?
NG73_Rationale and impact: Management of endometriosis when fertility is a priority,NG73,What are the treatment options for endometriosis when preserving ovarian reserve and fertility are priorities?
NG73_Context - Part 1,NG73,What are the recommended approaches for diagnosing endometriosis and reducing diagnostic delays?
NG73_Context - Part 2,NG73,What are the recommended diagnostic and management options for endometriosis in women presenting with pelvic pain?
NG74_Intermediate care including reablement & Overview,NG74,What are the key principles for delivering intermediate care and reablement services?
"NG74_Recommendations: 1.1 Core principles of intermediate care, including reablement",NG74,What are the core principles of intermediate care and reablement?
NG74_Recommendations: 1.2 Supporting infrastructure - Part 1,NG74,What are the key components of an integrated intermediate care service?
NG74_Recommendations: 1.2 Supporting infrastructure - Part 2,NG74,What are best practices for effective communication and team composition in intermediate care services?
NG74_Recommendations: 1.3 Assessment of need for intermediate care,NG74,How should healthcare professionals assess the need for intermediate care in patients at risk of hospital admission or with increasing difficulty in daily activities?
NG74_Recommendations: 1.4 Referral into intermediate care,NG74,What are the criteria for referring patients to intermediate care services?
NG74_Recommendations: 1.5 Entering intermediate care - Part 1,NG74,What are the key considerations for planning and initiating intermediate care services?
NG74_Recommendations: 1.5 Entering intermediate care - Part 2,NG74,How should intermediate care teams develop and document risk management plans and goals with patients to support their independence and wellbeing?
NG74_Recommendations: 1.6 Delivering intermediate care,NG74,"What are best practices for delivering and coordinating intermediate care to meet patients' social, emotional, and communication needs?"
NG74_Recommendations: 1.7 Transition from intermediate care,NG74,What information should be provided to patients about transitioning from intermediate care to other services?
NG74_Recommendations: 1.8 Training and development,NG74,What training and development should intermediate care staff receive to support patient independence and recognize common health conditions?
NG74_Recommendations: Terms used in this guideline - Part 1,NG74,"What are the differences between bed-based, crisis, and home-based intermediate care services?"
NG74_Recommendations: Terms used in this guideline - Part 2,NG74,What are the key principles of person-centred care and reablement in adult social care?
NG74_Context - Part 1,NG74,What are the different models of intermediate care and their roles in supporting independence for adults?
NG74_Context - Part 2,NG74,What are the key components of the intermediate care pathway according to NICE guidelines?
NG74_Recommendations for research: 1 Optimal time between referral and starting intermediate care,NG74,What is the optimal time to start intermediate care after referral for improving outcomes and patient experience?
NG74_Recommendations for research: 2 Team composition for home-based intermediate care & Recommendations for research: 3 Crisis response,NG74,What are the most effective team structures for delivering home-based intermediate care for adults?
NG74_Recommendations for research: 4 Dementia care & Recommendations for research: **4 Dementia care**,NG74,What is the effectiveness and cost-effectiveness of intermediate care and reablement for supporting people living with dementia?
NG74_Recommendations for research: 5 Reablement & Recommendations for research: 6 A single point of access for intermediate care,NG74,What is the effectiveness and cost-effectiveness of repeated or longer-duration reablement programs?
NG74_Recommendations for research: 7 Duration and intensity of home-based intermediate care & Recommendations for research: 8 Support for black and minority ethnic groups,NG74,What is the most effective and cost-effective duration and intensity of home-based intermediate care for adults?
NG75_Faltering growth: recognition and management of faltering growth in children & Overview & Recommendations: 1.1 Weight loss in the early days of life - Part 1,NG75,What are the recommended assessments for infants experiencing weight loss greater than 10% in the first days of life?
NG75_Recommendations: 1.1 Weight loss in the early days of life - Part 2,NG75,What are the recommended management strategies for infants experiencing weight loss greater than 10% in the early days of life?
NG75_Recommendations: 1.2 Faltering growth after the early days of life - Part 1,NG75,What are the recommended thresholds for identifying faltering growth in infants and children according to NICE guidelines?
NG75_Recommendations: 1.2 Faltering growth after the early days of life - Part 2,NG75,What are the recommended assessments and interventions for faltering growth in children?
NG75_Recommendations: 1.2 Faltering growth after the early days of life - Part 3,NG75,How can I support feeding and growth in infants with faltering growth?
NG75_Recommendations: 1.2 Faltering growth after the early days of life - Part 4,NG75,What are the recommended approaches for managing feeding and nutrition in infants and children with faltering growth?
NG75_Recommendations: 1.2 Faltering growth after the early days of life - Part 5,NG75,How should weight and height be monitored in children with faltering growth?
NG75_Recommendations: 1.3 Organisation of care,NG75,What is the recommended care pathway for infants with faltering growth or weight loss in early life?
NG75_Recommendations: 1.4 Information and support,NG75,What support and information should be provided to parents when concerns about early infant weight loss or faltering growth arise?
NG75_Recommendations: Terms used in this guideline,NG75,What are the signs of food or feeding aversion in infants and children?
NG75_Context,NG75,What are the recommended management strategies for faltering growth in children?
NG75_Recommendations for research: 1 High energy liquid feed supplements & 3 more sections,NG75,What is the effectiveness of high energy liquid feed supplements in promoting growth in children with faltering growth?
NG76_Child abuse and neglect & Overview,NG76,What are the recommended practices for identifying and responding to child abuse and neglect?
NG76_About this guideline: What is the purpose of this guideline?,NG76,What are the evidence-based recommendations for recognising and responding to child abuse and neglect?
NG76_About this guideline: Why do we need this guideline?,NG76,What are the recommended early intervention strategies for children showing signs of abuse or neglect?
NG76_About this guideline: What does it cover? & About this guideline: What is the status of this guidance?,NG76,What are the NICE guidelines for supporting children and young people at risk of or experiencing abuse and neglect?
NG76_About this guideline: How does it relate to statutory and non-statutory guidance?,NG76,What are the statutory and non-statutory guidance requirements for safeguarding children?
NG76_About this guideline: How has it been developed? & About this guideline: What evidence is the guideline based on?,NG76,What is the evidence base for interventions in child abuse and neglect management according to NICE guidelines?
NG76_About this guideline: How does it relate to other NICE guidelines?,NG76,How does this guideline relate to other NICE guidelines on child maltreatment attachment and domestic abuse?
"NG76_Recommendations: 1.1 Principles for working with children, young people, parents and carers - Part 1",NG76,What are the best practices for communicating with children and young people in healthcare settings?
"NG76_Recommendations: 1.1 Principles for working with children, young people, parents and carers - Part 2",NG76,How should healthcare professionals obtain and document consent for children and young people under 16 who are not Gillick competent?
"NG76_Recommendations: 1.1 Principles for working with children, young people, parents and carers - Part 3",NG76,What are best practices for communicating and building trust with parents and carers in safeguarding children?
NG76_Recommendations: 1.2 Factors that increase vulnerability to child abuse and neglect - Part 1,NG76,What are the parental factors that increase the risk of child abuse and neglect?
NG76_Recommendations: 1.2 Factors that increase vulnerability to child abuse and neglect - Part 2,NG76,What are the risk factors for recurring child abuse and neglect?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 1,NG76,What are the recommended approaches for healthcare professionals to recognize and respond to child abuse and neglect?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 2,NG76,What are the reporting requirements for female genital mutilation in healthcare and education settings?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 3,NG76,What are the recommended steps for safeguarding children when there are alerting features of abuse or neglect?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 4,NG76,What are the behavioural and emotional signs that may indicate child abuse or neglect?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 5,NG76,What are the signs of child abuse and neglect to look for during clinical assessment?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 6,NG76,"How can healthcare professionals identify signs of child neglect related to hygiene, nutrition, and development?"
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 7,NG76,What are the signs of physical or emotional abuse and neglect in children?
NG76_Recommendations: 1.3 Recognising child abuse and neglect - Part 8,NG76,What are the signs of child neglect and how should they be assessed?
NG76_Recommendations: 1.4 Assessing risk and need in relation to child abuse and neglect - Part 1,NG76,What are the recommended practices for assessing child abuse and neglect under the Children Act 1989?
NG76_Recommendations: 1.4 Assessing risk and need in relation to child abuse and neglect - Part 2,NG76,What are the recommended procedures for assessing child abuse and neglect under the Children Act 1989?
NG76_Recommendations: 1.5 Early help for families showing possible signs of child abuse or neglect - Part 1,NG76,What are the recommended early help interventions for families showing signs of child abuse or neglect?
NG76_Recommendations: 1.5 Early help for families showing possible signs of child abuse or neglect - Part 2,NG76,What training should practitioners have to provide effective early help and parenting support for vulnerable families?
NG76_Recommendations: 1.5 Early help for families showing possible signs of child abuse or neglect - Part 3,NG76,What are the recommended components of home visiting programmes for parents at risk of child neglect?
NG76_Recommendations: 1.6 Multi-agency response to child abuse and neglect,NG76,"What are the recommended multi-agency practices for supporting children and young people affected by abuse, neglect, or trafficking?"
"NG76_Recommendations: 1.7 Therapeutic interventions for children, young people and families after child abuse and neglect - Part 1",NG76,What are the recommended therapeutic interventions for children under 5 who have experienced neglect or physical abuse?
"NG76_Recommendations: 1.7 Therapeutic interventions for children, young people and families after child abuse and neglect - Part 2",NG76,"What are the recommended interventions for supporting parents and carers of children under 5 who have experienced abuse, neglect, or domestic violence?"
"NG76_Recommendations: 1.7 Therapeutic interventions for children, young people and families after child abuse and neglect - Part 3",NG76,What are the recommended therapeutic interventions for children and young people who have experienced sexual abuse?
"NG76_Recommendations: 1.7 Therapeutic interventions for children, young people and families after child abuse and neglect - Part 4",NG76,What are the recommended therapeutic interventions for children and young people after sexual abuse?
NG76_Recommendations: 1.8 Planning and delivering services,NG76,What are best practices for planning and delivering multi-agency safeguarding services for children and young people?
NG76_Terms used in this guideline - Part 1,NG76,What are the key indicators and assessment strategies for identifying child abuse and neglect?
NG76_Terms used in this guideline - Part 2,NG76,What are the signs and indicators of domestic abuse and honour-based abuse?
NG76_Terms used in this guideline - Part 3,NG76,What are the key indicators of child neglect and how should it be managed according to NICE guidelines?
NG76_Terms used in this guideline - Part 4,NG76,What are the key considerations for safeguarding children and young people with Prader-Willi syndrome?
NG76_Recommendations for research: 1 Recognition of child sexual abuse & Recommendations for research: 2 Recognition of risk and prevention of female genital mutilation,NG76,What are effective strategies for early identification and disclosure of child sexual abuse by practitioners?
NG76_Recommendations for research: 3 Recognition of risk and prevention of 'honour-based' violence and forced marriage & Recommendations for research: 4 Early help home visiting,NG76,What interventions are effective in recognizing and preventing 'honour-based' violence and forced marriage?
NG76_Recommendations for research: 5 Effective prevention of child abuse and neglect in the UK & Recommendations for research: 6 Reducing social isolation and associated child abuse and neglect & Recommendations for research: 7 Effective interventions for young people who have been abused or neglected,NG76,What are the most effective and cost-effective interventions in the UK to prevent child abuse and neglect in at-risk families?
"NG76_Recommendations for research: 8 Effective interventions for children and young people who have experienced online-facilitated abuse, including online grooming & 3 more sections",NG76,What are the most effective and cost-effective interventions for supporting children and young people who have experienced online grooming and abuse?
NG76_Recommendations for research: 12 Effectiveness of home visiting following child abuse or neglect & Recommendations for research: 13 Effective interventions for parents or carers with substance misuse problems & Recommendations for research: 14 Effectiveness of web-based parenting programmes,NG76,What is the effectiveness of home visiting programs in improving child safety and preventing recurrence of child abuse and neglect?
NG76_Recommendations for research: 15 Relative effectiveness of interventions to support foster carers & Recommendations for research: 16 Peer support for children and young people who have been abused or neglected,NG76,What is the effectiveness and cost-effectiveness of the KEEP intervention for foster carers of abused or neglected children compared to other support interventions?
NG77_Cataracts in adults: management & Overview,NG77,What are the recommended management strategies for cataracts in adults?
NG77_Recommendations: 1.1 Patient information - Part 1,NG77,What information should be provided to patients and their families about cataracts and cataract surgery?
NG77_Recommendations: 1.1 Patient information - Part 2 & Recommendations: 1.2 Referral for cataract surgery,NG77,What should patients expect on the day of cataract surgery and afterwards?
NG77_Recommendations: 1.3 Preoperative assessment and biometry - Part 1,NG77,What are the recommended biometry techniques for preoperative assessment in cataract surgery?
NG77_Recommendations: 1.3 Preoperative assessment and biometry - Part 2 & Recommendations: 1.4 Intraocular lens selection,NG77,How should intraocular lens power be adjusted in patients with previous corneal refractive surgery?
NG77_Recommendations: 1.5 Preventing wrong lens implant errors - Part 1,NG77,What are the recommended steps to prevent wrong lens implant errors during cataract surgery?
NG77_Recommendations: 1.5 Preventing wrong lens implant errors - Part 2,NG77,What are the recommended procedures for verifying intraocular lens selection and stock before cataract surgery?
NG77_Recommendations: 1.6 Surgical timing and technique,NG77,When is bilateral simultaneous cataract surgery appropriate and what are the associated risks and benefits?
NG77_Recommendations: 1.7 Anaesthesia,NG77,What are the recommended anaesthesia options for cataract surgery according to NICE guidelines?
NG77_Recommendations: 1.8 Preventing and managing complications & Recommendations: 1.9 Postoperative assessment,NG77,What are the recommended strategies for preventing and managing complications during cataract surgery?
NG77_Context - Part 1,NG77,What are the management options for age-related cataracts in adults?
NG77_Context - Part 2,NG77,What are the recommended referral criteria for cataract surgery in adults?
NG77_Recommendations for research: 1 Toric lenses for astigmatism,NG77,What is the cost-effectiveness of toric lenses compared to surgical options for astigmatism correction in the NHS?
NG77_Recommendations for research: 2 Quality of life in cataract surgery & Recommendations for research: 3 Indicators and thresholds for referral for cataract surgery,NG77,What are the most effective vision-specific quality-of-life measures for assessing outcomes in cataract surgery?
NG77_Recommendations for research: 4 Interventions to manage cystoid macular oedema & Recommendations for research: 5 Interventions to prevent endophthalmitis,NG77,What is the most effective postoperative medical management for cystoid macular oedema?
NG78_Cystic fibrosis: diagnosis and management & Overview,NG78,What are the current recommendations for diagnosing and managing cystic fibrosis?
NG78_Recommendations: 1.1 Diagnosis of cystic fibrosis,NG78,How is cystic fibrosis diagnosed in children and adults?
NG78_Recommendations: 1.2 Information and support - Part 1,NG78,What information and support should be provided to people with cystic fibrosis and their families?
NG78_Recommendations: 1.2 Information and support - Part 2,NG78,What information and support are recommended for people with cystic fibrosis during transition to adult care and at key life stages?
NG78_Recommendations: 1.3 Service delivery - Part 1,NG78,What is the recommended service delivery model for cystic fibrosis care according to NICE guidelines?
NG78_Recommendations: 1.3 Service delivery - Part 2,NG78,What are the roles and responsibilities of the multidisciplinary team in cystic fibrosis management according to NICE guidelines?
NG78_Recommendations: 1.3 Service delivery - Part 3,NG78,What are the NICE recommendations for managing cystic fibrosis care and transition from pediatric to adult services?
NG78_Recommendations: 1.4 Complications of cystic fibrosis,NG78,What are the common and less common complications of cystic fibrosis?
NG78_Recommendations: 1.5 Annual and routine reviews,NG78,What should be included in the annual review for people with cystic fibrosis?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 1",NG78,What are the recommended pulmonary monitoring and assessment procedures for people with cystic fibrosis?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 2",NG78,What are the recommended diagnostic and monitoring methods for lung disease in cystic fibrosis patients?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 3",NG78,What are the recommended airway clearance techniques and mucoactive agents for cystic fibrosis management?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 4",NG78,When is mannitol dry powder for inhalation appropriate for children with cystic fibrosis?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 5",NG78,What are the recommended antibiotic prophylaxis and treatment options for Staphylococcus aureus respiratory infections in children with cystic fibrosis?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 6",NG78,What are the recommended treatments for Pseudomonas aeruginosa infection in cystic fibrosis patients?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 7",NG78,What are the recommended antibiotic treatments for managing Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis patients?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 8",NG78,What are the recommended treatments for respiratory infections in cystic fibrosis patients according to NICE guidelines?
"NG78_Recommendations: 1.6 Pulmonary monitoring, assessment and management - Part 9",NG78,What are the recommended treatments for managing Aspergillus fumigatus infection in cystic fibrosis patients?
"NG78_Recommendations: 1.7 Other monitoring, assessment and management - Part 1",NG78,What are the recommended nutritional interventions and management strategies for exocrine pancreatic insufficiency in cystic fibrosis?
"NG78_Recommendations: 1.7 Other monitoring, assessment and management - Part 2",NG78,What are the recommended management strategies for distal intestinal obstruction syndrome in people with cystic fibrosis?
"NG78_Recommendations: 1.7 Other monitoring, assessment and management - Part 3",NG78,What are the recommended screening and management strategies for liver disease and cystic fibrosis-related diabetes in people with cystic fibrosis?
"NG78_Recommendations: 1.7 Other monitoring, assessment and management - Part 4",NG78,"What are the recommended assessments and management strategies for bone mineral density, exercise, and mental health in people with cystic fibrosis?"
NG78_Recommendations: 1.8 Preventing cross-infection,NG78,What are the recommended infection control measures to prevent cross-infection in cystic fibrosis care?
NG78_Recommendations: Terms used in this guideline,NG78,What is the definition of immunomodulatory dose in cystic fibrosis treatment?
NG78_Context & Recommendations for research: 1 Liver disease,NG78,Should children with cystic fibrosis and meconium ileus receive ursodeoxycholic acid from diagnosis to prevent liver disease?
NG78_Recommendations for research: 2 Airway clearance techniques & Recommendations for research: 3 Monitoring pulmonary disease,NG78,What is the effectiveness of daily airway clearance techniques in maintaining lung function in infants and children with cystic fibrosis?
NG78_Recommendations for research: 4 Psychological assessment & Recommendations for research: 5 Monitoring for cystic-fibrosis-related diabetes,NG78,What is the most effective method for routine psychological assessment in people with cystic fibrosis?
NG78_Recommendations for research: 6 Mucoactive agents,NG78,What is the most effective and cost-effective dosing schedule for rhDNase in cystic fibrosis patients?
NG79_Sinusitis (acute): antimicrobial prescribing & Overview & Background,NG79,What are the recommended criteria for prescribing antibiotics for acute sinusitis?
NG79_Recommendations: 1.1 Managing acute sinusitis - Part 1,NG79,What are the recommended management strategies for acute sinusitis without antibiotics?
NG79_Recommendations: 1.1 Managing acute sinusitis - Part 2,NG79,When should antibiotics be prescribed for sinusitis and what are the considerations for withholding or using back-up prescriptions?
NG79_Recommendations: 1.2 Choice of antibiotic - Part 1,NG79,What are the recommended antibiotics and dosages for treating acute sinusitis in adults?
NG79_Recommendations: 1.2 Choice of antibiotic - Part 2,NG79,What are the recommended antibiotics and dosages for treating children with bacterial infections according to NICE guidelines?
NG79_Recommendations: 1.2 Choice of antibiotic - Part 3 & Recommendations: 1.3 Self-care,NG79,What are the recommended dosing guidelines for co-amoxiclav in children with hepatic or renal impairment?
NG79_Symptoms and signs,NG79,What are the common symptoms and signs of acute sinusitis in adults and children?
NG79_Summary of the evidence: Self-care,NG79,What are the recommended self-care options for managing acute sinusitis?
NG79_Summary of the evidence: Nasal corticosteroids - Part 1,NG79,What is the effectiveness of high-dose nasal corticosteroids in treating acute sinusitis in adults and children?
NG79_Summary of the evidence: Nasal corticosteroids - Part 2,NG79,What are the systemic side effects of nasal corticosteroids in children and adults?
NG79_Summary of the evidence: No antibiotic - Part 1,NG79,Should antibiotics be prescribed for acute sinusitis in adults?
NG79_Summary of the evidence: No antibiotic - Part 2,NG79,What is the effectiveness of antibiotics in treating acute sinusitis and which clinical signs indicate benefit?
NG79_Summary of the evidence: No antibiotic - Part 3,NG79,What are the indications for prescribing antibiotics in acute sinusitis?
NG79_Summary of the evidence: Back-up antibiotics - Part 1,NG79,What is the effectiveness of back-up antibiotic prescriptions for managing upper respiratory tract infections?
NG79_Summary of the evidence: Back-up antibiotics - Part 2,NG79,When should a back-up antibiotic be prescribed for acute sinusitis?
NG79_Summary of the evidence: Choice of antibiotic - Part 1,NG79,What is the most effective antibiotic choice for treating bacterial infections in adults and children?
NG79_Summary of the evidence: Choice of antibiotic - Part 2,NG79,"What are the differences in adverse effects between cephalosporins, macrolides, and co-amoxiclav?"
NG79_Summary of the evidence: Choice of antibiotic - Part 3,NG79,What is the recommended first-line antibiotic for non-serious bacterial infections according to NICE guidelines?
NG79_Summary of the evidence: Choice of antibiotic - Part 4,NG79,What are the recommended antibiotic options and dosages for bacterial infections during pregnancy?
NG79_Summary of the evidence: Antibiotic course length,NG79,What is the recommended duration of antibiotic treatment for acute sinusitis in adults and children?
NG79_Other considerations,NG79,How can medication adherence be improved in patients prescribed antibiotics or nasal corticosteroids?
NG81_Glaucoma: diagnosis and management & Overview & Recommendations: 1.1 Case-finding - Part 1,NG81,What are the recommended tests for diagnosing glaucoma in primary care?
NG81_Recommendations: 1.1 Case-finding - Part 2,NG81,What are the criteria for referring patients for glaucoma diagnosis and management?
NG81_Recommendations: 1.2 Diagnosis,NG81,What are the recommended diagnostic tests for primary open-angle glaucoma?
NG81_Recommendations: 1.3 Standard practice for all assessments,NG81,What are the standard assessment procedures for glaucoma and ocular hypertension?
NG81_Recommendations: 1.4 Treatment - Part 1,NG81,What are the recommended treatments for ocular hypertension to prevent visual impairment?
NG81_Recommendations: 1.4 Treatment - Part 2,NG81,What are the recommended pharmacological treatments for ocular hypertension with IOP of 24 mmHg or higher?
NG81_Recommendations: 1.4 Treatment - Part 3,NG81,What are the recommended treatments for lowering intraocular pressure in patients with ocular hypertension or suspected glaucoma?
NG81_Recommendations: 1.4 Treatment - Part 4,NG81,What are the recommended treatments for people with chronic open-angle glaucoma according to NICE guidelines?
NG81_Recommendations: 1.4 Treatment - Part 5,NG81,What are the expected outcomes and potential side effects of 360° SLT for open-angle glaucoma?
NG81_Recommendations: 1.4 Treatment - Part 6,NG81,What are the recommended treatment options for patients with chronic open-angle glaucoma who do not respond to initial pharmacological therapy?
NG81_Recommendations: 1.4 Treatment - Part 7,NG81,What are the alternative treatments for patients with primary open-angle glaucoma who cannot tolerate standard pharmacological therapy?
NG81_Recommendations: 1.5 Reassessment - Part 1,NG81,"When should patients with chronic open-angle glaucoma, suspected glaucoma, or ocular hypertension be reassessed?"
NG81_Recommendations: 1.5 Reassessment - Part 2,NG81,What is the recommended follow-up interval for patients with ocular hypertension or suspected COAG based on intraocular pressure control and risk of conversion?
NG81_Recommendations: 1.5 Reassessment - Part 3,NG81,How should clinicians determine the timing of follow-up appointments for patients with chronic open angle glaucoma?
NG81_Recommendations: 1.6 Organisation of care - Part 1,NG81,What qualifications and training are required for healthcare professionals to diagnose and manage ocular hypertension and glaucoma?
NG81_Recommendations: 1.6 Organisation of care - Part 2,NG81,What are the criteria and procedures for offering and monitoring 360° SLT in glaucoma management?
NG81_Recommendations: 1.7 Providing information,NG81,"What information should healthcare professionals provide to patients about glaucoma diagnosis, treatment options, and living with the condition?"
NG81_Recommendations: Terms used in this guideline - Part 1,NG81,What is enhanced case-finding and referral refinement for glaucoma?
NG81_Recommendations: Terms used in this guideline - Part 2,NG81,What are the recommended repeat measurement protocols for diagnosing and monitoring glaucoma progression?
NG81_Recommendations for research,NG81,What are the most effective risk assessment tools for predicting the development of chronic open angle glaucoma and associated sight loss?
NG81_Rationale and impact: Selective laser trabeculoplasty for people with ocular hypertension or chronic open angle glaucoma - Part 1,NG81,What are the benefits and risks of selective laser trabeculoplasty compared to eye drops for treating ocular hypertension and open angle glaucoma?
NG81_Rationale and impact: Selective laser trabeculoplasty for people with ocular hypertension or chronic open angle glaucoma - Part 2,NG81,What are the benefits and considerations of using 360° SLT as first-line treatment for open-angle glaucoma and ocular hypertension?
NG81_Rationale and impact: Selective laser trabeculoplasty for people with ocular hypertension or chronic open angle glaucoma - Part 3,NG81,What is the long-term effectiveness of 360° selective laser trabeculoplasty (SLT) in reducing intraocular pressure and preventing glaucomatous visual field progression?
NG81_Rationale and impact: Generic PGAs for people with OHT or COAG,NG81,What are the recommended first-line treatments for open-angle glaucoma and ocular hypertension?
NG81_Rationale and impact: Organisation of care,NG81,How should healthcare professionals be organized and trained to perform 360° SLT for ocular hypertension and glaucoma?
NG81_Context,NG81,What are the current recommendations for the diagnosis and management of ocular hypertension and open-angle glaucoma according to NICE guidelines?
NG82_Age-related macular degeneration & Overview,NG82,What are the recommended diagnostic and management strategies for age-related macular degeneration?
NG82_Recommendations: 1.1 Classifying age-related macular degeneration,NG82,How is age-related macular degeneration classified according to NICE guidelines?
NG82_Recommendations: 1.2 Information and support,NG82,What information and support should be provided to people with age-related macular degeneration (AMD)?
NG82_Recommendations: 1.3 Risk factors,NG82,What are the risk factors for age-related macular degeneration (AMD)?
NG82_Recommendations: 1.4 Diagnosis and referral,NG82,What are the recommended procedures for diagnosing and referring patients with age-related macular degeneration (AMD)?
NG82_Recommendations: 1.5 Pharmacological management of AMD - Part 1,NG82,What are the recommended pharmacological treatments for wet age-related macular degeneration (AMD)?
NG82_Recommendations: 1.5 Pharmacological management of AMD - Part 2,NG82,What are the guidelines for using anti-VEGF treatments like bevacizumab and ranibizumab for wet age-related macular degeneration?
NG82_Recommendations: 1.5 Pharmacological management of AMD - Part 3,NG82,What are the criteria for using ranibizumab or aflibercept in treating wet age-related macular degeneration?
NG82_Recommendations: 1.5 Pharmacological management of AMD - Part 4,NG82,When should anti-VEGF treatment for wet age-related macular degeneration be stopped or switched?
NG82_Recommendations: 1.6 Non-pharmacological management of AMD,NG82,What are the non-pharmacological management options for age-related macular degeneration?
NG82_Recommendations: 1.7 Monitoring AMD & Recommendations: Terms used in this guideline,NG82,What are the recommended monitoring strategies for patients with age-related macular degeneration according to NICE guidelines?
NG82_Recommendations for research: 1 Strategies to slow the progression of age-related macular degeneration (AMD) & Recommendations for research: 2 Organisational models for AMD diagnosis and management,NG82,What is the effectiveness of antioxidant and zinc supplements in slowing the progression of early age-related macular degeneration?
NG82_Recommendations for research: 3 Stopping rules for antiangiogenic treatment for late AMD (wet) & Recommendations for research: 4 Frequency of monitoring,NG82,When should anti-VEGF treatment be stopped in patients with wet age-related macular degeneration?
NG82_Recommendations for research: 5 Self-monitoring strategies,NG82,Does self-monitoring for early detection of late age-related macular degeneration improve treatment timing and visual outcomes?
NG82_Context - Part 1,NG82,What are the classification and management options for age-related macular degeneration?
NG82_Context - Part 2,NG82,What are the treatment options and associated costs for neovascular age-related macular degeneration in the UK?
NG83_Oesophago-gastric cancer: assessment and management in adults & Overview & Recommendations: 1.1 Information and support - Part 1,NG83,What information should be provided to patients with oesophago-gastric cancer about treatment options and outcomes?
NG83_Recommendations: 1.1 Information and support - Part 2 & Recommendations: 1.2 Organisation of services,NG83,What are the recommended palliative management strategies for oesophago-gastric cancer patients?
NG83_Recommendations: 1.3 Assessment after diagnosis,NG83,What are the recommended diagnostic assessments for staging and treatment planning in oesophageal and gastric cancer?
NG83_Recommendations: 1.4 Radical treatment - Part 1,NG83,What are the recommended radical treatment options for T1N0 oesophageal cancer?
NG83_Recommendations: 1.4 Radical treatment - Part 2,NG83,What are the treatment options for localized oesophageal and gastric adenocarcinoma?
NG83_Recommendations: 1.5 Palliative management - Part 1,NG83,What are the palliative treatment options for non-metastatic oesophageal cancer not suitable for surgery?
NG83_Recommendations: 1.5 Palliative management - Part 2,NG83,What are the considerations for second-line palliative chemotherapy options in oesophago-gastric cancer?
NG83_Recommendations: 1.5 Palliative management - Part 3,NG83,What are the recommended options for managing luminal obstruction in oesophageal and gastric cancer according to NICE guidelines?
NG83_Recommendations: 1.6 Nutritional support & Recommendations: 1.7 Follow-up,NG83,What is the recommended nutritional support for patients undergoing radical or palliative treatment for oesophago-gastric cancer?
NG83_Recommendations for research: 1 External beam radiotherapy in addition to stenting to prevent bleeding & Recommendations for research: 2 Enteral feeding for people with luminal obstruction and dysphagia & Recommendations for research: 3 Radical treatment of squamous cell carcinoma of the oesophagus,NG83,What is the effectiveness of adding surgery to chemoradiotherapy for improving survival in patients with squamous cell carcinoma of the oesophagus?
NG83_Recommendations for research: 4 Radical treatment of T1bN0 adenocarcinoma of the oesophagus & Recommendations for research: 5 Nutritional support after radical surgery,NG83,What is the most effective method of nutritional support after oesophago-gastric cancer surgery?
NG83_Recommendations for research: 6 Jejunostomy support after radical surgery & Recommendations for research: 7 Follow-up after treatment with curative intent,NG83,What is the effectiveness of long-term jejunostomy support versus dietary counselling and symptom management after radical oesophago-gastric cancer surgery?
NG83_Rationale and impact: Luminal obstruction in oesophageal and oesophago-gastric junctional cancer - Part 1,NG83,What are the recommended interventions for managing luminal obstruction and dysphagia in oesophageal and oesophago-gastric junctional cancer?
NG83_Rationale and impact: Luminal obstruction in oesophageal and oesophago-gastric junctional cancer - Part 2,NG83,When should external beam radiotherapy be offered after stent insertion for oesophageal and oesophagogastric junctional cancer?
NG83_Context,NG83,What are the recommended diagnostic and management pathways for oesophago-gastric cancer?
NG84_Sore throat (acute): antimicrobial prescribing & Overview,NG84,What are the recommended criteria for prescribing antibiotics for acute sore throat in children and young people?
NG84_Recommendations: 1.1 Managing acute sore throat - Part 1,NG84,What are the recommended management strategies for acute sore throat in adults and children?
NG84_Recommendations: 1.1 Managing acute sore throat - Part 2,NG84,When should antibiotics be prescribed for sore throat based on FeverPAIN or Centor scores?
NG84_Recommendations: 1.1 Managing acute sore throat - Part 3,NG84,When should antibiotics be prescribed immediately or as a backup for sore throat?
NG84_Recommendations: 1.2 Self-care,NG84,What are the recommended self-care strategies for managing acute sore throat?
NG84_Recommendations: 1.3 Choice of antibiotic - Part 1,NG84,What is the recommended antibiotic treatment for adults with acute sore throat according to NICE guidelines?
NG84_Recommendations: 1.3 Choice of antibiotic - Part 2,NG84,What are the recommended antibiotic dosages for children with penicillin allergy?
NG84_Recommendations: 1.3 Choice of antibiotic - Part 3,NG84,How should antibiotics be dosed in children with hepatic or renal impairment according to NICE guidelines?
NG84_Summary of the evidence: Self-care - Part 1,NG84,What are the recommended self-care options for pain relief in adults with sore throat?
NG84_Summary of the evidence: Self-care - Part 2,NG84,"What is the effectiveness and safety of medicated lozenges containing benzocaine, hexylresorcinol, or flurbiprofen for sore throat pain relief?"
NG84_Summary of the evidence: Self-care - Part 3,NG84,What are the effective self-care options for managing sore throat pain in adults and children?
NG84_Summary of the evidence: Corticosteroids,NG84,Should corticosteroids be used for managing acute sore throat?
NG84_Summary of the evidence: No antibiotic - Part 1,NG84,Should antibiotics be prescribed for acute sore throat in children and adults?
NG84_Summary of the evidence: No antibiotic - Part 2,NG84,What is the effectiveness and safety of antibiotics in preventing suppurative complications and rheumatic fever in sore throat management?
NG84_Summary of the evidence: Back-up antibiotics,NG84,What is the effectiveness of back-up antibiotics compared to immediate antibiotics for treating pharyngitis?
NG84_Summary of the evidence: Identifying people more likely to benefit from antibiotics - Part 1,NG84,How can the FeverPAIN score be used to identify patients who would benefit from antibiotics for sore throat?
NG84_Summary of the evidence: Identifying people more likely to benefit from antibiotics - Part 2,NG84,How are FeverPAIN and Centor criteria used to assess the need for antibiotics in patients with acute sore throat?
NG84_Summary of the evidence: Identifying people more likely to benefit from antibiotics - Part 3,NG84,What are the recommended antibiotic prescribing strategies for acute sore throat based on FeverPAIN and Centor scores?
NG84_Summary of the evidence: Antibiotic choice - Part 1,NG84,What is the most appropriate antibiotic choice and dosing frequency for treating GABHS-positive sore throat?
NG84_Summary of the evidence: Antibiotic choice - Part 2,NG84,What is the recommended antibiotic choice and dosing frequency for non-life-threatening bacterial infections?
NG84_Summary of the evidence: Antibiotic choice - Part 3,NG84,What are the recommended antibiotic options and dosing schedules for sore throat in patients with penicillin allergy?
NG84_Summary of the evidence: Antibiotic course length - Part 1,NG84,What is the recommended duration of phenoxymethylpenicillin treatment for GABHS-positive sore throat?
NG84_Summary of the evidence: Antibiotic course length - Part 2,NG84,What is the recommended duration of phenoxymethylpenicillin treatment for bacterial infections?
NG84_Other considerations,NG84,What strategies can improve medicines adherence for antibiotics requiring long-term or frequent dosing?
NG84_Terms used in the guideline,NG84,What are the clinical scoring tools for diagnosing streptococcal sore throat?
NG85_Pancreatic cancer in adults: diagnosis and management & Overview,NG85,What are the recommended management strategies for pancreatic cancer in adults according to NICE guidelines?
NG85_Recommendations: 1.1 Diagnosis - Part 1,NG85,What are the recommended diagnostic procedures for suspected pancreatic cancer with obstructive jaundice?
NG85_Recommendations: 1.1 Diagnosis - Part 2 & Recommendations: 1.2 Specialist pancreatic multidisciplinary teams,NG85,What are the recommended procedures for pancreatic cancer diagnosis and surveillance according to NICE guidelines?
NG85_Recommendations: 1.3 Staging & Recommendations: 1.4 Psychological support,NG85,What imaging options are recommended for staging pancreatic cancer?
NG85_Recommendations: 1.5 Pain management & Recommendations: 1.6 Nutritional management,NG85,What are the recommended pain management options for pancreatic cancer patients experiencing uncontrolled pain or opioid side effects?
NG85_Recommendations: 1.7 Relieving biliary and duodenal obstruction,NG85,What are the recommended management options for biliary and duodenal obstruction in pancreatic cancer?
NG85_Recommendations: 1.8 Managing resectable and borderline resectable pancreatic cancer,NG85,What are the recommended management strategies for resectable and borderline resectable pancreatic cancer?
NG85_Recommendations: 1.9 Managing unresectable pancreatic cancer - Part 1,NG85,What are the recommended systemic chemotherapy options for unresectable pancreatic cancer according to NICE guidelines?
NG85_Recommendations: 1.9 Managing unresectable pancreatic cancer - Part 2,NG85,What are the current NICE recommendations for second-line chemotherapy options in metastatic pancreatic cancer?
NG85_Recommendations: Terms used in this guideline & Context,NG85,What is the recommended extent of lymphadenectomy in surgery for pancreatic ductal adenocarcinoma?
NG85_Recommendations for research: 1 Neoadjuvant therapy,NG85,What is the effectiveness of neoadjuvant therapy compared to postoperative therapy in resectable pancreatic cancer?
NG85_Recommendations for research: 2 Cachexia interventions,NG85,What are the recommended interventions for preventing or reversing cachexia in patients with pancreatic cancer?
NG85_Recommendations for research: 3 Minimally invasive pancreatectomy,NG85,What is the evidence comparing minimally invasive versus open pancreatectomy for pancreatic cancer outcomes?
NG85_Recommendations for research: 4 Pain management & Recommendations for research: 5 Psychological support needs,NG85,What are the recommended pain management strategies and psychological support interventions for people with unresectable pancreatic cancer?
NG86_People's experience in adult social care services: improving the experience of care and support for people using adult social care services & Overview,NG86,What strategies can improve the experience of care and support for adults using social care services?
NG86_Recommendations: 1.1 Overarching principles - Part 1,NG86,What are the principles for supporting individual decision-making and communication in adult social care?
NG86_Recommendations: 1.1 Overarching principles - Part 2,NG86,What are the best practices for involving carers and family members in social care decision-making?
NG86_Recommendations: 1.2 Information,NG86,What information should local authorities provide about care and support services for people and their carers?
NG86_Recommendations: 1.3 Care and support needs assessment and care planning - Part 1,NG86,What are the key principles for conducting care and support needs assessments under the Care Act 2014?
NG86_Recommendations: 1.3 Care and support needs assessment and care planning - Part 2,NG86,What are the best practices for documenting and sharing care and support plans with patients and their carers?
NG86_Recommendations: 1.3 Care and support needs assessment and care planning - Part 3,NG86,What are best practices for matching care workers to individuals based on needs and preferences?
NG86_Recommendations: 1.3 Care and support needs assessment and care planning - Part 4,NG86,What support and information should local authorities provide for people employing personal assistants in social care?
NG86_Recommendations: 1.4 Providing care and support - Part 1,NG86,What are the best practices for providing person-centered care and support in all healthcare settings?
NG86_Recommendations: 1.4 Providing care and support - Part 2,NG86,What are the best practices for staff handover and maintaining consistency in care support?
NG86_Recommendations: 1.4 Providing care and support - Part 3,NG86,What are best practices for designing residential care environments to support residents' autonomy and positive interactions?
NG86_Recommendations: 1.5 Staff skills and experience,NG86,What are best practices for recruiting and training compassionate social care staff?
NG86_Recommendations: 1.6 Involving people in service design and improvement - Part 1,NG86,How can health and social care services involve people in service design and improvement?
NG86_Recommendations: 1.6 Involving people in service design and improvement - Part 2,NG86,What strategies can improve participation and feedback from underrepresented groups in health and social care surveys?
NG86_Recommendations: Terms used in this guideline - Part 1,NG86,What is the process for conducting a care and support needs assessment under the Care Act 2014?
NG86_Recommendations: Terms used in this guideline - Part 2,NG86,What are effective strategies for building reciprocal relationships and peer support in adult social care services?
NG86_Recommendations: Terms used in this guideline - Part 3,NG86,What is personalized care and how is it implemented in social care services?
NG86_Recommendations for research: 1 Methods and approaches for gathering the experiences of people who use adult social care services,NG86,What are the most effective research methods for capturing the experiences of adults using social care services?
NG86_Recommendations for research: 2 Co-producing research into the views and experiences of people who use services & Recommendations for research: 3 Identifying barriers and enablers to using the views and experiences of people who use services to improve services,NG86,What are effective strategies for co-producing research with service users to improve public services?
NG86_Recommendations for research: 4 Use of technology in providing care,NG86,What are the experiences of adults using social care services with assistive technologies?
NG86_Context - Part 1,NG86,What are best practices for integrating health and social care to improve user control and satisfaction?
NG86_Context - Part 2,NG86,What are the best practices for supporting adults with learning disabilities and mental health conditions?
NG87_Attention deficit hyperactivity disorder: diagnosis and management & Overview,NG87,What are the recommended approaches for diagnosing and managing ADHD in children and adults?
NG87_Recommendations: 1.1 Service organisation and training - Part 1,NG87,What are recommended service organization and multidisciplinary team structures for ADHD management?
NG87_Recommendations: 1.1 Service organisation and training - Part 2,NG87,How should the transition from child to adult services be managed for young people with ADHD?
"NG87_Recommendations: 1.2 Recognition, identification and referral - Part 1",NG87,What are the criteria for referring children and young people for ADHD assessment and the role of schools and professionals in the referral process?
"NG87_Recommendations: 1.2 Recognition, identification and referral - Part 2",NG87,What are the recommended steps for primary care management of children with suspected ADHD?
NG87_Recommendations: 1.3 Diagnosis,NG87,What are the recommended diagnostic procedures for ADHD according to NICE guidelines?
NG87_Recommendations: 1.4 Information and support - Part 1,NG87,What information and support should be provided to adults and young people diagnosed with ADHD?
NG87_Recommendations: 1.4 Information and support - Part 2,NG87,What information and support options are available for people diagnosed with ADHD and their families?
NG87_Recommendations: 1.4 Information and support - Part 3,NG87,What information should be provided to parents and educational staff about ADHD diagnosis and management?
NG87_Recommendations: 1.5 Managing ADHD - Part 1,NG87,What are the recommended approaches for developing a comprehensive treatment plan for individuals with ADHD?
NG87_Recommendations: 1.5 Managing ADHD - Part 2,NG87,What are the recommended management strategies for ADHD in children under 5 years according to NICE guidelines?
NG87_Recommendations: 1.5 Managing ADHD - Part 3,NG87,What support and information should be provided to parents and carers of children aged 5 years and over with ADHD?
NG87_Recommendations: 1.5 Managing ADHD - Part 4,NG87,When should medication and cognitive behavioural therapy be considered for children and young people with ADHD?
NG87_Recommendations: 1.5 Managing ADHD - Part 5,NG87,What are the recommended non-pharmacological treatments for adults with ADHD?
NG87_Recommendations: 1.6 Dietary advice,NG87,What dietary advice is recommended for children and young people with ADHD?
NG87_Recommendations: 1.7 Medication - Part 1,NG87,What are the baseline assessment requirements before starting medication for ADHD?
NG87_Recommendations: 1.7 Medication - Part 2,NG87,What are the recommended pharmacological treatments for ADHD in children aged 5 years and over according to NICE guidelines?
NG87_Recommendations: 1.7 Medication - Part 3,NG87,What are the recommended medication options for treating ADHD in children aged 5 to 17 years who cannot tolerate methylphenidate or lisdexamfetamine?
NG87_Recommendations: 1.7 Medication - Part 4,NG87,What are the medication options for adults with ADHD who cannot tolerate lisdexamfetamine or methylphenidate?
NG87_Recommendations: 1.7 Medication - Part 5,NG87,What are the NICE recommendations for prescribing and managing medication for ADHD?
NG87_Recommendations: 1.7 Medication - Part 6,NG87,"How should medication dose titration be managed in children and adults with ADHD, especially when comorbid neurodevelopmental or mental health conditions are present?"
NG87_Recommendations: 1.8 Maintenance and monitoring - Part 1,NG87,How should medication effectiveness and adverse effects be monitored in people with ADHD?
NG87_Recommendations: 1.8 Maintenance and monitoring - Part 2,NG87,How should BMI and cardiovascular parameters be monitored in adults with ADHD during treatment?
NG87_Recommendations: 1.8 Maintenance and monitoring - Part 3,NG87,What are the recommended ways to monitor for sexual dysfunction and seizures in people with ADHD on medication?
NG87_Recommendations: 1.9 Adherence to treatment - Part 1,NG87,How can I improve medication adherence in adults and children with ADHD?
NG87_Recommendations: 1.9 Adherence to treatment - Part 2,NG87,How can parents and carers support adherence to ADHD medication and non-pharmacological treatments in children and young people?
NG87_Recommendations: 1.10 Review of medication and discontinuation,NG87,How often should ADHD medication be reviewed and what factors should be considered during the review?
NG87_Recommendations: Terms used in this guideline,NG87,What are effective environmental modifications and reasonable adjustments for managing ADHD in different settings?
NG87_Recommendations for research,NG87,What is the evidence on the effectiveness of parent-training programs for children and young people with ADHD aged 5 to 18 years?
NG87_Rationale and impact: Recognition,NG87,What are the signs and risk factors for ADHD in non-specialist settings?
NG87_Rationale and impact: Information and support,NG87,What information and support should be provided to individuals and families after an ADHD diagnosis?
NG87_Rationale and impact: Managing ADHD – planning treatment & Rationale and impact: Managing ADHD – children under 5 years,NG87,What are the recommended approaches for planning ADHD treatment in children under 5 years?
NG87_Rationale and impact: Managing ADHD – children under 5 years & Rationale and impact: Managing ADHD – children aged 5 years and over and young people,NG87,What are the recommended management strategies for ADHD in children under 5 years?
NG87_Rationale and impact: Managing ADHD – children aged 5 years and over and young people - Part 1,NG87,What are the recommended management strategies for ADHD in children aged 5 years and over?
NG87_Rationale and impact: Managing ADHD – children aged 5 years and over and young people - Part 2,NG87,What are the recommended treatment options for children and young people with ADHD according to NICE guidelines?
NG87_Rationale and impact: Managing ADHD – adults & Rationale and impact: Medication – care arrangements,NG87,"What are the recommended treatment options for adults with ADHD, including medication and non-pharmacological interventions?"
NG87_Rationale and impact: Medication – baseline assessment & Rationale and impact: Medication – choice - Part 1,NG87,What are the baseline assessment procedures before starting ADHD medication?
NG87_Rationale and impact: Medication – choice - Part 2 & Rationale and impact: Medication – considerations when prescribing and dose titration,NG87,What are the recommended non-stimulant medications for ADHD in children and adults?
NG87_Rationale and impact: Medication – monitoring effectiveness and adverse effects,NG87,How should the effectiveness and adverse effects of ADHD medication be monitored in children and adults?
NG87_Rationale and impact: Adherence to treatment,NG87,What strategies can healthcare professionals use to improve medication adherence in people with ADHD?
NG87_Rationale and impact: Review of medication and discontinuation,NG87,What are the recommended practices for reviewing and discontinuing medication in adults with ADHD?
NG87_Context - Part 1,NG87,What are the diagnostic criteria for ADHD in children and adults according to NICE guidelines?
NG87_Context - Part 2,NG87,What are the criteria for diagnosing ADHD and assessing functional impairment across different age groups?
NG88_Heavy menstrual bleeding: assessment and management & Overview & Recommendations: 1.1 Impact of heavy menstrual bleeding (HMB) on women,NG88,How does heavy menstrual bleeding affect a woman's quality of life and what interventions can improve it?
"NG88_Recommendations: 1.2 History, physical examination and laboratory tests - Part 1",NG88,What are the recommended history-taking and physical examination procedures for diagnosing heavy menstrual bleeding?
"NG88_Recommendations: 1.2 History, physical examination and laboratory tests - Part 2",NG88,What are the recommended clinical assessments and laboratory tests for women with heavy menstrual bleeding?
NG88_Recommendations: 1.3 Investigations for the cause of HMB - Part 1,NG88,What are the recommended investigations for diagnosing the cause of heavy menstrual bleeding?
NG88_Recommendations: 1.3 Investigations for the cause of HMB - Part 2,NG88,When should endometrial sampling be performed in women with heavy menstrual bleeding?
NG88_Recommendations: 1.4 Information for women about HMB and treatments - Part 1,NG88,What information should be provided to women about treatment options for heavy menstrual bleeding and their impact on fertility?
NG88_Recommendations: 1.4 Information for women about HMB and treatments - Part 2,NG88,What should women be told about the impact of uterine surgery on fertility and ovarian function?
NG88_Recommendations: 1.5 Management of HMB - Part 1,NG88,What are the recommended management options for heavy menstrual bleeding (HMB) according to NICE guidelines?
NG88_Recommendations: 1.5 Management of HMB - Part 2,NG88,What are the recommended treatment options for women with heavy menstrual bleeding and fibroids of 3 cm or larger?
NG88_Recommendations: 1.5 Management of HMB - Part 3,NG88,What are the recommended treatment options for uterine fibroids according to NICE guidelines?
NG88_Recommendations: 1.5 Management of HMB - Part 4,NG88,What are the recommended liver function monitoring procedures before and during ulipristal acetate treatment for fibroids?
NG88_Recommendations: 1.5 Management of HMB - Part 5,NG88,What are the recommended options and considerations for hysterectomy routes and ovarian removal in heavy menstrual bleeding management?
"NG88_Recommendations for research: 1 Hysteroscopy compared with ultrasound or empirical pharmacological treatment in the diagnosis and management of heavy menstrual bleeding (HMB) & Recommendations for research: 2 Effectiveness of the progestogen-only pill, injectable progestogens, or progestogen implants in alleviating HMB",NG88,What is the effectiveness of hysteroscopy compared to ultrasound or empirical treatment in diagnosing and managing heavy menstrual bleeding?
NG88_Recommendations for research: 3 Long-term outcomes of pharmacological and uterine-sparing surgical treatments for HMB associated with adenomyosis,NG88,What are the long-term outcomes of pharmacological and uterine-sparing surgical treatments for heavy menstrual bleeding associated with adenomyosis?
NG88_Recommendations for research: 4 Hysteroscopic removal of submucosal fibroids compared with other uterine-sparing treatments for HMB,NG88,Is hysteroscopic removal of submucosal fibroids more effective and cost-effective than other uterine-sparing treatments for heavy menstrual bleeding?
NG88_Recommendations for research: 5 Second-generation endometrial ablation for HMB associated with myometrial pathology,NG88,What are the outcomes of second-generation endometrial ablation for heavy menstrual bleeding in women with myometrial pathology such as adenomyosis or fibroids?
NG88_Rationale and impact: Investigations for the cause of HMB - Part 1,NG88,What are the recommended investigations for diagnosing heavy menstrual bleeding?
NG88_Rationale and impact: Investigations for the cause of HMB - Part 2,NG88,What is the most accurate imaging method for diagnosing adenomyosis in women with suspected condition?
NG88_Rationale and impact: Management of HMB - Part 1,NG88,What are the recommended management options for heavy menstrual bleeding in women without pathology or with small fibroids?
NG88_Rationale and impact: Management of HMB - Part 2,NG88,What are the recommended treatment options for women with fibroids larger than 3 cm?
NG88_Context,NG88,What are the recommended management options for heavy menstrual bleeding in women of reproductive age?
NG89_Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism & Overview,NG89,What are the recommended strategies for reducing the risk of venous thromboembolism in hospitalized patients aged 16 and over?
NG89_Recommendations: 1.1 Risk assessment - Part 1,NG89,What is the recommended process for assessing VTE and bleeding risk in hospitalized medical patients?
NG89_Recommendations: 1.1 Risk assessment - Part 2,NG89,What is the recommended timing for initiating pharmacological VTE prophylaxis in medical and surgical patients?
NG89_Recommendations: 1.1 Risk assessment - Part 3,NG89,"What are the recommendations for VTE prophylaxis and risk assessment in surgical, trauma, and obstetric patients?"
NG89_Recommendations: 1.2 Giving information and planning for discharge - Part 1,NG89,What information should be provided to patients and carers about VTE risk assessment and prophylaxis during hospital admission and discharge?
NG89_Recommendations: 1.2 Giving information and planning for discharge - Part 2,NG89,What are the recommended practices for patient education and management of VTE prophylaxis after hospital discharge?
NG89_Recommendations: 1.3 All patients - Part 1,NG89,What are the guidelines for using anti-embolism stockings in patients at risk of venous thromboembolism?
NG89_Recommendations: 1.3 All patients - Part 2,NG89,When should anti-embolism stockings be worn continuously in patients with reduced mobility?
NG89_Recommendations: 1.3 All patients - Part 3,NG89,What are the NICE recommendations for VTE prophylaxis in patients stopping anticoagulant or antiplatelet therapy before surgery?
NG89_Recommendations: 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients - Part 1,NG89,What are the recommended interventions for preventing venous thromboembolism in patients with acute stroke?
NG89_Recommendations: 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients - Part 2 & Recommendations: 1.5 Interventions for people with renal impairment,NG89,What are the recommended durations and medications for venous thromboembolism prophylaxis in acute stroke and acutely ill medical patients?
NG89_Recommendations: 1.6 Interventions for people with cancer,NG89,What are the current recommendations for VTE prophylaxis in cancer patients receiving chemotherapy?
NG89_Recommendations: 1.7 Interventions for people having palliative care,NG89,What are the recommended interventions for venous thromboembolism prophylaxis in palliative care patients?
NG89_Recommendations: 1.8 Interventions for people admitted to critical care,NG89,What are the recommended interventions for venous thromboembolism prevention in critically ill patients?
NG89_Recommendations: 1.9 Interventions for people with psychiatric illness,NG89,What are the recommended interventions for preventing venous thromboembolism in patients with psychiatric illness?
NG89_Recommendations: 1.10 Interventions when using anaesthesia,NG89,What are the considerations for using regional anaesthesia to reduce VTE risk during surgery?
NG89_Recommendations: 1.11 Interventions for people having orthopaedic surgery - Part 1,NG89,What are the recommended interventions for preventing venous thromboembolism in patients undergoing orthopaedic lower limb surgery?
NG89_Recommendations: 1.11 Interventions for people having orthopaedic surgery - Part 2,NG89,What are the recommended options for VTE prophylaxis after elective hip replacement surgery?
NG89_Recommendations: 1.11 Interventions for people having orthopaedic surgery - Part 3,NG89,What are the recommended options for VTE prophylaxis after elective knee replacement surgery?
NG89_Recommendations: 1.11 Interventions for people having orthopaedic surgery - Part 4,NG89,"When is VTE prophylaxis recommended for knee, foot, ankle, or upper limb orthopaedic surgery?"
NG89_Recommendations: 1.12 Interventions for people having elective spinal surgery or cranial surgery or people with spinal injury - Part 1,NG89,What are the recommended interventions for venous thromboembolism prevention in elective spinal surgery?
NG89_Recommendations: 1.12 Interventions for people having elective spinal surgery or cranial surgery or people with spinal injury - Part 2,NG89,What are the recommendations for VTE prophylaxis in patients undergoing cranial surgery?
NG89_Recommendations: 1.12 Interventions for people having elective spinal surgery or cranial surgery or people with spinal injury - Part 3 & Recommendations: 1.13 Interventions for people with major trauma,NG89,What are the recommendations for VTE prophylaxis in patients with intracranial hemorrhage or spinal injury?
"NG89_Recommendations: 1.14 Interventions for people having abdominal, thoracic or head and neck surgery - Part 1",NG89,What are the recommended interventions for preventing venous thromboembolism in patients undergoing abdominal or bariatric surgery?
"NG89_Recommendations: 1.14 Interventions for people having abdominal, thoracic or head and neck surgery - Part 2",NG89,What are the recommended methods for VTE prophylaxis in patients undergoing thoracic and head and neck surgery?
"NG89_Recommendations: 1.14 Interventions for people having abdominal, thoracic or head and neck surgery - Part 3",NG89,"What are the recommendations for VTE prophylaxis in oral, maxillofacial, and ENT surgery patients?"
NG89_Recommendations: 1.15 Interventions for people having cardiac or vascular surgery - Part 1,NG89,What are the recommended interventions for venous thromboembolism prevention in patients undergoing cardiac or vascular surgery?
NG89_Recommendations: 1.15 Interventions for people having cardiac or vascular surgery - Part 2 & Recommendations: 1.16 Interventions for pregnant women and women who gave birth or had a miscarriage or termination of pregnancy in the past 6 weeks,NG89,What are the recommended interventions for pregnant women and women within 6 weeks postpartum or after miscarriage or termination?
NG89_Recommendations: 1.16 Interventions for pregnant women and women who gave birth or had a miscarriage or termination of pregnancy in the past 6 weeks - Part 1,NG89,What are the recommendations for VTE prophylaxis with LMWH in women during pregnancy and postpartum within 6 weeks of delivery?
NG89_Recommendations: 1.16 Interventions for pregnant women and women who gave birth or had a miscarriage or termination of pregnancy in the past 6 weeks - Part 2,NG89,When should low molecular weight heparin be started and continued in pregnant women at risk of venous thromboembolism?
NG89_Recommendations: Terms used in this guideline,NG89,What are the recommended methods for preventing deep vein thrombosis in patients with lower limb immobilisation?
NG89_Recommendations for research: 1 Risk assessment,NG89,What is the accuracy of risk assessment tools for predicting venous thromboembolism and bleeding risk in hospitalized patients?
NG89_Recommendations for research: 2 Dose strategies for people who are obese,NG89,What is the clinical and cost effectiveness of weight-based versus fixed-dose low-molecular-weight heparin for VTE prevention in obese hospitalized patients?
NG89_Recommendations for research: 3 Direct oral anticoagulants for people with lower limb immobilisation,NG89,What is the clinical and cost effectiveness of direct oral anticoagulants for preventing venous thromboembolism in patients with lower limb immobilisation?
"NG89_Recommendations for research: 4 Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur",NG89,"What is the effectiveness of aspirin compared to other prophylactic treatments for fragility fractures of the pelvis, hip, or proximal femur?"
NG89_Recommendations for research: 5 Duration of prophylaxis for elective total hip replacement surgery,NG89,What is the clinical and cost effectiveness of standard versus extended duration pharmacological prophylaxis for preventing venous thromboembolism after elective total hip replacement?
NG89_Context,NG89,What are the recommended VTE prevention strategies for hospitalized patients?
NG90_Physical activity and the environment & Overview,NG90,How can the physical environment be improved to promote physical activity in communities?
"NG90_Recommendations: 1.1 Strategies, policies and plans to increase physical activity in the local environment - Part 1",NG90,What strategies and policies are recommended to promote physical activity and ensure accessibility for people with limited mobility in local environments?
"NG90_Recommendations: 1.1 Strategies, policies and plans to increase physical activity in the local environment - Part 2",NG90,What are the recommended practices for ensuring accessible street crossings and pedestrian routes to promote physical activity?
NG90_Recommendations: 1.2 Active travel - Part 1,NG90,What are effective strategies to promote active travel and improve infrastructure for walking and cycling?
NG90_Recommendations: 1.2 Active travel - Part 2,NG90,What are effective strategies for prioritizing pedestrians and cyclists when developing or maintaining streets and roads?
NG90_Recommendations: 1.2 Active travel - Part 3,NG90,What are NICE recommendations for improving accessibility and safety of footways and crossings for pedestrians with limited mobility?
NG90_Recommendations: 1.3 Public open spaces,NG90,What strategies can improve accessibility and safety of public open spaces for diverse communities?
NG90_Recommendations: 1.4 Buildings & Recommendations: 1.5 Schools,NG90,What are the recommended design features for promoting physical activity in school and campus buildings?
NG90_Recommendations: Terms used in this guideline,NG90,What is the definition of accessible crossings according to NICE guidelines?
NG90_Recommendations for research: Key recommendations for research - Part 1,NG90,What are the most effective public transport and public open space interventions to increase physical activity at a population level?
NG90_Recommendations for research: Key recommendations for research - Part 2,NG90,What evidence is available on the effectiveness and cost-effectiveness of environmental interventions to increase physical activity among groups with limited mobility?
NG90_Recommendations for research: Key recommendations for research - Part 3,NG90,What is the long-term impact of reducing car ownership on physical activity levels and health outcomes?
NG90_Recommendations for research: Other recommendations for research,NG90,What is the effectiveness of environmental interventions supported by behavioural interventions in promoting physical activity?
NG90_Context - Part 1,NG90,What are the recommended levels of physical activity for different age groups to prevent chronic health conditions?
NG90_Context - Part 2 & Glossary: Active travel,NG90,What are the environmental factors that support active travel and physical activity for people with limited mobility?
NG90_Glossary: Blue spaces & 12 more sections,NG90,What are the benefits of green and blue spaces for physical activity and mental health?
NG90_Glossary: Natural environment & 8 more sections,NG90,What is considered natural environment in public health guidelines?
NG91_Otitis media (acute): antimicrobial prescribing & 4 more sections,NG91,What are the current recommendations for antimicrobial prescribing in children with acute otitis media?
NG91_Recommendations: 1.1 Managing acute otitis media - Part 1,NG91,What are the recommended management strategies for acute otitis media in children?
NG91_Recommendations: 1.1 Managing acute otitis media - Part 2,NG91,What are the guidelines for prescribing antibiotics to children and young people with ear infections?
NG91_Recommendations: 1.1 Managing acute otitis media - Part 3 & Recommendations: 1.2 Choice of treatment,NG91,When should antibiotics be prescribed for children with acute otitis media and signs of serious complications?
NG91_Recommendations: 1.2 Choice of treatment - Part 1,NG91,What is the recommended treatment for children with acute otitis media according to NICE guidelines?
NG91_Recommendations: 1.2 Choice of treatment - Part 2 & Summary of the evidence,NG91,What are the recommended dosing guidelines for antibiotics in children with hepatic or renal impairment according to NICE?
NG91_Summary of the evidence: Non‑antimicrobial treatments & Summary of the evidence: Non‑antimicrobial treatments - Part 1,NG91,What is the effectiveness of paracetamol and ibuprofen in managing pain in children with acute otitis media?
NG91_Summary of the evidence: Non‑antimicrobial treatments - Part 2,NG91,What is the effectiveness and safety of eardrops containing an anaesthetic and analgesic for pain relief in children with ear infections?
NG91_Summary of the evidence: Non‑antimicrobial treatments - Part 3 & Summary of the evidence: Oral corticosteroids,NG91,What is the effectiveness of decongestants and antihistamines in treating acute otitis media in children?
NG91_Summary of the evidence: Oral corticosteroids - Part 1,NG91,Should oral corticosteroids be used to treat acute otitis media in children at risk of recurrence?
NG91_Summary of the evidence: Oral corticosteroids - Part 2 & Summary of the evidence: No antibiotic,NG91,What are the recommendations for using anaesthetic and analgesic ear drops in children with acute otitis media who do not require immediate antibiotics?
NG91_Summary of the evidence: No antibiotic - Part 1,NG91,Should antibiotics be prescribed for acute otitis media in children?
NG91_Summary of the evidence: No antibiotic - Part 2,NG91,What is the effectiveness of antibiotics in managing acute otitis media in children?
NG91_Summary of the evidence: No antibiotic - Part 3,NG91,What is the effectiveness of antibiotics in preventing late recurrence of acute otitis media in children?
NG91_Summary of the evidence: No antibiotic - Part 4 & Summary of the evidence: Back-up antibiotics,NG91,When should a backup antibiotic be prescribed for children with acute otitis media according to NICE guidelines?
NG91_Summary of the evidence: Back-up antibiotics - Part 1,NG91,What are the benefits and risks of back-up antibiotic prescriptions for children with acute otitis media?
NG91_Summary of the evidence: Back-up antibiotics - Part 2 & Summary of the evidence: Choice of antibiotic,NG91,What are the recommended antibiotic prescribing strategies for children with acute otitis media?
NG91_Summary of the evidence: Choice of antibiotic - Part 1,NG91,What is the most appropriate antibiotic choice for uncomplicated acute otitis media in children to minimize resistance?
NG91_Summary of the evidence: Choice of antibiotic - Part 2,NG91,What is the recommended first-line antibiotic for treating acute otitis media in children?
NG91_Summary of the evidence: Choice of antibiotic - Part 3 & Summary of the evidence: Antibiotic course length,NG91,What is the recommended duration of antibiotic treatment for children with bacterial infections according to NICE guidelines?
NG91_Summary of the evidence: Antibiotic course length - Part 1,NG91,What is the optimal duration of antibiotic treatment for acute otitis media in children?
NG91_Summary of the evidence: Antibiotic course length - Part 2 & Summary of the evidence: Antibiotic dose frequency,NG91,What is the recommended duration of antibiotic treatment for acute otitis media in children according to NICE guidelines?
NG91_Summary of the evidence: Antibiotic dose frequency & Other considerations,NG91,What is the most effective dosing frequency for amoxicillin and co-amoxiclav in treating infections?
NG93_Learning disabilities and behaviour that challenges: service design and delivery & Overview,NG93,What are the recommended approaches for designing services for people with learning disabilities and challenging behaviour?
NG93_Recommendations: Aims and principles,NG93,What are the principles for supporting individuals with learning disabilities and challenging behaviour to live independently?
NG93_Recommendations: 1.1 Achieving change: strategic planning and infrastructure - Part 1,NG93,What are the recommended strategies for local authorities and clinical commissioning groups to improve services for people with learning disabilities and behaviour that challenges?
NG93_Recommendations: 1.1 Achieving change: strategic planning and infrastructure - Part 2,NG93,What are best practices for planning and delivering services for people with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.1 Achieving change: strategic planning and infrastructure - Part 3,NG93,What are the recommended quality assurance measures for evaluating mental health or social care services?
NG93_Recommendations: 1.2 Enabling person-centred care and support - Part 1,NG93,What are the best practices for involving people with learning disabilities and behaviour that challenges in their care decisions?
NG93_Recommendations: 1.2 Enabling person-centred care and support - Part 2,NG93,What are the key principles for providing person-centred care to individuals with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.2 Enabling person-centred care and support - Part 3,NG93,What is the role of a named worker in supporting people with learning disabilities?
NG93_Recommendations: 1.2 Enabling person-centred care and support - Part 4,NG93,What are the recommended practices for reviewing care plans and developing behaviour support plans for people with learning disabilities?
NG93_Recommendations: 1.2 Enabling person-centred care and support - Part 5,NG93,What strategies and support options are recommended for managing behaviour that challenges in people with learning disabilities?
NG93_Recommendations: 1.3 Early intervention and support for families and carers - Part 1,NG93,What support and information are recommended for families and carers of individuals with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.3 Early intervention and support for families and carers - Part 2,NG93,What information should be provided to family members and carers about support services and how to access them?
"NG93_Recommendations: 1.4 Services in the community – prevention, early intervention and response - Part 1",NG93,What community services are recommended for prevention and early intervention in people with learning disabilities and challenging behaviour?
"NG93_Recommendations: 1.4 Services in the community – prevention, early intervention and response - Part 2",NG93,What are the recommended community interventions and support services for managing behaviour that challenges in people with learning disabilities?
"NG93_Recommendations: 1.4 Services in the community – prevention, early intervention and response - Part 3",NG93,What are the recommended approaches for commissioning and providing forensic community learning disability services to support individuals at risk of contact with the criminal justice system?
NG93_Recommendations: 1.5 Housing and related support - Part 1,NG93,What are the NICE recommendations for supporting adults with learning disabilities and challenging behaviour in choosing suitable housing options?
NG93_Recommendations: 1.5 Housing and related support - Part 2,NG93,What are the options for supported living arrangements for adults who need housing with care?
NG93_Recommendations: 1.6 Services for children and young people - Part 1,NG93,What support and services are recommended for children and young people with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.6 Services for children and young people - Part 2,NG93,What are the criteria for offering residential placements to children and young people with challenging behaviour according to NICE guidelines?
NG93_Recommendations: 1.6 Services for children and young people - Part 3,NG93,What are the recommended practices for supporting contact and planning for children in long-term residential care?
NG93_Recommendations: 1.7 Short break services,NG93,What are the NICE recommendations for providing short break services for children and adults with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.8 Making the right use of inpatient services - Part 1,NG93,What are the criteria for inpatient admission for people with learning disabilities and challenging behaviour?
NG93_Recommendations: 1.8 Making the right use of inpatient services - Part 2,NG93,What are the recommended psychological and environmental interventions for inpatient adults with challenging behaviour according to NICE guidelines?
NG93_Recommendations: 1.9 Staff skills and values,NG93,What are the recommended staff skills and training requirements for supporting children and adults with learning disabilities and challenging behaviour?
NG93_Recommendations: Terms used in this guideline - Part 1,NG93,What is the definition of learning disability according to NICE guidelines?
NG93_Recommendations: Terms used in this guideline - Part 2,NG93,What are the criteria for diagnosing learning disabilities and differentiating them from specific learning difficulties?
"NG93_Recommendations for research: 1 Models of person-centred support & Recommendations for research: 2 Supporting family members, carers and staff & Recommendations for research: 3 Models of supported living",NG93,What are the most effective models of person-centred support for people with learning disabilities and challenging behaviour?
NG93_Recommendations for research: 4 Effective components of integrated regional services for people with a learning disability and behaviour that challenges,NG93,What are the key components of effective integrated regional services for people with a learning disability and challenging behaviour?
NG93_Context - Part 1,NG93,What are the recommended approaches for managing behaviour that challenges in people with learning disabilities or autism?
NG93_Context - Part 2,NG93,What are the current NICE recommendations for transforming care for people with learning disabilities and challenging behaviour?
NG93_Context - Part 3,NG93,What are the recommended support and services for individuals with learning disabilities and autism who exhibit challenging behaviour?
NG93_Context - Part 4,NG93,How are NICE guidelines developed for managing challenging behaviour in people with learning disabilities?
NG94_Emergency and acute medical care in over 16s: service delivery and organisation & Overview,NG94,What are the recommended arrangements for emergency and acute medical care for adults over 16 in the community and hospital settings?
NG94_Recommendations: 1.1 Emergency and acute medical care in the community - Part 1,NG94,What are the recommended community-based emergency and acute care services to prevent hospital admissions?
NG94_Recommendations: 1.1 Emergency and acute medical care in the community - Part 2,NG94,What community-based multidisciplinary services are recommended for rehabilitation and palliative care in patients after a medical emergency?
NG94_Recommendations: 1.2 Emergency and acute medical care in hospital - Part 1,NG94,What are the recommended practices for managing hospital admissions and consultant reviews in emergency and acute medical care?
NG94_Recommendations: 1.2 Emergency and acute medical care in hospital - Part 2,NG94,What are the recommended practices for multidisciplinary care and ward management for patients admitted with a medical emergency?
NG94_Recommendations: 1.2 Emergency and acute medical care in hospital - Part 3,NG94,What are the best practices for handovers and transfer procedures for critically ill patients in hospital settings?
NG94_Recommendations: 1.3 Planning emergency and acute care services,NG94,What are best practices for monitoring hospital bed occupancy and managing escalation policies to improve emergency and acute care?
NG94_Recommendations for research: Key recommendations for research - Part 1,NG94,What is the clinical and cost effectiveness of extended access to GP and social care services outside standard hours?
NG94_Recommendations for research: Key recommendations for research - Part 2,NG94,What is the most effective way to organize services for assessing frail older patients presenting with medical emergencies?
NG94_Recommendations for research: Key recommendations for research - Part 3,NG94,What is the clinical and cost effectiveness of specialised elderly care assessment units for older patients with multimorbidity and frailty?
NG94_Recommendations for research: Other recommendations for research - Part 1,NG94,What are the most effective models for primary care assessment of suspected medical emergencies in the community?
NG94_Recommendations for research: Other recommendations for research - Part 2,NG94,What are the recommended practices for community nursing and urgent care services in primary care?
NG94_Context,NG94,What are the best practices for organising and delivering emergency and acute medical care services?
NG95_Lyme disease & Overview & Recommendations: 1.1 Awareness of Lyme disease,NG95,What are the recommended methods for preventing Lyme disease after tick bites?
NG95_Recommendations: 1.2 Diagnosis - Part 1,NG95,What are the clinical features and diagnostic criteria for Lyme disease?
NG95_Recommendations: 1.2 Diagnosis - Part 2,NG95,When should I consider testing and treating for Lyme disease in patients with symptoms but no clear tick exposure?
NG95_Recommendations: 1.2 Diagnosis - Part 3,NG95,What are the recommended testing procedures for diagnosing Lyme disease according to NICE guidelines?
NG95_Recommendations: 1.2 Diagnosis - Part 4,NG95,What should patients and healthcare professionals know about the limitations of Lyme disease testing?
NG95_Recommendations: 1.3 Management - Part 1,NG95,What is the recommended management and specialist referral process for Lyme disease in children and adults?
NG95_Recommendations: 1.3 Management - Part 2,NG95,What are the recommended antibiotic treatments for different manifestations of Lyme disease?
NG95_Recommendations: 1.3 Management - Part 3,NG95,What are the recommended antibiotic treatments for Lyme disease in children under 12 years old?
NG95_Recommendations: 1.3 Management - Part 4,NG95,Why should azithromycin be avoided in patients with cardiac abnormalities and Lyme disease?
NG95_Recommendations: 1.3 Management - Part 5 & Recommendations: 1.3 Management - Part 6 & Recommendations: 1.3 Management - Part 7,NG95,What should be done if symptoms of Lyme disease persist after completing antibiotic treatment?
NG95_Recommendations: 1.3 Management - Part 8,NG95,What are the recommended approaches for managing ongoing symptoms after Lyme disease treatment?
NG95_Recommendations: 1.3 Management - Part 9,NG95,What is the recommended management of Lyme disease during pregnancy and its implications for the baby?
NG95_Recommendations: 1.4 Information for people with Lyme disease,NG95,What should patients with Lyme disease know about treatment and recovery?
NG95_Recommendations: Terms used in this guideline,NG95,What is the Jarisch–Herxheimer reaction and how is it managed in Lyme disease treatment?
NG95_Recommendations for research: 1 Core outcome set for studies of management of Lyme disease - Part 1,NG95,Should a core outcome set be developed for clinical trials on Lyme disease management?
NG95_Recommendations for research: 1 Core outcome set for studies of management of Lyme disease - Part 2,NG95,What are the recommended management strategies for neuroborreliosis according to NICE guidelines?
NG95_Recommendations for research: 2 Clinical epidemiology of Lyme disease in the UK,NG95,"What is the incidence, clinical presentation, management, and outcomes of Lyme disease in the UK?"
NG95_Recommendations for research: 3 Seroprevalence of Lyme disease-specific antibodies and other tick-borne infections in the UK population,NG95,What is the seroprevalence of Lyme disease antibodies and tick-borne infections in the UK population?
NG95_Recommendations for research: 4 Antimicrobial management of Lyme disease - Part 1,NG95,What are the most effective antimicrobial treatments for different presentations of Lyme disease in the UK?
NG95_Recommendations for research: 5 Laboratory tests to diagnose initial and ongoing infection and determine re‑infection in the different presentations of Lyme disease in the UK,NG95,What is the most effective and cost-effective serological test for diagnosing Lyme disease in the UK at all stages?
NG95_Rationale and impact: Awareness of Lyme disease,NG95,What are the key signs and risk factors to consider for early diagnosis of Lyme disease?
NG95_Rationale and impact: Clinical assessment,NG95,What are the clinical signs and symptoms used to diagnose Lyme disease?
NG95_Rationale and impact: Laboratory investigations - Part 1,NG95,What are the recommended laboratory tests for diagnosing Lyme disease?
NG95_Rationale and impact: Laboratory investigations - Part 2,NG95,What are the recommended laboratory testing procedures for diagnosing Lyme disease?
NG95_Rationale and impact: Emergency referral and specialist advice,NG95,When should Lyme disease be considered for emergency referral in patients with neurological or cardiac symptoms?
NG95_Rationale and impact: Antibiotic treatment - Part 1,NG95,What is the recommended antibiotic treatment for Lyme disease with erythema migrans in adults and children?
NG95_Rationale and impact: Antibiotic treatment - Part 2,NG95,What is the recommended duration of antibiotic treatment for Lyme disease?
NG95_Rationale and impact: Antibiotic treatment - Part 3,NG95,What are the recommended antibiotic treatments and durations for Lyme disease affecting the nervous system and joints in adults and children?
NG95_Rationale and impact: Antibiotic treatment - Part 4,NG95,What are the recommended antibiotic treatments and durations for Lyme disease and its manifestations in children and young people?
NG95_Rationale and impact: Antibiotic treatment - Part 5,NG95,What is the recommended antibiotic treatment for adults and children with Lyme disease-associated carditis?
NG95_Rationale and impact: Ongoing symptoms after a course of antibiotics,NG95,What is the recommended management for ongoing symptoms after a course of antibiotics for Lyme disease?
NG95_Rationale and impact: Non-antibiotic management of ongoing symptoms,NG95,What are the recommended non-antibiotic approaches for managing ongoing symptoms of Lyme disease?
NG95_Rationale and impact: Management for women with Lyme disease during pregnancy and their babies,NG95,What is the recommended management of Lyme disease in pregnant women and their babies?
NG95_Rationale and impact: Information for people with Lyme disease,NG95,"What information should be provided to patients with suspected or confirmed Lyme disease about testing, treatment, and follow-up?"
NG95_Context - Part 1,NG95,What are the recommended diagnostic and management approaches for Lyme disease in the UK?
NG95_Context - Part 2,NG95,What are the recommended approaches for diagnosing and treating Lyme disease in the UK?
NG96_Care and support of people growing older with learning disabilities & Overview,NG96,What are the recommended approaches for supporting older adults with learning disabilities?
NG96_Recommendations: 1.1 Overarching principles - Part 1,NG96,What are the principles for ensuring accessible and person-centred care for older people with learning disabilities?
NG96_Recommendations: 1.1 Overarching principles - Part 2,NG96,How can healthcare providers support effective communication and decision-making for people with learning disabilities?
NG96_Recommendations: 1.1 Overarching principles - Part 3,NG96,How should health and social care practitioners involve and support people with learning disabilities in decision-making and care planning?
NG96_Recommendations: 1.2 Organising and delivering care and support - Part 1,NG96,What are recommended housing and support options for older adults with learning disabilities?
NG96_Recommendations: 1.2 Organising and delivering care and support - Part 2,NG96,What strategies are recommended to improve access to community health and social services for people with learning disabilities?
NG96_Recommendations: 1.3 Identifying and assessing care and support needs - Part 1,NG96,What are the best practices for assessing care and support needs in people with learning disabilities?
NG96_Recommendations: 1.3 Identifying and assessing care and support needs - Part 2,NG96,How can practitioners support the needs of family members and carers of people with learning disabilities?
NG96_Recommendations: 1.4 Planning and reviewing care and support - Part 1,NG96,What are the key considerations for planning and reviewing care for older adults with learning disabilities?
NG96_Recommendations: 1.4 Planning and reviewing care and support - Part 2,NG96,"What are the key considerations for planning future care, housing, and legal arrangements for adults with support needs?"
NG96_Recommendations: 1.5 Identifying and managing health needs - Part 1,NG96,What strategies can healthcare practitioners use to support people with learning disabilities during medical appointments?
NG96_Recommendations: 1.5 Identifying and managing health needs - Part 2,NG96,What are the recommended health checks and screening procedures for older people with learning disabilities?
NG96_Recommendations: 1.5 Identifying and managing health needs - Part 3,NG96,How can primary care services improve access and communication for older people with learning disabilities to ensure they receive appropriate screening and dental care?
NG96_Recommendations: 1.5 Identifying and managing health needs - Part 4,NG96,What are best practices for preparing adults with learning disabilities for hospital admissions and transfers?
NG96_Recommendations: 1.5 Identifying and managing health needs - Part 5,NG96,What are the recommended procedures for discharging patients with learning disabilities or dementia from hospital?
NG96_Recommendations: 1.6 End of life care - Part 1,NG96,What are best practices for providing person-centred end of life care for people with learning disabilities?
NG96_Recommendations: 1.6 End of life care - Part 2,NG96,How can healthcare providers effectively involve family and carers in end of life care planning?
NG96_Recommendations: 1.7 Staff skills and expertise - Part 1,NG96,What skills and training should staff have to support older people with learning disabilities?
NG96_Recommendations: 1.7 Staff skills and expertise - Part 2,NG96,What training and skills are recommended for staff supporting end of life care for people with learning disabilities?
NG96_Recommendations: Terms used in this guideline - Part 1,NG96,What is an annual health check and how is it used for adults with learning disabilities?
NG96_Recommendations: Terms used in this guideline - Part 2,NG96,What are the key considerations for supporting older people with learning disabilities?
NG96_Recommendations for research: 1 Models of care and support at home,NG96,What is the effectiveness and cost effectiveness of assistive technology and other care models for supporting older people with learning disabilities living at home?
NG96_Recommendations for research: 2 Identifying health conditions,NG96,What are the most effective and cost-effective methods for early identification of health conditions in older adults with learning disabilities?
NG96_Recommendations for research: 3 Education and training programmes: self-management,NG96,What is the effectiveness and cost-effectiveness of education programs to support self-management of chronic health conditions in older people with learning disabilities?
NG96_Recommendations for research: 4 Dementia education and training programmes for family members and carers & Recommendations for research: 5 Advance planning about end of life care,NG96,What is the effectiveness of dementia training programmes for family members and carers of people with learning disabilities?
NG96_Context - Part 1,NG96,What are the healthcare needs and considerations for older people with learning disabilities?
NG96_Context - Part 2,NG96,How can healthcare providers improve access to sensory checks and appropriate housing for older adults with learning disabilities?
NG96_Context - Part 3,NG96,What are the recommended care practices for adults with learning disabilities across different care settings?
"NG97_Dementia: assessment, management and support for people living with dementia and their carers & Overview",NG97,What are the recommended strategies for supporting people living with dementia and their carers?
NG97_About this guideline: Why is it needed? & About this guideline: What does it cover?,NG97,What are the current evidence-based recommendations for diagnosing and assessing dementia?
NG97_About this guideline: How has it been developed?,NG97,How are NICE dementia guidelines developed and what is the evidence basis for their recommendations?
NG97_About this guideline: How does it relate to statutory and non-statutory guidance? - Part 1,NG97,How does the NICE guideline on dementia align with the Care Act 2014 and other statutory guidance?
NG97_About this guideline: How does it relate to statutory and non-statutory guidance? - Part 2,NG97,What are the key legal and policy frameworks for dementia care in the UK?
NG97_Person-centred care,NG97,What are the key principles of person-centred care for people living with dementia?
NG97_Recommendations: 1.1 Involving people living with dementia in decisions about their care - Part 1,NG97,What are effective strategies for involving people with dementia in their care decisions?
NG97_Recommendations: 1.1 Involving people living with dementia in decisions about their care - Part 2,NG97,What are the recommended practices for discussing advance care planning with people living with dementia?
NG97_Recommendations: 1.2 Diagnosis - Part 1,NG97,What are the recommended initial assessment procedures for suspected dementia in non-specialist settings?
NG97_Recommendations: 1.2 Diagnosis - Part 2,NG97,What are the recommended tests for diagnosing Alzheimer's disease and its subtypes?
NG97_Recommendations: 1.2 Diagnosis - Part 3,NG97,What are the recommended diagnostic tests for uncertain cases of Alzheimer's disease and other dementias?
NG97_Recommendations: 1.2 Diagnosis - Part 4,NG97,What are the recommended imaging methods for diagnosing vascular dementia?
NG97_Recommendations: 1.3 Care coordination,NG97,What are the key components of care coordination for people living with dementia according to NICE guidelines?
"NG97_Recommendations: 1.4 Interventions to promote cognition, independence and wellbeing",NG97,What interventions are recommended to support cognition and wellbeing in people with mild to moderate dementia?
NG97_Recommendations: 1.5 Pharmacological interventions for dementia - Part 1,NG97,What are the recommended pharmacological treatments for mild to moderate Alzheimer's disease?
NG97_Recommendations: 1.5 Pharmacological interventions for dementia - Part 2,NG97,What are the NICE recommendations for prescribing acetylcholinesterase inhibitors and memantine in Alzheimer's disease management?
NG97_Recommendations: 1.5 Pharmacological interventions for dementia - Part 3,NG97,Which medications are recommended or not recommended for managing different types of dementia according to NICE guidelines?
NG97_Recommendations: 1.6 Medicines that may cause cognitive impairment,NG97,Which medications are associated with increased risk of cognitive impairment due to anticholinergic effects?
NG97_Recommendations: 1.7 Managing non-cognitive symptoms - Part 1,NG97,What are the recommended approaches for managing agitation and psychosis in people with dementia?
NG97_Recommendations: 1.7 Managing non-cognitive symptoms - Part 2,NG97,What are the recommended practices for initiating and managing antipsychotic treatment in people with dementia?
NG97_Recommendations: 1.7 Managing non-cognitive symptoms - Part 3,NG97,What are the recommended approaches for managing agitation and depression in people with dementia?
NG97_Recommendations: 1.8 Assessing and managing other long-term conditions in people living with dementia - Part 1,NG97,What are recommended strategies for assessing and managing long-term conditions and pain in people living with dementia?
NG97_Recommendations: 1.8 Assessing and managing other long-term conditions in people living with dementia - Part 2,NG97,What are the recommended HbA1c targets for people with severe dementia and type 2 diabetes?
NG97_Recommendations: 1.9 Risks during hospital admission,NG97,What are the risks associated with hospital admission for people living with dementia?
NG97_Recommendations: 1.10 Palliative care,NG97,What are the recommendations for palliative care and end-of-life planning for people living with dementia?
NG97_Recommendations: 1.11 Supporting carers,NG97,What support and training should be offered to carers of people with dementia?
NG97_Recommendations: 1.12 Moving to different care settings,NG97,What are the recommended practices for managing transitions between care settings for people with dementia?
NG97_Recommendations: 1.13 Staff training and education,NG97,What training should healthcare staff receive to provide person-centred dementia care?
NG97_Recommendations: Terms used in this guideline - Part 1,NG97,What are the recommended approaches for managing aggression in Alzheimer's disease?
NG97_Recommendations: Terms used in this guideline - Part 2,NG97,What are the recommended referral options for diagnosing dementia in community settings?
NG97_Recommendations for research: 2 Staff training & 3 more sections,NG97,What are the most effective non-pharmacological interventions for long-term recovery in people with delirium superimposed on dementia?
NG98_Hearing loss in adults: assessment and management & Overview,NG98,What are the recommended approaches for assessing and managing hearing loss in adults?
NG98_Recommendations: 1.1 Assessment and referral - Part 1,NG98,What are the recommended referral procedures for adults with sudden or rapid onset hearing loss?
NG98_Recommendations: 1.1 Assessment and referral - Part 2,NG98,When should adults with hearing loss be referred to ENT or audiology services according to NICE guidelines?
NG98_Recommendations: 1.2 Removing earwax & Recommendations: 1.3 Investigation using MRI,NG98,What are the recommended methods for earwax removal in adults with hearing loss?
NG98_Recommendations: 1.4 Treating idiopathic sudden sensorineural hearing loss & Recommendations: 1.5 Assessment and management in audiology services,NG98,What are the recommended assessments and management options for adults with idiopathic sudden sensorineural hearing loss?
"NG98_Recommendations: 1.6 Hearing aids, assistive listening devices and implantable devices",NG98,What are the recommendations for offering and fitting hearing aids and assistive listening devices for adults with hearing loss?
NG98_Recommendations: 1.7 Follow-up in audiology services,NG98,What is the recommended follow-up process for adults after hearing aid fitting according to NICE guidelines?
NG98_Recommendations: 1.8 Information and support & Recommendations: Terms used in this guideline,NG98,How can healthcare providers improve communication and support for patients with hearing loss in NHS services?
NG98_Recommendations for research: 1 Idiopathic sudden sensorineural hearing loss,NG98,What is the most effective route of steroid administration as a first-line treatment for idiopathic sudden sensorineural hearing loss?
NG98_Recommendations for research: 2 Earwax,NG98,What is the most effective method for earwax removal: microsuction or irrigation?
NG98_Recommendations for research: 3 Use of hearing aids and incidence of dementia,NG98,Does using hearing aids reduce the risk of developing dementia in adults with hearing loss?
NG98_Recommendations for research: 4 Hearing loss prevalence in people who under-present for hearing loss & Recommendations for research: 5 Monitoring and follow-up for adults with hearing loss,NG98,What is the prevalence of hearing loss among populations who under-present for hearing loss?
NG98_Context,NG98,What are the recommended referral criteria and management strategies for adults with hearing loss according to NICE guidelines?
NG99_Brain tumours (primary) and brain metastases in over 16s & Overview,NG99,What are the recommended approaches for diagnosing and managing primary brain tumours and brain metastases in people aged 16 and over?
NG99_Recommendations: 1.1 Investigation of suspected glioma - Part 1,NG99,What are the recommended imaging techniques and specialist referral procedures for suspected glioma?
NG99_Recommendations: 1.1 Investigation of suspected glioma - Part 2,NG99,What molecular markers should be tested in glioma specimens according to NICE guidelines?
NG99_Recommendations: 1.2 Management of glioma - Part 1,NG99,What are the recommended management strategies for low-grade glioma according to NICE guidelines?
NG99_Recommendations: 1.2 Management of glioma - Part 2,NG99,What is the recommended post-surgical treatment for low-grade glioma with 1p/19q non-codeletion and IDH mutation in patients aged 40 or over?
NG99_Recommendations: 1.2 Management of glioma - Part 3,NG99,What is the recommended sequence of radiotherapy and chemotherapy for treating grade 3 glioma with 1p/19q codeletion?
NG99_Recommendations: 1.2 Management of glioma - Part 4,NG99,What is the recommended radiotherapy and temozolomide treatment for newly diagnosed grade 4 glioma in patients aged around 70 or over?
NG99_Recommendations: 1.2 Management of glioma - Part 5,NG99,What are the recommended treatment options for newly diagnosed grade 4 glioma (glioblastoma) in patients aged 70 or over with poor performance status?
NG99_Recommendations: 1.2 Management of glioma - Part 6,NG99,What are the recommended treatment options for recurrent high-grade glioma according to NICE guidelines?
NG99_Recommendations: 1.2 Management of glioma - Part 7,NG99,What are the recommended surgical techniques and intraoperative adjuncts for glioma resection according to NICE guidelines?
NG99_Recommendations: 1.3 Follow-up for glioma - Part 1,NG99,What is the recommended follow-up schedule and imaging approach for patients with glioma?
NG99_Recommendations: 1.3 Follow-up for glioma - Part 2,NG99,What is the recommended MRI follow-up schedule for different grades of glioma after treatment?
NG99_Recommendations: 1.4 Investigation and management of meningioma - Part 1,NG99,What are the recommended investigations and management options for meningioma according to NICE guidelines?
NG99_Recommendations: 1.4 Investigation and management of meningioma - Part 2,NG99,What factors should be considered when deciding on radiotherapy for meningioma treatment?
NG99_Recommendations: 1.4 Investigation and management of meningioma - Part 3,NG99,What factors should be considered when choosing radiotherapy techniques for meningioma treatment?
NG99_Recommendations: 1.5 Follow-up for meningioma - Part 1,NG99,What is the recommended follow-up schedule and imaging approach for meningioma management?
NG99_Recommendations: 1.5 Follow-up for meningioma - Part 2,NG99,What is the recommended follow-up schedule for meningioma patients based on tumor grade and time since treatment?
NG99_Recommendations: 1.6 Investigation of suspected brain metastases,NG99,What is the recommended imaging approach for diagnosing suspected brain metastases?
NG99_Recommendations: 1.7 Management of confirmed brain metastases - Part 1,NG99,What are the factors to consider when choosing between surgery and stereotactic radiosurgery for a single brain metastasis?
NG99_Recommendations: 1.7 Management of confirmed brain metastases - Part 2,NG99,When should stereotactic radiosurgery be considered for patients with multiple brain metastases?
NG99_Recommendations: 1.7 Management of confirmed brain metastases - Part 3,NG99,What are the benefits and risks of whole-brain radiotherapy for patients with multiple brain metastases?
NG99_Recommendations: 1.8 Follow-up for brain metastases - Part 1,NG99,What are the recommended follow-up strategies and considerations for patients with brain metastases?
NG99_Recommendations: 1.8 Follow-up for brain metastases - Part 2,NG99,What is the recommended follow-up imaging schedule for patients with brain metastases?
NG99_Recommendations: 1.9 Care needs of people with brain tumours - Part 1,NG99,What are the recommended approaches for supporting the care needs of people with brain tumours and their families?
NG99_Recommendations: 1.9 Care needs of people with brain tumours - Part 2,NG99,What are the NICE guidelines for informing patients with brain tumours about driving restrictions and legal obligations?
NG99_Recommendations: 1.10 Neurorehabilitation needs of people with brain tumours,NG99,What are the recommendations for neurological rehabilitation assessment and support for people with brain tumours?
NG99_Recommendations: 1.11 Surveillance for the late-onset side effects of treatment - Part 1,NG99,What are the recommended surveillance strategies for late-onset side effects in brain tumour patients after treatment?
NG99_Recommendations: 1.11 Surveillance for the late-onset side effects of treatment - Part 2 & Recommendations: Terms used in this guideline,NG99,When should neuropsychology assessments and referrals be considered for people with brain tumours?
NG99_Recommendations for research: Key recommendations for research - Part 1,NG99,Does adding a dedicated supportive care clinic improve outcomes for patients with low-grade glioma?
NG99_Recommendations for research: Key recommendations for research - Part 2,NG99,What are the benefits of early palliative care referral for patients with glioblastoma?
NG99_Recommendations for research: Key recommendations for research - Part 3,NG99,Does early detection of glioma recurrence after treatment improve survival and quality of life?
NG99_Recommendations for research: Key recommendations for research - Part 4,NG99,Should radiotherapy be administered immediately or deferred in cases of incompletely excised grade 1 meningioma?
NG99_Rationale and impact: Investigations for suspected glioma: imaging,NG99,What is the recommended MRI protocol for diagnosing suspected glioma?
NG99_Rationale and impact: Investigations for suspected glioma: molecular markers,NG99,What are the recommended molecular markers for glioma prognosis and treatment guidance?
NG99_Rationale and impact: Management of glioma: initial surgery for low-grade glioma,NG99,What are the recommended surgical management options for low-grade glioma according to NICE guidelines?
NG99_Rationale and impact: Management of glioma: further management of low-grade glioma & Rationale and impact: Management of glioma: grade 3 glioma following surgery,NG99,What are the recommended management strategies for grade 3 glioma following surgery according to NICE guidelines?
NG99_Rationale and impact: Management of glioma: grade 3 glioma following surgery & Rationale and impact: Management of glioma: grade 4 glioma following surgery,NG99,What are the recommended treatments for grade 3 glioma after surgery according to NICE guidelines?
NG99_Rationale and impact: Management of glioma: grade 4 glioma following surgery - Part 1,NG99,What is the recommended management of grade 4 glioma following surgery?
NG99_Rationale and impact: Management of glioma: grade 4 glioma following surgery - Part 2,NG99,Which treatments are not recommended for glioma management according to NICE guidelines?
NG99_Rationale and impact: Management of glioma: recurrent high-grade glioma,NG99,What are the recommended treatment options for recurrent high-grade glioma?
NG99_Rationale and impact: Management of glioma: techniques for resection of glioma,NG99,What are the recommended techniques for safe and effective glioma resection?
NG99_Rationale and impact: Follow-up for glioma,NG99,What is the recommended follow-up schedule and imaging protocol for glioma patients?
NG99_Rationale and impact: Investigation of suspected meningioma,NG99,What is the recommended imaging approach for diagnosing suspected meningioma?
NG99_Rationale and impact: Management of confirmed meningioma following surgery or if surgery is not possible (or has been declined) - Part 1,NG99,What are the recommended management options for confirmed meningioma after surgery or when surgery is not possible?
NG99_Rationale and impact: Management of confirmed meningioma following surgery or if surgery is not possible (or has been declined) - Part 2 & Rationale and impact: Investigation of suspected brain metastases,NG99,What are the recommended approaches for delivering radiotherapy or radiosurgery in meningioma treatment?
NG99_Rationale and impact: Management of confirmed brain metastases,NG99,What are the recommended treatment options for managing confirmed brain metastases according to NICE guidelines?
NG99_Rationale and impact: Follow-up for brain metastases,NG99,What is the recommended follow-up schedule and imaging protocol for patients with brain metastases?
NG99_Rationale and impact: Care needs of people with brain tumours,NG99,What are the specific care needs of people with brain tumours and how can they be better supported?
NG99_Rationale and impact: Neurorehabilitation needs of people with brain tumours,NG99,What are the recommended approaches for assessing neurorehabilitation needs in people with brain tumours?
NG99_Rationale and impact: Surveillance for the late-onset side effects of treatment,NG99,What are the recommended strategies for monitoring late-onset side effects in patients treated for brain tumours?
NG99_Context - Part 1,NG99,What are the current recommendations for diagnosing and managing primary brain tumours?
NG99_Context - Part 2,NG99,What are the recommended management strategies for brain tumours in older adults and young adults transitioning from paediatric care?
NG9_Bronchiolitis in children: diagnosis and management & Overview,NG9,What are the recommended management strategies for bronchiolitis in children?
NG9_Recommendations: 1.1 Assessment and diagnosis - Part 1,NG9,What are the clinical features and diagnostic criteria for bronchiolitis in infants and young children?
NG9_Recommendations: 1.1 Assessment and diagnosis - Part 2,NG9,"How can I differentiate between viral-induced wheeze, early-onset asthma, and bronchiolitis in infants and young children?"
NG9_Recommendations: 1.2 When to refer - Part 1,NG9,When should babies and children with bronchiolitis be referred to hospital?
NG9_Recommendations: 1.2 When to refer - Part 2,NG9,What are the criteria for referring a child with bronchiolitis to secondary care?
NG9_Recommendations: 1.3 When to admit - Part 1,NG9,When should a child with bronchiolitis be admitted to hospital?
NG9_Recommendations: 1.3 When to admit - Part 2,NG9,What factors should be considered when deciding to admit a child with bronchiolitis?
NG9_Recommendations: 1.4 Management of bronchiolitis - Part 1,NG9,What are the recommended management strategies for bronchiolitis in babies and children?
NG9_Recommendations: 1.4 Management of bronchiolitis - Part 2,NG9,What are the recommended airway management and fluid therapy practices for infants with bronchiolitis?
NG9_Recommendations: 1.5 When to discharge,NG9,What are the criteria for discharging babies and children from hospital with bronchiolitis?
NG9_Recommendations: 1.6 Key safety information for looking after a baby or child at home & Recommendations for research: 1 Oxygen saturation measurement in primary care,NG9,What are the key safety signs and when should I seek immediate help for a baby with bronchiolitis at home?
NG9_Recommendations for research: 2 Paediatric early warning score (PEWS) as a predictor of deterioration & 3 more sections,NG9,Is the paediatric early warning score (PEWS) effective in predicting deterioration in infants with bronchiolitis?
NG9_Rationale and impact: When to refer - Part 1,NG9,What are the criteria for referring babies and children to hospital based on oxygen saturation levels?
NG9_Rationale and impact: When to refer - Part 2,NG9,How do the updated oxygen saturation thresholds influence referral and discharge decisions for babies and children?
NG9_Rationale and impact: When to admit,NG9,When should babies and children be admitted for bronchiolitis based on oxygen saturation levels?
NG9_Rationale and impact: Management of bronchiolitis,NG9,What is the recommended oxygen saturation threshold for discharging children with bronchiolitis?
NG9_Context,NG9,What are the recommended management strategies for bronchiolitis in infants and children?
